>ZF Recording 2016-06-02; tW: 300s; Start: 155737; End: 160240;
Recording: 1-1; Individual: 1; Drug: PCAP814 10 然 Apo 50 然
bLsbRgLsbLhbLsbLgbLsbRgbLgbLgbsbsbsbRsbLsbLsLsmbLgbLsRebRgbsbsbsbRsbsb
sbLsbLoLibRgbLsLgbLgbRebsbLoLsmbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 155737; End: 160240;
Recording: 1-1; Individual: 2; Drug: PCAP814 10 然 Apo 50 然
bRsbRjbRsbRebRjbLjbRsbsbRjbLebRebRsbRgbRjbsbLjbLebRsbsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 155737; End: 160240;
Recording: 1-1; Individual: 3; Drug: PCAP814 10 然 Apo 50 然
bLiLsbLoLsmbLjbLcbLobLobLobLsbLebLsbRiLsbRgLsbReRsRsmmbRcbRgRgbRibRibs
bLsLebLcLsmbLgbLoRobRibRgbLiLsbRiRiRsmbLebRsbLcLcRsbLsbLsbLsbsbRsLsRsb
sbRsLsbRiLsbLsLcRsbLcLsRsLsRsmbRsRsmbLsbRsRsmbRsbRgRsmbRiRsmbsbRsbsbRg
RsmbRsbsbsbRgRsmbLhLoRsbsbLcbLcbLgbRsbLsRsbLibLibLsLsLsLsmmmbLcbRcbLhb
LcbsbRsLgLsbRoRsmbRcbRcRsmbRcbRoRsRembsbsbRoRsmbLjbRobsbRsLsLsmbsbLsbR
sbRgLjbRebRsbRsbLsbsbsbRcbLiLsbsbLebRsbLeLsbRsLcbsbRcbLibRsbLcLsmbLsbL
cbRgbRibRsRsRgRsRsmmmbRgRsmbsbsbReLsLsmbLgbsbsbLgLsbLcLsLsmmbRsLsbLgLg
bRebRcbRcRsmbRsbLjbLgbRebRcbRcbRsbRsLsbLobRsLebRsbLsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 155737; End: 160240;
Recording: 1-1; Individual: 4; Drug: PCAP814 10 然 Apo 50 然
bRgbLjbLsLsmbRjbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 155737; End: 160240;
Recording: 1-1; Individual: 5; Drug: PCAP814 10 然 Apo 50 然
bRsRsmbRsbRsbRsRsmbRibLcRhbRcRibLgbLibRsbRsbLebRgbsbRsRsmbRsRsmbsbLebL
cbRsbLibLhLcbLsbLebRcbRebRcRsmbRsbRjbLibRebRgLcLeLsbLeRsbLebLebRsRsmbR
sbLsLsLsmmbLsbRoRsLsmbLgbLeLobRcbLiRsbRsbRcbsbsbsbRsRsmbLgbsbLibLsbsbR
sbLibLcbRsRsmbRsbRiLcbRcbRcLsbLcLcbLoLsmbLsLoLsmbsbLsLsmbLcbLibLcbRjbR
obLobLcLsmbLebLebsbLgLsbLibsbLgbLsRsLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 155737; End: 160240;
Recording: 1-1; Individual: 6; Drug: PCAP814 10 然 Apo 50 然
bLsbLsbLsRsbLjbRsbsbRsLsbLsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 155737; End: 160240;
Recording: 1-1; Individual: 7; Drug: PCAP814 3 然 Apo 50 然
bLgbsbLibLsbLsRsbLgLsbLiRsbRsbRsRsmbLoRsbLobRsbRsbLsbLoRsRsmbRsLsbLobs
bLibRsbLobsbLsbLsbLcLsmbLsRsbRgbLiLsbLibsbLgbLsbRsLcbLsbLcbLibRsbLibLg
bLsbLibLsbLsbLoRsbLsbLobLcbRgbLsLsmbLibLgLsbLgbRsbLiRsbLgLiRsRsmbLibRs
bLibLsbLgbLgLsbLgbLgbLiRsLsbRgbLibLsbLgLsbLgbLgLsbLgbLgLsbLgbRsbLibLsb
RsLsbLgbLiLsbLgbLgRsbLhbRibRcbsbLcbLhbLsbLsbLibLsLsmbLgbRsbLgbLsRsbLgb
sbLsbLsbLgLsbLgbLcbRibRhbRgbRsbRgbRsbRgbRsbRgbRgLsbRgRsmbRgRsLsmbRgbRi
bRgbRgbLobLibRebRsbRhRsmbRsbRgRsmbRsbRgbLgbRibRgbRgbRsbRsRgLsbRgbRgbLj
bRsLibLiLsbLsRsbLgLsbLibLsbLgRsbLsbLsLsmbLibRsLsbLsLsLgmbLsbsbLgLsbLsb
LsbLgLsbLsLsmbLgLsbLgLsbLgbLgbLgbLsbLibLgbLibRsRsmbRsLsbLibLsLsLsmmbLs
bLgbLsbLgbLsLsmbLgbLsbLgbLsbLsLsmbLsbLsbLgbRsbLsbsbRsbLsbLsbRsbRsbLibL
sbLsLsmbLjbLsbsbsbLgbRsRsRsmmbLibRgLsbLsbRsLsbRsLsbRsbsbLsRsbsbLgLsbLg
LsbLgLsbRsLsLsmbLiLsbsbLsbLsLsLsmmbLgLsbLsbsbsbLsLsLsmmbLsLgRsLsbsbLsL
gbLgbLjLsLsmmbLsLsmbLgbsbLsRsbLgLsLsLsmmbLgbLgbLgLsbLgbLgbLgbsbLsLsLsm
mbsbLgLsbsbLsLsLsmmbLgbLsLsmbLsbLsbLsLsmbLsbLgbLsLsLsLsLsmmmmbLsbLgbLs
LsLsmmbLsbLgLsLsmbLgbLgLsbLsbLgbLsLsLsmmbLsbLsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 155737; End: 160240;
Recording: 1-1; Individual: 8; Drug: PCAP814 3 然 Apo 50 然
bLgbRsbLibsbLsLsmbsbRsLsbLibsbLibRobLgbLsLibRsbsbsbLsLgLsbLgbsbsbRsbsb
sbsbLsbsbLsLsLsmmb

>ZF Recording 2016-06-02; tW: 300s; Start: 155737; End: 160240;
Recording: 1-1; Individual: 9; Drug: PCAP814 3 然 Apo 50 然
bRsRsmbRobRhRcbRobsbRgbRibRsbRiLsbRgbRgRhLsLsRimbRsbLsbLibLgLsbLsLsmbL
gbLgLsbLsbLiLsbLobRibRsbRsRsmbRsbRgbRsbRsRsmbRsbRgLsbRibRsbRgbRgRsmbRg
RiRobRjbLiLsbLsbLgbLiRsRsmbLhbRsRsmbRsLsbRcbLgbRgbRiRsmbRobRsLsbLiRsbL
obRsRsmbRibRsbRsbsbRibLebLgbRsLsLsmbLgbLgbLgbLsbRsLsbLoRsLibRgRsmbRiRs
mbLjbLhbRgbRjbLibLgbLgbLsLobLobLiLsbLcbRibLsbRibLsLsmbLsbLiLsbRsbRsbLs
bRebRebsbRibRsbLcbLobLibRsbRibRebLiLiLsbLibLiRsbLsbLibLsbRsbLsbLoLiRsb
RsbRsbRhbRobLgbRsbLobsbRsbsbLgbRsbLobsbsbRsbsbLsbLoLiRsbRiLsbLhRsbLgbR
sbLsbLsbsbRsbRsbRsbRsbRgRsmbRgRsmbRsbRsbRsRgbRsbRgbRsRsmbRsbRsRsmbRgLs
bLobLibLsbLgbLsbsbLsbLgbLgbLoLiRsbRgbRiRsmbRiRsmbRgbRsbRcLsLsLsmmbLgbL
cbsbLcbLhbLsbLibRsbLcbRsLsbRsbLsbLsbLgbsbLgbsbLgRsbLgbLibLgbLsbLgbRsbL
sbLibsbsbLsbLcLsLhLimbRgbRiLsbLsRsbsbRiRoRhRibRgbRgbRgbRgRsmbRsRsmbRgR
smbRsbRsbRiLsRcRibRsbLibLsbLgbLgLoRsbLiRsbLcbLgbsbLiLsLcbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 155737; End: 160240;
Recording: 1-1; Individual: 10; Drug: PCAP814 3 然 Apo 50 然
bRgbRibRibRiLsRsbRibRibRiRsmbRibRgbRibRgbRgRsmbLoRoRsmbRobLebLibLgbLib
LibLibLgbLibLibLgbLgbLibLgbRoRsRgmbLsRhbRgRsmbRsbRgbRgbRgbsbRgbLjbLobR
cRsLsmbRhRsmbRgbRgbRgbRsbRgbRgbRgbRgbLsRsRoRsmbRsRcbRgbRiRsmbRgbRibRgb
RgbRgRsmbRgbRgbRiRsmbRibRgbLsbRibRjbRsRsmbRgbRgbRgRsmbRgbLsbLjbRiRsmbR
sbRiLsbRsbLibLsbLibRobLsbRibLobLgLsbLcbRhLsbRsbLoRsbRhbRebLobRebRoRsmb
LgbRsbRgbLobsbLgbLobRebRgbLoRsbRgbLibLobRiRsmbsbLebLibRsbsbRebRcRsmbRi
RsmbRiRsmbLobLgLsbRsbLsbLjbRgbRjbLhRcbRsbRsbRgRsmbRibRgRsmbsbRsbRebRsb
RcbRsLsbLsbRjbRebRgbsbRsbRhbRhbsbLsRsbRjbRobLibsbLgbLgbLgbLgbLgbRsbLib
LgbLsLsmbLgbLibLgbLgbLibLsLsmbsbLsbsbLsLsmbLgLcLiRsbRgLsbRgbRibRgbRgbR
gbRgbRgbRsbLsbRgbRgbRsbRibRhbRsRsmbReRsLsmbRiRsmbRobLgLsbLgbLsbLsbLsbL
sbLobRgLhbRibLebLibLsbRsbLgbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 155737; End: 160240;
Recording: 1-1; Individual: 11; Drug: PCAP814 3 然 Apo 50 然
bLobLsbLcbLobLibLcbLsbRsbLibLobRsbLhRsbLcbsbLibLgbLobLobRsbLobRsbsbsbR
sLsbLsbLibLgbLgbLsLsmbLsLsmbRgbRibLibLibLsbLsbRsbLsbLsbLsbRsbLsbRsbLsb
LgbLsbLsLsmbLgbLsbLgbRsbLsLsmbLsbLsbLsLsmbLsLsmbLgbLsbLgbRsbLsbLsLsmbL
gbLsbRsbLsbLgbLsLsmbLsLgbLgLgRsbLsRsbLsbLibLibLiLgbLibLgbLsbRsbLsbLsbR
sbLsbLgLsbLsbLsbLgbRgbLsbLsbLgbLsbLebLhLsbLcbRibRoLsLsmbRgbRsbLsbLsbLo
bLsbRsbRibLjbRjbRcbLgbLibRsbRgRsmbRsbRhbRiLsbLsbRsbLcbLhbRgLsbLgbsbLsb
sbLgbLgbLgbLsbsbLsbRsLsbLgbLcbLsbLsbRsRsmbRcbRibRhbsbRgRsRiLsmbRsbLhbL
sbsbRibRibRibRsbLhbRgbRjbRsbRibRgLsRsLsbRsbLsbRibLsbRibRobRsbRsLsbLgbL
hbLsbLgbLgbLsLsmbLgbLgLsbLjbRgbRgbRgLsbRgbRgbRgbRebsbLgRsbLgbRjbRoRsLs
mbLhbLgbRjb

>ZF Recording 2016-06-02; tW: 300s; Start: 155737; End: 160240;
Recording: 1-1; Individual: 12; Drug: PCAP814 3 然 Apo 50 然
bLsbLgLsbLobRsRsmbLsbRgbLobLsbLcbLcbRgRsmbRobRcbLibLsbLgbLobLsbLsbLoLs
mbRsRsmbRcRsmbRsbRcbLoRsbRgbRiLobLhbLsLsmbLsLsmbLcLsmbLsbLobLsbRcbRcbL
sbRoLsbLsbRibRibRoRsmbLgLgbLobRsbRgbRebRgRsmbRobRsbLgbLhbLsRoLsbRibRgL
sbLsbLsbRsbRgLsbRgbRsRjbLsbsbRcRsmbLgbRibLcbLgbLsLsmbLibRsbLsbLgbLobLo
bRsbLobsbsbLhbRsbLobRgbRsRsmbRibRibRsRsmbRjbLsbRibLsbRgbRobLsbLgLsbLsL
obLgbsbLgbLsbRsbRsbRebRsbRgbLgRsbRgbRibLsRsbRgbRgbRjbLsLsmbLgbLobLsLsm
bLgLsbLcbRgbLjbLgbLsbLgbLsbLgbLibsbLcbLsLsmbRibRebLibLiLsbLgbLsLsmbRob
RibRgbRsbRsbsbsbRjbsbLjbsbLsbsbLobLsbLiLsbRsbsbRsLsbRjbRgbRgbRgLsbRgbs
bRgbLcbRsbLsbRjRebRibRsRsRsmmbRibLsLsmbLsbRgbRsbRcbLibRsbRgbRiLsbRgbLs
bRsbRibRsbRgbRibRsLsbRgbRgbRgbLsbRcbLsRsbRibRgbRgbLcLibLgbLcbsbLgRsbLs
RsbRsbReRgbRgRsmbRsbRsbLjbLibLibRcbRgbRibRsRsRsRsmmmbRoRsRsmmbLobLsLsm
bLiLsbLgbsbsbLgbLgbLeLsbLibLsbLiLsLgLhLsbRgbLsbRjbLhbLsbLcLgbLcLsmbRsR
smbLsLsmbLibLhbsbLobRsbRgbRgRsmbRibsbsbRgbRgbRgRsmbRgbRgbRgbRgbRsRsmbR
ibRgbRgbRjLsRsbRiRsRgRsmmbRibRgbRgbRhLsRsbLcbLgbLibLgbLgbLibLgbLcLsLsm
mbLhRsbLsLsLsmmbLgLsbLsbLgbLibLsLsmbLcRsbRsLsbLhRsRsmbsbRsRsmbLiRsbLsb
LsbRcLsRoRgRgbRiRgRsLsmbRgbRgbRsbRiRsmbRsbRgbRsbRgbRgbRgbsbRsRsRsRcRgm
mbRebRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 155737; End: 160240;
Recording: 1-1; Individual: 13; Drug: PCAP814 1 然 Apo 50 然
bRgbRsbRobRgbRsbLsbLoRsbRgbLoLsmbRibRibLsbLebLgbLoLsmbRibLsbRgbRobLebL
sbLjbLcbLsbRsbRibRcbLibRsbLcRsbRsbLobRoRsmbLgbRibRibRsbLibLibLsLsmbLgb
sbRcbRebRhbLebLcbLobRjbRsbRebRsRsmbsbsbLsbRsbLsLsmbsbLcbRgbRobRsRsLsmb
Rsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 155737; End: 160240;
Recording: 1-1; Individual: 14; Drug: PCAP814 1 然 Apo 50 然
bRsbRsbRsRsRgRsRommbLiLsbLgLsbLcbLsRsbRsbLoRsLsbLhbLcbLgbLgbLobLiRsbRi
bLjLsmbLsLhRsbRgRsmbLcLsmbRgbLobLibLcbLsLsmbLcbLobsbRgRsmbRobsbRobLsRo
bLsbRobLibRobRibRobRoRsmbsbRobsbRobRobRcbLibRoLsbLcbLobLsbLobLobLobLcb
LcbLobLobRobLsLsmbLsbRcbLsbLsbRebLobLsbLobLcLsmbLibRsbLcbLsbLsLsmbLcbL
sbLsbLsbLcbLcbLsbRiLsbLsLsmbLsbLsbLgbLobLgbLcbLsbLsbRiRsmbRsRsmbRibRcb
RsbRsbRcbLsRsRsmbRsbRgbRsbRiRsmbRsRsmbRsRsmbRsRsRsmmbsbsbsbsbsbsbsbRsb
sbRsbLobsbRsbLsbLiLsbLobsbsbRsbLsLsmbRsbLhLsbLgbLsLsLsmmbLsbLsLsLsRsmm
bLsbLsbLiLibLsbLsbRsLsbsbRsLsbsbLsRsbRsRsmbLsRsbsbLsbRsRsmbLsbLgbLgLsb
LsLsmbLgbLsbLsbLsLsLsmmbLsLsmbLsbLsbLgLsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 155737; End: 160240;
Recording: 1-1; Individual: 15; Drug: PCAP814 1 然 Apo 50 然
bRgbRsbLobRsbRsRsmbLobLjbLhbRiRsmbRibLoRsbLibLibRsbsbRobRobRobRsbRobLs
bLgbRcbRcbRibRibRcLsbRgRsmbLsbRsbRsbRgbRibRgbRibLsbRcbRhbLsbRsbLsbLgbR
jbRibRgbRibRsbLgbRibRgbRcbRiRsmbRgbLsbsbsbLgbLgbRsbRsbRjbRsbRsRsmbRgRs
mbRgRsLsmbRgRsLsmbLsbRibRsbRcbRgRsRsmmbRobRsRcbRsRsmbLsbsbsbRcbLsbsbLi
bRcbRibRsRiRsmbRsbRgbRgbRiRsmbRsbRsRcbLsRsbsbRjbRibsbsbsbRcRsmbLgbRjbR
gbRsRgRsmbRebRibRibRsbLobLgbLjbLibRebRibRhbRhbRebRebRgbRgbRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 155737; End: 160240;
Recording: 1-1; Individual: 16; Drug: PCAP814 1 然 Apo 50 然
bLsLgLsLsmbLobsbLgbLoLsmbLhbLsLsLsmmbLsLsmbLcbsbLhbLcbsbsbLobLcLobRoRs
mbLobLcbLgbLgLibsbLsbLsbLgLsLsLsmmbRsLsbLiLsbLebLibLobRsbRobRsbRsRsmbR
obsbLsbsbLobLobRibRebRcbLibLcbLcRsbLebLibRsbLobLcbRoLsbsbLsbRebRobLgLs
bLsbLcbLibLcbRgbRibLebRibLcRsbLcbRsbLcbLhbRiRsmbsbLcbLobRjRgbLcbLcbReb
RsLsLsmbRsRsmbRcbRsbLcbLobLhbLcbLibLcbLcbLhbRsbLibLsLibLhbRgbRsRibsbLs
bLebLiLsLcLibRsbRibRsbsbsbLebLibLgLcbLcRsbLibLcbRcbRhbRsbLsbRgbLiLsbLh
bLgbRsbRgbLeLibLcbRibLibLsLcRsbLiRsbLcLsmbLgRsLsbRsLsbLibRgbLcbRsLcbLs
bRsbRhbRsbLcbLiLsbLcbsbsbsbLsbLsbLibLsbsbLiLsbRsRsmbLgbLgbLiLcbLhRsbLs
bRiLsbRgbRsbRsLsbRsRsLsLsmmbRsbLjbLgbRgbsbRsRsmbLhbLcLsmbRoRsmbLobsbsb
RcRhbRiRsmbsbRcRsmbRsbsbRoLsbsbLgbLhRsbLiLibsbLgbLsbsbsbsbsbsbLcLsLiLs
mbLcRsbLgbLcbsbLgbsbsbsbLcbLeLhLcLibLsbsbRoRibRcbsbRsbsbsbsbRcRsmbRcbR
ibLcbLhbLcbLsbRsbLhbLjLgLsbLhbsbsbRhbsbRsbRcbRcLsbRgRsmbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 155737; End: 160240;
Recording: 1-1; Individual: 17; Drug: PCAP814 1 然 Apo 50 然
bRoLgLsbRibRcRsmbRiRibRgbLsbRobRoLsbLsbLgbLgbLgbsbLsbLgLsbLgbLgbLobLgb
LsbLibLsbLibLgbLobRibRgbLobLiRsbLsbLibLsbLgbLsbLobRsbRibRibRcLsbLsbLib
LibLiRsbRcLsbLsLsmbLibLgbLibLobLsbLjbLibLibRgbLsbLgLsbRcbLibLiLsbsbRsb
LibLcbRsbLsRsbLgbLibLgbRobLjbRoLsbLibLibLeRsbLsbRsbRibRgbRgbRsbLcbsbRe
bLibLibLgbLgbLgbRsbLgLsbLgbRebLeLsbLgbLoRsbRibRgbRobLgbLgbRcbLsbLibLob
LsLsLsmmbLsbLibRsbRsbRsbLcRsbLcbLibLsbLsbRsbRgRsmbRsbRgRgbRsbRgbRsbLob
RsLibRjbLcLsmbRcbRobLsbRhbLsbLsRgbLjbLiRsbLgbLsbLgLsbLgbsbLobsbRiRsmbL
obLgLsbLsLsmbsbLgbLgbLgbLsbLsbRsLgbRoLsbLjbLgbLsbLgbLgLsbLgbLgLgLsbLgb
RobLjbRhbLibRjbRibLsbRoLsbLgbRibRsbRgbRgbRgbRgRsmbRgbRgbLcbLgbRcbRibRs
LsbRoLsLsmbLgLsRsbLgbLibLgbRsRsRsmmbLgbLgbLsLebsbLgbLibLhbRiLsbRsLsbRg
LsbLjbLgbLgbLsbLobLgbLsLsmbLsbLsLgLgLsbLgbLgbLgbLgbLhbRibLsbLibLgbRsLs
bLibRgbLsbLsbLibLgbLsLsmbLjbRgbRsbLsbLhbLsbsbLsbLjbLjbLsbLsbRsbRibLgLs
bLgLgLsbLgbLgbLgbLcbLsRsbLgRgbRsLsbRgbRsbRgbRsbRgbLjbLcbLgbLcbLsbRsbLi
bLgLsbLsbRoRsmbsbLjbLibRsbsbLgLsbLcbsbRgbLsLsLsmmbRsbRsbLhbsbsbLibRsbL
iLsLibLibLgbRgbRgbLjbLibLgLeLgLsLibsbLgLsbRsRjbLcbRgbLcLsmbsbsbLcLsmbs
bLsbRjbRsbLjbLiLsbLgbRhbLibsbLsbLgLsbRobLibLhbLcbRjbRsRsmbLebLiRsbLgbL
sbLsbLgLsLgLgLebRsRsmbLsbLgbLiLsLibLgbLsLsmbLgbLgLsLgbLhLsbLgbRgbsbLcL
hbLgbRiRsmbRgbRsRebLcbLibRgbLgLsbLgRsbLgbLgLebLgbLibRsLsbLgbLibLibsbLi
bLibRsbRhbLsbLsLsmbLib

>ZF Recording 2016-06-02; tW: 300s; Start: 155737; End: 160240;
Recording: 1-1; Individual: 18; Drug: PCAP814 1 然 Apo 50 然
bLgLsbLobLibLsbLgLsbRobLsbRgbRgbLgbRjbLhbLibRgbRcRibRsRsmbRgbRibLsbRcb
LsbLsbLcbRgbLsRsbLjbLobRibLgbRsbLobRgbLsbLibLoLsmbRibRsbRsbLcLsmbLibRj
bLibRobRgbLsbLjbRcbRcbLsbLsbLgbRobRhbRibRoLsbLgbLsbLibRcbRhLsbRcbRcbsb
LhbsbRhbLebLibRsbRsRsmbLhbLcbLibRsRsmbRhRsmbLsbRsbLcbLibLibRgbLibRsbRs
bLibLcbLibRsbRibRibLcbLcbLibRsbLcbRsbLoRsbRgRsmbRgbRsbRgRsmbRgbRsbRsRs
RsRsmmmbLobLibLsLsmbLsbLibLhRsbsbLsbRsbLhRsbLiLsbLgbLsLsRsmbLibLsLsLsm
mbLiLhLsbsbLhRgbRiRsmbLebLibLcLsmbLibLsbLhbLsbLsLsmbLobLebLeLsbLgbRgbL
iLsbRcbLsbLcbRoRjbRcRsRsmmbLgbRjbRgRsRsmmbLcbLcbRsbLibLibRjbLsRsbLcbRs
RsmbRgbLibLoLibLhbLsbLsLsmbLsLsmbLsbLgLsbRsLsbLcLgbLsLsmbLsbLibLibsbLs
LsmbLgRsbLsbRsbLsbLgbLhbLebLsRsbsbLjbLsbLgbsbLibLsbLsbLibsbsbLibRsbsbL
cbRsbLhbsbRsbLsbsbLsRsbLsLsmbLsbRsbsbLsbsbLsbLsbsbLsLgbLsbLcbLhbRsbLsb
LiLsbLgLsbLsbLgbLsLsmbLgLgbLsbLsbRjbRiRgbRsRsmbsbRebLgLsbLcbLsbLibRcbR
cbRiLsbLsRsbLgbRsbsbsbsbsbsbsbRsbRsbLcbLsbLgbsbsbLsbsbLgbLcLsLembLsbRs
LgLgLsbLsbRsLgbLsbLsbLgbLgLiLsbLhLsbLiLgbLgLibLsbLsLgbLebRcRiRsRhRsLsR
jmmbRsRibRgbRgbRgbRsLsbRgbRcRiRsmbsbLsbRibsbRgbLsLsmbRsbRiRsLsmbRibRcL
sbsbRsRsmbsbsbRiLsRsbRsbRgRsmbRsbRsRsmbRsRsmbRsbRsbRsbsbRgbsbRibRsRsmb
LibLjLsmbLibRsbLcbsbsbLibLsbRcbRsbRsbRgRsmbRibRibRsbRsbRhRsmbRsbLcb

>ZF Recording 2016-06-02; tW: 300s; Start: 155737; End: 160240;
Recording: 1-1; Individual: 19; Drug: Control Apo 50 然
bLobLhbLobLoLsmbLgLsbLgRsbLoRsbLobLgbRobRibLgbRjbRobLsbsbLsLsLsmmbLsbL
sRsbLsbLsRsbLsLsmbsbRjLsLsLsmmbLsRsRsmbRsLsbLsbLsbRsRsmbLsLsmbLsbLsbRs
bsbLsbLsLsmbsbRobLsbLiLsbLgLsbLgLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 155737; End: 160240;
Recording: 1-1; Individual: 20; Drug: Control Apo 50 然
bLiRsbRgbLgRsbRsbLcRsbLcLsmbLhbLibLcbRcbRcbRobRsbRoLsbRcbLcbRgbLhbLcbL
hbLsLsLsmmbLsbRsbLcbLibsbRsbRsbLgbsbLgRsbLsbRsbLjbLsbRsbsbRsbRsRoRsmbs
bRsRsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 155737; End: 160240;
Recording: 1-1; Individual: 21; Drug: Control Apo 50 然
bsbsbsbRsRsmbRsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 155737; End: 160240;
Recording: 1-1; Individual: 22; Drug: Control Apo 50 然
bLoRsbRsRjbRobLobRcbRoRsmbRsRoLsbRcRsmbRsRhbRsRcLsbLsbsbsbLcbRcbsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 155737; End: 160240;
Recording: 1-1; Individual: 23; Drug: Control Apo 50 然
bRibLjbLobLjbRsbLjbLebRibRjbRsRsmbRsLsbLsbsbRsLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 155737; End: 160240;
Recording: 1-1; Individual: 24; Drug: Control Apo 50 然
bRgbRiRhRsmbRjbLobRgbRiRiLsbRibLsRgbRgbRsbLobLibRjbRebRibRjbLcRsbLcbLc
bLcbLcbLobLobLcbLjLhbLobLebLobLobLsbLibLobLcbLibLobRcbRjRsRiRsmmbRjbRj
bRjbRcbRjbRjbRhbRjbRjbRjbRhbRjbRebRjbLsbRjbRjbRjbRjReRjRjbLjLjbRibRjbR
jbRjbLjbRjbLjbLjbLsbLjLsmbLcbLjbLjbLjbLjRsbLjbLjbRsbLgLsLsmbRgbReRgbRj
bRjRgbRjbsbsbsbsbRsbRjbLjbLiLgbRjbLibLsbLibLjbLjRsbLjbRjbLibLgbLjLjbLj
bLibRjbsbRgbLjRsbsbRjbLjbRgbLjbRjbLibLjbLjbsbLgbLsRsbReRgbRjbRjbRjbLjb
RjbLibRjb

>ZF Recording 2016-06-02; tW: 300s; Start: 155737; End: 160240;
Recording: 1-1; Individual: 25; Drug: PCAP814 10 然 Apo 50 然
bsbLsbLebLsbLsLsmbLibLhLoLjbRgbRgLoRoLsbRsRobLsRsbsbLsbLsRsLsbLsRsbLsb
sbsbsbsbLgbRgRsmbsbRsbsbLsRsRsmbRsRsLsmbsbsbsbsbRsbRibRsRsRgmbRobLsbLs
bLsbLsbLsbsbRgLsbRgLsbsbsbsbRobRsRsRsRsLsmmmbLsbsbsbsbRsbLsbLsbsbsbsbs
bLsbLsbLsbLsbLsbLcbLgRsbsbsbRsRsmbsbRsbsbRsbRsbRgbLsRsRgbRsbLsbLsbLcbR
sbRsbLsRsbLsRsbRsbRsbLsbRsbRsRsmbRsbLebLoRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 155737; End: 160240;
Recording: 1-1; Individual: 26; Drug: PCAP814 10 然 Apo 50 然
bLebLeLsbRcRiRsRsmmbRsLsbRcbRhbRsRgRsmbRsRsmbRjRsmbReRsmbLebLiLsbsbLgb
LcbLhbRebLgbLobLcbLebLibsbLsbLgLsbLiLsbsbLiLsbRgbRsRsmbRhbRgbLeLsRebRg
bRobRgRsmbLsbLeLsbRiRsmbRsRibLeRjLsbLebRgLsbLsbsbRebLebRcbRjbRcbLhbRcb
LiLsRsRsLsmbsbRjbRcbsbLcRsbRsLsRebRgbRgbLibRibLsRibReLoRcbRsbRjRsmbLjb
sbRcLsbRgRsmbRhbLebLjbLibsbsbRibRgbLsLsmbsbLcbLgbLsLsLoRiRsRsRsRsRsmmm
mmmbReRsmbRhRsmbReRcRsmbReLgLsRsbLsbRsLsbLhbLsRsLsbRsbRjbRsLobLobRgLgb
sbsbsbsbsbsbRcRsmbRibRsRsRsmmbRsbRgRsmbRsLsbRsReLsbRsbRsbLsbLsbRsRgbRh
LsbLsRcbRjLsRibLjRsLjbLsLsmbsbRebRoRobRoLsbRibRiLsbsbRcbLsbLgLsLsRsLsm
bLsRibLcRoLsRsbRsbRebLgbLgbRjbLiRsLsbRibRhLsLsmbRibRsRsRsRsRiRgmmmbRjR
gbRibRsRgbRibRsbRgbRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 155737; End: 160240;
Recording: 1-1; Individual: 27; Drug: PCAP814 10 然 Apo 50 然
bsbRsRsRsmmbLibLibRcRgRsRsmmbRsRcRsLsmbRsReRiRgbRgbLcbLsLebLsLsmbRgbLg
bLhbRsbsbLiLsbRsLsLsLsmmbLsLsLsLsLsmmmmbRsLsbLsbLsbLsLsmbLsLsLsLsLsmmm
mbLsLsLsLsLsLsLsmmmmmmbLsLsmbLsLsmbLsLsLsLsLsmmmmbLsLsmbLsLsmbsbsbsbRs
bLhbRobRgRibRgRsmbRiRgbLjbLebRsRsmbRsRgbLsLsLgLhLhLgRjmbRgRsmbRgbRebLs
RgRgLgbLibLgRsbLsbLgbRjbsbsbsbLeLsbLgbRgbLsbLgbRsbsbLsbLsbLgbLsbLsbLsb
LsbsbsbLsLsLsLsLgmmmbsbLsbRcRobRgbRjbRgbRsLsbLsRsLsbRsRgbRsbLgbRsbRgbR
sbRsRsmbRsbRsbLsbRsbRsRgRsmbRgRsLsmbRsbRsRsLsmbRibRgbLsbRsbLeRibLsbsbL
gbLsLsLsLimmbRsbReRsmbsbRsbRgRgbRsRsmbRebRsbLsbRsbRgbRibsbsbsbRgLobLcb
LsbLgLsLsmbRsLsLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 155737; End: 160240;
Recording: 1-1; Individual: 28; Drug: PCAP814 10 然 Apo 50 然
bRsbRgbRsbLgbLcbRjbRibRsbLsbRgbRsLsLsmbRsRsmbRsLsbsbRsRsmbsbRsbRsRsmbR
sbRsbLsbRgbRgRsLsRsmbRgLsbRebLsbLsLgLsLebLebLibLsbRsLgbsbLeRsLsbLiLsbL
hbRobRhLebLgLsbLgbRjLjbRiRgbsbsbRsbRsbLgbRjbRsLsbRsLsbRgLsbRjRibRjLsbR
gRjbRgRsmbRgbRjbRsRsmbRgbRgbRsRsRsmmbRsbRsRsmbRsbLsbRcbRjReRsmbRjLsbRj
bRjRjLsRsbRsRsmbRsRsmbRsbRibLsbLsbLibRobRsbLgLsRsbRsbRsbRsbLsbLgbsbRsb
LsbRsbRgbRsbLibLsRsbLsLsmbLjbLsLebRsRsRsRsmmmbLcbLgbRsbRhLsLsmbLgLsbRc
bLjbLcbLsbLsbsbRsbRsbRsRsmbRgRsmbLsbRgbsbLsLeLsLsmbRsbLsRsbReLsLsmbReR
sRsLcLsmmmbLebLeLebLsbLsLsmbsbRsbRsbRsbsbRsRjbRjRsRgRgmbRhbLgLgbLjbsbL
sLgbRiLgLsLsLjmbLsbsbLgbLebsbLsLsmbRsRsmbRsbsbsbRsbRhbLsbRsbRjbLgbLibR
obRsLsbRsbRsRsmbLiLsbRsbRsRsmbRsRsmbRsbRsRsmbLsbRebRsbRjRsmbLobRsRcbLe
bLgbRgRsmbRsRsmbsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 155737; End: 160240;
Recording: 1-1; Individual: 29; Drug: PCAP814 10 然 Apo 50 然
bLgbLobLsbsbsbRsRsmbsbRsbLsRsbLsbRsbLsbsbsbRsbRsLsbRsbsbRsbsbsbRsbRsbs
bsbLsbsbRsbLsLsRsmbsbsbsbLsbsbsbsbsbsbRsbsbsbsbsbsbLsbLsbLsbRsbRsbsbsb
LsbRsRsmbRgbRsbLsLsmbsbLsLsLsmmbLobsbsbsbsbsbLsbRsRsmbsbRsRsmbsbsbsbLs
bRsRsmbRsLsbLsbLsbRsbsbRsbsbsbsbRsbRsbRsbsbRsbLsRsbLsbRsLsbRsbRsbRsbLs
bsbLsbLsbRsLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 155737; End: 160240;
Recording: 1-1; Individual: 30; Drug: PCAP814 10 然 Apo 50 然
bLgbLsLgLsbLebsbLsLsmbLsbLsbLsLibLgbLsRsbLcbLeLibLsbLjbRsbRsRjbRcRsmbL
gbLgbsbsbRsRsmbLsbRsRsmbRsbRsbLsRsbRsbRsRsmbRsRsmbRsRsRgmbRsLsbRgbRgRs
mbLsbsbRsRsmbRsbRsbRsLsbLsbLsbRsbsbRsbsbLsRsbRsbsbsbLcbLgbLsbsbLsbLsbL
sbLsbLsbLsLsmbLsLsmbLgbsbsbLsbLgbRsLsRsRsmbLsLsmbLsbLcbRibLsbLobLcbLsR
jbLgbRhbLsbRibLebLsbRsLsbLsbLgbRgbRibRgbRcbRibRsbLgbLsbLgbLibLsbRhbReL
sbLsLgbLsLsLsmmbLgbsbLsbLsLsmbLsbLsbRsbRsbLgbLibLsLgbLeLsbLgbLgbLsbsbL
ibLjbLgbLgLgbLebsbLgbRebLsLsmbLgLsbLgbLsLsmbRsLsLsmbRsbLgbLgbLsLsmbLsL
smbsbRsbLsbLibLgbLsLsmbLsbRgbRsbLsbLsLsmbLsRsbLgbLsbsbLsbsbLsbLsLsLgRs
mbRsbsbLsLsLsLsmmmbLgbLsLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 155737; End: 160240;
Recording: 1-1; Individual: 31; Drug: PCAP814 3 然 Apo 50 然
bLgbRgRsmbRgRsmbRsbLcLiRsbRgbRibLoRsLsbRgbRgbRgbRsbRgbLsbRibRgRsmbRsbR
sRsmbRgbLsbRgbRiRhbLgbRibRsbLcbRjbLiLsbLobLiLgLsbLsbLibLiLsLsmbLgLsbLo
bLibLibRibRebLgbLibRgbLibLcbLsbLjbRcbLsbRjbLiRsbLcLiLsbRsbRgRsmbLsbRib
RsbRgbLjbLcbLhbRjbRgbLjbRcbLibRjRsmbLibLibLibLgbRcbRibLjbLobRsbLhbLgbL
oRsbsbLsRsbRsbLsbLibLgLsbRsLsbLgbRsbLibRcbLsRcLsbLebLsbLcbRsbRsbLiLsRs
bRsLgbLgbLsbLgbLgbLiLibRsbRgRsmbLsbLjbLgbLgbLhLhbLsbRibLibRgRsmbRsbRsR
smbRgbLoLsmbRjbLibLobRibLibRgbRsbRibRsbRsbLobRcbLcLibLsbRgbLibRsbLgLsb
LsbLiLsbRgbLjLiLhbRibRsbRgLsbRibRsbRsbLobLiRsRsmbRsbRgbLgbLgbLgRsLsbRs
bRsbLgLsRsbLibLiRsbLgLsbRgLsbLsbLibLsbLgLsbLsbLgbLgRsbRsbLhbLibRgbLibR
sbRgbLobLibLcRsLiLsbRgbRgbRsbRibRgbRsbRobRcbRibLobLcbLsbRsbRsbLhbLgbLi
RsbRsRsLsmbRsLsbLiLsbLoRsRgLcbLhbRsbRgbLjbLibRsbsbRgbRobRiRsmbRsLsbLob
LibLiLsLsmbLgbLgbLsbLgbLsbLgbLiLsLsLgmbRsbLsbLibRsbLgbLgLsbLgRsbLsRsbL
ibLjbLsbRsLsbLibRjbRsbRoRiLsLgbLibLjbsbLibLsLsmbLgbsbLgbLsbRgbsbsbRsbR
sbLgbLibRgbRsbLgbLsbsbRsbRsbsbRgbLsbLgbLgbLsbRsbLsLsmbLgbsbsbLgbLsbLgb
LsbLgbLiLgLsRsbRsRgbLibLgbLibRsbsbsbsbRsRjRsmbLsbLcbLiLsbLhbLcLgbLsbLj
bLgbLgbLgLsbRsLsbLiLhbRgbRsbRibsbRgbRsbRgbRsRsLsmbRsbRgbLebRhbRsbRgbRs
bRsbLsLsmbRgbRsbRgRsmbLiLiLgbRsbLgbLibLibsbLsbsbRjbRsRsmbRsbRsbRsbRsbR
sRsmbRsbRgbRgbRsbRsbRebLsLsmbLgbLsLsmbLjbRgRsmbRsbRsRsmbRsbRgbRiRjbLib
LibLgbLsbRibRgRsmbRgbRsbRgbsbRgRsmbRjRoRjbLsLsmbLibLgLsbLgbRsbRsLgbLsb
RcRiRsmbLsLjbLsRsbLgLsbLgbLgbsbLgbRebLhbLibLsLsmbLgbLsbLsRsbLgRsbLgbLs
bRebsbLgbLgbLsbLsbLsLsRsmbLgLsbLsLsmbLgbLjbLsbLgLsbLgbLgbLsbLgLsbLgbLg
bLsLsLsmmbLsbLgLsbLsbRhRibLsbRgbRgbRgbLebRiRsmbRcRcLsRibLib

>ZF Recording 2016-06-02; tW: 300s; Start: 155737; End: 160240;
Recording: 1-1; Individual: 32; Drug: PCAP814 3 然 Apo 50 然
bLsLsmbsbLhLsRhbRebLgbRebRhRsRembRiRsmbRibRiLsbRgbRcLsbRiRgbRgbRiLsbRo
bRcbLsLsmbLcbLhLsRsLjLiLcLsmbLsRsbRibRgRsmbRgbRgRiLsbRcRsmbRhbRibRgRsm
bRibRgbRgbRcbRoRcbRibLsbLibLibLgbLgLsbLgLsRsbLgbLgbLgLsLebLobLgRsbRibR
eLsbRgbLobLjLsmbLobRcbRebLibRhbRsbLoLsmbRibLobLobLsbRcbRcRsmbsbLhbRebR
cbLsbLobLibsbRebRobLhbRobRsLsbReRsmbLibLsbLobLjLibRhbRgbLsbRobRcbLhbRg
bRobLibRcbLgbLgbRobLhbRcbRgbRebRcbLibLibLcbLcbLhbLoRsbLobRcbRobRgbRcbR
gbLsbRobLgbLgbLsbRcbLibLjLsmbLobLibRibRcbLgbLsbLsbRobLgbLsbRcbLibRoLsb
RsbLsbRibRcbLiRsbRgbRhbRebRgbLsbLibRsbLgbLibRjbRobRgbRgbRsRsmbRsbRgbRi
bLgbLgbLgbRibRgbRibRgbLsbLsbRebRhbLjbRibRgbRsbRibRibRgbLibLsbLibLibLib
RgbRgbRsRiRsmbRebRsbRgbRgRsRsRsmmmbRgbRgbRsbLibLsbLibLsbLgLsbLjbLsbReR
smbRibRsbRsbRhbsbsbRibRgbRsbRibLibLjbLgbLeLibRhbLibLobsbRsbRjbRsbRgbRs
bRgbRiRsmbRjbRgbRibLsbLgbLjbLibsbLgbRgbLcbRgbLgbRgbRjbRibLcLsLsmmbLhbL
jbRhbRibRsRsmbRebLgLsbRjbsbRiRsmbRgbRsbRebRgLsbLibRsbLgbLsbRjbLjLcLsmb
LibLsbLobLibRibLibLcbRgbRgbsbLgbRibsbRgRsmbRiRsmbLgLjbLibLgbLgbLgbLsbL
iRsbLsbRcbLcbLhbLgLsbLiRsbLgbRebRgRsRimbRsRsLsmbRsbRibRgbLiRsbLibRcbRs
bRgbRgbRgbLcbLgbLjRsbRsLsbLibLgbRibLhbLgLsbLibLibLsbLebLgbLibRsbRjbRiR
sRsmmbRibRgbRibLsbRgbRgbLsLsRsmbRcRsmbRgbRjRgbRiLsbLsbLibLib

>ZF Recording 2016-06-02; tW: 300s; Start: 155737; End: 160240;
Recording: 1-1; Individual: 33; Drug: PCAP814 3 然 Apo 50 然
bLebLcbLsLsmbLcbLeLsbLcbLsbLgbsbRgbRsLsbRjRibRcRsmbLibRibRcRsmbRobRebR
hRsmbLgRsbReRcbRsbLgbLibLgbLiRsbLsbRsbLibLgbLobLsRsLsbLoLsmbLgbLgLsLsm
bLcLsLhRgmbRgbRsbRebLobLcbRsbRobRjbLobLibLsbLcbRsRsmbRibRebLhbRjbRhbLi
bLjbLsLsmbLeRjbRobLiRibRebRsbRsbRgRgbRsbRsbRsRgbRsRebRobRhLsbRgbRjbLob
sbRebRibsbLjbRgbRcbRsbRsbRobLjbLoRsbRsbRiRsmbLgbLsbRsbRsbLcbLcbRgbRsRs
mbRcbLgbsbsbRobLsbLsbLobsbsbLcbRsbLobLcbRgbRsbsbRibRgRsmbRgRsmbLsbsbRc
bsbRjbLjbLibRoRsmbRgbLsLsmbRibLgbLobRgbLsbRcbRsbRgRgLsbLgbLobRibRibRsR
smbLibRsbRibRoRsmbLsbLgbLgbRsbRsbRiRsmbRcbRjbRibRobRgbLsbLobLhbLibLcbR
sbRgbRibRgbRsRsmbRebRsbRcbLibLsbLiLsbRsbLsbsbLiRsbsbLibRgbRsRgbLsbLibL
oLgbRgLsbRibRibLgbLhbLsLsmbLibLibLsbLoLsmbRebRsRsRsRsmmmbRsbRhbRhbLsbR
sb

>ZF Recording 2016-06-02; tW: 300s; Start: 155737; End: 160240;
Recording: 1-1; Individual: 34; Drug: PCAP814 3 然 Apo 50 然
bRsLsbLgbLgRsbLgbLsLsmbLgRsbRsbLgbLgLsbLgLsbLsbLgbLsLsmbLsbsbsbsbLsbLs
bRsRsLsRsmbsbLsbLsbRsbLsLsmbLsLsmbLgLsbLsbsbRsbLsLsmbRsRsmbsbsbRsbsbsb
RsbsbRsbRsbsbLsbsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 155737; End: 160240;
Recording: 1-1; Individual: 35; Drug: PCAP814 3 然 Apo 50 然
bRgbLoLsmbRibLobLobRobLiLhbLobRgbLobLeLsbsbRobRobRgbRoLsbLsbRsLsRobRib
RgRsLsmbRiRsmbLsbRsbRibRiLsbRsbRgRiLsbRiLsbLibLgbLgLsbLgbLgLobLsLsmbLs
bLhRsRsmbLsLsmbRoRsmbRobsbRiRsRsmmbRgbRgbRsRhLsbLsLhbLgbLgRsbRgbLsbLib
RobRibRgbRgbRiLsLsRsLsmbRsRsmbRsbsbRgRsmbRgbRgbLcLsmbLgbLsbLiRsbLgbRsb
sbLgRsbRsRsmbLhbLgLsbLsLsmbLsRsbLiLibLiRsLsbRibsbRgbRgbRgRsLsmbRsRsmbs
bsbRsbRgRsmbRobLsbLibLgLsbLibLgbLsbRsbRgbRsbLjbLcRsRsmbRibRsRsmbLjbLoR
sRsmbLhbRgbLgbLgLiLhRgbLsbLibRsbRsLsbLibLsbLsbLsbsbLgbLsbLsbLgLsLcbRsR
smbRsbsbsbRsRsRsmmbsbsbLsbLsRsbRsbLiLsbLsLgbLibLsLsmbLgLsbLibsbsbsbsbs
bsbsbsbsbsbsbLgLcLgLsLsmbRgbLibLgLsbLibLgbLgbLgbLsLgLgLsbLibsbLsbLgRsb
LsbsbsbsbLsbsbLiLgbRsRsmbLibLcRsRsLsmbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 155737; End: 160240;
Recording: 1-1; Individual: 36; Drug: PCAP814 3 然 Apo 50 然
bRoLsbLhbLgbLsbLobRsbRsRsmbLcbsbRsbLibLgbLgbLgbLcbRiRsmbRgbRsbRcLsLsmb
RibRcbRibRgbLobLgbLgbLgbLibLcbsbRiRsmbRgbRsbRebLsbLgbLgbRgbLgbLobRsbRs
bRhbRsRsmbRebRibRobsbRhbRcbRsbRhbRjbRibLsLsmbRsbRibRibRebRobRibRgRebLg
bLcbRsbRibsbRsbLobRcbRsbRgbRsRsmbsbRsbRsbRibRgRebRcRebLsbLsbLgbLibLgbL
sbLibRgbRsRsmbRgbRgbRsbRgbRjbRibRiRsmbRjbLsbLsbLgbLsbLsLsmbRjbRebRjbRg
bRsRsmbRsbRsbRgbRsbRgbRgbRsbRsbRsbRgRsmbRsbRgbRgRsmbRgbRgbRebLgbRebRgb
RgbRsRsRsmmbRsRsmbRgbRgbRgbRgbRgbRebRhbRgbRgbRsbRsbRsRsmbRgbRsRsRsmmbR
cRebRsRsRcmbLsbRibRsbRgbRgRsmbRsbRgbRsbRsbRjbRibRsbRgbRcbRsbRibRgbRsbR
sRsmbRjbRcRebLgbLgbLcbRibRhRsmbRsbLibLsbsbLhbLcLsmbLgbLibLcbRsbRiRsmbR
iRebRhbRiRsmbRsbRsbRsbRjbRsbRsbRsbRebLsRebLsbRibRibsbRibRiRobLgRsbLibs
bLgbLcRsbRiRsmbRibRobRcbRibRsRsmbRgbRgbRsRgbRsRsmbRgbRgbRgbRgbRgbRibsb
RcbRibRcRoRhbRhbRgRsmbRgRsmbRsRsmbRgbRgbRsbRsbRsbRsbRibRgbRgRsmbRsbRgb
RiRsRhmbsbRsbRsbLsbRibRgbRgbRgbRibRcRsRcmbRhbRibRgbRgLsbRsbRsbRsbRsRsm
bRsbRsbRsbRsbRgRsmbRsRsmbRsbRgbRsbRsRsRsmmbRgRsmbRsbRgRsRsmmbsbRgbRsbL
cLhbsbLibLgbsbsbRsRgbRsRsmbRcbRibRgbRgRsmbRiRsmbRhRcbRsbRsbRsbRiRsmbRs
bRsbRsbRgbRsbRsbsbRsbRgbRsbRsbRsbRgbRgRsmbRsRsmbRsbRgbRsRsmbRgLsRsbRsb
RsRgbRsLsbRsbLsbRsRgbRgRsmbRgbRsbsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 155737; End: 160240;
Recording: 1-1; Individual: 37; Drug: PCAP814 1 然 Apo 50 然
bsbRobRcLsbLsLsmbLsbLcbLoLsmbLibLobLhbLsRsbLsbRoRsmbRsbRcbRhbLsbLsRsbR
cbRhbRibLsbLgbRoLsbRibRobsbLhbLcbRsRsmbLobLcbLebLcbLsbLobRibRobRcbRibR
cLsbRobRcbRibsbRhbLgbLhbLcbLibLcLsmbLhbLcbsbLjLsmbRgRsmbRibRsbRibRibLs
LsRsmbRobRsbRcbsbRsbRiLsbRobLsbLsbRsLibLcbLsbsbLsbLibRsLsLsmbRobRgRsmb
RibRsRsmbRibLsbRsbLobLsRsbLobLgbRsbRsLsbRibRsbRibLsbRsbRgbRsbRgbRcbLib
LcbLibLgbLsbLsbLsbRsbLsLsmbLsLhbLgbLsbLgbLsLhbRsbLibLgbLibLsbLgbLsbLcb
RsbLsLsmbRcbRibRsbLcbRgbRcbRsbLcLsRsmbLsbLgbLgLsbLgLsbLsLsmbLsbLsbLgbL
sbLsbLsLsmbLsbLsbLsbLgbLsLsmbLgLgLiLsLsmbLcLsmbLsLsLsmmbLgLsLeLsLeLsbL
sLcRsbsbRcbRsbRsbsbRsRsmbRsRsmbsbRoRgbRsLsbRcRcRhbRiLsbRgbRgRgbRgLsRsR
smbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 155737; End: 160240;
Recording: 1-1; Individual: 38; Drug: PCAP814 1 然 Apo 50 然
bLobLcbLhbLebLcbLhbLobRsbRiRsmbRhLsbRsLsbLsbLobLsbLibLiLsbLgbLhbLcLsmb
LgLsbLcbLebLsbLsbLibLobLsbLsbLiLsbLhbLsbLsLsmbLhbLcbRsRsmbRgbLhbLibLsb
RcbRibRiLsbLsbLibLcLsmbLibLsbLsbLibLhbLgbLsbLsbLibLcbsbLgbLsbRsbLibLib
LgbLibsbLsbLgbLibLibLcbRcbRsbRsbRgbRcbRjbRjbRebRibRobRhbLsLsmbLgLsbLgL
sLsmbRcbLgbLiLibLcbLsbLibLibLhLsbLibLibRjbRjbRsbRsbLibLcbLibRjbsbRebRg
RsmbRibRcbLgbLcbLibLibRobRjbRobLsbRsbRibRgbRibRibLsbLgLsbLsLiLsbLgbLcb
LibLsbRobRibRcbRcbRgbRobRcbRgbLcbLgLsLsmbsbLibsbLgLsbLgLibLiLsbLgbLcbR
ibRebRcRsmbRgbRsbLsbRibRiRsRsmmbRiRgRgbLcbLibLcLsmbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 155737; End: 160240;
Recording: 1-1; Individual: 39; Drug: PCAP814 1 然 Apo 50 然
bRibRgRsmbRsbLcbLcbRobRibRobLsbLiLsbLobLcbLobLsbLobLjbLobLhbLcbRibLobR
sbRibRoRsmbLibLobRsRsmbRibRobLhbLgbRobRobLhbLebLebRibRibRobLibLibLcbRg
bRhbRiRsmbRsbRobLsbLsbRibRibRgbLsbRibRibRibLsbLgbLsbLibLobRsbRgbLibLgb
LibRsbLibLhbLsbLgbLibLsbLcRsbLibLibRgLsbRsbLsbLibLsbLibLibLhbLibRsRsmb
RibLsbRsbRgbRgbLobLiLsbLibsbRsbLgbLgbLcbLcbLsbRsbLgbRsbLibLgbLsbLibLob
RsbRsbLibRsbRgbRsbRsbRgbRgbRsbRsbRgLsbLobLibLibLgRsbLgLsbLibLsbLsbLgbL
ibLibLgbLgbRsbLsbLgLsbLibLgbLgbLjLsmbLgLsbLgLsbLsbLgbLibLsLsmbLibLibLi
bLsbLgbLsLsmbLgbLibLibRsbLsbLibLgbLgbLsbLiRsbLsbLgbLsbLsbLsbLsbLsbLgbL
sbLgbRsRsmbRsbLgLsbLsLsmbLibLibLibRsbRsbLcbLsbLsbLibLgLsLgRsbRsbLgbRob
sbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 155737; End: 160240;
Recording: 1-1; Individual: 40; Drug: PCAP814 1 然 Apo 50 然
bLgbLiRsRsmbLgbRgbLibLibLsbLebLgbRsLsbLsbLhbLiLsbRgbLsbLiRsbRobLsbRibR
gbRsbRibLiLsbRibRibRobRgbRcbReRsmbRhbRgbLsbRhbRcbLsbLgbRoRsmbRobRibRob
LebRjbRcbLgbRcbRcbRhbRsbLgbsbRebRjbRibLibLobsbsbLobRibLhbLhbRibRsbLhbL
obRsbLobRibRcbRsbRjbRhbLsLsmbLsbLibLhRsbLibLibRgbRibRsLsbLsbRibRobLgLs
bLibRsbLcLsmbRgbLobRgbRgbRhbRiRsmbRgRsmbRebRibRsbRsbRsbLsbRsbRibLhbLib
LsbsbRsbsbRhbLsRsbRibRcRsRsmmbRiRsRsmmbLeRsbLibsbRebRobRebRibRgLsLsmbR
gbRsRsmbRgbRgbRgRsmbRgbRgRsmbRgbRjLsbRibLsbsbLgbLsbsbsbsbsbsbsbsbsbRsR
smbsbsbLsbsbsbsbRjbRibLcLhbRobRgbRgRsmbRgbRsbRgbRgLsRsbRsbRgbRgbRibRib
LsRsbRebRgbsbsbLsRsbRcbRcbRjbLsbsbLsbRobRiLsbRgbsbsbRgRsRsmmbRibRsRsmb
RgbRsbRgRsmbRsRsmbRgbRgRsmbRsbRgbRgRsmbRibsbRgRsLsmbRibRiRsLsmbRgRsmbR
gRsmbRsbRiRsmbsbRiLsbRibRgRsmbsbRsRsmbRibRgRebLcbRgbLsLsmbRgbRibsbsbRi
bRiLsbRsRsRsRsmmmbRibRgbRgbRibRibLsbRibLsbRjbRibLcbLibRsbsbLobRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 155737; End: 160240;
Recording: 1-1; Individual: 41; Drug: PCAP814 1 然 Apo 50 然
bRgbRibRobLibRobRjRsmbRgbRgRsmbRibRibRibRsbRsbRsbRcbRsbRcbRoLsbRjbRebR
gbRgRsmbRgbRibRibRsbRhbRebRibRgbRibRibRebRibReRsmbRgbRgbRibRgbRibRhbRi
bRgbRibRgLsRsbRgbRgbRgLsbRibRgbRibRhbRibRgbRgbRiRsmbRgRsmbRiLsbRibLibL
jbLibLibLiLsbLsbLsbLgbLcbLgLsbRcbRsbLhbLibLgbLsbLsbLhbLgbLsbLibLhbLebL
gbLibLobRsRsmbRgLsbLhbLiLsbLgbLsbLsbLibRsbLsbLhLsbLsbLsbLgLsbLgbLgRsbR
cbRgbLgbRsRsmbLobLebLiLsbRgbRcbRibLebRsbLibRsbLcbLgbLgbRsLsbLsbLsbLcLs
LimbLgbLsbRoLsbLeLgbLgbLiLsbRcbRibRgLsbRsbRibRgbLobLgRsbLsbLcLsLgmbLeb
LsbLgbLeLgbLgLsRcbRcRsmbRibRgRsmbRcbLsLsmbRgbRebRgbRcbsbRhbRebRebLcbLo
LsLsmmb

>ZF Recording 2016-06-02; tW: 300s; Start: 155737; End: 160240;
Recording: 1-1; Individual: 42; Drug: PCAP814 1 然 Apo 50 然
bLsLsmbRsRsmbLiLcbRibLgRsRsmbRhbLsRgbRgbRgbRsRsmbRsbRgbRgbRgbRgRsmbRsb
RgRsmbRsRsmbRsRsRsmmbRsbRiLeLsbRobRibRsbRibRgbRgbRsbLsbRsRsRsmmbRgbRsb
RsbRsbRsbRsbRibLjbLcbLgbLiLsLsmbLgbLsbLsRsRsmbLsbsbLsbLsbRsbsbLsbRsbLs
bLgLgRsbLcLcbRsLsRsbRhbRsLsbRgbRsRsmbRsbRsbRsbRsbRgRsRgRsmmbRhRsmbLgbL
ibsbsbLsRsRsmbsbLsRsbRsbLsbLsbLsbRsbsbLsbLsbLsbsbRsbsbsbsbLsbLsLgLhRsb
RsLcbLjLsmbLgbLsbLgbRsbLsLsmbLsbLsbLsbLsbLgLeLgbLcbLibLgbLsbLsLsmbLgLs
LsmbLgLsbLsbLsLsRsmbLsLsmbLsLsmbLsLsLsmmbsbsbsbsbRsbLsbLsLsmbLsbRsbLgb
Libsb

>ZF Recording 2016-06-02; tW: 300s; Start: 155737; End: 160240;
Recording: 1-1; Individual: 43; Drug: Control Apo 50 然
bLsbLsbLsbLibLoLsRsmbLsbRsLgbLcbRsbLjbLsbLebRiRsmbLjbLebRebLgbLgLsbLib
RebLibRebRcLsbLibRoRsmbRgbRebLgbRjbLobLobLsbLobsbsbsbLsRsbRsLsbLsRsLsL
sRsRsmmbRsLsRsbRsRsmbsbsbsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 155737; End: 160240;
Recording: 1-1; Individual: 44; Drug: Control Apo 50 然
bLgLsbLcbRcbRsbLsbLjbLibLobLsRsbRibRsbRsLsbRcRsRsmmbLsbLibLsbLgbRsbRgL
sbLhbLsbRibLibLgbRsbLgbRsbLibLsbLgbRsbLibLsbLgbLsLsmbLgbLsbLgbLsbLgbRg
bLgbLgbRgbRcbRgbLsbRiLsbLsbLsbLsRibLiLsbRsbLgbRgbLibRsbLgbRsbLhbLsbLob
LsLgbRsRsmbRoRsmbLsbLgbLsbLsbLibRsbLgRsbRsbLcbLsbLgLsbRsbRgbLsbLgbLiLs
bLsbLebLibRobLsbLgbLgLsbLsbRsRsmbLgLsbLgbLsbLgbLgbLeLsbLebRsbLsbRcbRob
LsbRcbRsbRgbLsRsRsmbRjRgbRgRsmbRgbRsbRsbRsbRiRsmbRiRsRsmmbsbRiRsmbRsbR
gbsbRsbsbLsLsmbLsRsbRiLsRsLsbRsbRiRgbRsLsbRsbsbsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 155737; End: 160240;
Recording: 1-1; Individual: 45; Drug: Control Apo 50 然
bRibRgbRcLsbRsRsmbRsRgRibRsbRiLsbLoRsbRibRsbRgbLobRoLsbLsLsmbLoRsbLsLs
mbLebLobRgbLgbLibLibLibLgbLibLcbLsbLsLsmbLsbLsbLibLgbLsLsmbLsbLsbLsbRs
bLsbRjbRibRsbRsbLibLgbLgLsbLsbLgbLgLsbLsbLgbLgbLgbLgbLsbLgbLsbLgLsbLgb
LsbLgbLeLsLsmbLgbLgbLgbLsLsmbLgbLsbLgbLeRsbRgRsmbRsbRsbRsbRgbRibReRebR
gbRgbRgbRgbRgbRgbRgbRgbRsbRgbRgRebRsbRsbsbRgbRsRsmbRgbRgLsbRgRsmbRsRsm
bRgRsmbRsbRgReRsmbRebRgbRiRebRgbRsbRgbRsbRgbRsbRgbRgbRsRsRsmmbRsbRsbRg
bRgbRsbRsbRsbRgbRsbRgbRsbRgbRsbRsbRgbRgbRsRsmbRgbRsbRgbsbLsbRsbRsbRgbR
gbRsbRsbRgbRgbRgbRgbRsbRgbRgbRgbRsbRgbRgbRgbRgbRgbRgRsmbRgbRsbRgbRsbRs
RsRsmmbRgbRsRsmbRgbRgbRsbRebRgbRgRsmbRgRsRsmmb

>ZF Recording 2016-06-02; tW: 300s; Start: 155737; End: 160240;
Recording: 1-1; Individual: 46; Drug: Control Apo 50 然
bLgbLhLcRgbRsbsbRibRgbRgRsmbLobLcRsRsmbRgbLibLgRsbLgbLoLsRsmbLibLhbLib
LsRsbLgbLgLsbLgbLgbLsbLgLsbLhbRjbLobLiLsbLsbLsLsmbLgbLgbLgLsbLsbRjRcbL
hRsbLgbLgbLsbRjbRebRiRsmbLobLiLsbLsbLsbLgbLgbLsbLsbLgbLiRsbLhbLcbLcbLc
bLcRsbRcbRhbRcbRcbRcbRhbRcbRhbRsbRhbRhbRebRhbRcbRibReLsLsmbRhbRibRibRi
bRiRsmbRjbRjRsmbRgbRsbRsbRibRibRibRhbRjbRebRgbRibRibRjRibRhbRjbRibRibR
ibRibRsbRibRibRsbRgbRgbRgbRgbRsRsmbRibRsbLsRsbRsbRgRsmbRsRsmbRgRsmbRsb
RgbRsbRsbRgbRgLsbRgbRgbRiLsbRsbRiRsmbRgbRsLsRsbsbRgbRsRsmbsbRsbsbsbsbs
bsbsbRibRgbRiRsmbRgRsmbRiRsmbRgRgbRgLsbRibRgbRiRsmbRibRibRgRsmbRgbRgbL
sbRgbRgRsmbRgLsbRgbRgbRgbRsbRebReRsRembRebRgbRgbRgRsmbRibRgbRgRsRimb

>ZF Recording 2016-06-02; tW: 300s; Start: 155737; End: 160240;
Recording: 1-1; Individual: 47; Drug: Control Apo 50 然
bLobLcbLcbLcRsbsbRobsbLibRoRsRsmmbLobLcbLobLcbLoLsmbRsRsLsmbRobRcbRcbR
cbRobLibLobLcbLcbLobLcbRoRsmbRcbRcbLsbRcbRobRebLjLsmbLcbLcbRcbLobLjLgb
sbsbRcbLobLiLsbRsRsRsmmbLsLsmbLsbLsLsLsmmbLoLsmbRgbRsbRibLsRsbRgbRsbRs
RsmbRsRsmbRsRsmbsbsbsbsbsbLsbsbRsbsbsbRsbRibsbRsLjbRsbsbLsRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 155737; End: 160240;
Recording: 1-1; Individual: 48; Drug: Control Apo 50 然
bLsbLgbLgbLoLsmbLsbRsbRgbRgbRgbLobLjLsmbLgLsbLsLsmbLgbLgbLsbLgbLgbLgLs
bLsLgRjbsbRgbLgRsbLgbsbLsbLjbLibLiRsbRsLsbRsRgbRsbRibRoRsRsmmbLsbLgbLi
LsbRsbLgbRsbRsbLgLsbRsbLgLsbLcbLoRsbLibRsbRgbLsbRibLsbRsRsmbLsRsbLcbRo
LsbReRgbRsbRjbLobLibLsbLgbLgLsbLsbLgbLsbLsLsmbLobLsbRsbRibLoRsbLhbRgbL
gbRgbRjbRcbRgbRoRsRimbLsbLibLgbRgbLgRsbLsRsbLgbRsbRsRjbRhRiRsmbLsbsbRg
bLhbRcbRhRsmbRgbLsbLsbLobLjbLobsbLcbLsbLsbLgbLoLsLsmmbRsbRsbRjbRoLsbRi
bLsbLsbRgbRsRsmbLobLcbLgbLsLsmbLsRsbLsbLsbsbLsbLsLsmbsbLsbLsbLsbLsLsmb
LsbLsbRsbRsbRjbRjbRibRibRjbsbRhbLsRsbRsbsbsbRcRhLsbLsLsmbLsbLobsbsbsbR
obRcbLobLcbLcbLoLcLsmbLsbsbLcLcbLgbsbRsbsbRsbRsbLcbLcbRcbRibRgRsmbRgRs
mbsbsbsbsbsbLcbLcRsRsLimbRsbRsLsbLsbLgbLhbLibLcbsbsbsbRjRsRsmmbsbRibRs
bRsbRsbRsRsmbRibRcbRcbRib

>ZF Recording 2016-06-02; tW: 300s; Start: 160241; End: 160753;
Recording: 2-1; Individual: 1; Drug: PCAP814 10 然 Apo 50 然
bsbsbsbsbsbsbLsbLsbLsbRsbLsbLsLsmbLsbLsbLsbLsbLsbLgbLobRcbsbsbRebLgbLs
bRsbsbRsbRsbLsbsbRsbRsbRsbRsbRgbLobRjbRgbLsbLsRsbsbRsbRsbRsbRsRsmbsbRs
bsbRsbRsbsbsbLsbLsbRsbsbsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 160241; End: 160753;
Recording: 2-1; Individual: 2; Drug: PCAP814 10 然 Apo 50 然
bLsbsbRsbsbsbLsbRsRsmbLsbLsbsbLsbRsLsRsLsbLsbLsLsmbRsLsbsbRsRsmbsbsbRs
bLsbLsbLsRsRsmbLsbLsRsbsbLsbRsRsmbRsbRsbLsbsbLsbsbsbsbsbRsRsmbRgbRgbLe
bsbRsbRsRsmbRsbRsbRsbRibRsbRsbLcbsbsbsbsbLsbsbRsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 160241; End: 160753;
Recording: 2-1; Individual: 3; Drug: PCAP814 10 然 Apo 50 然
bLsLsLgLsmbsbRsbLjbsbsbsbsbRgRsmbRjbRcbLobRcbRgLsbRjbRhbRgRobLsbLsbLob
LgbRhbsbLgLobLiLsbLeLsbLsbLeLsbLcbRebLebRhbLsbRcbRjbRoRsLsmbRsbLsRsbRs
LsbRgRsmbRgbsbsbRgbRsbsbsbsbsbRjbRjbLgbsbsbRsLsRsRsmbsbsbsbRsbRsbsbRsb
sbLsbsbsbsbLsbsbsbLsbLcLsmbLsLsmbRibsbReRsmbsbRiRsmbRsbRsbLsbRsbRsLsbR
sbsbLsbLgLjbRsbLjbRgbRebLjbsbsbRsbsbsbsbLsbLsbRsbLsbsbRsbsbsbLsbRsLsbR
sbRsbLsbRsLgLsLgRsbRcbRsbRibLgbsbLebRsbLsLsmbLsbRsbRsRsmbRibsbsbsbsbRi
LsbsbsbsbRhbLgbRsbRsbsbsbRsRsmbLsbLsbRsLsbRsLsLsLsmmbsbsbLsbLsbRibLsbL
sbLgbLsRsbRsbLgRsLgLsbLsbLsLsmbLebLgbLsbLibRhLsbLsbRgLsbRsbsbRsbsbsbsb
sbsbsbRsbLsbLsRsRsmbRsbsbsbRsbsbsbRcbRgRsRsmmbsbRsbRsbLgbRgbLgbLsbRsbs
bLsbRibLsbRsRsmbLsLsmbRsRsmbsbRhbLsbRsbRcb

>ZF Recording 2016-06-02; tW: 300s; Start: 160241; End: 160753;
Recording: 2-1; Individual: 4; Drug: PCAP814 10 然 Apo 50 然
bLjbLoLsLcLsmmbLgbRgbRgbRcbRgbRsbLsbsbLsbRsbLcbRsbRsbLsbRibRsRsmbRsRsm
bLsbLsbLsbLsbLebRjbRsbsbLsbsbsbsbsbsbsbsbsbsbLsbLsbRgbLsbRgbRgRsmbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 160241; End: 160753;
Recording: 2-1; Individual: 5; Drug: PCAP814 10 然 Apo 50 然
bRgbRgbRcbLsLcbLgLsbsbRebLcbLsLebLsLiLsbRsbLebLebLgbLsbsbLeLsbsbLibLeb
sbsbRibRsbRiRsmbRgbRsLsbRgbRgbRsbRsbLebLibRsbRsbLebRsbReRsLjmbRobRgbLe
bRsLsLjbLsbRsRsRsmmbsbsbsbRsLebLsRsbLcbRsRsmbLgLsbLhbsbsbLibLsLsmbLsbL
sbLsbsbsbsbsbsbLsLsmbsbsbsbLibsbsbsbRcbRebLsbLsbRsbsbRsbsbLsbsbLsbRsbR
gRsmbLgLsbLebLsbLjbLebsbsbsbLibRgbRsbRsbRsbRgRsmbsbsbsbsbRgbRgbLsLsmbs
bRsbRsbsbsbsbRsbsbRsbRebRgbLjbLsbsbRibLibLebRobRjbRgLsbRgbRsRsRsmmbRsb
RibRsRsLsRsRsmmbRgbsbRsbsbRsbRsbRsRsRsmmbRsbRsbRsbRgbRsbRhRsmbLsbLobLg
bLibRsbLgbLeLsbLsLgbLsbLsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 160241; End: 160753;
Recording: 2-1; Individual: 6; Drug: PCAP814 10 然 Apo 50 然
bRjbRsbLjbRjb

>ZF Recording 2016-06-02; tW: 300s; Start: 160241; End: 160753;
Recording: 2-1; Individual: 7; Drug: PCAP814 3 然 Apo 50 然
bLsbLgbRsLsbLsLsmbLsLsLsmmbRsLsbLgRsbLsbLsLgbsbsbLgbLsLsmbsbLsbLgbLsLs
mbLsbLsLgLsbLsbRsbLgbLsLsmbLgbLsbLsLsLsmmbLgLsbLsLsLsmmbLgbLsbLsbLsbLs
bLsLsmbLsbLsbsbLsbLsLsLsmmbLsbLsLsmbsbLsLsLsmmbLsbLgbLsbsbLsLgLsLsLsmm
bsbsbLgLsbRsbsbRsbRsbsbRgbRsbsbsbRjRsmbsbsbsbLsRgRsmbsbsbsbsbRgbRsbsbR
sRsmbRsRsmbRgbRsbLobRgRsmbLsLsmbsbsbsbRsbRsbRgbsbsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 160241; End: 160753;
Recording: 2-1; Individual: 8; Drug: PCAP814 3 然 Apo 50 然
bLsbLsbLgbRsbLsLsmbLsbRsbLsbLsbLsRsbLsLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 160241; End: 160753;
Recording: 2-1; Individual: 9; Drug: PCAP814 3 然 Apo 50 然
bLcbLsLiRsLibLsbLsbsbLgbLgbLsbLsbLsbLcbLibRsbsbRibReLsbLsbLgbLcLibRsbs
bsbsbsbsbsbRsbRsLsRsbRsbRsRsmbRsRsmbsbsbsbLebRsbRcbRcRibLsLsmbRsbReLsb
RcbsbLsLsmbsbLgbRcbRibRsbRsbsbLsbLsRsbRsbsbRsbRsbLsbsbRsbLsbRsbRsRsmbR
sbRsbsbsbLsRsbRsRsmbRsbsbsbsbsbRsRsmbsbLsRsbRsbRsbLsbRsbRsRsmbsbRgbRsR
sRsmmbsbsbRsbRsbRsbRsRsmbRsRsmbRsRsmbLsbRsRsmbRsbRsLsbRsRsmbRgLsbRsbRs
bRsbRsbRsbLsbRgbRsbRgbRsbRgbRsbsbRsbRsRsmbRgbRsbRsRsRsmmbRsbRgbRsbRgbR
gLsbRsRsRsmmbRgbRsbRsbRsbRsbsbRgRsmbRsRsmbRsbRgRsmbRgbRsbRsbRgbRgLsRsb
RgRsRsmmbRgRsmbRgbRgbRgbRgRsmbRgbRgbRsbRgbRgbRsbRgRsmbRibRcbLsbsbRebRs
bRgbRgbsbRgRsRsmmbRsbRgbRgbRgbRgbRgbRsbsbRgbRgRsmbsbRgbRgbRibsbRgbLsbR
sbsbRgRiRsmbRibRgbRsRsmbRgbRgRsmbRgbRsbsbsbRsbRgbRgbLsRgbRgbRgbRgbRgbR
gRsmbRgbRibRsRsmbRibRcbRsbRhbRgbLsbRebRiRsmbsbsbRebRsRsmbRsbsbLsbsbLsb
LgbsbRsbLsLsLsmmbsbLsbLsbLsbLsbLsbLsbLgbLsbLsLsmbsbLgbLsbLsRsbLsbLsbsb
sbLgbLsbLgbsbLgbLgbsbLsbsbsbsbsbsbsbsbsbLsbLsLsmbLsRsbLsbLsLsmbLsLsmbs
bLsbLsbLgbLgbLgbsbsbLgbsbLgbLgbLgLsbsbLsbsbLsLsmbLsbRsbLsbLsbRsLsbLsbL
sLsLsmmbLsbLsbLgbLgbLgbLsbLsLsmbsbLgbLgbLgbsbLgbLgbLjbLsbsbLsbLsbLgbLg
Lsb

>ZF Recording 2016-06-02; tW: 300s; Start: 160241; End: 160753;
Recording: 2-1; Individual: 10; Drug: PCAP814 3 然 Apo 50 然
bRsRsmbRebLsRcbReRcbRcbRibRgbRgbRgbRgbRgbRgbRsbRgRsmbRibRgbRgbLsRsbLsb
RsbRsRgbRgbRgbRsRsmbRsRsmbRebRibRoLsbLibLgRsbLsLgbLgbLgbLsbLsLsmbRoLsb
ReRsmbsbLsRsbLsbRgbRibRgRsmbRgRsLsmbRsRsmbRsbRsbRebRgRsmbRsbRhbRgbRoLg
bLoRsbRgRsmbRibRibRgbRibLebLgbsbLebLgbLgbLgbLcbLgbLgLeLsbLgbLgbLsbLsRs
bLibLsbLgbLsbLsbLsLsmbRibRobRgbsbRsbLsLsmbLsbRsbRsbLgbsbsbRsbLsbLsbLgb
LibsbsbLsbLgLsbRsbRsbsbsbsbsbLsbsbsbLsbsbLsbsbsbsbsbsbsbsbLsbReRsmbsbR
sRsmbRsRsmbRgbRibRgLsbRibRibLsbRgbsbRsbRsRsmbRgbsbRsRsmbRgbRibRsbLsbLo
bLibLgbLhbLsbLhbsbLibLsbLsLsmbsbsbRgbLsbLsbLibRsbLgbLgLsbLibRsbLibLoRs
bsbRgbRhbsbsbRsbsbRsbRgbLebLjbLsbLgbLgbLsbLeLsbLsbRgbRebsbRsbRsbRibRcb
RsbRibRsbLsbLsbRsbRgbRsbLebLobLcbLjbLgbLsbLgbRebRgbRebRiRsmbRhbRsbRibR
sbRgbsbRibRgbRgbsbLsbRgbsbRjbRsbRobLsbsbsbRibRibsbRebRgbsbRgbsbRsbRsbs
bRgbRsbRsbRsbRsbsbsbsbsbRjbLobLsbRjbLsbLsbRsbRjbsbRjbRsRsmbRcbsbRibRhb
LgbRsbRhbRhbRebsbRebRcRsmbRgbsbsbsbRgbRsbRsbsbRhbRgbRsbLsbRhRsmbRgbLob
LgbLsbRsbRjb

>ZF Recording 2016-06-02; tW: 300s; Start: 160241; End: 160753;
Recording: 2-1; Individual: 11; Drug: PCAP814 3 然 Apo 50 然
bLsbRcbRgbLgbLjbLiLsbRcbRibRgbRgbLsRsbRsbLjbLjbLgbRsbReRsmbLsbRgbLgbRs
RsmbRgbRebsbRibRsRibRhbLobRhbRgbRcbRgbRsbLsbRgbRgbRgbRgbRgbRgbRsbRgbRg
LsbRgbRhbLsbLibRsbLcbRjbRobRsbLsbRhbRibRsbRgbRgbLcbLhbLgbLgbRsbLsbLsRs
bLsbLgbLgLsbRgbLsLgLsbLiRsbRsbRgbRiRjRgRsRimbRibRgbRgbRgbRgbRibRjbLibR
sbRjbLsRsRsmbRibsbLgbsbRobRgbRibRsbLsbLcbLgbLgbRsbLsLgRsbLsbLgbLibLebL
gbLibRobRibRhbLsLgbLsbLjbRsbRgbLsbLsLgLiLsbLgbLgbLgRsbRsbRjbRibRgbLibR
sRsmbRsRsmbRsbLgbRebLobLgbRsbsbRebRhbRsbsbLibLgbsbRsbLgbLsbLsLsLsmmbLg
LsLsmbRsLsbLgLgbLibLsbLebsbsbLibRibRibRhbRsbRgbRsbRsbRgbLsbsbLsRsLsbRi
bLcbRebLgbLcRsbLgbsbRsbLsLsmbRsbRgbLsbLsbRgbRgbRsbLsbRgbRsbRibsbRgRsmb
RsRsmbLsbLcbLjbRjbRcbLsbRiRsmbsbRsbRsbLsbRgbRsbLsbsbRcbRgbRsRgbLsbRsbL
sbLgbRsbRhRsmbRibRsbRgbRsbRgLsbRgRsmbRsbRsRsLsmbLjbRsbRgbRsbRsbRsRsRsm
mbRsbsbRgbRgbRsbRsRsmbRgbRgbRgbRsRsmbRsbRibsbRsbRgbRsRsmbRsbRgbRgbsbRs
bRebLsLsmbLsbLsbRibRobRibsbRgbRsbRsbRsbRsRsmbRsbRibRgbRsbRsRsmbRgbRobR
ibLjbRjbRiRsLsRsmbRsLsbsbLjbRsbRsbLhbLsbsbRjbRsbRsbsbLsbLsbLgbLsbRsbRe
bRjbLsLgbRsbRsbLgbLibLsbRgbLebLsRsbRsbRgbsbsbRobsbRsbLsbRsRsmbLibRobRg
RsmbsbLhbLibRsbRsLsbLsbRibRgbLsRsbLgbLsRsbRsbRoRsmbRsbRsbRibsbRsbRsbLs
bRsbRsbRgbRgRsmbRsRsmbRgbRgbRgbLgbRgbRgbLsbRsbRcbLsRsRibLsbRgbRiRgbRib
RjbRsbRsbRsbLobLibsbLebsbsbRjbLsbRjbLsbsbRjbRsLsbRcbsbsbsbRiRsmbRgbLsb
LgbsbLsbsbLsbLjbRgbLibRjbRhbRgRsmbLjbRgbLib

>ZF Recording 2016-06-02; tW: 300s; Start: 160241; End: 160753;
Recording: 2-1; Individual: 12; Drug: PCAP814 3 然 Apo 50 然
bLgbRcbRiReRgReRiReRgbLsbLsRsbLsbLjLhbRjRsmbRsRcRgRsmbRsRsmbRiRiRgLsbR
sRsmbLiLsbLcbLiLsbLsbLcLiLiLsbLgbLsbLsLebLebRjbRcbRiRsmbRgbRgLsLsmbRib
LsbLibsbsbLsbLiRsbLsLiLebRibRibRsbsbsbRiRcRibLcLebsbsbLsbLibLsbLgbLeLe
LhLebLsLsmbLobRcLsbRibRibLsLsmbRcbRgbRiRsmbRiRsmbRiLsbRiRsmbRgbRgbRgbR
gbLsbRibsbsbLcbsbRsLsbRibsbRgbRibsbRsbsbRebLsbsbRsbRhbRsRsmbsbLibLhbLi
bsbsbsbsbLsbRgbLsRsbsbsbRcbRsbsbRibLsbRgbRsbLsRsbRibsbRsLsbRsbLsbsbRgb
sbRgbsbRiRibLgRsbsbRhbsbsbsbsbRcRsLsmbsbRsbRoRsmbLgbRsbRcbsbRgbsbLsbsb
sbsbsbsbLsbRsbRsbsbLsbsbRgbsbsbLcLsmbLsbRjbRsbRgbRsbRsRsmbRiLsRsRsmbRs
bRcbsbsbLiLsbLsbRsbsbRsbLsbsbLibRsbsbLjLibRsbLsbsbRsbLsbLcbLcbLsLgbLoR
sbLsbRjbLcbRsLsbLcbsbLsbsbsbRhRsmbRiRsmbsbRibRsbRsbsbsbsbsbRsbsbLobLoL
sLimbLcLiLebsbsbsbsbRsLsLsLsmmbsbRcbRibLsbRsbRsLsbRcRibRibLsbLcbLsbsbR
sbRsbsbRsLsbRgbLsbsbLgbLsbRsbRsbRsLsbsbRiLsRsRsRsRsRgmmmbRsRsmbRgbRebL
sbsbsbLsbsbLsbLsbRjRjbRsRsmbRgbRsRsmbRgLsbRsbLjRsbsbLobsbsbsbsbLsLiLiL
gLcLiLebRsbLgbLgbLebLcbRsLsbLiRibRiRsmbRgLebLibLgbLibLsLsmbRiRjRibRcbs
bRgbLcLsLsLsmmmbLsLsLsmmbsbRsLsLsmbsbRcbRgRsRsmmbRgbsbsbRsbLsbsbLobLsb
Rsb

>ZF Recording 2016-06-02; tW: 300s; Start: 160241; End: 160753;
Recording: 2-1; Individual: 13; Drug: PCAP814 1 然 Apo 50 然
bLobRcbLobLobLcbLobRobLsbLobLcbLobLobLjbRobLebLobLobRebRebRjbRobRobLjb
LobLobLjbRjbLebRjbLjbLebLebLobRobLcbLjbRobLcbRcbLebLjbRebLebRebLibLcbL
obLobRobLgbRobRibLebLcbRebLobRobLcbLgbLjbRjbRobLgbRsbLebRobLobLobLobRc
bLobRobLibRebRibRobRobLebRobRobRebLebRebLobRcbLebLibLcbLebRgbRibLcbLeb
RobLobRobRebRobRebRcbLcbLibLebLgbRobLobRcbRebLobLibRobLgbLhbRebRcbLobR
obLobRobRgbLobRgbLgbRobLebLobRobLcbLebRobLjbLobRcbRcbRobLobRobLobRcbRo
bLgbLebLcbRobLobLobRobRebLobLobLgbLebRcbRobRobRgbLjbRobLgbRgbRobLobLeb
RjbRebLobLobRcbLobRsbLobLobRcbLgbRibLobRobRebLcbLsbRobLcbRsbRibRebRobR
obRgbLobRsbLibRobRobRobRgbRobLobLobLobRobLebLibRobLcbRebRobLebLobRibLi
bLobLcbRobLsbLebRobLibRebRobLobRobLebLebRebLgbLsbRobLebLcbLcbLgbRobLob
LobRebLobLsbRgbLobRobRebLhbLebRobRcbLobRebRobLebLobRobLebLebLebLebRibL
gbLobLebRgbRobRibLcbRobLobLjbLebLobLebLobLebLsbRobRebRobRsbLebRobLobLc
bLgbLobRobLobLibRsbLobRebRebRjbRobRgbRebLobRebRebLobLobRobRobRsbRobReb
RobRobLgbRebLobRobLobLebRobRobRebLobLcbLsbRobRebRebRsbRcbLebLibLhbRcbL
obRcbRjbRobLcbRobRgbRebRebLobRebLobRebLjbLebLsbLebRjbRcbLobRibRobLobRe
bRebLobLjbRjbRobRebRobRsbRebRcbLebRebRobLsbLobLebRobRobRjbRobLebRjbLob
RebRebRobRebLobLebRebRobRgbRobLebLebRebRobRebLobRobRebLcbRjbLcbLobRcbL
jbRebRobLcbRcbLgbLobRebLobRobLebRsbLhbLcbLcbLsbLobLcbRebRobLcbLcbLebRs
bLsbRebRjbRibLobRobLibLcbLhbRobLobLcbLebLobRsbRebLsbLjbLobLcbRjbRcbLjb
RcbRcbRibRjbLibRibLebLcbRobRcbLobRgbLebRebLobLebLobLobLebLsbRebRobLcbL
obRcbLcbLcbRebLcbRcbLcbLobRsbRobRgbLjbRgbRsbRobLcbRebLobRobLgbRobRebRo
bLjbRobLjbRebLcbLibRibRobLgbRobLobRcbLobRobLebLcbRobRobRjbLebLsbLobRob
LebRebRsbLebRcbLobLcbLcbRgbLebLobRebLebLcbRsbLhbRebRcbRebRebRcbLobLobL
ebLsbLjbRobRjbRjbLobRobLobRsbRjbRobRcbLcbLebRobLibRebLobRcbLjbLobLobLh
bRebLcbLhbLcbLobLcbLobRobRebLobLobLobLebLjbLobRobLebLebRobRebRibRcbRcb
RobRobRebRibLebRobLebRebLobRsbRebRjbRgbLobLcbLibLibLibLsbRcbLcbRebRjbR
ibRebRobLibLsbRebRjbRhbLcbRgbRcbRebRobRobLebLebLobLgbLobRobLobRobRobRj
bRobRobRsbLebRjbLibRgbLobLobRobRobLcbRobLsbRjbRobLebRobRobRebLhbRobRob
RobLebRcbLobRcbLobLobLcbRcbRobLobRobLebRcbLebRebRobLcbRobLgbLcbLibRobR
obRebRobRobRebLebLebLobLebLsbLebLsbRobLcbRobLobLjbLobRebRgbLobRobLobRi
bLibLobLobRobRobLgbRebRebRobLcbLebLebRobRobRobLobLcbRebRobRcbLibRobLsb
RgbRobRjbRobRobRobLebLebRobRcbLobRobLebLobLebLobLhbRobLobRobRobLcbRgbL
cbRobRebRcbLgbRebRobLobLobRcbLcbLobLobLcbLsbRebRobLobRhbRebRobLobLsbLo
bRhbLobLcbRobLgbLcbLcbLobLobLjbLobLobLcbRsbLebLcbRibLcbLcbRebLhbRobRob
RcbLcbLibRcbLebLobLobRobRobRebLcbRobLebLibRsbRebLjbRobLebRebRcbRsbRcbL
ebRebRobLobRebLobLebRebRcbLebRsbLebLebLibRjbLobRebLjbLcbLebRcbLobLhbRg
bLobLcbLebLebLcbRebRcbLebRjbLobLebLjbLjbRcbLobRjbRjbLgbLobLobLgbRebLob
LobLobRjbLibLcbLebRobLobRebRebRsbRjbLobRcbLobLcbRjbLobLobLibLebLobRcbR
jbRobRsbLobLob

>ZF Recording 2016-06-02; tW: 300s; Start: 160241; End: 160753;
Recording: 2-1; Individual: 14; Drug: PCAP814 1 然 Apo 50 然
bLgLsbLsLsmbLsbLsLsmbLsLsmbLsLsLsRsmmbLibRgRsmbRgbLsRsbLsLsmbLsbLgbLsL
smbLsLsLsLsmmmbLsLsLsLsmmmbLsLsmbLgbLsbLsLsmbsbLsbLsbLsLsmbLsbLsbsbLsb
RsbLsbLcbLgbLsLsmbLsLsmbLsbLgRsbLsLsLsmmbLsLsmbLgbLsbLgbLsLsLsmmbLsLsL
smmbLsLsmbLsLsmbLsLsmbLsbRsLsbLsLsmbLsbLsLsmbLsbRobRsbLsbRebLgbRgbLsLs
mbLsLsmbLsbLgbLgLsbLgLsbLsLsmbLsbLsLsmbLsLsmbLsbLgbLsLsmbLgRsbLsbLcbRs
bRcbLsbsbLgbLsbLsLsmbLsbLgLsbLgbLgbLgbLgbLsbLsbLgbLsLsmbLsLsmbLsLsmbLg
bLsLsmbLsRsbLsRsbLsbLsLsmbLsbLsLsmbLsLsmbLsLsLsmmbLsbLsLsmbLgbLsLsLsmm
bLsLsmbLgbLsLsmbLsLsmbLsLsLsmmbsbLsLsLsmmbsbLsLsLsmmbLsLsmbLebRsbLsbLs
bLsbLsbLsLsmbLsbLsbLgbsbLgbLsbLsbLsLsmbLgbLgbLsbLsbLsbsbLsbLsbLcLsLimb
RsbsbsbRcbRsRsmbRsbRsbsbsbRsbRsbsbRhbRsbsbRsRsmbRgbRsbRgbRsbsbLsbsbLsb
RsRsmbRsbLsbLsRsbRsbsbRgRsmbRsbRsRsmbLsbLsbLsbLsRsbRsbLsbLsbRgbRsLsbRi
RsLsRsmbRsbsbsbsbsbsbsbsbRsbsbRsRsmbRgbRsbRsRsRsmmbRsRsmbRsRsRsmmbRgbR
gbRgbRsRsmbRsbRsbLsRsbRsbRsRsRsmmbRgbRsbRsbLibLgbLsbsbLsbsbRsbRsbRsbsb
sbsbsbsbsbsbsbRjbsbRsRsmbsbRsRsmbsbRsbRsRsmbRsRsmbRsRsmbsbRsbRgbRsRsmb
RsbRgbRsRsmbRsRsLsmbRsbRsbRsbRsbsbRsbRsbRsbRsbRsbRgbRjbsbRsRsmbsbLsbsb
LsbLsbRsbRsbLsLsLsLsmmmb

>ZF Recording 2016-06-02; tW: 300s; Start: 160241; End: 160753;
Recording: 2-1; Individual: 15; Drug: PCAP814 1 然 Apo 50 然
bRebRcbRjRsmbRebRhbsbsbRcbRebRibRebRibsbLcbsbLgRsbLsbRjbRibRibRhbRibRs
bLsbsbLgbRsbLcbLcbLcbLibsbRjbRcbRsbRjRibRgRsmbRibRsLsbRebRibRibRobLsbL
gbsbRibRgbRiRsmbRgRgbRgbRhbLcbLiRsbLebLobRgbRiRsmbRjRsRsmmbRibRibRjbRi
bsbsbRsbsbRjbRsbRgbRgLsbRhLsbLsbRsbRcRsmbRebLgbRebRhLsbRibRcbsbRgbRsRs
mbLgbLjbLsbLgbsbsbsbsbRgRsmbRsbsbLsLsmbRsbLsbLhbsbLiRsbRsbsbLsLsmbRibR
cbRibRsbsbsbRsbsbLjbLsbLibLibLibLgbLsbLibLgbLjbLsbLgbRjbRjbRsbRhbRsbRs
bsbLsbRibRibRgbRhbRjbLgbRgbRibsbRhbsbsbsbsbRibRsbLibLibsbLibLjbLsbLibs
bRsbRibRcbRjbRgbsbLsbRebLibLgbLibLibLgbLsbLsbLgLsRsbLiLsbLsbLsbLgbLsbL
cLsmbLjbLsbLsbRiLsbRibLsbRsLsbsbRsRibRibRgbRebLsbRsbRibRjbRgbRsRsRsmmb
RiRgRsmbRibRibRhbRgbRibRibRgRsmbsbRsbRhbRjbRgbRsbRsbsbLgbLjbLsbRsbRsbs
bRsbRsbRjbRsRsRsmmbsbRebRibRjbRsRsRsmmbRebRsbLhbLjbRsbLgbRgbLsbLibLsbL
ibLibLibLsLsmbLibLsRsbsbLgbLibLibRsbLgLsbLjbsbsbRsRjbRjbRgbRgbRsbRgbRg
bRsbRebRebLjbRgRsmbRgbRcbRibRjbRsbRjbRjbRgbsbRsbRibRhbRhRsRsmmbRgbRgbR
sbRjbRibRgbsbRgbsbRjbLgbsbLsLsmbLgbLsbLibLibsbRebsbRgbRgbRsLgbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 160241; End: 160753;
Recording: 2-1; Individual: 16; Drug: PCAP814 1 然 Apo 50 然
bsbLsbLhRsbLsbLsbLsLsmbLsLsLsmmbLsLsLsLsmmmbLiLsLsmbLibLsLsmbLgLsbLgbL
jLgbLibLiLsbLsbLsbLsbLibLgbLjLgLsbLgLsLsLsmmbLsLsmbLsLsLsLsmmmbLibLsbL
sLsLsLsmmmbLsLsmbLibsbLsLsmbLsbLsLsLsmmbLgbLsbLgRsbLgLsbLsLsmbLgbLcbLg
bLsbLsbLcbsbsbsbsbLcbLsLsLsmmbLcbsbLgLsbLcbLgbLcLsmbRsbRgbLcbLiLsbLibL
sLobLsLcbLibRgbLsbsbsbLsbLsbLcbsbsbsbsbsbsbLcbLgLhbLsbLsbLibsbsbsbLsbL
ibLsbsbLsbsbsbsbRsbsbsbLsLsmbLsbLsbLsbRsbLsbsbLsbLsLsmbLsbsbLjbLsbLsbL
sbLsbLsLsmbsbLgbLjbLsbsbLiLsbLsLsmbLsbLsLsmbLsbLibsbsbLsbLhLsbLgbLhbRs
bLgLibLsbLgbRsbLcbsbsbRsRsmbsbLjLsmbLsbLsLsLsLsmmmbLsbLsLsLsLsLsmmmmbL
sLsmbLsbLgLsbLibLgLsbLgbLsbLsbLsLgLsbLsLsmbsbsbLsLsmbsbLgLsLsLsmmbsbLs
LsmbLgbsbLibLjbLsbsbLsbLibLgLsbLibLhbLgbLsbLcbLsLsmbLhLsbLgbLhLsbLsbLs
bLsbsbLgbLsLcbsbLsbLsbLsbLsbsbLsbLsbLgbLgbsbsbLgbsbLsbLsbLsbsbsbLhbLsb
LgbLeLgbsbLibLhLsbRsLsbLibLsbRsbLibLeLsbRsLgbLjbLgLsbLgbLcbsbLcLsLsmmb
LibRsbsbLsbLsbLsRsLsLsmbRsRsmbLsRsbRsLsbLsbRsbRsRsmbRsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 160241; End: 160753;
Recording: 2-1; Individual: 17; Drug: PCAP814 1 然 Apo 50 然
bRsbLiLsLsmbLsLsmbLgLsbLiLsbLiLiRsLiLsLibLgLsbLgbLsbLgLsLiLiLibLgRsbLg
LsLsmbLgbRsbLsbLhbsbLibLsLsLsmmbLsbsbLoLsmbLcbLjbLiLsbLgbLsLsLsLsmmmbL
ibsbLhbLcbLiLsbLcbLhbLcbLcbLibLcbLhLsbLsbLibsbsbsbLcbsbLjbsbLibLgbLsbR
sRsmbLsbsbsbsbLsbsbsbsbsbRsbsbLsbsbLsLsmbRsbLsbsbsbsbRsLsbRsbRsbLsbsbs
bsbsbsbsbsbsbLgbLsLsmbLsbLsbRsbsbsbsbLsLsmbRsbsbsbsbLsbRsbLgbLsbLgbLgL
sbLsLsmbRsbsbLsLsmbRsbsbRsbsbsbsbsbsbLsRsbLsbLgbsbLgLsbRsLsbLsLsmbRsbL
sbsbsbLsbsbsbRsbsbsbsbsbsbsbLgRsbRsbLsbRsbsbLsbLsbsbsbsbsbRsbLsbRsRsLg
mbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 160241; End: 160753;
Recording: 2-1; Individual: 18; Drug: PCAP814 1 然 Apo 50 然
bsbRgbLebLsbLsRsbLsLsmbLsbLsbLsbRsbsbLsbsbRgbRsbsbsbsbLsbLsLsmbLsbLsLs
mbLsLsmbLsbLsbLsbLsbLsbLgRsbLsbLsLsLsmmbLsbLsbLsLsmbLsbLsbLsLsmbLsbsbL
sbsbRsLsLsmbLsbLsLsmbLsbLsbLsRsbLsbLsLsmbLsbLsLsLsmmbsbLsbLsLsmbLsbLsL
smbLgLsbLsbsbLsbLsLsmbLgbLsbLsbLsbLsbLsLsLsmmbLsbLsbLsbLsbLsbsbLsbsbLs
LsmbLgbLsbsbsbLsbsbLsbsbLsbLsbLsLsmbLsLsmbLsLsLsmmbLsbLsbLsLsmbLsLsmbL
sbLsbLsLsmbsbLsbLsLsmbLsbLsbRsbLsLsmbLsbLsbLsbsbLsbLsLsmbLsbLsbLsLsmbL
sbsbLsLsmbsbsbLsbLsLsmbLsLsmbLsLsmbLsLsmbLsbLsLsmbLsbLsbLgbLsbLsbLsbLs
bRsbLsbRsbsbsbLsbLsLsLsmmbLsbLsbLsLsmbLgbRsLsbLsbLsbsbLsLsmbLsbLsLsLsm
mbLsLsmbLsLsmbLsbLsbsbLsbLsbLsLsmbLsLsmbLsbLsbLeLsbsbLcbsbLgbLsbLgbLsb
LsbsbsbsbsbRsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbRsbLgbsb
LibLsbsbLgbLgbLsbLsbLsbsbRsbsbsbLsbLsbLgLsbLgLsbLsLsmbLgbLsbLsbLsbsbLs
bLgbLgbLsLsmbLsbLsbLsbLsbLsbLsLsmbRsbRsbRsbRsbsbLsbLsbLsbsbLsbLsbLsbsb
RsbLsbRsLsbLgLsbLsbLsbLsbRsbLsbLgRsbLsbsbLsbLgbLsbLsbLsRsbLsbLsbLsbsbL
sbLsbLsbLsbsbLsbLsLsmbLsbLsbLsbLsLsmbLsbLsbLsLsmbLsbLsLsmbLsbLsbsbLsLs
mbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 160241; End: 160753;
Recording: 2-1; Individual: 19; Drug: Control Apo 50 然
bLsLsLsLsmmmbLobRgbRibRgbRgRsmbRsbRsbsbRsbRsbRsbRsbLsbsbLsbRsbLcbRgbRc
bRsRsmbsbRhbReRsRsmmbLsbsbsbLsbsbRsbsbRsbsbsbsbsbsbsbsbsbsbLeLsbLsRsbR
jbRsbRhRcbRsRsmbsbRgRsRsmmbLcbLgbLsbsbsbsbLsbLibRsbsbLobRsbsbRcbLcbLsb
LgLgbRsRsmbsbRsbsbsbLsbRsbRsbsbRsLsbRsLsbLsRsbLsbLsbLsLsmbLsLsmbLsbsbL
eb

>ZF Recording 2016-06-02; tW: 300s; Start: 160241; End: 160753;
Recording: 2-1; Individual: 20; Drug: Control Apo 50 然
bLsLsmbLjLsmbsbsbsbLgbsbsbsbsbLgbLjRsRsmbLibLjRsbLhLsbLibLibLgbLcbLsLh
bLsLsmbLjbLgRsbLcbsbsbLsbLsRsbRsRsRsmmbLsbRsbRibLsbLsLsmbsbLgLsbLjbRgb
LgLsbRsRsmbsbLgbsbLsRsbLhbLibLgLsbLcbLsbsbRsbLiLsbLsbRgbsbsbLsbRsbLjbL
sLsmbsbRsbLibsbLgRsbLsbLcbRsbRsbsbRibRsbRebRebRsbsbLsRsbLsLsLjmbsbLhbL
ebLgbLgbLgbLjLsmbLgbLibLgbLgbLgRsbLgbLgbLcbRsbRgbsbsbLsRsbLsbsbLsbLsbL
sbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 160241; End: 160753;
Recording: 2-1; Individual: 21; Drug: Control Apo 50 然
bLsbLsRsbRsbLsbRsbLsbLsLsmbLibsbsbsbRjbsbLcbLcbRobRibRcbRsRsmbRhbsbsbs
bsbsbsbsbsbsbsbsbsbRsbsbsbsbsbsbsbsbsbsbsbLsbsbsbRsbLsbsbsbsbRsbsbLsbR
sbLsRsLsbRsbsbsbsbsbsbsbsbRsbRsbRsbsbLsbsbsbsbsbsbRsbsbRsLsLsLsmmbsbRs
bsbRsbsbLsLsmbsbLsLsmbRsbLsbLsRsLsbRsRsmbLsbRsbLsLsRsmbsbsbLsRsbLsRsbL
sbRsLsRsbLsRsbRsRsmbLsbRsRsRsLsRsmmbRsbLsLsRsmbLsRsbRsRsmbLsbRsbRsbLsb
LsbLsbLsRsRsLsLsmmbRsLsbLsLsRsmbRsbRsbLsbLsbRsbRsbLsRsbRsbsbsbRsbRsbLs
bLsbRsbLsbLsRsbsbRsbLsbRsbLsbRsbRsbRsRsLsRsmbRsbLsRsLsLsmbLsRsbLsbLsbL
sbRsLsLsmbRsRsmbRsbLsbLsLsmbLsbLsRsbRsLsbRsbLsLsmbRsbLsRsbLsbLsbLsbLsb
RsbRsbLsRsbLsRsbLsbRsbRsbLsbLsbLsbRsbLsbRsbLsbLsRsbRsbRsLsbRsbRsRsmbsb
RsbRsLsbLsbLsLsRsRsmmbRsLsbRsbRsRsmbRsbsbsbRsbsbLsbLsbRsbLsRsLsbLsbLsR
sbRsRsmbLsRsbLsLsLsmmbLsbLsbsbRsRsmbRsRsLsmbRsLsLsmbLsLsmbRsLsLsmbLsRs
bLsbRsbLsRsbLsbRsRsLsmbRsbRsLsLsmbsbLsbLsRsLsLsmbRsLsbLsbRsbRsbRsbRsbR
sRsmbRsRsLsLsmmbRsRsRsmmbRsRsRsmmbRsbRsLsbLsbRsbLsRsRsLsRsmbLsbLsRsbLs
RsbLsbLsLsmbRsbLsbRsbRsRsmbLsbLsRsRsmbRsbRsbRsbLsbRsRsmbRsLsbRsbsbLsRs
bLsbRsbRsbsbLsbLsbLsbsbsbsbRsbsbsbLsbRsbsbLsbsbRsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 160241; End: 160753;
Recording: 2-1; Individual: 22; Drug: Control Apo 50 然
bRobLibLobLsbLiRsbLobLcbRobRsbsbRgbLobLcbLhbLgbLiLsbLibLibLsbsbRjbRcbL
oLsmbLhbRsbsbLjbsbLcLsmbsbsbRsbRobRjbLsbRsbsbLgbLgbLsbsbRsRsmbRsbRsbRs
bsbRsbLibLcLsmbRsbRibsbRsbRobsbsbRibRiRsmbRsbRsbRibLgbRobLsRsbRsbLsLsR
smbRsRsmbRibRsRsmbRibsbRibRibLsbRobRsbRhbRobLjbLsbLiLsbLibRsbLsLsmbRjb
LhbLsLebsbLeRsbLgbLsbLsbLibLsbLibLsbLsbRsLsbRjbRsbRgbsbRebRsbRhbRhRsmb
LgbLjLsmbLobRobRsRsmbRsbRgbRgbRsbRsbsbsbRsLsbsbLsbsbsbsbsbLsbRsbsbsbsb
sbsbLsbLsbRsbRsbsbRsbsbRibRgRsRsmmbsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 160241; End: 160753;
Recording: 2-1; Individual: 23; Drug: Control Apo 50 然
bLgbLcbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 160241; End: 160753;
Recording: 2-1; Individual: 24; Drug: Control Apo 50 然
bRsbLjbsbLibRsbRgRsmbRjLsbLobLibLjbLjbRjbRsbLjRsbLsLjbRjRgbLjbRgbLsbRg
bsbsbsbRsbLjbLibLjbRsbLsbRsbRsLsbsbsbsbsbLsbsbRsbLjbLjbsbLgbRsbRsLsbsb
sbRsRsmbLsRsLsbLsLsmbsbRsbLsLsLsmmbsbRsbLsRjbLjbLgbRsbLsbsbsbRsbsbsbsb
sbLsLsmbLsbRsbRsbLsbLsbsbRjbLjRsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbRsbsbLsbs
bLgbsbRjbsbRjbsbLjbLjbRjbRjbLsbLjbLsRsbsbRgbLjbsbRsLsbRgbLjRsbLjbLibLj
bLjRsbsbsbsbLjRsbLsbLgbLjbsbRsbsbLsbLgbRsbLibLgRsbLibRjb

>ZF Recording 2016-06-02; tW: 300s; Start: 160241; End: 160753;
Recording: 2-1; Individual: 25; Drug: PCAP814 10 然 Apo 50 然
bsbsbLsbLsbsbLsRsbLsbLgbRsbLoLsLsmmbRsLsbsbRsbsbRibsbRsbsbRsbsbsbRsbRs
bRsbsbsbLsRsRsmbRsRsmbRsbRsRsmbRsbRsbsbRgbRsRsmbRsbRcbRgRgbRgbsbRsbRsb
sbRsbRsRsmbRsbRsbRsRsmbLiLsbLhbsbsbLsbLsbRsRsmbLsbRsbLhbsbsbRsbsbsbLsR
sbRsbsbsbLsbsbsbsbsbRsbsbRsbRsbRsbsbsbRsbRsRsmbRsbsbRsbRsbLgLsbRgbsbLs
bLsbLsbsbsbLsLsmbRcRgbsbRibLsbRsbRsbLsbRsbsbLsbsbRsLsLsmbLsbsbsbRsbRsb
RsbLsbLsbsbRsbsbRibLsbsbsbsbLsLsmbsbRsbRsbsbRibRgbRsbRsbsbsbLsbRsbRsbR
ebRsbsbsbLsbLibLsbLsbLebRebRgbRgbRhbsbLsbRsbsbsbsbLsbRsbLsbLgbLsLsmbsb
sbsbLsbLsLsmbLsbLsbLsbLsLsmbLsLiLobsb

>ZF Recording 2016-06-02; tW: 300s; Start: 160241; End: 160753;
Recording: 2-1; Individual: 26; Drug: PCAP814 10 然 Apo 50 然
bRsbRoLgRsbRebsbRsbLsbsbsbsbsbLsbLsLsmbLjbRhbRsLsbsbRcLgLsbLsbLsbRsLsb
LsLsmbLibLsbsbLjLsLsRsRsRsmmmmbLsbLsbLsbRebRgRsmbLgbRhLsbLgLsbRsRcRsmb
RsLsbRsLsbLsbLgbLsLsmbLsLsLsmmbReLsbLsbRsRsmbRsbReRgbRsLsLsmbsbRsbRsLs
bLsbLsbRsbLsbsbLibLiLgbRebLsLsLhmbRobsbLsbLsbsbLsRsRsRsRsmmmbRjRsmbRsb
LsbRsLsRsbLsbsbLsbLsbLsbsbRsbLsbsbLsbRjbRgbLsbRsRgbsbRebRsbLsLcbRcRsmb
sbLsRgbLebRjbsbLsbRsRgLsbsbsbRiRsLsmbLsRsbLsbLsRgbsbsbRsRjbRsbRjbRiLgb
sbsbLsLsLsmmbLgbRsLsbRsbRsbLsbsbsbLgbLsbLsRsLjbRibRsRsmbRgbRhbsbLgRsbR
sRsmbRsbRsRsRsRsmmmbRsRgbLoLsLsmmbLcbRibsbLgbLsbsbLjLsmbRsbRsRsmbRebLc
bLobRobRsRjbsbLsRsbsbLsbLsbLsLiLsbRsbLsRsbRgbRsbLsbsbLsbRgbRsbReRsmbLs
LsmbsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 160241; End: 160753;
Recording: 2-1; Individual: 27; Drug: PCAP814 10 然 Apo 50 然
bLibRsRsmbLsbLibLsRgbLebRsbRgRgbRibRsbRsbRgbRgRsmbRsbRsbRsRsmbRsbLjbLi
bRcbLobRsbRsbLibRibLsbLsLiRsbRsRsLiRgmbLsbLsLgRgbRsLsbsbLgRsbRgbReRsRs
mmbRsbRsRsmbLsRibsbRsRgbRgRjbRgRebRiLsbRhbLjbRebLsbRebLsRgRsRsmmbRsbRs
bLgLsbRsbsbsbLibLsbLsbRsbsbRsRgbRsbsbReLgRsbRiRsRsmmbRgRsmbsbsbLsbRsbR
sbRgRsmbRsRsmbsbRgRebRebRsbLsbLsLgbLibLebLsRgbsbsbLjbLsRsRgbsbsbLsbsbR
sbRsbRsbRgbsbRgbRsRsRsRsmmmbsbsbsbLsbsbsbsbRsbLsbLsbsbLsbsbsbsbsbsbsbs
bLsbRsbsbsbsbRsRsmbLsbRgbRsLsbsbLsLsmbsbRsLsbLsbRsRgLgRsbLsbsbsbRsbRsb
RhRsmbRhRsmbRiRsmbRsbRsbsbsbLgLsLebsbLebLsbRgbLsbRsbRsbsbsbsbsbsbsbsbs
bLjbLsbLibLiLsbsbLsbLsbLsbLebLhbsbLgbLsbLsLsmbLsLsmbLsLsmbLebRsbRsRsRs
mmbsbRsRsRsmmbRgbRgRsmbsbRsRgbRsRiRhbRgRsmbLobLibLgbLsbsbsbsbRsbLsLsmb
sbsbLsLsmbsbLsLsLsmmbLsLsmbLsbLsbLsbLsbLsLebRsbRsbsbRsbRjbRsRsmbsbRsbs
bsbsbsbsbLsbsbsbsbLsLsmbsbsbsbsbRsbLsbsbsbRsbLjRgbRsbRgRebLsbsbRibsbsb
sbsbsbLsbLsLsLemb

>ZF Recording 2016-06-02; tW: 300s; Start: 160241; End: 160753;
Recording: 2-1; Individual: 28; Drug: PCAP814 10 然 Apo 50 然
bRsRsRsmmbRsbsbRsRsmbRgbLsRjbLcbsbRsbsbRsRsmbRsbLsLsmbsbRsbRsRsmbLgbRs
RsLsmbRsbRsbRsLsbLsLjLsmbLsLsmbLebRibRsbRsbLgbLsLsmbRobLobRsLgbRsLsbLs
LsmbLsbLjbLsRobRsbRobRsbsbsbRsRsmbsbsbRsbRsLsbLsbsbsbsbsbsbsbLsbsbsbLs
bsbsbRsbLsRsbRsbsbRsLsRsRsmbsbLsRsRsmbsbsbsbsbRsbsbsbsbRsLsbRsbsbsbRsb
RsbsbLsbsbRsbRsbRgbLsRsRsmbRsbLgbRebLcbLsbsbRsbsbLsbsbRsbRsbRsbRsRsmbR
sRsRsmmbRsbRgbRsbLsRsbRsbRsbRsbRsbLsbRsbLsbLsbsbRsbRsLsbLsRsbsbsbRsbRs
LsbLsbsbRsbsbRsLsbRsbsbsbRsbsbsbLsbRsbLsRsbsbLsbRsbsbsbLsbRsbRsLsbRsbR
sLsRsLsbLsbsbRsLsbLsbLsbLsbLsbRsbRsbLsLsRsRsmmbLsbRsbLsbRsbLsbRsLsbLsb
RsLsbLsRsRsmbLsbsbLsbLsbLsLsRsmbLsLsmbLobLjbRobLcbLcbRsbRsbLsbsbLsbLsb
RsbLgbLebLsbsbRsbRgbLgLgbLjLgbLsbLsbsbLsRsbsbLsbsbsbsbsbLeLsLsLiLsmbRs
bRgRsmbRsbsbRsbRsbRsLsbsbLsbsbsbsbsbRsbsbLsbsbLsRsbLsbsbsbsbsbsbLsbsbs
bLsbLsbsbsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 160241; End: 160753;
Recording: 2-1; Individual: 29; Drug: PCAP814 10 然 Apo 50 然
bRsbLsbRsbLsbRsbLsbRsbLsbRsbRsbLsbRsbLsbLsbsbsbsbsbsbsbsbsbLsbsbsbsbsb
sbRsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbRsbsbsbRsbsbsbsbsbsbRsbRsbLsbsbsb
sbsbsbsbsbsbsbsbsbsbsbsbsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 160241; End: 160753;
Recording: 2-1; Individual: 30; Drug: PCAP814 10 然 Apo 50 然
bLsLsmbLgbLgbLsbLsLsmbLsbLsbLgLgbLsbLsLsmbLgbsbsbLgLsLibRsbRjbRsbRsbLi
bRsbLgbLsLgLsLsmbLgbLgbLsLsmbLsLgbLsbLsLsmbLgLsbLsbLibLsLsmbLgbLsLiLsL
gbRgbLobLibLsbRhbRobRoRsRgLsRsmbLsLsLsmmbsbsbLsbRsbLsRsbsbLsbsbRsbRgLs
bRsbRgbRgbsbRsbRsLsbsbRsbRgbRgbRgbRsbsbsbLsbLgLgbLjLcbLgbLjbLgbLsbLsLs
mbsbsbLsLsLgmbsbsbLsbLgbsbsbLsbLsbRsbsbLsbLsbLsbsbLsLsmbLsLsmbLgbLsbLs
bsbLsbLgbLgbLsLsmbLsbLsbLsbLsbLiLsbLgbsbLsbRsLsbLsbRsLsbRsbLsLsRsmbLsb
LsRsbLsLsmbLsbsbRsbRgbLsbRsRsmbLjbLjbRsbLsbLsbLsbsbsbsbsbLsbLgbLsbLsbL
sbsbLsbsbsbLsbsbLsbLsbLsbsbRibLsLsLgmbLebRsRsmbRcbRjbRebLibRjLobRcRgbL
gRsbLsRsbRsbRsbsbLsbRsRsRsmmbsbsbsbsbsbLsbsbsbRsbLsRsbsbRsbsbsbsbsbsbL
gbRsRjbsbLsRsbRsbLsbRsRsRsmmbRsbRsbRsRsmbRsbRsbRsLsbLsbsbRsbRsbLsbRsbs
bRsbRsbRgbRsbRsbRsbRsbRsbRgbRibRsbLsbLgbLsbsbsbLsbLsbsbRsRsmbLsbsbLsbR
sbRsbsbsbRgbLsbRsbLsbsbsbLsLsmbRsbLgLsbLsbsbLgbsbsbsbLsLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 160241; End: 160753;
Recording: 2-1; Individual: 31; Drug: PCAP814 3 然 Apo 50 然
bLiLcLiRsbRgbRgRsmbRgRiRgLsLgLsbLibLibsbLibLgLsbsbLsbLgbRobLibLsLsmbLs
bLgbLgbLgbLsRsbLgbLgbLiRsLiLsRgbLgbLsbLiLsbLgLsLsmbLgRsbLgbRsbLgLiLgRs
bRsRgbLibLgLsbLgLsbLsRsbLgbLsRsbLgbLsbLgRsbLgbLgbLgLsLsmbLsRsbLgLsbLgL
sbLsbLgbLgLsbLsLsmbRsbRsbLibLhbLsbsbsbLcbLhLhLiRsbLsbLgbLgbLgLsbLsbLgb
LgLsLsmbReLsbRibRibRsbRgbRsbRsRsmbRsbRsbRsRgbRsbRgLsbRgbRgRsmbRgRgbRgR
smbRgbRsbRgbRgRsmbRgbRsbRsbRgRsmbRgbRsRsmbRgLsbLsbRgbRsbRgRjbRsbRgbLsL
sRsmbRsbRgbRgbsbRgbRsRsmbRsbRgbRsRsmbRiRibRsbRgbLgRsbLsbLibRgRsmbRibRi
RgLsRgbRsbRgbRsRsmbRgRsRiLsRiLgmbLibLgbLgbLsLsmbLgbLgbLsbLgbRjbLibRsbR
sLibRsbsbRsbRjbRgbRsbLsRsbRsbsbLsRsbRsbsbRsbRjLsRsLjbLobLgLibsbLsbLsbL
gbRsbLibsbsbLsbLiLsbRsLsbLcbsbLiLsbLibLibsbLcbRsbsbsbsbRgbRcbRibLsLsmb
RsbRjRsmbLcLibsbLsbsbLsLsmbsbLgbLiLibLgbRsbsbsbsbLsbsbsbLsbRsbsbLjbLsb
LsbLiLibRsbLsbsbsbLgbsbsbsbsbsbsbLsbLsbsbRgLhbLsbsbsbRibRsbRsbRsbRsbLs
bRsbsbsbRgbRsbRsbsbRsbRsbsbRgbLsbsbsbRjbsbRsRsmbRgbRibRjbsbsbLsbsbRiRs
mbRibRgLsbsbRgbsbsbRsRsmbRgbRibRsbRsRsLsmbLsRjbRsbLsbRcbRgbRsbRsbRgbRg
bRibRsbRsbRsbRjbRsbRibRgbRgbRibRgbRsbsbRsbRgbRibRsRsmbsbRsbRgbRgbRgbRs
bsbRsbsbRgbsbRsRsmbRibRgbsbRsbRsbRjbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 160241; End: 160753;
Recording: 2-1; Individual: 32; Drug: PCAP814 3 然 Apo 50 然
bRiRsmbRgbsbRsRsmbRsRsRsmmbRgbRiRgRsRsRsRsRsRsmmmmmmbRiReRsRsReRgmmbLi
bRibRibLhbLcbLcbLcbLcbLibRibRibRgbLsbRhRsmbLgLsbLjbsbRjbRibsbRsbRiLsbR
hbRibRgbRibRjbRsbRgbRsbRsbRibRgbLgbRibRgRsmbRgRsmbsbRebRibRsbRsRsmbRsR
smbRgRsRembLjRgbRcbLcbLcLiLsLiLiRsbLsLibLeLsbLhbLiRsbLibLgLgLhLsbLgbLg
bLsLsmbLibLebsbRcbRiRsmbRiLsLsmbRjbRgbRibRibRjbRiRsmbRibLibLcbLgbLgbLh
bLibRjRsRsmmbRoRsmbRiRsRimbReRsRsmmbRgbRibRibRcbRgbLgLsbLgLsbLsLhbLsbL
cbLgbLsLibLibLgbLgbLsbRjbRjbRgbLjbsbRsbRibLsLsmbRibRjbsbLsbsbsbRgbRibs
bLibsbsbLibRsbRgbRgbLcRsbLgLsbLibRsbLgbLsRsbRsRsmbLsbRsbRsRsmbRsRsRsRs
mmmbRsRgbRsbRebRebRibRebRgbsbRgbRgbLsbRsbLsLjLsmbLcbLcbLcbLjbLgbLibLjb
RsbLsbLibLsbsbsbRibRsRsRsmmbRgbRgbRgReRsmbRsbRebLsbLcLsmbsbsbLjbLibsbL
sbRjbRibLsLsmbRjbLgbRgbRcbRgbLsbLgbRsbRsbRsLsbRgRsmbRsbRsRsRsRsRgmmmbR
sbRgRsmbsbsbsbsbsbLsRsbRsLsRsbLsbLjbLsbLsbLsLgbsbsbsbRsbsbsbsbLsbsbLsb
RjRsmbRjLsRgbRgbRsRibsbLsbRibRsbLgbLsbLsbLsLsLsmmbsbRibLjbLsbsbRgbRcRs
mbRgRsRsRsmmmbRgbRjbRsbRsbRjbRebLcbRsbsbLgLsbLgbLgLsbLibLgbRibsbLgLsLs
mbLsbRgbLiLsbLgRsLsbLebLiLebsbRjbRebRhbRjbRsbRjbLsbLsbLgbRgbRsbsbLsRsL
sbLcbLsbLgbLiLsbRsLgLsbLibRgbRibRebLgbsbLsbLgbRsbsbsbRsbsbLsRsbRsbLsLs
mbLsbRsRsLsmbLjbsbsbLjbLsbsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 160241; End: 160753;
Recording: 2-1; Individual: 33; Drug: PCAP814 3 然 Apo 50 然
bsbLsbLibRibRibRsbRcRobRibRhbRgRsLsmbRsbRsbRgbRsbRsbRgLsbLobsbLcbRibLo
RsLgbRgRsRsmmbRibRsbRgRsmbLsRsbRgRsRsmmbRjRgbsbRcRsmbRcbRcbLsRsbsbRjRs
mbRiLsRsbRcbRcbRcbRcRcbRsbRjRgRsmbLsbRibLsbRhLsbRcbLsbRcbRsRsRsmmbRibR
sbRhbRsbRiRsmbRjbRcbRsbRsbRsRsmbRibRsbLsbRibRjRsmbsbLsRgRsmbRgbRcRsRsL
sRsmmbLsRsbRsbRgbsbRsRsmbsbRgbsbRibRjbRsbRhbsbRsbRgRsmbsbsbsbsbRgbRcLs
RhLsbsbRsRsmbLsbRibLsbRgbRsbRhbsbReRsmbLsbLsLsmbLsLsmbLgbRsbRsbRsbRsbR
sbsbRsbsbLsbLsbRsRsLsmbRsLsLsmbLsbsbsbLsRsbsbRsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 160241; End: 160753;
Recording: 2-1; Individual: 34; Drug: PCAP814 3 然 Apo 50 然
bLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 160241; End: 160753;
Recording: 2-1; Individual: 35; Drug: PCAP814 3 然 Apo 50 然
bLoLiRsRsmbLsbLsLsmbLsbLibRsbLiLibLgbRsbsbLsbLibRsRsmbsbsbsbLsbLsbLsbL
sbLsRsbLsbLsbLiLsLsmbLgRsbRsLsbLsbLsbLsLsmbLsLsmbRsbsbLsbsbsbRsRsmbLsL
smbLsbsbsbRsbsbsbLsbLsbLsbsbLsLsRsmbLsbLiLgbsbLsbLgbLsLsmbLsRsbLjbLsbL
ibRsbLsbsbsbLsbLsbLsbsbLsbsbsbLsLgbsbRsbLibsbLsbsbsbLgbLsLsmbsbRsLsbLi
LoRsbLsbsbsbsbLsbLgLsLsmbLsbLcbRgbsbLsbRgbRsRsLsmbLgbRsbLgLibRgbLsbsbs
bsbsbsbsbLgbsbLsLsmbLsbLgRsLsbsbsbLsbsbLsbsbsbLsLsmbsbLsbsbLsRsbLsbLsL
smbLgbsbLsbRsbLsLsmbLsbLsbsbLsRsbsbRsbsbsbLsbsbsbLsbRsbsbsbLsbLibLgbLg
LgLsLsmbsbsbsbsbsbsbRsbLsRsLsbRsbsbsbsbsbsbsbsbsbLsbLgLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 160241; End: 160753;
Recording: 2-1; Individual: 36; Drug: PCAP814 3 然 Apo 50 然
bRsbRsbRgbRsbRsRsmbRsbRsLsbsbsbRsRsmbRsbRsLsbRgbsbRsbRsbRsbRsbRsbRgbRs
bRgbRsbRsRsmbRsbRsbRgbRsRsmbsbRsbRsRsRsmmbRsbRsRsmbRsbRsbRsbRsbRsbRsbR
sbRgbRsbRsbRgbsbRgbRgRsmbRgbRsbRsbRsbLsReRcRsmbRcRsmbLgRsbRsRsmbRsbRgb
sbsbRsbsbsbRsbRgbRsbRsbRsRsRsmmbRsbRsbRgbRgbRsbRgRsmbRsRsmbRsbRgbRgbRs
bRsbRsRsmbRgbRsbRsRsmbRsRsmbRsbRsbRsbRsRsmbRsRsmbRsbRsbRgbsbRsRsmbRsbs
bRsbRsbRgbRsbRsbRgbRsRsmbRgbRsbsbsbsbsbsbRsRsmbRebRsbRgbsbRsRsmbRebRhR
sRsRsmmmbRsbRsbLsLsmbRsbRsRebLgbRibRgRsRsmmbRsbRsbsbRsbLsbRsbsbRsRsRsm
mbRsRsmbRjbRsbsbRsbRsbRsbRsbsbRsbRsbRgbsbRebRsbsbRgbRsbRsbRibRsbRgbRib
RebRsbsbsbRhbRsRsmbRsbRsbRsbsbsbsbLjbLsLsLsmmbsbRhbRsbLsbRsRsmbsbRsRsm
bRgbRsRsRsRemmbRsbsbRsRsRsmmbRsbRsbRsbLsbRobRgbRsbsbRsbRsbRgbRsbRsbLsb
RjbRsLsbRsbLsbRsbRsRsRsmmbRgbRsRsRsmmbRsbLjbRsbRiRebLsRhRsmbsbsbsbsbsb
sbRebRsRcbRsbRsbRsbRgbsbRgbRsbRjbLsRcbRgbsbsbRgRsmbRsbRgbsbRgbRsbRsbsb
sbsbsbLsbRsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 160241; End: 160753;
Recording: 2-1; Individual: 37; Drug: PCAP814 1 然 Apo 50 然
bLoLgLiLcbLcLiLsbLsLsmbRsbLiLebLobLgbLsLsLsLsLsmmmmbLsLsmbLgLsLebsbLeb
LeLsLebsbLsbLgLsbLgLsbLgLsbLgbLgLgbLiLsbLgbLsLsmbLsbLsLsmbLsbLsLsLsmmb
LgbLgLsbsbLgbRsbLsLsmbLgLsbLgbLgLsRsbLsLiLsbLgbLgLsbLgbLibsbLsLsmbLgbL
hLsbLgLsbLgLsbLibLiLsbLgLsbLibLgbLgLsbLgbLgLsbLgbLgbLgLsbLibLgbLsbLgLs
RsbLgbLgbLgbLgbLgLsbLibLgbLiLgbLsLsLimbLgbLsbLgbLgbLiLsbLgLsLsmbLiLiLs
bLibLsLsLsLsmmmbLsLsLsLsmmmbLgLsbLgbLiRsbLiLsbLiLsbLgbLiLsbLhLsbLgLsbL
gLsbLgbLsLsmbLgbLhbLsLsmbLgbLcLcbRjbRibRobsbRoLsbRcRiLsbLsRsbRobRsLsbs
bRgbRgbRsbsbRsbRibRsLsRsbLsbLsbRsbsbRsRsmbsbsbsbLsbLsRsRsmbsbRsbRsRgRs
mbsbRgbRsbRibsbsbsbsbsbsbsbsbRsbLsbRsbsbsbRibsbsbRsbLsbsbsbRsbsbsbsbRc
bRcbRgbLsbsbRgbsbRsbRsbsbRsRsRsmmbsbRsbsbRgbRsbRsbRsRsmbRsRsRsmmbRgbRs
bRsRsLsmbRsRsRsmmbRsRsRsmmbRjbRsRsmbsbRsRsRsRsmmmbRgbRsbRsRsmbsbRgbRsR
sRsmmbsbRgbRgbRsbRsbRsbsbsbRgbRsbRsbRsRsmbRgbRgbsbRsRsRsRsmmmbRgbsbRgb
RgbRsRsmbRsbRsbRgbsbRsbRsRsmbRsRsRsmmbRgRsLsmbRsbRgbRsbRsbRsRsmbRsbsbs
bRgbRsbRgbsbRsbRsRsRsmmbsbRgbRsRsmbRgRsmbRsbRsbRgbRsRsRsmmbRsRsRsRsmmm
bRsRsRsmmbRsRsmbRsRsRsmmbLsbRsbsbsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 160241; End: 160753;
Recording: 2-1; Individual: 38; Drug: PCAP814 1 然 Apo 50 然
bRhbRibRiLsbRcbRibLibLgbLcbLgbLcbRsbLibLhbRsbLiLsbLcLsmbLibLgRsbLoLsLs
mmbRjbRhbRgbRgbRsbRibRebRebLsbRgRsLsmbRobsbLgbLcbLgbLsbLibLibLhLsbLgbL
iLsbLgLsbLibsbRsLsbLgbLhRsbLgbRcbLcbLsbRobRibRiRsmbRebRibRgRsmbRibRiRs
mbLhLjLjbLgRsLsbLgbLibLiLsbLgbRibLhbLobRcbRgbRibRgbRgbRsbsbsbRebRibRsb
RhbRebRjbRcbRsRsmbLsbLgbsbLjbLgbLgbLgbLibLgbLsbLsbLgbLsbRsbRcbsbRebRjb
sbRcbsbRsbLsbLibLobRsbLibLibRgbLoLsmbLsbRibRebRibRcbRgbRibRgRsmbRibRsb
LsLsmbRjbRsRsmbLsbRsbLibLebLhbLebLgbLgbsbLhbRsbRsLsbLsRsbLsLsmbLsLsmbR
sLsbLjbLibLibLibRsbLgbsbRebRhbRcbsbRcbsbsbLsbLibLsbLsbLgbLhbLibsbLhbsb
LibLsbLibLsLsmbLiRsbLgbLebLgbLebsbsbRjbLibLsbLsbLgbLsLgbRsbLgbLgbLobLc
RsbLcbRibLjbRibRibLibLibLibLcbRcbRcbRsbRgbLsRsbRgbLjbsbLgbLsbLsbLgLsbL
gb

>ZF Recording 2016-06-02; tW: 300s; Start: 160241; End: 160753;
Recording: 2-1; Individual: 39; Drug: PCAP814 1 然 Apo 50 然
bRibRgbRsbRgbLjbLhbsbsbsbsbsbsbLibRcbRgbRobRsbRibLsbLcbLibRsbLibLgLsbL
sbLgbLhbsbLsbLcbLiRgbLhbLibLgLsbRcbsbsbRibRgbLjLibLibLibsbLeLsbLsLsmbR
sbLcbsbLjLsmbLibLsbLibLibRsbLgbLibsbLibLgLgbLhbLgbLgbLgbLhbLibRgbRjbsb
RibLgRibRibRcbRsbLhbLobLsbLibLebRsbLibLsbRsbLsbLgbLebLsRsbLibLcbLjbRgb
LsbRibLjbsbLsbLsbRsbLcbRsbLsbRgbRgbRsRgbsbRgbRsbRgbRsRsmbsbLsbLsbsbRsb
RsbsbLsbLsbLibRsLibLsbLgbLgLsLsmbLgbLjbLhLhbRsbLgbLsbRsbLsbLgbLibLhbLs
LsmbLeLiRcbLibRcLsLsmbRibsbRgbRsbRjbLsbRgbLsLsmbsbsbRibsbRsbRsbLsbLsbR
ebRgbRsbRjbRsRsmbRgLsLsmbLsRiLsbRibRibRgRsmbRgbRgbRiRebRiRsRgRiRgmbReb
RiRibRebLjbsbLsbRsbLsbsbLibLgbRgbRiLsbRgbRiRsmbRgRibLebLeLibLgRsbRsbRs
bRsbLsbLsLsmbLsbRsbLsbLsLsmbLibRsbRsbRsbLcbLsbLsLsRsmbLsbRibRcb

>ZF Recording 2016-06-02; tW: 300s; Start: 160241; End: 160753;
Recording: 2-1; Individual: 40; Drug: PCAP814 1 然 Apo 50 然
bLcbsbLibLiRsbLgbRsbLgLsbLhbLsLsmbLibLsbLibRsLsbLibLgbLibRsbLibLibsbRs
bLhbRgLsbsbLhbLibLsbLgbLhbLcbLsbLsRsbRjbRibRsbRibRjbRsbRsbsbRsbRsbLjbL
sbRgbRiRsRgmbRiRsmbLsbRibRgRsmbRgbLsbLsbLebLgLsLsLiLiRsmbRsbRgLsbRibRg
bRsbRsRsmbRgRsmbLsRsbRiRsmbRsRsmbRgRsRgRsmmbRgbRgbRhbRgbRibRiRibRiLsbR
ibRgbRsbLsRsbRsRsRsmmbRsbRsbRgRsmbRiRsRiRsmmbRsLsbRgbRsRsRsmmbRgRgRsmb
RsbRgRsLsmbRsRsmbLsbRsbsbsbRsRsmbRgLsRsbLjLsmbsbLsbLibsbsbsbsbsbsbsbRs
bRsbsbsbRsbRsbLgbRsbsbLibLjbLsbsbLsbRjbRgRsmbRsbRsRgbRgbRebRebRgbsbRob
RsbsbsbRibLibRsLsbsbLsbsbRsLsbRsbsbLibsbLgbLibLsbLsbsbRsbsbLsRsbRgbLcb
LgbLcbLhLsbRsbRhbLsbRhbRgbRjbRsRsRsmmbLsRiRsmbRjbRsRsmbRgbRibRgbsbRsbR
sRsmbLsRsbRsbRiRhbsbRgbRsbRgRsmbRjbRsbRsLsbLsbRsbRsRsmbRgRsRgmbsbRebRs
bsbsbsbRgbRgRsmbRsRsmbRsRsRsmmbRgbLgbRsbsbsbsbsbsbLsbsbsbsbsbsbsbsbsbR
sRsRsmmbRebRsbsbLsbRsbsbsbRgbRgbRgbsbRsbRgRsmbLjLgbLsLibRsbRjbRgRsRsmm
bsbRsbRsRsRsRsmmmbRsbRgbRsbRsbRsbsbRsRsRsmmbLsRsbRsbRsbRgRibLibRsRsRsm
mbRibsbRibRibRsbRibRsbRsbRsRsmbRsbRibRsbsbRgRiRibRibRibRibRcRsmbRiRsmb
RgRsRsmmbRgRsmbRsbRibRgRsmbRgRgRsmbRibRsbLsbLebLiRibRibRsbsbRibRsbsbsb
RsbRgbRsbLsbLgbsbRibLjbLjbRsbLgbRsbsbsbsbRsbsbLibLjbLsbLsbLcLsmbRgLsbR
gbsbLhbLjbRgbLgbLsbLibRsRsmbLsLsmbRgLsbLgLsbLgLibLebLgbLgbLibsbLsbLgLs
bsbLgRsbsbRiRsRsmmbRsbRsbRsbRsbLsbRgbRsLsLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 160241; End: 160753;
Recording: 2-1; Individual: 41; Drug: PCAP814 1 然 Apo 50 然
bRsbLcbLiRsbLgRsbLgLsLibLgLsbLibLibRibLgLsbLgbLhLsbRcbRhbLsbRsbRsLsbRi
bsbsbRebRsbLsRsbRsRsmbLoLgLebLibLebLebLgLsbLhbRsbRcbRsbRcRsmbRsLsLsLgL
smbLibLsbLsLsLsmmbLobRgRsmbRgbLsbLsRsbRsbLcbLcbRgbRcbRsbRibRoLsLibLibL
gLsbsbLibLsbLibLsbRibsbLobLeLsbLeLsbLgbLibRgLsbLebLiRsbLgbLebLeLsbLsLs
mbLgLsbLhLsbRgbsbRgLsbRcbRgbRsRsmbLsRsbRoRsmbRhbRsbLiLsbLgbRoRsmbRibRi
bRsbRgRiRsmbRibRgbRsbRgbRgbRsRsmbRsbsbRsbRsLgbRsbRcbLsbLjbRibReRsmbRgb
RgbRibRsbRgLsbsbLgbLsbLsbLsbLsbLibLsbLgbRsbLsbRsbLibLgLsbLgbLsbLgbRcbR
ibRibRgRsmbRsbsbRebLsbRebRsbLobLhRsbRgbRjbLcbLgbsbLgbLsbLibLsbRcbRjbRs
bRhRsmbRiRsmbReRsmbRgbLeLsbLgLsLsmbLsbLgbsbRsbLsbRebsbRgRsmbRsbRsbLsbR
sbRsbRgbRgRsmbRsbRsbsbLobLcbLgLsbLsbLibLgbLsbLsLsmbLgbRebRgRsmbRsbRgbR
ebRebRibsbLgbLiLibLsbLibLebLsbLeLsbLhLsbRsbLsRsbRhbRibRgbLsRsbLgbRjbRs
RsmbRjbsbRsbLcLsmbsbLsbLgbLiLsbLeLsbLgbLsbsbLobRsbLsbLgbsbRjbRgbRsbLsb
RsbRgRsRgmbRgLsbRgbRibRsbLiLgbLebLsbRsbLebLibRcbLsbLsbLsbRsbLebLgbRgbR
ibRobLsLsmbLibLgbsbLsbLsbLsbsbLiLsLsmbLsbsbsbRcbLebLsbLgbRsbLsbsbLsbLo
bLgbLgbLgbLgbLsbRsbLsbLhbLiLsLsmbsbLsbRsbLsbLcLsmbLibLibLibsbLibLgbLsb
sbRjbRsbRibRhRsmbRibLgbLibLebLsbLsbLcbLibRsLsbLsLsLsmmbRibLsRsbRobRiRs
mbRsbRgbLsbRsbLsbLgbsbLgbLsLsmbLgbRsRsmbRsbRsbLsRsbRcbLsbsbRsbRsbRobsb
LiLsbLebLhRsRgbLhbLibsbLgbRgbRsbRgbRebRsbsbsbLsbRgbRiRsmbsbLjbRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 160241; End: 160753;
Recording: 2-1; Individual: 42; Drug: PCAP814 1 然 Apo 50 然
bLsbLsbsbLgRsbLgbsbLgbRsbLgbLgbRsbLsbLgbLsbLsLsmbLsLsmbLsbLsbLsbsbLgbL
sLgbLgbLsRsbLsbLgbsbsbLsLsmbsbLsLsmbLsbLsLsmbLgLsbLsbLsLsmbLsbRsbRsLsb
LsbLsLsLsmmbsbLsbLsbLsLsmbLsbLsbsbsbLsbLsbsbsbsbsbsbsbsbsbsbsbsbsbsbsb
LsbLsLsLsmmbLsbLsbLsbLsbLsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbLsbRsLs
LsmbRgbRsbLgLsbLsbRgbLgRsbLsbsbLsLsLsmmbsbsbsbRsbsbsbsbsbLsbLsbLsbsbsb
LsLsmbsbLsRsbLsbLsLsmbLsLsmbLjbRsLiRsRsmbLibLgbLsRsbRsbsbLsbLibRsbLsbL
sLsRsmbLsbsbsbsbLsbsbsbRsbsbsbsbsbsbsbsbsbLgbLsRsbLsLsmbLsbsbLsbLgbsbL
sbsbLsbLsbLgbLsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbLsbsbsbLsbRsbRsbsbLsbLsbLs
bsbLsbLgbRsLsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 160241; End: 160753;
Recording: 2-1; Individual: 43; Drug: Control Apo 50 然
bsbsbsbsbsbsbsbRsbsbRsbLsbLsbLsRsbsbsbRsRsmbRsbsbLsbsbsbsbsbsbRsbRsbsb
sbsbsbRsbsbsbsbRsbRsbsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 160241; End: 160753;
Recording: 2-1; Individual: 44; Drug: Control Apo 50 然
bsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbRsbRgRhRsReLgmbRcbRsRsmbs
bRibRgbRgbsbRsbLsbsbsbsbsbsbsbLsbLsRsbRsbsbRsbsbsbsbsbsbsbLsbLjbLgbRsb
sbsbsbsbRsbsbRsbLsbRsRsmbsbLsbLiRsLsbRgbsbsbsbsbsbsbsbLsbsbRsbRgbRjbRc
bRgbRsbLibRsRsmbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 160241; End: 160753;
Recording: 2-1; Individual: 45; Drug: Control Apo 50 然
bLsbRsbRsbRgbRgbRsbRsRsmbRgRsRsRsmmmbRgbRsRsmbRgbRgRgbRgbRgbRsbRsRsmbR
gbRgbLsbLcbLibLsbLgLsLsLgmbLibLiLgLsbLgbLsbLebLsLgbLgLsbLsbLgbLsbLsbLg
bLsbLibLsbLobRgbRsbRgbRsbRsbRiLsbRsbLsbRobLsbLgbLsbLgbLsbLobRgbRgbRsbL
sLsLsmmbRsbLsbRsbRjbRjbRibLjbLsbLgbLebLsbsbsbsbsbLgbRibRjbRebsbRgRsmbR
gRsmbsbsbLsbRgbRsbRsRibRsbLjbRcbRgRsmbLobLgbLgLsLsmbsbRcbRibRsbLsbLgbL
gbLsbLgbLsbLgbLsbRsbLoRsRsmbRgbsbRibLsRjbLsbRgbRebLebRgbsbRsbLsbRgbLcb
sbsbsbsbRebRgbRsbRgbLgLsbRjbRsbLsbLibRebsbRsbRibLhLsbRhbLoRsbLhbLibRsL
sbLgbLsLsmbLcbRjbRsbRebRjbRsbRsRsmbRoLsbRgbsbLgbRcbRsbsbLsbLsLsmbLsbRe
bLjbLjbLgbsbLgbLgLsLsLgmbRjbRibRgbRsbRibLgbLgLsbRsRsmbsbLsbsbLsRsbLsbL
jbLsLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 160241; End: 160753;
Recording: 2-1; Individual: 46; Drug: Control Apo 50 然
bLgbLgbLsbLgbLiLsLibLiLsbRiRsmbRgbRibRobsbRsbRgbRgbRiRsmbRhbsbRgbRgbRs
bRgbRgbLsbRgbRsbsbsbRgbRsbLsRsRsmbRsbRjbRsbRsbRsbRgbRsRsmbRgLsbRgRgbRg
bRgbRgbRgbRgbRgbRsbsbRgbRgbRgbRgbRgRgbRsbRgLsbRgbRgbRsbRgbRgbRgLsbRgbR
gbRgbRgRsmbRgbRgbRsbLsRgbRsbRgRsmbRgbRgbRgbRsbRgbRsRgbRgbRgbsbRsbRsRsm
bRsbLsRsbRsbRsbRgbRgRsmbRgbRsbRsRsmbRsRsmbRsbRgbRgbRgbsbRsbRgbRebRgbRg
RsmbRgbLsbLcbsbRcbLcbsbLibsbsbsbLgbLsbsbLsRsbLibRsbLsbRsRsmbLibLgbLgbs
bsbLcbsbsbRsbLsbLsbRibRiRsmbRsbRsbRsbsbRibRsbsbRsbLgRsbRsbsbRgbRsRsmbs
bRgbLsRsbRsbRgbRsbRgbRcRibsbLgbsbRjbRjbRsbRsbRgbsbRsbRsbRsbRgbRsbRgbRs
LsbRsbRsRsmbRsRsRsmmbRgbRsRsmbRgbRgbRgbRgRsmbLsLsmbRgRsmbsbRsbLsLsRsLs
RsmbLsbLsRsbsbRsbRsbRsRsmbRsbLsbRgbRsbRjbRsbsbsbLsbRsbRsbRgbRgbRsbRibR
gbRsbRgbRsbRgRsmbRgbRgbLsRgbRgbRibRgbRgbRgbRsbRsbsbRgLsbRibRsbRgbLsRsb
RsRsmbRgbsbRsRsmbRgbsbsbRgRsmbLsbRsRsmbRsbRsbRsbRsbLsbRgbRsbRgbRsbRsbL
sbRsbRsbRsbRgbRgbRsRsmbRsRsmbRgbRsRsmbsbRsbRjbsbLsbsbRsbRsLsbsbRgLsbRs
RsmbRsbsbRgRsmbRsRsmbRgRsmbRgbRgbRgbRsbRgbRsbRsbRsbsbRibRgbLsRibRgbRsb
RgbRgbRgbRgLsbRibsbRgbRgbRgbRsbRgRsLsmbRgbRgbRsbRgbRgbRiRgbRebRsbRsbLs
bsbsbsbRgbRiRsmbRsbRibRgbRgRsmbRsbRgbRgbRgbsbRsbRsbsbRgbRsbRsbRsbRsRsm
bRsbRgbRgbRgbsbRsRsRgmbRgbRsLsbRgbRsbRsbsbRsbRjbRsbRsbRgbRsRsRsmmbRgbR
sRsmbRsRgbRsRgbRsRsmbRgbRgbRiLsbLsbRgbRsRsmbRgbRsbRsbRsbRsbLsbRibRgbRs
bRgbRsbRibRsbRsbRgbRgbLsRsbsbsbsbsbsbRsbRsbsbRgbLsbsbRsbRgbLsbRsbRgbRs
RsRsmmbRiRibRsRsmbRsbRsbRgbLsRsbRsbRsbRsbRsbRsbReb

>ZF Recording 2016-06-02; tW: 300s; Start: 160241; End: 160753;
Recording: 2-1; Individual: 47; Drug: Control Apo 50 然
bLjbLsbsbRcbRobLjbLsLsmbLgRsbRsbRsbLibLhbLhbLsLsmbLiLsbLibLibLibLibLib
RgbRcbRsRsmbRoRsmbLsbLebLiLsbLgRsbLgbRobRebRcRsmbRibRebRebRebRsRgbRsbR
jbLsbRsRsmbRsbLsbRgbReRsmbReRsmbLsRsbLjbRibRgbRsbsbRsbRgRibRebLjbLsbLe
bLhbsbsbRsLsLcbRobRibRsbRsbRsbRgbsbRsbsbRjbRgbLsbRgbRjbRsbRgRsRsLsmmbR
ebRibRgbRgbReRsRsmmbsbReRebRgLsRsbRsbRjbsbsbLjbLcbLcbLsLibLjbLjLsmbsbs
bLebRjbRgbLsbLjbRjbsbsbsbsbsbsbsbsbsbsbRsbLjRsbRiRsmbsbLjbsbLsbLcbLcbL
cLsmbLibLibLgbLsLsRsmbRjRsmbRibLjbRebRibsbRcbsbsbsbsbsbsbsbLcbLcbLhLsb
LobsbLjbsbLsbLgRsbLsbLibLhbLsbLgbsbLgLsbLibRsbLibRsRsmbLsbsbLgbRebRsRs
mbRiRsmbsbsbRgbRiRsmbRgRsmbRgbRgbRgRsmbRgbRsbRibsbRhbRgbRebRsbRjbRsbRj
bRsbRsRebRhbRsbsbLsLsmbsbsbRsbsbsbsbRjRsRsRsmmmbReLsbRcbsbsbsbsbRsRebR
sbRgbRgbRgbRsbRgRgbRgbRsbRgbRgLsbRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 160241; End: 160753;
Recording: 2-1; Individual: 48; Drug: Control Apo 50 然
bRsbRibRsbRsRsmbRsRsRsmmbRsbRsbRjbRcbsbRsbRcRibLsbRsRsmbsbsbRsbRgbRsbR
sRsRsmmbsbsbRgbRcRsRsmmbsbsbsbRcbRsbLsLsRsmbLsbRhbRgbsbRgRsmbRcbRgLsbL
sbRsbsbRcLsbRobRgbsbRibsbsbRsbLsbRsbRsbsbRsLsbsbRhbRhRsRgLsRsmbRsbLsbR
sbRsbRsRsmbRhbRsbLsbRsbLsbLsRsbsbRhbRsbRsbLsbRsbLsbsbLobsbsbsbsbsbsbsb
sbsbsbLsbLcbLibsbsbRcbRsbsbRebRibsbLsbLsbsbsbsbsbsbsbsbsbRsbsbsbsbsbsb
sbRsbRsRsmbRsbRsRsRsmmbsbRgbRibRjbRsbsbLsbLsbRhRsmbRsbRsLsbsbsbRsbRsbR
sbRsbRsbRsRgbRibRsbRjbsbRgbsbRgRgbRibRgbRsbsbRgbsbRsbRgRsmbRsRgLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 160755; End: 161300;
Recording: 3-1; Individual: 1; Drug: PCAP814 10 然 Apo 50 然
bLsbLsbRsbsbRsbLsbLsRsbRsbRsbRsbRsbRsbRsbsbLsbLsbsbLsLsmbRsbRsbRsbLsbL
sbsbsbsbRsbsbsbsbRsLsbsbLsLsmbLsbRsbRsbRsbRsRsmbRsbRsbLsRsbRsbRsRgRhbR
gRsmbRgbRsbRsLsbLgbRsbRsbLgbLgbRjbRgbRgRgRsmbRgRgbRsRgbRgRsmbRgbRibRgR
gbRgbRgbRsbRsbRsbRsbRsRsmbRsRsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 160755; End: 161300;
Recording: 3-1; Individual: 2; Drug: PCAP814 10 然 Apo 50 然
bLsbLsbLobLjLsmbRgbRgLebRoRsLimbRgbRgbRsbRsRgRsmbRibRibLobRsbRsbLjRsbL
cRcbRsbRsRsmbRsbLsbLebLobRhbLebRebsbRsbLsbsbRgbRsbRsRjb

>ZF Recording 2016-06-02; tW: 300s; Start: 160755; End: 161300;
Recording: 3-1; Individual: 3; Drug: PCAP814 10 然 Apo 50 然
bRsbRebLsLsmbsbsbsbLsbsbLgbRsbLsRsbLsbLsbsbsbsbsbRsbLeRsbsbLsbLsbsbRcb
LgRgLsbRsbRgbsbRgLsbsbLgbsbRsbLebLgbsbsbLibReLgLsLsmbLgLgbRcbLcbRjbRib
LsbRsbRebLhLgbRsLsLsmbLcbLgbRsbRsRsLsmbLiLsbLgLgbRsLsbLiLgbLgLgbRjbRib
RsRsmbRgbRsRgbReLsLsmbRcLsbRgbRgbsbRgRsmbRgRgRsmbLsLsmbsbRhLsLsLsRsmmb
LhbLebLgbsbRsbLgRsLsbLgLsbLgRsbLibLsRjbLjbRsRcbRhLsLsmbsbRebRsbsbsbReR
ibRebRsRgbLsbsbRsbRgbRebLsbLsbLebLhbRgbLgLgbLcLsmbRjLgbLsRcLsbRsLgbLcb
RgbsbsbLeLsbRiRsmbRcbRsbsbLcbLgbLhbLcLgbLeLsLsmbLibLhLgLgbsbLebLsbLebL
cLsRjmbLjbLgbLibsbLsLgbsbsbsbRsbsbLsLsmbLsRsbsbLsRsRsmbLsRsbLsbLsLsmbL
sLsLsmmbLsbLebRhRsmbRgbsbRsRsmbRsLsbRsbRsbRsbsbLsbLsbsbsbLsLsRsLsLsmmb
sbsbsbRsbLsLebLeLgbsbsbRsbsbLsLsRcmbRcbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 160755; End: 161300;
Recording: 3-1; Individual: 4; Drug: PCAP814 10 然 Apo 50 然
bsbsbRsbRsLsbsbLcbRebLobLsLsmbRsbRgbRiLsbRcRsRsmmbRsLsbLjbRibLsbRgbRjb
RsbsbRgbsbRebRsLcbRsbLgbRgbLsLsmbLsbLjbLobLsLsmbRsRsmbLsbRsbRsRsmbsbsb
sbsbsbsbsbsbLsbsbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 160755; End: 161300;
Recording: 3-1; Individual: 5; Drug: PCAP814 10 然 Apo 50 然
bLsbLsbsbsbRsbsbRsbRjbRcbRcbsbRebsbRsbRsbRsbRiRsmbLsbRsbLibLsRsbLsbLsb
sbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbLgLsbLsbLsbLsbRgbLsLsLsmmbsbLsbRsbLsLs
mbsbLsbRsbRsRsmbRsbLsLsLsRsmmbsbRsbLsbLsbLsbsbRsLsbsbsbLibRsbRsRsmbRib
RgbLebRsbRgRsmbsbLsbRebLiLsLsmbLsbLgbLgbRsLsLsmbLiRsbLsLsLsmmbLsbLiRsb
LibRebLcbLsLsmbLebRibRgbRgLsRsbRgbLsRsRsRsmmbRsRsRgRembLeLibRibLebLgRs
RsmbLebRcRsmbRsRgbReRsmbRgRsLsmbRsbRsbRsRsRsmmbRsRsmbRsbRgbRsbRsbRgLsb
RoLebLiLsLgbsbRsLebRiLsRsRsRsLcLsmmmbLgbLjbLgbLgbRsbRsbsbsbsbRsbsbLsbR
sbRsbRsLsbsbRgRsmbRsbRgbsbRsRsmbLsbRsRsRgmbRgbRsbReLoRebLsbLsLsmbLsLsm
bLsbsbRjbRibLjbLgLgbsbsbRsbRobRsRiRcbLsLcbLibLgLsbRsbLgbLsbLsLibRobLjb
LjbLiLsbLsbLsRsbLgbLsbLsbLsbRsbLebRsbLhbRsbLsRibLgLsbRsbRsbRsRsmbsbsbR
sbLsbRsbRsbRsbRsbRsbRsRsmbsbRgRsRsmmbsbRsbLjbRsRsmbRsbRsRiRsRsmmbLsLsL
gLembsbLjLiLsbLebLebRsbRebRsLsLsmbLhLsRobLjbLibsbsbLiLsbLiLsbsbsbLiRsb
LgbLgLhbLeLsLsmbsbRsbRcbRgRsLsRembLjbRgbRebRgbRsbRsbRsbRgbRsbRgbRsbRsb
RsbRsbsbsbsbsbsbsbRsRsmbRsRsRsmmbRsbLgbRsbsbRsbRsRsmbRsbRgLsRsbRsbLsbR
sbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 160755; End: 161300;
Recording: 3-1; Individual: 6; Drug: PCAP814 10 然 Apo 50 然
bsbRsLsbLsbLsbsbRsLsbsbsbLsbRgbRobLsbRgbLsbRsbsbRsbRhbLgbLsbRgbRjbRsLs
bLsbRsbRsbLsbLobRjLsbLibLsbRsbRibRsLsbLsbRjbRsbLeb

>ZF Recording 2016-06-02; tW: 300s; Start: 160755; End: 161300;
Recording: 3-1; Individual: 7; Drug: PCAP814 3 然 Apo 50 然
bRsbRsbRgLsbRsbRsbRsbRsbRsRsmbsbRgbsbsbRsRsmbsbRsRsmbsbRgbRsbLsbsbsbRs
bLsRsbRgbRsLsbRsbRsbRhLsRsLsbRgbRsRgbLsRsRsmbRgbLsbRgbRgbRsbRsbRsRsmbR
sbLsbLsRgbRsbRibLsbRsbRsbRsRsRsmmbLsRsbRsRgLsbRsbRsbRsRsmbRsRsRsmmbRsR
smbLsbLsRsbRgbRsbRsRsmbRsbRsbLsbRgRsRsmmbRsbRsRsLsmbsbRgbRsRsmbRsRgRsm
bRsbRsbRgRsmbsbRiLsRsbsbRgbRsbRibRsRsRsmmbRsRsmbsbsbsbsbsbsbRibLsLsmbs
bsbsbRjRgLsbRsbsbsbsbLsbLsbsbsbsbLsbsbLsbLsbLsbRcbsbRgbsbsbsbRsbsbRsbs
bsbsbsbsbsbLsbRgbRgbRgbRsbsbsbsbsbRgbRgbsbRsRsRsmmb

>ZF Recording 2016-06-02; tW: 300s; Start: 160755; End: 161300;
Recording: 3-1; Individual: 8; Drug: PCAP814 3 然 Apo 50 然
bLsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 160755; End: 161300;
Recording: 3-1; Individual: 9; Drug: PCAP814 3 然 Apo 50 然
bLgbLsLsmbLgbLsbLgLsbLgbLsbLgbLsbLgLsbLsbLgbLsbLsbLgbLgbLgbLgLsbLgLsbL
sbsbLsbLibLsLsmbLgbLgbLsbLgbLgLsbLgbLsRsbsbLgbLgbLgbLgbLgbsbLsbLsbLsbL
gbsbLgbLgbLgbsbLeLsLsmbLgbLsLsmbLgbLsRsbReRsmbRcbLsbLgbRsbLsbsbsbsbLsb
sbsbRcbLsLsmbLjbLeLsbLiLibRsbRsbLsbLgbLgbLgbLgbLsbLgbLgbLgbLgbLgbLgLsb
LsbLgbLgbLsLgbLsLsmbLgbLgLsbLgLsbLgbLgbLsbLsbLsbLsLsmbLgbLgLsbLsLsmbLg
bLsbLgbLgLsbLsbLgbLgbLgbLgbLgbLgbLgbLgLsbLsLsmbLsbLgbLsLsLsmmbLgRsbLgb
LgLsbLgbLgbLgbLgLsbLgLsbLgbLibLgbLgbLgbLgbLgLsLsmbLibLgRsbLgLsbLgbLgbL
sbLgbLgbLgRsbLsbLgbLgLsbLgbLgbLgLsbLgbLgbLgLsbLgbLebLiLsbLgLhLsRsbLsbL
iLsbLgbLsbLgbLgbLgbLgbLgLsbRsLgLsbLgbLsbLsbsbLgbLgbLgbLgLsbLgbLgbLsLgL
sbLgLsbLgLsbLgbLgbLibLsLsLsmmbLgbsbLgbLgLsbLgbLgbLgLsbLgbLgLsbLgbLgbLg
bLgbLgRsbLgbLgbLgLsbLgbLgbLsbLgbLsbLgbLgLsbLgLsLsmbLgRsbLgbLgbLgbLgbLg
bLsbLsbLgbLsbLsbLsbLsLsmbLsLsmbLgbLgbLgbLgLsbLgbLgLsbLgbLgLsbLgbLgbLgb
LgbLgbLgLsbLgbLgLsbLgbLsLsmbLgLsbLgRsbLgbLgbLgLsbLgbLgbLsbLsbLgbLsbsbL
sbLgLsbLgLsbLgbLgLsbLsbLgbLgbLgLsbLsbLgbLgRsbLgbLsbLgbLgbLgLsbLgLsbLsb
LgbLgbLgbLgbLgLsbLgbLgbLgLsbLgbLsLsRsmbLgbLgbLgLsbLgLsbLgbLgbLgLsbLsbL
gbLgbLgbLgbLgbLgbLgbLgbLgLsbLgbLsbLgbLgbLgbsbLsbLgLsbLgbLgbLgLsbLgbLgb
LgbLgbLsbLgbLgLsbLgbLgbLgLsbLgbLsbLsLsmbLgbLsLsmbLgbLgbsbsbLgbLgbLsbLg
bLgbsbLsLsmbLgLsbLgbLgbLsbLgLsbLgbLgbLgLsbLgbLsbLsLsmbLgLsbLgbLsLsmbLg
bLgbLgbLgbLgbLgbLgLsbsbLsLsmbLgLsbLgbLgbLgbLsbLgLsRsbLgbLgbLgbsbLgbLsb
LsbLsbLsbLgLsbLgbLgbLgbLgbLgbLgbLgbLgbLgbLgbLgbLgbLgbsbLgbLgbLgbLgbLgb
LgbLgbLgbLgbLgLsbLgbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 160755; End: 161300;
Recording: 3-1; Individual: 10; Drug: PCAP814 3 然 Apo 50 然
bLsbLgbLgbLsbLgbsbLgbLibRsbLsbLgbLjbLgLsbLgbLsLsmbLgbLsbLsbLibLgbLgbLs
bLgbLsbLebRgbLsbsbsbsbsbsbLsLsmbsbsbLoRsbRgbLcbLgbLibLsbLgbLgbLibRgLsb
LiLsbsbLgLsbsbLsLsmbsbLsbLgbLgbLibLgLsbLeLsbLsbsbLsbLsLsmbRsbLgLsbLcbL
iLsbLoRsRsRsmmbRoLsbLibLebLibLsbLgbLibLsLsmbsbLgbLibLcLsLhRsmbLobLiRsL
sbLiLsRsbRjbLjbRgbLobsbReLsbLibLiLsbLhbLgLsbLebLebLeLsbLebLobRibRobLgb
LhbLgLsbRsbRsbLsbLibRebRcLsRhRsmbRibsbRgbRsbRgbRcbLgRsbLgbLhbLibRgbsbR
oRsmbRibRsRibRibRgRsRsmmbRibRgRsmbRgRsmbRgRsmbRgbRibRibRibRgbRibRgbLgb
RebRebRjbRsbsbRobRcbLjbLebLibRsbRjbRjbRsbRgbRibLjbsbsbLjbLoRsbRsRsmbRe
bRcbLgbLjbLgbLebRhLsbLsLsmbRebRsLsbLcbLibRcbRibLhbLgbLsbLhRsbLebLibLgL
sbLiLsbLhbsbLsbLsbRgbRcRsmbRebLjbLgLsbLebLsbRibLsbRgbsbRsbsbRgbRsbRcRs
LsmbLhbLibLgbLsbLgbRsbLibLsbLgbRjbLcbsbRsbRsbLebLsbsbRsbRsbsbsbLsbLcbL
sbLsbRsLgbsbLobLsbLcbsbsbLibLibLgbLgbLebLebLebLgbLsbsbLgbLobsbRgbRsbRh
bRgbRcRsmbRibRsRgbRoLsLsmbLsbRcbRibRgbLobRsbRgbRgbRcbLsbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 160755; End: 161300;
Recording: 3-1; Individual: 11; Drug: PCAP814 3 然 Apo 50 然
bRibRibRebLebLjbsbRsRsLsmbsbsbRsbsbRgbRgRsmbRgbRhbRibsbRsbLhbLoRsbLibR
jbLjbLsbRsLsbRibRhbsbLgbRsbLsLsLsmmbRsbRsbRsbLgbLsbLgbLsRgbRsbLgbLsbLs
bRsbsbLsbsbLsbLsbLjbLgbLsbLsbRsbLgLsbRsbRjbsbLsbLsbRsbLobRsbRsbRibRgbR
obRsbRhbRibLsbRhbRgLsbLibLsbRgbRjbLibLhbLsbLgbLsLsmbLgbRsbLsbRgbLjbLiL
hRsbLgbRibRibRjbRjbRiLsbRsbRibRgbRgbRjbLoRsbLcRsbRcbRsbLgbLibLgRsbLobR
ibRibRibRiRsmbLgbLsLjbLcbLsLsmbRsbLobLgbLsRsbRhLsbRiRsmbRsbRgbLjbLibRc
bRgRsmbRiRsmbRgbLsbRgbsbRgbLsbLsRsbRsRsmbRgRsmbRgbRgbRgbRgbRgLsRsbLsRs
bLgbRgRgRsRgmbRsbRsbRsbRiRsRsmmbLsbLgbRgbLsRsLsLsRsmbRgbRsRgbLsLsmbRgb
RsRsmbRsRgRsmbRgbRsRsRsmmbLsRsbRsbRcLsbRgRsmbRgbRiRsmbRgbRgbRgbLcbRibR
gRgLsLsRsmbLsbLobRsRibRsRgbRsbLsRsRsRgRsRsRsmmmmbRibRsbRsbLgbRibRgRsRs
RsmmmbRsbRgRsRsRsRiRsmmmmbRsRibRsRsmbRsRsRgRsmmbRsRsmbLjbLibsbRebRebRh
RsmbRgbRibRsbRiRibRgbRsRsmbRgbRsbRsRsmbRgRsmbRgbRsRsLsmbRsRsmbRgbRsRsm
bRgbRsbLsLsmbLsLsmbRgbLjbRgbRsbRgRsmbRgRsmbRgRsmbRsRsmbLiRsbRcRiRsmbRg
RsLsmbLjbRibLebLibRgbsbsbRcbRibRsbRgRsmbRgRsRsmmbLsRsbLsRsbRgRgRsmbRsR
gLsbLgRsbLjbRebRgbRsbRsbLsbRsLsbLsbsbRgbRgRsmbRibRgbRhRiRsmbRhbRebRsbR
sbRsbRibRsbRgRsmbRsbLsbLjbRibRgbRsbRgRsRsmmbRiRsmbRibRsbRsbLgbRsbLjbRs
bRebsbLjbLgbLgbLsbsbRgbLsbLsbLsRjbRibLsbLsLsRsmbLsRsbRiRsmbRebReRsmbRi
bRgbLgbLcb

>ZF Recording 2016-06-02; tW: 300s; Start: 160755; End: 161300;
Recording: 3-1; Individual: 12; Drug: PCAP814 3 然 Apo 50 然
bLgbRgbRsbsbLcbLobRsbLsbsbLsLsmbLsRsbsbLoLsmbsbRsbLibLjbRsbsbRsbLcbLsR
sLsbLgLsLsmbLibsbLsbsbsbLsbLsLibsbLsLsmbLgLsbLgbLgLsLsRsmbsbLgbLgLsLeL
sbLsLgbRebRgbRjbRsbsbsbsbRobRsbRiRsmbRibLsbRsbRgbsbRgbRsRibRgbRsbRsbsb
RgLsbLsRsbLsbsbsbLhbLibLcRsbRjbRiRsLsmbRgRsmbRgRsRhmbRsRsLsRiRsRsmmmbR
gRibRgRsmbRhbRgRibRgbRhRsReReRgmbRcRsRiRsmmbLibLcbLsbLsbLibLsbLiLsbLgL
iLsLgbsbLgbLgbLibLsbLiLsbLiLsRsbLiLsLcbLibLgbsbLiLgbLgLsLibLgbLibLgLiR
sbLiLiLsbLiRsLsbLcbLsLsmbsbRibLobRsbLcbLsbLsRebRibRsbRcRibRsbRcRsRsRsm
mmbRibRgRsmbRibRsRsmbRhLsRsbLibRibLsRsLsLsmbRiLsRgRsmbRhbLebLgbLcLgbsb
LiLsbLhRiRcRgbRgbRibRiRgReRgRobRgRibRgbRgbLsbRgRsmbRibRhbRcbsbRibRgbRg
bLsbRgbRsbRsbRjbRsbRibRjbRsRsmbRgbRsRsmbRibRgbsbLgbLjLhbRsbLsLsmbLibLi
bsbLebLcbLibsbLsLsmbLhLhLiLcLebLibLiLsbLiLhbLgbReLsbRcRsmbRiRsmbRgbRgb
RsbRgbLjbLoLgLsLsRsmbLiLiLibLibLcbLcLsLsLsmmmbLsbRoLsbRibRgRsmbRgRibRg
bRgRsmbRgbRiRsmbLcbLoLsmbsbRcbRoLsbRgLsbLsbLsRsbRgbRibRsRsmbRgRhRsmbRi
bRsbRgRgRsmbRiRgRebRgbRgbRgRsmbRibRgRsmbRiRsmbLibsbLgbLibLgRsLsbLibLiL
sbLgbLibLgbLiLebLsbRebRjRsmbReLsbLsbLcbsbLsbRsLibLibLcbLcbsbLiLsLibLib
LiLsbLgbsbsbLsLsmbLsLgLsbRjbRiLsbRibRgRsRgRsmmbRgbRibRgRibRgbRgbRhLsLs
mbLsLsRgRimbRhbLsLsRsmbRhbRsbRgLsbRjbLsRsbRgbsbRsRsmbsbLsbRjbRsbRgbRgb
RsbRsbRgRsmbRgbRgLiLsLiLsbLsbLiLsLiLgLjbLgLsbLsbLiLibLcbRsRsmbRsbLiLsb
sbLsbRsbLjbRsbsbsbLsLsLsmmbRcLsbLcbLsbLibsbLgbRsbLsLsLhmbsbsbLjbLgbLcb
LsLcbRsbRsRibRhbsbRgRsLombReRgbRgbRgRsmbRibRgbRgLsbRsRebRcbRsbRcRsmbRg
RsmbRgbRsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 160755; End: 161300;
Recording: 3-1; Individual: 13; Drug: PCAP814 1 然 Apo 50 然
bLibLoLobLobRcbRobRsbLsRsbLjbRebRcRsmbLhbRobLobRsbRibLcbLobRhbRobRsbRo
bRobRgbRobLebRsbRhRsmbRebLcbLgbLebLsbLsRebLobLcbLobLgbRgbLsLebLobRsRsm
bsbRgbRhbRobRcbRibRhRsReRhmbRhbRsbRsbRhbRibsbsbRebRgbLsbRibRcbRibRhbLc
bRebRgRsmbRiRsmbLgbLcbLibRgbRebRibLgLsbLcRsbRsRsRsmmbsbRgbRsbRsbRgbLib
LibLibRhbRcbRsRsmbsbLsbLgbLebLibRsbRsRsmbLsRsLsbRsRsmbLsbRsbLsLsmbRsLh
bRgbLgbLhbRsbLebLebLsLsmbLcbsbLsbRsbsbLcbRiLsbsbLiLgbLsbLgbRsbRibsb

>ZF Recording 2016-06-02; tW: 300s; Start: 160755; End: 161300;
Recording: 3-1; Individual: 14; Drug: PCAP814 1 然 Apo 50 然
bRsbRsbRsbRgbRsRsmbRsbsbRsbRsbRsbRgbRsbRsbRsbsbRgbLsLsmbLsbLebRsbRsRsm
bRsRsmbRsbRsLsbRsbsbRsbRgbRsbRsbRsbRsbRebRsbsbsbsbRsbLsbRgRsmbRgRsmbRg
bLsRsLsbRsbRsbRgbRsbRsbRsRsmbRsRsmbRgLsbRsbRgbRsRsmbRsbRsRsmbRsRsmbRsb
RsRsRsmmbRsbRsbRsbRsRsmbRsbRsbLsbRgRsmbRebRcRsRsmmbRoLsbRcbRiRsmbRsbRi
RsmbRcbRsbRcRiRibRibRsbRgbLsbRebRibRsRsmbRhRsmbRsRsmbLcbLcbLcbRsbRsbRg
bRsRsmbsbRgbRsRgbRsbRsRsRsmmbRsbRsbRsRsmbRsRsRsLsmmbRsbRsRsmbRsRsmbRgb
RsLsbRsbRebRsbRobLsbRgLsbRsRsmbRgbRsRsmbRsRsRsmmbRsRsmbRsRsmbRsbRsRsmb
RsbRsbRsbRsbRgbRsRsmbRgLsbRgbRsRsmbRsRsmbRsRsmbRgbRsbLgbLgLsLsmbLibLgb
RsRsmbRsbRsbRsRsmbRsRsmbRsRsmbRsRsRsmmbRsRsRsmmbRsRsmbRsbRsbRsRsmbRsRs
RsmmbRgbRsRsLsmbRgbRgbRsbRsbRsRsmbRsRsRsmmbRsbRsRsmbRgbRsbRsRsRsmmbLsb
RgbRsbRsRsRsmmbRsRsRsmmbRsRsRsmmbRsRsmbRsRsmbRsbRsbRsbRgbRsRsmbRgLsbRs
bRgbRsbRsbRsRsmbRsbRsRsmbRsbRgbRsbRsRsmbLcRsbRsRsRsmmbRsRgbRgbRsbRsRsR
smmbRsbRsRsRsmmbRsRsRsmmbRsbsbRsRgRsLsmbsbsbRsbRgbRsbRsbRsbRgbRsbRgbRs
bRsbRgbRgbRsbRsRsmbRsRsmbsbRsRsRsmmbRsRsmbRsRsRsmmbRgbsbRgbRsbRsbRsLsb
RsbsbRsbRsRsRsmmbRgbRsbRsbRsbRsRsmbRsRsmbRgbRsbRsbRgbLsbRsRsmbRgbRgbsb
RsbRsRsmbRgbRsbRsbRsbRsRsRsmmbRsbRgbRsbRgbRsbRgbRsRsmbRgbRgRsmbRsbRgbR
sbRsRsmbRgbRsbRgRsmbRgbRsbRsRsmbRgbRsbRsbRsRsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 160755; End: 161300;
Recording: 3-1; Individual: 15; Drug: PCAP814 1 然 Apo 50 然
bRsRsmbLsbRcbRsbsbRjbRgbRsbRcbRsbRcbLsbRibRgbRjRgbRsbRcbLcLsLsmmbLsbLs
RsLsbRsbLsbLjLcLsmbRsbRsbsbRsbLjbLgRsbLsbLgbLibLsbLsbLsbLcbLsbsbLsbLjb
RgRsRsmmbRibRsbRebLsbRibsbsbsbLhbLsbRibRhbsbsbRebRjbRsbsbRgbLgLsbRjRsR
smmbsbsbRiRsmbRjbRsbLgbRsbRcbRsRsmbRobLgLgbRibRibRgbRgbLjbLcbLgLsLsmbL
gRsbLibLibLsLcbRcbLsbRjbRcbRhbRiRsmbReRsmbRsbRebRgbRsRsmbRiRsmbRgRsmbR
ibRgbRibRhbLsbLiLsbLibLcbLibLcbLgbRjbRibRgRsmbLsLsmbLgbRhbRiRsmbRgbRiR
sRgmbRgRgbLibLibLibLgbLcbLsbRobLcbRcbReRsmbRsRgLsbRgbReRsmbRebRebRjRiR
sRsmmbRgRsRsmmbRibRgbLsbsbRgRsmbRgRsRgmbRgbRsRsmbsbLgbRibRsbRibRhbReRs
mbRibLeLsbLgLiLgLsbLgbLgbLibRcbRibRibLgbRsRibRgbRebRoRsLsmbRibRibRgbRg
RsmbLjbLsLibLhbLgLgLibLibRcbRibRibRhRsmbRibRebLcLsmbLebLgLsbRsbLhbLibL
cbLsRsbRjbRhbRibRibLsLsmbReRsmbRebRsbRobRgRsmbRgbRibRibLsRsRsmbRiRsmbR
ibRibRcbRgbRibRibRibRhbLsbRiRsRsRgmmbRibRgbRjRgRsRsRsRsmmmmbLgbLhbLobL
gbLiRsbLibLibLgLsbLsbLhLsbLibLibLibRgbLibsbLsbsbLsLsLsmmbRsbLsbLsbRsbL
gbLsbLjLsmbRcbRsbRhbLsbRiRsmbLgbRsbRjRsRsmmbRhbRebRhbRsbRcbLgbRhbRsbRc
RsmbsbLhbLgbLsLsmbRsbLsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 160755; End: 161300;
Recording: 3-1; Individual: 16; Drug: PCAP814 1 然 Apo 50 然
bRsbLsbsbRsbLsbLsbRjLsbRjbsbsbsbRibsbLoLsmbLibsbLsLsmbLiLhLsLsLgmbLjbL
gLsbLibLsbLgbLsbLiLsLsLsLsRsmmmbLsRsbsbsbsbsbsbsbsbsbsbsbLsbLsbLsbLgbs
bLjbLsbLgbsbsbLsbLcLsmbLiLsLsLembLibLsbsbRibLgbLiRsRsLembLcRsbLcbLgLsb
LibLcbLsbLoLsmbRsLoLsmbLibLebLeLsbLgbLsbRobRgRsRsmmbRgbRgbRgbRsRsmbRgL
sbLsbLeLsbLgbLjbLhbLcLsLsmmbLiLsbLeLsLcbLiLsLhLsLsmbLsLsLsLgmmbLsLsLsL
sLsLsmmmmmbLgLsbLgbLiLsbRsLgLsLhbLiLsbLiLsbLibLeLsLibLgLgbLhLgbLibLiLs
LhLhbRsbLobLsLsLsLsLiLsmmmbLgbLiLsRsLsbLhRsbLebRgLsbLiLsLsmbLibLibLgbL
gbLiRsbLsLhbLiRsLsRsbLebRsLsRsbLgLsbLsLsmbLsLsLsmmbLgbLgbLgbLgLsLcLibL
ebRjbRjRgbRjRsmbRgbRgRsRsmmbRgbRgbRgbRsRsRsRsRsmmmmbRsRsmbRsRsmbRsRsmb
RsbRsLsRsLsbRsbsbRhLsLsmbRibRsbRsLsbLcLsmbLgLsLsLembLibLsLiLgbLiLsbLib
LiLsLgbLsLsLsmmbLsbsbLgRsbLiLsLeLsLibLgLsbLiLsbLiRsbsbLiLsbLgbLgbRsbRs
bLgLsbLgbLgbLibLiLsLsLsLcLsmmmbLibsbLsLsmbLgbLgbLgbLiLiLebLgLsLsmbLsLs
mbLgbsbLsLsLsmmbLgbLcRsLeLeLebLibLhbLcbLsbLsbLsbsbRsRsmbLsLsmbLgbLiLcL
gLsLsmbLgbLgLsbLibLiLsbLgbLibLibLgbLibLgLgLhbLgbRsbLsLsmbLsLsLsLsLsmmm
mbLgLsbLcbLhLsbLiLsLsLsLgLgLgmmbLgbLgLsbLiLsLsmbLebLebLeLsbLgLsbLgbLgb
LhRsLsbLhbLebLgLgbRsbLsbLhLiLhLsLhbLeLsbLgLsLsmbLebLsbLcLsmbLibLiLsbRc
bRibLsbLcLsmbLibLsbLgbLiLsLsLsLiLcRsLsmmbLgLsbLebLgLsbLsbLsLsmbLsLgLsb
LiLgbLhLsbLobLeLgbLsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbLgL
sbLsbRhRgbRgbLsbLsbLsbRsbLsbRsLsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 160755; End: 161300;
Recording: 3-1; Individual: 17; Drug: PCAP814 1 然 Apo 50 然
bsbsbRsLsbsbsbsbRsLsRsLsLsmbsbsbRsLsbRsbLsbLgRsbLsbLsbRsbLsLsmbLsLsmbL
gLgbRsbsbLsbRsRsmbRsRsmbLsbsbsbLsRsbLgbRsbRsbLgbLsbLsLsmbLsbLsbsbLsbLs
LsmbLsRsbLsbLsbLgbLsbLsbsbLgbLsbLgbLsbLgbLgRsLsbLsLsmbRsbLgbLsLsmbLsLs
mbLgbsbsbRsRsmbLsLgLsbLibLsbLsbLsLsmbLgbRsLsbLsLsLsLsmmmb

>ZF Recording 2016-06-02; tW: 300s; Start: 160755; End: 161300;
Recording: 3-1; Individual: 18; Drug: PCAP814 1 然 Apo 50 然
bLsLsmbLsbLsLsmbLsbLsbsbLsbLsbLsbLsbsbRsbLsLsLsmmbLsbLsbsbLsbLsbsbRsbR
sbLsRsbLsbLsbLsLsmbLsLsmbLsbsbLsbLsbLgbLsbLsLsmbLsLsmbLsLsmbsbLsbLgbLg
bLsbsbsbLsbLsbsbLsbLsLsmbLsLsmbLsbLsbsbLsLsmbLsLsmbsbLsbLgLsbLhbRsLsRs
bLibLeLibLcbLgbLhLiLsbLsRsbRsbLsLsmbLgbLgRsLsbLgbLgbLsLgbLgbLgbLsbLsbL
sLsmbLsLsmbLsLsmbLsLsRsmbLsLsmbLsLsLsmmbsbLsLsmbLgLsbLsbLsbLgbLsLsmbLg
LsbLgbLiLgLsbLgbLgLsbLgbLiLgbLgbLgbLgbLgLsbLgLsbLiLsbLhLhLobLebLgLgbsb
RsbLsbLgbLgbLgbLgLsRsbLgLsbLgbsbLgbRcbRibRibRgRsmbRibRiRgbRgbRiRsmbRib
RsbLsRibRcRgRgbLsbRsRsmbRcbRgRsmbRebLsbRcbRcRiRgRsmbRiRsRsRgRsRgmmmbRs
bRiRsmbRgRsmbRcRsLsmbRcRibRebRibRgRsmbLcLsmbLiLhbRsbsbLgbsbsbsbsbsbsbs
bsbLibRcbLcbsbLsLsLsmmbLsLsmbLgbLsbLgbRhbRhbRgbsbsbsbRsRsmbRsbRgRsLsmb
RsRsRsmmbRsbRsbRsRsRsmmbLsRsbRsRgbRgRsRsmmbRsRsmbRiRcRsRiRsmmbRgbRsRsm
bRsRsRsmmbRgbRsLsbRsbRsbRgbRiRgRsRimbRgbRsbRsbRgbRsbRsbRsbRibRgbRsRsmb
RgRibLebLibLgbLobLsbLsbsbsbLiLsLsmbLgbLiLsLgbLsbLgbLsLsLsmmbLgbLgLsbLe
LcbLebLsbLsLsmbLsbLsbLgbLsLsmbLsbLsbLsbLgbRsLsbLgbLgbLgbsbLgLsbLsbLgLh
bLibLgLsbLsbLsLsmbLsbLsLsmbLsbLgbLsLsmbsbsbsbsbsbsbsbsbLcbsbLgLsbRsbsb
sbLsbLsLsmbRhRsmbRibRsRsmbRsRsmbRsbRsRsmbRsbRsLsbsbRsbRsbRsbRsbRsbRsRs
mbRsRsmbRsRsRsmmbRsbRsRsmbRsRsmbRsbsbRsbRsbRsRsmbRsRsLsmbRgbRsbRsbRgbL
sRsbRsbRgRsmbRsbsbRsbRgbRsbRgbLsbRgbLsRsbRsRsmbRsbLsbLcbLibLgLsLsmbsbL
gbLsbLsbLgRsbLeLsbsbsbLsbLsbRsbLsLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 160755; End: 161300;
Recording: 3-1; Individual: 19; Drug: Control Apo 50 然
bRebsbsbsbRsbsbRsbsbsbRiRsRsmmbRsbRsRsmbLsbRsbsbLsbLsbsbsbLhbRjbsbRsbL
sLsmbLsbsbsbLsbsbsbsbLhLibRsLsbLgbLsbLcbRgbRibRgRibRgbRgbLsbLsbsbRsbRj
RsmbLobLsbsbRsLsbsbsbRebRhRibRiRsmbRsbRgbsbsbsbLsbLsRcRsmbRsbRsbsbRiRg
bRsbRgbLsRsbsbRsRibRsbRhbsbRobRcbRgRsmbRibRsbRsbRsbRsbsbRsLsbLcbRsbsbL
sbRsbLsbRcbsbsbsbsbLsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 160755; End: 161300;
Recording: 3-1; Individual: 20; Drug: Control Apo 50 然
bLjRsbsbRsbRjRsmbsbsbsbsbsbsbsbsbsbsbsbLsbRgbLsbLiLsbRjbsbLgbLgbLgbLib
RsbRcbRebLsbLhbLibReRsmbRiRgRsmbRsLsbLjbRsRsRsmmbRgbLsbLjbRibLeLsbLsbL
gbLgbRcbLcLsmbLibLiLsbLgbLibRsbRsbRjLsRsbRsbLsbRgbRsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 160755; End: 161300;
Recording: 3-1; Individual: 21; Drug: Control Apo 50 然
bsbRsRsmbRsLsbLsRsRsmbRsbLcbLcbRhbRobRebLcbLsbLhbRebRibLobLibRibRcbRcb
LobLcbLhbRcbLibRgbLsLsmbLsbLibLgbRcbLjbsbLeLsLsmbLjbRobRsbRebLsbRoLsbL
sbLcbLoRsbRebRobRibRcRsmbRibRcRsmbRcbRcbRibRobLobLgbLcbLcbLibLobLgbRcb
LcbLhbLobLobRcRsmbRebRgRsmbLjbRiRsmbRibLhbLobLcbLcbLhRsbLeLsbLcbLobLjb
LebLcbRobRcbRsRebRebRibRcbRcbRhbRibRsRcbRobsbRebRebRcRsmbRjbRcbRebLgbL
ebLjbLgbLibLcbRgbLibLgbLobLobLibLcbLcLibLebLibLsbRobRhbRibRsRsmbRiRsmb
LgbRsbRcbLsbLsbsbRsbsbRhbLsbRcbRcbRcbLibRcbRiRsmbRobLsbLcbLcbLib

>ZF Recording 2016-06-02; tW: 300s; Start: 160755; End: 161300;
Recording: 3-1; Individual: 22; Drug: Control Apo 50 然
bRsbsbsbsbRgRsRsmmbLoLsLsmmbLibLgLsbLibRsRsmbRjbLcLsmbLobLcbRobRobLibL
sbRobRibRhRsmbRgRsmbReRsmbRgRsmbRcbsbsbsbsbsbRsbLsbsbsbRsbRsbsbsbLsbRs
bsbsbLsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 160755; End: 161300;
Recording: 3-1; Individual: 23; Drug: Control Apo 50 然
bLebLcbRcLsRcbRhLsbRhbRcbRebReRsmbRibRobLobLhLsLsLgLsmbLcbRjbRibRiRsmb
RebRjbRcbRibRobLsbLgbRibLobLebLgRsLsbLcbRoLsbRibRsRibRcbRibRsbLcbRgRsR
imbLibRhbRibRibRgbLobLsLibLgbLiLsbLibLeLsbLibLhbLibsbLebsbRsbsbLsbRjbR
sbRgbRsbRcbLibLsbLhbLsbRsbLebRcLsbRhRsmbRhbRhbRjbLsbRsRsLsmbRgRsmbRibR
ibRhRsmbRobRcbRibRibLobLsbRobRibRebLgbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 160755; End: 161300;
Recording: 3-1; Individual: 24; Drug: Control Apo 50 然
bLjbsbLjbLjbLjbsbsbsbLjbsbsbsbLjbLjbLgRsbsbLjbLjbLjRsbLibRjbLhbLgbLjbR
jbRjLsbLjLsmbRsbLjbRsbLibRjbRjbRsbLjbLjbLjbLjRsbRsbLsbLjbLjbLjbLjbLjbR
jbRsbLsbLgbRebRibRiRsmbLjbLsLsLjmbLibLhbLjbsbLjLsmbLibLjbLhbsbRsbLibLj
bLjbLsLsmbLsbLsbLsbLjbLjbLibLjbsbRsbRebRobRjbRcRebRebRebRebRibRjLsbRiL
sbLcRsRsmbLibsbsbLibsb

>ZF Recording 2016-06-02; tW: 300s; Start: 160755; End: 161300;
Recording: 3-1; Individual: 25; Drug: PCAP814 10 然 Apo 50 然
bLsLsmbLgbsbsbLsbLsbsbsbLsbLsbRsbRsbRgbLsbRcbsbRsbRsbRgbsbsbsbRsbsbsbs
bsbsbRsRsmbRcbLgbsbsbsbsbsbsbLsRsbLsbsbLgbsbLcLsRgmbRjbLgRsbRibsbLsbsb
RgbLsbRsbRsbRoRsmbLhbsbRsbRsRebLsbRebsbRgbRobLsbLsbLgbLsLsLsmmbLgLsbLg
bLsbLsbLsLsmbRsbLsLsmbLsbsbRhLsbRcLsbRgRsmbRsbRsbRsbsbRsbRgbRsbRsbRsbR
sbRsbRsbLsRsRsRiLsmbLcLjbRgbRsbRsbRsbRsbRsRsmbRsbRsbRsbLebRsbLsbRgbLgb
sbRsbLsbsbsbLsbLibLsLgbLjbRgbRsbRsbRgbsbRsbLsbLsbRsbRjbsbRsbRsbRsbRsbR
sbsbsbsbRsbLsbsbLsbRsbLsbsbsbRsbsbsbsbsbRsbLsbLsbsbRsbRsbLsLgbRsbRsLsb
RcbRebLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 160755; End: 161300;
Recording: 3-1; Individual: 26; Drug: PCAP814 10 然 Apo 50 然
bLsbLsbRgbRgbsbRsbLjbsbsbsbRcbRobRsRsRsmmbsbLjbRgRsmbRgbLsbLsbRsLsbsbR
sbReRobLobLsLsLsmmbLsLgLsbLhRsbsbLsbLgbsbLgLsLsmbRsLsRsbRsLsbRebRsbLsR
sbsbsbsbsbsbsbRsbsbsbRsbsbRsRobLsRsbLsbLsbRebLjLsLjLsmmbRibReRsmbRsbRs
bLjbLsbLhbLsLgbLiLsbLgbLeLoRsbRsbLsLsmbsbsbLjLsmbRsbLsbLjbRjRsmbRsRsRs
mmbRsbsbRsbRsLsRsbRsbLsbRsbRsbRsbRsbRjRgbLobsbRgbLjRsbsbLjLsLsLgLsLiLh
LgLsLgLsLgRgLsmmbLgbReRsmbsbRsbRsbsbLsbsbRoRobLobLgbLcRsRsmbRsbsbRsLsb
RsLsbLsbRgRsmbRgbRsbRsbLsLsmbRsbLobRgRgRsmbRsbRgRsRgRgRsmmbLsRjbRsbRsR
smbLsbLgbLibRsbLobRcbLjbLjbLjLsLsLsLsLgmmmmbRgRgRsRgRgmbRsRsRsmmbRsbsb
sbsbRjbRsLsbLsbRgRcRibRsRsRgRsRsLsmmmbRoRibRibRsLgbRiRgbRjLsbRsRsmbLsb
LsbLjbLsRsbLsRibLgbLsbLsLsmbRsbRgRiRsRgmbLibRgRgbRsRsRsRsLsRsRgmmmbLob
RjbLsbRsbLsbRcbRiRsLsmbRebLcbLsLsmbRiRgRgRsRsmmbRibRsbRhRgRibLobLsLsmb
LgbLiLsbsbsbsbsbLsbRgRjbRsbRsRsRsRimmbLsRsbRsbRsbsbsbRsbsbsbLib

>ZF Recording 2016-06-02; tW: 300s; Start: 160755; End: 161300;
Recording: 3-1; Individual: 27; Drug: PCAP814 10 然 Apo 50 然
bsbsbsbsbsbsbsbsbsbsbsbRsRsmbRibRgbLeLsbsbLsbLjbsbsbsbsbRsRsmbRsRsmbRi
RhbsbLibLsbsbLsbLeLsbLsbLsLsmbLcbsbLsRgbRsbRsbRgbRsbsbsbRgLsbRsLsbRsbR
sbLsRsRsmbRgbLibLeLebsbReRsRgLgRsmbRsbRsbsbRsbRgRsLimbLcLgLsLgLsbLsLiL
eLsLsmbLgbLsbsbRsbRsbLebRsbRhRsmbRgReRgRsmbRibsbLsLsmbLeLsbRsbRsbRsRgL
gbLjbLeLebRsRsmbLibRibLgbRgRsmbRsRjRjRsRsReRsmmmbRgbRjbLeLsbLsRiRsmbRg
bRgRsRsRemmbRgbRgbsbLsLeRsLjbRcbLsbsbLeLebRsLsLsmbRgLsbLgbRgbLsLjbRobs
bLsbRsbsbsbsbLsbRsRsmbsbLeLiLgbsbLsbsbLsRsLsLsmbLsRgbLsbLjLcLgbRgRiLib
RibsbLebLsLsLgLembRibRibRgbRsLsbRgLsbRgRibRsbRjReRsmbRsbLsLeLibLebsbLs
bRsLsRsbReRsmbRgRgbRgbLsbLebLsbsbRsRsmbRsbRgbRsbRsRsLsRimbsbLsbRsbRgRi
RsLsmbRgbLgLsbLgbLiLhbLsbRsbsbsbLsbsbsbRsbRsRsmbLsbRcbsbsbRsbLgLgbLcbL
gLjbLsbsbsbLsbsbLebLiLsbRgLsRgbLsLsmbsbsbRsbRiRsmbRgbsbsbsbsbsbsbRsbsb
sbsbsbsbsbRgbRgbsbLjbLgbLibLsbLsLsmbsbLsbLsLsmbRsbsbLsLebRsRgRjbRibRgR
sRsmmbRsbLgbLeb

>ZF Recording 2016-06-02; tW: 300s; Start: 160755; End: 161300;
Recording: 3-1; Individual: 28; Drug: PCAP814 10 然 Apo 50 然
bRgbsbLsbLsbRsbRsbLsRsbsbsbsbsbLgRsRsmbsbsbRsbLsbRsRsRsRsRsLsRsmmmmbRg
LibRcbLobReLobLsbLsLgbLsbLiLebRoLsbRhbLsbRsbRebRebLjbsbLsbLsbsbsbsbsbs
bLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 160755; End: 161300;
Recording: 3-1; Individual: 29; Drug: PCAP814 10 然 Apo 50 然
bsbRsRsLsLsmmbLsbRsRsmbsbLsbsbsbsbsbRsbLsbLsbRsbsbRsLsbRsbRsbLsbsbsbsb
sbLsRsbRsbLsLsmbRsbLsbLsbRsbsbRsbsbsbsbsbsbsbRsbsbsbsbsbsbsbsbsbsbsbsb
sbsbRsLobsbsbRsbRsbLsbsbsbsbsbsbsbsbsbsbsbsbRsLsRsbLsbRsLsbLsbLsLsmbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 160755; End: 161300;
Recording: 3-1; Individual: 30; Drug: PCAP814 10 然 Apo 50 然
bsbRgbLsbsbRsbsbRsbsbsbsbsbRsbsbRsbRsbRsLsbRsLsLsmbRsbRsbRsbsbsbsbRsbs
bsbRsbLsbLsbLsbLgbLgRsbLsbLsbsbsbLsbLsbLsbLsbLsbLsLsmbLsLsmbLsbLgbLsbR
gRsmbLsbLgLsbLsbRsbRsRsmbRsbLsbRsbRsbsbsbRsbRsbsbRsbLsbLsbLgbLsRsbRgbL
iLsbRsRsLsmbRgLsbsbLibRsbsbRgbLsbsbsbRibLsbRgbRgRsRsmmbRsbLcbLebLsLsmb
LsbLsbLsbLsbRgbLgLsLsmbRibRgbRsbLsbRgbLjbRsLsbLsbLgLsLgbsbRgbRsbRsbRsb
LsbRsbLsbRgbLgbLcbLgbRgLsRsbRebLibRcbRgbLsRsbRgRgRsmbLsLsLsLsLsmmmmbLs
LsmbLsbRsLsbLsbLsLsLgLsLsmmbLsbLgLsbsbRsbRjbLsbLsbLgLsbsbLsbLsbLsLsLsm
mbLgbRebRsbRsbRsbRsbRsbRsbRsbRsbsbsbLsbsbRsbRsbRcbRcbLobRgbRebLgbRsbRs
bLcbsbRsRhbLjbRsbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 160755; End: 161300;
Recording: 3-1; Individual: 31; Drug: PCAP814 3 然 Apo 50 然
bsbsbLsbRsRsmbLsbRibsbRsbRibRiLsbsbsbsbLsbLobsbsbRsRebRgbRhLsLsmbsbRsb
LsbRsbRgbRsbRgbRgbRsbRgRsmbsbRsbRsbRgRsmbRsbsbRcbRgbLsbRsbLgbsbRsRsmbR
sRsmbRjbLgbLsbsbsbsbRsbRcbsbRsbRgbRsbRibRsbRsbRgbRgRsmbRgbRgbRgbRgLsbR
sRsmbsbRgbRiRgbRgRsmbLsbRibRiLsbsbRsRsmbRibRgbRgbRgbRgbRcLsbLsbLibLibL
hLhbRibRoRgLgbLhLhbLsLsmbRsRibRcRsRimbLsbRibRgbRgbReRsmbsbRibRgRsmbRsb
RibRiLsbRgRsmbRgbRgbRgbRgbRsbRiRsRimbRiRgbRgbRiRsmbRgbRgbsbsbsbRgRsRsL
smmbRgbRsbRgbsbLsRsbRsbRibRgbsbRsbRgbRsbRsbRgbRiRiRsLsmbRiRsmbRgbRgbRs
bRgLsbRhRgbRibRgbRibRiRsmbRgbRgbRcbRgRsmbRiRgbRibRgbRgbRcLsLsRgmbRhLsR
sbRsbRsbRgbRgbRgbsbRgbRgRsmbRgRiRiRsmbsbRsbsbLsbRibRiRgbRiLsbLjbRsbLsb
LcbsbLgbLsbsbRsbLsbsbLgbLiLsLibsbLsbLsbRsLsLsmbLcLibLgLsbRsRsmbLiLsbLi
LsbsbLsbRjbsbRcbLsbRgbRsbsbRgbsbsbsbLsbRsLsRsbLsbsbRgRsmbRsbRgbRsbRgLs
bRgbRgbRgbRgbLsbRibsbRgbRjbRsbRsRsmbRgbRgRsmbRsbsbsbRgbsbRsbsbRgbLobLi
bLibsbLibLebLiLgbLibsbLgbLiLgbRgbRjbRsbsbsbsbsbsbsbsbRjRsRsmmbRibRsbRg
bRgRsmbRhbRsbLsbRgbRiLsbRibLsbRsbRibRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 160755; End: 161300;
Recording: 3-1; Individual: 32; Drug: PCAP814 3 然 Apo 50 然
bLgbsbRibRgRcRobRhbsbRcbRsbLebLcbLsbLibLsbLcbsbLcbLibLiLgbLebLeLsbRsbs
bRsRsmbLgLsbRjbRcbLcbLgbLsLgbLsbLjbLhbLibsbLgbLsbLsLgbLgbLhbLcbLsbRebR
jbRsbRgbLgbRgRsmbRgbRgRgRsRsmmbLebsbLibRsbRjbLjbLsbLibLibsbRjbLsbRsbsb
RgbRibsbRebLgLsbLjLsmbLcLsmbLiRgbRibLeLsbRjbRsbRsRsLsmbLsbRsbRobRhReRs
RgRsLeLhRsmmbLcbLiRsbLibLibLibLibRibRibReRgRsRsRgmmbsbLsbRibRgRsmbRgRs
mbRoRsmbRsbRibRhbRgRgbRhbRsLibLiLgbLcRsbLhbRgbLobLgLebLcRsbRgbLjbLhbRi
bLhbLcbLibLgbRhbRgRsmbRsRsmbRsbsbRsbsbRcRsLsmbsbsbRgbLeRsbRiLsbRjLgRsL
sbRgbsbRibLibsbLsLsmbLsbLgLsLsmbLiLsbRsbLsLgbRsLsRsLsbRjLsLsmbsbsbRsbs
bsbLsLsmbLgbLsLhbRsLsbLsLsLsLsLsmmmmbsbsbsbLsLsmbsbLgbsbsbsbLsbsbsbsbs
bLsLiLcLcLgRiRhRsRimbRsRobRhbRoLsbLhbLibLsbRjbRibRcLsbRcbLeLsbRsLibLob
LhbRibRibRibRibsbRgbRiRsmbRgbRsbRgbRjbLgbLsLsmbsbRsbRhbLcbLjbLsLsLsmmb
LcbsbLgbLjLsmbLiLsbLebLibRibRibRibRgbRgbRgRsRsLsmmbLsRjbRsbRibRiLsLsmb
LibLhbLgbLibRsLsbLcbLsbLsbLibLeLsbLgRsbRibRebLiLsbRebsbLgbsbRcbsbRjbsb
RibLcbLhbLobsbRgbRgbLibRsbRibRiRsmbRsbRsbLebLgbLibRgbLhbsbRsRsmbRibLsb
sbRjbRsbLcRsbLgbLgbRjbLsLgbLibRsbRjbRibRgbRgbLgbRiLsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 160755; End: 161300;
Recording: 3-1; Individual: 33; Drug: PCAP814 3 然 Apo 50 然
bRgRsmbsbsbLgbLgbLsbsbLgbLgbLsbRibLibRjbRobRsbsbRgbReRsmbLgLsbRsbRgbRg
bsbRsbRsbLsbRoRsLsRsmbRcbRibRiRsmbRobsbLhbRcbRcbRgRsmbLsbRcLsbRsRsRsmm
bRsRsRsmmbRhRibLsbRcLsRsbRhbsbRsbsbRsbLsRgbRibRgRsmbRsRibRsbLsbLsbLsLs
mbRhbsbRsRsmbsbRsRsmbsbRsRsmbRsbRsRsLsmbLsbRgbRgRcRibLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 160755; End: 161300;
Recording: 3-1; Individual: 34; Drug: PCAP814 3 然 Apo 50 然
b

>ZF Recording 2016-06-02; tW: 300s; Start: 160755; End: 161300;
Recording: 3-1; Individual: 35; Drug: PCAP814 3 然 Apo 50 然
bLsbLgRsbLgLgbLsLsmbLebRsbRsbsbsbLibsbLsLsmbsbLsbLsLgbLgLsbLgbLsbLsRsb
RsbsbsbsbRsbLsbLsbLsRsLsbLsbsbLsbsbLsbLsbsbLgbLgbsbsbLsbLsbLgbLgbLgbLs
bLgbLsLsmbLsbLsLsmbLgbLgbLgbLgLsbLsbsbLsbLgRsbLsLsLsmmbLgLiLgbLgLsRsbL
ibsbLgbLsLsmbLibLsLsRsRsmmbLibLsbLgbLiLsLsmbLsbLsbLgbLgbLgLgbLibRsbLcb
LsLsLsmmbLsLsRsmbLsLsLoLimbLiRsbLsbLgbLgbLsbLsbLcbRsbLgbsbLgbsbLgLiLgb
LiLhLibLsLgbLgLiLsbLsLsmbLsbLgbLgRsbLiLsbLgbLsLsmbLgbLcbsbRsbLsLsmbLjb
LiRsRsmbLgbLibLsLsmbLibLsLsmbLgbLgLsbLsLsmbsbLsbsbLsLsLsmmbLsRsRsmbsbL
sRsbRsLsbLsLsmbRsbLsRsbLsbLsRsbsbLsLgbLsLsRsmbLgbLgbLsbLsLsmbLgbLiLoRs
bsbLsbsbLjbLibLgLsLsmbLibLiLsbLgbLsbRgbsbLgLsbLiLcRsLgbLhLsbLgbRsbLsbL
sRsbLsbRsbRsbsbsbsbRsbsbsbLsRsbsbsbsbsbsbsbsbsbLsbsbRsbLsRsbRsbLsbsbsb
sbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbLcbLibLsbLgbRjbRgLsbRgbRgRsR
sLsRimmbRgbsbLibLsLiRsbLsbLibLgbLgLiLjbLgbLgLsLhbLibRibRiLsbRsLsbRgbsb
RebRsLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 160755; End: 161300;
Recording: 3-1; Individual: 36; Drug: PCAP814 3 然 Apo 50 然
bRsbLsLsmbLsbRsbRsRsmbRgbRsRsmbRsbsbRsbRsbRgbRsRcbRcbLsRcbsbRgRsmbsbsb
RsbsbRsbsbRsRsmbRiRsmbRhbRiRsmbsbRsbRsbsbsbsbRibRcRcbRcbRgbRgbRgbRsbRs
bRsbsbLsbRsbRsRsmbRsbLsbRsLsRsbRsRsmbsbRgRsmbRsRsmbRiRhRcRsRsRcRimmbLs
RsRsmbRsbRsRsmbRsRsmbRgbRsbRsbRsRsmbRsbRsRsmbRgbRsRsmbRsbRsRsmbRgbRsbR
sbRsbRsbRsbRgbRsbRgbRsbRsbRsbRsbRsbRsbRsbRsRsmbRsRsmbRsRsmbRsbRsRsmbRs
bsbRsbRsbRsRsmbRsbRsbLsbRgbRibRibRsbLsbRgRsmbRsRsRsmmbRsRgRsmbRgbRsRsm
bRgbRsbRsbRsRsmbRgbRgbRsbRgbRgbRhRoRcbRsbRgbRgbRsRsmbRgbRgbRsbRsbRsbRs
bRgRsmbRsbRsbRgRsRsmmbRhRsRoRcRsRsRcRsRimmmmbLsRsbRsbRsRcbsbRsbRsRsmbR
gbRgbRsbLsbRsbRsRsmbsbRgbRibRebRgRsRsmmbRhRsRgmbLsbRsbRsbRibRsbRsbRsbR
sbRcbRgbRsbRgbRgRsmbRibRgbRiRsmbRjbRsbRgbRsRsmbRgbRgbRgbRgLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 160755; End: 161300;
Recording: 3-1; Individual: 37; Drug: PCAP814 1 然 Apo 50 然
bsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbLsRsbsbsbLs
bsb

>ZF Recording 2016-06-02; tW: 300s; Start: 160755; End: 161300;
Recording: 3-1; Individual: 38; Drug: PCAP814 1 然 Apo 50 然
bRgbsbLibRebLsbsbRibRgbLjbRsbLhbRebRhbRsbRsbRgbRebRebsbRsbRibLobLibLib
sbsbsbsbsbsbsbsbLcbLgbLibsbsbsbLibLibRsbLsbRobRcbRsbRiRgbRgbRebRgLsbRc
bLhbsbLibLibRobRibRhRsRsmmbRhbRoRsmbRsbLibLibLgbLhbLsbLcbRibLibLsbRjbR
iRsmbRiLsbLgbLibLgbRgbLibRcbLsbLiLsbLiLsbLgbRjbRcbRibLibLjbLibLgbLibLi
bRobLiLsLsmbRcbReRgbRebRibRibRiLsbLsbRgbRibRsLsbLjbRsbsbRsbLgLsbLibLgL
sbsbRsLsbLibLgbLgbLhbLiLsbLsbRiRsmbRgRsmbRgLsbsbRsbRibLsbRsRsmbLcbLibR
obRjRsmbRgbLobLibLiRsbRjbLibRsbRiLsbLgbRcRsmbRgbRibRibRgRsmbRsbRsbRsbL
cLsmbLibLibLsLsLsmmbLibLibLsRibRiRsmbLgbRobsbLgbLibsbRibLsbRsbLsbRcRsm
bRiRsmbRsbsbReRsmbRsbRgbRebRobLsbRhbLsbsbLjbLgbLibLgbLhbLsbLjbLsRiLsbR
gbRcbLiLsbLhbLcbsbLgbLhbLhbLhbLibLibLeb

>ZF Recording 2016-06-02; tW: 300s; Start: 160755; End: 161300;
Recording: 3-1; Individual: 39; Drug: PCAP814 1 然 Apo 50 然
bLsbsbRiRsmbRsbRibRsbRibRgbRsbRobLibsbLgRsbRgbRibRebRiRgbRgRhbRhLsbRsb
LcbLiLibLgLsbLiLsLgbLsbsbsbsbsbLibRsbLiLsbLibLibLhbLeLibLhbRibRsbLsbRs
bsbRgbRcbLibLibLibLgbLibLobLcbLiLsbLibLiLsbLgbLiLgbLhLeLgLsbLcLsmbRhbR
sRobRcRibRsbRibRgbRibRibRgbLjbLibLgLsbLgbLgbLsbLgbLgbLgbLgbLgbLgLsbLsb
LibLiLeLsLebLgLsbLgLsbLiLsLebLeLebLoRgbsbRgbRjbRcbRhbRibRebLcbLibLgLsb
RsLgLsLgbLgbLsLsmbLgbLibLsbLcLsmbRsbLiLgLiLsbLgLeLsLiLsLebLeLsbLsbRjbL
hbRjbLibRiLsbRsRsmbRgbRibRsRsmbRibRibLibLgbsbRibsbRgLsbRgbRgbLsbRsRsmb
RgbRgbRgLsbRgRsmbsbRgbRsRsmbLsLsmbRsRsRsmmbRgbRgbRgbRhbRsbRibRsbRobRib
RcbRoLsbsbLgbsbLhbLgbLiLsRsLsbLgbLgLsLsmbLgbLsbLgbLibLibLsbLibLibLibLg
bLgbLibLiLebLgLsbLhLsbLgbLiRsbLibLibRhbLcbLibLsbLibLgLsbRjbRcbRibLcbLi
bLgbLiLsbLsLsmbsbRjbLcbRjbRiRsmbRgRsmbRgbRgbLsbLibLiLsbLsbLibLgbLgbLgb
LgbLibLgbLgbLibLgbLiLsbLgLsbLgbLiLsbLibLgbLiLsbLgbLgLgbLgbLsbLibLgbLsb
LiLsbLsbLgbRcbRgbRgbRebRibRibRibRibRsbRgbLsRsbLsRsLsbRsLsbRsRsmbRjbRsb
RgRsmbRgbRgLsbRebLgbLsbLibRsLsbLgRsbLgbLgbRsbLgLgbLibLsbRjbLibLibLjb

>ZF Recording 2016-06-02; tW: 300s; Start: 160755; End: 161300;
Recording: 3-1; Individual: 40; Drug: PCAP814 1 然 Apo 50 然
bRhbRgbsbRibRibRsbRsRsmbRgRsmbRgbRgbsbRsbRsbRibLsbLibLjbLcbLsbLgbRsLgb
sbLgbLgbsbsbLgbRjbRsbLiLsbRsbLsbsbLsbLgbLcbLsbLsbRgbLibLibLsbLgbLgbLgb
LgLsbLsLsmbLgLsbLiLibLgRsbsbsbRsbLgLsbLsbLibLiLsbLgbRsbLgbLgbLgbsbLsbL
sbLgbLsbLgbRsLsbLibRibRibRsRgRsRsmmbRsbRgLsbRibRhRsmbReRsmbRgbRgbRgRgb
RibRgRhbRiRsmbLhbRibsbRibRibsbRibRibLsbRsRsLsmbRebRibRibRgbRibRibRobRh
RsmbRibRiRsmbLibRsbLgbLgbLibLibLsbLgLsbLgbLsbLibLhbRsRiRsLsmbRiRsmbRsb
RgbRiRsRsReRiLsmmbRgRsRsmmbRebRgbRiLsbRgbLgbLgbLhbLibLcbLobRgRsmbLgbRg
bLibLsbLibLgbRjbLiLsbLgbLibLeLsbLgbLeLsLsmbLibLsbRgbLhbRsbLiRsbRsbLibL
sbLgbLobLsbRibRibRobRsbRhbRgbRgbRsLsbRiLsbLsbLjbRoLsRsbRsbRgbRgbLsbsbR
gRgbRgbRsbRgbRsbRgbRgbRiRgbRgRsmbRiRiRsRimbRibRgbRgbRsbRgRsmbRcbRiRsRs
mmbRsRsmbRgRsmbRsRgRsRiRembRgbRiLhbLhbLsbRibRgbRgRsRsLsmmbRgRsmbRiReRg
bRsbRiLsbRibLsbRgRsmbLsbLjbLcRsbRibRjbRibLsRsRgbLsRsbRsRsmbRibLsbRgLsR
sbLcbRsbLsbLsbLibRsbRcbLjbRcbRgbRobLgbLibLobsbLsbLhbLiLsbLsbLgbLsLsmbL
iLsbLsbLibLgbLsbLgbLgbLgbRjbRiLsbRibRcbLsbLsbLsbLibRjbLibLibLhbLgbRibR
iRsmbRiLsLsmbLsbRibRcbRiLsbRgRsRgRsmmbRibRhbRiRgbRgReRsmbRebRebRsRebRg
bRsbRsbLgbRhbRjbRsbsbLjbRjbLsbRsbRibRsbRsbRibRsbRibRcbsbLsbLjbsbsbsbLi
bLsLsmbLgbLsbLgbRgbsbLiLsbsbLgbsbRsbLcbLibLibLsbRibRibRibRcbLsbLsbLibL
hLsbLsbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 160755; End: 161300;
Recording: 3-1; Individual: 41; Drug: PCAP814 1 然 Apo 50 然
bLhRsbLsbLgbRgbRsLsbRsbRsbRsbRsbRcLsRsbRgbRsbsbLsLsmbRsbsbLsbRjbRebLsb
sbRibRiRsmbRgbRgbLobRcRsmbRibRgbRsRsmbsbRhbRgbRgbRobLsbLgbLobLsbLsbLoL
smbLgbLiLsbLgbLsLsmbLeLsbLibLsbLjbRsbLsbRhRsmbRibRgbRsRsmbRjbRebRebRsR
smbRsRsLsmbRsRsmbRgbLjbLobLebLsbLeLsbLibLsbLebLjbLsbLgbLsRsLsbLgbLoRsR
gbRgRsmbRsbLebLgbLibLgLsbLgbLgLsbLgLsbRcbRcbRgRsmbRgRsmbRgRsRsRsRemmmb
LobLoLsmbLhLsbReLebLgbLjbRsLsbsbLgbLsbLhbRsbLeLiLsbLhbLeLsbLcLeLebLebR
sbLobLsbLsLsmbLiLsLsmbRgbRsbRjbRebLhbLcLsmbLgbLiLsbLiLsbRcbRebLsbLgbLc
bLjbLobRgRsRsmmbRjbRhLgbRobLjbLcLjbLibLeLsbLibLcbLgbLsbLibLgLsRibRobRi
RsmbReRsRgRsmmbLsLsmbLsRsbRobRsbRsbLsLgbRsbRsbRsbRhRsmbLibLgLsbRgRsmbR
cRjRgbRiRsmbRgbRhbReRibLsbLcLobLgbRsbRgRsmbRhRsmbRibRgbLsbRgRsRsLsmmbR
gbRhbLibLcLgLsLsmbLebLebLibRebLibsbLgbLiLsLsLsmmbRhbLjbLgbLsbLsRsbLjbR
gbRebRibRibRebRibLgLibRgRsmbLhLsbLebLhRsbRsbLsLsmbLoLsmbLgbLebLiLsbLeL
sbLhLsbLcLsmbLiLsbRcbRibRibRgbRhLsbRhLsLsmbLibLgLsLsmbRsbRjbRiReRsRsmm
bLsLsmbRsbRhLsbLsbReRsmbRhRsmbRgbRsRsmbsbRsRgbRgbLcbRebRgRsmbRibLcLsmb
LiLsLsmbLsbLgbLsLgbLgbRsbReRsRsmmbRibLgbRhbRibRibRsbLibLsbLsbLgLsbRsRs
mbLsLsRembRcbLebRsbsbLgbLsRsbLcbLsbRsbLeLsbLhLsbLgbLgbLgbLgLsbLibLobRs
bsbLcLsmbLibLsbLgLsbLsbLsbRcbLeLsbLibsbsbLobRibLgbLsbLgRsbLibLgLsRsbLg
bLsbLgbLgbLsLsmbRjLsbRsbLgLsbLiLsbLebLibLobRgbRiRsmbLcLsmbLgbLgLgbsbLg
bLsbLcLsmbLgLsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 160755; End: 161300;
Recording: 3-1; Individual: 42; Drug: PCAP814 1 然 Apo 50 然
bLsbLgbsbsbRsbLsbsbLsLsmbLsLsmbLsbLgbRsLgbsbLhbLjbRsbLgLsbLgbLsbsbLsbL
gbLgbLsbLsbLgbLsRsbLsbLsLsmbLsbLsbLsLsmbLsbLsbLsbsbRsbsbLsLgLiLsbLibLg
bLgRsRsmbLgRsbsbLsbLsbLsbsbLsbsbsbLsbRsbLsbLsbLsbRsbLsbLsbLsbLsbLsbLsb
LsLsmbLgbLsbLsLsmbLsLsmbLsbLsLsmbLgbLsLsmbLsbLsRsLsbLsbsbsbLsbsbLsbLgb
LsbLsbLsbLsbLsbLsbLsbLgRsbLsbLsbLsRsRsmbLsbLsbsbLgbLsbLgbLgLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 160755; End: 161300;
Recording: 3-1; Individual: 43; Drug: Control Apo 50 然
bsbsbsbsbsbsbsbsbsbRsbsbsbsbsbsbsbLsbsbsbRsbsbsbsbsbsbsbsbsbsbsbsbsbsb
sbsbsbsbsbsbsbsbsbsbsbsbsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 160755; End: 161300;
Recording: 3-1; Individual: 44; Drug: Control Apo 50 然
bLsRsbsbRgbsbsbsbLobsbsbsbRsbsbsbsbsbRsbsbLsbRgbRgbRsbRsRsmbsbRsbRsbRi
bRsLsLsmbRgbRhbRgbRsbRsRsRsRsmmmbRgbRgbLiLsLsmbsbsbsbRsbsbsbsbsbRsbLsb
RsbsbsbsbsbsbsbsbRsRsmbRsLsbRibsbsbsbsbRgRcbRsRsRsmmbRsbLsbRiRsmbRibRs
bRgRsmbRsbsbsbRsbRsRsmbRgLsbRibRibRgRhbRebRsbRhbRsRsRsRgRsRemmmbRgbRib
LgbLsbLgbLgLeLebLsbRsbRibsbLsbRsbRsLsbLeLsbLgbLgLsbLgbLebLeLsbLgbLgbLi
bLsbLsbRsbLibsbsbsbLgbRsbRiLsbLsbRsbRjbRibLcbRsbLsbLsbLsbRgbsbLibRsbRj
bLibLsbLibLsLsmbRsbLsbLsbLiLsbLibLgbLsbRibRebRgbLgbsbRgbRsbLsLsmbRebRi
bLsbsbRjb

>ZF Recording 2016-06-02; tW: 300s; Start: 160755; End: 161300;
Recording: 3-1; Individual: 45; Drug: Control Apo 50 然
bRebLcbLebLsLsmbRsbLibLibLsbLsbLsbLibLsbsbRsbRcRsmbRibRhRsmbsbRibLsbRg
bRhbRsbRebRibLobLsRsbRsbRsbLjbLebLibLgbLsLsmbLiLsLsLsmmbLebLoRsbLgbRgb
RsRobRiRhbRobLsbLsbReRsmbRibRsRsRgmbRiLsLsmbRgbRibRsRsmbRebLgbLiLibLgb
LsLsmbLebLgbLiRsbLgLgbLjbLcLgbRcRsmbRibRibRcbLobLobRiRsmbRobLsRsbLgbLg
bLhbLibLhRsbsbRsbLgbRebRjbRgbRebLgbRsbRsbRoLsLsmbRsbLsbLgLsLgLsLebRcbR
ebRgRsmbRjbRoRsmbRibRhLsbRiRsmbsbRcbRibLhbLgbRebRgbRsbLebLgbLgbLibRobR
sRsmbRsRsmbRiLsbRebRebRjbRibRgbLjbLsbRebLgLsbLcbLgbRgbRobRibRjbRibRsbL
cbLcbLsbLcLsLsLsmmmbLsbLsbLgbRsbRgbRcbLsRsbRjbLsbLsbLsbsbRgbRsbRhbRsRs
mbRebRgbLsbLsbRibRsbRiRsRsRsRsmmmmbRiRsmbLjbRsbRibRsbRhbsbLibRibLoRsRs
mbReRsmbRoLsbRibRhbRcbReRsRsRsRemmmb

>ZF Recording 2016-06-02; tW: 300s; Start: 160755; End: 161300;
Recording: 3-1; Individual: 46; Drug: Control Apo 50 然
bLsbLjbLsbsbLsbRsRsmbsbsbsbLobRsRsmbLsbRsbLsbRgbRsRsmbRgRsmbRsbRsRsmbR
sbRsRsmbRsRsmbRgbRsbRgbRsbsbRsbRgRsmbRsbRsRsmbLsbRsbRsbRgRsmbRgbsbRsRs
mbRsbRgbRsRsmbRgbRsRsmbRgbRsRsmbRgRsmbLjLhbsbLjbLgbsbLsbLsLsmbLsLsRgmb
LgbLsbRsbRsbRgbLgbLsRsbsbLsLsmbRsRsmbsbRsbRjbLhLsbRsbLgRsbLsLsmbLgbRsL
sbLsbLsRsbsbsbsbsbsbsbsbsbsbsbLibLcLsRsmbRsbLibLiRsbLsbLgbLsbsbLsbRgbL
oRsLsRsbRsRsmbRiRgbsbRgRsmbRibRsbRiRgbRsbRiLsbRgbRibsbRgRsmbRgbRgbRgbR
gLsbRgRsLsmbRgbRsbRgbRsbRsRsmbRgbRsbRsbRgRsmbRgbRiRsmbRgbRibRgbRgbRsRs
mbRgbRsRsmbRsbRgbRhbRibRgbRibRgbRsLsbRgbRsRsRsmmbRgbRgbRsbsbRgRsRsmmbR
gbRiRsRsmmbRgbRsbRgbRsRsmbRgbRgbRgbRgbRgbRibRsLsbRsRsmbRibRsRsmbRgbRgb
RgbRgbRgbRgbRgRsmbRgbRibRiRhRsmbRgbRebRsbRgbReRebRgbRgRsmbRsbRhRsmbRgb
RgRsmbRgRgLsbsbRiRsmbRgbRsRsmbRgbRiRsmbRsbRgbRgRsmbRgbRgRsRsLsmmbsbRsb
RsRsmbRgbRsRibRgRsmbRgbRgbRgbRgbRsbRgbRgRsmbRgLsbRgbRgRsmbRgbRgbRgbRgb
RgbRgbRgbRgbRsRsmbRgbRsbRgbRibRibRgRsmbRsLsbRsRsmbRgbRgbRgbRgbRgbRibLs
LsmbRsbRgbRgbRgbRgbRgbsbRgbRgbRgRsmbRgbRgbRgbRsRsmbRgRsmbRgbRgbRgRsmbR
gbRgbRsRsmbRsbRgbRibRsRsRsmmbRebRgRsmbRgRsRsmmbRgbRgbRgbRgbRgbRsbRsbRs
bRgbRgbRgbRgbRgbRsbRsbRsbRgbRsRsmbRgbRsbRgbsbLsbsbLsbsbsbsbsbRgbRsRsmb
RgRsmbRsRsmbRsbsbRsbRgbReRsmbRibRgbRgbRibRibRgRsmbRgbRgRsmbRebRgLsbRsb
RsbRgRsmbRsbRsbsbRgbLsbRsRsmbRsbRgbRgbRgRsmbRgbRsRsmbRgbRsbRibRibRgbRs
RsmbRsbRgbRgbRgRsmbRgbRgbRibRebRibRgbRsbRgbLsbRsRsmbRsRsmbRsbRsbRsbRsR
smbRgbRsbRgbRiRsmbRgbRibRibRgbRgbRgbRgbRibRgbRsLsbRgbRgRsRsmmbRsbRgLsb
RgLsbRsbRsRsmbRsbRsbLsRsbRsRsmbRsbRgbRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 160755; End: 161300;
Recording: 3-1; Individual: 47; Drug: Control Apo 50 然
bLjRsbRobLjbsbLibRcbLsbRsbsbLsbsbRgLsbLjbsbLsLsmbsbLsbsbRsbsbRsbRsbRib
RsbsbsbLjbRsbLjbLibLgLsLsLgLsmbLibLibLhLsLgbRsLsRsLsbLiLgbLsLsLsmmbLsL
sLsmmbLibLgbLsbLsLsmbLgLsRsbLgRsbRsbRsbLgbRgbRibsbLsRebRsRsmbRibRsRibL
hLsbLcbsbLiRsbRjbRebLjbReRsmbLibRcbRiRsRgmbLeLsbLibLsbLibLgbLiRsLsbLgL
sbLiLsbLsLsLsmmbLgLsbLgLsbLgLsbLibLsbLjbRjbRsbsbLhbRsbLhbRcRsmbLhbRjbR
sbLsbRcRsmbRibRgbLgbLjbRjbRiRsRsmmbLjbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 160755; End: 161300;
Recording: 3-1; Individual: 48; Drug: Control Apo 50 然
bRibsbRgbRsbRsbRgbRgbLsRsRsmbLsRgbsbRsbRgbRgbsbRsbRhbsbRsbRsLsRsbsbsbs
bsbsbsbsbsbsbsbLcLsmbRsbLsbLjbLsbLibLsbLcLsmbRsbsbLjbLhbLiLgbLsLsLsmmb
RcbRhbRiRgbRgbRgRobsbRibRhRibLsbsbsbRsbRiRgbRsRsmbRsbRgbRsRsRsRsRsmmmm
bLsLsmbLsbRsbRgRsmbRsbRsRsRsmmbRsbRgRgRsRgRgmbRibRibRsRsmbRcLsLsmbRiRi
bLsbLsRsbsbsbsbsbsbRsRsRsmmbRcbRsbRsLsbsbRgbsbRibRgbRsbRiRsmbRiRiRsmbR
iRsmbRibRgbRibRgbRgRgbRgRsmbRgRebReRsmbReRebRsRsRsmmb

>ZF Recording 2016-06-02; tW: 300s; Start: 161301; End: 161811;
Recording: 4-1; Individual: 1; Drug: PCAP814 10 然 Apo 50 然
bLsbRsbRsbRsbRhbRgRobRsbsbRsbLebRcRsmbRgbRsbRjbRgbRsbRsbLgLsRsbLgbLgbL
jbLgbLiRsbLgLgbRsbLgbRsbLsbLgLibLgLgbLsbLgbLsbLsRsbLsbsbRjbLjbLjbLsbRs
bRsLsbsbsbRsLsbRsRsmbsbLsbsbsbsbsbsbsbRsLsbLsbsbLsRsLsbLsbLsbLsbRsbLsR
sLsbRsRsmbLsLsmbsbLsbRsLsbLsRsRsmbRsLsbRsLsbRsRsRsmmbLsbLsRsbLsRsbLsbL
sbRsbRsLsbRsbRsbLsbRsbRsbLsbLsbRsbLsbLsbRsRsmbRsbRsbsbLsbLjbRsbLsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 161301; End: 161811;
Recording: 4-1; Individual: 2; Drug: PCAP814 10 然 Apo 50 然
bRgbRgbsbsbRibLsbRcbLebRsbLsbLobRsbRsbRsbRsbRsbRgbRiLjRsbRgRsmbRjbsbLe
bRgRsRsRsmmmbRsRsRsmmbRsbLsbRibLsLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 161301; End: 161811;
Recording: 4-1; Individual: 3; Drug: PCAP814 10 然 Apo 50 然
bRsbLsbsbLsbLibLsLsmbLsbLgbLsbLebLebLebLjbRebRebRcbsbsbRsbRjRgLsbsbRgR
gRsmbsbRgRsmbsbRebsbsbLgLsbLjbLebLgLsbRjbRsRsmbLiLsLsmbLsbLsLsLjmbRobs
bRjbLgLsbRgbsbRsRsmbsbLsbLsbLsLsmbLgLsLsLsmmbRsbLsLsLsmmbRcbLcbRgbLjbs
bRjRsmbRsLsbRsRsLsmbRsRsRsRsmmmbRsbLsbRsbRsbRjLsbRsRebsbsbLcbLsbRjbLgL
sbLsbRgbsbsbsbRgbsbsbRsbRgRsmbsbLsbLsbRsbRsbRsRsmbsbsbLsbsbsbsbRsRsmbL
sbLsbsbsbsbLsbRsbsbsbsbsbsbLsbLsRsbsbLsbLsbLsbRsbsbRsbLobRiLsbsbLjbLib
RhbLsbRibRsLsbRsbsbRsbRsbRsbRibRsbsbLsLsmbLsLsmbRebRgRjLgbsbRsRsmbLjbs
bsbsbRsbLsbRsbRsbsbsbRsbLjbRsbRgRsmbRsbRgbReRsmbLsbsbLsLsLsmmbLgbsbsbs
bLebLsbRgLsbRsbRsbLsbLsbRsbRsLsbsbsbsbsbsbsbsbsbLsbsbsbRsbsbsbRsLsRsbL
sRsbsbRsbLsLsmbsbLsLeLeLebLgbsbLjLsmbLsbLsbLgbsbsbRsLsbLsbRsbsbsbsbRob
LsLsmbRsLsbLsbRsbRhLsbLgLsbRsLiLcbLgbRgRsmbLibLsLsmbLjbRsbLgbLsLsmbLgb
LsbRobRjbRgLsbsbLsbsbsbLsbLjLsmbLgbLsbLsbLsLsmbsbLsLsmbRsLsbLsRebLsbLg
bLsbRjbLsbLebLsbLjbRsbLgLsLgLsLsmbLsLsmbLsLsmbLsbRcLgLsbRgLsbLsbLeLsbL
sLgbRsbRjbRsRsmbRsbRsRsRsmmbRsbRgRsmbRsRsmbLsbRgbRsRsmbLsbsbsbRsbLsLsm
bRsLcbRgRhbLebLgLsRebLgbLgbRsLsLsmbLsLsLsmmbLsLsmbLjbRgbRsbRgbRibRgRsm
bLsRsbLsRsbRsbLsRsbRsbRsRsmbLsRsbLsRsbsbsbLsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 161301; End: 161811;
Recording: 4-1; Individual: 4; Drug: PCAP814 10 然 Apo 50 然
bRsbLsbRgbRsbRsbRjRsmbLobLsLsmbLsbsbsbRsLsbsbsbsbsbLsbLsbRsbLsbsbsbLsb
LsbRgRsmbLgbLjbsbRgbLgLgbsbsbsbsbsbsbLsbsbsbRsbLsbRsbRgLcbLibRsbRsLjbL
ibLsbRjLsbLcbRob

>ZF Recording 2016-06-02; tW: 300s; Start: 161301; End: 161811;
Recording: 4-1; Individual: 5; Drug: PCAP814 10 然 Apo 50 然
bLsbsbRsbLsbsbRsbRsRsmbRsbRsbsbLsbLsbRsbRsbRsbRsbRsbRsbRsbLsbsbRsbRsbR
sbRsbLsbRsbLsbsbRsbsbRsbRsRsmbRsbsbLsbRgbRsRsmbsbRebRsbRsbsbLsbsbLsbsb
LsbLsbLsbsbLsbsbLsbsbsbLsLsmbLsbLsbRsbLsLsmbLsLsmbLsbLgbLsbRsbLsLsmbLs
bRgRcbRsbsbLgbLsbLsbRsbLsLsmbLsbLsLsmbsbLsbLsbLsbLsbLgRsbLeLsbRsbRgbRo
bRsbLsbLsbsbLsbRebsbLsbRgbRebRgRsmbRgLsbLjbsbLsbRgbRibRhRgbRsbRsbLeLsb
sbLobLcbLsbRsbRsRsRembRgRsmbsbRsbRgbsbsbLsLsmbsbRsRsmbLsbsbsbRsbLjbReb
LsbLsbsbRcbRcbsbsbLsbsbsbLgbRsbRsbLjbLsbRsbsbLjbLjbLjbLobRjbLsbLsbLsbR
sRsRgRgmbRiRsmbRhbLsbRsbRgbsbsbsbRsbRsRsRsmmbRgbRsbRgbLsLgbLgbLsbLsLsm
bLgRsbLebRhbLsbRebsbRsRgbLgbRgRibRgbRsbRsbRsRsmbRiRsRsmmbLsbsbsbRsRsmb
RsbRjRebRsRsmbsbRsbRsRsmbLibLsbLgRcbsbLsRsbRsbRiRsmbLsRsRsmbsbRsReRebL
ibLsLsmbLsbLiLibRsbRjRsmbLjbLsbLgbLsRgRgbRgRsmbsbRiRsmbRsbRebLgbLsbLgL
ebRsbRgbRsRgbRsbRsbsbLjbLeRsbRsbLsRgRsRgRsmmbLsbRgbLsbRgRsmbRibRgbRsbL
sRgbLibReRgbRcbRsRiRsmbLsbLhbLsbLsbRsRsmbRsbsbLjLsmbRsbRjRhbRibLgbRsbR
sbsbRsRsmbRsbRsRsRgLsmbLsbLgLebLgbsbLsbRsbRsRsmbLsbRibLsbLjbRjbLcbsbRg
bRsbRsbRibRgbRsbRsRsmbRsbRsbRsRgbRgRsmbLjbRsRgRsmbRsbLjbRhbLibLsbLgbRg
RsmbRgRsRsmmbRsbRsbLhLsLsmbLgbLsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 161301; End: 161811;
Recording: 4-1; Individual: 6; Drug: PCAP814 10 然 Apo 50 然
bLsbLjbLsbLsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 161301; End: 161811;
Recording: 4-1; Individual: 7; Drug: PCAP814 3 然 Apo 50 然
bRgbRjRsmbRsbRibsbLgbRcbLjbLiLobRsRsmbRsbLsbsbsbRgbRibRibsbsbLsLsmbsbs
bRsbRgLsbRgbRsbRsbRsRsmbRgbRsbRsbRgbLsbRgbRsbRsLsRsbRsbRgbsbRgbRsbRsbs
bRsbLsbsbsbsbsbRsbsbRsRsmbRsbRgbRsRsmbLsbsbRsbsbLsRsbRsRsmbRsbRsbRsbRs
bLgbsbRsRsRsmmbsbLsLsmbRsbRsRsmbRgbRsRsmbsbRsbRsbRsLsbRsbRsbRsRsmbRsbR
gbLsbRgbLsbRgRsmbRgbRsbRsbRsbRsbsbRsbRsbRsbRgbRgbsbsbRsbsbRgbsbRsRsmbR
sbRsLsbRgRsmbRsbRgbRsbRgbRsbRsRsmbRsRsmbRgbRsbRsbRgbRsbRgLsbRgbsbRsbRs
bRsbRgbRsbLsbRgbRsbRgbRgRsRombRcbRjLsbRgbRsbRsbRsRsmbRsbRgbLsbRsRsRsmm
bRsbRsbRsbLsbRgbRsbRsbRgbRsbRsRsmbRgbRsbRsRsmbRgbRsRsmbRgLsbRsRsmbRsRg
RsmbRsRsmbRobRhbRhb

>ZF Recording 2016-06-02; tW: 300s; Start: 161301; End: 161811;
Recording: 4-1; Individual: 8; Drug: PCAP814 3 然 Apo 50 然
bRsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 161301; End: 161811;
Recording: 4-1; Individual: 9; Drug: PCAP814 3 然 Apo 50 然
bLgbsbLgRsbLgbLjbLgbLjbRsbLgbLgLsbLsbLsbLgbLsbLsbLsbsbLgbLgbLsbLgbLsbL
gbLgbLgbLgbLsbLsbLgbLgLsbLgbLgbLsbsbLsbsbLgbLgLsbLsLgRsbLsbLgRsLsbLsLg
bLgbLgbLsbLsbLsbLgLsbLgbLgbLgbLsbsbLgbLgbLgLsbLsbLsLsmbLsbRsbLsLsmbLgL
sbLgbLgbLgbLgbLgbLgbsbLgbLgbLsbLgbLgbLgbLsbLgbLsbLsbLgbLsbLgbLgLsbLsbL
gbLgbLgbLsbLgbLgbLgbLgbLgbLgLsbLgbsbLgbLsbLgLsbLgLsbLgbLgbLgbLgbLgLsbL
gbLgbLgbLsbLgbLgbLgbLgbLgbLsbLsbLgbLgbLgRsbLgbLgbLgbLsRsbLgbLgbLgbLgbL
gbsbLgbLgbLgRsbLsbLsbLgRsbLgbLsbLgRsbLgbLgbLsbLgbLsbsbLgbLgbLgbLgbLgbL
sbLgbRsbRsbLsbLgLsbLgbLgbLsbLgbsbLsbsbLgLcbsbsbsbsbRcbRobsbsbsbLgbsbLs
bsbsbsbsbsbLjLsmbLiLsbLgbLgbLgRsbLgbLgbLsbLgbRsbLgbLsLsmbLsLsmbsbLgbLg
bLibsbLobsbLsLsmbLgLsbLsbsbLsLsmbsbsbLibLgbLgbLgbLsbLgbLsbLsLsmbLgbLgb
LgbsbLgbLgbLsbLsRsbLgbLgbLsbLsbLgbLsbLsbLgbLgbLgbLgbLgbLgbLsbLgRsbLsbL
sLgbLgbLgbLgLsbLgbLgLsbLgbRsbLgbLsbLgbLgLsbLsLsmbLgLsbLgbLsbLgbLgLsbLg
bLgbLgbLgbsbLgbLsLsmbLsbLsbLsLsmbLgbLgbLgRsbLgbLgbLsbLsRsbLsbLgbLgbLgb
LgbLgLsbLsbLgLsLsmbLsbLsbRsLsbLgbLgbLgbLgbLgbsbLsbLsbLsbLgLsbLgbLgbLgb
LgbLgbLgbsbLgbLgbLgbLgbLgbLgLsbLgLsbLgbLgLsRsbLgbLsbLsbLgRsLsbLgLsbRsb
RsbLgbRsbLgbsbsbLgbLgbLgbLgbLgLsbLgbLgRsbLsbsbLgLsbLgbLgLsbLgbLgbRsbLs
bsbLgRsbLgbLgbLgbLsbsbLsbLgbLgbLgbRsLgbLgbLsbLgLsbLgbLgbLgbLgbLgbLsbLg
LsbLgbLgLsbLgbLgbLgbLgLsbLgLsLsmbLgRsbLgbLgbLgbLgbLgbLgbLgLsbLgLsbLgbL
gbLsbLgLsbLgbLgLsbLgbLgbLgRsbLgLsbLgbLgLsbLgbLgbLgbLgbLgbLsbLgbLgbLgLs
bLgLsbLgbLgbLgbLgLsbLgbLgbLgbLgbLgbLgbLgbLgRsLsbLgbLgbLgbLgbLgLsbLgbLg
bLgbLgRsbLgLsbLgbLgbLgbLgbLgbLgbLgbLgbLgbLgbLgLsbLgbLgbLgbLgbLgbLgbLgb
LgbLgbLgbLgbLgLsbLgbLgLsbLgLsLobRoRsRsmmbLob

>ZF Recording 2016-06-02; tW: 300s; Start: 161301; End: 161811;
Recording: 4-1; Individual: 10; Drug: PCAP814 3 然 Apo 50 然
bRjbRsbRgbRsbRjbLsbRibRgbRibRsbRibRgbRgbRsbRjbLsbRsLsbRebsbRebsbLsbRsb
RgbRsbRgbRibRibRsbLiLsbRgbRebRjbRsbsbRibsbsbsbsbLjbLcbRobsbRgbRgbLsbsb
sbsbsbRgbsbRsbRsRsRgmbRsbRgbRgRsmbRsbLgbLgbLsbRjbRgbRjbRebLobsbRjbRgbR
ibLjbRsbRgbRcbRibRebRsbRsbLcbLgbRjbsbLsbLsLsmbRcbLcbLgbsbRgbLsbsbRsbRc
bRsbLsbLsbRgbLgbLsbLsLsmbLebsbLhbLsbLsLsLimbLgbLgbLgbLsLsmbLibLibLsbLh
bLgLsbLibRsLsbLgbLsbLgbLsbLibLiLsbLoLsmbLsbRsbsbsbLjbsbLoLsmbsbLsbsbsb
LhLsbLhbsbsbRsbRsbLibRibRsbLoRsbRjbRsbRiRsmbLsbLsbLhLsLsmbLgLsRsbRebRg
bLsbLcbLsbRjbRcbRibsbLsbLjbLcbLibLgLsbLhbLhbLiLsbsbLebLsbRgbsbRhRsmbsb
LcbLsbsbRjbLsbRcbRgbLsRsbsbsbRsbsbsbLobRsbLsbLgbRsRsmbLsbLibLiLsbLibsb
sbLsbLsbRebRjbRsbRobsbRibRcbRgbRsbLobLsLsmbsbRibLsbRsRsmbLsbLsLsmbsbRi
bsbRsRsmbsbsbLsbsbLcbsbRsbLsbLsLsmbLgbLiLsbsbLgLsbLhLsbLgbLibLebLibLeL
sbLiLsbLeLsbLiLsRsbLsbLcLsLsmmbLgbLgbLebLgbLsbLgbLsLsmbsbLsbRcbRhbsbLs
bLebLgbLeLsbLgLsbLsbLgbLsLsmbLibLgbLiLgbLebLiLsbLoLibLobLibLgbLhbLsLsm
bLobRgbLobLcbRgbLcLgLsbLhbLobLoLsmbLeLsbRsbRebRgbRgRsmbRiRsmbRib

>ZF Recording 2016-06-02; tW: 300s; Start: 161301; End: 161811;
Recording: 4-1; Individual: 11; Drug: PCAP814 3 然 Apo 50 然
bRhbRgbRjbRsbRibRiRsmbLgbLsbLcbLsbRsRebRibLsbRsbLsbLsbLsLsmbLsbRsbsbRj
bRsbsbLsbsbsbLsbRsbRgLsbRsbLsbRsRsmbLsRsbsbRgbRsRsRsmmbRsRsmbRsbRibRsb
RgbRhbLsLsmbRjbRsbRjRsmbRsRsRsmmbRgRsmbRibLgbLobRgbLsRsbLjbLobRsLsbsbR
jbRsbRsbRsbRgbLibLsbLgbLsbLgbsbRsbRsbRjbLjbRsbLgbRsRsmbLsbRsbRsbLsbLsb
LsbLjbRobLgRsbRsbLsbLsbLsbLsLsmbRsbRjbRgbRgbRgbsbLgbLgbRhbsbRibRjbRsRs
mbLsbRcbRsbRjbsbLgbsbsbRhRsmbLsbRcRsmbRsbRjbsbRgbRsbRgbLjbLoRsbRsbsbLs
bRsbRsbLjbLcbRsbLsbRsbLsbLsbRsbRsbRsLsbRsbLsbsbRsRsmbRgbRsbLsLsmbLsbLs
bRgbLsbLgbRsRsmbRobRibRiRsmbRgRsmbLsbRsbLoRsbLsbLibsbRhbLjbLsRsbRgbRjb
RsRsmbRsRsmbRsbLsbRgRsmbRsbRsbRsRsRgmbsbRobLsbRgbsbLsRsbRsbRgbsbRsbRsb
RsbLsbRgRsmbRsRsRsmmbLobLgbLsbLsLsmbRjbRjbRsbRsLsbLsbRjbRsRsmbRgRsRsmm
bLsRsRsmbLsbLsbRsbLsRsbRsRsmbRsbRgRsmbLsbRsbRgbLsbLsbRsbRgRgbRsbRsRsmb
RiRsmbLsLsmbRjbRsbRsbLibRsbLjbRjbRibRjLsbLgbRsLsLsmbRsbRsbLgbLsbRgbRgR
sRimbRsbLjbRsbsbLgbRsbRgbLjbsbRsLibsbRgbRibRgbRsRsmbRgbRgRsLsmbRgRsmbR
iRsRsmmbLgLsbRsbLsLsmbRgbRgbLjbsbRibRibRhRsRsmmbRoLsbLsLsmbLsbLibLhbRg
RsRgmbRcbRgbRibRiRsmbRgRsRsRsRsmmmmbRgRsmbRsRsRsmmbRgbLgbRsbRgRsmbRsLs
bLjbLibLgbLgLsbLgLsRsRsmbsbRcLsbLgRsRsmbRsLsbRiRsmbRibsbLcbLgbRibRgRsm
bLgbRiRsmbLsLsRcRsmmbRjRsmbLoLsmbRhRgRsRsRsmmmb

>ZF Recording 2016-06-02; tW: 300s; Start: 161301; End: 161811;
Recording: 4-1; Individual: 12; Drug: PCAP814 3 然 Apo 50 然
bRsRsmbsbLhLsbsbRgbLsbLibRsbRsbsbLgbLcbLibsbLsbRsRgbRgbRebRibRibRibRgb
RsRgbRibsbRibRsbLcLsLsmmbLibLgbsbsbLgLsbLibRsbLcLsLgmbsbLibLgbLibLoRsb
LsbLjbRsbLgbLgbRsbLgLsbRiLhbLcbsbLcLsmbLjbLcbLsLsmbLgLsbLsbRebRcbsbRiR
smbLgLsLsmbRsbsbRgbRsbRgbRibRsbRiRibRsbRibLsbsbLgRhbRgbRebsbRgbRibsbLj
bLcbLibLiLsbLsLibRsbLjbRsbRsLsbRgbLcbRsbsbLgLsbLgbLgbLsLgLsLibLgbLibLs
bRibRiRsmbRgbRsbRibRsbRsbReRsmbRgRsmbRibsbRgbsbLsbLgRsbRsRsmbLsbRsbRgb
RgbRgRsmbRcbLsbsbLsbsbLsbRgbRsbRgbRibRsRsmbLjbLibLsbsbRsRsmbRsbLsbRsbL
sbLjbLsLsRsmbLsbLobLsbsbLgLsbLsbsbLoLsmbLsLsmbsbLiRsLgbLjbLgbsbLsbRsRs
mbRsbRibRcbRibRobRsbRgbRgbsbRgbRgRsmbRsbRsbsbLsbsbsbRgbRsbLgbRsbRibRsb
RsRsmbRgbRsbRibLsLsRsmbRobLsbRibRiRsmbRgLsbsbRebRgbRgbRsRsmbRsRsmbLsRo
bLsbRcbRsbRebLsbLobRgbLsRsbLgbRsLsbLiLsLibsbLsbRjRiRjbRsLsbLibLsbsbRib
LgbLeRsbsbRgbRiLsbLcLsmbRcRsRombLsbRibLsLgLsbRsbsbRcRsmbLgbRibsbRgRsLs
mbRiRibRgbLibLsbLibLgLsbLsbLsLsmbLebLebLebLgbLsbsbLgbLibLsLsmbLsLsmbsb
LsbLiLsbLsbLsbsbsbRsbRsbLgbLgLsLsmbLsLsmbLcbLsbsbLcbLgbRsRsmbRjbRsRsmb
RgbRsbRgbRibRsRsmbRgbRsRsmbRgbRgRsmbRgbsbLsbRsRgbRsbRibRibRsbRsbRhbRib
RgbRsbsbLcRsbLgLsbRsbRiLsbsbLsLsmbLiLsLsmbLiLsbRsbsbsbsbRibRsbLebLsLsm
bLgbLsLibLsbLsLsLeLsmbsbLiLeLgbLgLiLsbLhRsbRibLcLiLsbRhbRobsbRibRsLsbR
sbLsbLsbLibLobsbsbLibLsbLsbLiLsLgLsbLhbLsbLsbLsbLgbLgbLhbLsLgbRsbLibLg
LsbsbsbsbLsbLiLsbLcLsmbRgbRjRjRcbRibLsbRcRsmbRiRsmbRibRgbRgRsmbRcLsLsm
bRgbRibRibRibRibLgbLebLibLsbLiLiRsLiLsbLgLsbLgLsbLgLsbLgLgbRsLobLgbRjR
smbRibRgbRsbLcbLibRjbLiLsbsbLiLsbLgRsbLgLcLsLsmmbLhbRsbLhbLibLoRgbRiRs
mbRibRsbRgbRiRgbRgbRgbRibRibLsbRibRobsbRgbRgbRibLsRsRibRibRibRiRsmbRsb
RiLsbRgRsmbRgRsmbRebRcRsRsmmbLhbRibRhbRibRibLsLgbLibLiLsLiLibLoRsbLsbL
obLiLgbLibRhbRcbRibLoLsmbLobLgbLiLgLsbLhbLgLsbLsReRibLebRcbRibRgbLsRsb
RiRsRsmmbRsRgbRibRgReRsRimbRoLsRsbLsRsbRhbLgLsRsbRcRsmbRobRjRhbRhRsmbR
gLsbLobLiLgLsbLibLgLsLibLoLsmbRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 161301; End: 161811;
Recording: 4-1; Individual: 13; Drug: PCAP814 1 然 Apo 50 然
bRcbRsbRsbsbRgbsbsbsbsbsbLsbLjbRcbRsbLsbRgRsRgmbRsbRgbRsbLsRsbLsLsmbsb
LsbsbRsbRsbsbLebsbsbsbLsRsbRebRsbsbLsbRhbLsbsbsbsbsbsbsbsbsbLsbsbsbRsb
sbsbRsRsmbsbsbsbsbRsbLsbLsbLsLsmbRsbLsRsbLsbsbsbsbLsbLsbRsbRsbRsbLsbLs
bRsbLsbLsbLsRsbLsbRsbLebLsbRcbRgbsbsbsbsbsbsbsbRsbsbsbsbRobRgbsbLsLsLs
mmbsbsbsbsbsbLsbsbsbRsRsmbsbsbsbsbsbsbLsbsbsbsbsbLsbLsbsbsbsbsbsbsbLsb
RsbLcbsbRebsbsbRsbRcRgbLsbRobLsbRcRsmbRhbLsRsbRsRsmbRcbRobRibLsRsbRjRi
RsmbRobLiLsLsmbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 161301; End: 161811;
Recording: 4-1; Individual: 14; Drug: PCAP814 1 然 Apo 50 然
bRsbRsbRsbRgbRsbRsbRsbsbRsbLsbRsbRjbLsRsbsbRsbRsbRibRsbRgbRgbRsRsmbRsb
RsRsmbRsbRgRsmbRsbRsRsmbRsRsmbRsRsmbRsRsmbRsbRsRsmbRsbRsRsRsmmbRsbsbsb
RgbRsbRsRsmbRsRsRsmmbRgbRgbRsbRsbRsbRsbRsbLsbRsbRsRsLsmbRgbRsbRibsbRgb
sbRgbRsRsmbRsbRsbRsbRsbRsbRsbRgLsbRgLsbRsbRsbRsbRsbRsRsmbRsbRsbRsLsbRg
bRsbRiLsbRsbRsbsbRsRsmbsbRsbRsbRsRsmbRsbsbRsbRsRsmbRsbRsRsmbRsRsmbRgRs
mbRgbsbRsbRsRsmbRsbRsbRsbRsbRgLsbRsbRsbRsbRsbsbRgbRsbsbsbsbsbRsRsmbRsR
smbRsRsmbLsbRsbRsbLsbRgbRsbRsbRsbRsbsbRsbRsbRsbRsbRsLsbRsbRsRsmbRsbRsb
RgRsmbRgbRsbRsbRsbRsbRsRsmbRsbRsbRsbRsbsbRsbRsbRsbsbRgbsbRsbRsRsmbRsbR
sbRsbRsbRsRsmbsbRsbRibsbsbLsbRsbRsbRgbRsRsmbRsbRgbRgbRsbRsRsmbRsbRsbRs
bRsbRsbRgbsbRsbRsbRsbRsRsmbRgbRsbsbRsbRsbRsRsmbRgbRsbRsRsmbsbRsbsbRsbR
sbRsbRsRsmbRsRsmbRsbRsbRsRsmbRsRsmbRgbLsLsRsmbRsbRsbRsbRsbRgbReRsRsmmb
RsRjbLsbsbsbLgbLhbsbLsbsbLgbLhbRsbsbLsbLsbsbsbLsbRsbRcRsmbRsbsbRibsbLs
RgRiRsmbsbRsbRsbsbsbRcbsbRhbsbRhbsbsbRobRsbRhbRsRsmbRhbsbRsbRebRiRsmbs
bRsbsbRsbsbRjbLsbsbsbRsbRsbsbRgbRgbRsbRsRsmbRjbRgbRsbRibRsbsbRjbRsbRib
RcbsbsbRsbsbsbRsbRcRsmbRgbRsbRibRcRgRsmbLhbLiLsbLcRsLgLsbLsbsbLibLiLsb
RsbLgbLobLsLsmbLsbLhRsbLiLibLsbLiLiLsRsLsbLiLsLsmbRsbLsbLgbLgbLgbLsbLi
LibsbLgLsRsbRsLiLsbLsRsbLgbLgbLgbLsbLibRsbRsbLsbLsbLsbLgLsbLibLiLgLsbL
ibLgbLoLgLsbLibLibRcRcbRiRsmbRiRsReRiRsRimmbRgRsmbRiRsmbRcbRgbLibRcbRc
bRgRsRsmmbRgRsRiRsmmbRiRgbRiRsRsRiRsmmmbRgbRiRsmbRibsbRsRsmbLsLsmbRgRs
mbRiRgLsRsbRgbsbRiRsmbRgRsmbRibRgRsmbRiRsLsmbRgbRgbRibRiRgRgbRsbRibRgb
RibRhRsRgRsmmbRjRsmbRgRsmbRgbRsRsmbRiRsmbRgbRgbRgRsmbRiRgRsmbRiRsRgmbR
iRsmbRiRsmbRoRsmbsbRcbsbRibRsbRgbRgbRsRsmbRgbRgbRsbRsbRgbRsbRgRgbRgRsm
bRibLibLsbRsRsmbRgbRibRsRsmbRgbRgbRsRsRsmmbRsLsbRgbRsRsmbRgbRsRsmbRsbR
gLsbRsLsbRsbRebRebRsRsRsmmbRsRgbRgbRsbRgbRgbRsRsmbRgbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 161301; End: 161811;
Recording: 4-1; Individual: 15; Drug: PCAP814 1 然 Apo 50 然
bLgbLgLsbLjLsmbsbsbLibLobRsbLgbRsbLsbLsbRsbRcbRibRgbLsbRgbRebRhbRjRsRs
mmbRebRcbRgbsbsbRsbsbRsbRcbRsLsbRibRsbRsRsmbRibRsbLjbLsbLjbRsbLjbLsbLs
bRsLgLgbLgbLgLsbLgbLsLsmbLgbLsbRjbLgbLsbRsbRhbRjbRgRsmbRebRgbRsbRcbLjb
LsbLsbLsbsbsbsbsbRsRsLsRsRsmmbLsbLsbRsbLsbReRsmbRhbRgbRsbRgbRebRibsbRs
bRibLgbsbsbRhbRibsbsbRsbsbsbLjbLsbLcbLsbLebRibLgbsbLgbLsbLsbLgbsbLsbsb
sbLjbRsLsbLsbRcLsbRibRebRgbRjbRsbLjLsmbRibRsbsbRibRsbRjbRgbRsLsbLgbLsL
sLsmmbLjbLsbRebRsbRhRsRsmmbRgbRsbRsbRsbRsbRhbLjLsmbRgbsbRjbRjRsmbRsbLs
bsbRibRibRiRsmbRhbRhbsbRhbRebRgRsmbLsbLibLsbLebRgbRsbRgbRiRsmbRgRsmbRs
bLsbRhbRgbsbRsbLsRsRsRsmmbRcRsmbRgRsRsmmbLgbReRsmbRibLjbLibLibsbsbsbsb
LsbsbsbsbsbRsRsmbRjbRibsbRibRcbRgbLsbRhRsRembLgRsbRebLjbLebLibRjbsbRjb
LgbRgRsRsRgmmbRsbRgbRsbRgbRjbRgbRgbRsbRibRsbsbRcbLcLsmbRgRsmbRgbLjbLgb
RsbLsbLgbLsbLgbLsLgLsbLsbsbsbRsbsbRsbsbsbsbsbLsbRsLsbLgLsbLgbLsbLgbLib
RsbLhbsbsbsbsbsbsbsbsbsbLjbLiLsbRcbRgRsmbRiRgbRgRsRsmmbRgRgRsLsmbRsbRi
bRhbsbLibsbLgbLgbRsbLgLsLsLsLsmmmbRsRsmbLcbLgbLsbRgbRgbRcRsmbRgbRsbLsb
LcbsbRjbReRgbRcLsbRibRebRgRsmbLgbLsbLgLsLsLsmmbLebLibLgLsbsbLgbRhbRcRs
mbRibRsbRobRiRsmbLibRibRiRsRsmmbReRsmbRibRgRsmbRsbRiLsbRibRiRgbRgReRsm
bRebRgbRgbRiRsRsmmbRgRsmbLsbRsLsbLiLsbLgLsLsLsLgLsmmbLibLsLsmbLgLsLsLs
mmbLhbLcRsbRibLgLsbRsbLiLgLsLsmbLgLsLsLsmmbRsbLsLsmbLgRsRsmbRsbRiRsRsR
gRgRsmmmbRiRsmbRiRsmbRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 161301; End: 161811;
Recording: 4-1; Individual: 16; Drug: PCAP814 1 然 Apo 50 然
b

>ZF Recording 2016-06-02; tW: 300s; Start: 161301; End: 161811;
Recording: 4-1; Individual: 17; Drug: PCAP814 1 然 Apo 50 然
bLsbLsbLsbsbLsbRsbsbsbLsbLsbLsbRsLsbRsLsLsmbLsbLsbRgLsbsbsbsbsbsbsbsbs
bsbsbsbsbRsbsbsbsbsbsbLsbRsbLsbRsbRsRsmbRsLsLsmbLsbsbLsLsmbLsbsbLgbLsb
LgRsbLsbsbRsbLjbLsbLsbRsbRsbRcbLsLsmbsbRgRsLsmbRsbRibsbRibsbRsbRsbRsbR
hbsbRsbsbsbsbsbsbRjbLsbRsbRsbsbRgLsbLsbRgbRsbRsRsmbRgLsbsbLsbLsbRgbRsb
sbsbRsbsbRgbLsbRsbsbLsbRsRsLsLsmmbsbsbRsbsbsbsbLsbLsbLsRsLsRsRsmbLsbRs
bRsLsbsbsbsbsbsbsbRsbLsLsmbRsLsbLsbLsbRsbLsbsbsbsbRsbRsbRsRsmbsbsbsbRs
LsbsbRsRsmbsbsbsbsbsbsbsbsbsbRgbRsbRgbLsbRsbsbLsRsbsbsbsbRsbRibRsbsbLs
bsbRibRgRsmbRsbRgbRiRsmbLsLsmbsbsbRsbRsbRsbRgbRgbRsbLsbsbsbRsbRcbsbRgb
Lsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 161301; End: 161811;
Recording: 4-1; Individual: 18; Drug: PCAP814 1 然 Apo 50 然
bLsbLsbLsbsbLsbRsbsbLsbLgbLgLsbLsbLgbLsLsmbsbLsbLsbLsRsbLsbLsbsbLsLsmb
LsbLsbsbLsLsmbRsbLgLsbLsbLsbLsRsbLgbLsbLsbLgbRsLsbLsbLsbLsLsRsmbLsLsmb
LsbLsbLsbLgLsbLsbLsbLsbsbLsbLgLsbLsLgLsbLgbLsLsLsmmbLsbLsbsbLsLsmbLsbL
sbLsbLsbLsLsmbLgbLsbLgLsbRsbLsbLsbLsbLsbsbLsbLsbLsbLgbLgLsbLgbLgbLgLsb
LgLsbLsbLsbsbLsLsmbsbLsbLsLsmbsbRsbLsLsmbLsbLebLiLgbLgbLhbLgbRsbLsbLcb
RsLeLsbLibLgbsbLobRgRsmbRgbRgbRsbRsLgbLibLgbLsbLgbLibLibLsbsbLgbLgRsbL
gbLgbRsLsbLgbLgbsbLgLsbLibLsLgbsbsbLjbLsbRsbLeLibLsbLgLsbLgbsbsbsbsbRs
LgLsbLsLcbLgbsbLcLibLibsbsbLgbLgbLsbLsbLsLsmbsbLsLsmbLgbLsbsbLibLcbRgR
smbsbRsbRsRsmbRgbRgbRibRebRcbRebRebRhbRebRsbRsLsbLsbRgbRsbRgRsmbsbRgbR
ebsbsbsbsbRsbsbsbLsLsmbLsbsbsbsbsbsbLsbsbsbsbsbsbLsbLjbRsbsbsbRsbRgbRc
bsbLsbLjbLsbLcLsmbLsbLgbLgbLsbLsbLgbLgbRobRiLsbsbRibRgbRsbRsbRsbRgRsmb
RsbRsbRgbRibsbRhbsbRgbRgRcbRgRsmbRgbRsbRsRsmbLsbsbRsbLjbsbRcbRgbRiRibR
ibRiLsbRibRibRibRsRibRgbRgbLsbRsbRsRgbsbRgbRiRgbLsbRsbsbRgbsbsbRgbRgbR
sbsbsbLsRsbRgbRsbsbRgbRgbRsbRsbRsbRsbRgbRgbRgbRiRsmbRgbRibRibRcRsmbRgb
RgRsRgmbRgRgbRgbRiRgRsmbRiRgRsmbRibRgbRgbRiRiRsmbLhbLibLibLibLsbsbRjbL
ibLsbLsbLsLsmbLsbLsbLsbLsbLgbLgLsbLsbsbLgbLibLsbLsbRcbRgbRgLsbRsbRsRsm
bRsbLsRgbRgbLsbRgRsRgRgmbLsLsmbLcbLobLebLhbLibLsbLibRcbRgbRibRebRebReR
gbRcbRebRebRoLsRgbLgRsbLibLgbLcbRsbRibLcLsRsmbLsbRsbLsbsbRiRsmbLjbRcRs
mbRsbLsbRibRgbRgbLgbLgbLibLsbLgLiLsLgLsbLhbLcLsmbLiLsbLcLsLgmbLobLiLsb
LsbRsLsbLoLsLsRsmmbLgRsbLcbLcb

>ZF Recording 2016-06-02; tW: 300s; Start: 161301; End: 161811;
Recording: 4-1; Individual: 19; Drug: Control Apo 50 然
bRsbLsbRsbLsbLsRsbsbsbRsbRsbsbsbLsbsbsbsbsbsbRsbsbLsbLsRsbRsbLsbRcbsbs
bsbRsbLsRsbRsRsLsmbRgbRsRgbLsLsmbsbsbsbsbsbsbLgbsbRgbsbsbsbsbsbsbsbRsb
RsbsbsbLsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbLcbLsLsLsmmbLi
LsbsbRcRsmbRsbsbRgbLjRsLsbRsRsRsmmbRsRsmbLsbRsbRsbLsRsLsLsmbLsbRsLsbRs
LsbLsRsbLsbsbsbsbRsbsbsbsbsbRsLsbsbRsbsbsbsbsbRsbsbLsbsbsbsbsbLsbsbsbR
sbRsbRsbLsbLsbsbsbRsLsbsbsbsbLsbLsbLcbLsbsbRsbLsRgbRsbRgbsbLsbRsbLsLsR
sRsRsmmmbsbsbsbsbRsbsbRsbRsRsmbLsbsbLsbRcRsLgmbsbsbRiLsbLcLgbLibLsbRob
RsRsmbLjbLjLsLeLsmbLoRsRsLgmb

>ZF Recording 2016-06-02; tW: 300s; Start: 161301; End: 161811;
Recording: 4-1; Individual: 20; Drug: Control Apo 50 然
bLsbRgLsbsbLgbLsbRsbLsLebRgbRjbLgbsbLibRsbLsLiLsRsbRebRobLgbLobLibsbRc
bRsLsbRsLsbRsbRhbRibRcbRebRiLsbLcbLsbLgbRsbRsbRhbsbRgbsbsbLsbRebsbsbsb
RhbRhbRgbLhbLobRjRsmbReRsmbRgbRhbRobRhbLsbLhbLcbLibLsbLhbLibRsbLsLsmbL
gbsbLibLsbLcbLsbRsbLibLgbLgbRsbRgbLgbLibsbRcbRebRibRhbLjRsbLibLeLsLeLe
LgLsbLgbRcbRcRsmbRgbRibRgbRsLjbsbLibLibLibLgbLeLsbLebLeLsLeLibLgbLgbLg
bLibRsbLcbLsLsmbLsbLibRsRsmbLibLgLsbLgbLgbLgbLgbLibLgLsbLjbRibRgbRgbRs
bRsbRibRsbLibLcbLibLgbLgbLgLsbLgbLcRsbLgbRsbLsLjbRgbLibLgbLibLibLibLgb
LcbLsbLibLcbLgLgbLhbLsRsbRjRhLsbRgbLjbLgbRhbRibRibLsRsbLjbLhbLhbLibLgb
RgbRhbRibRgbRgbLsbRibRgRsmbRsbLhLsbLibLibLgbLgbRcbRibRgbRcRsmbRiLsbLgb
RibLgbLsbRibLgbRjb

>ZF Recording 2016-06-02; tW: 300s; Start: 161301; End: 161811;
Recording: 4-1; Individual: 21; Drug: Control Apo 50 然
bRsbRgbRgbRibRsbRcbRsbRgbRcbRsbRibRsbRibRcbLsbsbLibLsbLibLsbLibLsbLgbL
hbLgbLsbRsbLgLsbRsbRsRsRjmbRibRobsbRebRibRsbRibLsbLjbLsLsmbLcbRibsbRib
RsbLcbsbRsbLcbRgLsbLjbLcLibsbLcbRibsbLcbRsbLsbLibLgbLgbLgbLibLjbRjbsbR
sbRhbLgbRsbReLsbLsbRobRjbRgLsbRibRsbRjbsbLibLcbLsbsbRsbRsbsbsbsbsbLsbR
sbsbsbsbRsbLsbLgLsLsmbLsbRsLsLsLsLsmmmbLibLsbLsbsbsbLsbRsbRcbRsbRibRsR
smbRsbRobRjbLsLsmbsbsbRcRsRsRsmmmbRjbRgbRcbLsbLsbsbRebLcbLcLsmbLcbLcbL
sLsmbLcbRsbLibRsbLcbLgbLibLobLgbRcRsmbRibRhbRsbRsRcbRsbLgbRcRsmbRsbRsb
LhbLjbLsLgLsbLsLsmbLiLsbRjbRcLsbRhRsmbRcbRobRhbLcLsmbLiLhLsbLcbLcbLibL
cRsbLcbLiLsbLobLcLsmbLibRjbRhbRobRebRobRiLsLsLgRsmbRhRebRhbRcbRhLsbReb
RsRhbRebLcbLibLibLibRibReLsbReLsbLjbsbLsbRhbLjbRcbLcbLcbRcRsmbRib

>ZF Recording 2016-06-02; tW: 300s; Start: 161301; End: 161811;
Recording: 4-1; Individual: 22; Drug: Control Apo 50 然
bsbLsbsbLsbsbsbsbsbsbsbsbsbsbRsbsbRsbsbsbsbsbsbsbRsbsbsbsbLsbsbsbLsbsb
LsbsbsbsbsbsbsbLsbsbsbRsbLsLsmbRsbRsRsRsmmbsbsbRsRsmbRcbsbLgLgbRobsbsb
sbLsRsbsbRibsbLsbsbRibRsbLhRsRsmbRgRsmbLobLibsbRgRsmbRgbRebLobRsbRsbRj
bRsbLsbRobLsbsbLcbLgLsbLcbLsbRgbsbsbRgbLsbRhbLsbRjRsmbLjbLobsbRgbLjbLs
bRebRgbRibRiLsRsbLsbsbRjbRhbRoRsLsmbRgRsmbReRsmbLgbRsbRgbRcbRoLsbRcRsm
bRobLsRobRhbLibRcbRsbRoRsmbRobRibRobRibLsbRhbRgbRiLsbRcbRcbRcbRibRibRi
bRobRgRsmbRibRibRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 161301; End: 161811;
Recording: 4-1; Individual: 23; Drug: Control Apo 50 然
bLcbRsbLgbLsbLsbRsbRibRibLobLibLjbLsLsmbRgbLibLhbLobRsLsbRsbRsbLjbsbRh
bLgbRsbRsbLcLsmbLgbLsbLiLsbsbRcbRgbLobRebLjbRhbRsbRsbRgbRgbLsbRsbLsbRs
bRsbRsbRsLsLsmbLsbLsRsbRsbRsbLsbsbRsLsbLsbsbLsbLsbLsbLsbsbLsbLsbLsbRsb
LsbsbRsbsbsbRsbLsbsbsbLsbRsLsbLoLsmbRiRsmbRebRcbLcbLgbLcbLiLsLsLsRsmmb
LhbRjbLebRebLgbRibRebRjbLgbRebRcRsmbRcbRebLcbLgbRjbLsbLgLsbLibRjbLcRsb
RsbRobRibRcbRobRebRibRcbRibRsRgbRsRsmbRibReLsbLgbRcbRgRsmbRibRgbRcbRiL
sbRobLiLsLsLsLsLgmmmbRoLsbLobLibLibLibLgbLhbLib

>ZF Recording 2016-06-02; tW: 300s; Start: 161301; End: 161811;
Recording: 4-1; Individual: 24; Drug: Control Apo 50 然
bRsbRgbRjbLjbLjbRoRsmbRjbRjbRiLsbRibRibRibLiRsbsbRhRsmbRsbRjbsbRsbLibs
bLcbsbRsRsmbRgbLjbLgbLibLjbRsbLjbLgbsbLibRsbLibLibsbsbLjbLjbsbsbLsbLjb
LsbLjbLsbsbLjbsbsbsbsbLcbLcbLhLgLibRsRsmbRsbRsbsbsbLjbLibsbLjbLsbRjbRj
bRsbsbLjbRsbLsbLjbLgbLjbLebLiLsRsbLiLgbsbsbLcLsLgLsmbLibsbsbsbsbsbsbLg
RsbsbLibLibLsbLiLebLsRsbLgRsbLibLebLibLgbLgbLsbLgLsbLsbLgbLgbLhLiLiLiL
sbLgLsbLgbLgbLiRsLgLgbsbsbLibLgRsbLibLgbRcReLsbRibRsRsmbsbRsbLgbRjbRib
RibRiRsmbRibRibRebLsbRjRgRjbRiRgbRsbRsbRsbRjbRhbRgbRjbRibRiRsmbRiRsmbR
jbRjLsbRhRsmbRjRsRiRsmmbRibsbLiRsbLcLsLgmbLiLsLsmbLgLsRsbLgLgbLcb

>ZF Recording 2016-06-02; tW: 300s; Start: 161301; End: 161811;
Recording: 4-1; Individual: 25; Drug: PCAP814 10 然 Apo 50 然
bLsbLsbLsbsbLsbLsbsbLsbLgbsbRsbsbLsbLsLsRsmbsbLsbRsbRobsbsbRsRsmbLsbLs
bLsbLgLgbLgLsbLsLsLsmmbLsbLsbLebLebRsbsbRsRsmbLgLsbLsbLgbRsbRsbLsbLsbL
gLsLgbLiRsbLsbLsbRibLjbRsbRsLsbsbRgbLsbLibsbLsbRgbRsbsbLsbRgRsmbRsbLsb
RsbsbsbsbsbRsbLsbRsbRsbRsbRsbRsbLsbsbRsbRsbRsbRoRsmbLsbLibLiLsbsbRjbRg
bLsbRsbRsbLsLhLsbRsbLgbsbRsbRgRhbLibsbsbRsbsbRsRsmbLsLsLsmmbLsbRsbLsbL
sbLsbRgbRsbLsbLgLsLsLcmbRjbLsbRsbRsbRsbRsbRgbLsbLgbLsbRcbLsbRsRsmbRsbR
sbsbsbLsbsbRsbRsbRsbLobsbLsbLsRebRibRsbRgRhbRsbLsLsmbRsRsRsmmbRsbsbRsb
RsbRsbsbRcRsmbRsLsbLsbLsbRjbLsbRsbRsbRsbRsRsmbRsbRgbRgbRsbRgbLsLsmbRsb
LsLsmbLsbRsbsbRgLsbRobRsbRgRsRimbRcbRsbRsbRsbRsReLsbLsbLsLsmbLsbRsbLgb
RsbLsbLsbLebRsbRsbLsbReRsmbRibRgbRsbRsbLsLsmbRsRsmbsbRsbRsbLsRsbRgbRsb
LsbLsbsbLsbsbRsbLsLsmbRhb

>ZF Recording 2016-06-02; tW: 300s; Start: 161301; End: 161811;
Recording: 4-1; Individual: 26; Drug: PCAP814 10 然 Apo 50 然
bsbRsbLsLsmbsbLsbLsbsbRjbLiRsbsbsbsbRgbRjbsbLgbRsRsmbsbsbLsRsbRsbRsbLs
bLsbLsbLcbsbRsbLsbsbLgbLsbRsLsbLsLsmbLsbRebRsbsbRsbRsbRsbRsbRsbLsbRsbR
sbRsbRsbRsbRsbRgbRsbsbRjbLsLsmbLsbLsbRjbLsbRsbLsRsbRsbsbRsbRsbRsbReRsL
sLsmmbsbLgbLsLgbLiLsLsRsmbLgbRsbLsbLsbsbLsLsmbLsbLsbsbLsbLsbLsbRsLsbLs
bLgbsbLsbsbLsLsmbLsbRsbLsLsmbsbLsbLsbRsbRsbLsbRsbLsLsmbLjbLgRgbRsbRsbL
sbLsLsmbLsbLsbLjbLgbLgbRsbRsbLsbRgbRsbRgbLsLsmbRgbLobRsbLsbLgRsbRsLsbL
sLsLsmmbRsbLsbLsLsmbLsLsmbsbsbLsLsRsmbRjbLibLebRsbLsRsbRsbLsbLgbRsbLsb
LsbLiLsbLgbLsLsmbLsbLsLsLsmmbRgbLsbLsLsmbLsLsmbLsbLsLsLsmmbLgRgRsmbLsL
sLgRsLsmbRsbLsLsLsmmbRsbLsLsLsmmbLsbLsbLsbLjbLgRsRsmbLiRsbLgLsbLsbLebR
ibRsbLgLsLsmbRsRgbLgbLsbLsLsmbLsRsbLsLsmbRsbRsLsLsLsmmbLsLsLsmmbLeRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 161301; End: 161811;
Recording: 4-1; Individual: 27; Drug: PCAP814 10 然 Apo 50 然
bRsbLsbLsbRibLibsbLsRsLsbRsbsbRsbLsRsLsbsbRsbLsbLsbsbsbsbLsbRsbLsbLsbR
sRgRsmbRibRsbRsRjbRjbsbsbRsLsbRsRsmbLsbLsbLgbLhbLjbRsbRsLsbsbRsRsLsmbL
sRsbLsRsbLsLsmbRsbLsbLsLjLjbLsLebRsbLsbRjRjbRsRsmbRsRgRsLsmbRsLsbsbLsb
LsbLebLsbLsLsmbLjbsbsbLsbsbsbsbsbsbLsbLgbsbLebsbLsbLsbRsbLsbLsLsmbLsLs
mbRhbRjbRsbsbRsbRsbsbRsbLsRsbRsbsbRsbLsRsbRsbLsbLsbRjLsRsbLibRsbsbsbRs
RsLsmbsbLsbLsLjbLjbLsbRsLgbLsbsbsbLsbsbLsbLsbLgbLsbRgLsRgRgbLjbRsbRsbR
sLsbRsRsmbLsbRsRsRsRsmmmbRsbsbsbRsbRsbsbRsRsmbLsbsbLsbsbsbLsLsmbsbLsbR
sLsbLsRsbLsbLsLjbsbLsbLsbLsbRsbLsbLjbRsbRgbRsRgRsmbsbLsbLsLgLsLgbLgbLs
bLgLebRsbRebRibLebLgLsbRsbLsLjbLibRsRsmbRgbRgLsbRsbsbsbsbLibRsRsRsmmbR
gRsLsmbLsbLgLsbRsbRsRgLgbRsbRsbLsLsmbLsRsbLsbLsbsbsbRsbRgbRjbLgLsbRsbL
sLsRgLsLsmmbLgLgLiLsbLebRgbLsbLiLsbsbRjRsmbRebRsRjLsLsmbLsLsLsmmbLsLsm
bLeLgLsbRsbRsLsRsbRjbLsRhRsmbLhbRsLjbLiLsbLgLsbLsbLsLsmbLgbRgLsbLsLjbR
gbLsbLgbRsLsLsmbLgLeLsbLsbLsLsmbRsRgLsRsbRsRsmbRgbRibRsRsRsLgmmbRsLsLs
LsLsLsLsmmmmmbLsbLsbLsbLsbLebLebRsbRsbRsbRsbRsRgLsLsmbRgRsRsRsLsLsmmmm
bRgLgbRsRsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 161301; End: 161811;
Recording: 4-1; Individual: 28; Drug: PCAP814 10 然 Apo 50 然
bsbsbsbsbsbsbsbsbsbsbsbsbsbsbRsbRsRsmbsbRsbsbRsRsRsRsRsmmmmbRsRsRsmmbR
sRsRsRsRsmmmmbRsRsRsmmbRsRsRsmmbRgRgbRsRsmbLebLsLjRsbLsbLsbRsbRsbLibLs
bLgbRgbRcbLsbLsbLsbLebRsbLsLsmbLgbLsbLsbRjbLsLsLsLsmmmbRsRsRsmmbsbRjRs
mbsbRsRsmbsbsbsbsbsbsbsbsbRsLsbsbRsbRsRsmbRsbLsbRsbRsRsRsRsmmmbRsRsRsm
mbRsbRsRsRsmmbRsRsmbRsbsbsbsbRsRsRsRgmmbLsbRsbLsbRsbLsbLsbRsbLsbLsbRsb
RsbLsbLsbRsbLsLsmbRsRsRsRsRsRsRsRsRsmmmmmmmmbRsRsRgRgRsRsRgRsRgRsmmmmm
bRsRsRsRsRsRsmmmmmbRsRsRsmmbRsbRgbRgRsRsRsRsRsRsRgRsRsRsmmmmmmmmmbRsRs
mbRsRsRsRsmmmbRsRsRsRsRsmmmmbRsRsRsmmbLgRsbRsRiRsRsRsmmmbRsRsRsRgRsRgR
smmmmbRsRgRsRsRsRsmmmmbRsRsmbsbRsbsbRsbRsRsmbRsRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 161301; End: 161811;
Recording: 4-1; Individual: 29; Drug: PCAP814 10 然 Apo 50 然
bRsbsbLsLsmbLsbsbsbsbsbLsbsbsbsbLsbsbsbsbRsbLsLsmbRsRgbLsbsbsbsbsbsbsb
sbsbsbsbsbRsbRsbsbsbsbLsbsbRsbLsLsRsmbLsbLsbLsRsLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 161301; End: 161811;
Recording: 4-1; Individual: 30; Drug: PCAP814 10 然 Apo 50 然
bsbRsbRsbRsbLsbLebLhbRibRebLsbRsbsbLibLgLsLsLsmmbsbLsbLsLsmbLsbLgLsbLg
bLibLsReRgbRsRsRsmmbRsbLsbRsbRsRsmbsbLsbRsbRsbLsbLsbRsbLsbsbLsLgbRsLgR
jbRibLsLsLembLgbsbRsbLsbRgbRsbRgbLsbRsRsmbRjbLsbLsbRsbLsbLsbLsbRsbRsbs
bRsbsbsbsbRsbLjbLibLgbLjbLeRgLsbRsbLjLsmbRsLsbLibRsRsmbRsbsbLsbRsbLsRs
bsbsbRsRsmbRjbRcbLsbRsbRsbLsbLsbRgRsmbLsbLgRsbsbRsbLsbLsbRjbRsbRsbLsbR
sbLjbLsbLgbLgRebRibRsLsbLsbLsbLsbLjbLsbLsLsmbLjbLibLsbLsLgLsbLsbLhbReb
LsbLsbRjbsbLsLgbLsbLsbLsLsmbsbRsbRsbLgbLsbRsbsbRsRsmbRsbRsbLsbRsRsmbLs
RsbRsRsmbLsbRsbsbsbsbLsbLsbLsbLgbLsbLsbLgbsbLsbRsbLsbRjbRhLsbsbLsbRsLo
LiRsbLsbLsbLsbLsbLhbLgbLsbLsbRsLsbRebLsbLsbLiLsbLebLiRsbLibLsLsmbLgbLj
RsbLsbLgbLsbLjbLsbRcbLhbLsbsbRsbLsbLsbsbsbLsbLsbsbLgbsbLsLsmbRsLsbsbLs
bsbLsbsbLsbsbsbsbsbsbLsLgLsbLsLsLsmmbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 161301; End: 161811;
Recording: 4-1; Individual: 31; Drug: PCAP814 3 然 Apo 50 然
bRgRsmbRjbRsbRsbsbRsbRiRsmbRsRsmbRsLsbLsRgbLsbRcbRcbRoRsmbLsbRibsbRgbR
gbRgbRgRibsbRgbRsbRgbRgbRiLsLsmbLsbsbsbsbsbLsbLsbLsLsmbRsbsbsbLsbLsRsb
LsbsbLsRsbRsbLsbLsbRsbRsbRsRjbRibsbRibLsbsbRsbRgbRhLsbRsRgbRiRsmbLsbRs
bRgbRsbRsbRgbsbRsbRgbRsbLsbsbRgbRsRsRsmmbRsRsRsmmbsbLsRsRcbsbsbLsLsLgR
cmbsbLsbLsbRsbRibRibRibsbRsLsbsbLgbRsbLibsbLsbLsLsmbLhbLhbLsLsmbsbLsRs
bLsbRibRibRsbsbRibRibsbLsbLgLsbRobRobsbRsbsbRsRcbRgbRsbRsbLgRsbRibLsbs
bRsbRsbLgRsbRsRhbRibsbRgbRsbRgbRhLsLsmbRibLsbsbRsbRcbRhbRsbRsbLiLsbsbs
bsbRibRsRsmbRsbLsRsbRgLsLibRibRibRibRsRsmbRgLsbRhbRgbRibRsbsbsbRibRgbR
sbRgbRgbRsbRsbRsbRibRgbRjbRsRsmbRibRsbRiRsmbRsbRibRgRsRimbRgbsbRjbRsbR
sbLsbRjbLjbRgbRgbsbLsbLsbLibLibsbLgbsbsbRsbRibRsbRgbRsbRsbRsbRsbRcLobR
sbRcbRgbRibLsbRhbRcbLsbLsRsbLibLgbLhbLsbLgbLgLsbLsbLsLcbLiLsLsmbLibLjb
RgbRgbRgRcbRsLgbLcbLgbLcbLhbLibRibLcLsmbLoRsbRgbRhbRgbLibRibRibRiRsmbR
gbRgRsmbRgbRgbRgRgbRibRgbRgRgbRgRibRgbRgbRsbRgRsRgmbRgRsmbRibRgRsmbRgR
smbRgbRsbRgbLobLibsbLoLcbLsbLibRoRsmbRibRhRsmbRiLsbRgbRgbRcbLsbRibRgbR
ibRgbRibRsbRibRsbRibRgRgbRibRgRsmbRgbRgbRgbRgbRibRibRgReRsmbRiRsmbRgRs
mbRhRsmbRgRibRgbRgbRibRgbLhbLgbRjbLcb

>ZF Recording 2016-06-02; tW: 300s; Start: 161301; End: 161811;
Recording: 4-1; Individual: 32; Drug: PCAP814 3 然 Apo 50 然
bLsbLsbLsbLibLgbLebLgbLgbRobLsLcbsbRgbRsRsmbsbLgbLiLsbRibsbLibRgbRjbsb
LibLibLeLebsbsbRjbLsLsmbLgLsLsmbRgbLibsbsbRsbsbRsbRsbRjbLcbLgLsbLiRsbL
hbLibLgbLsbRibRsbRibRsLsbsbLobsbRjbRsbRgRsmbRgbsbLjbLjbLebLsbRsbsbLjLs
mbLibsbRibRjbRgbLibLibLsbRjLsbLgbRsLsbsbLgbLgbRsLsbLgbLibLhbsbLgRsbRsb
LgLsbsbsbLgLsbRsbsbRhbRjbsbRgRsmbRsRsRsLsmmbRgbRsRsLsmbRsbLsbsbsbRsbRs
RsmbLjbRsbsbLsbRgbRsbRsRsmbRgbRsRsmbRsbRsbRsLsbsbRsbsbRsbsbsbRsbsbsbsb
sbsbsbRsRsmbRsbRsbRsbRgbRsRsmbLsbLsbLsbLsbLsbsbsbRsbsbLsbsbsbsbsbsbsbR
sbRsbRsbsbRsbsbsbsbLsRsbsbsbRsRsLsmbsbsbRsRsmbLsbsbRsLsbLsbLsbsbRsbsbR
sbsbRsbsbRsbsbsbsbsbLsRsbsbRsbLsbsbsbsbsbLsbsbRsbsbLsbsbsbsbRsbsbsbRsL
sbsbRsLsbsbRsLsbRsbRsLsLsmbLsbsbRsbLsbsbsbLsbRsbRsbLsbsbsbsbsbsbsbsbsb
RsLsbsbRsRsmbsbLsbLsbRjbLsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 161301; End: 161811;
Recording: 4-1; Individual: 33; Drug: PCAP814 3 然 Apo 50 然
bRcbsbsbRhRsmbsbsbsbsbsbsbRgbRgbRebRsbsbRibRsbsbRsRsmbRibRcRsmbRgbRsbs
bsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbRsbsbsbRsbRcbRjRs
mbsbRsLsbLsbRgbRsbsbRsRsmbLsbRsRsRsmmbRsbsbsbsbsbsbsbsbsbsbsbsbLsbsbLs
RsbLsRsbLsbLsbRiRsmbRibRsbsbLsbsbsbRgbsbRcbRsRcbLsbRgbsbRsbsbsbsbRcRsm
bRsbsbRsbsbsbsbLsbsbsbsbsbsbsbsbsbRsLsbsbsbsbsbsbRibRsbRsbRsbsbsbsbsbs
bsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbRsbsbsbRsbsbsbRsLsbLsbLsbRsLsbRsL
sbLsbRsbsbsbsbsbsbsbsbsbsbsbRgRibRgRsRsmmbsbsbLsbsbLsbsbLsLsmbRsLsLsmb
RsRsRsmmbsbRsbsbsbsbsbsbRsRsmbRsLsbsbLsbRsbsbsbsbLsbsbsbsbsbRgRibsbsbR
sbRcbRcRiRgbLsbsbRsbLsbLsbLsRsbsbsbsbRgRsmbRiRsmbRsRsmbsbRiRhRiRsLsRsm
bRiRsmbRsbRsRsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 161301; End: 161811;
Recording: 4-1; Individual: 34; Drug: PCAP814 3 然 Apo 50 然
bLsbLobRoRsmbsbsbLsLgbLgbLgbLib

>ZF Recording 2016-06-02; tW: 300s; Start: 161301; End: 161811;
Recording: 4-1; Individual: 35; Drug: PCAP814 3 然 Apo 50 然
bLjbLibLcbsbLiRsbLgLiLsLoLgbLsbRsbLibLsbLgLsbLgbLgLsbLgbsbRsbLsbLgbLgb
LsbLgbLgLibRsbLiLsLibsbsbLgbLsbLsbsbRsbsbLsLsmbsbsbLsbRsbLsLsLgmbLsLsL
gmbLsbLgbLgbLgbLgbLgbLgbLsbLsbLgbLiLsLsmbLiLsbLsbsbLsbRgbsbLsbLsbsbLsL
gRsLsbLgLsLgLsbLgbLgbLibLgLgLsbLgLsLgLsbLgbLgbLgbsbLsbLgLgLsLiLibLgLsb
LgbLgbRgbLsbLsbLgbLjbsbRsLsbsbsbLgbLsbLsbLsLsmbLsbRsRsmbLsbsbLgbRsbLsb
LgbLsbLgbsbLiLsbLjbsbLgbsbsbLjLsLsmmbLibLcbsbLsbsbLgbLgRsbRsLsbsbLgbsb
RsbLsLiLsLsmbsbsbsbLibLgLsbsbLsbRsbLsLsmbLgbLsbLsLsmbLsRsbLjbRsLsbsbLs
LsLsmmbLsbsbLjbRgLsbLgbLibLsLsmbLgbLgbLsbRibsbsbLibRgbLebLsbLsbRsbsbLi
bLgbLgbRsbLsbLgLsbLgLsbLgbLgbLgbLsbLsLsmbLsLgbLgbLsbLsbLsbLsbLgLgbRsbR
sbLgbsbRcbLibLsbLgbLgbLibLgbLgLsbLgbLgbLiRjbLgbsbLgbLsbLibLsRsbLsLibsb
RibLsbsbRibRgRsRcmbRsbRsRsmbRsbsbRsRsmbRsLsbsbsbsbLsbsbLjbLibsbsbsbLsb
LiLsLsmbLjbLsbLgbLhbLibLiLsbLgbLsbLsbLsbLibLgRsbRsbLgbLsbLsbLsLsmbLsLs
mbLoLgbLsbLoLsmbLsLsLsmmbLiLsbLiLebRibRgRsRgRsRiRimmbRiRsmbRibRgbRibRh
RsRiRsmmbRgRsmbRgLsbRiRsmbRgbRgRsmbRibRgbRibRgbRgRsRsmmbRgRsmbRgRibRsR
ibRiRsmbRiRsLsmbRibRgbRcbLsbLibLgLsbLgLsbLgbLsLsmbLibLgLsbLibLgLsLiLsb
LgLiLiLsLibLsLgbLsbLgLsbLgbLgbLgLgLsbLgbLibLgbLgbLibLgbLgLsLsmbLibLgLi
LiLibLgbLgbsbLgbLgbLgLgLsbLhRgRsmbRhRgbLsbRgbRgbRsbRgbRgbRiRsmbRibRgRi
LsbRcbRgbRsbRgRsRsmmbRgRsLsmbRsRsmbRgbRsLsbRgbRgRsmbRibRibRgbRiRsmbRgb
RgbRibRsbRgbRiRhbRiRsRiRoRsRsmmmbLjLibLiLgRsbLhRgbRibRibRgRsmbRhRiRsRg
RiReRimbRiRgReReRgRsmbRsReRsmbRhLsbLgbLjLsLgmbLgbLgLsbLgbLgbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 161301; End: 161811;
Recording: 4-1; Individual: 36; Drug: PCAP814 3 然 Apo 50 然
bRgbRsbRjbLsbRsRsmbRsbRsbRsRsmbRgRsmbLsRsbRsbReRibRgRsmbRibRgRgbLsbRiR
sRsmmbRsbRiRsmbRgRsmbsbRibsbRgbRhbReRsmbRibsbsbRgbsbRgbRgbsbRgbRebRsRs
mbRsbRcRsmbRgbRgbRgbRgbRgbRgbRebRcbRiRsRsmmbRgbLsbLsbsbsbRgbRgbRgbRsRs
mbRgbRjbRcRsRembRsbLhRsbsbRsbLsbRsLsbLsLgbRsbRsbsbLgbLsbLsbsbLgbRsbRcb
RsbRsbRsbsbsbsbRjbRebLiLsLgbRgRsmbLsbLjbRcRsmbsbsbLgbsbRgRsmbRcbRgbRgb
RsRcbsbRobRgbReRsmbRsbsbRgbRgLsbRgbRibRibLsbsbsbRsbRgRsmbRgRobRsbRcbRi
bRsbRgbsbRibRgRsLsmbRjbRsbReRiRsmbRebRsRgRiRsmbRsbRibRgbRgRsmbRgRsmbRs
bRgbsbsbRiRsRsRcRsRhmmmbRsbLsbRcbRsbRjbLcbLsbsbLgbLgbLgbRjbLsbRsbsbsbs
bsbsbsbsbsbsbsbsbsbsbsbsbsbsbLsbRgRsmbLibsbsbsbRgbLobsbRsbRsLsbLgLsbLg
RsbsbLjbLsbRjbRsbRjbLcbsbLgbLsbLibLhLcRsLibRgbRiRsRsmmbsbRgRsmbsbRsbRi
bRgbRgRsmbRjbLsbRcRhbsbRgRsmbRsRsRsmmbRsbRiRsmbsbRgRsmbRgRsmbReRsRombR
hbRsbRgbRiRsmbsbRsRsmbRsRsmbRgLsRsbRsbRoRcRcRsRsRgRsmmmbRiRsmbRgRsmbRg
bRgbRgRsRsmmbRgbRgbRsRsmbRiRsRsmmbRgRsmbRgbRgbRgbRhRcRcbRcRsmbRcbRgRib
RcbLgbLgLobRcbLibLgLgbLsbLgLsLsmbLsbLsbLsLsmbLibLsbLgbLgbLgLsbLgLsbLsb
LgbLhbRsRsRsRsmmmbRgbRibRhRsmbRcRoRsmbRcRsmbRgbRiRsmbRsbRgbRiRsmbRcRsm
bRibReRsmbRebRcbRcRhbRsRsRimbRgbRgbRgbRgRsLsmbRsbRgbRgbRibRgbRgRsmbRgR
sRsmmbRgbRgbRgbRhRcRcRiRsRgRsmmbRibRgbRgbRgbRgbRgbRgbRgbRgbRgbRgbRibRc
RhLsbRhbRgbRgbRgRsmbRgLsbRsRsmbRgRsLsmbRgbRiRsmbRibRibLibLcbLiRsLsbRsL
sRsbRcRcbRobRibRiRsRsmmbRsbRiRsRgmbRgRsmbRgRsmbLsbRiRsmbRgRsmbRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 161301; End: 161811;
Recording: 4-1; Individual: 37; Drug: PCAP814 1 然 Apo 50 然
b

>ZF Recording 2016-06-02; tW: 300s; Start: 161301; End: 161811;
Recording: 4-1; Individual: 38; Drug: PCAP814 1 然 Apo 50 然
bsbsbRgRsmbRsbLsbRsRsRsmmbRsLsbRiRsmbRibRgbRibRgbRgbRibLsbRsbRgbRsbRsR
smbLjbLjbLibLibRjbRgbRibRgbRgbRhbLobRgbRsRsmbRibRsbLsbsbRsbRsbRibRgbsb
LibLjbRsbLsbLibLgbsbLjbRsbLgbLsbLibsbLjbRcbsbsbRibRibRibRobRsRsmbsbLiL
sbRcbsbRjbRsbRobLsbLsbLgbsbRsbRhbRsbRsbLcbLjbLsbLgbLsbLgbLgbRsbLjbLobL
iLsbRjbRsbRibRgbRgbRsRsmbLhLsbsbRgbLgbLgbLsbLebRsbRjbRiLsbsbLibLjbLibR
iRsmbRsbLibRibLgbsbLsLsmbLsbLsRsbLsbLsbLiLsbLibRgLsbsbLsLsmbLsbRibRjbR
sbRgbRsbRsbLjLgLsbLgLsbLibLibLgbRobLgLsbLsLiLsbRcRsmbRoLsLsmbRiRsmbRcb
RibRiLsbRibLcbLiLsbLiLsLsmbLibLcbLgbLjLsLsmmbLibLibLobLiLsLsmbLhbLiLsb
RjbRhRsmbLsLibRibRibRibLibRobsbRobLsbLoRsbLibLcbLsbLiLsbLiLgbLoRsLsbRh
bRiRsRgmbRgbRobLibLsLsmbRobRjbLcbLiLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 161301; End: 161811;
Recording: 4-1; Individual: 39; Drug: PCAP814 1 然 Apo 50 然
bsbLgLsbLjbLjbLsbLgbRibRhbRsbRsbRgLsbsbsbsbsbLcbLsLsmbLsLjLsmbRsbRsLsb
LgbsbLgbLibLsbLgLsbRjbLsbRcbRsbRgbRgLsbRibsbLsbsbsbsbsbRsbRibLsLsmbLgb
LgbLiLsbLgLsbRjLsbRobLiLsLsmbLiLgbRoRsmbRhRsmbRgbRsLsbRibRjbLsbRjbRsbs
bsbLhbRjbRgbRgRgbRobsbLsbLsbRebRgLsbRgbsbRjbsbRgLsLsmbRsbRibRebRcbLsbL
oLsRsLsmbLgbLiLsLsmbLiLsbLgbLobRibRjRsRsRsmmmbRgLsbRgRsmbLsbLgbLiLsbRc
bRibRgbRiRiRsmbLsbRibLgbRsbRsRsmbRsbLjbRgbRgbRgbRibRgbRibLgLsbRsRsmbRg
bRhbLsbLibLibLibLgLsbLiLsbLobRgbRjbRobRibRiRiRgbRsbRobsbRsbLhbLgbLgLsb
LiRsbLgRsbRoRsmbRgbRiRgRsmbRobsbRiRsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 161301; End: 161811;
Recording: 4-1; Individual: 40; Drug: PCAP814 1 然 Apo 50 然
bRgbRjbRsbsbRsbRobRsbLsbLsbLibRgbRobsbLsbLgbLgbsbRgbRsbRibsbRjbRibRjbR
gbLcbRgbRibLebLsbsbsbRsbRsbLsbRsbsbsbLsbLibRgbLsbRibRgbRibRsbRgbRsbRjb
LgRsbRsRsmbRjbRsbRgbRibLsbLsbRsbRibRibRsLsbLsbLsbLsbsbRsbLgbLsLsmbLebL
sbRsbLsRsbRibRgbLjbLobRsbLjbLsbRobRibRsbRsRsmbRhbsbRibRjbLsbsbRhbRsbRs
bLsbLibRebRsbRsbRsRsmbLsRsbLobLibsbRsbLobRsbsbRsbRsbsbLjbLibLsbLsbRsRs
mbLsbRsbsbRsbsbLsbRjbsbRsbRjbsbLibLsbLhbsbRsbLjbRsbLiLsbLsLsmbLhLsbsbR
gbLsbLsbRhbRsbRsRsmbRgbLsRsRsRgmbRgbRibRiLsbRibRgRebRiRhbLibLibLsbLsRs
bLsbRcbsbsbLjbsbRgbRjbRibRgRsmbRibRibLsbLjbLgbRiRsmbRsRsRsmmbRsLsbsbLo
bLsbRjbRsbLibRsbRjbRsbRsbRsLsbLjbLhbsbLobRsRsmbLgbRsbRgRsmbRobsbRsbsbs
bRjbRcbLsLsmbsbRibsbRgbRsbsbRsbLsbRsRsmbRsbRsRibRgbRsbRebsbsbsbsbLsLsm
bsbsbsbsbsbsbsbsbLgbsbsbLjbsbRjbRibLsbLjbLhLhbRsbLgbLibLsbsbLgbRsRsmbR
gbRiLsbRibLgbRiRsmbLsbLsbLjbsbLhbRsbLsbLjLsmbRsLgbLcbLiLsbLsbRsbLiLsbR
sLsbsbsbLhbLsLgbRjbRibRcbLjbLhLsbLibRjbLsbRcLsbRgbRgbRibLobLibLiLsbLgb
LgbLebLebLibLsbLibLsLgbLibLgLsbLeLibRgbsbsbRsbLibLsbLibRjbLhbRjbLcbLob
LsbRgbRcbLsbLcLsmbLgbLgbLsbLibLeLobRhbRsRsLsmbLjbLcLsmbLgLgbLgLsLsmbLe
LsbRsbLgLsLeLgLsbLgbsbRsbLgbLhbRcbLiRsbLib

>ZF Recording 2016-06-02; tW: 300s; Start: 161301; End: 161811;
Recording: 4-1; Individual: 41; Drug: PCAP814 1 然 Apo 50 然
bLibLoLsmbsbLgbsbsbLibLsLibsbLiLsbLibLsLsmbLgbRsbRobLsbLsbRsbsbRibLsbR
sLsbRsbRgbLgbRgRsmbRibLsbLsbRsbsbRsbsbRebRibLobLgbsbLgbLobLsbRgbRgbRiL
sLsmbLgLsbRsRsmbRgbRibLsbLsbsbRhbRjbLgbsbLgbsbLcbLibsbLibLgbLgLsbLsbLi
bsbLsbRebsbLgbLcbLsbLsbLgbRsbsbLibLgbLhbLoLcbLcbLsLsLsRsmmbLjbLsLsmbsb
LsbLgbLsLsRsmbRsbLsbLsbLibRjbLibLgbRsbRcbsbsbsbRsbLgbLgbLebsbsbRsLsbLs
bLcbLsbLibLsLsmbRgRhbRsRsmbRgbLcbsbLsLsmbLebLebLsRsbRsbLsbRsbRibsbRibR
sbLcbLgLsLsmbLiLsLsmbLjbLsLsLsmmbRibLebLgbLsbRgbLgLsbLhbLsLsLsLsmmmbLs
bLsbsbLsLsmbLsLsmbLsbLsLsmbsbsbRiRsRsmmbRsRsRsmmbLjbRcRibsbRsLsbRsbsbs
bRcbLgLsbLibsbLeLsbsbLgbLcLsLsmmbRebRiLsbRebReRsmbRgbRsRsmbLibsbLsbLgL
sbLsRebRibRsbRgRsmbLebLibRsbLgbsbLobLsLsmbLsbLgLsbLgbRsbLgbLcbLhbLgLsb
LobLeLsbLgbsbLjbLgbRiRsRsmmbRgbRsbRgbLsbRsbLsbRsLgLsbLibLsbsbLgbLsbLgb
RsbLsbLjbLgbLgbLobRsbLgRsbLsbLsLsmbLsbLgbRsbLsbsbsbsbLsbRsLsbsbRcbLsLs
RsmbLsbReRsmbRcbRibReRsLsmbRsLsbRsRsmbLoLsmbLibRsRsLsRsmbLsLeLcLsmbLib
LgLsLsLsmmbLsbLcbLibLgLgRibRjbLcLsmbLobLcLebLeLsbLhLsbLgbLsbLebLgbLgLs
bLeLsbLgbRebRibRibLebLgLiLsbLsbRgRsmbRsRibLcbLibLsLsmbLgbRobReRsRsRsRs
mmmmbRebRibLebLhbLeLsbLibLgbLebLeLsLebLebLibLiLsbLeLsLsmbLiLsbRgbLeRib
RoLsbRsRsRgmbRgRsRsRsmmmbRibLcRsLsbRsbRcReRsRsRsmmmbRiLsbLgbRhbLebLhLs
bRgbReRsmbRgRsmbRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 161301; End: 161811;
Recording: 4-1; Individual: 42; Drug: PCAP814 1 然 Apo 50 然
bsbsbsbsbsbsbsbsbLsbLgbLgbLsbLsbRsbLsbLsbRsbsbLgbLsLsmbLsbsbsbLgbLsbLs
bLsbLsRsbLsbLgbLsbLsbRsbsbRsbLsbsbLgbsbLsbLsbsbLsbLsLsmbLsbLsLsmbRsbLs
bLsbsbsbLsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbLsRsbLgbLsb
LsbLgbRsRsmbLsbLsbsbRsbsbsbsbRsbLibRsbsbLobsbLsbLcbsbLsbLsbLsbsbLsbLsL
smbsbRsbLsbLsbLsbRsbLsbLsbLsbLsRsbLsbLsbLsRsRsmbLsbLsbLsbsbRsbLsbLsLsm
bLsLsmbLgbsbLsbLsbsbsbsbsbsbsbsbsbsbsbsbsbLsbLgRsbLibLsbsbRsbLgLsbLgbL
sLsmbLsLsLsmmbLgbLsbRsbLsbRsbLsbLsbLsbLgLsbLsbLsbLsLsmbLsbLsbLsbLgbLsb
LsbLsbLsLsmbLsRsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 161301; End: 161811;
Recording: 4-1; Individual: 43; Drug: Control Apo 50 然
bLobLebRgbRgRsmbRsbLsLsmbLibLcbLgbLgbLobRsbRoRgbRsbsbRcbLsRgbRiRsmbRsR
obLgbLsLsLgmbLgbsbLcbsbLgbLsRsbLsbLcbLsbLiRsbLibLhbsbsbRsbRibRgbLsbLib
RibReRebRgbRsRibLsbLgbsbRsbLgbRiRebRibReRsRimbRhbRsbRgbRiLsLsmbLsRsbRh
bsbLsbLsbRsbsbRsbLsbRsbRcbLsbLsLsmbRsLsbsbsbsbsbsbsbsbsbsbsbsbsbRcbRgR
smbsbsbLebLjbLgLsRsRsmbLgbsbsbsbLsbsbsbsbsbsbsbsbsbLsbLsLsmbRsbsbsbsbs
bsbsbsbRebRgbsbsbRoRsRsmmbsbsbLibsbRsbLsLsmbsbsbsbsbsbsbsbsbsbsbLsbLjb
LhbsbLsbRcRsmbsbsbLsbRoLsbRgLsLsmbRsLsbLgbRcLsbLsbRsRsmbRgbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 161301; End: 161811;
Recording: 4-1; Individual: 44; Drug: Control Apo 50 然
bRsbRsbsbLsbLgbLebLjbsbRsLibRgbRsRsRsRsmmmbsbsbsbLsbsbsbsbLgbLsRsbRsbR
obLsLsmbLibLgbLsbRsRsLsmbRgbLsLsLsLsLsmmmmbLsbsbRsbsbLsLsmbLsbLsRsbsbL
gRsbLsbLsbLsbLsbRsbLsbRgbRsbLsbRsbLsRsLsbLsbRjbLsRsbLsbRsLsRsbRsLsbLsb
RsLsRsLsbRsLsbRsLsbRsLsRsRsLsmbLsbLsRsLsRsbsbsbRsLsbRsLsbsbsbsbsbLsbsb
sbRsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbRsbRsbsbLsbRsbs
bsbLsbRsbLsbRsbLsbRsbLsbLsbRsbRsbLsbsbRsbRsbsbsbRsLsbLsbRsRsmbsbLsbRsb
sbRsLsbLsbRsbsbLsbsbsbLsbsbRsbRsLsbLsRsbsbsbLsbsbsbsbsbsbsbsbRsRsmbRsb
sbLsbRsbsbRsbRsRsmbLsbsbsbRsLsbLsbRsbsbLsbsbRsRsmbRsbRsbRsbLsLsmbsbsbL
sbLsLsmbRsbRsbRsbLsbRsbRsbRsbLsbRsbsbLsbRsbsbLcbLsbRgLsbLsbsbsbLsbsbsb
LsbsbsbsbsbLsbsbRsbsbsbsbsbsbsbsbRsbLsbsbsbRsbRsbsbLsbsbsbsbRsbsbRsbsb
LsRsbLsRsLsbRsLsbsbLsRsbRsLsLsmbRsLsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 161301; End: 161811;
Recording: 4-1; Individual: 45; Drug: Control Apo 50 然
bRgbRjbLsRsbRgbsbRibRsbsbsbLcbRsbLcLsmbRjbLsbRsbRgbRsbRibLgbLjbsbLibLs
bLsbLgLsbRsbsbRibRsbLibRsbRsbRibRgbRebLibRgbsbRibRibRsRsRsmmbsbRsRsmbs
bRsLsbLsbsbsbsbLgRsbsbLhbLeRsbLgbLsbLcbsbLgbLsRsbLgbLsbLgbLsbLsbLiRsbL
ibLsRsbLiLsLsmbsbLgbLibLgbLobLsbsbsbLgLsbLeLsRsbLibLsbsbLgLgLsLsmbLiLs
LsmbsbsbsbLgbLgbLsbLsbLgbLgbsbLibLgbLsbRcbLsRsbRibRibRsRsmbRsbRsbRsbsb
RcbLsLsmbRgbRjbsbLgbLoRsbLcbLsbLsbLsbsbRsbsbsbLiLgbLgbLsbLsLsmbLibLsbR
sRobLgLsbRebsbRiRsRsmmbRgbRcbRjbRhbRcbsbsbRcbRjbLsbLeLsbLgLsbRgbsbLibR
gRsmbRgbLgbLibRcbRjbRsbRgbsbRsbRibLoLsLsmmbRhbsbLsbsbRgbRsRsRsmmbRgbRs
bRsbRgRgbRsbRiRsRsRsRimmmbRibRebRibRgbRgbsbRobRsbLobLsbLsRsbRobRiRsmbR
hbRsbLgbLibLiRsbLcbRsbLibsbLoLsmbLcbLgbLibLsLsmbRoLsbRebRgbRgbRgbRebRg
bRsbRgbRcbRibRobRcbLibRoRsmbLiLsLsLsLimmbLeLsbRsLsRsLsLsmbLhbLgLgbLgLs
LcbRgbRobRebRebRibLobLhbLobRiRsRsRimmbRoRsmbRibLjbLibLobRgbRhbRgbRibRg
RsmbRoLsLsmbLsLsLsLsmmmbRcRsmbRibRoLsbRebReRcbRiRsmbRgbLoRsbLeLsLsmbLg
LsLgLsLsLsLsLsmmmmbLebLibLgbsbLiRsbLiLsLsmbLgLsRsbLibLeLsLsmbLhRsRsmbR
sbRgbRibRiLsbRibRsRsLsRsmbRsbRiRsLsmbRiRsmbReRgRsmbRsRsLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 161301; End: 161811;
Recording: 4-1; Individual: 46; Drug: Control Apo 50 然
bRsbRsbRsbRsbRsbRibRsbsbRsbRsbRibRsbRsbRsbRsbsbRsRsmbsbsbRsbsbRgbRgbRg
RsmbRiRsmbLsbRibRgbLsbsbRgbRgbRsbRgbsbRgRsmbRgRsmbRgbRibRgbRibRgRsmbRe
bRgbRgbRsbRsbRjbRsbRsbRgbRsbRsLcbLibLibLgbLsbsbsbsbLsbLsLsmbsbsbLgbsbL
gbRsbsbRsbLsbRjbRibRsbsbRsbsbRsbRgbRsbRsbsbRsbRibRsRsRsmmbRibRsbsbRsbR
gRsmbRgbRsbRgbRgRsmbRgbRsbRgbRgbRibsbRsbRsbRgRsmbRgbRsRsmbRibRiRibRsbR
gRsmbRgbRsbRsbRebRsbRsbRjbRgbsbRgbsbRsbRsbsbRgbRsbRgbRiRsmbRgbRiRsmbLs
bRsRsmbsbRsbsbRgbRsbRsbRgbRsbRsbRsbRsbRgbRsbRsbRibRsRsmbRsbRsbRsbRgbRs
bRsbRgbRsbRsbRsbsbRgLsbRsbRiLsbRsbRebRibsbRgRsmbRsRsmbRsbRsbRgbRsbRgRg
bRibRsbsbRgbRibRgbRibRibRsbRgbRhbRgbRsbRgbRgRsmbRgRsmbRebRibsbRhRsmbLs
bRgRebRsbRsRsmbRsbRsbsbRgRsRimbRgbRgbRibLgbLsbsbRsbLsbRsbsbRibRgbRgbRg
bRgbLsbRgRsRhmbRibRiRsmbRibsbRgRsmbRgbRgbsbRiLsbsbRibRsbRibRsbRgbRiRsm
bRgbRsbRsRsmbRgRsmbRgbRibRibsbRgbLgbRibLsLsmbRibLibLgbLsbsbLgLsbLgbLeb
LgLsbLsbLsbRsbLsbLgLsbLgbsbLgbRsbLsRsLsbLsbLsbsbsbRjbLiLsbLgbsbLjLsLsm
mbLsbRsbLhbLjRsbLibsbLiLsbLgbsbRsbLsLgLsbLibLibLgbLgbLsbsbLsLsmbRsbsbL
gbLgbsbLgbLgbLgbLibLgbRsbsbLsbLiLsbLgLjbLsbLsbLibLgbLibLgbLebsbLsbLgbL
ibLgbsbRcbRcbRiLsbRsbRsLsbsbRsLsRsbLsRsbRibsbRiRsmbRebRsbLsbRibsbRibLs
bLsbRjbRsRgbRgRibRsbRibRgbLcLsmbRsbsbRsbLsbLjbLsbRsbsbLsbRgbLebLibRgbL
jbRibRiRsmbRebRsbRgbsbRsbRgbRgbRgbRsRgbRgbRgbRgbLsbLgbRjbLsbLsbRebLgbR
sbLhbLibLgbLgbLcRsbLgbsbLgbLgbLgLsbRsbLibLibLiRsbLibRobRgbRobLgbLibLib
LgbLibLgLsbLeRsRsmbLgbsbLgbLgbLibLgbLgbRsRsmbRsRibRgbLcbLhbLsbRsLsbLib
LibLibLsbLsbLhbLibLiLsbLibLgbRsbLibLjRgbRibRcbLhbLibRjbRobRgbRgRsmbRgL
sbRsLsLsmbRsRsRsmmbRibRsbRgbRgbRgbRgbRgbRiRsmbRiLsbRsbReRsRsmmbRebReRe
bRibRibLgbRebReRebRgbRcbLsbLgRobLibRiRsmbLjbRibRiLsbLibRibRgRsLsmbRebR
eReb

>ZF Recording 2016-06-02; tW: 300s; Start: 161301; End: 161811;
Recording: 4-1; Individual: 47; Drug: Control Apo 50 然
bRiRsmbRsRsRsRsmmmbLsbRsbsbsbRgbRsRsmbLjbLjbLcbLjbsbRsbRobLgbLcbLsbRob
RgbLjbRgbsbRsbsbsbsbsbsbLibRsbRsbLjbsbsbsbsbsbLsbsbsbRsbRsRsRsmmbRsbRs
bRsbRgbRgbRjbRgbRsbRgbLsbsbLcLsmbRcbsbRcRsmbLjbLebLgbLgLsbRsbsbRsbsbRs
LsbRsbRjbRiRsRsmmbRgRsmbRibRobRsbRsbRcbLsbLsbLibLhbRjbLibRsLsbRsbRsbRi
RsmbLibRjbRjbsbsbLgLsbRebLsRsbRgbRhbReRsmbLsbRebReLsbRcRsmbRibLjbLcbLi
bLgLiLsbLibLiLsbLibLibLsLsLgmbLcbLibLiLsbRgbReRsmbRhRsmbRibRibRcbRibLi
bLiRsbRiRsmbRsbRibRgRsmbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 161301; End: 161811;
Recording: 4-1; Individual: 48; Drug: Control Apo 50 然
bRsbRsbLsbLsbLsbRobLobRsbRsbRsbRsbLsbLjRjbRsbLsbLsbRsbRsbRsbLsbRjbLjbR
sbLobLsbLsbLjbRsbRobLsbRsbLebRsLsbLobRsbLobLebRsbLsbLsbLsbRobRsbRobRob
RsbRjbLebLsbRobLebRsbRobRjbRsbRebRsbRjbRobRobRobLjbRjbLsRsbRsbLsbRebRo
bLsbLsbLsbLsbLsbLsbLsbLsbLebRsbLsbLobLjbRjbRsbLsbRsbRjbLebLsbRebLjbLeb
RebRjbRsbRebRsbRsbLsbLebLsbLjbRsbRjbRjbRsbRjbRobLobRebLjbLobLebRsbLsLj
bRsbLsbRsbRobLcbLsbRobLobLobLsbLsbRjbRobRebLebLjbRebRcbRsbRjbLebLsbLeb
LjbRsbLjbRjbLebLjbRsbRsbRsbRsbRebLobLebLsbLsRsbLcbRsbLsbRsbRebRjbLsbLo
bRsbRsbRobRsbLsbRobRebRobLebLebRebRobRjbLjbRjbRsbRsbLcbLjbRebRjbLsbRsb
RobRcbRjbRsbLjbLsbRobRjbLsbLjbLsbLebLjbRjbRjbLjbLcbRebRobRobLsbLsbLebL
obLebLsbLjbLjbLsbRebLobLebRsbRjbRobRjbLcbRsbLcbLebLsbRobRsbRebLjbRsbLo
bRebLobRjbRsbRsbLcbLsbLebRobRobRsbRsbRobRobRobLebRobRebRcbLsbLjbLcbRsb
LsbLobRebRsbLjbLjbLebRebRsbLebRobRsbRebLobLobLsbRsbRjbRsbRebRcbLebRobR
obRjbRobRobRebRebLsLsmbRsbRsbRobLobRsbLobLsbRebRsbLsbRsbLjbLjbRjbRcbLe
bRebRjbLsbRobRobLsbLsbRsbLobLebLobRjbLebRjbLebRebLebRcbLcbRsbRcbLebRob
RebRobRsbLcbLobLjbRcbLjbRobRcbRjbLebRebLcbLsbLjbRobLsbLebLebRsbLobRjbR
jbRobLjbRsbLobRsbRjbRobLobRobLobLobLobRsbLjbLebRobLebLebLebRebRcbRjbRj
bRebLjbRobRebRjbLebRsbRgbRobLsbLobLsbLobRobLebRobRobLobLjbRebLcbRebLob
RobLebLjbRebLsbLjbRsbLobRebRcbLobRjbLobRjbRobRobRobLsbLsbRcbLobLsbLcbL
jbLebLcbRebRjbRsbLobRsbLebRjbLebRjbLobRobLcbRobLebRsbRjbLebRjbLobRjbLe
bLsbRebRebLjbRobLobLobLebLsbRobLjbRebRebRebLebLobLebRobRobRebRjbLobRob
RsbRcbLobLobRobRobRjbRcbRsbLcbRobRjbRebLjbLebLobLobRobRobLjbRobRobLebR
obRebLcbRjbRobRcbLebRobRobLobRobRcbLobLobLjbLebRobLobLsbRsbRjbLobLsbRo
bRebLobLcbLobLcbRobLobLjbRebRcbRobLsbLobRobRjbLsbLjbRjbLebLjbRobLjbRob
RcbRjbRebLcbLcbRobRobLobLjbLjbRobLobRcbLebRjbRebRobRjbRjbLebRjbLjbRobR
obLgbLebRobLobRebRobLobRebRgbRcbLjbLobLjbLebLebRobLobRobLsbRobRjbRsbLe
bRebLebRebLebRcbRebRobRobRebRebRsbRobRgbLsbRgbLsbLobRobRjbLcbRobRobReb
LibLjbLcbLobLgbRibLsbLebRebRebRebLibLhbRgbRcbLcbRobLsbLibLsbRebLcbRobL
ibLibRobRcbLobRebLobLobLobRobLobRcbLebRcbRobRobLcbRobLobRgbRobRgbLobRc
bLebLobRebLgbLobRcbLobRcbRobRobRebLobLobRebLibRibRebRebLobLebRebRcbLib
RgbRobLhbRcbLobRcbLobLobLebRcbLobLebLebLsbRobLobLobLebLobLcbLcbLobLobL
obRibRebRebRcbLebLebLobLobLcbLhbRobLobRobRgbRobRebLcbLobRebLobLcbLobRo
bRgbLebRebRobLgbRebRobRebRobRebLgbLobLebLsbRebRgbLobRcbRobLebRcbLebLob
LcbRobRobLcbRobLcbRgbRibLgbLobLebLebLobLcbLebLibLibRcbRobLcbLobRibRcbL
cbRebRebLcbRobLobRobLobLcbRcbRobLcbLibLebRcbRsbRobLibLcbLobRcbLcbLgbRe
bRebLcbRebRgbRobRobRobLobLebRobRibLobRebLobLobRobRsbRobLgbRgbLobRcbRob
RsbRibRcbRebRhbRobLebRhbRibRobRobLobLebRebLobLibRcbRcbRobLobRebLobLcbR
obLebRsbLebRobRobRcbRsbLobRcbRobRibLsbLebRobRcbLobRibLebRibRebLobLebRo
bRobLobLobRgbRobRebLebRobRcbLobRobLgbLobLibRobLcbRibLobLibLebRob

>ZF Recording 2016-06-02; tW: 300s; Start: 161813; End: 162319;
Recording: 5-1; Individual: 1; Drug: PCAP814 10 然 Apo 50 然
bRsLsbsbsbLsRsbLsbLsbLsLsmbRsbRsLsbLsbsbsbsbsbRsbsbsbRsbsbsbRsLsbLsbsb
sbsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 161813; End: 162319;
Recording: 5-1; Individual: 2; Drug: PCAP814 10 然 Apo 50 然
bRgRebRgbLsRsbRgbLoLsmbLibLebLcLsmbLsRsbLhRsbRgbLsbRgbRsRsLsLgmbLsbRsb
RsbRsbRgLsbLsbLsbRsRsmbRsbsbRsbsbsbsbRsLsbLsbLsLsmbRsbsbRsbsbsbsbsbRsb
RsbRgbRsRsLsRgRsmmbsbRgbRsRsmbsbRsLsbsbLsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 161813; End: 162319;
Recording: 5-1; Individual: 3; Drug: PCAP814 10 然 Apo 50 然
bRsbRibRebRgbLsbRsbsbLsbsbsbRsbRsbRsbRsRgRsmbRhbLsbLcLsLsmmbLjLsLcmbLe
LsLsmbLibRsbRsbLsRsbsbsbLsbRsbRsLsbsbRsbLsbLgbLgbRsbRhLsbRgbLgbRiLsbRi
LsbRiRsmbRgbLgRsbLsLsRgmbRsLjbRjbRsbRsbRsbRsbRsRsLsmbRsbLsbRsRsmbRsbRs
RgLsbRsbRsbRsLsRsbRsRsmbRsbRsbRsRsmbRgbRcbLsLsmbLsbLgbLibLsbsbLsbLebLe
bLiLsbLsLsLsmmbLgbLsbLgbLgbLsbLsbLgbLibsbLebLjLsmbRsbLibLgLcbLebLebRiL
sLsLsmmbReLgLsRsbReLsbRcbLsRsbRhbLcLsLsmmbLgLsbsbLsLgbLsLibLsLsRembLgR
sbLsLebLcbRiLsbLsbRsLsbRsRsRsmmbRsbRebReLsRsbRjbReLsLebLibReLsLsmbRsRs
mbReLgLsbRsbLsbRsRsmbRsRgbRsRsRsmmbRsbReRsmbsbRsbLsbRsbRsbsbLsRsbsbLsb
sbLsRsbsbsbsbsbRsbLsLsmbLsbRsRiRsmbLsbRsbsbRsbLsRsbRsbRgbRiRsmbLgbLsLs
mbLebLiLgbReRsmbLsbRiRsmbRsbRsRsmbLsRsRsmbsbRgRgLsLsmbsbLsLsLsmmbLsbLs
bLgLsbLiLsLsmbRsbLeLsbRcLsbsbsbsbRsLsLsmbLsbLsLsLsLsmmmbLsbLsbLeLsbRsb
RsbRebRsbLiLsbRgbRjbRsbRsbRsbRgbRsbRsRgbRsbsbRsbRsbRsLsbLsbLiLsbRibLeb
LgbsbsbLgRsbLsLsLsmmbLsbLibLgLgLsLiLgbRsbLcbLsLsmbLsLgLgbLiLsbsbsbsbLi
LsbLibRjbLgbLgbLsbLsbLsbLsbLsbLsbLsLsmbRibsbRsbLsbLsbRgbRsRsRsmmbsbsbR
gbRgbRsbLiLgLsbsbsbLiLobLeLjbRibsbRgbLgbLsbLgbsbLebLsRebLgbLcbLiLsLsmb
RsbLsLsmbLgbLsbLsbLsbLgLgLsLsmbLsbLhbLsRsbLsLibLiLsbsbsbRibLgbLsLsmbLs
bLsbLsbLsbLgbRjbRgbLsbLsbsbRiRsmbsbLsbRebsbRsbRsRsmbRgbRgbsbsbsbLsbsbs
bsbsbRsbsbsbsbsbsbRsLsbsbLsbRsLsbsbsbsbRsbsbsbsbsbLsbsbRsLsRsLsbsbsbLs
bsbsbLcbsbsbsbsbLsRsbReRsmbLsLsLsRsmmbsbLsbLjbLsbRsbLsRsRsLsmbRsbLsbRg
LsbsbLsbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 161813; End: 162319;
Recording: 5-1; Individual: 4; Drug: PCAP814 10 然 Apo 50 然
bLgbLgbRsbLsRsbRsbRsbRjbLgbRjbRsRsmbRsbLgbLiRsbLsLsmbLsLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 161813; End: 162319;
Recording: 5-1; Individual: 5; Drug: PCAP814 10 然 Apo 50 然
bsbsbsbsbsbRsbsbsbsbsbsbLsbsbRsbLsbRsLsbRsbRsbRsbLsbRsRsLsRsmbLsbsbsbs
bsbRsbsbRsLsbsbLsbRsbsbRsbsbsbsbRsbsbRsLsLsmbsbsbsbRsLsRsbLsbLsbRsbLsb
sbRsbLsbRsbLsbsbRsbsbLsRsbLsbsbLsbsbRsbLsbsbLsbLsbsbLsRsbLsbsbLsLsmbRg
RsRembLgRsLsbLsRgbRsbLibRsRsmbsbRjbLgLsbsbRsLsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 161813; End: 162319;
Recording: 5-1; Individual: 6; Drug: PCAP814 10 然 Apo 50 然
bRsbRebLibLsLgbLsbsbsbLsRsbLsbsbsbLsbsbLsbRsLoLsmbLsbRsbRsbRsbLsRsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 161813; End: 162319;
Recording: 5-1; Individual: 7; Drug: PCAP814 3 然 Apo 50 然
bRsRsmbRsbRsbRgRsLsLsmmbRsRsRsmmbRgbRsRsRsmmbRsbRgbRsbRsbRsbRsRsRsmmbR
sbsbRgbRsbRgLsbRsLsbRsbRsRsmbRgLsbRgbRgbRsbLsbRgbRsbRsbRsbRgRsmbRsbRgb
RsbRsbRgbRsbRgbRsRsmbRsbRsLsRsbRsRsmbRgbRsLsbRgRsmbRsbRsbRsRsmbRsRsmbR
sRsRsmmbRsRsRsmmbRgRsmbRsbRgbRsbRsbRsbRgbRgbRgRsmbLsbRobRsRsmbLsLsmbRg
bRsRsmbRgbRsRsmbRgbRsbRgbRsbRgLsbRsbRsLsbRgbRsbRsRsmbRgbLsRsbRsbRsbRsb
RgbRcRjbRcLsLsmbLebLibLsbLgbLgLsbLgbLgbLgbsbsbLsbLsLsmbLsbLsbLgbRsRsmb
sbLsbLgbsbLsLsmbRsbLsbLsLsmbRsLsbLjbLsRsbRsbRsbLiRsbsbLgbLsbLibRsbRsbL
sLsmbLsRsbsbLibsbRsbRsbLsbsbsbLsLsmbsbLsbsbsbLgLgbsbsbsbLsbLjbLsbRsbLs
RsbLibLsbLsbLiLobsbRibsbRsRgbRibRsbRgbRsbRjbLsbsbsbLsbRsbRgbRsbRsbsbRs
bsbsbsbsbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 161813; End: 162319;
Recording: 5-1; Individual: 8; Drug: PCAP814 3 然 Apo 50 然
bLsbLibRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 161813; End: 162319;
Recording: 5-1; Individual: 9; Drug: PCAP814 3 然 Apo 50 然
bLjbLiLsLsmbLhRsbRsbLsLsmbLcLsmbLcbsbLsbRsbLeLsbLhLsLiRsbRsbLhbLibLgbL
gLsbLgbLsbLgbLsbLsbLgbLsLsmbLgbLgbLgbLgbLgbLsbsbLibLiRsLsbLgbLiRsbLgbL
gbLgbLgbLgLsbLgbLgbLgbLgbLgLsRsbLgbLgbLgbLgbLgLsbLgLsbLgbLgbLibLgbLgbL
ibLgbLibLgLsLsmbLgbLgbLgbLsbLgbLgLsLsmbsbLsbLsbsbsbRsRsmbRsRsmbLsbLibL
ibLgLsRsbLgbLgLsbLgLsbLgbLgbLgbLgbLgbLgbLsbLgbLgbLgbLgbLgLiLsbLsbsbLgb
LgbLibLgbLgbLgbLgbRsRsmbLsbLgbsbLgbLgbLgbLgbLgbLgLsbLsbLsbLgbLgbLgbLsL
sLsmmbLsLsmbLsbLgbLsLsmbLgLsbLgbLgLsbLgbLgbLgbLsbLgRsbLgbLgbLgbLgRsbLg
bLgbLsLgLsbLgbLgLsbRsLgbLsLsmbLgbLgbLgLsbLsbLeLsbLibsbLhbLiLsLsmbLiLsb
LhLsLsmbLiLsbLiLsLsmbLhLiLiLibLibLgLsbLgbLsbLibLgbsbLgbLibLibLiLsbLgLs
bLibLiLsRsLiLibLiLsLsmbLgLsbLgbLibLgLsbLgbLgbLiLsLsmbLgLsbLgbLgbLibLgb
LgbLgbLgbLgbsbLgbsbsbLsbLsLsLsmmbLibLgbLjbLsbsbLgbLsLsmbLgbsbsbLgbsbLs
bsbLsbRsbsbsbsbsbLsbsbsbsbsbsbRsRsRsmmbsbLsLsmbRsLsRsLsRsbLsRsRsmbLsbR
sLsbRsbLsbLsbLsLsmbLsbRsbRsRsmbLsbLsbsbsbsbsbsbsbsbsbsbsbRcbRibsbLsbsb
sbLsbRsbLsbRsbRsLsRsbLsbsbsbsbRobRsbsbsbLgbsbLobRsbLsLsmbLgLsbLhbsbLib
RsbLgbLiLsLsmbLgbLgLsbLgLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 161813; End: 162319;
Recording: 5-1; Individual: 10; Drug: PCAP814 3 然 Apo 50 然
bReRsRsmmbRiRsmbRhbRgRsLsmbRgbRgbLsbRsbRcbRcbRcbRcbRobsbRjRsmbRhbReLsb
RcLsbRiRsmbLjbLobRsbLhbLcbLiLsbLgbLcbRgbLcLsmbLcbLobRoLsbRibRibRibLsbL
hbRebRibRsbRoLsbRsbLgbRhbRhRsmbRgbRibRcbRebRsbRhbRcbsbLibRibLcbLibLgbR
cbLsLgbLjbLiLsbLsLsmbReRsmbLsbRiRsRsmmbRebRsbReRsmbRiRsRsmmbRsbLobLgLs
bRgbLgbLcbRibRebRsbLcbLgbRsbRebLjLsLsLsmmmbRgbLebRebLsbsbRiRsmbRhbRsRs
mbRgbLsbRgbsbLebLebRsbRebLsbsbLebLgbLsbLgbLgbLgbRebRgbLoLsmbLobReRsmbR
gbRibRgRsmbRhbRgbRobReRsmbReRsmbRibRebRhbLeLsbLcbRebReRsmbLebLiLsbLsbL
sbRoRsmbLcbLobRgbLsbsbLobLgRsbRhbRsbRgReRsmbRsRsRsRimmbRobRibLgLsbRsbs
bsbsbsbsbsbsbsbsbsbRsbRsbRebRsRsmbRhbsbRsbRsbRgRsmbLjbLsbLgbLibLibLgbL
gRsbLibsbLgbLhbsbLiLsbLsbLgbRsbLibLobLcbLebRsbsbLsbRsbsbLsbLcbRsbsbsbL
oLsmbRsbLebLsbLsbLgbRjbLsbRobRgRsmbRoLsbsbLgbLibLsbLsbLiLsbLgbLgbLgbLg
bLebLsLsmbLobRsbRsbsbRibLsbLgbRiRsmbLsbLsbsbsbLgbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 161813; End: 162319;
Recording: 5-1; Individual: 11; Drug: PCAP814 3 然 Apo 50 然
bRgbRsRsmbLsRsbRsRsmbRiRsRsmmbRsRsmbLcbLcRsbLsRsRsmbRjbRiRsRgRsRsmmmbR
sRsmbRsRsRgmbRgbLsbLgbRibRgRsmbsbRgRsmbRsLsLsmbRgLsbRsbRhRsmbRiRsRsmmb
RibRcbRsRsmbLgbLibRsRsmbLobRsbRsbLeLsbLoRgbReRgRsmbRsbRgbLjbLhbRsbRcbR
gLsbRsRsmbReLsbRiRsmbRgbRsbLsRsbRsRsRgmbRgRsmbRjRgRsmbRiRsmbRjbRiRsmbR
ibRcbLcLsmbLgRsbsbsbRgbRgbRsbRjbRibLjbLsbLgLsbRjRsRsRsmmmbRibRsbRgbRsb
LhbLhbLobLsbRcLsRsbRsRsmbRjRsmbRiLsbRsbRsRgRsRgmbLsbRgbRgbLsbLsbRgRsmb
RsRsmbLgLsbLiLsbLgbLjbLobLgLsbRcbRhRsRsmmbRsRsRsRsRsRsLsmmmmmbLsbRsbLs
RsbLsRsbRsLsbRsRsmbsbLgRsbRibRiLsbRiRsRsmmbRibRsRsmbRiRsmbLgbLibRjRsmb
RibRibRgRsRsRsRsmmmmbRjRsmbRgbRibRgbRgbRsbLgbRsRsRsRsmmmbLsRsbRgRsRsmm
bRgbRgRsRsRsmmmbRhLsbLsbLsRsbRgbsbLjbRjbRibLsbLsbLsbRsbsbLsLsLsmmbLsRs
bsbLhbLibRjRsmbRsRsRsmmbLcbLsbRgLsLgbRsbsbLgLsbRgbLsbLsbLgLsLsLsLgRsmm
bRgbRjbsbsbRibRgbRsRgRsmbLgbLgbRjbRsbRsbLsbLgRsbRsbRgLsbsbRsbRiRsRsmmb
RsbRsbRsRsmbLebLsLsRsmbLsbRcbLsbLgbLsbLsRsLsbLjLsmbLibLsbRsbRsLsbLsRgR
smbRsRsRsmmbLgLsRsbRibRsbRsbLobRsbRcbLsbRibRjbLsbRsRgRsRgmbLeLsRsbLsbL
sbLsbLsbLsbRsRsmbRsbRsbRsbRsRsmbRsbRsRsmbRsbLsbLsbLsbRgbRcbRsbRsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 161813; End: 162319;
Recording: 5-1; Individual: 12; Drug: PCAP814 3 然 Apo 50 然
bLiLgbLibLibLiLsbLgbLgbLiLgLsbsbLiLsbsbLsLsmbLgLsbLsbLsbLibLgLsbLgbLib
RgbLhbLgbLcLsmbRsLsbRibRhbRiLsbRgRiRsRgmbRiRsmbRgRgbRoLsRsbLsLsLsmmbLi
bLhbsbLsLsLiLsLimbRsbLhLsLgbLibLsLibLobLoLsmbLiLsbLiLsbRiLsbRjRibRcbRg
bRsbRsbRibRiRsmbRgbRibRibRsbRsRsmbLcbLcLsmbLcLsLsLgLsmmbRebLcbLibLgbRs
LgbLibLgbRoLgLsbRibRobLsbLiLsbLibRcbRsbRobRsbLcRsbLsRsbRgbRcRibRgLsbLs
RsRibRcLsbLjLsmbLhbLhbLibRsRsmbLcLsmbLhLsRgbsbLiLsbLsbLiLsbLgbRsbLcbLs
bRgbLhLsbLibLgbLibLcbRsbLiLgbLhbLgbLiLsLsLsmmbLibRsLgLgLsLgLsbLgLsbLcL
sLgLsLsmmbLoRsLsbRibRiLsRgRibRibRgbRgbRgbRebLsbLsbRibRibRibRibRibLjbLh
bLiLsRgLsbLiLsbLibLhbLibLibRgLsLiLsbLhbLgbLibLsbLibLcLsLsLsmmmbLgbLhLs
LsmbLibLiRsbRsLsbRsLsbLcLsRsmbRsbRoRsmbRsbRibRjLsbLibRobRibRibRibLsbLs
bRhbRsbRiRsRimbRhRsmbRsbsbRjbRhbsbRjbRsbRiLgbLsbLibLibLgbLobRgbRcbRgbR
iRebRiLsLsmbRsbRcLsbRibRgLjbRebRiLsbLsbLgLsbRibRobLsbLgbLobLsbLiLsbLib
LsLsmbLiLsbLgLsRgRsmbRobRgRsmbRgbRgbRgRibRibRibRebRgbRgbLsRsbRiLsbLgRg
RgRsmbRiLsbRgbRibRobLgbLiLsbLibLibLiLsbLgLibLgbLsLsmbLcbLibLgbRsbLjbLi
bLibLhLsbLsRsbRjRsmbRiRsmbRiRhbRibRhbLibRjbRibRibRsbLsbRgLsbRcbsbRiLsb
LgbLibsbLgbLgLsbsbsbLcbsbsbLhbLgLsbLgLsbLgLsbLiLsRsbLgbLgLsbLgbLgbLoLs
mbLcbLeLsbLcbRgbLgbRcbReRsmbLsRsRsmbRibRibRiLsbRgbRobLsbLoLsmbRhbRhbRs
bsbRgbRsbsbsbsbRsbRsbsbRjbLsbsbRsRsRsmmbRjbRgRsRsRsmmmbLjbRsRcRsmbLgbs
bRobLsbsbLcLsmbLgbLsLsmbRsLsbRsRsmbsbRgbsbRibLsbLgbLibLsLsmbLsLjbLsLsm
bsbLsbRsbLsbLebLsbRibRsbRjbRsbRcbRsbsbLibsbRsbLsbLsbRgLsbLobRsbLobRsbR
ibRsbRgbLsbRibsbsbRsbRcbLgbRebRsLsbLiLsbsbLcbLsbsbRsbLjbRsbLgbsbLibRjb
RjbRibsbsbLsLsmbLobsbLiLsbLgbRsbRibRobRibRgbsbRsRsmbRibRsbLsbLebsbLsRs
RsRsmmbsbLobsbLsbLsbLebLebRgbRcbRsbReb

>ZF Recording 2016-06-02; tW: 300s; Start: 161813; End: 162319;
Recording: 5-1; Individual: 13; Drug: PCAP814 1 然 Apo 50 然
bLcbRobLebLiLsbRsRsRsRsmmmbLsbRsbRsbLsLsmbLsLsmbLsbLgLsbLsbLsbLsbLsLsL
smmbLibLsLsmbLgbLsLsLsmmbLsbLsLsLsLsmmmbLsLsmbLsLsmbLgbLgLibLsLsmbLgbL
cbLsLgbLsLsLsmmbLsbLibRjbRsRsRsRsRsRsRsLsmmmmmmbRgRsRsmmbRgRgbRsRgbLsL
smbsbRgbsbRsbRibsbsbsbsbRgbRsbRgbRsLsbLsbLsbLsbRsbRsbRsRsmbRsRgRsmbRib
RsbRsbRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 161813; End: 162319;
Recording: 5-1; Individual: 14; Drug: PCAP814 1 然 Apo 50 然
bRsbRgbRsRsmbRgbRgbRsbRsbRsbRgbRgbRgbRgbRsRsmbRgbRgbRsbLgbRsbRgbRgbRsR
smbRsbRgRsRimbRgbRsRsRsmmbRgRsmbRgbRgRsmbRsRsmbRgbRjbRsbRibRgbRgbRgbRg
bRgbRgbRgbRgbRgRsmbRsbRgbRgbRgRsmbRgbRgRsmbRgbLgbRhRsmbRgbRsbRibRgbRgR
smbRsRsmbRgRsRgmbRsRsRsmmbRgbRiRsRsmmbRiRsmbRcbRsRsmbRiRsmbRgRsmbRgRsm
bRgRsRimbRgbRgbRgbRhRgRsmbRgbsbRcbRgbRgbRiRsmbRcbRgbRsbRibRibRiRsmbRgR
smbRiRsRgRimbRhbRsbRgbRibRcbRcbRgbRgbRiRgbRiRsmbRiRsmbLcLsmbLoLsmbLsLs
mbLiLcbLgbLibLgbLibLcLsRsmbLibLibLcLgbLibLgLiLgbLgLsbLibRsbLhbLoRsbRsb
RsbLebLibLiRsLgLsRsbLgbLgbLiLsLgLsbLibLiLsbLibLgbLiLsbLgbLibRcLsbsbLsb
RibRebRibRibRibRibRiRcbRibRsRsmbRgRsRsRimmbRgRibRibLjbLebLiLsLsmbRibRs
RsmbRgbRsRsmbRgbRsRsRsmmbRsLsbRgbRgRsmbRsbRsRsRsmmbRiRsRsLsmmbRsbRgRsm
bRsRsmbRgRibRsRsmbRgRsmbRsLsbsbRsbRsLsbsbRsbRgbRibRcRsmbRgRsmbRhbRgbRi
RsmbRcRiRsmbRgbRgRsmbRgbRgbRgRiRgRsmbRibRgbRibRsRsLsmbRgbRsbRsRsRsmmbR
ibRsbRgRsmbRsbRgbRsRsmbRiRsmbRsRsmbRsRsmbRgbRgbRgbRgRgRsmbRgRsmbRsRsmb
RgbLsRibRgbRgbRgbRgbRiRsmbRsRsmbRgbRsRsmbRgLsRsbRgRsmbRsbRsbRsbRibLgbR
ibRgbRgbRsRsmbRsbRgRsRsmmbRgRsmbRsbRgbRgbRgbRgbRsRsmbRsRsmbRsbRsbRgRsm
bLebLgbRsbRgbRgbRgbRgbRgbRgbRgbRgbRgbLsLsmbRsbRsbRsRsmbRgRsmbRgRsmbRgR
smbRgbRgbRgbRgbRgRsmbRgbRgbRsbRgbRsRsmbRgbRgbRgRsmbRgbRgbRgLsbLsbRsRgb
RgbsbRsbRgbRgbRsbRsRsmbRsbRsRsmbsbRsRsmbRsbRsRsmbRgRsmbLsLsmbLsbRsbRsb
sbRgRsmbRgbRgbRgbRsbRsRsmbRsbRsbRsbsbRsbLsRgbRsbLsRsbRsbsbRgbRsbRsbRsb
sbRibRsbRgbsbRgbRsbsbRgRsmbRgbRgbRgbsbRgbRsbRgbRgbRgLsbRgbRgLsbRjbsbRs
bRsbRgbLsbRsbRsbRgbRgbRsRsmbRgbRgbRsbRsbRgbRsbRsbRgbRsbRsRsmbRgbRsRsmb
RgbRgbRsLsbRibRibRsLsbRgbRsbRgbRsbRsbRgbRgbRgRsmbRgbRsbRsbRgbRgbRgbRsb
RgbRsbRgbRgRsmbRsbRgbRsRsmbRgbRsbRsbsbRsbRsbLsbRsbRgbRgbRgLsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 161813; End: 162319;
Recording: 5-1; Individual: 15; Drug: PCAP814 1 然 Apo 50 然
bRcRsRsmmbRiRsRsmmbRgRsRsmmbRgRsmbRiRsmbRgbLibLgLsLsmbLiLsLsLsmmbLgbLg
LsbLebRsRsmbLibRibRcbRjRgbRibRgRsmbRgRsRsLsmmbRcRgRgbRsRsmbRiRsmbRiRgR
sRsmmbRibRobLoRcbRhbLhbLiLsbLibLsbRcbRhRsmbRibRsRsmbRebLgLsbRiRsmbRebR
ibRgRsmbLgbRjRsmbRsbRgRsRsRsRsRgRsmmmmmbRibRiRsRgRgmbRibRobLebLebLibLe
bsbRibRiRsmbRibRiRsmbRiRibRgbRsRsRsRsRsRgRgmmmmbRhbRhLsbRgbLebLibLgLsb
LsLsLsmmbLibLgLsbRiRsmbsbLgbRcbRibRsbRgRibRsbRibRhbRcRsmbLeLsbLgbLiLsb
LhRsLsbLibLsbRgbRgbLiLsbLiLsbLsbLibLgbRcbRibRcbRsRiRgLsbRibRcRsmbRcbRg
bRgbRgbRibRgbRibRgbRiRsRsRsRsmmmmbRsRsmbRsRsRsRsRsmmmmbLjbRcRsmbRiRsmb
ReLsbLiLsbLiLsbLgbLsLsmbRsLsLsLsmmbRsLsLsmbLcbRsRsmbRebRsRsRsRsRgmmmbR
ibRibLsRsbsbLiLsbLibLiRsbLgbLiLsLsLgLsmbLiLsbRsbRsRsRsRgmmbLsRcRgbRsRi
RsmbLgbRsbRibLibLibLibLiRsbRjbRcbRgRgRsRsmmbReRsmbLgbLgLsbLibLsbLgLgbL
gbRsbLsbLsbRsbLsbRsbsbsbRsbRsbLgbsbLgbRsbRibRsbLsbLjbRebRiRgRibRsbLsRs
bRsbLibLsLsmbLgbLsbRoRsRsmmbRsbRgRsmbLhbLsbLsbLebLjbRgbLsRsbLsbRiRsmbR
gLsbLsbsbRjRsmbRjbRsbLgbLsRsbRsRgRsmbRiRsRsmmbRiRsmbRgbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 161813; End: 162319;
Recording: 5-1; Individual: 16; Drug: PCAP814 1 然 Apo 50 然
b

>ZF Recording 2016-06-02; tW: 300s; Start: 161813; End: 162319;
Recording: 5-1; Individual: 17; Drug: PCAP814 1 然 Apo 50 然
bsbRsbRgLsbRsbRsbsbRibRsbRgbRibRgLsLsmbRsbRgbRiRsmbRgbRgbRgbRsbLsbRgbR
iRgRsmbLsbLsbLsRsRsLsmbRgbsbsbsbRgbRgbRsbRsbRsLsbLsbsbLsbRgbRgbRsbRgbs
bLsbRsLsbLsbRsRgbRcbRgRsmbRgRsmbRgbRgLsbLsbRgbRgbRgRsRgRsmmbRsbRgbsbRs
bRgLsbRcbRsbsbsbLsbsbsbsbsbsbsbsbRgRsmbRgLsbsbRgbRsbRgbsbsbsbsbRgbsbRs
bsbRsbRsbRgRsmbRgbRgbRgbRgbRsRsmbRjbRsbRsbRsbRsbRibLsbsbRsbsbsbsbsbsbs
bsbsbsbsbsbsbsbsbsbsbsbRsbsbsbsbsbsbsbRsbsbsbRsRsRsmmbRsLsbLsRsbLsbLsb
sbRibsbsbsbRsbRsRsmbRsbRibRibsbRgbRsbLgbRgbRibsbRsbRib

>ZF Recording 2016-06-02; tW: 300s; Start: 161813; End: 162319;
Recording: 5-1; Individual: 18; Drug: PCAP814 1 然 Apo 50 然
bRiRsmbRsbRgbRsbRsbRsbRgbRsbRgRsmbRibRiLsRibRiRsmbRgRsmbRibRibRiLsRibR
ibRebRgbRobRgbLiLsbLgLiLibLgbsbLgLsbLgbLsbLsLsmbsbsbLgLsbLsbLiLsbLgbLg
LsbLgLsbLgbLgLsLsmbLsbLibLsbLgbLgLsLsmbLgbLiLgbLsbLiRsLsbLsLsmbLgbLgbL
ibLgLiLiLsLhLsbLgbLibLcbLibLibLibLcLsLsmmbLcbLhbLibLgbLcLsRimbRsbRibRg
bRgRebRcbRsbRebRebRhbLsbRhbLobRibRsbRibRgRsmbRsbRsRsmbRgRsLsmbRsbRsbsb
RsbRiRsmbLjbRoRsmbRebRgbRgRibRgbRgbRgbRgbRgbRgbRgbRgbRiRgRsmbRebRebRiL
sRsbRgbRgbRgbsbRgRsRsmmbRgbRgbRgbRgbRgbRibRgbRibRgRsmbRgbRiRgRsmbRiRgb
RcRsRsRgRsRsmmmmbRiRhRsmbRibRsbRsLjbLiRsbLsbRjbLcbRiRsmbRibRgRsmbRgRsm
bReRsmbRhbRcRebRjRsmbRgbRibRgbRibRoLsbRibRcRsmbLjLibLhbLibLiLgbLebLgbL
ebLgbLibLgbLgbLibLgbLibLebLiLsLsmbLibLebLsLsmbLgbLiLsbLsbLiLsLsmbLibRs
bLibLsbLsbRjbRgbRgbRgbRsbRgbRgbRiRsmbLgbLhbLibLgLsbLgbLgbLiLsLsLsmmbLg
bLsbRgbLibLgbLsbLgbsbsbLibLibLibLoLsmbLibLiLsbLobLhLsbLhLsbLsbLsLsmbLg
bLgLebLiLsbRibRibRibRsbLsbLgbLiRsbLsLsLsmmbLgbReRsmbRibRibRhRibRebLsbR
ibLgbRebReLsRsbRhbRibRiReRsmbRiRsmbRhRsmbLsbRibRgbRibRgbRgbRcbRcbRgbRi
RsmbRcLsbRgRsmbRibRibRsRsmbRiRsmbRgbRsRsmbRgbRhbRhbRcbRibRiRgbRgRebLjb
LobLibRcbRsbLsLcbRsLgLsbLgbRsLsbLgLsbLgbLeLsbLgbRjLsbLobLsbRsbLsLsmbLg
LsbLgbLgbLebLiLsbLhLcbLibLibRcbRiRsmbRsRgRsmbRgRsmbRgRsmbRibRgbRcbRiRs
mbRiRsmbRiRsmbRgbRibLcbLibLgbLibLsbLsLsmbLsbsbLjbLsbsbsbLsbsbRsbsbLgbL
sLsLsmmbLsbLhLsbLiLsbsbRgbLsbLsbLibLsbRsbRsbRsLsbRsbsbLsbRsbLibRsbLjbL
hbsbsbLibLibLgbLgbLsbLgbLhbsbLgbRsbsbLibsbLgbLgbLcbLgbLsLsmbLgbsbLiLsb
LibRsbLgbLsbLgbLibLibLgbLiLsLsmbLibLjbLsLsmbLiLsbLiLsbLibsbLcbsbLsRsRs
RsmmbsbLsbRibRgbsbRgbRsbsbsbRgbRiRsmbRsRsmbRsbRibRiLsbRgbRgbRgbsbRhbsb
RsbRjbLsbRgbRgbsbRsbReRgbRgbRhbRsbRsbLgbRsRsmbsbRgbRsbLsbRsRsRsmmbRgbR
sbLsbRibRgbRgRsmbLjbLcbLobRsbLibRsLsbsbLibLobRsbLjbLhbsbLcbLsLgbLgbLsb
LsbsbLsbLgbsbRjbLiLsbLiLsLgbLgLsbLsLgbLgbLgbRsbsbLjbLgRsbLsbLebRsbLgbs
bRsLsbLsLsmbLsbLjbRhbRgbRsRsRsmmbRib

>ZF Recording 2016-06-02; tW: 300s; Start: 161813; End: 162319;
Recording: 5-1; Individual: 19; Drug: Control Apo 50 然
bReRsmbRcReRibRibRiRsmbRiRsmbRibRibRebLgbLibLibLgbRcbRcRsRiRsRhRimmbRi
bRsbReRsRembRebRcRsLsRimbsbLsbLobLibLibLobRsLsbLiLgbLobLcbLhLsbLgbLiLg
bLgLhLibLibLebLgLgbRjbLsLsmbRcRsRembRsbsbReRgbReRsmbRcbRgbRibLcbRjRsmb
RiRebRiRsmbRcbRsRsmbRhRsmbRibRgbRgbRibRoRsRsmmbRgbRcbRobRebRibRiRcbRiR
smbRhbRjbLcbRebRsbLebLgbsbLibLgbRsbLsbRsbsbRibRsbLjbsbLgbLibRsbLgbRsbL
ebLjbLebLgbLgbLgLsbsbRsLsbLiLsbLsbRsLsbRsbRsRsmbRsbLsbsbLhbsbsbRsbsbLs
bLgbLsbLjbRsbRsLsbLsbLibLgLsbLsbRgLibLhbRgbLsLjbLsLebRsbLsbLgbRsbLsbLi
bLsLsmbLeLebLsRsLsbLsbLsbsbsbsbsbsbsbsbsbsbsbLsLsmbRebsbRcRsmbsbRsbRcb
RcbRgbRcbRibRcbRsbRebRgbRsbRgbRebRsbRgLsbRsbLsRsRsmbLsbRsbLsbRsRsmbRgb
RibsbRgbRhbLgbLsbRobRibRsbRebRgRsmbRsbRsbLsRsRsmbRsbsbRebRgbRsbRsbLsbR
sb

>ZF Recording 2016-06-02; tW: 300s; Start: 161813; End: 162319;
Recording: 5-1; Individual: 20; Drug: Control Apo 50 然
bLjbLhRsbRcbLjRiLsbLgbLgbRsLsbLibLibRgbLsbLibLcbRsbRgbRibRibRibRgbLjbL
gbLobLgbLibLibRgbLgbLgbLsbLjRsbLgbLgbLgbLcbRiLibLgbLibRsbLjLsmbLsbLgbL
obLsbRjbRibRibRibLjLjbRgLsbRibRgbRgbLjLhLsbLsbLgbLsbRjbLcbsbsbsbsbRcbs
bRibsbsbRjbRgbRsbRcbRgbRjbRsbRsbRgbRibLgbRibRjbRsbRsbLjbLgbLcbLsbsbLib
LgLsbLgbLiLsbLcbsbRjbLjbLcbsbLsbRgbLsbRobRgbRgbRsRsmbRibsbRsbLgbLsbLsb
LibRsbLsbLsbsbLsbRsbRsbRibRcbRibRgbRjbRsbRsbLjbLgbLcbRsbLjbRgbRcbLsbRg
bRibLgbLsbLgLebLibLiLebLebLibLebLebLebLibRgRsmbRsRsmbLgbLsbRsbLjbRsbLs
bLjbRgbLsLsmbLjbLgbRsbLibRsbLsbRsLsbLgbLsLsmbLjb

>ZF Recording 2016-06-02; tW: 300s; Start: 161813; End: 162319;
Recording: 5-1; Individual: 21; Drug: Control Apo 50 然
bLhbLobReLsbRobLibLhbLiLsbRebsbLjbLibLibLibLibLibRjbRhbLobLhbsbReRsmbR
gbLgbsbRobRgbLcbLobRobRgbLgbRobRsRcRsmbRcRsmbRibLobLgRsLsbRobRebLgbLeb
LiLsbLjbRoLsbRjbRoLsbRjbRhbLobLibLcLsmbLcbLgbLsLsmbLsbLibLebRibRibRjbR
gbRibsbLobRsbRsbsbLgbLsLsmbLgLibLcbRobRibRjbLobLhbRjRsmbRjbLsbRgbLobRs
LsbRibRhRsRsmmbRjbRsLsbLsRsbLibLobLcbRcbRiRsRsmmbRobLibRhbReRsLsmbLebR
ebLiRebRoLsbRgbLsbLobRcRsmbRobRjbRsbRhbsbLjbRsbRhbRhbLiRsRsmbRibRcbsbL
sbLibsbRcbRibRobsbRsRibLobRgbsbLgbRsbsbsbsbLsLsmbLsLgLsbLgbLsbLsbLiLsL
sLembLebRsbRjbRsbsbLobLsbsbLibLhbsbsbsbsbRgbLhbLsbRjbLiLsbLsbRsbRsbRgR
sRsmmbRibRgbRsbRibLjbsbRgbRibRgbRsbRcbRebRobRobLsbRibRsbLsLgbRibRsbLjb
RsbLsbsbRcRsmbRcbRsRsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 161813; End: 162319;
Recording: 5-1; Individual: 22; Drug: Control Apo 50 然
bRibRgbRiRsRsmmbRiRsmbRgRsRsRsmmmbLsLsLsLsLsmmmmbRiRsmbRibRiLsRsbRsLsb
RsLsbRjRsmbLgbRoRsmbRiRsmbRgbRgbRgbRgRsmbRibRsRsLsRsRsRsRsRsmmmmmbRjRg
RsmbRibRibLsbRiLsbRsRsmbRgbRgRsRsmmbRgRsRsmmbRibLcbLcRsbLiRsbRsbRgRsRs
RsRsmmmmbRsRgRsRsmmbRsbRgbRgRsmbRibRibRgRsmbRibRsbRebRibsbRhbRsRsRsmmb
RsRsmbRgLsRsbRsRsLsRsRsRsmmmbRibLobLgbRgbsbLhLsbLsLsmbLiLsbsbLibRobRjb
LsLsRsmbRibRsbRgbRsbRgbRsbRcbRsbRgbRsRsmbRebRgbRgRsmbRgRsRsLsRgmmbRgbR
ibRgbRsRsmbLsRibRgbRiRsmbRsRsmbLobLcbRebRsRsmbRgbRibRibRsLsbsbLjbLibRs
LsbRsRsmbRsbLoRsbRibRhRsmbRobRgbRibRibLjbRibRibRgbRjLsbRiLsbRsRsmbRgbR
cbLsbLsbLsRsbLsbLsbLsbRsbRsbRsbRsLsbRsbLsRsLsbLsbRsLsbLsbLsLsmbRsbsbLs
bRgRsmbRibRsRsmbRsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 161813; End: 162319;
Recording: 5-1; Individual: 23; Drug: Control Apo 50 然
bRsbRgbRgbLjbLcbLibLebLsbRsLsLsmbsbLsLsLsRimmbLsbRobRgbLibRebRcRsmbRiR
smbRibRsRsmbRobRcbLsLsmbRcbRibRibRiRebRcbLibLibLibLibLibRcbRobRiLsbRib
RoLsbRgbRobReRsRsmmbRhLsbsbLsLcLiLsbLjbLhbLiRsbLsbRgRsmbRobRgbRhbRsbLh
bLsLsmbsbsbLsbsbRsRsmbsbsbsbRsLsLsLsmmbLsLsLsLsmmmb

>ZF Recording 2016-06-02; tW: 300s; Start: 161813; End: 162319;
Recording: 5-1; Individual: 24; Drug: Control Apo 50 然
bLjbLibLgLsbLgbLiLjbLgLiLiRsbLsbRsLsbLebLebLebsbsbRsLibLhbLebLsbLiLgbL
gbLsbLsbLebLsbRsbsbLgbLsLsmbLiLibLibLjbLgbLibRcRsmbRjbLibLibLjbsbsbRib
ReRiRibRjbRjRsLsmbRibRibRebRhbRgbRjbRiRiLsLsRiRsmmbRebRebRiRsRiRgRsRem
mbRibRgbRjbLebLjbLjbLjbLjbLcbLjRsRsmbLgLibLjbLjbLjbLibLibsbLjbLcbLcRsL
ibLiLsbsbLibLjRsbLsbLgbLibLibLcbLhLeLsbLgbLgbLibsbRsbsbsbRjbRjbsbRjbsb
RjRjbRjRjbsbRiRibRebRibRibRjbRjRebRgRsmbRibRiRibRjbRsRsmbLsbRebRebLgLs
bsbLjbLsbRjbLjLjbLebLiLsLsLsmmbLgbLjRsbRsbLsbLjbLobLjRsbLiRsbLibRjbLib
LcbLjbLibLiRsbLjbRsbLjRgbLgbLhbLiLsLsmbLiLgbRsbsbLgbLhbLcLsLsLsmmmbsbL
cbLjbLcbLsbRsRsmbLgbRhRsmbRiRsmbRhbRjbLibLjbLhbLhLgbLiLsbsbsbLgbRsbLcb
LcbLgbLgbsbLgLsLjbLsbLjbLgbsbLgbLgbLjbRsLsbRsbsbRsbLsbRibRsRsmbRsbLsbR
ebLsbRibRgbRibRebRsbRjbRibRjbRibRjbRiRsLsmbRgbRsbRibLsbRebRebLsRsbLjbR
sbRgbsbLsbRebsbRebRjbRsbLsbLgbRjbsbsbsbRsbsbLsLsmbLjbsbLsbLibLgbRsbLib
sb

>ZF Recording 2016-06-02; tW: 300s; Start: 161813; End: 162319;
Recording: 5-1; Individual: 25; Drug: PCAP814 10 然 Apo 50 然
bLsbLsbLgbLsLsmbRibRsReLobRsbsbReRsRgRimbRsRsmbRsLsbRsbRsbRsbsbsbRsRsm
bRsbRsbRsbRsbRibLgbLsbRsbRsbLsbRibLsbLebLiLcbLgbRgRebRjbRgReRsmbLobReL
obRobRsbRsbRsRgbRgRiRsLombLsbRsbLgbRsbLjbLsLsmbLsbsbLsbLsbsbsbsbsbLsLs
mbRsRsmbLcbLcRebLebLiRsbRsLsbLsbsbLsbRsbRsbsbLsbLsbLsbLhbRsbRsbLsRsbsb
RsbRsRgRgbLjbLjbRgRsmbRsRsmbLsbRsbRgbLibRoLsbLebRebLgbLgbLgbRcbRsbRsbR
ibRsbLsbLsbLsbLsLsmbLsLsmbRsbLsbRsbRsbLsbLsbsbLsbsbReb

>ZF Recording 2016-06-02; tW: 300s; Start: 161813; End: 162319;
Recording: 5-1; Individual: 26; Drug: PCAP814 10 然 Apo 50 然
bLsbLsbLsLsLsmmbLgbLcbRgbLsLsLsmmbLsRsLsRsLsbRsLsLsmbLsLgbRsbLsRsbLsbL
sLsmbLsbLsbLsRsLgbLsLsLsLsmmmbLsbLsLsmbLsbLsbLsbRsbLcLsmbRsbLsLsmbLgLs
bLsLsmbLgbLsRsLsbLjbLibLjbLeLsbRgLsbLgbLsLgbRsbRsLgbLibRsRsmbRsLsbLsLs
mbsbRgbLgbLsbLsbLsbRoRsLembLsbLsbRsbLsLsmbLsbLibLgbLsRgRsmbLsLsmbLgbRg
LsbRsbRcbLibLsLsLembLsbLsLsmbLsbLsbsbLsbLsLsmbRsbLsbLgbRsbLiLsbLsRsbLg
bLgbRsbLoRsbLcbLsLsLimbLsbLsLsmbRsbLcLsLsmmbLsbLsLsLgLsLsmmbLsbRcRsmbR
sRibLsRsbLcbLjbLjbLsRsbLgbLsLsmbRsbLoLsLsmmbRsLsbsbLsbLgbsbsbLeLgbLsbL
sbLsRsLsbsbRjbsbRsbLsbLgbRsbLsbRsRjbRgRsmbLgbLjbRibRsbLsLsmbRjbLsbRgRs
mbRsbLsbLsbRsbLgbLsLsLsmmbLgbLsbLsbRsbRjbLobRsRsmbRibRjbRjbRgbRoLgbRsb
sbsbLsbsbLsRsbLsbLsbsbsbLsbLsbRsbsbLobLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 161813; End: 162319;
Recording: 5-1; Individual: 27; Drug: PCAP814 10 然 Apo 50 然
bLibLsRsbLebRiLgbRsLsRgbRjbRibLsLsmbRsRgRebRgLsLsmbRsbRsLgLeLsbLhbLsLs
LsLsmmmbLsRsbRsbsbRsRsmbLsbRsLsbLsLsLsmmbLsbLsbsbRgbRsRgLgLsbsbRsRsLgm
bLjbLgLsbLsbLsLsLembRgbLgLsbLsLgbRsbRsbLgbLgbLsbLsLebRsRsLsLsmmbRsLsLi
LsLgbLsLsLsmmbRebRoLsbRsLsbLsLsmbRsLsbRgRsRsRsmmmbRsRiLsLsLsLsmmmbLsLs
LsmmbRsbRgRsLsmbRsbRsbRsRsmbRsbRgRsLsmbsbRsbLsLsRsRsmmbLsbRsbRsRgbRsLs
RsLsRsbRsbRsbRsbLobRcbRsRsRsRimmbRsRsRimbLsbLobLjbLsRsbRgbRgbRgbRebRsb
RobRhLsbLsbLsbLgRsbRsRsmbLsbsbLsbRobLoRsRsRsRsRsRsmmmmmbRgRsmbRsRsRsRs
RgmmmbRgbRsLsbRsbRsbLsbRsbRgbRgLobLibRsbLjbLsLsLsmmbRsbRsbLebRobRgbRsb
RsRibRgbLsbRsRsmbRsLsRsRsmbRsbRsRsmbRsbLsbLsRsbRsLsbsbsbRsRsmbsbsbRsbR
sbRsbsbLsbsbRsbsbsbLsbsbsbsbLsRsbRsbsbsbsbsbsbsbRsbsbsbsbsbsbsbsbsbRsb
sbsbsbRsLsLsmbRsbLsbLsbRsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 161813; End: 162319;
Recording: 5-1; Individual: 28; Drug: PCAP814 10 然 Apo 50 然
bRsLsbsbRsbLsbRsRsRgRsRsRsmmmmbLsbLsbRsRsRsRsRsRsRsRsRsmmmmmmmmbRsRsRs
RsRsRsRsRsRsRgmmmmmmmmbLgbReRsRsRgRsRsRsRsRsRsRsRsRsmmmmmmmmmmmbRsRsRs
RsRsRsRsRsRsRsmmmmmmmmmbsbsbRsRsmbsbsbsbRsbLsRsbRsbRgRsRsRgmmbRsRsRsRs
RsmmmmbRsbRsRsRsRsRsRsRsmmmmmmbsbRsbRsRsRsRsRsRsRsRsmmmmmmmbRsRsRsRsRs
mmmmbLsRsRsRsRsRsRsmmmmmbsbRsRsRsmmbRsRsRsRsmmmbRsRsRsRgRsmmmbsbRsRsRs
RsmmmbRsRibRsRgRsRgRgmbRcbRsRhbRobLgbLobLcbRcRsmbLsLebLgbRsLsRobRgbRsR
gbLiLsbRsLhbRebRsbLsbRsRsRsmmbsbRsbRsRgRsRsRgmmbRobLoLeRsbRgRgRibRibLe
bLsbsbLsbRsRebLebLsRsbRgRsmbLoLsRsRsRsRsmmmmbRsbLobRsRjbLsbsbRsRsmbReb
RobRcbsbsbsbsbsbsbRsbLsbLsbRsbRsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 161813; End: 162319;
Recording: 5-1; Individual: 29; Drug: PCAP814 10 然 Apo 50 然
bLsRsbsbLsbLsbRsLsbsbsbLsRsbsbsbRsbLsRsbLsLsmbsbLsRsbsbsbRsLsbRsbRsbRs
bRsbLsbRsbLsbsbsbsbLsbsbsbsbLsbsbsbsbLoRsbRsbRsbsbRgbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 161813; End: 162319;
Recording: 5-1; Individual: 30; Drug: PCAP814 10 然 Apo 50 然
bLobRobRebsbsbsbLsbRsRsmbRsbRsLsbLhLsbLsbRibsbLsLhbLibRsbRsbLjbLsbRgbL
gbLgbLsbLgbLsLsLimbLiLgLgLsLgbLgbsbLsLhLsbLsbLebLibLsbRjbRgbRcbLsbsbRg
LsbRgbRgbLibLsRsbLibLebRsLsbLeLsbLsLgLsbLgbLsbLgLgLsLsmbLgLsbLibLsbLsL
sLgmbRebRobLsLsLhmbRhbRsbLsbRsLsbRsLsLsLimbRgbLsbLgbLeRsbLobLsLobLsReb
LcbRebLsbLibLgbLsLsmbsbRsbsbLibLsLgbLsLsmbLcbRsbLjbRiLsbLsbLsbLjbRobLg
LsbLgbsbsbLsLgbLsLibLsbLsbLsbLobLgbLsbLsLebsbLgbLsbLsbLsbLsLibsbsbsbsb
RsbRsbRsbRsbRsbLsbsbsbsbsbLsbsbLibRsbRebRsLsbsbsbLsbsbLsRsbRsLsbsbRsbR
sbLgbsbRsbRsLsbLgbsbLgbLsbRsLsbsbRsLsbRgbLsbsbRjbLsLsLsLsmmmb

>ZF Recording 2016-06-02; tW: 300s; Start: 161813; End: 162319;
Recording: 5-1; Individual: 31; Drug: PCAP814 3 然 Apo 50 然
bRibRcbRgbLjLjbRibRhbRgbRibRgbRgRibRgRsmbRgbRsbRgbRibRgRsmbRiRibRsbRib
RgbRjbLsbRgbRhRsmbLibLibLibLgbRsbRoRsmbRiRsmbRgbRsbRgbRgbRgbLsbRiLsbLg
RsbRgbRgRsmbRsbRgbsbLsbRsLsbLsLsmbLsbRsRgbRgbRgbRgbLebRhRsmbLsbRgbRsbR
ibLgbRsbRsbRgbRibRgRsmbRsbRsbRibsbRibRgbRgbRibRsbRibRgbRgbRobRsbLibLiL
sLgRsbLsLsmbsbLsbLibLcbLibRjbRiRsRsmmbRgbRiRsmbRsbRsbLiLsbLobRsRhbRibR
iLsbRibRibRibRsbRjbRibRgbRsbRibRibRsbLgbLgLsLiLsbLgLsbRsRsmbLsLgbLsbRs
bLiLsbLobLsbRhbRgbRiRsmbRibRibRgbLsbRgbRcRsmbRgbRoRsmbRibRsbRiRsmbRobL
sLsmbLibLibRsbLiLsbLsLgLsbLibLibLgbLsbLgbRgbRibRgbRiLsRgRsmbRiLsbRiLgL
sbRibRgRsmbRgbRgbRgbRsRsmbRgbRsRsmbRsbLsLsmbRsbRibLcbLibLsbLjRsbRsbRsb
RjbRobRgbRiRsmbRsRsmbRibRibLsbRgbRibRibRsbRibRiLsbLsbRsbRsRgbRgbRsbRgb
RsbRsbRsRsRsmmbRsRsmbRsbsbRgLsbsbLsbLsbLsRsbsbsbsbsbRsbsbRsbRgbRsbRgRs
mbRsRsmbsbsbLgbLsbLobRgbRobRsbRibRcLsLsmbLgbLibLsLsmbsbsbLsRsbLsbsbsbs
bRsbsbsbsbsbsbsbLgbLgbLgbsbLjbsbLhbsbsbsbRcbRsbLsbsbsbLsbRsbRibRibRgbs
bRjbRsbLsbRsbRcbRsbRibRhbRsbRiRibRgbRgRgbRsbRibRgbRibsbRsbRsbRgbRjbLsb
RgbRsLsbRsbLiLsbRebRgbRibsbRjbLsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 161813; End: 162319;
Recording: 5-1; Individual: 32; Drug: PCAP814 3 然 Apo 50 然
bsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbLsbRsRsmbRsLsbLsLsLjmbR
sRsmbsbLsRsLsbRsbsbLgbLsLsmbLsLgLsbsbLsbLiLsLiLsbRcRobRobRobRgbLibLgbL
gLeLcRgRsmbRiRsmbRiRsmbRcbRcLsbsbRhbRgbRiRsmbRibRibRibRcLsbRibRgbRcbRo
bLibLibLcLibRiRsmbLobLibLsbLsLibLsLsmbLgLsbLiLsbRcbRcRsRcmbRcRsmbRiRsm
bLsLsmbRgbLgbLsLsmbRgbRsLhbsbLcbLgbLgbsbLsbRsbRgbsbRsbRsRsmbLsbLsLsmbL
sbRsbRsRcRsmbRsRsmbLgLsbLgLsbsbsbLibLsbRsbsbsbsbsbsbsbsbsbsbsbsbsbsbRj
bLsbsbRsLsLsRsmbLsbRjbLgbLhbLobLcbsbLsbRhRibsbLsbRcbRibLcRsbLgbLcbRsbR
cbRhbRsbsbRjbRhbRebLgLsbLsbRsbsbLibLibRsbLsbLsbLgbLsLgbLgLgbLgbLsbLgRs
bRhbRhbRibRgbRiLsbLcbLsbLsbLgbLebsbLgLsbRjbRcbLcbLsLibsbLgLibLgbLiRsbR
ibsbRjbsbRibRibRgbsbRgbRjbLsLsmbsbRjbRsbLsbRsbRsbsbLibsbRcbLjbsbLiLsbL
jbRsbLgbRsbRsLhbRsbRjbRsbRibRgbsbsbRibRibRgbRgbLgRgbRibsbRgbLibLjbLiRs
bRjbLcbLibsbLibLsbLsbRsbRsbRsbRsbRgbLgbLsbLsbLibsbLgRsbsbRjbRjbRgbRsRs
mbLjbLibRsbLsbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 161813; End: 162319;
Recording: 5-1; Individual: 33; Drug: PCAP814 3 然 Apo 50 然
bsbRgRiRsmbRiRsmbRhRibsbsbsbsbsbLcbRcbRibRsRoRsmbRsRiRsRiLsRsmbRsRhRsm
bsbRsbLsbRsRsmbRsRcRsRhLsmbRsbRiRsRiRsmmbRobRjbRcbRgRsRsLsmmbRgbRsRhbR
sbRsbsbRsLsbLjbLgbRgRjbLsbLsbLsbLsRsbRsLsRsLsLsmbLsbLsLsmbRsRsmbsbsbsb
sbRsbRcRiRsmbRsbRgRsmbLgbRsRjbLgbRsbRhbLsRsbRgbRsbRsbsbRsRsRsmmbRcbLsb
sbRsRsRsmmbRgRsmbRgLsbRiRiRsmbRgbRibsbRibRsRsmbRgRsmbRibRcRsRsmmbsbsbs
bsbsbsbRobsbRsbRsbsbRsbRsbsbsbsbsbRhRsmbRsRsmbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 161813; End: 162319;
Recording: 5-1; Individual: 34; Drug: PCAP814 3 然 Apo 50 然
bLsLsmbRsRsRgmbsbsbsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 161813; End: 162319;
Recording: 5-1; Individual: 35; Drug: PCAP814 3 然 Apo 50 然
bLgbLgbsbLgLsbLgbLgLsbLgLsbLsLgLsbLsbLiLgLsLsmbLsbLgbLgbLsLsLsmmbLsLhL
gLhbLsbLibLgbLgbLgbLgLsbLgbLgLsbLiLsbLgLsbLibLsLgLsLsLgLsmbLgbLsbLgbLg
bLsbLgLsbRsLsLsmbLgbLibRsbLgLsbLiLsbRjbLibLgbLgbLsbRsLsbLgbLsLsLsLsmmm
bRsLsLsmbLgbLgRsbLgLsRsbLsbLsLsmbsbLibRsbLibLsbLgbLcbLsbLgbRsbLiLsRsbL
jLsmbLsRsLsbLsbLsLsmbLgbLsbLsLsmbLsbsbsbsbsbLgbRobRibRsbLcLsmbLgbLsRsb
RhRhLsbRgbRhbRsRsmbsbRsRsmbsbLibRsRsmbsbRcLsbRgbRiRsRsmmbRsbRgbRgbRoLs
bRsbRgbLjLsLsmmbRsbRsbRsbRsbRsbRcLsbLsbLcbLsbLcbRjbRsRsmbRsbRsRsmbLebL
gbLsLsmbLcbRsLsbLsbRjbLsbsbLgbLsbLsbRjbRgbsbRsbLsbLsbRsbRobLgLsbLsbRsb
RgbRgRsmbLsbRsRsmbLjbRhbsbRgbsbLsRsbsbLsLibsbRjbRebLsbLsbRiLsbRsbsbLsb
RsbsbsbsbRgbRgbLcbLsbRsbsbsbsbsbsbsbsbLjbLibLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 161813; End: 162319;
Recording: 5-1; Individual: 36; Drug: PCAP814 3 然 Apo 50 然
bRgbRgbRsbRsbsbLjbRsbLcbLgLsbLgbLgbLgLsbLgbLibLgLsbRsbRgbRibRgbRgRsmbR
sbRiRsmbRsbRibRsbRsbRgbRgbRibRgbRiRcRibRibRibsbRibRibRiRiRsmbRibRcRsmb
RgRsmbRcbRiRcRsRiRimbRiRibsbRcRcbLjbLibLebLiLsLsLsLgmmbLiLgLibLgRsbLgb
LcLhLsbLgRsLibLgLsbLsbLsRsLsbLsRsbLibLiLsbLgbLhLsbRsLgbLgbLgbLgbLcbRgb
RsbRhbRgbRhbsbRibRgbRgbsbRiRsmbRcRcRsRsRhRimmbRibRcRsRimbRhRsmbReRsRsR
cRgmmbRiRsmbRgRsmbRgbRiRsmbRsbRsbRgbRgbRgRsRsmmbRibLobLibLjbRsbLgbLgLs
LsmbLiLsRsbLgbLgRsbLsbLibLibRjbRcbRsRsmbRoRcbRcRiRsRimbRiRsmbRgbRgbRgR
gbRgbRgRsmbRgbRsRsmbRgbRgbRgbRsbRgRsmbRgRsmbRibRgRsmbRsRsRiRsRsmmmbLsb
LcbLgbLgbLsbLgbLsbLibLgbLibLsLiLsbLiLsLeLsLibLgbLibLibLibLgbLgbLsbLgbL
gbLgbLsbRjbRibRcRsRsRcRsRsmmmmbReRsmbRgRsmbRgRsmbRgbRsbsbsbsbRiRsmbRsR
smbRiRsmbRgbRgRsmbLgbRhbsbRgRsmbRhRcRsmbRcRsRsRsmmmbRcReRsmbRgRsmbRgbR
gbRjbRsbRobsbRsbRcbsbRjbRsbRoRsmbRcbRhbsbRoRsRcmbRcbLgLsbLibLgLsLsRsmb
LibLibLgbLsLsmbLgbLsbLsbLgbLsbLsbLsbRsbRsbLsbsbsbsbsbLsbRsbLgbRsRsmbsb
sbsbLcbLibLcRsRsmbRgbRsRsRsmmbRgbRgbRsbRsbRsbRsbRsbsbsbsbRsbRgbRsRsRsL
sLsRsLsmmmbsbLsbLsbRsLsbsbRsbRsbsbsbsbsbRjbsbRgbsbsbRsbRgbsbRsbRsbsbsb
RsbRsbRsbLsRsbRsbsbRsbRsRsmbRsRsmbsbsbRgbsbRibRsbLsbRgbRsbRib

>ZF Recording 2016-06-02; tW: 300s; Start: 161813; End: 162319;
Recording: 5-1; Individual: 37; Drug: PCAP814 1 然 Apo 50 然
bsbsbLsbsbLsRsLsbsbRsRsmbLsbsbsbLeLgLsRcbRcbRhbRsLsbRcbRhbRcRibRcbRhRs
mbRsRsmbRsbRobRcbRibRiRgbLobLobLcbLcbLibLibLobLcbLibLsbLibLoRsbRgbRibR
gRsmbRiLsbLsbRsbRibRiLsbRsbRiRsLsmbRibRhbLhLsbsbsbLcbRhbRhRsmbRibRsbRi
bRgbRiLsRsbRibRcLsbRcbRgLsRcbRsbLcbLcbRsbLsbLgbLgbLgbLsLsmbRsbLsbsbLsb
LgLsbLgLcbLsbRsbRsbsbLsLsmbLsbLsbLcbLsbLgbLgbLgbLsLsmbLgbRsLgLsbLgLsLs
LsmmbsbLgRsbLgbLsbLsbsbLsbsbLsLsmbRsbsbsbLsbsbLgbLgbLsLsmbLgLsbLsRsbLs
b

>ZF Recording 2016-06-02; tW: 300s; Start: 161813; End: 162319;
Recording: 5-1; Individual: 38; Drug: PCAP814 1 然 Apo 50 然
bLsbLgLsbLgbLgLsbLgbLgRsbRgbRjbRobsbLibRjbLibLiLobLibsbLcbRobRobRobRiR
smbRibRoLsbLgLsbRjbRhbRgLsbRsRobRsbLiLsbRobLibsbLgLsbLibRobRsRsRsLsmmb
LsbLhRsbLibLibLibLgbLibLjbLgbRcbLcbLibLiRsbLebLgbRibLgbsbRjbRiRgbRgRgb
RebReRsmbRsbLcbRiRsmbRibRibRebRebRhbRsbLobLibLibsbLjbRibRibRhbRgbRcbRi
RsmbLibLibRjbLgbLcLsmbLjLsmbLibRsbLgbLgbLibLiLsbRgbLgbRgbLibLgbLgLsLsm
bLgbLhbLiLsLsmbLiRsbRibLiRsLsbRcbReRsRgRsRsmmmbRibRhbRiRsmbRebRebRobRi
RsmbLiLsbRgbLjLsmbLibLibLibRibRiRsmbRobRibLgbLiLsbRobRgbRibLsbLsLsmbRs
bRsRsmbRgbRibRgbRibReRsmbRsLsbRebsbRgbsbsbRsbLjbRobRgbRjbRsbsbRsbLgbLs
bRsbRsbLgbLsbLhbRgbLjbLsLsmbsbRgbLsLsmbLebLibLgLsLsmbLsLsmbLhbLebRjbLs
bsbLgbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 161813; End: 162319;
Recording: 5-1; Individual: 39; Drug: PCAP814 1 然 Apo 50 然
bRhbRgLsbRsbLsbRibRsLsLsmbRcbLgbRcbRhbLgLsbRebRgLsbRgRgRiRobsbsbRsRsmb
RhbLsbRgbRsLsbsbRibRibRgbsbsbRgbLsbLhbRjbRiRsmbLjbLsLcLsmbLgbRsbLibLib
LgbsbRhbRcbLcbLgLsbLsRsLsbLsLsmbLiLsbLibLgLsbLibLgLsbLibLibLiLgbRcLsbR
ebRiLsRgbRiLsbLcbLgbLibLsLsmbLcbLiLsbLgbLibLiLsbLgbRsbLgbLsLsmbLgbLibs
bRgbRcbRgbRhbRgbRibRgbRsRsmbsbRgbRsRsmbRsRsmbRgbRibRgLsbsbLsbLgbRhbRiR
smbRgLsbRgbsbRsbRgbRsbRgbRhbRibRjRsLsmbRiRsmbRgbRsbRgLsbRgbRibLgbRgbRe
bRibRibRibRiRhbLibLibLibLgLsbLhbLibLsLsmbLiLsbRsLsRsbLibRsbLcbLibLgbLi
LsbLibLoLsmbLibLiLsbLgbLobRgbRgbRhbRobRsbRiRsmbRiRsmbRgbRsbRgRsmbRoLsb
LgLsLsLsmmbLsbRsbLibLsLgLsRsbLsbLibLsbRgRsmbRcbRgRsmbRgbRcbLhbLhbLcbLs
bLgbReRsmbRgbRgbsbLsbRgbRibRibRhbLsbRcbRcLsbReRsmbRiRsmbRibRhbRgbLjbLg
bsbLiLsbLsbsbLgbLjbLcbRhbRjbRsbRibRsbLgbRgbRebLcbsbLibLiLsbsbRgbRgbRsb
sbLsbLsbLiLsbRsbRjb

>ZF Recording 2016-06-02; tW: 300s; Start: 161813; End: 162319;
Recording: 5-1; Individual: 40; Drug: PCAP814 1 然 Apo 50 然
bLgbLiLsLsmbLiLgbLgbLgbLiLsLsLsmmbLgbRsLgbRcbRiRsmbLgRsLsbRiRsmbLcLsmb
LibRsbLibRobRcbRgbRibRibRibsbLibLobRgbLobLibLsbLobLgbRobRibRobLibLobsb
LcbLobRhbRobRgbRgbRgbRgbRiReRsmbsbLsbRibRsbLobRjbRiRsmbLsLobLsbLgLsbLs
bLgLsLsLsmmbRobLgLsbLgLobLibLibRgbRobRibLibLsRsbLhbRiLsbLibRgRsmbLgLsb
LgbLobRiRibRgRsmbRebRgbLiLsbLgbLobRhbRibLcbRobRibRibRibRsbRibRebRgbLgR
gRsmbRgbRgLsbRgbLsLsmbRsbLibRjbLiLsbLsbLobRibRibLibRjbRsbLhbRsbLsbsbsb
LibsbLjbRsbRjRsmbLgbLgbLgbRsbRjbRgRsmbRiLsbRsRsmbRgbRgbLibRibLhbLjbLsR
sLsbLobLsbRgbRibRibLiLsLsmbLsbRhbRibRiRsmbRgbRebRsbRsbRsRsRembLsbRibLi
bLobReRsmbRibRgbLibLcbRjbLjbLsbRgbLsbLhLsbsbsbsbsbLcbsbLgbLibRjbRsbRsb
RsLsbRjbRsbLsbRibRsbRibLgbRsbRgbsbRobsbRsbsbRgbRgbLibLsLsmbLcbRibLgbLs
bLibLsbsbRsLsbLsbLsbLebLibRsRgbLjbLibLjbLsbLsbsbRibRjbLcbLgbRsbLgbLgbL
gbLgbLgbLgbLsbLgbLsbLgLsbLgbsbRsbRsbsbsbLsbsbsbLsbLgbRsbsbsbLjb

>ZF Recording 2016-06-02; tW: 300s; Start: 161813; End: 162319;
Recording: 5-1; Individual: 41; Drug: PCAP814 1 然 Apo 50 然
bRoLsbReRgbRsLcbLibLcbRgRsmbReRsmbRibLsbLeLsbLgLsbRobReRsmbRiRsRgRgmbR
sRiRgRibReRgbRiRgbLsRsbLgbLcRsLsLsmbLsLsmbLsLsmbLgLsbRcbRgRsRsmmbRgRsR
smmbRsbRsbLcbLibLgbLgbRsbLgLsLibLcbLgLsLsmbLibRjbLgbLebLgbLsRsbLcbLhbL
cbLibRcbRgRsmbRiRsRsmmbRsbRibRiRgRsRhRsReRsmmmbRgbRebRhbRgbRsbRgbRgLsb
LcLsLsmmbLgLsRgRsmbLgbLeLebLiLsbLcLsmbLgbLsLsmbRsLcbLoLsmbLeLsLsmbLgbL
ibLgbLibLgLsbLebLcLsmbLhRsLsbLeLeLsbRobReRhbRcRsmbRcRsRsRiRsRsmmmmbRib
LgbRoLsbLibRsbRebRjbLgbRebLsLsRsmbRibReRsRimbRiRsRhRsmmbLibRhbRiRsRgmb
RobRibRgbRcbReRiReRsLsRsmbRgbsbRgRsmbLcLsmbLcLhLsbLcLgbRiRsRsRiRsRsmmm
mbRgbRgRsRsRsRgRsRsRsmmmmmmbRibRcLsLsmbLsRhRsmbRobLgbRobLebLeLsLiLsbLg
LsbRsLoLsLsmmbLiLsbLgLsbLebLoLsLsmmbLcLsLeLsmbLgbRebRcRsRsRsmmmbRcbLeb
LgLgbLsbRebReRsRsRsRsRgmmmmbLjbLgbReRsmbRsRsmbLeLgLgLsbLgLsbRsRsLsmbLg
RsbLcLhLsLeLgbLiLsLsmbLcLsRsmbLgbLgbRsbLcLibLcLsLembLibLoLebLgbsbLsbLs
bLgbRibRebRibLcLsmbLibRgLsLsLsLsLsmmmmbLgLsRsbRjRebRgRsmbLcbLgLsLsmbRe
bRsbLhRsLibRsbLgbLsbLibLgbLibLcbRhbRsbRsRsmbRsRsRsmmbsbLjbLgLsbsbLcLsL
smmbLjbLibRjbRsbRsRsRsRsRsRsRsmmmmmmbRgbRiLsbRgRsLsmbRibRgbRhbRgbLgbsb
LsLsmbLsLsmbLsbLobLsbRsbRhbLsbLsbLiLsbLgbLsbRgbLibLgbLcbLeLsbLgbRgbLcb
sbLgbLsbLgbLsbLsbLsbLsbLebRjbRhRsmbRibRoLsLgbsbLiLsbLgbLobRgbRgRsRsmmb
RgbRjbRgLsbsbRebRsbRcbRsbsbReRsmbRebLcbLgbLhbLgbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 161813; End: 162319;
Recording: 5-1; Individual: 42; Drug: PCAP814 1 然 Apo 50 然
bLsRsbLsbLebLhbLiLiLsbLsLsmbLsbLsbLsbLsbLsLsmbLsbLsbLsLsmbLsbLsbLsLsmb
LsbLsbLsLsmbLgLsLgbLiLgbRsLsbsbLsLgbLsbLsbLsbLsRsRsRsmmbLsbLsbLsbLsbRs
bLsbLgbLsbLsRsbRiRcbRebRsRibLsbRsbRsbLsbRcRsmbRiRsRgmbRsbLsbsbRgbRebRs
bRsbRiRsmbRgRibRgRsLsmbRgbRiRibRgRibRiRcRsmbRiRgRibRibRsbRsbRsbsbRibsb
sbLgbsbsbLsbsbsbRsbsbRsbsbRsbRsbLsbRsRsmbRsbsbLsbsbLgLsbRsbLsbLsbLgbLs
bRsLsbRsbLsRsbLsbsbLsLsmbRsbsbsbsbsbsbsbsbsbsbsbsbsbLsbLsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 161813; End: 162319;
Recording: 5-1; Individual: 43; Drug: Control Apo 50 然
bsbRsLsbLsRsbRsLsbRsbRsbLsbRibRgbRibRiRgbRcbLsbsbLsLsmbRsbLsbLsRsbRsbs
bRsbsbsbLgRsLsbRsRsmbRiLsLsLsmmbLsbLoLsRsmbLsLgLsbsbLobLsbLsLsmbRsbsbs
bsbLcbRjbLsbRibsbsbRcbLsbRsbRsbRgbRsLsbLiLsbLibLibLibLebRcbsbsbRsbLeLs
bLsbLsLsLembLibRsbRebRgbLgbLibLibRibLgbLsLsmbLgbLibLgbLiRsbLgbLiLsbLgL
gbLeLgbLibLsLhbRsbLebLsLiLsbLobLjbRgbLibRgLsRsRsmbRgbRsbLsbsbsbRobRsbs
bRgRsmbLsbRgbsbRsLsRsbRsbRcbRsbRsbRebRobRsbRibLsbRsRsmbLsbsbLsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 161813; End: 162319;
Recording: 5-1; Individual: 44; Drug: Control Apo 50 然
bLsLsLiLsLgmbLgLgbLsLsmbLgbLsLgbLgbLgbLsRsbRsbLsbLsbLsbRcbRgRsmbRsRsmb
RcbRsLsbLebLiLsbLsbRgbRoLsbRsLsbRibRgbRgbLeLhLsbLibLibLhRsLsbLhLsLsmbL
ibLhbsbLhLsbLgbLcbLeLsbLoLsRsmbLgbRhRiRsmbRcbRibRgbRebRebLsRgbLjbRebRc
bLgbRjbReRsmbRebRgbRiRibRgbRsbRcRsmbLibRsbRobRibLsbsbLobLibLebLiLsLsmb
LgLsLsmbLibLebLibLsbLgLsbLibRsbRoRsRsmmbRgbRgLsbRobLcbRsbRgbRgRsLsmbRg
bLsbRjbRcbRobRgbRgbRgbRgbRgbRgbLibRhbRsbRjLsbRgbRiRsmbRgRsmbRibRibRsbL
gbLsbLhbRgbRgbRcbRsRgbRibRibRiRgRsRsRsmmmbRgbRgbLsbLibLibLgLsbLsbLgbRe
bRsRhbRsRibsbLgbsbLsLsmbLgbRcbRiLsbRgbRgbLsbRsbRibRgbLsbRsbsbRibRgbRgb
RgbLgbRcLsbRgbRgbRgbRobRsbLibLsbLgLsbLsLsmbLsbLibRibRsbRcbRibRibRgbRgL
sbRibLjbLhLsbLibLibLgLsLsmbLsLsmbLsbRoRsmbRsRsRsmmbsbRgbRgbRgLsbRgbRgb
RjbRsbLsbRgbRgRsmbRibsbRiLsbRhbLibLsbRobRobLsbLsbRibRsbRgbsbRgRgbRsbRg
bLsbRsRsmbsbLjbLebLhbsbRobRhbsbLsLsLimbLgbLgbLibLebLebsbsbsbsbsbRjbLeb
LebLsbLgbLgLgbLgbsbLsbLsbLsbLsbRhbRsbRsLsbLhbLjbLsbRsLsbRibsbsbLsbLsbR
sbLsLsmbRgbsbsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 161813; End: 162319;
Recording: 5-1; Individual: 45; Drug: Control Apo 50 然
bRsRsRsRsRsmmmmbRebRgRsmbRgRsmbLjbLcLsmbLibLoLsRsmbLibLjLsLsmmbLhbLsLs
mbRcbRcbLgbRobRcRsmbLobLebLoRsRsmbLibLgLsLgLsLeRsbLeRsbLibLiLsbLebLhLs
bLsbRsbLebLebLgLeLsbLibRgbRjbRiLsbRibRobLcLsmbLibRiRsmbRgRsRsRsmmmbRib
RebLgbLsLsmbLoLsmbLeLsLsmbLgLsbLhRsbLibLsLsmbLebLgbLebLebLibLiLsbLhbLo
bLibLcbLhbLgLsLsmbLiLsbLibLiLsbLiLsbLiLsbLgRsbLebLiLsbLiLsLgbLeLsbLgbR
obRibRobRibRgbRhbRebRibRcbRobRibRibRgRsmbsbReRsmbReRsReRsmmbRiRsRsmmbR
gbRibReRsmbRgRibRsRebLsRsRsmbLoLsmbLeLsbLhbLibLgbLcbRsbLsbRsbRsbLsbLsL
smbLiLsbLebRebRibRibRibLgbLsbReRsRsmmbRgReLsbRiRsLsmbLsRiRgRsRsRsmmmbR
hRsmbLgbRsRsmbRsRsRsRsmmmbRiRsmbRgbRgbRgbRibLibLjbLhbLibLhbLgLsbLcbLob
LcbRhRsRsmmbRiRsRsmmbRebLgbRjbRgbRibRebLibRiRgbRhRsRsmmbRiRsRsmmbReRsm
bRoRsmbRebRhRsmbRiRsmbLsRsRsmbRiRsRsmmbRgRsmbRgRsRsRsRgmmmbRebRibRsbRs
RibRgbRsRsRsRsmmmbRiRsRgRgmbRsbRsbRsbRsbLoLsRsmbLjbLsbsbsbLibLiLgbRsLs
bsbRgbRobsbsbReRsmbRcbLgbsbRebRgbLsbRhRsRgmbRebRsbRgbRebRsRsmbRibRsbRi
bLsRsbRebRgbRsbRgbRsbRsbRsbRgbRsbRebLsRsbRibRsRsmbRsRsRsmmbRgbRibRsRgR
gbRgbRibRsbsbRgbsbLjbRsbRjbRsRsRsmmbRebRsbsbRgRsmbLjbLsbsbsbRgbRgRsmbR
sRsmbsbRgbRiRsmbRsbRibRgbRsRsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 161813; End: 162319;
Recording: 5-1; Individual: 46; Drug: Control Apo 50 然
bRgRsmbRibRiRsmbRgbRibRiRsmbRsbRibRibRibRsbLcbLhbRsbRcRsmbRgRsmbRibRgb
RibRibRsbRebRgbRibRsbLjbRsbRjbRhbRgRsmbRhbLsbRsLibRhbRjbRibRjbLiRsbRgR
smbsbLibRibRjbRcRsmbRcRsmbRgbRiRsmbRcbRhbRcRsRsRsmmmbRgbRiRsLsmbLsbRsb
RibRjRsmbsbRsLsbsbsbLsbLsLsmbLsbRsbRjbLsbRjbRsbRibRgbRibsb

>ZF Recording 2016-06-02; tW: 300s; Start: 161813; End: 162319;
Recording: 5-1; Individual: 47; Drug: Control Apo 50 然
bRgbRobsbLibRibRgbRhbRgRsmbLsRsbRiRsRsRsRsmmmmbReRsmbRoRsmbLibRiRsmbRc
RsmbLjbRjRsmbLsbRsbLcbRjbRhRsRsRsmmmbLjLsLsLcLsmmmbRgRsmbRjbLeLsbLsLsL
smmbRjbLibLgbReRsmbReRsmbRsRsmbRsRsRsmmbRsLsbRiRsmbLcbRobRcbRsbLiLsRsb
LiLsLsmbRsbLgbRsbRebLibLiLsbLgbLgRsbsbsbsbsbsbsbLsRjbLobRebRgbRsbRgbRi
bLobRjbsbLiLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 161813; End: 162319;
Recording: 5-1; Individual: 48; Drug: Control Apo 50 然
bLjbRobLebRebRebLjbRobLebLjbLobRebLjbRebRobRobRebRcbRobLobLobRsbLobRcb
RebLebRobRobRjbLobRjbLobRobRobLobRobRobLobLebLebLobRsbLebRsbRjbLebRsbL
ebRcbLcbRjbLjbRebRebRobRcbLebLobRobRebRobLebRsbRobLobLjbLobLobRebLebLe
bRcbRobRobRebRobRjbRjbLjbRebLebLsbLebLebRobLjbLobLobRebLobRjbLobRebRcb
LobRjbRjbLobRebLobLjbRebRobRobLjbLobLebRobLcbRobLobRjbLebLjbLebLobLjbL
ebRebLcbLebLebLebLjbRobRobLebRcbLjbRjbRsbLebLebLjbRgbRobLobRcbLcbLebRe
bLobRjbLebLebLjbRjbRebLobRjbRjbLobRebRjbRobLobRcbRobLjbLsbLebLebRebLsb
RjbRobRjbRjbRobLjbRcbLebLebLobRobRsbRebLebLobRcbLobRobRebRjbLobRebRobR
ebRcbLebLebLjbLebLjbLebRebLjbLobRebRobLebRobRobRjbRsbLjbLobLibLsbRobLs
bLobRobRebRibLebRobLobLebLobLobLsbRobLobLebLjbLebLjbLcbLebLobLebLobRcb
RobLobRobLobLebRebLobLobLjbLobRobLjbLobRjbLebRobLebRobLcbLobRebRobRobL
sbLobRibRjbLebRjbRobRobLobRebLobRebLjbRcbRobLjbRobLjbLsbRobLobRjbLobLi
bLobLjbRobRobLjbLjbLobLcbLebLcbLjbLobLobLjbLobLsbRsbRcbRobLcbRebLebRjb
LobLebLobRobRobLcbLsbRjbLjbLcbRebRebLebLjbRobLebLobLebLobRjbLcbLebRobR
jbLcbLobLobLjbLobRobRibLebLcbRjbLobLebLjbLjbLobLebRobRjbRobLobLjbRobRo
bLobRjbLobLjbLebRobRobLcbLjbRjbLobLjbRebRjbLcbRobLsbRobRcbRobLobRcbRjb
LobRjbRobLebRobRobLsbLobRobLobLebRobRobLobRsbLobLobRobLcbLcbRobLobLebR
ebLjbLcbRebRebRobLebRobLcbLobRobRebRebLobRobRobLcbLsbRebRsbRebRcbLobRo
bLebRobRobLobLjbLebLebRobLcbRjbRobRebRjbLebRebRcbRjbRcbLebLjbRobRebReb
LobLobLobRebRcbRebLjbLebRobLobLobLebRebLsbRebLjbRebRjbRjbRobRcbLobRobL
jbLjbLobRjbLebLobRjbRobRcbRobRobLjbRebRjbLjbRobLebRsbRcbRebRebRjbRobLj
bLebRobLjbLjbRcbLebLcbRobRobLebLcbRcbRebLcbLjbRcbLjbLobRobRjbRobLobRob
RobLebLobRobRobRhbLcbRobLebLobLjbRobLcbRsbLjbLobRobLobLebLgbLebRcbRsbR
ebLobLobLobRebLcbLebLobRobLobLibRebLcbRobRobLcbLobRobLcbRobRsbLcbRebRo
bRebLobRobRebRobLobLebLobRcbLobLobRcbRcbLebRobLgbRebLobRgbLobLobRibLeb
RcbLebRobLibRsbLibRobRobLibLcbRibRcbRobLgbRobRobLobRebLcbLobLebLcbLobR
cbRcbLobRobLebRobLibRobLobLcbRebRgbLebLobLjbLebLcbRobRebLebLebLobLebRi
bLgbLebRebLobLsbRobLebRibLcbRobLobLobLhbRcbLcbLgbLobRcbLibRobRobRibLob
RobLebLobRebRebLibRobRhbLebLebRobLsbLobRobLobRobRobRebRcbLhbLobLcbRobL
ebLobRebRobRobLobLcbRhbRhbRobLebLebLhbRobRgbLobRobLcbLebLobRsbLebRcbRe
bLcbRobLebRhbLcbRhbLibRobRobRobLjbRobLhbRobRebLobRebLobRebLibRobLsbLeb
LibLobLcbLibLhbRibLobLobLsbRobLcbLobLobRebRobRhbRibLobLcbLgbLcbRsbRebR
cbLobLobLobRobLobLebLobRgbLcbRobLcbRgbLhbLibLcbRebRcbLobRsbRcbLibRobLc
bRebLobRobRebLebRcbRobRobLebRobRebLebRgbRobLebLcbLcbLibLibRjbLebLjbLib
LebLebRcbLobLobLobRcbLebLobRebRebRobRgbRebLcbRobLebRobRobLcbRibLobRobL
cbLcbLgbLobRobLcbRobRebRcbRobRcbLibLebLobRgbRobRibLhbLcbRibLobRibLobLg
bRcbRobRebLsbRibRsbLobLobRibLebLobRobRobRobLobLobRcbRcbLobLobLobLobRib
RgbLebLobLcbRebRebRobRobRcbLebRgbLebRgbLsbLcbLobLobLcbRgbLobLebLobLcbL
obLcbRcbRobRobRobLobRobLebRcbLobRobLobLebRobRcbRobLobLibRsbLhbRobLobRo
bLsbLcbLobRebLebLebRobLobRebRhbLobRobLebLhbRgbRcbLsbLebLgbLcbRcbLobLgb
LcbLebLobRcbRobRebRcbRsbRcbLebLobLcbRibRibRibLebLobLobRgbRebRsbRgbLgbL
obLibRebRgbLobLibLobLobRobLgbLobLobRobRcbLcbRobRebRobRobRobRobRhbRebLe
bRobLebRcbRcbRebRebRebRibRibLobRobRobLobRcbLebLhbRcbLibRobLobRibRobLhb
RebLjbLobLcbLobRobRobRobLcbRgbLebRibLobRobLibRobRobRsbLibRebRobLobLobL
ebLobLobRobRgbLobLobRobRebLebRobRhbReb

>ZF Recording 2016-06-02; tW: 300s; Start: 162321; End: 162831;
Recording: 6-1; Individual: 1; Drug: PCAP814 10 然 Apo 50 然
bLsbRsbLsbRsbsbLsbLsRsbLsbRsbLsbLsLsLsmmbLgbsbRsbsbsbLsbRsbsbsbsbLsbsb
sbsbLsbLsbsbLsbsbsbsbLsbsbsbsbsbsbRsbsbsbLsbLsbsbsbRsbsbsbsbsbRsbRsbsb
sbRsbRsbRsbsbRsbsbsbsbsbsbsbsbLsbRsbsbRsbsbLsbRsbsbsbsbsbsbRsbsbsbsbsb
sbsbLsbsbRsbsbRsbsbsbRsLsbsbsbsbsbLsbsbsbsbsbsbsbRsbsbsbsbsbsbRsbsbsbL
sbLsbRsbRsbsbsbLsRsbsbsbsbRsRsmbRsbRsbLsbsbLsbsbRsbsbLsbsbLsbsbsbRsLsb
LsLsmbsbLsbsbRsbsbLsbsbLsbsbsbLsbsbsbRsbsbsbLsbRsbsbsbsbRsbLsbsbLsbsbs
bsbsbsbsbRsbsbsbLsbRsbsbsbLsRsbsbsbsbsbsbRsLsbLsbsbsbsbsbsbRsbRsLsbsbR
sbLsbsbsbsbLsbRsbsbLsbsbLsbsbsbRsbsbLsbRsbsbsbRsbsbsbsbLsbsbsbsbsbsbsb
sbLgbLsbLebRsbReRsmbLiRsRsmbRsbLsbRsbRgbLgbRgbReLsbRiRgbRebRsbRsbRsbRg
bRsRsRsmmb

>ZF Recording 2016-06-02; tW: 300s; Start: 162321; End: 162831;
Recording: 6-1; Individual: 2; Drug: PCAP814 10 然 Apo 50 然
bsbRjbsbsbsbLsbLsbRsbsbsbRsbsbLsbLsbLsbLsbLsbRsbRsbRsbLsbRsLsbRsbLobsb
RsRsmbsbLsbRsLsbRsbRsbsbsbsbRsbLsbRsRsmbRsRgRsmbLsbRsbLsLsmbRgbRgRsmbR
sbLsRsbRsRsmbRsRgbLsRjb

>ZF Recording 2016-06-02; tW: 300s; Start: 162321; End: 162831;
Recording: 6-1; Individual: 3; Drug: PCAP814 10 然 Apo 50 然
bLsbRsbsbsbLsbsbsbLsRsbsbsbsbsbRsbLsRsbsbRsRsmbRsbsbRsbRsbRgRsLsmbRgbR
cbLebLcbLsLsmbLgLibLeLsbRcbRsbsbLsbRsRsmbLsRsbRsbRibRgbRsbsbLgbLsLgLgR
sbLsLgbLgbLebLebRebLgbLsLsmbLjbRibLgbLgbLsLsLsmmbRsbRgbRgbLsbLebRibsbL
sbLsbRsLsbLsLsLsmmbLsbRsbLsLsmbsbLsbLsbLsLgRobLsbRibRebRgRgbsbsbsbLsbs
bLsbsbLsbLsbLgbLsbLgbRsbRsbLsbLebLsbLobsbLsbLsbLsbLibLsLsLsmmbsbRsbLsb
LsbLsbLsbLsbsbLgbLibLobRgbRsbRhRsmbsbsbLsbsbLsbLsbsbRsLsbsbsbsbLsbsbsb
sbsbLsbLsLsLsmmbLsbLsLsmbLsbLsLsLsmmbLgbLibLeLsbRhLsbsbsbRhbRsbsbRsbsb
RjbRsLebLebLcbLsLsmbRgbLibRobRsbLebRsRsRiRsmmbLsbRebLsbLsbLsbRsbRgbLsb
LsLsmbLsbRsbRgbLsbLsbLgbLsbLsbLsbLsbRsbLsbLsbRsbLgbRgbLgbLsbLiLgLsbLgb
LsLsmbsbLsbLjRibLcbReLhbLsbLgbLsbLsbLsbLgbRsbLsbRgbRibRebRsbRebLsbRebR
eRsmbsbLsbRebLsbRsRsmbRsRhbRgbRebRgRsRsmmbRsbLiRsRiRebsbRebLhbLebRsbRc
bLobRgbRhRiRsmbLsbLsbLsbLsbLsbRgbRsbLebRgRgbRibLiLiLsLsmbLsbLsbRsbsbRe
RgbLgbRsRsmbRibRsbLgbLgbLgLsbLobsbRgbLsbRsRsmbRgbRsbRibRsbRgbRsbRsbRsb
RsRsRgmbRsbLsLsLsLsmmmbLsLsmbLsLgbLibLhLsbLsbLsbLsbLcbRgbRibRsbRgbRsbL
sLsmbLsbRsLsLsLsRsLsmmbRsbLgLebRibRobRsLgbLsLgbLiLsLsLsmmbLsLsLsLgmmbR
sRsmbLsLsLsmmbLsLsLsmmbLsbLsLsmbLsbLgLsbLsbLsbLsLsLsmmbRsLsLsLsmmbLsLs
mbLgbRobRsbRjbRgbLjbRcbLibLibLsbLibLsRsbLsbRsbRobRobLgbLebLsbRgbRsRsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 162321; End: 162831;
Recording: 6-1; Individual: 4; Drug: PCAP814 10 然 Apo 50 然
bRsLsLsmbLsbLsbsbsbsbsbsbsbRsbRsbLgbRsbsbRsbLsbRsbsbsbRsbLsbsbsbsbsbRs
LsbLsbsbRsbLsbLsbsbLsbsbRsbLsLsRsmbLsbsbRsbLsLsmbLsbLsRsbRsbRsbRsbLsbR
sbLsbLgbLgbRsRsmbsbsbLsbsbsbRsbRsbLsbLjbLsbRgRsmbRsbRsbRsbLsbLcbLsbsbs
b

>ZF Recording 2016-06-02; tW: 300s; Start: 162321; End: 162831;
Recording: 6-1; Individual: 5; Drug: PCAP814 10 然 Apo 50 然
bRsbsbsbsbsbsbsbsbsbsbsbsbRjbLsbRsbsbsbsbLjbRsbRgbRebRsLsbsbsbRsbRgbRs
bRsbLsbRsRsLsmbLsbLsLsmbsbsbRgbsbLsLsLsLsLsLsmmmmmbLsbLgbLsbLsbsbLsbLs
LsmbLsLsLsLsmmmbRsbsbsbLsbsbLsbLsbLobRsbRiRsmbRgReRgbRgRsmbRgRibRgRsmb
RiLsbRhbLgbLhLsbRebRgbRgLsbRgbRhRsmbLsRsbRgbRibLsbRsRsRsmmbRgLsRsRsRsm
mbLsRsLsRsRsRgLsLsRsmmbRgbLsbLgbRjbsbRgRsRsmmbRsRsmbRgbRiRsmbLjbRsbLiR
ebRiRsRsRsRsmmmmbRjbRiRgRsRsmmbsbsbsbLsbRgbLsbLsbRsbRsbLsbLsbLsbLsbRsR
smbsbLsbRsbsbRsLsbLsLsmbRsRsLsRsLsmbLsbRsbsbLsbRsbLsbRsbLsbsbRsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 162321; End: 162831;
Recording: 6-1; Individual: 6; Drug: PCAP814 10 然 Apo 50 然
bLsbLgbLgbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 162321; End: 162831;
Recording: 6-1; Individual: 7; Drug: PCAP814 3 然 Apo 50 然
bLsRsbsbLsLsmbsbLsbLsbsbRsbsbsbsbsbLsbLsbRsbsbLsbLsbLgbsbsbLsbsbRsLsbL
hbsbsbRsbsbRsbRsbRsbLsLsmbsbsbLsbLgbLgbsbLsbRsbLsbLsRsbLsLsRsmbRsbLgbs
bLgRsbLsbsbLsbLgbsbLsbLsbLjbLsbLsbRsbRsbRsbLgbLsbRsbLgRsbsbsbLsbRsbLiL
sbRsbLsbRsbLsbsbLgbLsbLsbLsbLgbsbsbsbLgLsbsbsbRsbLsRsRsmbRsbLsbRsbLsbL
gbLsbLgbLsbLsbLsbRsLsbRsbsbRsbRsLgLsbLsbLgbLsbLgbsbLsbsbsbLsbLgLsbLsRs
bLsbLsLsmbLsbLsLsmbLgbLsbLsLsmbLgbLsbLgbLgbLsLsmbLoRsRsmbRsbLsbsbsbsbR
gbRsbRgbRsRsmbLsbRsbRgRsmbRsbRsbRsRgbRgbRsbRgbRsLsbRsRsmbRibRibLibLsLo
RsbRsbLgbLsbLsLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 162321; End: 162831;
Recording: 6-1; Individual: 8; Drug: PCAP814 3 然 Apo 50 然
bRsbLsbLsLsmbRsbLsbsbsbLsbLsLsmbLsbLsbLsbsbRebRsbsbLsRsbLsRsRsmbLsbRsb
sbRsbsbLjbsbLsbsbsbsbLsRsbRsbLsbLjbLsbsbsbRsbRsbsbLsbsbRsbsbsbsbsbsbLs
b

>ZF Recording 2016-06-02; tW: 300s; Start: 162321; End: 162831;
Recording: 6-1; Individual: 9; Drug: PCAP814 3 然 Apo 50 然
bLsbLgbLsbLsbLsbsbRsbRsbsbRsbRhbsbRsbLsRsbsbsbsbsbsbRsbsbLsbsbRobsbsbL
hbLibLibsbLibLiLibLibLibsbsbLgRsbLgbLiLsbLiLsbLhbLgbsbsbLsbRsbLsbLgbsb
LgLsbLgbLsRsbLjbRsbLsbLsbLibsbLsbRsLsLsmbsbLgbLsbLgbLgLsbsbLhLsbLiLsbL
gbsbLsbLgbLsbLgbLibLsbsbLgLsbLsbLgLsbLgbLsLsmbLgbLgbsbLsbLgbLgbLsLsmbL
ibLsLgbLjbRsbRsbLgbLgLsbLgLsbLsbLgbLsbLgbsbLgbLsLsmbLibLsbLgbRsbLgbLsb
RsbLgbLgbLsLsmbLgbLgLsbLgbLgbLsbRsLgbRsbLsbLgbLgLsbLgbsbLgbsbsbLgLsbsb
LgbLsLsmbLgLsbsbLgRsbLgbLgbLgLsbLsbLgbLgbLgbsbLsbLgLsbRsbLgbLgbLgbLgbL
gbRsLsbsbLsbLgbsbLgbLgbLsbLsbLgbLgbLhLebsbsbLibLsbLgbLgbsbLsbLsbLgLsbL
gbLgbLsbRsLgbsbLgbLgbLgbLgbLgbLsbLgbLsbLgbLgbLgbLsbLgbLgbLgLsbLgLsbLiL
sLsmbLsLsRsmbLgLsbLgLsbLsbLgbLgbLgbLgbLgbLgbLgbLgLsbLsbLcLsmbLcbRebRgb
RiRsmbRgbRjbLgbsbLgLsbLibLcbLgbLgbLgbLiLsbRobRgbRgbRcbLgLsLsmbRcbRgbRi
RhRsmbLgbRobRjRgbRsLsbRiRhbRiLsbRgbRiLsbRiRsmbRgRsmbRcbLsbLib

>ZF Recording 2016-06-02; tW: 300s; Start: 162321; End: 162831;
Recording: 6-1; Individual: 10; Drug: PCAP814 3 然 Apo 50 然
bLsbRsbLsbsbRobsbRsbLsbRsbsbLjbLsLsmbLsbLsbLsbsbLsbLebLobLgbLsbLsbsbLs
bsbLibRsbLsbLibLebLsbRsbLsbLibLsbRgbLgbLsbLsbLsRsbRsLsbLgLsbLsbRsbLsbL
gbLhLsbLsbLsbsbLgRsbRsbLcLsmbLgbRsbsbsbsbLsLsLsmmbRebRobsbRiRgbRgbRgRs
mbRgbLsbRsbRibRsbRsbRjRjbRgbReRsmbsbRgRsmbLcbsbRsbsbRcbsbRgbRsbsbRsbRi
bRsbRsbLobsbLibRgRsmbsbRsbRsRsRsRsRgmmmbRsRsmbRsbRsbRsbRsbLobLsbLjbLgL
sbLsbRsbRsbRsbRebRgRgbRsbRsRsmbsbRsRsRsmmbRgbRsbRgbRsRsRiRsRsmmmbRgRsm
bRsbRsRsRsRgmmbRsRsmbRsbRgRsLsmbRsbRsbRsRsRsmmbRgbRsRsmbRgbRgRibRebRgb
RsbRsRsmbRgRsmbRgbRgRgRsmbRsbRgbRgbRibRsRsmbRsbRsbRsRsRsRsRgmmmbRsRsmb
RgbRgbRgbRsRgbRgbRsRsRsRsRgRsmmmmbRgbRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 162321; End: 162831;
Recording: 6-1; Individual: 11; Drug: PCAP814 3 然 Apo 50 然
bsbLsbRibRsRsmbLsbRsbRsbRsbRjbRjbRgRgbRibRgbRsbLgbsbLjbLsLsmbsbsbRsbRs
RsmbRsbLsRsbRebRsbLsRjRsmbRsbRsbLsRsLsbLsbRsbRsbsbRjbsbLobRgbRsRsmbRsb
LsbRsRsLsmbRiLgbLsLsLsLsLsmmmmbRsbRsbLsbsbLsbLsbRibsbRjbRgbRjbRsbRsbLs
bLgbLsbRsLsbRgRsmbRsLsbRsLsRsRsRsRsRsLsmmmmbRsRsmbRsbRsbRsbRsRsRsmmbRs
bRsLsbRsbsbLobLobLcbLjLsmbsbLjLsmbsbLcbsbRsRsmbRsRsRsRsmmmbsbLgLsbRsRs
LsmbLsLsmbLebLsbLsLsmbLgbRsLsbRjbsbLsbRsbRsbRsLsLsmbLibLsRsbRgbLsbsbLs
bLgLsLsmbLsLiLsLsRsLsLsLsmmmbRsRsRsmmbsbRsbLsbsbLsbRsbsbsbLsbLsbRsLsbs
bsbLsbRsRsmbLsbRsbRjbRgRsmbRsRsRsRsmmmbRgbsbLibLsLsmbLsbLsbRgLsLsmbLsL
smbsbRibLgbLgLsbLsbsbRjbRjRsmbRsbLsLsLsLsRsmmmbRsbRsbLoRibRibRgbRiRsmb
RsRsRgmbRibRjRsRsmmbRgRsRsLsmmbLsLsmbLsLsRsLsmbRgbLiLgLsbRsRsRsRsmmmbL
sRsbLgbLsLsmbRhLsbLjLgLsbLjbLsbRcLsLsmbRebsbRsRsmbLsbRsRsmbRsbRsbRsbRj
bRsRsmbsbLsRsRsmbRsLsbsbLjLsmbLcbRgRgRsRsmmbRjbRebsb

>ZF Recording 2016-06-02; tW: 300s; Start: 162321; End: 162831;
Recording: 6-1; Individual: 12; Drug: PCAP814 3 然 Apo 50 然
bLsbRebsbLsbsbRgbLjbLsbRibsbsbsbLsbsbRsbsbLgbLibRjbsbRgLsbsbLgLsbLibLs
bLgbLcbsbLsRsbsbsbRiLsbLsbRjbsbRgbsbLgLsbLcbLhbRsbsbLjbsbsbRsbLgbLibLi
bsbsbLcbLsbsbLsbRjbRsbRibRgbRsbLibsbLcbsbRebRibsbLsbsbRibRgbLcbLcbsbsb
LsbLibsbsbsbRgbLjbLsLgLsbLcbLsLsmbRibLiLsbLgLsbLgbLiRsbsbRjbLsbLcLhbRg
bsbLjbLsbLibLgbLibLsbRsbRhbsbsbsbLsbLsLsmbLhbLcbRsbLsLsmbRgbRiRsmbRibs
bRsbRsRsmbRgLsbsbsbLgbRsbRgbsbsbLebLsbsbRgbsbLjbLhLsbLgbsbsbRgbsbLibLs
bsbRgbRcRsmbsbsbsbLcbRcbRsbRjbRsbRjbLsbsbLsbRobRsbRgLsbRsbLjbLsbsbLsbR
sLsbsbLsbLsbLgbRsbLgbsbRsbLibRsbLiLgbLsbLibRsLsbLgLsbLgbRjRcbRibRgbRgb
LsLibsbRsbRjbRjbsbRgbRsbRcbLgbLsbsbsbLcbLsbsbsbLcLsRsmbRsbsbLsRsbRsReb
RsbRsbRsbLibLiLsbRjbLobsbsbsbsbLcLsmbsbsbLobLsbRibsbRibRgLsbRebsbLsLsm
bLibLsLsmbLsbLhLsbsbLobsbRibsbLhbRsLsbLsLsLsLsmmmbRsRsmbsbRsbLsbLsbLsb
LcbRsLsRsRsmbLsbRjbRibRsLsbRgbRcbLsRsbsbRibRsbLsbLiLsbLiLsbRcbRibLsbsb
RjbLsRsbRgbRiLsbRsbsbLcbLgbLgbLsLibLsLsmbLcbRgbsbLsbRsbsbsbLibLebsbsbL
obRibRibRsbLsbsbRsbRhbLsbLhbRgbRibLjbLsLsmbLibLsbLibLjbLsbLibLcRgbsbLh
LsbRsbLsbRsbLibLsbLsbsbsbsbRgbLgbLcbRsbRgbRibRjbRsbRsbsbLsbLhbsbsbRjRs
mbsbRgLsbRsLsbLhLsLsmbRgbRcbsbRgbLcbRsbsbLcbLjbLgLsbRsbRcbLibLcbLgRsbL
sbRcbRgbRoLsbRjLsbRiRoLsbLibRjbRibRgbRibRibRsbLoLsmbLcLibRgbRsLsbRebLs
bRcbLgbLibLsbLiLjbRsbLgbLhRsbRsbRibRjbRibRgLsbRsLsLsmbRcbRsLsbLsbRsbRs
bRcLsbLgbLcbLsLsLgmbLgbLiLsbLjbRgbLsbLgbLhbRsbRebRsbLsbRjRsmbRiLsbRhbR
ebLgLsbLgbLgRsbLiLsbLibRsRsLsmbLcbRebRgRsmbRgRgbRgLsbLsbRibRiRsLsmbLsb
RhbLcbLeLsbLjbLiLsLsmbLhbLsbLsbLjbRiRjRebLgbRebLibRjbLibLsbLhLsbLcbRiR
ibRebLeLsbsbRebRoLsbLobLcLsLsmmbRgbRcbLsLibLobLgLgLsbsbRcbLgLsbLgLsbLi
LsLsmbRgLsLsmbLiLsbLsbLsLsLsmmbRobRibRibReb

>ZF Recording 2016-06-02; tW: 300s; Start: 162321; End: 162831;
Recording: 6-1; Individual: 13; Drug: PCAP814 1 然 Apo 50 然
bRsbRsbsbsbLsbRsRsRsmmbLsbRsRsmbRsbRsbRsRsRsmmbRsRsRsRsmmmbRsRsmbRsbRs
bsbsbsbsbsbsbsbsbsbLsRsbsbsbsbsbsbRsbRsbsbRsbRsbRsbRsbRsbRsbRsbsbRsRsm
bRsbRsbRsLsbLsbRsbRsbRsRsmbRibRsRsmbRsRsRsRsLsmmmbRsRsRsmmbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 162321; End: 162831;
Recording: 6-1; Individual: 14; Drug: PCAP814 1 然 Apo 50 然
bRsbRsbRgbRgbRsRsmbRsbRgbLsbRjbRsRgbRgbLsbLsbRsbRsbRgbRsbRgbRgbsbRgRsR
smmbRsRsmbRgRsmbRsbRibLsRsbLsbRgbsbsbRgbsbRgbRgbRgbRgbRgbRsbRgbRsbRsbL
sbRsbRgbRsbRsbRsbRsbRsbRebRsbRsbsbsbsbLsbsbRgbRgRsmbRsbRsbRsbRsbRibLsb
RiRsRsmmbRsRsmbRgbRsbRsRsmbRsbRsbRsbRsbLsbRgbRgbRsRsRsmmbRgbsbRgbRsbRg
bRsbLsbRsRsmbRsbRgbsbRsbRgbRjbRsRsmbLebRsRsmbLsbRibRsbRgbLsRsbsbRcbRsR
smbRsbRsbRcbsbRsbsbsbLsbRgLsRsRsRimbsbsbLsbsbRsbRsRgbRibsbRgbRgRsmbRib
sbRgbRsRsmbRsbLsbRsbLsbRsbRsbRgbRsbRjbRsRsmbRsbRsRsmbRibRgbRobRcbRjbRj
RiLsbRgbRibRsbsbsbRiLsLsmbsbLcbLgbsbLsbLibsbRgbRebRsbRsbsbRsbsbsbRsbRs
bLsbsbRsbsbsbRsLsbsbRgRsmbRobLcbRebRsRsmbLiRgbRgbRsbRsbRsbsbsbsbRsbRsb
RgbRsbsbRsbRsbRgbRsbsbLsbRsbRsbRsbRgbRibLsbRsRsmbRgbRgbRgbRgbRgbRgbRgb
RsbRsbRibRgRsmbRgbRgbRgbRgbRgbRgbRgbRsbRgbRgbRiRsmbRgRsmbRgbRgbsbRgbRs
bRsbRsbRgRsmbRsbRgbRgbRsbRsbRgbLsRsbsbRgbRgbsbRibRcbsbRibRsRsmbLsRgbRi
bRibRsRsmbRiRgRsmbRgbRsbRsRsmbRibRsbRgbRsbRsRsmbRgbRgbRsbsbRjbLsbRsbRs
bRsbRgbRgbRgbRgbRgbsbsbsbRsRsmbRgbsbRsbRgRsmbRgbRibLobRibRgRsmbRgRsmbR
gbRgRsmbRsRsmbRiRsmbRgRsmbRiRgbRcbRgbRibRcbReRsmbRgbRibRoLsLsLsmmbLgLs
bRobRcRsmbRsbLjbLcLiLhLsbLjbLeLebLebLebLebLcbLebLebRoRsmbRibRgbRcRsmbR
gbRcRsmbLiLibLoLsmbLibLibLcbLgbRgbLgLsbLibLgLsLibLgbLibLcbLgRibLjbLgbL
sLsmbRibLcbRcRsmbsbRgbRsbRgbRgbRgbLsRsbRgRsmbRgRsmbRgbRsRsmbRsbRgRsmbL
obLhbLcLsmbLsbRsbLibLgbLibsbRcbRhbLsbRsbRgbRgRsRsmmbRgbRsRsRsRsRsmmmmb
RgbRcbRsbRibRiRsmbLjbLcbLhbLcLsmbLiRsbLibLhbLibLiLsbLgbLibLsLsRsmbLgbR
sbRhbRibRsbLsbRgbRgRsmbRgbRsRgbRgbRsRsRsRsmmmbRgRsmbRiRsmbRsRsmbRsRsmb
RgbRhRsmbRcbRgbRiRsmbReRsmbRcbRcbRoRsmbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 162321; End: 162831;
Recording: 6-1; Individual: 15; Drug: PCAP814 1 然 Apo 50 然
bRjbRgbRsbLgbLsbRiRsmbsbRibsbsbRcbsbLibLgLsbRibRgbRgbRsbRsbRsbRsRsmbRg
RsRsmmbRsRsmbRsbsbsbLjbRsbRgRsRgmbLibLgbLebLgLsbLsLsLsmmbRsbRibsbsbsbs
bRgRsmbRjRsRimbRibLsbLsbLeLsbLibLgbLgbRsbLgbLsbRsLsbsbRcbRibRsbRsRsmbL
sbLgLsLsLsLgmmbLsLsmbLgbLsLsmbsbLsbLsLsmbLiRsbLgbLgbLgbRsbRsLsLsmbsbLj
bLibLsbLsbLsbLsLsLsmmbLgbRsbRsbRsbRsRgRsRsmmbRibLsbRsbsbsbRsbRsRgbLebs
bsbsbsbsbRsbRgRsmbRsRsmbRsRsRsmmbsbRsbLsbLsbRsLsbRsbRibLiLsbLsbLgbsbsb
sbRjbRgRsmbRgbRiRsRgmbLgLgbRsbRgbRsbsbsbRsbLebLgbLsRsbRsbLsbLsLsLsmmbL
sbLsbLsLsLsLgmmbLgLsbLgLsLgLsbLgLsLsLsmmbLiLsbLsRsbRibLsbLhLsbRhbReRsm
bRiRsmbLsbRiRgbReRsRsLsmmbLeLsRsbRsbsbLsbRsRsRsmmbRcRibsbRsRsRsLsmmbLs
bRiRsRgRsmmbRsRsRsRemmbRiRsLsmbRsbLiLsbLsbLiLsLsmbsbLsbLsLsmbLsLsmbLsb
LsLsmbLsLsmbLsLsLsLsmmmbLsLsLembLiLsbRjbRiRsRsRsRsmmmmbRgRsmbLsbRhRsmb
RiRiRsRsmmbLibLgbLsLcbRgbLibRcRsmbRebsbRiRsRsRsRsRsmmmmmbRsRsRimbLsRsR
smbRiLsLsmbRgbRsRsmbRjRsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 162321; End: 162831;
Recording: 6-1; Individual: 16; Drug: PCAP814 1 然 Apo 50 然
b

>ZF Recording 2016-06-02; tW: 300s; Start: 162321; End: 162831;
Recording: 6-1; Individual: 17; Drug: PCAP814 1 然 Apo 50 然
bRsbsbRgbsbLibRsbsbRsbRsbRgRsmbsbRgbRsbsbRsbRsbRibRsRsmbRoLsbLoRsLsLsm
bLibsbLiLsbLgbRsbLsbLgbLgLsLsmbRsbLgbLgbsbLgLsbLgbLsbLsbRgbsbLsbLsLibs
bLsbLhbLsbsbLgLsLsmbLibsbLjbLsbsbLcbRsbRsLgbRsbRsbLsbLsbLsbLsRsbLsLgbs
bLsLjbLhbsbLgLiLibLibLsbLsLsLiLsmbLgbLgbLgLibLjbLsbLgbLgbsbsbRsLsbLiLg
bLsRsbLgbLsbLsbLgLsbLgRsLsLiLeRsbLgbLeLsbLgbLibLsbLibLgLsbLsbLgbLsbLgb
LibLgbLsbLgbLsLgbLeRsbLgLsbRsbLjbLsLsLsLgmmbLibsbRibLibRsbLsbRsLsbLsbs
bLsbRsbLgbLsbLsbLibLgRsbRsbLgbsbsbLsbLsbLibsbsbsbLgbLebLeLibsbLiRsbLiL
gbLibLsLeLebLhbLgLsbRgbRebLjbLebLgbLibLebLebLgbLsbsbRgRsmbRsbLsbLsbLjb
LgbLhbLgbLhLsLsmbRjbRgLsLsmbLgbLiLibLgbsbLiLebLsbLhLiLsbLgbRsLgbLibLib
LsLsmbLibLsbLsLsmbLgLibsbLcbRsbsbRsbRsbsbsbRjbsbLgbRsbLsRsbRsLgbLgbLhL
gbLsbLebLibsbsbsbsbsbsbLgbRjbRgbLsLsmbLsbLgLsbLjbLgbLibLibsbLibLsbRibR
sbsbsbLjbRsbRebLsbsbLiLsbLibLgbLsbLhLibLhbsbLibsbsbLgbLsbsbRsbLgLsbRsb
RsbsbLsbsbLsbsbLibLgLsbLgbRjbRjbsbRobRgbLhRsbLsbLjbLgbLgbLsbsbsbLsbsbL
sbLsbLcbLcLsmbLcbLcLsmbLibLsbsbLibLgbLgbLibLgLiLebLebLibRsbLcbLsbsbsbL
jbRcRsmbRsbRiLsbRsRsmbRibRsReRsmbRibRcLsbRibsbRobLgbLebLcbLibLeLsbLiLs
LebRcbLcbLhbRcbRcbRgbRgbLsRibRgbLsLsmbsbLsbsbLsbRobLsLsmbLcLsLsmmbLcbR
hLsRsbLebLgLsLebLobLobLiLsbLgbLibLgbLgLgLebLgRsbRsbLibLiLsbRsLsbLsbLib
LgbLsLsmbLgLeLibLibLibLibLgbLsbRsLsbRsLsbLgbLgbLgRsbLibLgLsbLgbLiLsLsR
smbLcLcbLibLsLiLsbLgLeLibLgLsbLibLiLsbLgbLcbLcbRibLgbLgbLiLsLsmbRsbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 162321; End: 162831;
Recording: 6-1; Individual: 18; Drug: PCAP814 1 然 Apo 50 然
bsbLhbsbLgbsbRsbsbLjbLsbLjbRsbsbLgbLsbLgbLsbLcbRsbRsbLsbLcbLgbLsbLibRs
bRsRibsbRsbRsbRibRebRibRsbLsbLjbRibRcbRsbRgbsbLsbLgbsbLibLibLjbRsbLgbL
ibsbLgbRsbLjbRsbsbRcbRgbRebRcbRibLgbLhbLhbLsbLsbLgbsbLsbLsbLgbRsbLsbRj
bsbRsbLcLsmbLibLsLsmbRsbsbsbLgbLsLsmbLsbsbsbLjbLibLsLsmbLebLsbLgbLgbLc
bRsbLsbRiRsmbRgRsmbsbsbRsbRobLsbLsbRcbLsbRhbRsbsbLgbLgbLcbRibRsbsbLgbR
sbRgbLjbRhLsbLibLibLgbLgbRgbLsLsmbLjRsbRsbRsbsbRjbLgbLsRsLsbLsbLsLsmbR
sbsbLsbsbRsbLgbRsbLjbLjbRsbsbRsbRgbRcRsmbLsbLgbLgbLibRjbLibLjbLibLcbsb
LibRgbLgLibLcbLsbRobRobRsLsbRoRsLsmbRibRjRsmbLibRjbRgbLhbLjRsbLgbLjRsb
LsbLibLgbLgbRgbLibLgbRgbLsbLsRsRsmbLiRsbLibLcbRgbRcRsmbRibRiRsmbLsbRoL
gLsLsmbLcbLibLiLsbRsbLcbLgbLsbLcbLgbLgbsbLiLgbRgbRhbLjbLjbLjbLgbLibLcb
LgbLibLsLjLsmbLiRsLsbLsbLsbLibLgbRsLsbLibLibLibLgbLsbLiRsbLsRsbLibLgLs
bLgLsbLgbRjbRcbLjRsbLibLiRsbLibLcbRgbLhbLsbRsRsmbLibLgbLiLsbLiLsbLibLg
bLhbRobRcbRcbLhbLgbLgbLibLsbRcbLsRoRsmbRsbRobLgbRcbRiRsmbLiLsbRsLsLsLs
mmbLgLsbRsLsLsmbLhbLibLsbRobRgbLcRsbLiLsbLibsbLgbRjRsmbRhRsmbLsbRobLsR
sbLjbRoRsmbRsbRoRsmbLiRsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 162321; End: 162831;
Recording: 6-1; Individual: 19; Drug: Control Apo 50 然
bRgbRsbLsbLsLsmbRsbLsRsbRsbRgbRsbRsbRgbRsbRsRgbRsbRsRsmbLsRsbRsRsmbReb
RsRsRsmmbRibRcbReLsbsbLgbRjbRgbRgbRsbRsbRsbRhbRsbRgRsmbRgbReLsRsbRgbRg
bRsbRsbRgRsRgmbLjbRsRsmbRibRsRsmbLjRsbRgbRgbRebRobLsbsbRibsbRsbRgbRibR
sbRsRsmbLgbsbsbsbRgbsbsbsbsbsbsbLsbRcbRgbsbRcbRibRibRgbRsbsbRgbRibRgbs
bRebRgbRsbRibRsbRsbLobsbsbLgbLiLsbRhbLsbRsbLobsbLibLsbRibRjRsmbRjbRcLs
RsbRibsbRibRgbsbRhbRsbsbsbsbRsbsbLjbLibLsbRjbsbsbLhbLsbRsbLsbsbRjbLjLo
bLcRsbLibLsbLgbLsLsmbLgbRsbRsbRsbRsbLsbsbRsbRsLsbLsbsbsbsbsbsbLsbsbsbs
bsbsbsbsbsbsbsbLsbLgbRsLsbRsbLsLsLimbLsbLsbLsbRsbRsbLsRsbLsLgbRsbsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 162321; End: 162831;
Recording: 6-1; Individual: 20; Drug: Control Apo 50 然
bLsbsbLsbLgbRsbRjbLibLsbLjbsbLgbLsbRjbLgbRgbLsbRgbsbRsbLsbLgbRibsbLjbR
sbLgbRjbLibRhbRsbRgbRsbRsbsbRgbsbsbsbRsRsRsmmbLcbLsbRsbLsbLsbLsbLgbRsb
RsbRsbLgbLsbLsLsmbLjbRgbLsRsbRjbsbLhbLgbLebLcbLsLsmbRsbRjbRsbRibLgLsbL
jLjLsmbsbRsbLjLsmbLgbRjbRsLjbLsbLibRibLsbsbLjRsbLjbsbRsbRiRsmbRsbRjbsb
LibsbLsbsbRibRgbRibRibLsLjbRebLcRsbLibLcbLibLsRiRsmbLsLibLjLsmbLsLcbLs
bLhbLhbLibLgLsLsmbLgbLsbLibLobRibRsRsmbRsbsbRibRsRebRjbRsRsmbRgbLgRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 162321; End: 162831;
Recording: 6-1; Individual: 21; Drug: Control Apo 50 然
bLgbLibRgbRgbLgLsbLebLibRsbRsLsbReRsRgRsmmbRibRsbRebRgbRcbsbsbRgbsbLgb
sbsbLcbLsbRgLsbLgbLgLsbLjbRgbRsbRsRsmbLgbRibLsbsbRgbLibLgbLjbLgbLsLsmb
RibLhbLibLsbLgbLsLsLjmbLsbLhbRsbLsbLsbRgbRjbRgbRibsbRcbsbsbLobLhbLgbRc
bRibsbsbsbsbsbsbsbRiLsbLgbLjbLsbRgbsbsbsbsbLgbLsLsLsLsLgLsmmmbLgbLibLs
LsmbRsbLsbLsLsLimbLebLhbLsLebLgRsbRjbRhbRcbLsbLhbsbLgbsbRcbRgbLoLsmbLh
bLibLsbLgbLsbLcbLhbRebRgbsbsbRsbRsRsRsLsmmbLsbsbsbsbLsbLsbsbRjbRsbLgbL
sbRgbLsbLsbLebLsbLibsbLjbLsLsmbRhbLsbLsbsbRjbRgbRsbRhbsbRsRsmbRjLsbLob
LibLebLobLibLcbRcbRiLsbRibRobLcbRebLgLsbLiLsbLsLiLsbLjbLsLsmbRcbRjbRsb
LibLiLsbLiLsLsmbLibLsbLcbRgbRjbLsLsmbLgRsbLgLsLsLsmmbLhRsbRgbLsLsmbLgb
LcLsmbLgbRgbRebRhbLibLjbLiLgbRsLsLsLsmmbLsLibLsLsmbLsLsRsmbRjbLcLsRsmb
RobRgbLhLsbLiLsLsLsmmb

>ZF Recording 2016-06-02; tW: 300s; Start: 162321; End: 162831;
Recording: 6-1; Individual: 22; Drug: Control Apo 50 然
bRhbLsbRgbRgbRsbRsbRsbRsbRibRgbRsbRsLsbRgbRgRsmbRgbRsbRgbLgbRibRsbRsLs
bRgbsbRjbLsbsbLgbLsLsmbRjbLsbLsbLsRsLsbLjbRgbRjLsbRjbRgbRibRcbRgRsmbsb
RsbRsbRsbsbRgbRsbRsRsmbsbLsbRsbsbsbsbRsbLsbLsbsbsbLsbsbsbsbRsRsRsRsmmm
bRgRsmbRsbRiRsmbRsbRsRsmbRsRsLsmbRsbRsRsmbsbsbRsbRsbsbRgbRgbLsbRgRsmbL
sbRoLsbLgbLgLsbReRibRobRgbReRsRsRsmmmbRibRsRsRsRsmmmb

>ZF Recording 2016-06-02; tW: 300s; Start: 162321; End: 162831;
Recording: 6-1; Individual: 23; Drug: Control Apo 50 然
bLsLsmbLsRsLsbLsLsLsmmbRjbRebRsRsmbsbRsbsbsbsbsbLsbRsLsbRsbLgbRsRsmbRo
bsbsbsbsbRgRsmbLsbRebLsbRsbRobLgbRibsbRsbRsbRcbLsbLsLsmbRjbLsbRiRsRsmm
bsbLgLsLsmbRibRgbRsbLjbRsLsbLcbLsLsmbLsbLgbRobRiRgbLcbLhLsbLgLsRsbLhRs
bRsbLcbLsRsbLsbRjbRjbRsbsbLsbsbLiLsbLgbRjbRhbRhbRibLsbRgRsRembLibLibLg
bRibRjbRgbRgbRgRsmbRiRgbLsbLsLsmbRsRsRsmmbRibRibRsRsmbRobRjbRhRsmbRgbL
hbLiLsLsmbRobRjbLsbRobRobLoLsmbLibLgLsbLibRhbRibRcbRebReRibLsbLcLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 162321; End: 162831;
Recording: 6-1; Individual: 24; Drug: Control Apo 50 然
bLjbsbLsbRibRsbRjbRjRsmbRcbRibRebRibsbRgbRgbsbRibReRibRibRgbRgRsmbRgbR
gbRibRsbsbRgbRibRcbRebRibRobRsLsbRsbsbRibRjbLsbRibRibRsbLjbLibRgbLgbLj
bLgbsbRgbLibRsbLjbLgbLibLibLsLhbLsbLibRjbRsbLiRsbsbsbsbLcbLsbLgbLibRsb
LjbLiLsbLibLgbRsbLgbLgbLsbLgbLsbRsbLcbsbsbLibRsRsmbRgbLjbLgbRsbRsLsbLs
bLgbsbLebsbsbsbRgbLiLgbLjbLibLibsbLiLsbRsLjbLgbLsbLsbLsbLgbLsbLgbLgbLs
bLsbRgbRsbLgbLgbLibRgLsbRsbRgbLjbsbRjbsbRjbLjbLjbRjbsbRiRgbLjbsbsbLsbR
sbLgbLjbRsbRsbLibLibLgbsbLgbLibRsbRsbRgbLibsbLjbLsRsbRgbLsbRibRgbLjbLj
bRsbLibLsbLibsbLgbsbLgbLjRsbLjbRgLsbLibLjbRibRiRibLjRibRibRjbRjbRsbsbR
gbRsRibRsbRsbRsbsbLsLsRsmbRsbsbLsbLibRsbRsLsbRsRsmbsbLjbLibRsbRebRsRsm
bRibRgbRjbsbRgbRsbRjbRjbRjbRsbsbRibRsbLsbLibLjbLibLibLjbLjbLjbsbLibLjb
LjbLjbRsbLjbRsRsmbLiRsbLgbLibLjbLjbLgbLjbLjbLjbLgbLjbLjbLgbRsbRgRjbRjb
LhbLjbLibLhbLiRsbLjRsbLjRsbLiRsbLjRsbLjbRibLhbLibLibLibLhbLibLibLibLib
LhbLibLjLibLcbLcLgbsbLsbRsRsmbRebRhRgRibLhbLoLsmbLibLhbLib

>ZF Recording 2016-06-02; tW: 300s; Start: 162321; End: 162831;
Recording: 6-1; Individual: 25; Drug: PCAP814 10 然 Apo 50 然
bsbLhbLibsbsbsbsbsbLsbLsLsmbLsbLsbLsbLsbLsbLsbLsLgLsbLsLsmbRsbsbsbLgLs
LsLgmbLsbLsbRgRsRsRsRsRsRgLcmmmmmbRobsbLsbsbRsbsbsbsbLgRsbLsRsbRsbLsLs
mbsbsbsbLcbLjbLsbLsLsmbLgLgbRsLsbRgRsLjmbRjbRobsbRsbLsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 162321; End: 162831;
Recording: 6-1; Individual: 26; Drug: PCAP814 10 然 Apo 50 然
bLsbLsbLsbLgbLsLsmbRobRsbsbRgbsbLiRsbRsbsbLsLsmbLsLsmbRebLjbLgbLgbRsbL
sLsmbLjbLgLgbLgLsbsbsbRsbsbsbsbLgbRebRiLsbsbRsLsbLsbRgbRsbLsbLjbLgbRsb
LsbRsbLsbRsRsmbRsbRsbLsbRsbRsbRsbRcRgbsbsbRsRsmbRsbLsbRsRsmbLsbRgbLsbR
sbRsbLgbsbsbsbLgLsbsbLsbLsbRsLsbLsbsbRsbRsbLsLsmbLsbLsLsmbsbLsbsbLsbLi
bsbRsLsbLsbLibLiLsLsLgmbRsRsmbRsbRiLsbsbLibsbRsbsbLsLsmbLsbRsbLsLsmbLs
bLsbsbRsLsbLsbLsbsbLsbLsbsbLgbRsbLsLsmbRsbLsbsbLsbRsLsbsbRsbLsbLsbRsbs
bsbRjbLsbRsbLsbLgbRsRsLsmbLgRsLsbLsbLgbLsLsmbsbsbRsbLgbRgLsbLsbRsbRsbL
sRsbLebRjbRibLsRsbLibRsbLsbRibLcLsmbLebRsLsbRibLsbLeLsbLsLsLsmmbLsbLiR
sbRsbLsbRsLsLsmbRgbRsbLibRsbRebRgbRsRsmbLgbLgLsbRsbLgbLsLsmbLsLsLsmmbR
sLsbLgbRibRsbRsRsmbLsLsmbLsbLiLsbRsbLsbLsLsmbLiLsbLgLsbsbLgbsbLsbRgRgR
iRsmbLgbLebsbLsbRcbLhRgRsmbLsRsbRiRsmbRsLsLsmbLsRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 162321; End: 162831;
Recording: 6-1; Individual: 27; Drug: PCAP814 10 然 Apo 50 然
bLgbRsbRjbRsbLsRsbsbsbRsbLsbRsRsmbRsLsbsbsbsbsbRsbsbLsbsbsbRsbsbsbLsbR
sbLsbLsbLsbLsbLsRgRsRgLembLebLibsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsb
RsbRsRsmbRsbLsbRcbRjbLobLsLgbRsbsbsbsbsbsbsbsbsbsbLsbsbLsbsbsbsbsbsbsb
sbLsbRebsbLhbLibRobsbLjbLjbRjbsbRsbsbLsbRsLsbRsbLsbRebRibLgbsbLsLibRjb
LsbLsLebRsRsmbRebRcbRgRsmbRsLsLsLsLgmmbLjbLsLsLsLsLsmmmmbLobsbLgLsLsLs
mmbLsLgbLsLsLsLsLsLsmmmmmbLgbLgLsLsLsmmbLsbsbsbLsLsmbLsLsLsLsmmmbRsRsL
sLsLsmmmbLsLsLsLsLsRsmmmmb

>ZF Recording 2016-06-02; tW: 300s; Start: 162321; End: 162831;
Recording: 6-1; Individual: 28; Drug: PCAP814 10 然 Apo 50 然
bLsbRsbsbLsbRgRsmbsbsbsbsbRsbRsRsmbRsRsmbsbLsRsbRsLsbsbsbsbsbsbRsRsRsm
mbRsbsbLsbsbLsbsbsbLsbsbRsRsRsRgmmbRsbRjbsbsbsbsbsbsbsbsbsbsbsbsbsbsbs
bsbRsRsRsLsmmbRsRsmbRsbRsbRsbsbRsbLsLsmbLsbRsbLsbRsbsbRsbRsbsbsbLgbLgb
RsbLcbLsbRebLsRsbLsbLsbLjbsbLsbLsbRsbLgbLobRgLsLsmbLgbLsbRsLsbRgbLobRj
bLjbLjbsbRsbsbLsRsRsmbLsbsbRgLsbRsRsLsRsmbRsRsRsRsRsRsRsRimmmmmmbLsRsL
sbLsLsLsmmbsbLsLsmbLsLsLsmmbRgbLebRobLiRebRobLobRgRgRsmbRgbsbRsRsmbRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 162321; End: 162831;
Recording: 6-1; Individual: 29; Drug: PCAP814 10 然 Apo 50 然
bLgbsbsbLgbLsLsmbLsRsbRsbLsLsmbsbLsLsmbLsbLobRgRsmbRcbReRoRoLsbLobLibR
jbRibRibLhbRiRsRcmbRobRhbRebRoRsRsmmbRoRsmbRiRsmbRgRsmbRsRobRgbLib

>ZF Recording 2016-06-02; tW: 300s; Start: 162321; End: 162831;
Recording: 6-1; Individual: 30; Drug: PCAP814 10 然 Apo 50 然
bLsLsmbLgbRgbLsbLsbLgRsbLsbLsbLsbLsbRsLsbLiLhbsbLsbLgbLsRebRgbLsbRgbRs
bLgbsbsbsbsbsbsbRsbRsbsbLsbLsbLebsbsbsbLsbLsbLsbLjRsbRsRsmbLsbLsbRsLsb
LjbLsbLsbLhbLgbLsbLeLsbsbLhbRsbLebLsLsmbLsbsbLgbLibLiLsbsbLsbsbLibsbLg
bLgbLsbsbLebLsbLsLsRoLsmbLibLeLsbLsbsbsbLsbLsbRobRobLgbLgLsbRsLsLsmbLs
LgbLgbLoLsLsLsmmmbLsLsmbLsLsLsmmbsbLgbLsbLgbLgbLebRsbLeLsbRgLibsbsbLsL
gbLsbLgbLsLgbRcbLgRebLob

>ZF Recording 2016-06-02; tW: 300s; Start: 162321; End: 162831;
Recording: 6-1; Individual: 31; Drug: PCAP814 3 然 Apo 50 然
bRsRsmbRsbRsbRsbRsbsbsbsbsbsbRsbsbsbsbRsbLsbsbsbsbRsbRcbLgbLjbLsRsbRib
RsbRsbsbLjbLsbsbRjbRjbRsbRsbRgRsRsmmbsbsbsbsbsbsbRsbsbsbsbLsbLsbsbsbsb
sbRsbsbsbLsbRsLsbRsbLsRsLsbLsLsmbRsbRsbRsbLsRsRgRsmbRgbsbsbsbsbsbsbsbs
bsbLsbsbsbsbLsRsbRsLsbLsbRsLsbsbLsLsmbRsLsRsLsbRsLsLsmbsbRjRsmbsbRsbsb
sbRsbRgbsbLsbsbLcbsbRjbRgbRcbsbRsLsbsbLsbsbRsbRibLsbRcRsmbLsbRsLsbRsbR
sRibRsbRibLsRsbsbRgbsbsbsbsbsbRsbRsRsmbRsRsmbRsbRgRsmbLsbLobLsbRjbsbLc
LsmbLsbsbsbRsbLsbLsbsbLsbsbLsbLgbsbLsbRjbRcbRsbRgbLsbsbRcRsmbRsbRjbLsb
RgbLsbRgRhbRibRobRgbRhbsbLsbLsbRsbRjbRsbRgbsbRsbRgbRgLoRibRgbRgRsmbsbR
sbRsLsbRgRsmbLcbLgbLsLsmbRsbRcbLoLsmbRcRsmbRibLcbRhbRobsbRhbRibLgbRgbR
sbRgbRgbRgbRgbRgbLibLobRsRsmbRiRgbRibRgbRsRsRiRsRgRiLsmmbRobRibRgbLibL
ibLibLsbRjbRibRibRgRgbRgRgRsRiRsRiRimmbRgRsRgmbRibRgRsRsRsmmmbRibRiRgR
iRiRiRsmbRgbLsRsbRhRiRgRsmbRiRsmbRsbRhRsmbLibLibLgbLgbLiRsbLsbLibLgRsb
LsbLgLsbLgbLsbLjbLcbLhbLsbLsbLibLgbLibLsbLgbLibLgbRsLsbLibRgbLobRsLcbL
gLsbLgbLsLsmbLgbRsbRsbLsbRobRibLcbLgLsbLibLgbLgLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 162321; End: 162831;
Recording: 6-1; Individual: 32; Drug: PCAP814 3 然 Apo 50 然
bLjbsbsbLhbLsbLgbsbRsbRjbLibRsLsLhbLsbLsLsmbRjbLgbsbLgbsbRsbLiLsLsmbLg
bLsbLgbsbLgbLsbLsbLsbRsbLsbRjbLcbsbLcbLibLibLibsbRgbRjbRjbRibLjbLhbLgL
sLsmbLgbRjbLgLsbLsbRsbLgLsbLgbLsLsmbLgLsbLsbRsbRsbLsLsmbRsbsbLhbsbsbRi
bLibLcbLsbRibRjbRhbLjbLgLgbLsbRsbLcLsmbsbLiRsbRsbRsbsbRsbLgbLsLsmbRsbL
sLsmbRjbsbsbRsbsbLsbLsbRsbRibLibRgbLgLsbRgRsmbRgbsbRgRsmbRjbLsbsbRgbsb
RhbLsLsmbLibRgRsmbRiLsbsbRjbsbRsbLibLgbLsbRibLsRsbRgbRsbsbsbsbLjbRibLs
RsRsmbLsbLiLsRsbRsbLsbLsbLgbsbsbsbsbLsRsbLsRsbLibLsbLiLsbLgLgbLsbLsLsm
bsbLhbLsbLobsbsbLebsbRjbRjbLsbLsLgbLjbRjbsbLjbRjbRcbRjbRsbRgbLsbsbRhbR
cbLgbRiLsbRcbRjRsmbLjbRebRsbRgbLsLsmbsbLiLsbRgbRibRgbRiLsbRibRgbRgbRsb
RsbRsRsmbLhbRsbRsLsbLgbLsbLsLsmbsbLsbLsbLjbRsbsbsbRsbsbsbRsbsbRibsbReb
sbsbRebsbRgbRsbLjbLsbRsbRgRsmbRibRgbLgbRibLsRsbLgbLgLsRsbRcbLgbLibLoRs
bRgbRgbRcLsbRibRibRgbRgbLibRhbRibRgbLsbRibRgbRgbRgRsmbRiRsmbRgbRibRibL
ibLhbLoRsbLcbLibRjLgbLcLsmbLgbLgRsLsbRhbRsRgRsLsmbRsRsRsmmbRsRsmbRibLj
LsmbLiLsbLsRsbsbLgRsbsbLsbLgLsbLsLsLsmmbLsbLsbRjbRibRcRsRsRsmmmbLobLcb
LcbLcLsmbLebLjbLsLsLsmmbLhbLhbRibLcbRjbLsbLibLcbLibLhbLeLsbLcRibLcbLgb
LiLsbLcRsbRibRcbRgbRibRgbRhbLsLsRsmbRhbRhLsbRgbRgbRhLsbLgLsbRgbLgbRhbR
gbRsbRibRgbRgRsmbRgRsRgmbRgLsbRibRhRsLsRsmbRgbLibLibLcbRibLcbLgLsRsbLg
bLgbLjLsmbRibLsbLjLsmbRgbLibRsLsbLsLsmbLsLsLgLsLsmmbLgLsLsLsLsLsmmmmbL
gLsLsmbLibLsbLgLsRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 162321; End: 162831;
Recording: 6-1; Individual: 33; Drug: PCAP814 3 然 Apo 50 然
bRibsbRsbsbRsbRsbLgRibRsbLsRibRsbsbRibsbsbRsRsmbRsbRibRgbsbRobLgbRiRcb
sbRoLsLsmbLsRsbLgbLcbsbsbLgbRsRsLsmbLgbRiLgbLhbRsbRcbRsbsbRgbsbRibsbRg
RsRsmmbRgRsRsmmbRobLsRcRebRgbsbsbRgRsmbRgbLsRgbRibRsbRsbLsbLsbRibsbsbR
sRsmbLibLgLsLobRsbRgbsbLsbRgbsbsbRsbRibsbsbRsRsmbRjbLsbRsRsRsmmbsbsbsb
sbsbsbsbsbsbsbsbsbRibLsbsbRebLgbsbsbRsbLsbsbsbsbsbRhbsbsbRsbsbRsRsmbRi
RsmbLsbLcbRjbRgbRsbRgbRgbRcbRsbLobRsbsbsbsbsbRiLibLhbRsbRgbsbsbRiRhbLs
bsbRsbLsRoRsRgRsLsmmbLgbLhbRibRhbRibsbRsbsbsbsbRgbReRsmbRibLgLsbRsbRiR
smbLsbRsbRgbRhbRobLsbLhRsbLsLsmbsbRsbLsbsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 162321; End: 162831;
Recording: 6-1; Individual: 34; Drug: PCAP814 3 然 Apo 50 然
bLgLsbLsbRsRsRsmmbsbRsbsbsbRsbsbLcRsRsRsmmbRiRsmbRiLgbRobRgbLsbRgbRsRs
mbsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 162321; End: 162831;
Recording: 6-1; Individual: 35; Drug: PCAP814 3 然 Apo 50 然
bRgbRjbRsLsbsbRgRsmbRsbRsbRsbRsbRgbRsRsmbLsbsbsbsbsbsbsbsbsbsbRgRsmbLs
RibLgbRsbRgRsmbRgbRcbLsbsbsbLsbLsbRgbRsbRibRiRsRsmmbRibRibLsbRibLsRsRs
mbsbLsbRgbRgRsmbRebRsbRcRsRsmmbLsbsbRsbRsRsmbRgbRgRsRgRsRiRiRsmmmbRcbR
gRsmbLibLgbLgbLgbLjbLgbLgLsLsmbLsbLiLibRibLibLcbLgbLgbsbLsLsmbRsLgbLsL
sLsLiLimmbLsLiLibLgbLgbLgbLgLgbLsbLibLgbLibLsbLsbLsbLsbRsbsbLsbLjbsbRj
bRobRsLsLsmbRgbRhRiRsmbRsRsmbRibsbRgbRsbRsbRjbRsbRsbRsbLsRebLibRsbLsLi
LibLgLsbLgbLibLiLibLgbLibLsbLiLsLgbRgbLibLibLgbLsLsmbLcbRgbRsbRcbRsbRj
bRsRsmbsbRibsbsbRgbsbRibRiRgbRgbRibRsbRhbRibLsbLsbRgbRsbLgbLibLcbRibsb
RiRsmbRgRgbsbRsbRsbsbsbsbsbsbsbsbsbsbsbsbsbLiLsbRjbRsLsbRgbsbRsbLsbRgb
RsbRsbRgbRsbLsbRsLsbLgbRibRibsbRsLsbRsLsbRgRsmbsbsbRebLsRsbLsbLgbRgbRh
bRgbRsbRsRsmbLobRsbLcbRsbLibLgLsLibLgLsbRhbsbsbRsbsbRsbRsRsmbRsbRobsbs
bsbRgLsbRiRsmbRgbsbRibRsbRibRiRiRgbRiRsLsmbRgbRsbRgbRgRsmbRgbRgRsLsmbR
ibRibRibRhRhRgbLsRsbRibRgbRsbRibRsRsmbLibRobRgbRiRsmbRsbRgbRgbRoLsbLeL
sbLibLibLgbLsbLgbLgLsbRsLsbLgbLgRsbLcLgbRhLsbRgbRgbRgbRiRsmbRgbRgRsmbR
gbRibRiRgRsRsmmbRgRsmbRgbRgbRgRsRsRsRsRiRsLsmmmmmbRgbLgbLcRsRsLsmbLsbL
gLsbLibLsLsmbLsRsbLgbLgbLiRsbLsbLibLgLsbLgbLgbLgLsbLsbLgbLgLsbLibLgLsb
LgLsLiLsLgLibLiLiLsRsbLibLiLsbLcbRsbLibRsbLibLibLgbLgbLsbLiLsLgbLibLcR
sbLgbLiLsLcbRebReReRcRsmbRiRsRimbRiRsRimbRebRibRgRsmbRibRibRoRgRsmbRib
RiRsmbRibRibRiRibRiRgbRibLcbsbLgLsbLjLsmbRsbLsbLhbLgbRsbLgLsbLgRsbRsbL
gbLgLsbLibLgLsbLgbLgbLibLgbLgLsbLsbLibLgbLgLsbLsbLgLsbLiLsbLgbLcLsLimb
LibLsbRobRibRiRsLsLsmmbRsbRcRsmbRgbRibRgbRgbRsbRgbRgRsmbRiRsRsLsmmbLjb
LiRsLobLibLhbLgLiRsbLsbLibLgbLiLsbLiLiLsbLiLiLsbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 162321; End: 162831;
Recording: 6-1; Individual: 36; Drug: PCAP814 3 然 Apo 50 然
bRjbRsbRgRsmbRgbLobRsbsbsbRsbLcbsbsbLibLgbLobsbLsLibLsbLgbLiRsbLsbLibL
cbLiLsbRoRsRgmbRiRsmbRibRsbRibRgbRgbRgbRsbRsRsmbLsRcRsmbRebRsbRgRsmbLs
bRsbsbRgbsbRgbRsbRgbRjbRsbRgbsbRobsbLsbRcbsbsbRgbsbLsbRsLgbRsbLgLibLgb
LgRsbLibLsbLsbLgbsbsbLgRsbLgbLsbLsRsLsbLsRsbLgbsbLsbLsLiRsbLhbRsRsLgmb
RibRsbRgRsmbsbRgbRgbRgbsbRgRsmbRgRsmbRgbRiRsmbRgbsbRgbRsbRibLhLhbLsbsb
LgbLgbLsbLsbLsbRgbRsbRsbsbsbLsbRsbRsbsbLgbLsbRsbLsbRsbsbLsbReRsmbRgRsm
bsbsbRjbsbRgbRcRsmbRsbRsbRsbRsbLsbRjbRsbsbsbsbsbRgbsbsbsbsbsbRsbRsRsmb
RibRgRcRsmbRgbRsRsLsmbRgbRsRsmbRsbRsbsbRsbsbLibLcbLsRsbLjbRobsbLibRgRs
mbRibRsbRgbRjbRjbRobLsbsbRsbRcbRjbLsRiRsmbRgRsmbRgRsmbRiRgbRsbRibRsbRi
bRsRebRsRsLsmbLgLgbsbLsLsmbLiRsbsbsbsbLjbsbRgRsLgmbLibsbsbLsbsbLsbLgbL
sbLgbsbLgbLsbLsbLibLgLsbLsbLgLsRsbLsbLgbLjbLsbLsbLgbRsRsmbLibsbRobRhRs
RhmbRibRcRsmbLsbRgbRsRcRsmbRsbRjbRiRsRsRsmmmbRgRsmbRgRsmbRgbRsbsbRgbLs
LsmbRibRjbLsbRcRcRsmbRgbRsbRsbLsbRsbsbRcbLsbsbsbRhbRsbRsbRebRsRsRsmmbR
jbRsbRgbRebRsbRibsbRibsbLebLgbLibLsbLgbsbRcbRiRsmbRcbRcRhbRibRebRoRsmb
RcRebLebLiLsbLibLebLgbLgLsbLsbLiRsbsbRgbLcbRibLcLsmbLibLiLsbRsLsbLgbLg
RsbLibLiLgbLgbLsbLsbLibLibLgLsLgLibLiRsbRsRsmbRgbRgbRgbRgRsRsmmbRgbRhL
ibRoRsmbRcRsmbRcRsRhmbRgbRgReRsRsRcmmbRiRsmbReRsmbRcbReRsRgmbRebRibRiR
smbRhbRibRiRsmbRcbRhbLhbLiLiRsbLiRsbLhLsbLgbLgbLsbLgbLsbLsbRsRsmbLsbsb
sbRsbRiRsLsmbRsRibRsbRebRcRsmbRcbRcRsReRsmmbRibRgbRgbRgbRgRsmbRsRsmbRg
RsmbRgRsmbRgRsmbLsRsbLebLiLiLsLsmbLgLibLgRsbLgLhbLibLgbLhRsbLsbLhbLgRs
bRsbLgLsbLgRsbRsbLgLsRsbLgLsbLiLsbLgbLgbLibLgLsbLcbRsRsRimbRcRhbRcbRhR
sLjmbRoRibRhRsmbRcbRebRiRsReRsmmbReRcRsRiRsmmbRhb

>ZF Recording 2016-06-02; tW: 300s; Start: 162321; End: 162831;
Recording: 6-1; Individual: 37; Drug: PCAP814 1 然 Apo 50 然
bLsLsmbLsbLgbLgbsbLsbLsLsmbLibLsbsbsbRsbRcbRiRsmbsbLsbsbsbsbRsRsmbsbRs
RsmbLobRgbsbRsRgbRgbRcbLsbsbRcLsbsbRsbLibsbRgbsbsbsbsbsbsbsbLsbRsbRobs
bLiLsbsbLsbsbsbsbLsbRgbsbRsbLjbLsbLsbsbLsLsmbRsbLsLsmbLsbLsbLsbLsLsmbL
sbLsLsmbLsbLsbLsLsmbLsLsmbLgbLgbLsbLsbLsLsLsmmbsbLgbLsbsbLsLsmbsbsbsbL
sbLsbLsLsmbLsbsbLsLsRsmbLsbLsbLgbLsbLsLsLsmmbLsbLsRsbLsbLsLsmbLgRsbLsL
smbLsLsmbsbLsLsLsmmbLsbLgbLsLsmbLsLsmbLsLsmbLsbLsLsmbsbLsbLsbsbLsbLsbL
sbLsLsmbLsLsmbLgbLsbLsLsmbRsLsbLgbLgbLgbLgbLgRsbLgbLgbLcbRcRibRcRsRsmm
bRebsbsbRsLsbsbRjbLsbsbRsbsbRgRsmbsbRsbsbsbsbsbsbsbsbsbsbsbRhbsbsbRsbs
bRibsbLsbsbsbsbLiLcbsbsbLibRsbsbsbRsbsbRsbRjbRsbLhbLsLsmbRgbsbLgLsbLsL
smbsbLgbsbLsbsbRsbLsbLsbLsbLsLgbLsbLsLsmbLsLsLsmmbLsbsbRsbLsbLsLsmbLsb
RsbLsbLsbsbLsLsLsmmbLsbLgLsLjbLsbLsLsLsmmbLsbLsLcbRsbsbsbRjbRsbsbLobRs
bLsbLibLgbLgbLgbLiLsbLgbLibLsLgbLgbLiLsRsbLsbLgbLgbLgRsbLgLsbLsLsmbLgb
LsRsbLsbLgLsbLsbLsLsmbLgbLgbLsLsLsmmbLsLsLsmmbLgbLgLsbLsLgLsbLsLsmbLsL
smbLgLsbLgLiLsbLibRsbLsbLgbLgLsbLsbLsLsmbLsLsmbLsLsmbLgLsLsLgLgLgLsmbL
gbLgbLgbLgbLgbLgbLgbLibRjbRcRgLsbRiRsmbRiRsRsmmbLgbLsbsbLsbLoLsmbLhLsb
LsbRsbRsLsbLsbLsbLsLsmbLsbLsbsbLsLsLsmmbLgbLsLsmbLgbLgbLgbLsbLsLsmbLgb
LgbLsbsbLsbLgbLgbLgbLsbLsbLsbLgRsbLgbLgbLgLsbLgbLgbLgbLsbLsLsLsmmbLgbL
sbLsLsmbLsbLsbLsLsLsmmbLgbLsLsmbLsLsmbLsLgbLgbLgbLsLsmbLsbLiLsbRsbLgLs
bLgbLgbLgbLsLsLsmmbLgbLgLsLgbLgLsbLgRsbLsLsmbLsLsLsmmbLgbLgRsbLsbLsbLs
LsLsmmbLsbLsbLsbLsbLgbLgbLibLgbLgLsbLgbLsbLgbLsLsLsmmbLgLsbLsLsmbLsLsm
bLsLsmbLsbLsbLgLsbLgRsLsLgbLgbLgbLgbLgbLsLsLsmmbLgLsbLsbLsRsbLgbLgbLsL
smbLgRsbLgLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 162321; End: 162831;
Recording: 6-1; Individual: 38; Drug: PCAP814 1 然 Apo 50 然
bsbsbRsbLgbRsbLibLsbLgbLgbLsbLgbLgbLibLsbLgbLgbLiLsbRgbRsbRcbRsbLjbLsb
LjbLsbRsbsbLiLibsbsbLgbLsLsLsmmbLiLgLgbLhbRsbLiLsbLsLsLsmmbLgbLsbLgbLe
bLgbLgbLgbRsbRjbRibsbRsbLcLsmbsbLgbRgbsbsbsbsbLsbLsLsmbLsbsbLsLsmbLsbL
sbLgbLhbLsLsRsmbRcbLgbLsbLsbLibLsbLsbLsbRsbLsLsmbLgbLgLsbLsbLsbLsbLgbL
gbLebRcbLsbLebLsbLsbLgbLcLsmbLiLsbsbLiLsbLsbLsbsbLsbRsbLgbRjbsbsbsbRcb
RsRsmbRgLsbRsRsRsRsmmmbRgRsmbLsbRgbRgRsmbRhRsRgmbRgRsmbRiRsmbRsbReRsRi
RsRsmmmbRgbReRsmbRsRibRebRgRsRiReRsRimmbRgbLsbLsRsbRsRsRsRsRsRimmmmbRg
RgRsmbRebRsRsRsmmbRsbRsRsmbRgbRsbRsRsmbRhbRiLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 162321; End: 162831;
Recording: 6-1; Individual: 39; Drug: PCAP814 1 然 Apo 50 然
bRgbsbRgbRgbsbsbRsbLsbRsbsbRgbRsbRiLsbRsbsbLjbsbLcLsmbLhbLsLsmbLgLsbLi
bLibLsbLgbLsLsmbLgbLobsbLsbLsbLhbLgbRsbLsbRjbRsLsbRcbLsbRsbLgbLibRsbsb
LgbRsbLgbLsLsmbRjbsbsbsbsbRibRsbRgbRsRsmbRsbRgbsbRgbRsRsLsmbsbRsbRgRsm
bRgRsmbsbLsbsbLcbLsbRiRsmbRcbLsbRsLsbLjbLsbsbLgLsbLgbRgbRjbLgbLsbRiRsm
bRjbsbRgbRjbLsbRsRsRsmmbRgbRsbRsRsmbRsbLsbRsbRjbRsbsbRjbLsLsmbRjbRsRsm
bRgbsbRjbLsbsbLsbLcbLoLsmbRgbRgbRibLeLsbRsRsmbRiRsmbRhRsmbLibLhLsbLsbL
iLsRsbLibLsLcbRgbLibLgbLibLibLsbLibLgbLibLeLsbLebLsbLiLsbRgbRibRcbRsLs
bLgbRsbRgbRibRgbRsRsmbRiRsRsmmbRgRsRsmmbRgbRgRsmbRiRsLsmbLsbRiRsmbRsRs
RsRsmmmbRsRsRsRsmmmbRsbRsbRcRsRsmmbRgLsbRhRsmbRgRsmbRgbRjRsmbRsbLsbRsR
smbRgRsRsmmbRgbRgbRgRsmbRibRgbLjbLibLibLibRsbLcbLgLgbLgLsbRsLsbLsbLsbR
sLsLsmbLsbRiRsmbRiRsmbRsRsmbRgbRgRsmbRsbRsRsmbRgRsRsmmb

>ZF Recording 2016-06-02; tW: 300s; Start: 162321; End: 162831;
Recording: 6-1; Individual: 40; Drug: PCAP814 1 然 Apo 50 然
bRjbRsbLgbLibLibsbLsbRibLgbLsbRsbLibLibRibLibLibLsLsmbLsbLibLsbLgbLibL
jbLgbLibLibLibRsLsbLsLibsbRobLgbLjbLsbLsbLsbLhbRsbLibRgLsbRcbRgbLgbsbL
sbsbsbRsRsmbRebRsbLjbLibLsbLsbRsbLjbRgRsmbRgbRibLjbLhbLsbLsLsmbLibRsbL
jbRsbRsLsbLgLsLsmbLgbLsbLhbLebsbRsbRsbLcLsmbLgbLcLsmbRibsbLsbsbLsbRsbL
gbLsbsbRsLgRsbLsbLsbLgbLsbLgLgbLgbLsbLgbLsLsmbsbLsbLsbsbsbLgbLsbRgLsbL
jbLsbLsbRsbLgbRsbLsbLsbLsbLsLsLsmmbLgbsbRgbRjbsbRsLsLsmbLiLsbLsbLsLsmb
LiLsLsmbLsLsmbLgbsbsbLsbsbRgbLsbRjbLibLgLsbLgbLgbRsLsbRsLsbLgbRjbLsbsb
LgLsbsbLibLsbLsLsmbLsbLsLsmbLibLiLsbLsbLgbLgbRgbRsbLsRsLsbLiLsLsLgLsmb
LgbLiLiLgbLibLsLsmbLeLebLsbLgLgLsLsmbLibLgLsbRsLgLsLgLsbLibLebLsbLsRsL
eLsbLsLsLsmmbLgbLsLgLgbLibLebRibRsbLjbsbRsLsbsbLiLsLsmbLiLsbLgbLgbRsLg
bLgLsbLebLhLgbLcbLsbRibRibRgbLjbLhbLgLgbLsLsLsmmbLgbLsbLgRsLgbLsLibLhb
LiLgLgbLsLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 162321; End: 162831;
Recording: 6-1; Individual: 41; Drug: PCAP814 1 然 Apo 50 然
bRibRjbRgbRsbsbRgbRsbRsbLgbLcbLjLsmbLsLsmbLeLsbLebLgbsbLgbsbLsRsbLgbLi
bLobLgLgbLgLsbsbLsbLhbLjbLgbsbLobLobsbLsbRsbLgbLgbLsbRibLcbLsLsRsLgmbL
sbRgbLsbLsbRsRsmbRgbRsbLsbLsbLsbLiLsbLsbLgbLsbLebRgbLsRsbLebLjbLcLsLsL
gLsLsmmmbRsbRebLgbLgbLsbRsbRsbLsbRsbLgbLcbRsRsmbRsRsmbRiRsmbRjbRibRgRs
mbLebLgbRsRsmbsbLcbLgbLgbLsRsbsbLebLsbLsbLgbLsbLgbLsbsbsbsbLgbLibLsbLc
LgLsbLgbLjbsbLgbsbLsbLsbLgbLcLsmbLgLsLsRsmbLsbsbLsRsbRcRsmbRgRsRgmbRgb
LebRobRebRsbsbLsRsbRcbRgbRgbRibLsbLgRsbRcRsmbRsRibRgRsmbRhbRebRsbRgbRs
bRsbRibRgbRebRsRsmbRgRsRsmmbRhbRibLiLebLiLsLsmbRsbRebRsbLoLsLsmmbLeLsR
gRgbReRsRgRsRsmmmbLoLsmbLebLeLsLgbLgbLgbRgRsRsRsRgRsmmmmbLsRsbLobLgLsL
gLgbLcLsmbLsLiLsbLcbLcLsmbLgRsRsmbReRsmbRgRsRsmmbReRgbLgLsLsLgLcmbRsbL
sLsmbRebLcLsLsmmbLeLsbLgRsbLcbLibLebLcbLeLsbLgLsbRsRcRsRsmmbLebRcbLibL
ibLgLsLsmbLiLsbLoLsmbLeLsLsmbLibLebLibRcbRoRsRsRsmmmbRcbRgRsmbRgRsRsRs
mmmbRiRsmbReRgbLcLgLsbLcbLebLiLsLsmbReRgRgbRebLeLsbRsLsbLibLsRsLsLsLsm
mb

>ZF Recording 2016-06-02; tW: 300s; Start: 162321; End: 162831;
Recording: 6-1; Individual: 42; Drug: PCAP814 1 然 Apo 50 然
bLsbLsbLsbRsRsmbLibsbRoRsmbRsbRsbLsbLsbLsbRsbLsRsbRsbLsRsbsbsbRsRsmbsb
RsbRsbLsbLsbRsbLsLsLsmmbRsRsmbRsbRobsbsbRsbsbsbLsbLgbLgbLgbsbLgbRsbsbR
sbLsbsbsbsbsbLsbLgbLjbLjbRsRsLsLimbRsbsbLhRsbsbLsbLsbsbLgbsbLsbLgbRsLi
bRsbRsbRsbLsbsbsbsbsbsbsbsbsbsbsbRsbLsbLsbsbsbsbsbsbsbsbsbLsbLsbRcbLsb
sbLsbLsbsbsbsbsbsbRgbsbLgbsbRgbLsbRibsbsbsbLsbRsRjbsbRsRsmbLsbRsLsbsbL
sbRgbsbRhbRjbRhbRjbRibRhRsLsmbLsLsmbRsbRgbRgRsmbRgbRsbsbRgbLsbsbLsbRgb
RsRsmbRgbRgbRgbsbRgRiRgbsbRgRsmbLsbsbRsbsbRsLsbRgbRsbRgbRsRhRgbRibRgbR
gbRgbRgbRsLsRsbRsLsbRsbRgbRgbRsbRsbRsbRgbRgRsmbRsbRsbRsbRgbRsRsmbRgRgb
RgRgRsRsmmbRgRsmbRgbRiReRsRiRimbRgbRgbRgbRgbRobsbRsbLgbsbLibLgbLiLsbLg
bLiRsLiLiLsLgLsbLibLgbLgbLgbLgLsLsmbLgbLgLgbLgbLsbLgbLgbLgbLgbRsLgbLgb
LgbLgLgRsbsbsbLgbLsbLgbRsbRsLsbLsbLsbLgbLsbLgRsbLsLsmbLgbLsbLsLsmbLgLs
bLsbLsLsmbLsLsmbLsbLsbLsLsmbLsbLsbLgLsbLsLsmbLsbLsbLgbLgbsbLsbRsbLgbLg
bRsbLsbLsbLsbLsbLsLsmbLsbsbLsbRsbLsbLsbLgbLsbLsbRsLsbLsLsRsmbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 162321; End: 162831;
Recording: 6-1; Individual: 43; Drug: Control Apo 50 然
bsbsbsbsbsbsbsbRgLsbLsLsRsRsRsRiRsRsmmmmmbRibRibLsbLsbRsRsmbRebLsbLobL
iRsbLiLsbLobRobRgbLsLiLiLiLiLebLeLibLgbLsRsbRcbLsbRsLoLsmbRsbLebLibsbR
sRsmbRjbRsbRsRgbLcbRebRsRsmbRsbRsLsRsRsmbRhRiRsmbRgLsbRsbRibRsLsbRibRg
RsmbLibRsbLjbLobLgbLoRsLiLsbLgbLibRcRsmbLobLobRsbRiRsmbRibRsbRsbsbRsRs
mbLebLgbLsLobLsRsbLjbRsbLsbLcRsbLjbLhLsLebsbLebLeLsbRsLsbRjRcbRsbRsbRe
bRsbRgbLsbRgbRibRhbRobLgbLgbLebRsRsmbRiRsmbRibRgbRgbRobRgRgbRibRgbRsbR
ibRcbRsbLgbLiLsbRibRiRsRsRsmmmbLsbLsRsbRsbRsRsLsmbRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 162321; End: 162831;
Recording: 6-1; Individual: 44; Drug: Control Apo 50 然
bLgbRsbLsbsbsbsbRsbRsbLsbLsbLgbLsbsbLgLsLsmbLibLsLsRsmbRibRsbRsbRsbLgb
LsLsmbLsbLsbLsbLgbLsbLgbLsLsmbLsbLsLsRsmbLsRsbRgbRgbLcLsRsmbRebsbLsbRs
bLsbRsRsmbRgbLibLgbRsbLjbLjbLsbRibLsbRebLsbLiLsbLsLsmbLsbLsbRjbLibsbsb
sbsbLsbLsbLsbsbRgbRsRsmbsbRhbRjLsbLsbRibRhbRsbLgbRibRgbRebRobLsbRcbLjb
LhbLsbLibLgbRgRsmbLobLgLsRgbRibRcLsbLsLgLsbLibLsbLsbsbLsbLgRsbLsLsmbRo
bRiRsmbRsbRgbRgRsmbRsbLgbRiRsmbRsbRsRgLsbRsbRsbRcbRsLsLsmbRsLsbRsbLsbL
sbLsbRsbsbRibRibRsRsmbRsRsmbRsRsmbRsbRgRsmbRsRsmbRsRsmbLsRsRsmbRgbRsRs
mbRgbRibRebRibRsRsmbsbRgbLsLsmbRibRsLsRsbRsLsbLgbRoRsmbRibRsbLhbRcbLgL
sbLsbRebLiLsLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 162321; End: 162831;
Recording: 6-1; Individual: 45; Drug: Control Apo 50 然
bRgbRsRsmbRsbRsbRibRgbRsbRsbRsbRgbsbRgbRgRgbRsbRibRgbsbRgbLobLebLgLsbL
ibsbLsLsLsmmbLiRsbLcbRjRsmbLibLeLsbLsbRjbLibRsRsmbRobRiRsRsRsmmmbLebLs
bsbRsbLjbLgLsLsLsmmbLgLsLsmbLgLsbLiRsbsbLjbRsbLsbLsbRsRsmbRgbRsbRgbLjb
LiLsbsbLsbsbLsbLiLsLsLsLsmmmbRsbRgbRobRsRsmbsbLsLsmbRgbRibRgRsRgmbRgbR
sbsbRibRsbLibLgLsbLhbLsbLcbLsbLibLhbLsbRsLsLsmbLgbRsbsbsbRsbRgRsRimbsb
LsRsbRsbLsbRcRsRsmmbLsbRoLsbLgLsLsLsLsmmmbLgbLsLsmbLgbLgbLgLgLgbLibLgb
LgbLsbLgbLgLsbLsbRsbRibsbRsRsmbRsRsmbRsbLgLsbLgLsbLsbLiLsbsbLibRsLsbRj
bRsRsmbLibsbLsbRsbRsbsbLsbRjbsbLjbLiLsLsLsmmbLsLsLsLsLsLsLsmmmmmmbLgbL
gbLgLsbsbRsbLsbRsbsbLebLsbRsbLsbRsRsmbRoRsmbLjbRiRsmbRiRsmbLsRsbRsRsRs
mmbLjbLgLsbLibLgLsLsLsLsmmmbLgLsLsmbLibLibLiLsbLebLebLgLsLsLsmmbLhRsRs
mbRhbRiRsmbRsbRcRsmbRsLsbLsLsmbRsbRiRsRsmmbRsbRhbLhLsbLhbLgLsLsmbLgRsb
RjbRoRsmbRgRsmbRiRgbRcbLiLsbLiLsLsmbLgLsLsmbLgLebRhbLsRsbLgbLeLsLsLsmm
bLsLsLsmmbLcRsbLgbRsbLiLsLsLsmmbLgLsLibsbLsLsLsLemmbsbLebLebLiLsLsmbLe
LsbLgbLgbLiLsLgbLgLsLsmbLgLsLsmbRjbRebRebRibRcbRibRoRsmbRsbLhRsbLsLsmb
LeLsLsmbRsLsbLiLsbRebLsbLebLoRsbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 162321; End: 162831;
Recording: 6-1; Individual: 46; Drug: Control Apo 50 然
bRsbsbsbsbsbsbsbsbsbsbsbLsbsbsbsbsbsbsbsbRsRsmbRjbRsbRebLgbLcbLiRsbLhb
LobLebsbLcbLsbRiRsmbRcbRjbRobLibLcbLiLsbLgbLibsbLsbRsbRebRgbLsbsbRgbRj
bLsbsbLobLsbRsbLibLebLebLeLsbLsLibRjbsbLcLsmbLgbLgbRhbRcbLsbLsbLhbsbLs
bRsRsmbRgbRsbRjbRsbLcLsRsmbLjbLcbLebLhbLgRsbRsbLibRebRebRgbRibRiRsmbRi
RsmbRibRibRhbLibRiRsmbLsbRiRsmbRgRgRsmbRgRsRsmmbRebReb

>ZF Recording 2016-06-02; tW: 300s; Start: 162321; End: 162831;
Recording: 6-1; Individual: 47; Drug: Control Apo 50 然
bRsbRjbRsbLgbLcbLibRcbRebRgbLgbLsbLjbLibLgbLsbLsbLsbLhbLsbLgbLobRsbRsb
RsbRgbRsbRgbRgbsbLsbRibLsbsbsbsbsbLgbLsbLgLsbLgbsbLibRsbLibRsbLibLsbLi
bLgbLsbLgbsbsbRsbLsRsbRsbRsbRjbRsbRjbRsbRsbRebRgbLsLsmbRebLsRibRgbRsRs
mbRibRgbLibLgbsbsbRgbRgbLsbRhbRgbRibRsbRsbLsbsbsbsbsbLjbRgbRsRsmbRiRsR
smmbReRsmbRibLsbLgbRibRgbRsbLgbsbRibRgbLgLsbLcbRibRebRgRibRebRiRgRsRsR
immbRgbRgRsRsRsRsmmmmbRiRsmbRsRgRsRgmbRgbRhRsRgmbRebRcbRiRsmbRhRsmbRhR
smbLibLebLibLcbLcbRsbRobRgRebRibRhbRgbRibRhbRebLibRcbRsRsRsmmbRgbLgbLj
bLcbLibLibLhbLhRsbLiLsbLibLibLsLsmbRjRsmbRgRsRsRsmmmbRgRsmbRib

>ZF Recording 2016-06-02; tW: 300s; Start: 162321; End: 162831;
Recording: 6-1; Individual: 48; Drug: Control Apo 50 然
bLebLiLeb

>ZF Recording 2016-06-02; tW: 300s; Start: 162832; End: 163336;
Recording: 7-1; Individual: 1; Drug: PCAP814 10 然 Apo 50 然
bRsbsbLsLsmbRsbLsbsbsbLsbLsbRsbLsbLsbRsbsbLsbRsbRsbRsbRsbLsbRsbRsbLsbL
sbRsRsLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 162832; End: 163336;
Recording: 7-1; Individual: 2; Drug: PCAP814 10 然 Apo 50 然
bsbsbRsRsmbRsbRsbRgbRsbRgbsbRsLsbRgLsRsbLsRsbRsbRgbsbRsbRgLsbRsRsmbsbR
sbRsbRsRsmbRsbRsRsmbRsbRsbRsbRsbRsRsmbRsbRgRsmbsbsbsbLsbRsbRsLsbRsbRsb
sbsbRsbRsbLsRsbRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 162832; End: 163336;
Recording: 7-1; Individual: 3; Drug: PCAP814 10 然 Apo 50 然
bRjbLsbRsLsbsbsbRsbsbsbRsbRsbLgbLibRsbsbLsbsbLgRgbRebRjbLeRsbsbsbsbRiL
sbRsLsbLsbsbLsbRsbLgbRsbRsbRsbRsbsbLsLsLgLsLgLeLsmbLjLsmbLsbLsLsmbRjbR
gbRsLsbsbsbRsbLgbsbsbsbLsbsbsbsbRsbLsbRsbsbRebLsbRgbsbLjbsbsbLsbRsbRsb
RsbsbRgbRcbsbsbRsLsbRsbRsbLobLsLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 162832; End: 163336;
Recording: 7-1; Individual: 4; Drug: PCAP814 10 然 Apo 50 然
bsbsbLsRsbsbLsbsbLsbRsbRsbRgbLsbRsbLjbLsLibRsbLsbRsbLsbRsbLsbLsbLsbsbs
bLsRsbsbRsbRjbRsbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 162832; End: 163336;
Recording: 7-1; Individual: 5; Drug: PCAP814 10 然 Apo 50 然
bRsbLgbsbsbLsbsbRsbsbsbLsLsLsmmbRsLsbLsbsbLsLsRsmbRobRsbLibRiRsmbRgRsm
bRsRsRimbRgbLobLcbLjbRgbRiRsRsRgmmbRsbRgbRgbRgbRsbRsbLsRsRsRsmmbLsbRgR
sLsmbRsbRgRsmbRsbLjRjbRsbRsRsRsRgRsRsmmmmbLibLibRgbLibLjbRjbLcbLsbLgLs
bLsLsmbRsLsRsbsbLsbLsLsmbLsbsbsbLjbRobsbsbsbRsRsmbsbsbsbsbsbsbsbsbsbsb
sbsbsbsbsbsbsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 162832; End: 163336;
Recording: 7-1; Individual: 6; Drug: PCAP814 10 然 Apo 50 然
bRsLgbsbLsbLgbLsbRobsbRsbLsRsbRsLsbLsbRsbLsbsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 162832; End: 163336;
Recording: 7-1; Individual: 7; Drug: PCAP814 3 然 Apo 50 然
bLgbsbLsLsLsmmbLgbLsbLsbLsLsmbLsRsbLebRsRsmbLoRsbLhbRgbsbsbRiRsmbRsbRs
bRsbRgbRsbRgbRsRsmbRgbRsRsmbRsRsmbLsbRsbRsbRgRsmbRsbRsbLsbRgRsmbRsbRsb
RgRsmbLsbRsbRsbLsRsbRgbRsbRsbRiLsbRcbRgbRibLsRsbsbLsbLsbsbRsbRgbRsbRsb
RsbRsbRsRsmbRsRsmbRgRsLsmbLsbLiReLsLsmbLgbRgbRsbLibLsbLsRsbLgbLsbsbLgb
LsbsbRsbsbsbsbsbsbLgRsbLsbLjbsbLsLsmbLobRsbRsRsmbRibRibLsbLsbRsbRgbLeR
sbsbRsbLsLsmbLsRsRsmbLsbsbsbsbsbLsbsbsbLgRsLsbLsbsbRsbLsbLsbLgRsbRsbLs
bLsbLiRsLibLcbRibRibsbLsbRibLsRsbRsRsmbLobLjbRibLsbRibLsbsbRiRsLsmbsbR
sbsbsbLsbsbsbsbLsbRiLsbsbLibsbLsbsbsbLsbsbsbsbRibRsbsbLjLobsbsbLsbLsbs
bLsLsRsmbsbRsLsbsbsbLsRsRsmbsbsbsbsbLsbRsbLsbsbsbsbsbsbsbLsbsbsbRsbsbs
bsbsbsbsbsbLsRsbsbsbsbsbsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 162832; End: 163336;
Recording: 7-1; Individual: 8; Drug: PCAP814 3 然 Apo 50 然
bLgbLsbLjbRjbLjbRobLsbLjbRjb

>ZF Recording 2016-06-02; tW: 300s; Start: 162832; End: 163336;
Recording: 7-1; Individual: 9; Drug: PCAP814 3 然 Apo 50 然
bLgLsbLgbLibLiLsbLgbLibLgbLgLsbLgbLgbLgbLgLsLsRsmbLgbLgLsbLgbLibLgbLgL
sbLibLiLsbLibRsbLsbLgLsbLgbLsLgRsLsbLibLgbLibLgbLgLsbLiLsbLibLibLibLib
LgbLibLibLgbLgbLgbLgbLibLgbLgbLibLgbLiLsbLiLsLgLsbLgbLgLsbLibLgbLiRsLg
bLgLsbLiLsbLgLsbLgbLibLgbLibLgLsbLgbLibLgRsbLgLsbLiLcLhbRcLsbRcbRobLgb
LhbLgLsbLeRsLsRsbLsbLibRsbLiLsbLgLsbLgbLgbLgbLiLsbLhLsLsmbLsbLsbLcbLgL
sbLgbLiLsbLibLgLsbLgbLgbLiLsbLibLibLiLiLsLsmbLibLoLebLiRsLsRsbLgbLgLsb
LgLsbLibLgLsLhLsLhLeLsbLgbLhLsLiLsLhRsLsLhLsbRebLgbLiRsLeLiLsLgbLgLsbL
ibLoRsbRiRibLoLsLsLsmmmbsbLiLsbLgbLgLsbLibLiLsbLgbLgbLibLgLsbLibLibLgb
LibLsLiLsbLgbLcLcLsmbRjbRgbRiRsmbRgbRgbRiLsbLcbLhLsbLgLsbLobLibLcbLiRs
bLgbLiLsbLibLibLibLgbLibLibLgbLiLsbLibLiLsbLiLsbLgbLibLibLgbLibLibLibL
gbLibLiLsbLgbLibLibLiRsLsbLibLiLsbLiLsbLhLiLsLgLsbsbLgLgbLgbLgLsbLibLi
bLiLsbLgLsbLgbLgbLgLsbLiLiLsbLgLsbLibLiLibLgbLibRjbRcRibRsRgRsmbRibRgb
sbRsbsbsbLjbRobLebLibLgbLgbLgbLiLsbLgbLgbLgbLsLsRsmbLgbLgbLiLsbLgbLgbL
gbLsbLgbLgbLgLsbLgLsLsRsmbLgbLgLsbLgRsbLgbLgbLgbLsbLgLsbLgbLgbLgbLsbLs
LsmbLgbLgbLiLsbLgLsbLsbRgLsRsbRcbRsRoLsbRsRcbLcbLcLiLiLsbLiLsbLibLgRsb
LibLgbLgbLgbLsbsbLgLsbLibLibLgLsLiLsLsLhmbLcbLebLgLsbLibLgbLibsbLgLsbL
ibLiLiLsLsmbLgLsLsmbLhbLiLsbsbLgbLgbLgbLsbLoLhLsbLibLibLiLsbLgbLibLibL
cLcRsbLhbLgLsbLibLgLsbLgLsbLgbLiLsbLgLsbLiLsbLgbLiLsbLibLhLgLsbLebRsbs
bLgbLgbLsbLsLsmbLgbRsLsLsmbsbLsbLibLsRsbLgLsbLibLgbLgbLgbsbLsLsmbLgLsL
smbRsbRsbRsbRgbRsbRgbRgRsmbRibsbsbRcbRsbLsbsbRsbLcLsmbsbsbLsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 162832; End: 163336;
Recording: 7-1; Individual: 10; Drug: PCAP814 3 然 Apo 50 然
bRsRsRsmmbsbRgbRsRsmbRsRsmbRsRsmbRiRsmbRsRsRsRsmmmbRsbRsbRibRgbRsRebRi
bsbRiRgRsRsmmbRsRsRgmbRebLgbLibLsbLsLsmbLsbLgbLsbLsbLsLsmbLsLgLsbLsbLg
LsbLgLgbLgLsbLsbLsbsbLgbLsLsmbLsLsRsmbLibLibLgLgbLsLsmbLsLgbLgbLsLsLgm
bLgbLsLsmbLgbLhbLibLgLiLsbLgLsbLgbLsLsmbLsLsLsmmbLgRsbLgbLsbLsLsmbLibL
gLsbLsLgbLgbLsbLsbLsLgbLsLsLsLsRsmmmbLsbsbLsLsRsmbLgLsLsLsmmbLgLsbLgbL
gLibLsLgbLibLgbLibsbLobLhbLgLsRsbLebLebLcLgLsbLiLsbLsbsbRgbsbRsbRsLsbR
sbRgLsbLsbRsbRebLgbLsbLsbLsbLsLsmbsbsbsbRsbLsbLsLgbLjbLgbLsbLgbLgbLibL
sLgbLsbLsbLsbLsbLsbLgbLsLsmbLsbLsbsbLsbLsbsbLsLsmbRsbLsbLsLsmbLsbLgLsL
smbLsbLsLsmbLsLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 162832; End: 163336;
Recording: 7-1; Individual: 11; Drug: PCAP814 3 然 Apo 50 然
bRsRsRsRsRsmmmmbRjRsRsmmbLiLsLsLsmmbRsbLsRsbRsRsmbRgbLsLsLsLsLsLsmmmmm
bLhLsbRebLgbRjRsRsRsRsmmmmbRsRsmbLgbRebRjRsmbRibLsLsLsRsmmbRsRsmbRgRsm
bRgbRsbRsRsRsmmbRsRsRsmmbRjbLsbRjbLgLsRsbLsbLibRsbsbRgLsLsmbLsRsbRiRsR
smmbRiRsRsmmbRgRsmbRsRsmbsbLsbRiRsRsmmbRsRsRsRsRsmmmmbRgbRhbsbLsbReRsL
smbLsbsbRsRsRsmmbRgRsmbRsRsRsmmbRibRsRsmbRsRsRsRsRsRsRsmmmmmmbRjRsRsRs
mmmbRjRsRsmmbLsLgLsbLcbRgbsbRjbLsbsbRsbRsRsmbRgRsmbRsbsbRsbRgRsmbRibsb
RjbsbLsbRgbLsbLsbRebLibRhbRsRsmbRsRsmbRsbLsbRsbLjbsbsbsbLjbRsbRjbRsbLs
bsbRsRsmbRsRsmbLjLsLsmmbLsbsbRjbRsRsmbRsbsbsbLsbsbLsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 162832; End: 163336;
Recording: 7-1; Individual: 12; Drug: PCAP814 3 然 Apo 50 然
bLsbRcbLgLsLsmbRcbLibReRsmbRgRsmbRibRibLsbLcbLobLsbLgbLcbLgbLsbLibLebL
obRgbLibLibLgLiLsbLhLsRsbRgbRibLsbRgbRibRjRcbRsbLcLsmbLsLsmbLgLsbLhbLi
bRgLsbLgbLibLibLibLcRsbLiLsLsmbRibLeLsbLibRjbRjRsmbRibRibRiRsmbRgbRcbR
gbRhbRibRcbRsbLibLcbLsbLibRsbLobRsbRjRsRsmmbRgLsbRcRsmbRgbLiLibLgLsbLo
LsmbRgRsmbRibRgbRsbRobRibLibRhbRhRsmbRgbRjRsmbLcbRsLgbLibRsbLobRgRsmbR
ibLsLobLhLsbLibReRgbRibRjLsbRcLsRsbLibLiLsbRebRiRsmbRebLcbLsLsmbLibLib
LgbLgbRgbRibRibRgbRgbRgbRgLsbLsbRjbRebLhbLgbLhLsbLgbLcbRsbRcRsmbRjRiLs
bRibsbRsLsbRjRgbRsLsbRebRsRsmbRiLsbLgbLcbLeLsbLobsbRibRcRgRsLsmbLgLsbR
obLsLsmbLcbLhRiRsRsmmbLcLsmbLcLsmbRoLsbRibRgbRjRgLsbRhbLgLsLsLsmmbLsbR
ibRibRiLsbsbLsbLsLsmbLibLoLsmbRcbRiLsbLebLebLhbRiLsLsmbLcLsLsmmbLgLsbL
iLsbLibLgLcbRhbLcbLiLsbsbLgLsbLsbLibRsbLibRgbRebRcbRibLgLsbLsLiLsbRcbR
hRsLsmbRcLsLsLsmmbRcLsLsmbLgbLcLsmbLsLsLsmmbLibLibLcbRsbLsbLcLsmbsbLhb
RsbLsbsbLgbLsbRjbsbRobRgbsbsbRcLsLsmbsbLiLsbLeLsRsbLibLsbRcbsbRobLhbLs
bsbLhLsbLsLsLsmmbLsLsmbRebRhbRgbRibLebRcbLcLgbLgLsbLsbLgLsbLsbRcbRcbLg
RsbRsbRibRcbLcLsmbLsLsmbLhbLibRgbLgbLibLibLgbLsLsmbRgbRcbReLsbRsLsbLgb
LiLsbLsLsmbRjbRhbRibRgLsLsmbRgRsmbLibRobsbLcbLgbLcLsLgmbsbLiLsbLibLgLs
bLoLsmbLhbLiLsLsmbLcbRgbLiLsbLgbRgbRsbLsRcbRoLsbRcRsmbRsbLebLgLsbLgLsb
RjRcbRobRgLsbRoLsbLhLsbLsLsmbLjLibLgbRibLcbRsbRobLoLsLsmmbRjLibLcbsbLg
bLibRgRibRcbRgbRgbLsbLhbLjbRsbRhbRgbRgbRjbLsLsmbLibLsbLcbLsbRsbRgLsbLc
LsmbRsLsbLibLgbRsbRsbRcbsbLsbRcbLsbRsbRjbLsbRibRibRgbRsbLjbLsbLjbRsbRo
bRsbsbLgbLibsb

>ZF Recording 2016-06-02; tW: 300s; Start: 162832; End: 163336;
Recording: 7-1; Individual: 13; Drug: PCAP814 1 然 Apo 50 然
bLsbsbRsbRsbLsbRsRsmbRsRsmbRsbRsbRsbRsbRsbRsbRsbRjbRsLsbLsbRsbLsbRsbRs
bLsbLsRsbRsbLsbsbRsbRsRsmbLsbRsbLsbsbsbRsRsmbLsbRsbsbLsbLsLsmbRsRsmbRs
bLsbRsbsbRsbsbLsRsRsmbRsbRsbRsRsLsmbRsbLsRsRsmbRsbRsbLsbLsRsRsmbLsbRib
RhbRsRsLsLsRsmmbRsbsbsbsbsbsbsbLsbRsbsbRsbRsbRsbLsRsbRsRgbRsbRsbsbsbsb
sbRsbsbRsbsbRsRsmbLsbRsRsRsmmbRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 162832; End: 163336;
Recording: 7-1; Individual: 14; Drug: PCAP814 1 然 Apo 50 然
bRjbLibRhbRibRgbLoLsmbLibLibLobLibRhbRsbRcbRsbRcbRcbRcLsbRibRibRcLsbsb
sbRjbRibRibRsRsRsmmbRgRsmbRgRsmbRcRsRsmmbLibRjbRobRsbLcbLcbLcbLcbLcLgb
LgLsbLgLibLgbLibLibRcRsmbRcbRsbRiLsbLgbRgRsmbRgRsRsmmbRiRgbRsbRsRgLsbs
bRhRsmbLgbRsbRgbRgbRiLsLgbRsbRibRsRsmbRsRgbRgRsLsmbRgbRgbRsLsbsbRgRsmb
RgRsmbRiRsmbRsRsmbRibRsRsmbLebLcbsbLjLgbLebLhbLgbRcbRgbsbRiRgRsmbRgbRg
bLsRsbRgbRgbRgRgbRgRsmbRsRsmbRsbRibsbRgRsmbLsRgRsmbRiRsmbRsLsbRgbRgbRi
bRcbRsLsbRsbRcbRsRsmbRgbRgbRibRiRsmbRgbRsRsmbRibRibRcRsLsmbRobRsbRsbRh
bRsRsmbRgRsmbRibRgRsmbRgRsmbRsRsRsRsmmmbRgbRibRhbRgRsmbRgLsRsbsbRgbRib
RiRsmbRiRsmbRsbRsbRcbRcbRsbRibRhRsRsmmbRcbRibRcbRibRgbRcbRoRsRsmmbLjbR
oRsRsmmbRgRsmbRgbRibRgbRsbRsRiRgbRsbsbRgbRsbsbRgRsmbsbRiRsRsmmbRgbRgbR
iRgbRiRsmbRibRibRcRsmbLcbLsRobLjbRsLsRsbLsbLibRiRsmbLgLiLsLsmbLibLcRgb
LhLibLgbLgbLiRsbRsbLgRsbRsLsbsbsbRhbRgbRgbRgbRsRsRsRsmmmbRsRsLsmbRgbRg
bRgbRsbRgbRibRhbLsbRgRsmbsbRgbRgbRsRsmbRgRsmbRsRhbRgbRgRsmbRibRhbRgbRs
RsmbRgbRgbRibRgbRibRobRobRsbsbsbsbsbRsbRsRgRsRsmmbRsbsbRcRgRsRsmmbRjbL
sLsmbRibRgRsmbsbRgRsmbRgbRsRsRsmmbLsbsbRgbRibRoRsmbsbRoRsmbLobLibLcbLc
bRsbsbsbsbLsRsbRsbRsbRgbRiRsmbsbRsRsmbsbRgbsbLsbRsbsbLhbRobRsRsmbsbRsb
RsRsmbRgbRgbRsbsbLsbRgbsbRgbsbRgRsmbRiRsmbRgRsRsmmbRgbRsbsbRsRgbRgbRgb
LsbsbRgbLcbLobLiLsbLgLsRsbLgLsbRsbLsbLhbRsRsmbLsRsbLibLsLsmbRhRsmbRsbR
jbLsRsbRsbRsbRsbRgbRgRibRgRsmbsbRsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 162832; End: 163336;
Recording: 7-1; Individual: 15; Drug: PCAP814 1 然 Apo 50 然
bLiLsLsLsLsLsmmmmbRsRsRsmmbRcbRsRsmbRgbRgbRgLsbLjbLebLsLsmbsbRsRsmbLsb
LgbLiLsbLgbLiLsLsmbLsbRsLsLsRsmbLsLsmbLsbRsLgLiLsLsmbRjbReRsmbRgRsRsmm
bRsRsRsmmbLsRsbRsRgRgbRiRgbLibLiLsbLgLsLsmbLsLgbLgLsLsmbLgbRgbLgLgbsbL
sLsmbLsbLgbLsLsLsmmbsbLgLsLsmbRgbLsbLsLgLsLsLsLsRsmmmbLgRsLsLgLsbLiLsb
RibsbLsLgbLsLsLgLsmbLiRsLsLsmbRgRsRsLsRsmmbRsLsLgLsbLgLsbLsLsLsRsmmbLs
LgLsbRgbRcRsmbLhbRjbRgRgRsRsmmbRgbLibLsbLhLsLsmbLsRsbLsbLsbLsLsLgLsLsL
smmmbLsLgLhbLsbRsbLsbLgLsbLsLgLsLsRsmbLgLsLsLsmmbLsbRsRsmbRsbRoRsRsRsR
sRsRsRsRsRsRsmmmmmmmmmmbRsLsbRsLsRsRsmbRsRiRsmbLsRgRgbRcRgbLeLsLsmbLcL
sLgmbLgLsLsLsRgmmbRsRjbLibLsLgbLgbLsLsmbsbRsbLsLsLsmmbLsLsLsLgLgLgLsLs
LsLsLsmmmmmmbLsLsLsLsmmmbLsLgLsLsLsLsLsLsmmmmmbLcbLsRhRsmbRiRsmbRiLsbR
gbsbLsbsbLgbRhbLhbLsLsLsmmbLsbLsbLsLsLsLsmmmbLgLsbLsbLsLsLsmmbLsbLsbRs
RsmbsbLgRsbLsbRsbLsbLsbLsbLsLsmbRsbLsLgLsLgbLsbLgLebLsbRgRsmbLsbLiLsbR
jbLsbsbsbsbRibRibRsRsmbLsLsmbRsRsLsmbRsbRsRsmbLsbRsbRsbLjbLsbLibLsLsmb
LsbLsbLsRsbsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 162832; End: 163336;
Recording: 7-1; Individual: 16; Drug: PCAP814 1 然 Apo 50 然
bRibRobLobLcbRobLebRebRgbRibLobRebLobRobLibRobRjbRebLobLobLgbLobRobLob
LobLebLobRsbRobLebLobLcbRobLibLobLobRcbLobRcbLobLobRebLsbLgbRobRcbRobL
ebRobRcbRgbRobRobLobLebRobRobRobLobRebRibRobRebRsbLhbRobRobLobRebRibLc
bLebLcbLgbLobRebLgbRcbRobRebRebRebLobLobRobRobRobRobRebLcbRibLebRobLeb
LobRebRjbRcbRibLebRobLebRobRibLobRcbLobLgbRebRebRobRobLsbRcbLobLobRebL
ebLobRobRobLobLibLgbLebLibRobRcbLsbLebRibLsbRobRhbLobLobLobLebRobRcbLe
bLebRcbLebRobRibLgbLebRobRobLebRobLebRsbLibLobRhbRebRebRobLcbRobRcbLeb
LcbRobLcbLgbRebLsbLebLcbLebRhbLobLcbRobLsbRebLobLebLobLobRobLebRobLebR
obRcbLebLcbLibLcbRsbRibLibLebRcbRebRebRebLobRobRobRcbRgbLobLobRobRibLe
bRgbLobLsbLcbRobLcbLibRsbLobLsbRebRobRcbLgbLebRobLebLebRcbRcbRobRobReb
LsbLobLobRsbRobRsbRebLebRebRobLcbLibLobRibLebLebLgbRgbLhbRebRobRcbRibL
ebRsbLobRobRobRobLobRsbRsbRobLcbRobLcbRgbLcbLobLobRcbLobLobRgbRgbLebLi
bLobRebLjbLobRobLebRebRgbLcbRobRobRebRobRgbLobLcbLcbLobLebLebLsbLobLeb
RhbLobRcbLebLobRebLobRhbLobLobLebLobLobRebLcbLcbRobRebLsbLcbLobLsbRobL
obLobRebLcbLcbRebRgbRibLhbRobRobLobLobLebLobLobLobRobLcbLebLobLobLgbLe
bRobRobRobLebLobLobRcbLobRcbLcbLobLobRgbLobLgbLjbRobLibRebRcbRobLsbRcb
LobLcbLobRebLcbRibRobRgbLobRobRcbLebLebRibRebLobRgbRibLobRobLebLsbRcbL
obRebRcbRobRobRobRobRobLobRibRebLgbLjbLebRebLcbRibRobRebLcbLsbLibLobLo
bRobRhbLobRebRcbRibLebRcbLcbRcbLebLobRcbLobRobRobRebRibLebRcbLhbLobLcb
LcbRibRobRobLcbLobLgbLebLobRobLhbLobRebRebRobRebRobRobRcbRobLobLobLcbR
ibLobRobRobLobRobLebRobRibRobLebRcbRobRobLobLhbRebRibRobRgbRebRebLhbLc
bLcbLsbRebRcbLobRcbRebLebRobLgbRebRcbLsbRobRgbRobLibLebLebLcbRebLobLsb
RebRcbRcbRobRobLcbRobLcbLobRebLebRobLobRjbLobRgbLebRobRebRcbLebLcbLebL
cbLobLobLibLobRsbLibRcbLebLgbRobRobLhbLgbRebRobRgbRebLibRebRebRobLcbRc
bRcbLhbLobLsbRebRobRobRebLgbRobLebLibRcbRebLobLebLebRobRobLebLobRgbLeb
LebRobLobRobLibLgbRibRibLcbLobRobRobRcbRebLobRobLebRhbRibLobLcbLebLebR
ebLobRobLebLcbLobLobLobRebRebRcbRgbRhbRjbRgbRcbRobLobRcbRebLobLobRobLi
bLibLobRcbRcbRobLibLebLcbLobLobLobLebLcbLsbLebRibRobLobRobLobRsbRebLeb
RsbLobLsbLcbRobRobRobRgbRobLobLobLobLobRebRebRcbRibLgbLobRcbRebLcbLobL
ebLcbRobRobRobRcbLibRobLsbLobRobRobLobLebRibRebLobLgbLobLebRobRobLcbRo
bRebRebRobRebRgbLebLsbLibLcbRcbRobLobLsbRcbLibRebLebLebRcbRebRibRgbRjb
RebRobLcbLebLcbLebLgbLobLcbRibLobLobRebLobRcbLcbRsbLgbLibRgbRebRobLebR
ebRobLsbLobLibRcbLebRobRobLgbLhbLobRgbRebLibLebRcbRcbRobLobLcbLibRebLe
bLcbLhbRhbRobLobLibRibLebLebLsbLcbRibRobRgbRobLobLebRgbRcbRobLebRsbLib
LebRibRcbLobLebRsbLhbLobLgbRibLcbRcbLebLobLobLobRsbLibRobRobLobRebLcbR
obRhbLobLebLhbLebLebLibLebLebRcbLobRgbLebRebLobRebLobLebLebRobRobLobRo
bLobLobRobLcbLcbLobRobRobRobLebLsbLebRgbLobLibLobLobLobRsbRcbRsbLebLcb
RibLebLgbRobRgbLebRhbRibLcbLobRcbRhbLibRobRebLibRgbLebLobRcbLobLobLjbR
ibLobRsbRcbRobRobRebRobLobLgbRobLcbRobRobRebLobRcbRobLebLebLgbRobRobRo
bRobRobRebRobLcbLebRobLobRcbLebRsbRgbLebRebRcbRebRobRcbRcbRhbRhbRibLob
LibRobLobLobLcbLobLobRobRobRobRebRobRebRobLcbRebRhbLobRcbRibRibLebLebL
obLobLcbRobLhbLcbRcbLcbLsbLobLobRgbLobRebLobLobRebRgbLobLobRobRobRjbLc
bRebRibLobRobLobRsbLobLjbRebRobRobLobLgbRcb

>ZF Recording 2016-06-02; tW: 300s; Start: 162832; End: 163336;
Recording: 7-1; Individual: 17; Drug: PCAP814 1 然 Apo 50 然
bRsbRsbRsbRiLsbRgbLsbRibRsbRcbsbLiLebRsRsmbLibLebLiLsbLsLsmbLgbLibLcLs
mbRsRsmbLcbLhLcbLsbRibRsbLjbLibLgbLeLsbLibLsbLeLsbLibLiRsbLibLibLiLsbL
sbLgLsbLgbLibLgLsbLgbLoRsbLsbRiLsbRgbRiRsmbRgLsbRgbRibLjbRcRsmbLgLsbRi
bLibRcLsbRiRsLsmbsbRgbLjbsbRhLsbLcLsmbLgbLibLgLebRsLsbLiLsbLgRsbLibRob
RhbRibsbRibRgbReLsbRsbRibsbRobRsbLhbLobLgRsbRsbsbsbsbsbsbsbsbRhbsbsbLg
bsbRibsbRsbRsRsmbRsbRiLsbRoRsmbLgbRobsbRgRsmbRgbRibsbRhLsbRcbRibRsbLib
LgbLgbLsLsLsmmbsbRsLsbLgbsbLiLsbLsRsbLiLsbsbLcbLcLcbLsLibLgbLgbLebLhLs
bLhbsbRobsbRsbRhbLsLsmbRibRibsbRsbsbRsbLsLsmbRobRsbRsbsbRibRsbRobRsbLh
bLsbRsbRsbsbRjbRsRsmbLsbLsbsbsbsbRjRsmbsbsbRgbRjb

>ZF Recording 2016-06-02; tW: 300s; Start: 162832; End: 163336;
Recording: 7-1; Individual: 18; Drug: PCAP814 1 然 Apo 50 然
bLiLsbLibLhRsbRibRsbRebRiRsRgLsmbRiRsmbReRsmbReRsmbRibRsRhRsmbRebRebRg
bLsRsRsmbRiRsmbRsbRsRsmbsbsbRsRsRsRsRsmmmmbRsbRcbsbLcbRcbLibRcRsmbLibR
ibLjbLibRgbLibRjLsbRhbLibLgLsbLcbRgbRsbRcRsmbLgbLgbLhbRibRsbLcbLibLgbL
iLsbLsLsmbRgbLcLsmbLgbLgbLcbLsbLibRcbRiRsRsmmbRibLsLibRhbRgRsmbLjLjLsm
bRiRsmbLgbLcbLsRsbLibLibRsbRibRsbRobRibRsbsbRibLiLsbRsbLgbLcbLibsbLgbL
ibLhbLiLsbLebRsbRobRibRgbLibLsbRsbRiRsRsmmbReRsmbRgbRsbRgbRibRibRjLsbL
sbLjbLibLibLibLsbLiRsbLgbLsLsmbLcLsRsmbLsbRsRsmbLhbLibLibLgbLgbLgbLiLg
bLiRsLsbLhLsbRgbLjbLiLsbLgbLiLsbLgbLiLgLhbRiRsmbLcbLibLibLsbsbLcbLsbRg
bRiRsmbRsbRgbLjbRcRgbRcbRgRsmbLiRsbLgbRsbLcLsmbRgbRgbsbLibLgbLgbLgLsbR
sbLsbRsbRsbsbRhbLcbLibLgbLgbLgbsbRgbLjLsmbLgbRsbLhbRsbRsbLhRsLsbLebLgb
LiRsbLsbRsbLibLibLgRsbLiRsbLsbLibLiLsbRsbLgbLhbLibRibRjbLebLhbLibLcbLs
bRhbLgbRibRibRgbRibRgbLibLsbLcLsmbLgbLsbLgbLgbLebLgbLibLibLjbLgbLhbRcR
smbRgbRsRcbLsRsbLhbLiRsbRsbRsbLibLibLgbLibLibLgbLibLibLsLsmbLiRsbRgbLh
bRgRsmbRjbLjbLsbRcbRebRibRgbRjbRibRsbLebRjbLibsbRcbLcbLibLjRgbRcbLibRg
bRcbRgbLcbLsbLgbsbLsbsbRgbLgbsbLsLsmbRhbRjbLjbLgbLgbLjbRcbRsbRgbLibLsL
smbLgbLsbRsLsbLsbRsbLibLsbRjbLibLibLgbRsbRsRsmbRibLibRsbLjbLsbLgbLibLj
bLjLsmbLsLsmbLgbLibRsbRjbLhbRcbRgbRibLsbLsbRibLgbLgbLhbLsbRsbLiLsbRgRs
mbRsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 162832; End: 163336;
Recording: 7-1; Individual: 19; Drug: Control Apo 50 然
bsbsbsbLsRebRiLsbRebRsbRgRsmbRsbLsbsbRgRgRgbRsbRoLsbRoRsmbRcbRhbRcbRsR
smbLiLsbLibLobLoRsbLcRsbLiLhbLebLcLsLsLsmmmbLsLsmbLibLgbsbLgbRsLsbLiLs
bLcLsLimbLcbLhLsbLcbLebLeLebLiRsbRcRiRgRsmbRcbRibRibRibRoLsbRebRoLsbRi
bRcRsRsRsReRsmmmmbRibsbLcbRsbLcbRgbRsbRgbLsRiRsmbReRgRsmbRsbLgbsbRcbLs
bLobLsbLcLsLgLcmbLcbLhbLibLibRgbRsRsmbRhbRibLsbLsLibLsLsmbLibLiLsbLibR
cbRibRcbRhbRiRsmbLgbRgbLjbLobRgbLjbLhbLsbLgbLsLsLsLgmmbLsLsLsmmbLsLsmb
RsbLsLsmbLsbLsLsmbRcbRgRsRsRemmbLsLibsbLgLiLsLsmbLsbLsLsLgLgmbRebLsbLi
bsbLsbLobLsbLibRsbRibsbLoLsmbRsbRsbRibRiRsmbRgbRcbRcbRhbRjbLsbLsbRibRi
RsmbLcbRgbLibLgLsbLgLsbLsLsmbsbRcbRibRibRgbsbRibRgbRgbRebLgbLcbRcbLsbL
sbRsbRcbLsbRibRgbRgbRjbLjbLibRjbsbRjRsmbRgbLsRsRgRsLsmbRsRsmbRsbLsbRiR
smbRcbLjbLgbLcbRsRgbLobLjbsbLsbLcbLsbLobRgbRgbLgbRsbRsbsbRibRsbRsbLjbL
sbLcbLgbLibLiLsRsbLibLebLiLsbRsbRsLsbsbsbsbsbRjbRiRsmbLsbsbsbsbsbRsRsR
gRsmmbRsbRgbRsbRgbRsRsmbRgbRsbRgbsbsbsbsbsbsbsbLsbLcbLgbLiLsbLiLsRsbsb
RcbRibsbRsbRgbRgbRcbsbLsbLgLsbLsbLsbLsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 162832; End: 163336;
Recording: 7-1; Individual: 20; Drug: Control Apo 50 然
bLcbLibRjRsmbLibLsLsmbLsRibRcbRgbLgLsbRibRebRgbRiLsbRibLcbRjbRgbRgbLcb
RjbRhbRiRsmbRobRibLibLgbLibLcbRsbLibLgbLibLgbsbLjLibRgRsmbsbLibRibLcbR
jLsLsmbLgbRjbRjbRsbRhbRsRsmbRsbRibRhbLiRsbLiRsbLsLsmbLsbLibLgbLhbLhbLi
bLsbLsRsbLhLsbRgbRcbRibRgbRgbRibRibRgbLgbLgbRgbLibLgLsbRjbRcbRibRgbLsb
RibRgbRsbRibRgbRgbsbLibRjbLsLibRjbLgbRjbRsbLjbRibLsLjbsbLcbLjLgbRsRsRg
RsmmbRjbRebRgbRgbsbsbsbLsbLjbLjbRjbLsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 162832; End: 163336;
Recording: 7-1; Individual: 21; Drug: Control Apo 50 然
bLgbLsbRcbRgRsmbRjbRiRsmbsbLsbRsbLsbRsbReRsmbLcbLiLsbLibLcbRcbLcbLibLi
bRcbRcbRcbLgbLhLsbLibLcLsmbRcbRebRgRsmbRibRibRebLhbLgbLhbLibLibRebLebL
cLgbLjbRsLsbsbLgbLibLcbLibLjbRgbLhbLhbRcbRgRgbLobLebRebLcbLgbLibLgbLiL
sbLjbLsbLsLsLsmmbLiLsbRjbRcbRsRsmbLebLibLcLsmbLebLhbLcbRcRsRsmmbRcbLsR
sbLcbLcLsLimbLgbRobRhbRcRsmbRibRibLhRsbLjbsbLhbLcbLgLsbRjbLcbRjbLebLgb
LobRiRsmbLibsbRcbRiLsbRcbLiLsbLgbRibLibsbLibRgbRebLgLsbLoLsmbLhbRsRsmb
RgbsbRibRibRsbRjbRsbsbRibsbsbRsbRsbLsLsmbLsbLsbRsbLsbLhbLhbLsbRsbsbLib
LsbLsbLsbLsbLgLsbLsbLgbLgbLgbLibLsLsmbLsbLibLgLsbRsbLsbRsRsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 162832; End: 163336;
Recording: 7-1; Individual: 22; Drug: Control Apo 50 然
bRsRsmbRgRsRsmmbRsbLsRsbsbsbLsLsmbLsbRgLsbRsRsLsmbRgbRoRsmbRibRgRsmbRs
RgbRgbsbRgbRgbRgbRsbRsRsmbRgbRsRsRsmmbRsbRgRsmbRsRsRsmmbRgbRsbRsRsRsRs
mmmbRsRsmbRsRsmbRgRsRsLsmmbRsLsbRsbLsbRgbsbRsbRsbRsbLsRsRsmbRsRsmbRsRs
RsRsRsRsRsmmmmmmbRibLobLgLsLiLsbLsbRgbRgbRibRibRsRsmbRibRsbRgbRgbRgRsm
bLsbLibLgbLgbLiLsbLgLsbLsbLsbLgLsbLgRsbLsbLsLsmbLgbLsbLibLsbLsbRsbReRg
bRgbRebRsbRsbLsbRsbRsRsRsmmbRgbLsbRsbLsbRsRsmbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 162832; End: 163336;
Recording: 7-1; Individual: 23; Drug: Control Apo 50 然
bLgbLcLsmbLcLsmbLibLiLgbLgRsbLsRsbLsbLsLsLsmmbLsbLgLsLsmbRsLsbLibLiLsb
LeLsbLgbLcbLiLsLiLsbLiLsbLibRebRsRsmbRsRsRsmmbLsRsRsmbsbsbRsRsmbRsLsbR
gRgRsLsRgmbLsbRibRibLsbLjbLcLsmbLhbRibRcRsmbRibRobRibRhbRibRobRhbRibRi
bRoRsmbRiLsRsbRhbRibRiRsmbRsRgbRgbRsbRgbLcbLibLoLsLgmbLsRsLsLsmbLibLgR
sbRsbRjbLjbLibLhbRhLsbsbLsRsLsbsbsbsbsbsbsbsbsbsbsbsbsbsbRibRobRibRebR
sRgbRobRcbRiRsmbRibRobLgLsbLcRsbLcbRgbLebLsLsmbLcbLobRiRsmbRiRsmbRibRs
bRgbRhbRhbLibLsbLobLsbLsbLsRsbLiRsLsbLgbLjbLgbsbsbRsRsmbsbLsRsRsmbLsRs
bsbRsbsbLsbRsbLsbsbsbLsbsbsbLsbRsbRsRsLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 162832; End: 163336;
Recording: 7-1; Individual: 24; Drug: Control Apo 50 然
bRsRjbLhbLhbLobLcbLibLibLiLgbLibLsLgbLjLsmbLibLhRsbLhbLibLjbRjRhbRjbLj
bLcRsbLgbLgLgRsbLiRsbLibLjbRsbLibLiRsbLjRsbLibLibLobLibLgbLibLgbLgbLjb
LcbLibRgbRebRibLjbRibRgbRgRgRsmbRgbRibRsbRiRsmbRgbRiLsbLjRsbLibLjbLjRs
bLgbsbsbLjLjbRsbLjbLgLsbLjbsbLgbLjbLjbLgbLibLiLsbRsbLjbRjbsbsbLsLibLcR
sbRjRjRsmbLhbLhbLibLgbLgbLsbLjRsbLjRsLebLcRsbLibLsbLibLiLsbLibLhbLgbsb
LjbRhRibRjbRjbLjLsmbLcbLjbLsbLgbLgbLibRsbLibLsbLgbLebLgbLgbLjbLibLibLi
LsbLsbLgbRgLsbLibLsbLiLsbLsbLgbLgbLgbRsbLibRjbRjbsbRjbRebsbRibLibLibLg
bLsbLgbLgbRibLjbLjbLgbRgbRjbsbsbsbLsbLsRsbLjbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 162832; End: 163336;
Recording: 7-1; Individual: 25; Drug: PCAP814 10 然 Apo 50 然
bRsbsbRsRsRsRsmmmbLsbRsbRjRoRsmbRobLjRsbRhbsbLebLobLgbRgRsRsRsmmmbRsRs
mbRsRgbRsRsRsmmbRsRsmbLjRsbRobLgLgbRsbsbsbsbRsbRsbLsbLsbLibRgbRiRsmbRi
RsmbRsbLcLsmbLhbRcbLcRsbLgLsbRgbsbsbRsbRsbRsRgRsmbRsRibReRobRsbRsLsbsb
sbRsRsmbRsRsmbsbsbRsbsbsbsbsbsbsbsbRsLsbsbLsbRsbsbRgbLjbLsbRsbLsbRibRs
LgLsbLsbRcbRsbRsbRsRsRgRsRsRsmmmmbRebRibLgbLsLsmbRibRsRjbRobLsbLsbsbLs
bRsbLsbsbLsRsbLsbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 162832; End: 163336;
Recording: 7-1; Individual: 26; Drug: PCAP814 10 然 Apo 50 然
bLsbLgLsbRsbsbRsbReLsbRsLsbsbLsLsmbsbLsbRsbRgLsbRsbRsbRsRsmbLsbLsbLgbR
ibRobLgbRjbLgbLsbLiLsLsmbRsbLebLibLsLsmbLiLsLsmbLsbLiLsbLsLsLsmmbLsLsm
bRcRsmbRsRgLibReRsRsmmbLobLsLsmbLsbsbRsbLibRgRsmbRsbRsLsbLsLsLsLsLsmmm
mbLsRsbsbLsLsmbLsLsLsRsLsmmbLsLsLsRsmmbLsbLobLsLsLsmmbRjbLsbLsbLsLsLsL
sLsmmmmbRsbLgbRsbLsbRcbRebLsLsLsmmbRsbsbLgbLsbLgbRiRgbRgbLgbLgbRsbRsbL
sbLsLiLsbRjbRsbLsRsbRsbReRsmbRsRsmbRsbRiRgRebLgbRiLsbRsbLgbLsLsLsmmbsb
LsLsmbLsbLsbLsLsLsRsmmbLgbLsbsbLsbsbLsbsbRsLsbLgbRjbLgbRgbLsbLebLjbsbL
sRsbLsbLsbLsbsbLsLsmbRsbLsbLgbLsLsmbLsbRsLsbLsbRsbsbRgbLsLsmbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 162832; End: 163336;
Recording: 7-1; Individual: 27; Drug: PCAP814 10 然 Apo 50 然
bsbLsLsLsmmbLsLgLsLsmbLsRsbLsLsRsLsmbsbLsbLsLsLsmmbLsLsmbLsRsLsLsLsmmb
LsLsLsLsmmmbLsLsLsLsLsLsmmmmmbLsLsLsLsmmmbLsLsLsLsmmmbLsbLsbLsLsLsLsLs
mmmmbLsRsLsLsLsLsLsLsLsLgLsmmmmmmbLsbsbLsLsLsLsmmmbRsbLsRsbLgLsLsLsmmb
sbRsLsbLsbLsbLsbRsbLsbRsbLsLsLsLsLsLsmmmmmbLsLsmbLsLsLsLsRsmmmbRsLsLsL
smmbLsLsLsLsLsmmmmbsbLsbsbLsRsbLsLsmbLsbLsbLsLsLsRsmmbLsbLsLsLsmmbLsbR
sLsbRsbLsLsRsLsLsmmbLsLsLsRsmmbLsLsmbLsLsmbRsLsbLsbsbLgbsbLsLsLsLsmmmb
LsLsmbRsRsRsmmbLsLsmbLiLsbLsbLsLsLsLsLsLsmmmmmbLsbRsLsLsLsLsLsmmmmbRsR
sLsmbLsLsmbLgbLgLgLsbLgLsLsLsmmbLgLgRsbLsLsmbRsLgRsbRiLsbLsLeLsbLjbRsL
gLsLsLsmmbRsbsbRsbsbRsbRsRsmbRsRsRsmmbRsRsRsRsmmmbRsbRsbsbLsbsbLsbLsRs
bRsbLsbRsLsbsbsbRsRsLsLsmmbsbRsLsbLsbsbsbRsbsbsbLsbsbRsbRsbsbLsbRsbsbR
sLsbRsbLsRsbRsbLsbsbRsbLsbRsbLsbLsbRibRsLsbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 162832; End: 163336;
Recording: 7-1; Individual: 28; Drug: PCAP814 10 然 Apo 50 然
bRsbRgbLsRsLsbRjbLsbLsbRsbRgbRgRsmbRsbRsbLebLebLhbRobRgRsRsmmbLebLgRsb
RibRsbRsLsLgLsbLgbLsbRgbLsLsLsRsmmbLjLjbLgbsbsbsbsbLsbsbRsLsbsbsbLcbRs
bLsbLsRsRsRsmmbsbRsRsRsmmbRsRsmbRsRsmbRsbsbRsbRsbRsRsRsRsRsmmmmbRgRsmb
LgbLjRsbRgbLsbLsbsbsbsbsbLsLsmbLsLsLsLsmmmbLjbLebRobLjbRsRsmbsbRgbLsbL
sbLsRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 162832; End: 163336;
Recording: 7-1; Individual: 29; Drug: PCAP814 10 然 Apo 50 然
bsbsbsbsbsbsbsbsbsbLsLgbRgRsRcmbLiRsRhbRcbRgbRcRsmbRsbRobLiRibLsRebRcb
RgbRiRsmbsbRebRobLhbRsbRebRobLsLsmbRibRoRebLoRsRsRgRsmmbsbRiLsRsbLsbRs
bLsbRsbLsbRsbRsbsbRsbsbsbsbsbRsbLsbsbLsbRsbsbRsRsmbRsbLcbLsbLcbRsbRsbL
hbLiLsbRgbRgLsbRgRsmbsbsbsbsbsbRgbRjRsmbLsRsbRibRebLibLobRsRsmbRoLsRsb
RebRobRoLsbRiRsmbRgbRcbRibLsbLsRsbLcbLiRsbsbLiRsbReRibRcbRibRobRhRsmbR
ibRobRoLsbRobRcbRgbRibRsLsbRibRoLsbRsbLsLsmbLcbReLsbRsbsbRebReRsmbLgRs
LobRibLhbRgRsmbRobRhRsRsRommbRgbRibRgbRibsbRsRgRsmbRgbRibRobRiRcbRebRg
RsRsmmbRgRsRsmmbRjbLsRsbRgbRiLsbRsbRgRsmbsbRgbRsbRsRsmbsbsbsbsbRsbsbLs
bRobLsbsbLsRsbsbsbRsbLsbRsLsbLsbRsbRsbLsbRcRsRsRgmmbRsRjbLsRsbsbRsbRgb
RsbRgRsmbsbLgbsbLhbLibLgbLgbsbLgbLsbLjbRgbRsbRsbsbRebsbLibLsbRcRsmbRib
sb

>ZF Recording 2016-06-02; tW: 300s; Start: 162832; End: 163336;
Recording: 7-1; Individual: 30; Drug: PCAP814 10 然 Apo 50 然
bLgLibLgLibLsLsmbLsLsmbLsbsbLibLgbLsLsmbLsLgbLibRoRsmbRsbRjbRsbLebLgbR
sbLsbRobRibRsbLibRgLsbRebLgRsbRsLsbRebLebRobRsbLcbRiLsbRsLibRiRsmbRsbL
gbLgbRsRsRsmmbRsLsbRsRsmbsbLcRsbLsRsbsbLsbRgbRhRsmbRjbLgLsbLsbRsLsbRsb
RsbRgReRsmbLsLgLsbRcbRobsbsbsbsbLsbRsbRsbsbLgbRsbLsLsmbLsbLgbLibRgLgLs
bLsLsmbLsLsmbsbLgLcLsmbRsRsRsRsmmmbLsLsmbRsLsLsmbLsLsLsLsmmmbLsbLebLjb
LcbsbLgbLgbLhLsLgbsbsbsbRobLgLsbLsRsLsbRsbsbLsLsmbLsbRsbLsbRsbRsbLsbLs
bRsbsbsbsbLsbRsbRsbLsbRsbRsbRsLsRsbLsRsbLsLsmbRsbRsbLsbRsbLsbLsbRsbLsb
RsbLsbRsLsbLsbLsbLgbsbsbLgLsbLsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 162832; End: 163336;
Recording: 7-1; Individual: 31; Drug: PCAP814 3 然 Apo 50 然
bRibRibRgbRgbRgRsmbRgRsmbRgbRgbRgbRgbRibRgbRgbRsbRibRsbRibRgbRgbRsbRgb
sbRgbRgbLsbRsbRsbLsbLcbRobRiRsmbRobRcbsbLibLcLsmbRibRcbRgbRgbRgbRiLsbR
sRsmbRiRhRiRsmbRiRsmbRgRsmbRiRsRsRsmmmbRgbRgRsRsRsmmmbRsRgbRsReRsRimbR
obLibsbLiLsbLibLibLgbLibLiLsbLiRsRsmbRsbLibLiLsbLsbLiLsbLgbLibLgbLibLg
bLgLibLiRsRsmbLsbRgbRjbRiRgbRhRsRsmmbRebRgRsRsmmbRibRgbLgbRibRiRsmbRgb
RiRgbRgRgbRgbRgbRgbRgbRiRsmbRibRibRgLsbRibLsbRsRibLcbRcbRhRsmbRsbLgbLc
bRibLgbRsbRsRobLgbLebLibLiLsbLibRsbRcbRibRibRgbRgbRgRsmbRsbRibRgbRibLe
bLgLsbLgbLhbLjbRcLgbLcbLobRgbLgbRcbRcbRgbLsbRcbRiRsmbRiRsRcmbRibRhbRhb
RgbLibRcbLgbRibRsbRcbRsbLsbRibRiRsmbRibRsbRgbRgbRgLsbRsbRibRgbRgbRgRsm
bRsbRsbRgbRsLsRsbRgbRsbRgbRebLhbLobRjbRobRsbRibRgbRgRsmbRgRsmbRsbsbsbR
sLsLsmbsbsbRgbRgbRiRsmbsbLsLsmbLobLiLsbLiRsbRobRhbRcbRibRgLsbRsbLjbRob
RibsbRiRsRsmmbRiRsmbRgRsmbRgbRgRsmbRgbRsbRgbRgbRibRgRsmbRgRibLebRjbRiR
smbRgbRgRgbRgRsmbRibRcbRcLgLsbRoRsmbRgRsmbRgRsmbRgbRoRsRsLgmmbLebLsbRo
RsmbRsbRgbRgRsmbRgbRhRgRsmbRgbRgbRiRsmbRgbRgRsmbsbRsbsbRsRsmbLjbLjbLiL
sbRsbLsbRsbRcbLsbRgbRsbLsbRsbRsbRgbRebRcbRsbLgbRibRobLsbLibLcbLsbLibRg
RsmbLibLibLsbLjbRsbLgbsbLibsbRgbLibsbLsbLjbRibRsbLobsbsbRsLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 162832; End: 163336;
Recording: 7-1; Individual: 32; Drug: PCAP814 3 然 Apo 50 然
bLsLsmbRjbRjbLsbsbRiRsmbLibLgbLgLgLsbRjbLiLsbRhbRsLsbRsRsRsmmbRsbRgbLj
bsbLiLsbLgbLhbLsRibLgLsLsmbLgRsbLgLsLsLsLsmmmbLgbLgLgbLgLsbLgbRsbRgRib
LhbLgRsbRjbLiLgbLsbRsbLjLsLsmmbLgbLsbLsLsmbsbLsLsLsmmbRsRsmbLgbRsbRiRs
mbLiLsLsLsmmbLiLsLsLsmmbLibLobLiLsbRsbRjbsbsbLcLsmbRsLsbRjbRjbLibLgLsL
sLsmmbLsLsLsLsLsmmmmbLibLsLsLimbRsLsbLiLsLsmbLsLsmbLgLsLsLsLgmmbLsbLgL
gbLsLsLsLsLsLsLgmmmmmbLcRsRsmbRebRsLsbLhbLgLsbLgbLsbLibRhbRhLsbLeLsbLg
bLgbLibsbsbRjbRjRsmbLjLsmbLgLsbLgLsbRgRsmbLgLsLgLsbLgbLgbLsLsLsLsLgLsL
sLsmmmmmbLsLsmbLsLsLsmmbRsLsLsLsmmbLgLsLsmbLsLsLsLsmmmbLibLsbLiLsbLiLg
LsbLsbLgbLgLsbLsbLsLsmbsbLgRsbLsLsmbLsbLgLsbLgbLsLsmbLsLsLsLsmmmbLibRs
RsmbLsLsmbLsLsmbLsLsLsmmbLgLsbLsLgLgbLsLsmbLsbLsLsmbLsbsbsbRsLsbLhbLob
RibRjbLsbRcbRsRsmbRjbsbLibRjRsmbRhRsmbLibRibRjbLsbLsbLsbRsbRibRgbRgbsb
RibLibsbRgbLgbLgbLsbLsLsmbLsbLsLsmbLsbLsbLsbLgLsbLgLgbRsLsbLgRsbRgbRjb
RhbLsbLebRibLjb

>ZF Recording 2016-06-02; tW: 300s; Start: 162832; End: 163336;
Recording: 7-1; Individual: 33; Drug: PCAP814 3 然 Apo 50 然
bRobRgbRcbLsbLsbRsbLsbLsbsbsbRgRsmbRibLgbReLhbLcbRiRobRcRsmbRiRsmbRgRs
LjmbLibLhRsbRebsbRsbRsbRsbsbRjbRcRsmbsbRcbRgbsbRsbRobRgRsRsLsmmbRgbRcR
sRcRsmmbRgbRcbsbsbsbRiRsmbRgLsbRcbRsbLibLhRsbLoRsRsmbLobRsRsRsRjmmbRhb
sbRgRsmbRoLsbLgbLsbLgbRgbRibRgLsbRgRsLsRsmbRibRoRsRhmbRcbRiRsmbRiRsmbR
ibRgRsReRiRiRsRimmbRhbRiRsRsmmbLibRhRsRsmmbRgRhRsRgmbRhRgbsbLjbLhRsReb
RsReRsmbRgbRgbRcbRcbRsRcb

>ZF Recording 2016-06-02; tW: 300s; Start: 162832; End: 163336;
Recording: 7-1; Individual: 34; Drug: PCAP814 3 然 Apo 50 然
bRgbRgbLsbLgbRsbRgbsbRsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 162832; End: 163336;
Recording: 7-1; Individual: 35; Drug: PCAP814 3 然 Apo 50 然
bLsLsmbRjbLiLsbLibLgbLgbsbLsbLiLsbLgbLibLgbLgbLibLgbLoLsLgmbLsbLsbRcbR
gLsbRgbRgRsmbLcbLhbRsRsmbLibLgbLgbLibLsbLhbLgbLibLsbLibLiLsbLiLsRsLiLs
bLibLibLgLsbLgLsbLibLiLsbLeLsRsRsRgmbRibRcLsRiRsmbRiRiRiRiRsmbRibRgbRg
bRibRibRibRgbRgRiRiRsRhmbRiRsmbRsbRiRiRiRiRibRgRsRiRsRiRsRimmmbRhRsmbR
ibRiRibReRsmbRiRsRiReRsRsLsmmmbLobRgbRgRsmbReReRsRsRemmbRjbLiRsbLjbLgb
LebLgbLjbRobRgbRibRsbRgbRgbRobLcbLibLobLiLsLsRsmbLibLiLsbLsbLsLibLcbLi
RsbLiLeLsbLgbLibRhbLsLsmbLhLsbLcbLcbsbLsbLibLsbLgbLgLsbLsLsmbsbLsbLibR
oRsmbRibRiLsbLobLsbLgbLsbLgbLsbLobRgbLebLoLsmbLiLsLsmbLjbRcbRgbRgbRgbR
jbLgbRebRoLsbLsbRhLsbLsbRjRsmbRsbRoLsLsLgmbsbRsbRibRgbRgbLsRibLcbLoRsL
gbLebLsbRcbRgbRgbLsbRgRibRgRsRsRhRsmmmbRibRgRsRgmbRibRibRobRgRsmbRibRc
LsbLcbLgbLibLgbLgbLgbLibLgbLgbRsLsbLsLiLsbLgbLgRsbLibRgbRoRsRsmmbRgbRs
bLsRsLsLsRsLsmbLcbLgRsbLiLsLsLsmmbLibLibLgbLiLibLgLsLoRsbRgbRhLsbsbRhL
sbRiRsmbLebRsbLcbLiLsbLiLsbLsbLgLsbLibLgLgbLgbLgbLgLsbLiLgLsLsLgmbLiRs
bRobRobRibRebRjbLsbRobLsLsmbRcRibRsbRhbRgbRsbRsbRcbRibRsbRgbRibLoRsbLg
bLgbRibRibRibsbRgbLgbLhbRcbLsbRsbRsRsRsmmbRibRhRsmbsbLcbsbLgbRjbRoLsRs
bsbRsbLibRobRibRgbRgLsbLgbLibLibLgbLiRsRgbRsbLebLhbLiLsbRgRsmbRoRsmbRi
bRiRsmbRsbRiRsmbRiRcRsRhmbRiLsbLcbLobLhbLcLsLiLiLsmbLhbLgLhLibLibLoRsb
LgLsLsLsLsmmmbLjbLibLgbLgbLsLsmbLgbLsbLsbLgLsbLgbLgbLsbLeLiLgLiLsbLibL
hbLibLiLsbLgLsbLgLsbLiLsbLgbLgLsLsmbLgbLsbLibLgbLgbLsbLgbLiLsbLgbLibLe
bLiLsLsmbLgbLiRsbLeLsLsmbLgbLiRsbRibLcbsbLhbLibRgbRgbLoLsmbLiLsbRsbReb
LgbRibRcbRgbRibRobRibLgbRsbLsLsmbsbLibLgbLiRsLsbLgbRsbLibsbRsbLsbLjLsm
bLgbLsbsbLibLgbLgbRsLcbRsbsbLjbLibRsbLgLiLibLibLsbLsbLiLsbLgbRebRsbsbs
bLsLsmbLsbRsLsbLibLibLsbLibLibsbsbLcbsbRobRebLgbRjbsbLsLsmbsbLibRcbLgb
sbRsbRsbRibRiLsbRsbLgbRobsbLsbRgbLcbsbLcLsRsmbLgbsbsbRibRgbsbLcbRgbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 162832; End: 163336;
Recording: 7-1; Individual: 36; Drug: PCAP814 3 然 Apo 50 然
bRibRgRsmbRgRsmbRgbRgbsbRgRsmbRgbRsRsmbLsbRgRsmbRgbRgbRgbRgRsmbLhRsbLh
bsbLcLsmbLibRgbRcRsRcRsmmbRcbRcRsRembRgRsmbRibRgRsRgRgRsRsmmmbRgRsmbRg
bRgbLsRsRhRcRsmbRcRsmbRcRsRsmmbReRsmbRgbRhbRiLsbRebRgbRibRsbRgbRgRsmbR
ibRcbRcbRcbRcLsRsLsbLebLgbLiLibLiRsbRsRsmbLiLsbLgRsbLgLsbLgLsbLgbRsbLg
LsbLgbLgbLiRsbLgbLgbLsbRjbRcbRiRsmbRgbRibRcLsbRibRgRsmbRebRcbRcbRobRcb
RsbRibRhbRhbRcbRibRibRgRsmbRiRsmbReRsmbRibReRsmbRibRgbRgbRhbLgbLgbRgbR
ibRcbRsRsLsmbLiLsbRibRiRsmbRibRgbRibRgbRgbRgRsmbRibRsRsmbRgbRsbRsRsmbR
gbRgbRgbRebRcRsRsmmbRcbRibRibReRsmbReRcRsRsmmbRcRsmbRhRsmbRebRibRcbRcR
smbRhbRebRibRcbRhRsmbRsbRcRsmbRcRsmbRcRsmbReRsmbRcbRibReRsmbRobRgLsbRc
bRibRibRgbRobRibLsbRgbReRsmbRiLsbRobLgbLsbRcbRcbRcbRibRsbLsbRcbRsbRsbR
gbRgRsRgRgmbRgbRgRgRsmbRsbRgbRsRsmbRgbRgRsmbRsRsmbRsbRgRsmbRgbRgRsRsmm
bRsRsRsmmbRsRsRsmmbRsbRsbLsRsbRsbRibRibRgRsmbRibRibLsLjLsmbLibRgRsRsmm
bRgbRgbRiRsmbRsbRsRsmbRgbRgbRgbsbRsbRgbRgbRsbRgbRsbRsbRsRsmbRsRsmbRsRs
RsmmbRgbRsRsmbsbsbsbLsbsbLsbsbsbLsLsLsmmbRsbRsRsmbRsRsmbLsbRsbRsbRsRsm
bRsRsmbRsbRsRsRsmmbRibLhbLibLsLibRgbRsbLgbLgbLsbRsbsbsbRebRgRsmbRsbRsR
smbRgRsRsmmbsbRcbRcRsRsmmbRcRsRsmmbRiRsmbRgbRiRsmbRcRsmbsbRcbReRsmbRgb
RiRgbRgbRiRsmbRgRsRsLsmmbRsRgRsRgRembRiRsRgRgmbRibRgRsmbRgRgbRgbRiRsmb
LcbLsbLiRsbLgbLibLgbLibLiRsLsbLgbLibLibLgbLhRsbLcLsLgmbLgbLiLsbLgbLibL
ibsbsbRsRebRcRsmbRcbsbRcbRhRsmbRgRgbRgbRgRsmbRgRgReRsRsmmbRiRsmbRgRsmb
RibRgbRcRsmbRcRsmbRcbRiRsmbLsRsRhbRcbReRsmbRcbRebRgbRibReRgbRibRgbRsRs
mbRebRibLiLsbLibLiRsbRsRsmbRsbLcbLiRsbLibRgbRiRgRsRsmmbRiRiRsmbLsRsRsm
bRiRsmbRgbRgbRgbRsbRgbLcbLcbsbRcbRsbRobRcbRcRsmbRjbRgbRibRgbRgRsRsmmbR
gbRiReRsmbRsbRgRsmbRsbRgbRsbRgbRgbRgbRsRgbRgRsmbRgbRsRsmbRibRsbsbLcbLj
bRsbLibsbLgbLsbLsRsbLibsbRgRsmbRsbsbRsbRsRsmbRsbRgRgRsmbRsbRsbRibLsbRo
RsmbsbsbRsbRhbsbsbRebRsbRjbRsbsbRebRcRibReRsmbRcbRsbRgbRgbRibsbRjbRsbs
bRjbRsRsmbsbRobsbRgbLgbRhbRiRcbLsbRcbRibLibLibLgbsbLgbLcRsbLsbLibLgRsb
RgbLibLiRsbRsbLsbRsbLgbRibRsbLjbLsbLgbsbLsbRjbsbRgbRibsbsbRiRsmbRgbsbR
ibsbsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 162832; End: 163336;
Recording: 7-1; Individual: 37; Drug: PCAP814 1 然 Apo 50 然
bRgbLsbRibRiRhLsRibRibRgbRsbRiLsbsbRgbRgReRibRhLgbRgRsmbRebReRhbLcbRcR
smbRgbRsRsLsmbsbLsLsRsmbLobRcRsRsmmbRsbLhbLjLgRsbLsRgbsbRiRsmbRsRsmbsb
LsRsbLjbLibLcbLibLiRsLebLsLsmbLgLsbLgbLgbLsbLgLsbLsbLsLsmbLsbLgLsbLiLs
bLiLsLgLsbLgLsLsLimbLsbLgbLgLsbLiLsbLiLgLsbLgLsbLgRsbLsbLgbLsLsLsmmbLg
bLgbLsbsbLiRsLgLsbLgbLsLsLsmmbLgLsLsmbLgbLgbLgbLgLsLsmbLgbLgLsLsmbLgLi
bLgLiRsbLibLgbLgbLgbLgLsLsmbLgbsbLgbLgbLgbLgbLgLsbLgbLgbLgbLgLsbLiLsbL
ibLgbLibLeLsLeLsLibLiRsRsmbLobRoLsbRhRsmbRcLsLhbsbLcbRsbLoRsLsbLoLsRsm
bLsLibLgbLgbLiLsbLgbLibLibRcLsbRsRsmbRibLebLgbLgRsbRebRiRsLjmbRhRsmbLj
bRibRgbRsbRsbsbRibsbLcbLcbLsRsbRsRsLsRsmbRebLcbLhbLgbLsbRsbLsbRsbLsbRs
bRsbLjbLsLsLsLsmmmbLiLsbLgbRsLgbLgbLgLsbLiLsbRobRibLebRcbRsbsbLjbLhLsb
LiRgbLobLgbLiLsbLiLsbLgbLoLibLcbsbRjbRsbRcbRhbLsbRsbRibRsbRebRgbRgbRiR
smbLhbLebLibLibLiLsLebLibLcLsmbLebLiLsbLeLsbLibLebLgbLeLibLeLhbLebRjbL
gLgbRebRjbRibLjbLebLibLeLsbLgbLgbLebLgbLgbLiLsLebLsbLibLgLsLibsbLcbRib
RobRcbLcbLiRsbLibLgLsbLgLsLsmbLiRsLiRebLibLibLibLsbLgbLhLjbLsbLibLgbLi
bLibRsbLjbLsLsmbLibLgLsbLgbLgbLgbLsLgbLsRsbLgLsbLgbLgbLsbLgbLsLsLsRsLs
mmbLgbLgbLsbLgbLjbLsbsbRcbRibsbsbRobsbRcbRsRsmbLebLsbLebLebLebLjbLebsb
LjbRsbRsbsbRsbsbRebsbRcLsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 162832; End: 163336;
Recording: 7-1; Individual: 38; Drug: PCAP814 1 然 Apo 50 然
bRsbRsRsRgmbReRsmbRiLsbLsRsbRgRsRgRgRgRsmmbRgbLsRsRsRgmbRsbRsbRgbLsbLe
LsbRsLsbRebLsbsbRjbRsLsbsbLgbLgLsLsLsLsLsLgLgmmmmbLgbLgLgbLgLsbLgLsbLs
bsbLsLsLgLsmbLiLsbLiLsbLsLgLgbLsbRsbLsLsmbLsbLibLgbLsLgLsLsmbLgRsbLsLs
mbLsbLsbsbRsRsmbRsbLsbLsLsmbLsLsLgmbLsLsLgLsmbLsLsLsmmbLgbRsRsmbsbLsLs
LsLgmmbLsRsbLgLsLsmbLibLgLsLgbLebLcbLibLsbsbRsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 162832; End: 163336;
Recording: 7-1; Individual: 39; Drug: PCAP814 1 然 Apo 50 然
bRgRgRsRsmmbRsRsmbRibRsRsRsmmbRsRsRsmmbRsRsmbRsbRgbRsRsRsmmbRgbRibRsbR
gRsmbLcbLgbLiLsLsmbLiLsbLibRsbLsbLibLgbReRsRgmbRgbRsbRgbRsbRsbRsRsRsRs
RsmmmmbRsRsmbRsRsmbRgRgRsLsmbRhbLsbLgbLcbRsbLibLcbRgbLsbsbRhbLoLsLsmmb
LibRsbLsRsbLsbLsbRsLsLsmbLsLsmbRiRsmbRsbRgbRsRsmbRgbRsbRgbRgRsmbRsRsRs
mmbRgbRgbRsbLsbLcLsLsmmbLgbLsLgbLsbRsRsLsmbLgbLgLsbLibRgbRibRsRsRsRgRs
mmmbRsRsRgmbRsRsmbRgRsmbRgbRsRsLsmbRiRsRsmmbsbsbRsbLsbRsRsRsmmbRsRsmbs
bLjbLcbLsbRsRgbRgbsbRsRsRsRsmmmbRiRsmbRsbRsbRgRsmbRsbRsbRsbRsbRsbsbRjb
RsbsbLsbRsbRsRsmbRibRsbRibRsRsmbRiLsbLsLsmbsbLgLsbLiLsbLsLsLsmmbLgRsbL
sbLsLsRsmbLsbRhbRsbRsbRgLsbRgbsbLsbRgRsmbRsRgLsRsRsRgmbRsRsRgRsmmbRgRs
RsmmbRsbRgbRjbLsbLgbLjbLibLgRsbLibLgbLcLsmbLgbsbRsRsmbRsbRibsbRsRsRsmm
bRcbRsRsmbRsRsRsmmbRsbRsRsmbRsRsmbRsRsmbRsRsmbsbsbRsbsbRsbRsRsmbRsbRgb
sbLcbLibLsbLibLibsbRsRsmbRjbLiLsbLibLsbRsbRsLsLsmbLsLsLsmmbsbRsbLsbLsb
sbLsbsbsbsbsbLcLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 162832; End: 163336;
Recording: 7-1; Individual: 40; Drug: PCAP814 1 然 Apo 50 然
bLsLsLimbLiLsbLsLgbLsLsLgLgLsmbLhbLgLgbLgLsbLgLsLsLsLsLsmmmmbLebLebLiL
sLgLsLsmbLibLibLgLsbRobRibLjbLgLsLgbLgbLgLsbLgbLgLsLsLsmmbLsLsmbLsLgbL
sRsRsLgLiLimbLgbRsLsbLiLsLsmbLiLsbLiLgbLhbLgbRcbRgLsbRsbRgbRiRsRsmmbRg
RsmbRgbsbRibRibLcbLsLgRsbLgLsLsmbLsLsmbsbLsbLgbRsLiLsbLsLsLgLsLsmmbLgb
LiLsbRibRibRibLgbRhbLsbsbRhbLiLsbLiLibLgLsRsLsbRgbLiLgbLiLgLiLgbLobRib
RsbRsRsmbLsbRsbsbsbsbLgbsbLsLiLsbLiLsbLsLgbLiLsbLsLibLiLsbLgbLsLsmbLsL
smbRsbsbLsbLgbLsbLibLiLsbLibLibLgbLiLsbLibRsbLsLibLgbRgLsLsmbLsLiLsLgL
sbLgbRgbLsbLsbLsLeLsbLsLsLsLsLsLsmmmmmbLsbsbsbLibLjbLsLsmbRsbLsbLsbLgb
LgbLsLsmbLsbLgbLsLsmbLgLsbLsbLgbLsbLsbLsbsbRsbLsbLgbLgbsbLibLibRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 162832; End: 163336;
Recording: 7-1; Individual: 41; Drug: PCAP814 1 然 Apo 50 然
bLebLiLsbRsbLsbLoLhLgbLcRsLsbLgbLcLsLimbRhbRibRsbRebRebLgLibLoLgLsbLeb
LobReRsRsmmbRcbRhbRgRsRsRsmmmbRhbRiRsRsmmbLcLsmbLcLsLsmmbLcLsmbReRsmbL
eLhbLhbsbLeLsbLiLsbLebLibLsRsRsRgRsRcmmbRiRsmbRcLsbRgRsRsRsRsRemmmmbRh
bReLsbLeLiLsLsmbRebLgRsRsmbLibLiLsbLgLsbLsRsbLiLsbRibLgbRcbRgbRgbRgbLe
LgLsLsmbLobLcLsmbLcLibLobRhbReRsmbRiRsRsRsRsRsmmmmmbRsbRsbRhbLsRsbLjbL
ebLhbLeLsbLcLsmbLibLoLsmbLeLsbLebRebLeLsbLiLsbRjbRsbReRsmbRiRsReLgmbLe
LsbLebRiRsRsRgmmbReRsmbLsbRiRsRsmmbLebLcbLsLhbLsbRjbLsRsLsRsbRsRsmbLcR
sbLeLgbRibRibRgRibReRsRsmmbRiRsmbRiRsmbRhRsRsRsRsmmmmbRiLsbRsRsmbRiRsR
smmbLebLeLgbLhLsbRsRsRsmmbLeLsLsmbLgLsbRgLsbLsbLibLeLsbLcbLsLsLsmmbsbR
sbsbRcRsRsmmbRsRsmbRhRsRsRsRgRsmmmmbLsbLcLgRsbLgbRgbLsbLsbLobLsLsmbLhL
sLsmbLeLsbLsbRgbRjbRsbRibLebLgLsLsmbRgbLeLsLsLembLhLgbLhLsLsmbLgbLibRc
RsmbRibLsbRsbLobLsLsmbLgbRebRsbRgbRgbRsLsbLjbLcbLgLsbLsbLsLsmbReRsmbRs
RgbRsRsmbRgbRgbLsbLebLcbLsbLebLibLsbReRgbReRhbRgbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 162832; End: 163336;
Recording: 7-1; Individual: 42; Drug: PCAP814 1 然 Apo 50 然
bLsLsmbLsLsmbLgbsbLsbsbLsRsbLsbLgLsbLsbLsLsLsmmbLsbRsbRsLsbLsbLsRsbLsb
LsbLsLsmbLsbLsbLsbLsbLsbLsbsbsbLsbLsbsbLsbLsbLgbLgbLsbLsbLgbRsRsRsmmbL
gbLsbLsbLsbRsbLsbLsbLsbLsRsbLsbLsbLgLsbLgbLsbLsbLgbsbLgRsbLgLsbLsRsLsb
sbLsbLgbLsbLgbLsbLgRsbLgRsbLiLsbLgbsbLsbLsbRsLsbLcbLibLgbLibRsLiLsLgLs
bLibLgbLgbLsLsmbLsbLgbLsRsbsbLgbLgLibLhLsbLsbLiRsbLiLsbsbsbLgbLgLsLsmb
LgbLsLsmbLgbLsbsbLsbLgbsbLgbLgbLsLsmbLgLsbLsbLsLsmbLgbLgLsLgbLgbLiLgbR
iLsbRhbRsbsbRibRsRsmbRgbRgbRoLsRiRsRhRsRimmbRgRsmbRgbRgRsmbRgbsbRgbRiL
sbRiRsmbRiRsmbRgbLsbRsbRgRsmbRgbRgRiReRibRebRgRsmbRgbRsRsRimbRiRsmbRhL
sbsbRhbRgbRiRsmbRgbRsbsbRiRiRsRembRibRgRsmbRiRiRibRhbRiRsmbRiRsRhmbRiR
sRiRembRebRebRhRhRebRiRsmbRhbRebLgbRgbLsbRebRsbRsbRobRgbRhbRibsbLgbLib
RsLsbLgRsbsbLgbLsbLsLsmbLsbLsbsbLsbLsbLsbRsbRgbLgbLgbLgbLgbLibLgbRsbLi
bsbLgbsbLgbRsbRsbLgbLgbLsbLjbLsLsLhmbLsRsbLcbLgbRgRsmbsbLgbLgbLgbLsbLs
bLgbLgbLsRsbRibRgLsbsbLsbLgbLgbLgbsbLsbsbLgbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 162832; End: 163336;
Recording: 7-1; Individual: 43; Drug: Control Apo 50 然
bReLsLsLcLsLsmmmbLebLsLsmbLsbRsbsbRgbRsbRsbLsbLsbRsbLjbLgLsbRibRibRibR
sbRoLsbRebLgbRgbLcLsmbLiLsLsRsmbLcLgbLcbRebRibRebsbRgbRhbRgbRgbRibRsRs
mbLibLiLsbLcLsmbLibLobRgbLibLobRgbRibLsbReLsbRsbLsbLsbRsbRgbRsbsbsbsbs
bsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbs
bsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbRsbsbsbsbsbsbsbsbsbsbsbsbsbsbsb
sbsbsbsbsbsbsbsbsbsbsbsbsbsbLsbsbsbsbsbsbsbsbsbsbsbsbRsbsbsbsbsbsbsbsb
sbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsb
sbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbRsbsbsbsbs
bsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbLsbsbsbsbsbsb
sbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsb
sbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsb
sbsbsbsbsbsbsbsbRsbsbsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 162832; End: 163336;
Recording: 7-1; Individual: 44; Drug: Control Apo 50 然
bLgbLsbLhbLibRgRsRgRsmmbRsRsLsmbRsbLgLsLsmbLsbLgLsbLgbLibLsbRsbRsLsbRg
RsmbLibRcbRsLsbLibLgbLibLgbRsbRobRhbRgbRhbRsRsRgmbRgbRsRsmbRsRsmbRibRi
bRebLsbRsbRcbRibRgbRcbLgbRsbRgRsmbsbLobLiLsLgbRobRcRgbsbRjbRibRobLiRgR
smbsbRcbRsbRibsbRsRgbRibLsbRgbRgbRibRibRibRiRsmbRgbRsbRobLhbLcbRgbLjbL
sbRsLsbRsbRsbRsbRsbRgbsbLsbLibLgbLibsbRsLsbLibLibLgbLsLsmbLsLgbLeLgbsb
LgLsbLeRgbRibLobRcbsbRcbRsRsLsmbLsbRcbRibRiLsRsbLgbLsbRsbLjbLgLgbLibsb
LgbLsbsbLgbLgLsbRsbRjbRgbRhbRgbRgRsRsmmbRsRgbRgbRsbLsbRcbLsbRgbRsbRsbs
bLgbLsbLsbLsbLsbLsbRsbLsbRsbLsbsbLsbLsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 162832; End: 163336;
Recording: 7-1; Individual: 45; Drug: Control Apo 50 然
bLgbLgLsLsLsLhmmbLeLsbLebLhbLibLgbLsbLeLsbLibRobRcbLsbRiRsmbLsbLjbLcbL
iRsbLeLsLgbLiLsRsLgbLiLsLibLgLsbLgbRsbLibLebLgbLiLsbLgbLsbLoRsbLibLibL
gLsLsLsLsmmmbsbLiLiLgLsLsmbLibLibLebLibLiLibRobRibRibRiLsbLsRsbLobLeLs
bLeLsbLibLgLsLsmbRgLsLgLsbLgLsLsmbLgLsbLgLsLgbLebLgbRsLsLsLsmmbLebLiLs
bLgbLgbLsbLsLgLsbLibRgLsbLiLsbLgbLsLsmbLcbRsbRgbsbRhbRsRsmbRgRsRsLsmmb
LgbLebLgLgLebLoRsbsbLsbRgbsbLjbLsbLiLsLsmbLgLgLsLebLsLsmbLgLsLsmbLgLsL
smbsbRibLsbLcLsmbLibLibLebLibLsbLcbLeLsbLhbRibRsRsRsRoRsmmmbLsLsLsLsmm
mbReRsmbRebRsRsRsRsmmmbRsbLjbLgbLsbLgLsbLsLsLsLsLgLsmmmbLgLsLsmbLibLib
LgbRhbRebRibRcbRiRsRsLsmmbLiLgbLgLsLsLsLsLsLsLhmmmmmbLsbLsLsmbLgLsbLgb
LsLsLsmmbLibLgLsbLsLsmbRsLiLsLsLsLsLsmmmmbRgRsmbsbLiLsbRgRsRsmmbsbLgbL
ibsbLiLsLsmbRebLeLsLsLsmmbLgbLsbLgLsLsLsmmbLsbLsbRibRobLsLsmbLsbLebLgb
LiRsbRgbLeLgLsLsLsmmbLgbLgLsbLgLsbRsbLgLsbLgLsbLsLsLsmmbLsLsmbRgRsmbLi
LsbLgLsRsbLibLgbLgbLsRsbLgLsbLsbLsLsmbRjbRebLsbLsbsbsbLebLgbLhLgbLjLsR
smbLgbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 162832; End: 163336;
Recording: 7-1; Individual: 46; Drug: Control Apo 50 然
bRibRebRgRgRsRsmmbRgRsmbRhbRgRsmbRebLgRsbRcRebRgbLsbRebRiLsbRsbLcLsmbL
sbLebLhRsLsbLsbsbsbsbLiLsLsmbLibRgbLobLibRhbRhbLoLsmbLgbRobRgbRgbRibRh
RsmbRgbRgbRibRcbLibRiRsmbRhRsmbRgbLsbLcLsmbLobsbRsbsbRjRsmbRibLsbRsRsm
bRibRibRhbsbLsRsRgbsbsbsbsbRsbsbRsbLsRsbRsLsbLsLsmbRsbRsbsbRsbRibRsRsR
sRsRsRsmmmmmbRsLsRsbRsRsmbRcbRgbLgbRgRsmbRjbRsbRjbRsbRibRsbRsRsmbsbLsb
sbsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 162832; End: 163336;
Recording: 7-1; Individual: 47; Drug: Control Apo 50 然
bRgRsmbLiLsbsbRsbsbRiRsRsmmbRsbRcbRgRsRsmmbRsRgbRgRsRgRsmmbRgRgbRsRiRs
mbRiRsRsmmbRgbLsbRhRsRsRsRsRsRsRsRsRsRsRsRsRsRsmmmmmmmmmmmmmmbRgbRsRsR
smmbRsRsRsRsRsmmmmbRsRsRsmmbRsLsbRsRsRsmmbRsRsRsmmbRsbRsRsmbLsRsRsRiRs
RsmmmbRsReRgRsmbRsRsRsRsRsRsRsRsmmmmmmmbRsbRsbRiRsmbRgRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 162832; End: 163336;
Recording: 7-1; Individual: 48; Drug: Control Apo 50 然
bLoLsmbLcbLibLobLebRgbLcbLgbLobLibRcRsRsmmbsbRsbRcbRsbLsbRibLobLhbLgLi
LsbLibLiRsbLibLobLgbRjbRcbRsRsLsLsmmbLsbRgbLsbRsRsmbRsbReRsmbRibRsbLgb
LebLsbLiLsbLibLeRsbLoRsbLobLjbLobLibRgRsRsmmbRcRsmbRcbLsbLibLhbLsbRibR
hbRibRiRiLsbRibRcRsmbRgbLobLoLsRsmbLiLsbLgbLgbLsLsmbLiLsbLhbLgbLibLgLs
RsbLiLebLgbRgbLobLcbRsRsmbLsRsLgLsLiLgRsbLiRsLsLebLsbLgbLobLcbLobLgRsb
LgbRsbRjbRebLsbLcbLsLsLsmmbLcbRcbRgbRiRjbRiRsmbRibRibLibLiLsbLebLeLibL
ebLsbLebRibsbsbRgbLobLibLjbLiLsbLebsbLibLcbsbLsRsbRsbLsbLsRsbRibRjbRob
RjRgbRiLsbRgbRsbLcbLcbLobLjbLgLsLgbLsbLcLsLgmbLibLgbLcbLjbRobRhbRgbReR
smbRgbLobLgbLcbLiRsbLibLibLobLgbRsbLgbLhbLgbLsbLcLgbLibLgLsbLiLsLsmbLo
bRsbLobsbsbsbsbRsbRgRsRsLsmmbRsbRsbRjbLcbLcbLjbLcbsbLgbLsbLgbLibLjbLeb
LgbRcRhbLibLiLgbRgbLsLsmbLsbLibLibLgbLgLgbLebLebLgbLgbLcLsmbLobRibLibL
ibLcbLsbLjLsmbLebLgbLgRsbLobsbLgbLsbLobLobRjRgRsmbRhbRsbsbLobLcbLsbLgb
LibLsbLgbLgbRcbRibRibsbRsRsmbLsLsmbLjbLhbRsRgRsmbLjLsLsmmbLcbRebRgbLcb
sbLhbLgbRsbRsbRibLgbLcbLgbLgbRibRibRjbRibRgbLgbRcbLibRiLsbLobLgLsbRhbL
ibLgbLgbRsbLgbLsbRsbRebLsbRiRsmbLgLsbRibRgbsbRsbRibLsbLgbLcbRgbLgbLsbL
sbRsRsRsmmbRjb

>ZF Recording 2016-06-02; tW: 300s; Start: 163338; End: 163850;
Recording: 8-1; Individual: 1; Drug: PCAP814 10 然 Apo 50 然
bRsbsbLsbRsRsmbLsbLsbRsbRsbRsbLgbsbLsbsbRsbLsbLsbLsbLsLsmbRsbRsbRsbLsb
LsRsbRsbLsbRsbRsbRsbLsbLsbRsbLsbLsbLsbRsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 163338; End: 163850;
Recording: 8-1; Individual: 2; Drug: PCAP814 10 然 Apo 50 然
bsbsbRsRsmbsbRgbRgbRgRsmbsbRsbsbsbLsbLsbsbsbsbRsbsbsbsbLsbsbsbLsbLsbsb
RsbRsbsbsbsbLsbRsbRsbRsbLsbRsbLsbRsbRsLsbLsbsbRsbRsbRsbRsbRsLsbRsbRsRs
mbsbRsbRsbRsRsmbLsbRsRsRsmmbRebLsLsmbRsRsmbRsbRgbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 163338; End: 163850;
Recording: 8-1; Individual: 3; Drug: PCAP814 10 然 Apo 50 然
bsbLsbsbsbsbsbRsRsmbLsbsbLsbsbRsbLsbRsbLsbRsbLsbLsbLsbRsbsbLsbsbLsbsbL
sbsbsbsbLsbLsLsmbsbLsbsbsbsbsbsbsbsbLjRsbLsbsbsbRsbRsbsbRjbsbsbsbsbsbs
bsbLjbRjbRjbsbsbRgbRjbsbRsbsbsbLsbRsbsbsbLsbLsbRsbLgbsbRsbLsbsbRgbsbRs
bsbRsbsbLsbRsbLsbRsbsbsbLsLsmbLsbsbsbsbsbsbsbsbRsbsbRsbRibsbsbRsbRgbRg
bsbLsbLsbRsbLjbRsbRsbRsbLsRsbLjbRgRsmbLebLsLsmbLsbLgRsbRsbRsbLsbLgbLsL
smbRsbsbRsbLjLsRsmbLgLsLsLsmmbRgbLcbLibLsbLgbLibsbRsbLeb

>ZF Recording 2016-06-02; tW: 300s; Start: 163338; End: 163850;
Recording: 8-1; Individual: 4; Drug: PCAP814 10 然 Apo 50 然
bRsLsbsbsbsbRsbLsbLsbRsbRsLsbsbRsLsbsbsbsbsbsbsbsbsbsbsbLjbRsbsbsbLsbs
bsbsbsbLsbRsbLsbsbsbsbsbsbRsbsbsbLsbRsbLsbLgRsbsbLjbsbLsRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 163338; End: 163850;
Recording: 8-1; Individual: 5; Drug: PCAP814 10 然 Apo 50 然
bsbRsbsbsbsbsbRsbRsbsbRsbsbRsbLsbLsLsmbsbsbLsbRsbRsbsbLsbLsbsbsbsbsbsb
sbsbsbLsbsbsbRsbsbsbRsbRsbsbsbLsbsbsbsbsbsbRsRsmbsbsbsbsbLsbsbRsbRgRsR
smmbLsbRsbsbLsbLsLsmbRgRsRsmmbRsbsbsbsbRsbsbLgbRsRsmbRsbRcbLcbLobRobLs
LsmbLjLsmbRiRsRimbLgbRsbRjbRsbsbsbsbRsLsbsbLebRgbRgbsbRiRsRsRsRsRgmmmm
bLsbsbsbRjbRgRsRsRsmmmbsbLsbsbsbsbsbsbsbLsbsbsbsbRsbsbLibRobLjRsbLsLsL
smmbLsbRsLgbLsLsmbLsbRsLsbLsbRsRsmbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 163338; End: 163850;
Recording: 8-1; Individual: 6; Drug: PCAP814 10 然 Apo 50 然
bLsbLsRsbLsbRsbRsbRsbRsbRsbLsbLsRsbRsbLsbLsbLsRsbRsbLsbLsbLsLsmbRsbRib

>ZF Recording 2016-06-02; tW: 300s; Start: 163338; End: 163850;
Recording: 8-1; Individual: 7; Drug: PCAP814 3 然 Apo 50 然
bsbsbsbLsbsbLsbLsLsmbsbsbRsbRsbLsRsbsbLsbLsbLgRsbRgbLsbLsbsbRgbRcRibsb
sbLibLibLsbsbsbLibLibsbRgRsmbLsbLgbLsbsbsbRsRsLsmbLsLsmbRsLsRsLsbLsbRs
bsbsbsbRsbsbLsbsbLsLsmbLsbLgRsbLsbLsbLsbLsbLsbLgbsbsbLcbsbsbRsbsbsbsbs
bsbsbRsbRgbsbRsbsbsbsbsbRgbRsbsbRsbLsbRsbsbsbsbRsbsbsbsbsbsbRgbsbRiRcb
RhbsbLcbLjbRsRsmbsbRsbRsbsbLhbsbRjbRibRsRsmbLsbsbsbRibsbRsbLgbRsLsbsbR
sbRjbLsRsRsmbLsRsbLsbsbsbRgbsbLsbRgbsbRsbRgbsbsbLjbLibsbsbsbsbsbsbLsbR
sbLsLsmbsbLsbLsbsbLsbsbLsbsbsbRsbLsbLsbsbLsbLgbLsbLoRsbLgRsbLsRsLsbsbR
gRsmbLsbRibLibLobLibRsbLgLsbsbsbLsbLsbLgRsbLsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 163338; End: 163850;
Recording: 8-1; Individual: 8; Drug: PCAP814 3 然 Apo 50 然
bLsbLgLsbRsbLsbLsbRsRsmbRsLsbsbLsbsbLsbsbsbsbLsbsbsbLsbRsbRsLsbsbLsbsb
Lsb

>ZF Recording 2016-06-02; tW: 300s; Start: 163338; End: 163850;
Recording: 8-1; Individual: 9; Drug: PCAP814 3 然 Apo 50 然
bLiLsLsmbLsbsbLsbLgbLgLsLsmbLsbLgbLsbLgbsbsbsbLgLsbLibLgbsbsbLgLsLsmbL
gbLgbLsbLsbLgbLsbRsbLsbLsbLsbLgbsbLgbLgbLgbLgbLgbLgbLgLsbLgbLgbLgbLgbL
ibLsRsbsbLgbLgbLgbLibsbRsLsbLobRsbsbLibRsbsbsbLgbLiLsbLgLsLsmbLibRsbLi
RsbLibsbLsbLsbLiLsbsbLjbLsbLobRsbsbsbLoLsmbLhLsLsLgmbLiLsbLibLibLibLiL
sLcbsbRsbLgbsbRsLsbsbLibLsLsmbsbRsbLsbLgbsbLjbLsbLgbLsbLgbLgbLsbLsLsmb
sbLsbLibLhbsbLgLsbLsbsbLibLsLsmbLgRsLsbLsLsmbLgbRsLsLsmbLsLebLsLsLcLsL
smmmbLiLsLsmbRsLsbLebLibsbLebLsbLebsbLsLibLobLsbLobLsbLgRsbLebsbLiLsbL
iLsRsbLiLsLsmbLibLibLgbLgbLsbsbLibLsbsbRcLsbsbRgbLsbLsbsbsbRsbsbRibRsL
sbLsbRsRsRsLsLsRsmmmbLsbLsbsbsbRsRsLsmbLeLsbsbsbLsbsbsbsbLgLsbLsbLgbLs
bLsRsbLgbLgbLsbLgbLgbLgbLgRsbLgRsbLgbLgbLgbLgbsbLgbLgbLgbLgbRsbLibsbsb
sbLgbsbsbRsRcbsbsbsbLsbLsbsbLsRsRsmbRiLsbRgbsbRcbRsbRsbLibRsbsbsbLebsb
LibsbLsbsbLcbsbsbLsbLgLsbLsLsmbLsbLgLsbLsLsmbLsbsbLsbLsbLsbLsbLsbLsbsb
LgLsbRsbLgbLgbLsbLsbLsbLgbLsLsmbLsLsmbLgLsbLsLsmbLgLsbLsbLsbLgRsbLsbsb
LgbLgbRsLsbRgbRsbsbsbsbLgbsbsbRsbsbRgbLsRsLsbsbLcLsmbLibsbRgbsbLgLsbsb
RsbLibLobLcbLgbLibsbLibLgbLiLsbLgLsbLgbLsbLgLsbLgbLgbLsbLsbLibsbLgbLgL
eLobRgRgbRibRibRibRibRsbRgbRibRhLsbRsbRsLsbLsRsLsRsbsbsbsbsbLsbsbsbRgb
RgRsmbLsbRsbRcbLsbsbRhLsbRcRsmbLsRsbsbLjbRobsbsbRgbRcbLsbLsbRobsbsbLgb
LoLsmbLcLsmbLcbLiLsLsmbsbLibLibLgbsbLgbLsbLsLsLsmmbLsbsbLjbLsbLjbLsbsb
LiLsbLiLsbLibLiLgbLsbLgLsbLgbLiLsbLibLibLiLsbLibLhLhLsLhLgbLgbRjRgbRcR
ibRibRibRgbRgbRgRsLsmbLsbsbRsbLsbRsbRsbRsbsbsbsbLsbLsbLgLsLsmbsbsbsbsb
LgbLgLsbLgbLsbLsLsmbLsbRebRibsbsbRcbLibLsbRcRsmbRcLsbRsbsbRsbRibRiRsmb
RiRsmbRsbRiRsmbRgbRibRsbRgbRgbRcbRcRsmbRhbRobRcRsmbLsLcbLiLsbRoLsbRiLs
bRgLsbRgbRgbRgbRgbRgbRgbRgbRgRsmbRgbRgbRiRsmbLjbLhbLhbLhbLhb

>ZF Recording 2016-06-02; tW: 300s; Start: 163338; End: 163850;
Recording: 8-1; Individual: 10; Drug: PCAP814 3 然 Apo 50 然
bLsbLgbRsbsbRsbRsbsbsbsbRsLsbLsRsbLsbLsbLsbLsbLsbsbLsLsLsmmbLsLsmbLsbL
sbLsbLgbLsLsmbsbLsbLsLsmbLsLsmbLsbLsbLsbLsRsbRsLsbLsbLsbsbsbsbLsLsmbsb
LsbLsLsLsLsmmmbLsbLsbRsbLsRsbLgbLsbLsbLsbLsLsmbLsLsmbsbLsbLsLsmbLsbLsL
gbLsbLsLsmbLsLsmbLsLsmbLsLsmbLsbLsLsmbLsbLsbLsLsmbLsLsmbLgbLsLsLsLsmmm
bRsbsbLsLsLsmmbLsbLgbLsbLsbLgbLsbLsbLsLsmbLsbLsbLsLsmbLsLsLsmmbLsbLsbL
sLsmbLsbLsbLsbLsbLsbLsLsmbRsbLsbLgLsLsmbLsLsmbLsRsbsbLsLsmbLsbLsbLsbLs
LsmbLsbsbLsbsbsbLsbLsbsbsbsbRsRsmbLsbsbsbsbRsLsbsbLgbLsLsmbRsLsLsmbLsL
sLsLsLsmmmmbRsbLsbsbLsbRsbLsLsRsmbsbLsbLsbLgbLhbLgbLibRsbLibsbRsLsbLsL
smbLsbLsbLsbLgbLsbLsLsmbLsbLsbLsLsmbLsbLsbLsLsmbLsbRsbLsbLsLsLsLsmmmbs
bLsRsbsbRsbsbsbsbsbsbsbsbsbLsbsbLsbLsbLsbLsbLsbLsbLsbsbsbLsbLsbsbLsbLs
LsmbLsbLibLgRsbLsLsmbLsLgLsbLsLsmbLsbLgbLgRsLsbLsLsmbLsLsLsLsLsmmmmbLs
bLsLsLsLsmmmbLgbLgLsbLsLsmbLgRsbLsbRsbsbLsRsbLsbLsbLsbLsLsLsLsmmmbLsbL
gbLibLgbLsLsLsLgmmbLsLsmbLsLsmbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 163338; End: 163850;
Recording: 8-1; Individual: 11; Drug: PCAP814 3 然 Apo 50 然
bLgbLsbRsbRgbRsRsmbsbRsbLsRsbRsbRsbsbsbsbRsbRgRsmbRsbsbsbRsbsbLsbLsLsm
bLsbLsbLsbsbsbsbsbsbRgRsmbsbLsbLsbLsbsbsbRsbRsbsbsbLsbLgbRgbRsbRsbRsbR
cbsbLsbRgbRsRsmbLsRsbLsbsbLsbsbRsLsbRsLsbRsbRsbRsbLsbsbsbsbsbsbsbsbLsb
sbsbsbsbRsRsmbRgRsmbsbRsbRsLsbRsbRsbRgbRjbRsRsmbRsbsbRgRsmbsbsbLsbRsbR
sbLsLsmbLsbLjbLsbRjbRjbsbsbRsbLsbRcbsbsbRsbRsbLsbLsbsbsbsbLsbRsbsbRsbs
bsbRgLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 163338; End: 163850;
Recording: 8-1; Individual: 12; Drug: PCAP814 3 然 Apo 50 然
bRjbRsRsRsmmbRgbLsbLgbLibLgbLsbsbLhbRgbLibsbRsbsbsbsbsbRsRsLsmbRobLsbR
sLsbRebRsbRjbRsbLsbLsbRobsbLcLsmbsbRsbLcbsbLsbRgbLcbRsbLsbLcbRsbRgbLcL
smbRgbReRsmbRibRobLsbsbLsbLjbLibRsbsbRgRgbRgbRsbLgLsLsmbLcbRcLsbRgbsbR
sbRsbRebLsbsbsbsbsbLcbLcbLjbRhbRebLgbsbsbRjbLibLgbLebRsRsRsmmbRibLcbLe
bLibLhbLgbRibRhbRsbLsbRibRsLsbLsbRgbLibLcbRgRsmbRcbRjbLcLsmbRsbRsbRibR
ebLcbLsbRebLjbLjbRsbsbRsbLibsbRsbLcbRsbsbsbsbRibRsbLhLsbLcbsbLcbsbRsbR
ibRsbRsbRhbRobRgbRsbRebRgbsbsbsbsbsbsbsbRsbLsbsbLebLsbLibRgbsbLobRsbsb
LhbLhbLcLsmbRjbRsbsbRjRsmbsbRebLhLsbsbRsbRgbRjbRibRsbsbRcbsbRjbLsbsbRo
bRsbRebLjbLsbRjbRsbRjbRsRsmbRibLsRsbsbLcbLsbRhbsbRjbRebsbLsbRsbLgLsbRe
bLsbLsLsmbRibRebsbRgRsLsmbRibLiLsbRjbRsbRsRsmbRgbLsbRsbLsbLsLsmbLobsbs
bLgLsbLibRibLsbLsbsbLhbLsbRibRebRsbRgbRjbRcbRibRsLsbRsLsbLcLsLgmbRsbLj
LsmbLibLjLebLcbRibRhbLeLsbLiLsbLiRsbLobLsbLeLsbRcLsbRcbRibsbRsbLcLsmbL
gbLobRibLsLsmbLiLsbLoRsRibLcbLibLcbRobLiLsbLgLsbLiLsLsmbLsbLhLsbLgLsbR
iRsmbLsbLhbRjRcbRjRgRsmbRgLsbRibRsRsmbReLsbRgbLsbLcLsmbLgbLobRgbLsbReb
RgbRgbRhbRgbRibRibRhbLgbLgbLsbLcLsmbRgbRhLsbRgbRgbRibLgLsLsmbLib

>ZF Recording 2016-06-02; tW: 300s; Start: 163338; End: 163850;
Recording: 8-1; Individual: 13; Drug: PCAP814 1 然 Apo 50 然
bsbsbRsbLsbLsbRsRsmbRgbRsbRsbRsRsmbRsbRsbRsbLsbRsbsbsbRsbRsRsRsmmbRsbs
bRsRsmbsbRsRsmbRsbRsbsbRsbRgbLsRsbRsbRsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 163338; End: 163850;
Recording: 8-1; Individual: 14; Drug: PCAP814 1 然 Apo 50 然
bLibLjbLsbsbLsRsLsbLgbLgbLsbsbsbLsLgbRsbLsbsbsbLibsbsbLsbsbRibLsbLgLsb
LibLsRsbLgbsbsbsbsbLcLcbLsbLsbLobsbLsbsbLgRsbLcLsmbLgbLiLsLibLgLsLsmbL
gLsbLsbLgbLsbRsbsbsbLgbLiLsbLgbsbLsbLsbLgLibsbLgLjbLsLibsbLgbLibRjbRsb
RsbRsbLobLsbLsbsbLsbsbLoRsbsbLsbLiRsbLjbRsbsbLibLjbLsbLsbLjbsbLsbLibLc
bsbLgbLsbsbLibsbRsbRsbRsbRsbLhbRobRsbRjbRsbRebsbsbsbsbLsLsmbRcbsbRsbsb
RsbRcLsbLsbsbsbsbRjbLhbsbsbLcbRgbRibRcbRjbRibRsbsbRgbLibRoRsmbRsbLsRsR
smbRsbRgbRsRsRgmbRsbRjRsmbRgbRsRsmbRibsbRibRsbRibRgbRsbRsRgbRjbLsbLsbR
ibRsRsmbRgRsmbRsRgLsbRsbRsbRibLsRsRsmbsbRsbsbRibRsbRgbLhLsbLobsbsbsbRi
bRsRsmbLibLsbLiRsbLsbsbRsRsmbRgRsmbRgbRjbLhbLsLsmbLgbRcbRebLgbsbRiRsmb
sbsbLcbLsbLsbRcbRsbRobsbRgbsbsbsbRhbRsbLsbsbLgbLcbLgbLhbLebLgRsbLsLsmb
LcLsmbLiRsbLgbLiLsbLgbLhLsbRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 163338; End: 163850;
Recording: 8-1; Individual: 15; Drug: PCAP814 1 然 Apo 50 然
bRsbLsLsmbRsbLsLsmbLgbLsbRsbRebRcbRsbLgbLsbLsbRsbLgbLsbLsbLsLsmbLsbsbs
bsbsbsbRsLsLsmbsbLsLsmbsbsbsbsbLsLsmbLsLsmbLsbLsRsLsbLsLsLsLsmmmbLsbLs
bLsLsmbLsbLsbLsbLsbLsLsmbsbsbRjbRibRsbRibsbLjbLibLsLsmbLgLsLsLsmmbLsLs
LsmmbsbLsbLsbLsbRsLsbRsbLeLsRsbReRgRsRsRsRsmmmmbRoLsbLsbRiRsmbRsRsLsmb
sbsbsbsbLsbsbsbLsbsbLsbsbRibRgRsmbLsLsLsmmbLgbLsbsbsbLsbLsLgLsLgbLgLsb
LsLsmbLgbLgbLsLsmbLsLsmbLsbLsbLsbLsLsLsLsLsLsmmmmmbLsbLsbsbsbLsbsbsbsb
sbRsbsbLsbsbLsbsbRsbsbLsbLsbLsLsRsmbRjbRhRsmbRgbRsRsmbLgbRsbLsbLcbsbLs
LsLsmmbLsLsLsmmbRsbLsLsmbLsLsmbRsLsbLsLsmbLgLsLsmbsbLsRjbRiRsmbRgbLsRs
bLgbLsbLiLgLsLsmbLsLsmbLsLsLsmmbLsLsLsmmbLgLsbRebRcbRsRsRgRsmmbRsbLsbR
sRsmbRsbRsbRsRsRsmmbRgRgbRsbLsLsmbLsbLgLsbsbLsbLgLsbRsbLsbLsbLsLsLsLsL
smmmmbLsLsLsmmbLsbLsbRjbLgbLsbRsbRsbsbLgbLsLsLsmmbLsLsmbLsbsbsbsbsbsbL
sRsbsbsbLsLsmbLsLsmbLsLsRsLsmbLsLsmbLsbLsbLgbLsbLibLsbsbsbsbsbRgRsRemb
LgbLsbRsbReRsmbRsbRsRsRgRsmmbRgRsRsmmbLibLhLsLsmbRsbRsbLgLsLsLsmmbLsLs
LsLsRsmmmbLgRsLsbsbsbLsLsmbLsbLgLsbRsRsmbLsbRsLsLsmbRsLsbLsLsLsLsLsmmm
mbLgLsLsLsmmbLiLsLsmbRsRgbRcLsbRsbsbRsRsRsRsmmmb

>ZF Recording 2016-06-02; tW: 300s; Start: 163338; End: 163850;
Recording: 8-1; Individual: 16; Drug: PCAP814 1 然 Apo 50 然
bLebLebRobLjbRobLjbLsbLebLobLjbRsbRjbLjbRjbRcbRobRobLjbRjbLebLsbRjbRjb
LsbLobLebLebRobLobLebLobRcbRsbRebLebLjbRsbLsbRobRobLcbLjbLebRobLjbLcbL
obRobLebRebLcbLobRjbLobRebLebRcbRobRsbRebRobLebRobLsbRobRjbLebLebRebLj
bLcbRjbLobRebRcbRobRebRebRobRobRebRebLobRebLobLjbLebLebRsbLsbRobLjbLob
RjbRjbRsbRobRcbRobRobLsbRobLebLobRobLjbLjbLobRsbLcbLobLobRcbRebLobRebL
sbRjbRsbLebLebLjbRjbRjbLjbRebRebRjbLobRjbRobLobRebRobLjbRcbRobRcbLebRc
bRobRjbLcbLcbLjbLobRsbRjbRobRebLebLsbLobRobLcbLjbLebLjbLcbLcbLebRobLob
LobLebRebLobRebRjbRobLebLebRcbLcbLobLjbRsbLobRebLebLjbRcbRsbRsbRjbLjbR
obLobRcbRjbLebRsbRjbRcbLobRebLobLjbLebRobRjbRsbLebRobLebRjbLsbRjbLobLo
bRobLsbLcbRcbLjbLgbRobRobRcbRobRobRebRobLcbRebRobRobLcbRgbLobRebRobRib
RobRobLobRebLobLobRebLebLebLobLsbRebRsbLgbLsbRgbLobRgbRsbLebLgbRgbRobL
obRhbRcbRcbLcbRobRcbLgbRobRhbLgbLobRebLebLcbLgbLobRgbLobLobLobLcbLcbRg
bLgbLibRcbLobRebRgbRebLebRobRobLcbLebLcbLibLobRcbRsbRobLobLobLebLobRib
LobRsbRgbRobLobRebLobLobRobLibRcbLebRebRgbRcbRebRebLobLcbLcbLgbLebRobR
obLobRobRobLcbRobRcbRcbLobLobRgbRgbLobLgbRsbLibLcbLobLebRobLhbLobLebRo
bRgbRsbLebRcbLsbRebRobLobRebLibLebLobRsbLgbLsbRgbRebLgbRcbLobLebLebLeb
RcbRebRsbLcbRebLgbLcbRebRobLobLebRobLcbRobLjbRhbLebLobLcbLcbLobLcbLgbR
cbRebLobLgbRebRobRcbLibRibRibRobRcbRibRobRcbRobLobRsbLhbRcbLobRibRcbRe
bRobLcbLhbLobRcbLobLobRcbRobLobRebRobLcbLebRobLcbLcbLgbRebRebLobRobRob
LebRibLobLobRhbRibRcbRobLobLibLcbRibRhbLebLobLcbLcbRobLobLebLobLobRebL
cbLebRobRobLcbRebRcbRsbRibLobLcbLibLsbRobLobLobLcbLobRibRgbRobRhbRcbLo
bLcbLcbRebLcbRcbLobRebLobLcbLgbLsbRebLobRobRcbRobLibRibLobLebRgbLgbRob
RcbLobLebLobRobLgbRebLebRebLcbLebRobRebRobLibRebLobLebLjbLobRsbLobLebL
ebLjbLobRcbLgbRhbRcbRobRobLjbRcbRobRgbRgbRebLcbRebRobRobLcbLebRobLgbLi
bLebLobRobLcbLcbLobLcbRebLcbLsbRobRcbLsbRobRebLebRobRcbRibRhbRgbRebLob
RhbLcbRsbRibLobLcbLsbLebRobRobLibRibRebLsbLcbRibRebLobLcbRcbLobLobLobR
ibRebLobLgbRobRibLobRebLebRcbRobLibLobLobRcbLebLebRgbLsbLobRobLobLobRc
b

>ZF Recording 2016-06-02; tW: 300s; Start: 163338; End: 163850;
Recording: 8-1; Individual: 17; Drug: PCAP814 1 然 Apo 50 然
bLsbLsbRjbRsbLsbRsbRsbRsbLsbLsbLjbRsbRsbLjbRsbRsbRsbLsbLsbLsbRsLsbLsbR
sbLjbRsbRsbRsbLsbRsbLsbRsbRsbRsbLsbLsbRsbLsbRsbRsbLjbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 163338; End: 163850;
Recording: 8-1; Individual: 18; Drug: PCAP814 1 然 Apo 50 然
bRjRsmbRsbLibLsbRsbRcbLjbsbLjbRsbRcbRsbLsbLjLsmbLsLsmbLsbRsbsbsbsbLjbL
sLsmbLsbLgbLsbRsbRobRgbsbRsbLsbRjbsbRsbLsbRsbsbLsbRsbsbLibsbsbLsRsbLib
LsbLsbLcbRsLsRsbLjbRibLsLsLsmmbLsbLsbLgbLiRsbRjbLibsbsbLsbLsLsmbLibLgb
LsbLsbRsRsLsmbLsLsmbLsbLsbLsbLgbRsbRsbLcbLsbRibRgbRcbLsbRsbLjbLiLsLsmb
sbRsbLibLsbRgbsbLibLgbsbRsbLsLsmbLsRsbLjbsbsbLgbsbRhbLjbLsbLsLsmbLibLs
bLgLsbLsbsbRsLsbRsbLgbLgbLsbsbLsLsmbsbLsbLsLsmbLsbRcbLhbLsbRsbLsbsbRsL
sbLgbLsbsbLsLsmbLgbsbsbsbLibRgbRebLebRjbLjbsbLjbLsbLjbLsbsbLjbLsbLgbRs
bLgLsLsmbLjbLiLsbLgbLibLibLgbLeLsbLgbRjRsRsmmbRsbLiLsRsbLgbLgbLsLsmbLs
bLgbLgLsbRgbRsbLsLsmbLsLsmbsbsbLsbLgbRibLgbLgbsbRcbLcLsmbLibRsbLibsbsb
LgbLgLsLsLsLsmmmbLsLsLsLsLsLsmmmmmbLgbLsRsbLgbLgLsbRsbLsbLgLsbLsbLgbLi
bLjbLsbsbRsRsRsRsmmmbLgbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 163338; End: 163850;
Recording: 8-1; Individual: 19; Drug: Control Apo 50 然
bRjbRsRsmbRsRsmbLobRsbLsbRcbRsbLsbLsbsbsbLsLsmbsbsbLsbsbRgbRebRsbsbLsR
sRsLsmbRgbRgbsbRgbsbLibLeLsLsmbLibRsbLjLcbsbRsbsbsbRgbRcbRsbRsbRsbLobL
gbRsbLhbLgbLsbLcbRgbRsbLobLsbRgbRjbRsbRsbRsbRgbsbRsbRsRsmbRjbRsRibLsbs
bRsbRsbsbLsLsmbLgLsbLsLsLsmmbLgbLsbRcRsmbsbRsbRjbLibsbLjbsbsbLsbsbLsbL
sbReRsmbLsbsbsbLsLsmbRsbLsbLsbLsbsbsbsbsbsbLobLcRsbLsLsmbLsbRsbRsRsmbR
sRsmbRsbsbsbLsRsbsbsbLsbLgbsbRibRebRgbsbRgRsmbRiRgRhbRsRibRibsbRgbLjbR
sbRsbRcbRsRsmbRsbRsbLsbLsbLsbsbsbsbLsRsbLsbLsbsbLgLsbLsbLsLsmbLsLsLsmm
bLgbsbRsbLsRsbLgbsbLobRgbRibRibRgbRgbRsbRgbRibRsbRsbsbLsbsbsbRsbsbsbsb
RgbLgbsbsbsbsbLcbsbsbLsbLjbLsLsmbLgbLjLsmbLgbLgbLibRcbRsbLsLsLsmmbLgbs
bsbsbsbsbsbsbRsbRsbRsLsbLsLsmbLibRsbLsbLsRsbLgbLsbLsbsbsbLhLsbLsLsLsLs
LsLsLhmmmmmbLsbLobRsbLhbLsLsmbLobLgbsbsbLjbLsLsmbLsLsRsLsRsLsLsLsLgRsm
mmbLgLsbRcRsmbRsRsmbRhRsmbReRsmbRibRcbRibLsbRcbRsbRgbRhbLobLibLhbLcbRg
bRsbRiRsmbRibRgbRibRcbLgbLib

>ZF Recording 2016-06-02; tW: 300s; Start: 163338; End: 163850;
Recording: 8-1; Individual: 20; Drug: Control Apo 50 然
bLjbRsbRibLjbsbLsbsbsbsbsbsbsbLhbRcbLjbsbLgbLgbLhbsbRgRsmbLsbRcbLsbRjb
LsbRibRjbLjbLibLibRsRsmbLsbRsbsbRsbRjbLsbLjbsbRsbLsbRsbLebsbLjLsmbRsbs
bLgbLcbLibLgbLsbLsbLgbLibLibLjbRsbsbLgbsbLsbLgbLgbLjbRsbLgbLgbLjbRsbLg
bsbLgbRsbLiRsbLgbLsLsmbLibLgbRsbLsbsbLibLsbsbLgbLhbsbsbLsbsbLsbRibRibR
ibLsbLsbRibLgbsbRjbsbRibRgRsmbLjbRsbRibLgbLsbLsbRgbRibRgbRsRsmbRjbLsbR
gbLjbRsbRsbLibRjbLjbRcbRgbRgbRibLsbLcbRsbRhbsbsbRsbsbRsRsmbLgbsbRhbReb
RgbRjbRsbRgbLjbRsbRibRibRsbRibRgbLjbLcbLsbLibsbLsbLsbRjbRjRsmbLgbLcbLi
bLgbLgbLgbRgbLsbLsbLsbLibLgbLgbLjbRsbLsbLsbLeLgLebLeLsbRhbRsbLjbLsbsbL
ibRjbRsbLsLsLsmmbRibRjbRsbRsbLiLsbLgbLibLgLsbLgbLsbLsbLsLsmbLgbLgbLgbL
gbLgbLsbsbLgLsbRsbLgbLjbLsbLgbLsbLibLibsbRibsbLsbLsbLsbLsbRjbLgbLsbsbs
bLjbsbLibLibLgbLgbLsbLsbRsbsbRsbRsbsbLsbLsbRsbLsbLsbLsLhbsbLsbRjbsbRiL
sbRsbRiLsbRsbRjbRsbRsbLsbRcbRjbLsbLsbRibRjbRibLcbRsbLjbLibLibLsbRsbRib
RibRjbRhbsbRjbRsLsbRsbRibLgbLobRsbLibLgbLgbLgbRsbLgbLibLhbRsbRibLsbRsb
sbsbRsbLcbLjRsbLsbRgbLsbLgbRsbRjbRsbRgbsbRsbLibLjbLsbRjbRibRjbLsbLgLsb
RibsbsbRibLibLsbLobLsRsbLsLsmbLsbLsLsmbLsbsbLjbRsbLibLsbLsbRsbRibLsbLs
bLibLgbRjbRcbsbLibsbRjRsmbRgbRgbRcbRibRsRsmbRhbLjbLgbLibLcLibLibLcbRsb
RiLsbRgbLsbRibLjbRhbRsbRibRibRgbRsbRjbLgbRjbRgbRiLsbRgbRiRsRsRgmmbRibR
ibRiLsbRsbRcbsbLgLsbLibLgbLgbLoRsbLgbRsbRsLobLibRcRsmbLjbRjbLgbRgbLhbL
ibLgLsRsbLgbLgbLhbLsbLgbLibLgbRsbLibLibLgbLgbLsbLgbRsbLgbLhbLibLsLsmbR
sbLibLibLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 163338; End: 163850;
Recording: 8-1; Individual: 21; Drug: Control Apo 50 然
bRgbsbRibRsRsmbRsRsmbRibRsbRsbLsbLsbRsbsbLsbRsbsbsbsbLsbLsRsbRiRebRgbR
ibRhRsRsmmbRsRsmbRsbsbRgRsmbRsbLsbRgbRibRebRsbRsbRgbRgRsmbLgbLsbRsbLib
LsLsmbsbRsRsRsmmbsbsbsbRsbsbRsRgbRobRsbRgbRjbRsbRsbRgbRsbRsRsRsmmbRsbR
sRsmbRsbRibRsbReRsLsmbsbRsbRsbsbsbLsbLsLsmbRsRsmbsbsbsbRgbsbLjbLsbRgbR
sbRsbRsbRgbRgbRibRgbRsbRgRsmbLsbLsbLjbLibLgLsLsLgmbRsRsmbLsbsbsbsbLsbL
sbLsbRsbRsbRsbLsbsbsbRjbLibLgbRsbLgLgbLgbLsbLgbLsbLibLsbLsLsmbLsbLjbLs
bRobRsbRibLsbsbLsbsbsbsbsbsbsbsbsbsbRsbsbsbRebRsbRsbRgbLibsbRsbRsbRibR
ibRibRgbRibRsRsmbsbsbRsbLsbRcbRsRsRimbLhbLgbLebLsbRsRsmbLgLsbsbLsbLibL
sbRcbRebRjbRgbRsbRgbRgbLsbLgbLsbLhbLhbLgLsbLibRebLhbRiRsRsmmbRcbRsbReb
LjbLcbLgLibLibRjbLebLgLsbLgbLibLibRgbLgLsLsmbLeLsbLgLsbLgLsbLhbRibLeLs
LsmbLiLsbLebRjbLhbLiLsbLsbLcbRibRsRsmbRebRiRsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 163338; End: 163850;
Recording: 8-1; Individual: 22; Drug: Control Apo 50 然
bRsbRobLibsbRgbsbRebRibRsRsmbRsbRgbRsbRsbRibLsbLibLgbLgbLgbRibLsbRgbLc
bRibLsbRhbRibsbsbRcbRibRebRsbLibLebLiLsbRcbRhbLobRsbLsLsmbLsbsbsbLsbsb
RsbLsbLsbRsbsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 163338; End: 163850;
Recording: 8-1; Individual: 23; Drug: Control Apo 50 然
bRibLsbsbLsbRsbLsbsbsbsbsbsbsbsbsbsbLsbsbsbsbRsbRsLsbsbsbsbRgbLebLsbLs
bRsbsbsbsbsbLsbsbsbRsbsbsbsbsbLsbsbLsbsbsbsbsbsbsbsbsbsbsbsbsbLsbsbRsb
RsbsbsbsbsbsbsbsbsbsbLsbsbRsbsbsbsbsbsbsbsbsbLsbsbsbRsbsbLsbsbsbsbsbsb
LsbsbsbsbsbRsbLsbLsbsbsbsbsbsbsbsbLsbsbLsbRsbsbLsbLebRibLhbRgRsmbLsbRs
bRsbRsbRsbsbRsbsbsbRsbRsRsRsmmbRsRsmbRsRsmbRgbsbRsbRgbLsRibRobRibRsbsb
sbsbsbLsbRjbRsbLibRsbRsbRjbLibLgLgbsbRsLsbRjbLsbRjbLgbRebLsbRibLsbLsbL
sLsLsmmbLsLsLsmmbLsbLsLsmbLsLsmbsbLsLsmbsbRsLsLsmbLsbLsbLsbLgbRsbLsbLs
LsLsmmbLsLsLsmmbLsbLsLsmbLsbLgbLgbLcbLsbsbLcbLobLsLsmbLgLsbLobLsLsmbRg
bLsLsmbLibLsLsLsLsmmmbLsbLsbLsLsmbLsLsmbLsbRibsbRjbLsbLsbRiRsmbRhbRobL
gRsbRhbRsLsbRibLebLsbLsbsbsbsbLsbLsLsLsLsmmmbLsLsLsmmbLsLsLsmmbsbLsLsL
smmbLsLsmbLsbLibLgLsLsLhmbLsLsRsLsmbLcbRsbRiRsmbRgRsRsmmbRgbRsbRiRsmbR
gLsbRibRibRgbRibLcbLcLsmbLgbRhbRibRebRobRsbRsbRobRiRsmbRibRhRgbRsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 163338; End: 163850;
Recording: 8-1; Individual: 24; Drug: Control Apo 50 然
bsbsbLgbLsbsbRsLsbRgbRsbsbRjbsbsbsbRsbsbLsbLjbLsbLjbLsbLhbLibRgbsbLgRs
bLsbLsbLibLibRsbsbLjbLibLcbsbLcbsbsbLsbsbsbsbsbsbLsbsbsbsbsbsbsbsbsbsb
RsbLjbRjbRjbRsbsbsbsbsbsbsbsbsbsbsbsbLibsbLjbsbRsbsbsbsbsbsbsbsbsbsbsb
sbLjbLjLsLsmmbRgbLibsbLjbLhbLjbLsbLjbLibLjbRsRsmbLjbRjbRebRgbRcbRsbLjb
RgbsbLjbLjbsbLhbLjbLjbLibLjbLsbsbLjbLibLsbLsRsLjbRsbLsbLsRsRsLsLsmmbsb
sbLibLgbRsbLsbLibLhbLjbLsRsbLgbRsbsbsbRsbsbRsbLsbRsbLsbRsbRsbLsLsmbRsb
LsbsbsbRjbLsbRjbRsbRjbRjbsbRgbLjbsbRjRsmbRibLjbRebsbRgRsmbsbRgbRjbRsbR
jbRsLsbsbsbsbRsLsbRsbRsbLgLibLibRgbLgbLsbLgbRsbRsbRsbLgbRsbRjbsbLcbLgb
LibLjbLsbLibsbLibLibLibRsbRsbLjbLsbLibLsbsbLsbsbsbsbsbsbsbsbsbsbsbsbsb
sbsbsbRsbsbLsbLsbLjbRjbLjbRsbsbRibRgRgbRgbLgbRsbsbsbRgbRjbLsbRsbRgbRiR
smbRibRibRiRsmbRgbRgbRgbRgbRibRibRhbRgbRibLjbLsbLcbLiLgLsbsbLjbRsbLgRs
bLibLibRsbRsbRibRibRgbRsbRiRsRsmmbRibRiRiLsbRgbRibRgbLjbRjbRjbRgRsmbLj
bsbLjRsbRjbLibLjRsbRebRjbLcb

>ZF Recording 2016-06-02; tW: 300s; Start: 163338; End: 163850;
Recording: 8-1; Individual: 25; Drug: PCAP814 10 然 Apo 50 然
bLsRsbRsbLsbRgbRgRsmbLsbsbsbsbLsbRsbsbsbRsbsbRsbsbRgbLsbLobRsbLsbLsLsm
bLsbRsbRsLsbLsbLsbLsbRsbLsRsbRgbRjbLjbRsbsbRjbsbsbsbsbsbLobRgbRsRsmbLs
bRgbLjbLsbLjbLjbsbsbsbsbRsRgRsRsRsRsmmmmbsbsbRsbRsRsRsRsmmmbRsbRsRsmbR
jbRibsbsbsbsbsbsbsbsbRsRsmbRsbRsbRsbRsbsbLsRsLsbRsRsmbRsRsRsRsmmmbsbRi
bLsRsRsRsmmbLsLsLsRsRsmmmbLsbLgbLsbsbRsRsmbRsRsRsRsmmmbRgbRsRsmbRsbRsR
sRgmbRgbLjbRsbRsbRsbRsRsRsRsmmmbRsRsRsRsRsmmmmbRsRsRsRsLsmmmbRsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 163338; End: 163850;
Recording: 8-1; Individual: 26; Drug: PCAP814 10 然 Apo 50 然
bLsbLsbLsbRsbRjbRsbLsbLsbsbRsLsbLsbLsbRsLsbLsbRsbsbsbLsLsmbRsbRsbLsLgL
sbRsLgbRgRsmbRsbsbLsbsbLsbLsbRsbLsbsbLgbLsbLsbRsLsbLsbLgRsRsmbRsbLsbRs
bLsbRsbLsbLsbLsbLsbLsbRsbRsbLgbsbLsbRsbsbsbLgLsbRsbRsbRsbRsbLgbLgbLsbs
bRsbRjbLeLsbsbRsbsbRsLsLsmbLsLsLsmmbLsLsmbLgbLsbLgLgbRsRsmbsbLgbLsbLgb
LsRsbRsLsbLgbLsbRsbLgbLsbRgbLsLsLgmbLsbRsbLsbsbRgLsbRsbRsbLsbRsbReLsRg
bsbsbRsbRsbRsbLsbRgbRsbRsbLsbRsbLsbRsbRgbLsbLsbLebLgbLsbLsLsmbRsbRsbsb
sbLsbRsbLsbRjbRsbRgRgbLsLsmbRsLsRsbRsbRibRsLsbLsRgbsbsbRsbRsbLsbRsbLsb
LsbLgbRcRsmbsbsbRsRsmbRsbLsbLsbLsbRjbLsbRsbRsbLgbsbRgbLgLsbRsbLgbRsbRs
bLgbsbRsLsbRsbRsbRsbsbLibLsbRsbLgbLgLsbRgbRjbRhLgbsbLsbLsbsbLsbsbRsbsb
RsbLsbLsbLgbRsbRjbLsbLsbLgbLgbLsbLsbLsRsbLsbLgbLsbLsLsmbLsbLsLiLsbsbLg
LsLsLsLsmmmbRsLsbLsbLiLsbLsLsmbRebRjbLhRsbLsbRcRsRsmmbLsbRebRsbRsbLcLs
mbLsLgbLsLsmbLsLsmbLsLsRembsbLsRsbLsRsbLsRsLsbsbLsbLsbRsLsbRsbReRsmbRg
bsbLsLgLsLsmbLsbLgbsbsbRsbLsbLsbLsRsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 163338; End: 163850;
Recording: 8-1; Individual: 27; Drug: PCAP814 10 然 Apo 50 然
bRsbRsbLsRsRsLsmbRsbRsbRsbRsbsbRsRsmbRsbsbLgbRsbRsRsLsmbLsbLsbsbRsRsmb
RsbLsbsbsbsbRsbsbRsbRsbsbsbsbsbsbRsbsbLsbsbLsbLsbsbsbLsbRsLsbsbsbLsbRs
bLsLsmbLsbLgbRsRsmbRibLgLsbsbRsbRgbRsbLsbLsbRsbLsbRsbLsLsmbsbRsbLsbsbL
sbRsbRsbsbRsbLsRsbLsbLsbsbsbRsbsbsbsbsbRsbRsRsmbsbRsbsbRgRsLsmbLsbRsRs
mbLgRsRsLsLsmmbRsbRsbLsbRsbRsbLsbLsbRsbRsbsbsbRsbLsbLsbRsbLsRsbRsbsbRs
bsbLsbsbLsbsbsbsbRsbLsbsbsbsbRsbRsbsbRsbRsbRsbRgRsRsmmbRsRsRgmbRsLsbsb
RsbsbLsbRsbLsRsLsbLsbsbsbRsbsbsbsbRsbsbsbRsbsbsbRsbRsLsbRgLsLsmbLsbRsb
RsbLsbRsLsbsbLsbRsRsmbsbRjbsbLsbRsbRsbRsbRsbRsbRsbLsbLsbLsbRsRsRsmmbLs
RsbsbsbsbRsbsbsbsbsbsbsbRsbRsRsmbsbsbLsRsRsmbLsbRsbLsbLgbLsbRjbRsbRsLs
bRsbLsLsmbRsLsRsRsmbRsRsmbLsbRsRsLsRsmbRsbRsbLsbRsbRgLsRsbsbsbsbsbsbsb
RsbRsbLsbRgbLsbRgbLsRsLsRsLsbLsLsmbRsRsmbRsbLsbLsbRsbsbLsbLsbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 163338; End: 163850;
Recording: 8-1; Individual: 28; Drug: PCAP814 10 然 Apo 50 然
bsbRsbRcbRjbLsbsbRsbsbsbsbsbRsbLsbLsbLgbLgbLgbRobLsLsmbRgbsbsbsbsbsbsb
sbsbsbRsbsbsbsbsbsbsbsbsbRsRsmbsbRsbsbsbRsbLsLsmbLsRsbsbsbsbsbsbsbsbsb
sbsbsbsbLsbsbRsbsbRsbsbsbRsbsbLsbsbsbLsbsbsbsbLsbsbsbsbLsRsRsRsRsRsmmm
mbsbsbsbsbLsRsbLsbLobRsbLsbsbsbsbsbRjbRsbLsbRsbLgbRsbsbRsbRsbsbLsbRsbR
sbRsbRsRsRsmmbsbsbsbsbsbsbsbsbRsbsbsbsbsbsbRsbRsbRsbsbRsbRsbRsbLsRsbsb
sbLsRsbRgbsbsbsbsbsbsbsbsbsbLsbsbRsbsbRsRsRsRsmmmbRgbRebRsbRsbRgbRsbRg
bLsbRsbRsbRsbRsbsbLsbLsRsbsbLsbRsLsbRsRsmbRsRsmbRsRsRsmmbRsRsRsRsmmmbR
sbRsRsmbRsbRsRsRsmmbsbsbsbsbsbsbRsbsbLsRsRsRsRsRgRsRsRsmmmmmmbRgbRsRsm
bsbRsbRsbRsbRsLsbsbLgLsLsmbRsLsbLgbRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 163338; End: 163850;
Recording: 8-1; Individual: 29; Drug: PCAP814 10 然 Apo 50 然
bLhbsbsbLgLsbLsbLibRgbRebRgRsmbRsbLsbsbRiRsmbRgbLsbRobRsRsmbRgbRsRsRcm
bLsbRgLebsbLebLjbLgLibsbLgbLhbRsbLsbsbLoRsbsbLcbLgLobsbLgbsbLcbLcbLcbL
obRgbsbRibLsbRebRsRsLsmbsbsbRjbRebRsRsmbRsbLgbsbsbRibRsbRsRiRsmbRjbRgb
sbRobsbRcbLsbRobLsbsbLgbLgbRsRsmbRsbLgbLsLsmbLsbLgbRgbsbLjbRibLibLjbLe
bLcbRsbsbRsRsRsmmbRibsbRhbsbRobsbRgLsbLsRoRsmbRoLsRsbLibLgbLhLibLjbRsL
ibLiLsbLobRsbRcbLoRsRgbReRsmbRibRgRsmbRibLobsbLgbRsbRsbsbRsbsbsbsbsbLs
RsbsbLsbRsbLsbsbsbsbsbsbsbsbsbsbsbsbRsRsmbLsbRsbsbsbRsbRsbLobLobLcbRob
sbRsbLsbLgbLhRsRsmbRibRsbRgbRiRsmbRjbRsbsbRibRoRsmbRgbRsbRcbRobLsRjbLg
bsbLgbLobRgbLobLsLoRsbRgRsmbLjbRhbLoRsLibLsLebLibLhbsbLobLhbLebRsbLgbR
cRsmbRsbRoLsbRhbsbsbRibLsbRsbRsRsmbLgRsbLobRgbRebRobRobLgLsLsmbRsRsmbL
jbLsbsbsbsbLgRsbRibLcbLcbLsLgLsbLjLsmbLsbLgbsbsbsbsbsbLsbsbLsbLsbRsbsb
sbRsbsbRsRsmbRsbsbLsbLgbLgRsbLsbLebLobsbLeLobRiRsRsmmbRgbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 163338; End: 163850;
Recording: 8-1; Individual: 30; Drug: PCAP814 10 然 Apo 50 然
bLsbLsLibLsbLebLsbRobRsbLsbLsbRebRiLsbRsbLsbLgbLsbLsbLsLsmbLsLsmbLsbRs
bLsbLsLgbLsbLgbsbLsbLsbLsbLjLsmbLsbLsbsbLsbLebLebRsbRebLjLsmbsbsbsbsbs
bLsLsRsmbRsbRsRsmbLsbLsLsmbsbRsbLsbLsbRsbRsbsbLgbLsbLsbLhbLsbsbLsLsmbL
sbLibLsLgLsbLjbLsbsbLibLgRsLobLhLsbsbLsbsbLsbLsRsbLibLsLsmbRsLsbRibLsb
LsLgbLsbLgLgbRgLsbLsbsbLsbsbsbsbRsbLjbLgbLsbRsLsbsbRebLsbRsbsbLsbLsbLs
bRsbsbLsLsLgmbLsbLgLsbRsLsLgbLsLsmbLsbLsbLsRsbsbsbLsbsbsbLsbLsbRsbLsbR
sRsmbLsLsmbLgLgLgbLsbLgbRsLsbLsRsbsbsbsbsbLsbsbsbsbsbRsbLsLsmbLsbLsbsb
LsbsbsbsbsbsbsbLsbRsbRsbRjbLiRsbsbLiLsbLsLsRsmbLgLsLsmbRobLsLgLsLsLsmm
bRsbLsLsLsLsLgLsRsmmmbLsbLsLgbLsLsLsmmbLgbLsbLsbLjbRgbLsLsmbLsLsmbLsLs
LsmmbLjbRsLsbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 163338; End: 163850;
Recording: 8-1; Individual: 31; Drug: PCAP814 3 然 Apo 50 然
bRsbsbRgbLiRsbLsbLibsbRsbsbRsbLhbLibsbRsbLsbLibLgbLibLsLsmbLsbLiRsbLgb
LsbsbLgLsbLgbsbsbLibLjbsbLibLsbLsbRsbLsbsbsbsbRsLsbLgbLsLsLsmmbLsLsmbL
sbLgbLgbLgbRibRiRsRjmbRibsbsbLsbRibLsbRebRsbRsbLibLsbLibRgbRcbLsbsbsbR
ibRsbRebLsbRcbLobRsbRgbRgbsbLibRjbRebRoLsbRcbRibRibLgbRsbLsbRsbRsbRsbR
gbRsbsbRgbRsbsbRgbLsbRsRsmbRgbLsbRibLgbRsbRsbLsbRsbsbRgbRgbsbRsbRsbRgR
smbReRhRsmbRiRibRsbRiRgbRgbLcbsbsbLobLjbRsbLcbsbLcbsbRibRsbRibLibLcbsb
RhbRcbRhbLsbLgbRcbRobRsbRgbLsbsbRsbRgbLsbRgbRsbsbRgRsmbRgbRsRsmbRsbsbR
gbRgbRsbLobsbLgbRsbRibRsbRsbRsbRgbRgRsmbLsbLgRsbsbRsbsbRibRibRsbRgbRgb
RiRsmbRgbLhbRjbRsbRsbRgbRsRsmbRsbRibsbRsbRsLsRsbRsbLiLsbLobLsLsmbRibRs
bRgbRgbRgRsmbRgbRgbRgbsbLgbsbsbsbRjbRhbLobRebLsbRgbsbRgbRgbRsbRsbRsbsb
RsbRcbRsbsbLibRsLsbLgbLgbLsbRibRibRiLsbRgRiRsmbRgbLgbRiLsbRgbRgbRsbRgb
RsbRgbRgRsmbRibRgbRgbLibRsbRsbRgbsbLgbLsbLsbLjbRgbRgbRibRgbRgbRgbRsbRg
bsbRgbRgbRgbRsbRiRsmbRgbsbLsbRsbRgbRsRsmbsbLobRgbLsbRjbRsbsbRibRgbRibR
sbRsRsmbRgRsmbRgbRiRsRgmbsbRsbRgbLsbRgbLsbsbRjbLsbLjbLjbRgbRjbRgLsbRcb
LhbRoRsmbRibLcbRsbRebLgRsLgbRsbRibRjbRsbLsbRsbRgbRibRgbRgbRgbRsRibLcbL
cbLjbRebRibRsRsmbsbRsbRibRsbRibRgbLsbRgRsmbRgbRgbRgRsmbRjbLobLoRsbLsbR
sbsbsbRgbRgbsbRsbRgbRiRsmbRhbRgbRhbsbRsbLjbLhRsbRsbLiLsbLhbRgbLobLsbRh
bRjLsRsbRgbRgRsmbRgbRibRsbRgbRgbRgRsmbRgbRgRsmbRgbRgRsRsmmbRgLsbLsRsbR
gbRgRsmbRcLgbLgbLibLgbRsbRgRebRsbRgbRgbRgbRgbRsReRsmbRgLsLsmbLgbRcbRib
RgbRsbRgRsRsRsmmmbRgbRibLhbLjbLobRsbRsbRibRhbLjbLcbLiLsbLgbRsbLhbLibRg
bLcbRgbRjbLcbLibRgRsmbLgbLibLsbLjRsbRsbLiRsbLibRgRsmbLibRgbRsRjbRhbRcb
RgbRgbRiRsmbRibRibLsbRsLgbRgbRiLsbRsbLgbLsRgbsbsbsbLsbRsRsmbRgbLjLsmbL
cbRjbRsbLhbRgbLibLcbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 163338; End: 163850;
Recording: 8-1; Individual: 32; Drug: PCAP814 3 然 Apo 50 然
bLjRsbRsRjbRsbLiLsbLsbLgbLsbRgbsbsbLgLsLsLsmmbRsbLsbLibRsbLsbLgLsbsbsb
sbsbsbLsbLgbLsbLsLsmbRsRsmbLsbLgbsbLsbLsbLsbLgbLsLgbLgbLgbLgbLsbLgbLsL
sLsmmbLsbLgbLsbLsbLsbLsbLsbLgbLsbLgLsbLsbLsbLsbLsbsbsbLsLsmbLsLsmbLgbL
sbLsbLsbLsbLgRsbsbRjRgRcRsmbsbRsbRsbRgbsbRsRsmbRgbLsbsbRgbRsbRcbRsRsmb
RhbLjLsmbLjbsbsbRjbsbsbLsbsbsbsbsbsbRcbRsbsbRjbRsbLsbLibReRsmbRiLsRsbL
ibLibLsLsLsmmbLsbLgbLhbRsbLsbLsbLibLgbLibRcbRhRsmbLgbRsbLsbLsbLsbLibsb
sbsbRebRjbRsRsmbsbLjbRgbLjbLsbLjbRsbLsbsbLgbRjbRsbLsbsbLgLsLgLgbRsLsbL
gbLsLsmbRjbLsbLsbLibRsbRsbRjbLsbLsbsbsbLgLsbRsbsbsbRjbsbsbsbLgbLsbLgbL
gRsbRsbRebLjbLjLsmbRjRsmbLgbRhbsbLsbsbsbsbsbLsbRsLsLsmbLgLsbRsRsRsmmbR
gbRgbRgbLcbRjbLcbLebLobRiLsbLcbLibRsRsmbRibLsbRjbLjbRsbLgbLsbLibLgRsbL
sLsmbLsLsLsmmbLsbLsLsLsLsmmmbLsLsLsLsmmmbLgbLgLsbLgRsbRibRhb

>ZF Recording 2016-06-02; tW: 300s; Start: 163338; End: 163850;
Recording: 8-1; Individual: 33; Drug: PCAP814 3 然 Apo 50 然
bLsbRsbLsbsbsbsbsbRsRsmbRibRsbsbRobsbLsbsbLsLsRsmbRsbRgbLsbRsbRgbsbRob
sbRgbRoRsmbRsbsbsbRsbsbRsbsbsbsbsbsbsbsbRsbRsbRsbRgRsRsmmbsbRsbsbsbsbs
bLsLsmbLsbLsbRsbsbLsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 163338; End: 163850;
Recording: 8-1; Individual: 34; Drug: PCAP814 3 然 Apo 50 然
bRsbRsbsbLsLsmbsbLsbRsbsbRsbsbsbsbsbsbsbsbsbRgbLsbsbRsbRsbsbsbRsbsbsbL
sbLsbsbsbRsbLsbLsRsbsbsbsbsbLsRsbRsbsbRsbsbRsbsbsbLsRsbsbRsRsmbsbLsbsb
RsLsbLsbRsbsbsbRsbsbLsbsbLsbsbsbRsbLsbLsbsbRsbsbsbLsbLsLsmbRsbsbRsbsbR
sbRsbRsbsbsbsbRsLsbsbLsbsbsbRsbsbsbRsbsbsbsbsbsbsbsbsbLsbsbsbLsbsbsbLs
bsbsbLsbRsbsbLsbLsbRsbRsbsbRsbsbRsRsmbsbsbsbLsbsbsbsbsbsbsbRsbRsbLsbsb
RsbRsbRsbLsbRsbRsbRjbRsbsbRgbsbsbRgbLsbsbRcbLsbsbRobsbRobRsbRsRjbRsbRs
bRgRsmbRsbRsbRsbRgRsmbRsbRgbRgbRsbRgbRsbRsRsmbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 163338; End: 163850;
Recording: 8-1; Individual: 35; Drug: PCAP814 3 然 Apo 50 然
bRibRsbRgbRibsbsbLebLhRsbsbsbRjRsmbRcbLcbsbLgbRsLsbLsbRsLsbLgbLgbLsbLs
bLgbLsbsbLjbsbLsbLsbLibsbRsbsbLsbRcbLsbsbLsbRebLgbLibLgbRobRibLsbsbRiL
sbRgbRibLsbLsbRibRjbRgbLjLsmbRcbRibRgbRgbRsbRsbRoLsLsmbLibsbRsbsbRsbLi
LsbsbsbRsRsmbRsbRebLsRsbRsbRibLjbRsbLjbLsbRcbLsRsbLsbLcLsmbLgbsbLiLsbR
ibLobsbLsbRsbRsbRsRsmbLobsbLcbRibRsbRobRibRgRgLsbsbRjbLsbRsbRsbRsbRibR
gbRobRibRibLibLibLiRsbsbRgbsbsbRsbRsRsmbRsRsmbsbLsbLjbsbLibRibLcbLsbLg
bsbRgbLibRhbLcbLgbLsbRsbLsbLobLibLjbLsbLibRsbsbRsbsbLsbRcbLoLsmbRsbRsb
LgRsbLsbLhbRsbLjLgbLgbRibLjbRebRsbRibRsbRcbRhbLsLsmbLjbsbRsbLobRjbLsLs
mbRsbLgbLobRibRjRsmbLcLsmbLgbsbRibRoLsRsbRsbsbLcbLsbLcbLibsbsbsbsbsbRs
RsRsmmbsbLibRhbRsbRcbLgLsbLobRgbsbRsbLoLsmbLsbLgbRgbsbLgLsbLgbsbRsRsmb
LcbRgRsmbRsRsmbsbLsbLsbLsLsmbRsLsbLibLsbLgLsbLgbsbRibRgbRcbLsbLsbLsbRs
bLgbRsbLgbRsbLsbLjLsmbLobRsbsbLsLsmbRgbRcbsbRgRsmbRcbsbLsLsmbLgbLcRsbs
bLcbsbsbLgRsbRgbsbLibsbLjbRgbLsbLgbLgbsbsbRsRsmbsbRibsbRgbLsbsbRobLsbR
sbLsbLsbRjbRobRgbRobLsbRibRgbsbRgbRgbRcbLsbsbsbsbLgbLjbLibLobLgbLsbLsb
RsbRibRjbLsbRsbLsbLjbLsLsmbLgbRsbLibRibLjbLjbRsbLcbsbRsbReRsmbRsbRsbRi
bsbLjbRibsbsbLsLsmbsbsbRsLsbLhbLgbLsbLibLjLsmbLcbLiLsbLebLgbRsbLcLsmbL
gbsbRsbRcLsbLoRsbRsbRobRjbLcLsLsmmbRhbLjbsbRobLsbLsRoRsmbsbRibRsbRsLsb
LjLsmbLcbLgLsbLiLsbLgRsLsbLgbRobRgbRsRsmbLjbLibLgbLgbsbLgbRsbLibRsbRcb
RhbRiLgbLiLsbLgLsbRcbLsbRhbLiLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 163338; End: 163850;
Recording: 8-1; Individual: 36; Drug: PCAP814 3 然 Apo 50 然
bRjbLsbLibLgbRgbsbRsRsmbLjbLjbLsbRsbRgbRsbLjRsbLjRsbRsbLgbLgbsbRsbRsbL
sbRjbRsbRgbRgbRgbRgbRgbRsbRsRsmbsbRhbsbRcbRjbRsbLjbRobRibRcbRsRsmbRsbR
gbsbRsbLsbRsbRsRsmbRibRgRsmbRibRsRsmbsbRsbRsbRsbRsbRsbRsbRsbsbRgbRsbRs
RsmbRsbRsbRsbsbsbLsbRsbRsbRsbRsbRsbRsbRsbRsbsbRsRsRsmmbRsbRsbRsbRsbRsR
smbRsbRsbsbRsRsmbLsbRsbRsbRgbRsRsmbRhbsbRobRsbsbRcbRsRebRsRsmbRjbRsRsm
bRgRsmbRibRsbRgbRibRsbRsbRsbRgRgbRgbRgbRsbRsbRgbRibRcbRsbLsRcRsRsReRsm
mmbRgbLcbLibLiLsLjbsbLgbLibLgbLoRibLobLgbRsbLgbLgbLibLjbLgbRsbLsbLsbsb
LsbLsbLgbsbRsbLsbLsLsmbRsbLsRcRsmbRgbRsbRgbRsRsmbRsbRgRsmbRgRsmbsbRsRs
mbLibsbLcbsbRsLsbRgbsbLibRsRsRsmmbRsRsLsmbRiRsmbRebRcbRhbRsbRjbRcRsLsm
bRsbLgLsbLsbLsbLsbRsbRsbLsbsbLsbLsbLsbsbLsbRjbsbsbsbsbsbsbsbsbLsbRsbRs
RsRsmmbRsbRsRsmbRsbRgbRsbsbLjbLjbRibRgbsbLjbsbLsRebsbRsbRcbsbRsbRcbsbL
hbRgbRgbRsbsbLibRcbRobRsbRsRsRgmbRsbLsbLcbLibRgbLsbLibLsbRsbLjbLsbRsbL
sbLsbLsbLsbsbLsbLsbLsbLsbRsbRsbRsbsbRsbsbRsbsbsbLsRsbLsbsbsbsbLoRsbsbL
sbLsbsbsbRsbsbRgbRsLsbRhRsmbLjbLjbLcRsbLsLsLsmmbLsLsmbLsbLsLsmbLsLsmbs
bLsLsmbRjbsbLibLibLibLcbLiLsbRsbRsbRsbRiRsmbRgbRebRgRsmbLobLgLsbLgbLhb
RibLcbLiRsbLgRsbLcbLibLsbLgbLhLsLiLsbLiRsbRgbRcbRcRsmbRhbRcbRcbRcRsLsm
bLsbRcRsmbRcbRhbRhbLgbRcbRhbRibRibRcbRebRhbRibRcbRgbRsLsbLcbLibRiRsmbL
ibLibLsRsbLibRiRsRsmmbLgbLgbLibLgbLgbRgRsmbLiRsbLgbLgLsLsmbLgRsRsmbLcb
LibRsbRgRsLsmbLgbRcRsmbRgbRcbLsRsbLsLsmbLgbRgRsmbRjRsmbRhbRjRsmbRgbRgb
RibRsRsmbRiRsmbRibRsRsmbRsbRsbRsbRgRsmbRgRsRsmmbRiRsRimbRsbRsRsRsmmbRg
bRgbRgbRsRsRsmmbRsRsmbRsRsRsmmbRsRsRsmmb

>ZF Recording 2016-06-02; tW: 300s; Start: 163338; End: 163850;
Recording: 8-1; Individual: 37; Drug: PCAP814 1 然 Apo 50 然
bRgbLiLsbsbsbLoRsbLoLsmbLcLsmbLsbLsbRsLsbsbLsbsbsbsbsbsbsbRsbsbRsbsbRs
bRsbsbsbsbRsbsbsbsbsbsbLsbsbsbsbRsbRsbsbRsbRsLsRsbLsbRsbRsbLsbRsbLsbRs
bsbRsbRsRsmbRsbLsbsbRsRsmbRsbLsbLsbRsbsbRsRsmbRsbLsbLcLsmbsbsbLsbLsbLo
bLsbLoLgbsbLgbLsLsmbLgLsLsLsmmbLsLgLsLebLebLeLsbLgbRsbRoRsRsmmbRsbsbLi
bLcbRsbLsLsmbLcbLsbsbRcbLsLsRsmbsbRsbsbsbsbRsbLsbsbLsbsbsbLsRsbsbRsbsb
sbsbsbsbsbLsbsbsbsbRsbLsbLsbsbsbRsbsbRsbLsbRsbLsbRsbLsbRsbLsbLsLsmbRsb
LsbLsbRsRsmbRsbLsbLsbLsbRsbLsbRjbLsbRsbLsbLsbRsbLsbRsbLsbLsRsbLeLsbRhb
LjbLsbLsbLsbLsbLsbRsbRgRsRsmmb

>ZF Recording 2016-06-02; tW: 300s; Start: 163338; End: 163850;
Recording: 8-1; Individual: 38; Drug: PCAP814 1 然 Apo 50 然
bLsbsbLsbLsLsLsmmbLsbLsbLsbsbLsbLsbLsbLibLgbLsbLsLsmbsbLsbLgbLsbLsbsbL
sLgbLsbLsLsLsLgmmbLsRsbLgLsLsmbLgbLsbLsRsLsLsmbRsbLsbRsbRsRsmbsbsbsbLs
bLsbsbsbsbsbLsbLsbLsbLibLgbLsLsmbLgbLgLsLgbLibLsbLsbLsLsLgmbLsRsbLsLsm
bLsbLsLsmbLsbLgbRsbLsbLsbLsbLsbLgbRsbLsbsbLsLsmbLsbLgbLgLsbLsbLgbLsbsb
sbLsLsLsmmbLsbLsLsLsmmbLsLsmbLsbLsLgbLgbLsbLgbLgbLsbRsbsbRsbLsLsmbLsLs
LsmmbLgbLsbLibLsbLgbLsbLsbLsLsLgmbLsbLsbLsbLsLgbLsbLsbLgbsbsbsbLsbLsbL
sbLsbLsbLgbLsbLgbLgbLsbLgLsbsbsbsbsbLsbLgRsbLsbLsbLsbsbLsbLsbLsbLsbLsL
smbLsbLsbLsbLsLsmbLsLsmbLsbLibLsbLibLsbLgLsbLibLgLsLsLgLsmbLgLsbsbLsbL
gbLgLgbLibLsLgbLgbLsbLsbLsLgbLsLsLsmmbLgbLgLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 163338; End: 163850;
Recording: 8-1; Individual: 39; Drug: PCAP814 1 然 Apo 50 然
bLobLsbLgbLsbRsbLsLsLsmmbLibLgbRsbLsLsmbLsbLgLsbLsLsmbLsbLsbLsbLsbLsLs
LsmmbLjbLsbLsbLsbLsLsmbLsbLebLgbLibRebRsRsRsmmbRsRsRsmmbRsRsRsmmbRsbRs
bsbsbRgbsbRsbRgbsbRsRsmbLsbRjbRjbRsbLhbLgbsbRsbRsbRsbRsLsbLsLsmbLsbLsb
RsRsLsLsmmbLsLsLsLsLsmmmmbLsbLsLgbLsLsmbLibLsLsmbRsbRcRsRsRsmmmbRibsbL
ibRsbRjbRsbRsbRsRsRsRsRsmmmmbRsbRjbsbRsbLsbRsbLsbLsRsRsRsmmbRsbRsRsRsR
gRsRsRgRsRsmmmmmmbRsRsmbLsbsbsbRsRsmbLsbLsbRibRjbRsbLsLsmbLsLgLsbsbRiR
smbRsbRsRsRsmmbRsRsRsmmbsbsbRsbsbRgbRsRgRgbRsRsmbRsRsRsmmbRsbRsbLsbsbR
sbsbRgbRsbRsbRsbsbRsRsmbRsRsLsRsmbRsbRsbRsbRsbRsbRsbsbRsbRsbLsbRsbRsRs
mbRsRsmbLsbRsbRsRsRsmmbRsRsmbsbsbRgRsRsmmbRsRsmbRsbRsbsbLsbLsbLobLsLsL
smmbLibLgbLsbLsbLgbRsbLsbLgLsLsmbLsLsLsLsLsmmmmbLgLsLsmbLsLsLgmbLsbLsb
LgbLsLsLsmmbsbRsbLsbLgbLsbsbsbsbLgbLsLsmbRsbLcbLsbRsRsmbRgbRibLsbLsbLi
bLsbRsLsRsbLgbRsbRsRsmbsbRsRsRgRsRsmmmbRsRsRgmbRsRsmbsbRgbRsbRsRsRsRsR
smmmmbRsRsmbsbRgRsmbRgRsmbsbRsRsLsmbRgbLsbLsbLsbLsbLcbLsbLgbLibLsbRsbL
gbRcbRhbLsRsbRobLsbLcLsmbLibLsbLsbLibLgLsRsbRibRjRsRsRsmmmbRsRsRsRsRsR
sRsRsmmmmmmmbRiRsRsmmbRgbRgRsmbRgbRsbsbRsbRsRsmbRsbRgRsmbRsRsRsRsRsRsR
sRsRsRsRsRsRsRsRsRsmmmmmmmmmmmmmmmbRgRsRsmmbRgbsbRgRibRsRsmbRsRsmbLsbR
sRsRsRsmmmbRsbRsRgRsRsRgRsmmmbRsbRsRgbRsRsRsRgmmbRgRsmbRsRsRsmmbRsRsRs
mmbRsRsmbRsRsRsRsmmmb

>ZF Recording 2016-06-02; tW: 300s; Start: 163338; End: 163850;
Recording: 8-1; Individual: 40; Drug: PCAP814 1 然 Apo 50 然
bLgbLgbLgbLsbLgbLgbLsbLsbLsbLgbLsLsLsLsmmmbsbLsbLgbLsLgbLibLibLsbLsLsR
sLsmbLsbsbsbsbLsbLgbLsLgLsRsbLsbLibLsLsmbLgbLsLsmbLgbLibLsLsmbLsLsmbLs
bLsLsmbLgbLsbLsLsLsmmbLgLsbLgLsbsbsbLibLsLsLsmmbLsbsbLsbLgbRsLgbLsRsbL
sLsLgLsmbLgbLsbRjbRsbLsbLgbLsbsbsbLiLsLsLsmmbRsbLsbLibLiLgLsbLgbLsbLsL
smbLsbLsbsbLgbLgbsbLgLsbRsbLsLsmbLiLsbRsbRsbLsbLsbLsbLsbLgbLsLsLgmbLsL
smbLsLsLgLsLsmmbLgbLsLgbLgbLsbLsbLsbRsbLsLsmbLsbLsbLgbLsLsLsmmbLsbsbLs
LsLsmmbLsbLsbsbLsbLsbsbLsbLsbLsLsmbLgbLsbLsbsbLsbLgLsbLsbLiLsbLsLsmbLs
bLgbLsbLgLsbLsbLgLsbLsbsbLsLsLsLsLsmmmmbsbLsbLsLsLgLgmbLgLsbLsbLsLsmbL
sbLgbLgbLiLsbLsLsLsLsmmmbLsLgLgbLgLibLgLsLgLsLsmbLgLgbLgLibRjbRhbRibRs
bLsRsLsbsbRgRsmbLsRsLsRsLsbRibRsRgRsmbRsRsmbLsRsLsRsbRsRgRsmbLsRsLsbRs
RsRsmmbRsRsmbRsRsRsmmbRiRsmbRsRsmbRsRgLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 163338; End: 163850;
Recording: 8-1; Individual: 41; Drug: PCAP814 1 然 Apo 50 然
bsbRsbLgbLsbsbLsbLsbsbLibLgLsLsmbLsLsmbLsbRsbLsbRebLsLsmbRsbLsbLjbLebL
ibLgbLsbLjbLsbLgLsbLsbLsbRsbRsRsRsmmbRjRsmbRgRgbRgRsmbReRsRgmbLibRibRh
bRgRsmbsbRgbRsRsmbLgbLeLsbsbLsbRgLsLsmbLsLsmbRcRgRsmbRsRsRsLsmmbRsbRsb
RsRsmbRsbRsbsbLcbLibLgbLsbLgbLgLsbLjbLgLsbLgbsbLsLsmbLsbsbRsbRsLiLgLsL
smbLgbLcbLebLgLsbLebRoRebRsbRsbRsLsbLsbLsbRsbLsLsmbLsbsbLjbLgbLsLibLgb
RsRsmbRsbRjbRgbRgbsbLsbLjbLjbLsLsmbLgLsbLgLsbRsbLsLsmbsbLjLsLsLsLsmmmm
bLgbLgbLsbLsbLgbLsbLgbLsbsbLgbLibsbLjbLhbLibRibRsRsmbRsbRsbRsbRcRgbRjb
RsRsRsmmbRsRsRsmmbLebLgbLsLsmbsbLsbLsLsLsmmbLsbRsLsbLiLsbLgbLgbLibLhbL
gLsbLcLsmbLebLebLibRsRebRsRsRsmmbRsRsRsRsmmmbLsbLsbLjbLgbLgbsbLgbRsRsm
bRcbRsRsRgmbRhRsRsRsRsmmmmbRhRsRsRsRgmmmbRsbLsLsmbLebLhLsbLiLgbLhbLeLs
LsmbLgbsbsbRjbsbRgbRgbsbLeLsbLhbLsbsbLgbRibRsbLsbLsbRobRsbRibRsbRsRsRs
mmbRsbRsbLgbLgbLsLibLeLsbLsbLsbLcbLsLsmbLsbLgbLgbLsbsbLgbLsbLsbsbLgbLs
bLhLsLsmbLsLsLsLsmmmbLgbLgLsbLsbLebLgbsbLcLsmbLiLsbLebLsbLibLgLsbLsbsb
RgRsmbsbLsbLgLsbLsbRgbLebLgbLsLsLhLsmbLhbsbLsbRsbRsRsRsmmbRibRsRgbLcbL
hbLgbLsbLgbRjbRgRsRsmmbLjbLsbRgbLeRsbLhbRsRsmbLsbLeLsbLiLsbRcRsmbRhbRi
bLcLiLiLsbRiRsmbLeLsLsLsLsmmmbLgLgbLeLsbLeLsLsmbReLsLsmbRgRsRsRsRsmmmm
bRsRsmbLeLsbLgLsbLhLsbLgLsbRsbRsbRcbRiRsRsRgLsmmbRsbRsbRgbLsbLebLgLsbR
sbRibRjRsRsRsRgmmmbRgbLcLsLsmmbLsbLsLsmbLsLsLsLsLsmmmmbLsLsmbLsbLsLsLs
LsmmmbLsLsLsLsLsmmmmb

>ZF Recording 2016-06-02; tW: 300s; Start: 163338; End: 163850;
Recording: 8-1; Individual: 42; Drug: PCAP814 1 然 Apo 50 然
bLsLsmbLsbLgbsbsbLsLsmbLgbLsbLibRgbLibsbsbsbLsbLjbsbLgLsbLsbLsbsbLsbsb
LsbLgbLgbsbLgbLsbsbLsbsbLjbLsRsbLsbRgbLgLsbRcLsbLsbLgbLgbLsbLgRsbLgbsb
LibLgbLsbLibLibsbRsbRsbLibLibsbsbLsbLgbLsbRcbsbRcRiRsRimbRsbLsbRgbsbsb
RjbLsRsRsmbRsbsbsbsbRgRsmbsbRibsbsbRgbRsRsmbRibRibRsRsmbRsbRibRgbRibsb
RsbRsbRsbsbLsbRibRsRsmbRgbRibRgbRsRsmbRebRebRebRibRhLiLsbRsRebRgRsLsmb
LgbLsbLiLsbLsLsmbsbsbsbRsbLsLsmbLsLsmbLsLsRsmbLebLgLsbLsbLsbsbLsRsbLsb
sbLsRsbLsbLjbsbRcRsmbRsbsbRsbRibsbsbsbRgbsbsbsbRsbRjbRsbsbsbRgRsRsmmbR
jbRsRsmbRsbRgbRibRebRsLsRgbsbRgbRgbRjbRgbRgbsbLhLibLjbLsLsmbRsbLgbLgLs
RsbRsbRsbsbLgLsbsbLibsbLibLgbLsbRgbLjbLsbLsbLgbLsbLsbLsbLsbLsLsmbLsbLs
LsmbLsLsmbLsbLsbRsLsbRgLsRsbLcbLsbLsbLsbLgbsbLsbLsbRsbLsRsbLjbLsbLsbLg
bLgbLsLsmbLsLsmbLsbLsLsRsmbLsLsmbLsbLgbLgbLsbLsbLsLsLsmmbLgbLsbLsbLibR
hbLobLibRcbRcLsRgbLebLibLsLsmbLibLgbLgLsbLgbLsbLgbLgbLgbLgbLgLsbLsbLib
LgbLgbLibLgbLgLsbLgbLgbLgbLgbLgbLibLgbLgLsbLgbLiLsbLgRsbLgbLiLebLibLeb
LhbLgLiLibLiLsbLsbLgLsbLgbLgLsbLibLgbLgbLgLsbLibLgbLiRsLebLiLsbLgRsbLi
RsbLgbLgLsbLiLsbLgbLiLsbLgbLibLibLibRcbRiRsmbRibsbRgbRibRibLgbRhbRsLsb
RsRsmbRsbRgbRsRsmbRibRsbLcbLibLiLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 163338; End: 163850;
Recording: 8-1; Individual: 43; Drug: Control Apo 50 然
bsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbLsbsbRsbsbs
bsbsbsbsbsbsbsbsbsbsbsbsbRsbLsbsbsbsbsbRsbsbsbsbRsbsbsbsbsbsbsbsbsbsbs
bsbLsbsbsbsbLsbLsbLebLgLsbsbsbLsbLgbLcLsmbRgbRsbLgbLsbLsbLsbLgbLgbLsbL
hbsbLebLgbsbLgbLgbLebLgbsbsbLoLsmbsbLsbRsRsmbRcbRgLsLgbRsbRobRsbRcRsmb
RsRsmbRibRsbRgbsbRsbRgbLgbRhbsbsbsbRsbReRsmbRibLgLsbLcbLgbLsbLsLsLsmmb
RsbRgbLibLjbLgbLgbLsbsbRsbLsbLjbRsbsbLiLiLsbLibLiRsbLsLibLiLebLebLsbRj
bsbsbsbLsRsbLsbsbsbLibsbsbRjbsbsbsbsbLsRsbsbsbsbsbsbLoLsmbsbLgbLsLsRsL
smbLsbRhbLsbLsbRsbLsbsbsbRsbsbsbsbsbsbsbsbsbRgbLgbsbsbsbRibLsRsRgbRgbL
sLsmbRjbRsbRsbLsLjbLjbRgbRsbsbLsbRsbsbLcLsmbLiLsbRgbRsbLgbLhbLsbLgbLsL
cbRsLsLgbLgbLobRsRsmbsbLsbLsbRsbRsbRsbsbLsLsmbRgRgbRgbsbsbLobsbLjbLsLs
LgLsmbRsbLibRgbLsbLsbLcLjbLsbLgbsbRgbLhLsbRsbLsLebLebsbLibLsRsbLobLsbR
gLcbRsbLobLiRsbLjbRsbRsbRsbRibLsbLsbRsbRsbLsbRsbRsRsmbRsbRsbLsbRsbLsLs
mbRsbsbsbRsbRibRgbRgRebRgRsmbRgbRsbLsbLsbLcLgbLibLeLiLsLsmbLibLgbLhbLc
LsLimbLsbRjbLsRsRgbLjbLibLibLobRiLsbRebRiRsmbRsbLgbLhLiLsLsmbLgbLibRsb
LcbReRsmbLiLsbRjbLsLsmbRhbRcbRibRobRibLjbLebLcbRsRsRsmmbRobLhbLoRsbLob
LoLsLsmmbLcbLsLcbLgLsbLgbLibLibLcLsmbRiRgbRibRsLsbLjbReLsRsbRibLsbRsbL
sbRgbRibLgbLobsbRjbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 163338; End: 163850;
Recording: 8-1; Individual: 44; Drug: Control Apo 50 然
bLsbLsLsmbLgbLsbLsbLsbLjbLgRsbRsbRsbsbLgbsbLsbLgbLsbLibRsbRcbsbLsbsbRs
bsbLsbsbsbRsbRgbRgbRsbRsbRsbRgbRgbRsbRgbLsRsLsbsbsbsbLsbRhRsmbLsbRibRs
bLsLsmbRsRsmbLsbRsLsbRsbRsbLsbLjbLsLsmbsbRsbsbLsbRsbLsbLsbLsbLsbLsbsbL
sbsbsbLsRsLsbRsbLgLsbLsbRsbRsbRsbLebRsLsbRsRsRsmmbRgbRsbLsbRsbRsbRsbLc
bsbLsLsmbLsbLsRsbLsbLsbLsbsbLsbsbsbLsbLsLsmbsbRsRsmbLsbsbRgbReRsRsmmbR
gbRsbRsbRsbRsbRsbRsbRgRsmbRgbRgbRgbRsbRibRsbRsbRobRsbRsbRjbRibRsbRgbRs
bRsbRiRsmbRebRsbRsbRgbRsbRsbsbLsbsbsbsbsbLgbLsRsbRsbLsbsbsbLsbRsbsbsbs
bLjbRsbsbLsLsmbLsbsbRsbLsbLsbsbLsbLsbLsbLsbLsbLsbLsbLsbRsbLsbRsLsbLgbL
sbLsbLgbLgbLgbLgbLebLgbLsbLgbLsbLgbLsRsRsmbLsLsmbLsLsmbLsLsmbLsbLsLsmb
LsbLgLgLsbLsbLhbLgLgbLibLsLsmbLsbLsLsmbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 163338; End: 163850;
Recording: 8-1; Individual: 45; Drug: Control Apo 50 然
bRgRsRsmmbRsbRgbRgRsmbsbLgLsRsbRsbLgbLiLsbLsbLibRsbRgbsbsbLjbLibLiLsRs
bLiLsbsbLiLgbLsLsLsRsLsmmbLsRsLsLsmbRsbLibRsbLsbLsbsbsbsbsbLgbRsbRsbLg
bLgRsLsbLgLsLsmbLgLsLsLsLsLsLsmmmmmbLsbLsLsmbLsLsmbLsbRsbLgLsbLsbLsbLs
LsLsmmbLsbRsLsbLgbLsLsmbLiLsbRgbsbLgbLiLsbLsbLiLsbsbRsLsbLsbsbLgbLsbLg
bLsbLsbLgbRcbLjbLhLsbLgLsLsmbLsLsLsmmbLsbLsLsmbLsLsLsmmbLgbLgLsLsLgmbL
sLsmbLsLsmbLsbRsbLgbLiRsbLebLjbRsbLsbRjbLgLsbLgLsbLsLsLsLsLsmmmmbLgLgb
LgbRsbLsbRibLsbsbLgbsbsbLcLsLsmmbRsLsLsmbLsbsbLsbLsbLsbLgbLsLsmbLibLgL
sLsmbLsRsbLgbRgbLsLsmbLsLsLsmmbLgLsbLsbLgbLgLsbLgbRibRjbsbLgbLsLsLgmbL
gLsbLjbLsbLsLsmbRgRsRsmmbLibLsLsLsLsmmmbLibLgLsbLgLsbsbsbsbsbsbRsbLgbR
gbLsbLsbLsbsbLsLgbLsLsRsLsLsmmbLsLsmbLgbLsLsLsLsmmmbsbLgLsbLgbLsbLsbsb
sbLgbLsLsmbLsRsbLibsbRsbLgLsbLsLsLsmmbLiLgLsLsLsmmbLhLsbLiLgbLebLgbLsL
sLsmmbLcbLeLsbLibRgLsbLhLsLsmbRsLsLsLsLgmmbLgLsbLsLsLsLsLsLsLsLsLsLgmm
mmmmmmbLgbLsbLsLsmbLgLsbLgLsbLgbLsLsLsLsmmmbLibLsbRsLsLsmbLhbLgLsLsmbL
ibLsLsLsmmbsbsbRibLgbLgLsLsLsLsmmmbRsLgLsbLsLsmbLgLsLsLsmmbLgbLgLgbLsL
smbLgLsLsmbLsLsmbLgbLsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 163338; End: 163850;
Recording: 8-1; Individual: 46; Drug: Control Apo 50 然
bRebRgRsRsmmbRgbRsbRhbsbRhRsmbRgbRgRsmbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbs
bsbRebsbRsRsmbRsRgRibRsbLgbRcRsmbRebLsbRsbLcRsbLebLebLebLebLsbLsbsbLjb
LgbLebLibLebLgbLgbRsLibLebLebsbRsbsbRsbLgbLsbRsbRsbLsbRjbLsbsbsbsbsbsb
sbsbsbsbsbRsRsmbsbsbRjbRjbLgLsbLsbLsbLgbLsbRsRsmbRibRhRsRsmmbRsRsRsmmb
RgbLsbRebsbsbsbRibReRsRsRsmmmbRsbLsRhbLib

>ZF Recording 2016-06-02; tW: 300s; Start: 163338; End: 163850;
Recording: 8-1; Individual: 47; Drug: Control Apo 50 然
b

>ZF Recording 2016-06-02; tW: 300s; Start: 163338; End: 163850;
Recording: 8-1; Individual: 48; Drug: Control Apo 50 然
bRhbRhbLcbLsbRhbLjbLcbsbRgbLjbLibRsbRgbsbLjbLsLsmbLibsbRsbRgbRsbsbLjLs
LsLsmmmbRibRgbRibLsbLgbLsbLgbLjbLsbLsbLjbsbLgbLcRsbsbsbsbsbsbsbsbsbsbR
gbsbLcbsbRsbRsbLhbRsRsmbLsbRibRiRsmbRsbLibRsbLsbRsRsmbLcRsbsbRgbRgbLcb
sbLsRsbRjbRgbLsbLsbRsRsmbRjbLjbRhbRjbsbsbsbsbRjbRsRsmbLjbsbRjbRsbsbLsb
RjbRsbRsRsRsmmbRsLsRsbLsbLsbRsbsbLcbRsbRjbRsbLsLsmbLgbLsbLsRsbLsbLsbLj
bRhbLibLgbsbLsLsmbLsbRsbsbsbLsbRsRsmbRcbLoLsmbLcbLsbLsbRgRsLsmbLcbLsLs
mbLgLsbLibLgLsbRsLsbLgbRsbLibLsLsLsmmbLsLsLsmmbLsbLgbRsRsmbRcbLsbLobLh
LsbLsRsbRsRsRsmmbRsbRsRsmbLsLsLsmmbRsRsmbRgbRibRhbRgbLhbRibRgbRgRsmbRg
RsmbRoLsbLcbLibLgbLjbsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 163851; End: 164352;
Recording: 9-1; Individual: 1; Drug: PCAP814 10 然 Apo 50 然
bRsbsbRsbRsRsRsmmbLjbRjbRgbRsbRsbsbRsbRsLsbRgbRsLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 163851; End: 164352;
Recording: 9-1; Individual: 2; Drug: PCAP814 10 然 Apo 50 然
bsbRsbRibRsLsbRsRgbLsbsbLsbLgbRsbLgbLsbRsbLsbLsbLsLsmbLsbLsbRsbLsRsbRs
bLgbLsbLsbLsLsmbRsbLsbLsbLsLsmbLgLsbLsLsmbLsLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 163851; End: 164352;
Recording: 9-1; Individual: 3; Drug: PCAP814 10 然 Apo 50 然
bRsLsbsbRsLsbRibRsLsbRsbLjbRsbLgbRsbLgLsbsbLiLsbLgbsbRsLsbRsbLsLsmbsbL
gLsRibLgbLjbRsLsbLsRsbLibLgbLgLgLsLsmbLgbLsLsmbRgbRsbLsbsbLsLsmbLsLsLs
RsmmbLsLsmbLgbRgbLgLsbLsLsmbLsLsmbLgLsbRobLjbLobRgbLsRsRsmbLebLgbRibRj
RgRsRsRsLgmmmbLjbLiLsbRibsbsbLobLsbRsbRsLsbRsLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 163851; End: 164352;
Recording: 9-1; Individual: 4; Drug: PCAP814 10 然 Apo 50 然
bsbLsbLsbRsbsbsbsbLsbLsbsbLsbLsLsmbLjbsbLsRsbsbLsRsLsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 163851; End: 164352;
Recording: 9-1; Individual: 5; Drug: PCAP814 10 然 Apo 50 然
bsbLsbLsLsmbLgLsRsbLgbReLsbLgRcbRsbLsbLgLsLsmbRsbRobLsRsRsRgRsRsmmmbRs
bRsbRsbLsLsRsRgmbsbsbsbRsRsRsmmbRsRsRembsbsbsbRjbRsbRgbsbLibRjRsmbRsRs
RsmmbRibLobLobLsRsRiRsmbRsbRoLsbLebLoRibsbLsRsbsbsbRsRsRgRsmmbRsRsmbsb
LgRgRsmbRsbRsRsRsmmbRsbLgbsbsbRsbRgRsmbsbRsbsbRsbRgbLsbRgbRjRsmbRgRsmb
RgRsRsmmbsbRsRsRsmmbRgbsbRgRsRsRsmmmbRsRgRsmbRsRgRsmbRsbRsRsmbLsbsbRsb
RgRsRsLsRsRsmmmbRsbRsbRsbRsRsmbRgbLgRsRsRsmmbRsbLgRiRsmbRsbLebLhbLsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 163851; End: 164352;
Recording: 9-1; Individual: 6; Drug: PCAP814 10 然 Apo 50 然
bLgbLsbRsbsbsbLsbLob

>ZF Recording 2016-06-02; tW: 300s; Start: 163851; End: 164352;
Recording: 9-1; Individual: 7; Drug: PCAP814 3 然 Apo 50 然
bLgbRgbLibLibLiLhRsbRsbRhbLsbRgbsbRgRsmbsbRgbRgbRgbRsbRgbLjbRibsbsbRsL
sbLsRsbRsLsbsbRsbRibLsLsmbRgbLcbLcbRsLsbLsbLgbLsbLgRsbLsbLhRsRsRsmmbLo
bLibRsbLsbLsbsbLsbLsbLsRsbLsbLsbLsbLgbLsbLgbLiLoRsLsLsmbRgRsmbRiLsbRsR
smbRiLsbRoLsbLgLsbLsbsbsbLsRsbLgbRsbLgRsbLsbLsbLoRsRsmbLgbsbLsbsbsbRsb
LjbsbsbsbLsRsbLsLsmbLsbLgLsbRsbLsbLsLgbLsbLsbLibRsbsbRsbRsLsbsbLsLsmbs
bLgbRsbRcRsmbRgRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 163851; End: 164352;
Recording: 9-1; Individual: 8; Drug: PCAP814 3 然 Apo 50 然
b

>ZF Recording 2016-06-02; tW: 300s; Start: 163851; End: 164352;
Recording: 9-1; Individual: 9; Drug: PCAP814 3 然 Apo 50 然
bLcLsmbLiLsbLibLgbsbLgbLgbRebLsbRsRsLsmbLsbRsbLsbLsbRibsbLsbRsbsbsbRsR
smbRsbRgRsmbsbsbsbLsRsLsRsbsbRsbRsLsbRibLsbLiLsbsbRsbRcbLcbsbsbsbsbsbs
bLsbLiLsLsmbLcLsmbLcbLcbLsLsmbLcbLcbLeLsbLcRsLsLoRsbLiLsbLhLsbLibLiLsL
sLgmbLibLcbRjbLiLobLiLsLsLeLsmbLgbRcbRobRcRiRsRimbLgbRibRiRsmbLsbRgRsm
bsbsbsbRibRibsbLsbLobLhLebLiLsbLeLsbRsLiRsbLgbLgLsbLgLsbsbLgbLsLhbRcbR
ibRibRibRgbRiLsbRgRsmbRgbRibLcbLhbLobLcbLcLsmbLgLsbLhLsbLsRsbLgbLiLsbL
sbLgbLgLsLsmbLgbLgbRsLsbLsLsmbLsbLgbLsLcbsbRhbRobRcbRhRsmbRibRebLgbLgL
sbLibLiLsbLgbLibLiLsbLgbLgLsbLibLgbLsbLgbLsLsmbLgbLgbLsLsmbLsbLgbLeLsb
LhLebLhLsLsmbLiLsLsLimbLhLsRsbLhbLhbLhbLiLsbLiLsLsLsmmbsbLgbLhbLgLsbLi
LsbLibLibLhLsbLhbLibLcLsmbLibLcbReRsRsmmbRiRgLsRsRcbRhbRiRibLgRsRiRsmb
RsbRoRiLsbRcbRgRsmbRgLsRsbRsbsbsbsbRsbLsLsmbsbRsLsbLsbLsbLsbLsLsmbRibR
sbRsbRgRsRsmmbRsRsRsmmbRgRsLsmbRgbRsRsmbRgbRgLsbLebLhbLgLsbLsLsmbLcLsm
bRobRcRsmbRiRsRsmmbRoLsbLsbLibLiLsbLgLsbLobLcLobLebLgLsbLibLgbLiLsbLcL
sLsmmbLiLsbLiLsbLibLibRcbRoRcRsmbRcRsmbRiRsmbRebRgRsmbRgbRgLsbRibRoLsb
RcRsmbRhbRiRsmbRgLsbLsRsbRiRsmbLsRsRsRsmmbRgRsRsmmbRsbRgRsmbRiRsRsRsmm
mbRgRsmbRgbRibLsbRiRsmbLcbLoRsbLibLiLsbLoLsLombLgbRhbsbRgbRgRsRsmmbRiR
sRsLsmmbRsRsmbRgbLsRsbRgbRgbRibRgRsmbRgbRgLsbRsRsRsmmbRgbRiRsmbRgbRsRs
RsmmbRgRsRsmmbRsRsRsLsmmbRsbRsbRsbRgbRgbRiLsLsmbLobLcLsLsmmb

>ZF Recording 2016-06-02; tW: 300s; Start: 163851; End: 164352;
Recording: 9-1; Individual: 10; Drug: PCAP814 3 然 Apo 50 然
bLgbLsLgLsLsmbLsbLsbLsbLsbLsRsbLgLgbLsbLsLsmbLsRsbLgbLsbLsbLsLsLsmmbLs
LsLsRsmmbLsLsmbLsLsmbLsbLsbLsRsLsbLsLsLsmmbLsLsmbLsbLsbLsbLsbLsLgbLsRs
bLsbLsbLsbLsbLsbsbsbsbsbsbsbLgbLsbLsLgbLsLsLsLsmmmbRsLsbLsLsRsmbRsLsbL
sbLsLsLsmmbLsbLsLsmbLsLsmbLsbLsbLsbLsbLsbLsbLsbLsbLsbRsbRsbLsbLsLsmbLs
LsmbLsbLsLsmbLsbLeLgbLsLsLsmmbLsbLsbLsbLsLsmbRsLsbsbLsbLgLsbLgLgbLsLsm
bLsLsmbLsLsmbLsLsLsmmbLsbRsbLsbLsbLsbLsbLibLiLgbLsbLsbLsLsmbLsbLsLsmbL
sLsmbLsbLsLsLsmmbLsbLsbsbLsLsLsmmbLsbLsbLsbsbLgLsbLiLsbLgbLsbLsbLsLsmb
LsLsmbLsLsLsmmb

>ZF Recording 2016-06-02; tW: 300s; Start: 163851; End: 164352;
Recording: 9-1; Individual: 11; Drug: PCAP814 3 然 Apo 50 然
bsbRsbsbsbLcbsbsbsbLsbLsbRsbsbRsbsbLsbsbsbLcbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 163851; End: 164352;
Recording: 9-1; Individual: 12; Drug: PCAP814 3 然 Apo 50 然
bLcbRgLsbLibLgbRebLobLibLibLcLsmbRsbLsbRcbRibRgbsbLsLsmbRsbRhbLgLgbLeL
sbLibLiLsbLgbRgbRgbRhbRsbLiLsbLibLsLcbRgbRebRebRcLsbRgbRibRibLgLsbRibR
gbRcbRgLsbLobRgRsmbRibsbLjbRcbLgbRgRsmbRiRsmbRgbLsbRhLsbRoRsmbLoLsmbLg
bLcLsmbLsLsmbLcLsmbRsbLeLsbLobRsRsmbRgRsmbRibLsbRgbRiLsbLgbReRsmbRsbRc
bsbLsRibLsLsmbLebLgLsLsmbsbRsbRsbRcbLsbRjRsmbRgbRcLsbLibLobRcbLsLsLsmm
bLibRjbRhRsmbRibRcbRcbsbLsbRibRgbRgLsbRcbLibRsbRibLgbReLsbLcLsLsmmbLib
LcbLsLsmbRsbLgbLgbRiLsbLoLsLsmmbReLsbLcLsmbLsbLibLcbLsLsmbLibLsLgLgbLi
bRsbLsbReRsmbRgbRgRsmbRgbLcLsmbLgbRcbRcbLsLsLhmbRhbRibLobLebLiLsbLhbLs
bLibRsRibRebReLsbLcLsmbLibRibLcbLgLsbLibLebLgbLibLibRsbLjLsLsmmbRsbsbL
hLsbRjRgbLsLsRsmbLibLsbLgLgbLgbLgbLsbRjbLhbLgLsbRcbRcbRcbLjLsmbLgLsbRi
bRhLsbRibRiRsmbLibLcbLsbRcbReLsbRcLsbRsLsbsbLcLsmbRibRibLgbRibRcLsbLiL
sLsmbRibRsRiRsmbRcbLcLsmbLiLsbLgLsLsmbLgbLebRgLsbLsbRcbLcLsmbLiLsbRibL
ibLhbRjbRgbRjRsLsmbRgbRsbLoLsmbLibLcbLibLgbRhbRobRjRsmbRibRibLsLsmbRib
RcRsmbLcbLibRsLsbLgbLiLsbRgRsmbLgLsbLcbLcbRsLsbRgbRibRebRgbRcbLsbLsLsm
bRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 163851; End: 164352;
Recording: 9-1; Individual: 13; Drug: PCAP814 1 然 Apo 50 然
bRsRsRsRsRsmmmmbRsRsmbRsbRsbRsRsRsmmb

>ZF Recording 2016-06-02; tW: 300s; Start: 163851; End: 164352;
Recording: 9-1; Individual: 14; Drug: PCAP814 1 然 Apo 50 然
bRibLgbLcbRgbLoRsbLibLsLsmbsbLgbLibLhbLgbRgRsmbRibRhbLcLsmbLgbRhbLsLsm
bRsbLsbsbsbLiLsbLgLsbLgbRgLgbLgRsbLiLsbLcLsmbRhbLsLobLhbLebRoRsmbLgbRo
bRsbRobRsbRobRgbRobsbRgbRhRsmbRobRgbRobLeLsLgRsbLeLsbLiLsLeLebLiLiLeLe
RsbLiLsbRobRgRsLgmbReLsLsLeLgLsLgLsLsmmbsbLsLsmbLsRsRsmbsbsbLsbRsRsmbL
cLsmbsbRsbLcbLcLsmbLoLsmbLgbRcbRob

>ZF Recording 2016-06-02; tW: 300s; Start: 163851; End: 164352;
Recording: 9-1; Individual: 15; Drug: PCAP814 1 然 Apo 50 然
bRsbRsRsmbRgRsRgRsmmbLebLhbLsLsLsLsLsmmmmbRsbLsbLgLsLsmbLgLsLsLsmmbLgL
sLsmbLgbLgLibLiLsLsmbRiRsRsRgRgmmbRsbLgbLsbLgLsbLsLsLsLsLsmmmmbRsLsLsL
sLsmmmbLsLsLsLsLsmmmmbsbsbsbsbsbsbsbLsbRsbRsLsbsbsbLsRsbRsbLsbLsbRsLsb
LsbLsbRsRsLsmbsbLsbLgLsRsLsbLgbRiRsLsmbRibLsbsbLgLsLsLsLsLsLsLsmmmmmmb
LsLsRsLsmbLsLgLsLsmbLsLsLsLsmmmbLsLsLsLsLsLsmmmmmbLjLgLsLsLsmmbRjbRcbR
cbRsRsRsmmbLgRsbLsbRgRsRsLsRsRsmmmbLobLsLgLgLsLsmbLsbLsLsLsLsmmmbLsLsL
smmbLsLsLsLsmmmbLsLsLsLsLsLsRsmmmmmbLsLsRsLsmbLsLsmbLoLgbLsLgbRgRsmbRg
RsRsmmbLhLsbLgLsbLgLsRsLsLsRsmbRsRsLgLsmbLgLsbRsLsbLsbLsLsLsmmbLsLsRsm
bLsbLsLsLsLsmmmbLsRsLsLsLsLsmmmbLsLsmbLsbLsRsbLsbLsbLsbsbsbLsLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 163851; End: 164352;
Recording: 9-1; Individual: 16; Drug: PCAP814 1 然 Apo 50 然
bLibRsbLobRcbLibLobRgbRebLibLobRcbLgbRcbRcbRgbRobLobLebRcbRobRibRobReb
LebRobLgbRebLebRsbLobLobRobRobRobRcbLobLobRjbRobLobRobRhbLobLobRobRibR
obRebLsbRcbLcbLcbLebRibRibRobLgbLobRobLobRebLebRibLgbRobLobRibLgbLebRh
bRgbRebLcbRibLsbLobRcbLibLobRobRobRobLgbRcbLobLebRobLebRobRobLgbLebLob
RebRcbRcbLobLobLibLebRobLobRebLobLcbRcbRgbLebLebRobLcbLhbLcbLgbLebLebL
obLobLebRcbRibLjbLgbRsbLcbLobRebRobLcbLebRobRebRhbLobLobLcbLebLsbLebLo
bLobLobRebRsbLobRcbRobLobLebRsbLibRobLsbRobLebLgbRobRobLobRcbRgbLcbLcb
LcbRcbRcbRcbRcbLebRobLebLobRgbRsbRobRebLcbLebRibRobLibLhbLobLebLebRgbR
obRobRibRcbRjbLibRobLobRebLebRobRobLobRobLobLebRgbLgbLebLsbLebLebLcbRo
bRobRibLsbRjbLibLobLjbLobLebLsbLobRebRobRobRebRobRobLobRjbRobRobLsbLob
LobRobLebLobRgbRcbRsbLobLcbRibRobLebRobLcbRebLsbLebLebLcbRebRgbRobRobR
ebRebRcbLebRcbRobRibLcbLobLgbRebLcbLcbRebLsbLebRobRibRcbRebRibRcbLsbRo
bLsbRcbRgbLobRebLebRhbLebRebRgbRebRebRcbLobLebLhbRcbRobLobRebRcbLobLib
RobRebLobLibRibRobRebRebRjbRhbLebLebLcbLobRobLobRobLebRobLibLebRobLebR
obRobRobRobRgbLcbRcbLebLebLebLcbRobRebLobLebRebLjbRobLobLebRobLhbLobLg
bLobRsbRobRcbRebLjbRjbLsbRebLebLobLobRebRcbRebRcbLobRobRobRobLobRcbLob
LobRebLcbRebLobLebRobRebLobRhbLcbLebRsbRobRobLobRobRjbLcbRobRsbLebLsbR
jbRhbLcbRcbRgbRobRobLcbLjbRgbLebLsbRebRcbRobRgbLobLsbRebLobRebLobRobRs
bLobLobLgbRobRobRobRcbLobRobLobRobLobLobLebLobRobLobLobRcbRobRebRobReb
LobLobRebLcbLebRjbRobLibRibRibRebRobRebLobLobLsbLcbLobLgbLcbLobRobLobL
ibRobRobLobLcbRobRgbRobRcbLsbLjbLobRcbLebRobLebRibRebRobLsbRcbRebLobLo
bRebRobLsbRcbRobLobLebLibRobLcbRobLsbRobRobRcbRobLcbLobLcbLebRsbLebRob
LhbRobLobRcbLebLobRcbLobRebLobRobLobRobRcbLibLobRebRgbRcbRobRsbRobLibL
cbRobLobLebRgbLjbLobRjbRebLgbRgbRsbLobRebLobLsbLsbLobRebRgbRobRobRibLo
bRobLebRgbRebLcbLibLobLibLcbLebLcbLobRobRebRhbLobLebRobLibRobRobRobRob
LebRebRcbRobRibRobLobRobLobLobLobRobLcbLobLcbRobLobRebLobRobLebRobRebR
ibLebRobLobRobLibRibLibRcbLobRobRcbRibLobLobLobLebRcbRobRsbLebLibLibLe
bLobRcbRcbLcbLcbLobRibLebLobRcbLobLobRgbRcbRgbRobLobRobLcbRobLobRobRob
LebLgbRhbLobLebLobLibRobLobLebRebLobLobLcbRcbLobRebLsbLgbRobRobRobLobR
obLibRobRobLcbRjbRgbRcbLebLcbLebRibRcbLebRcbLgbLobLcbRcbLcbRsbLebRcbRc
bLobRobRcbLebLobLobLebRcbRcbRcbLjbLibRobLebRobLcbRobRibLgbLobRebLebRcb
RobRebRcbRjbLebRcbLcbLobLobLcbLobRibRebRibRebLebRgbRobLebRobLobRobRebR
jbRebLobLebRebRobRobRobLcbLobRhbLobLcbLobLebLobRcbLobLebRcbRcbLebLobLo
bLobRobLobLcbLebLobLibLebRobRobRobRobLobLcbLhbLjbRebLebLsbLobRebRobLib
RcbLobRibLebRebLebLobRobRcbRcbLobRcbLebLgbRobLobRgbLcbLhbLjbRsbLebLjbL
gbLebRebRobLobLcbRobRobRebRibRibLobRebLebRobRobLibLebRcbRgbLobLhbRibLo
bLobRobRebLobLcbLobLobLobLcbLibRobRobRhbRobLobLobRobRobLebRobRsbLibRob
RgbLobLobRobRebRgbRobRobLobRebRebRcbRobRebLebLobLgbRcbLebLsbRobRgbLobR
obLobLgbLgbLebLebLobLcbRobLobRobRcbLobLobRobLcbRobLebRebRobLibLobRibRo
bRobRhbLsbRobRgbRgbLebLibLebRobRhbRgbRcbRcbLebLobLibRobRobLibRgbLobLeb
RcbLobRebLobRgbLgbRebRobRobRobRebLcbRobRobLobLebRsbLebLcbRgbRebLobRobR
obLebRobLebLobLobRsbRgbRebRob

>ZF Recording 2016-06-02; tW: 300s; Start: 163851; End: 164352;
Recording: 9-1; Individual: 17; Drug: PCAP814 1 然 Apo 50 然
bRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 163851; End: 164352;
Recording: 9-1; Individual: 18; Drug: PCAP814 1 然 Apo 50 然
bLiLsbLsbLsbRsbRibLsbLiLsbLgbsbLgbsbRsbLgbLgbLgLsbLsbLgRsbLgbsbsbRgbLg
LsbLsLsLsLsLsLsRsmmmmmbsbLsLsmbLgbLsbLsLsLsLsLsLsLsLsLsmmmmmmmmbLgbLgb
LgbLgbRibLcbLibLgbRibRgbsbLsLsLsLsmmmbLgbRsbLgRsbLsLsLsmmbRsbRsLsbLsbL
sLsLsmmbLgbLgLsbLgRsbLgLsbLgLsbLgbLgbRsRsmbRsbRgbLsbLsbLibLsLsmbLsLgLs
LsLsLsLsmmmmbRsbLgbLsbLgbLibLibLgbLgLsbLsRsbRgbRgbLsbLsbLiLsbsbLgLsbLs
bLiLsbLsLsmbLsbLsLsmbLhbLsbLibLsbLgLsbRgRsmbRjRsmbLgbLhbLgLsRsbLiRsbRs
bLgbLgLsbLgLsbLgLsbLibRgbLgLsLgLsLsmbLsLgLsbLcbRgbRibRgbLgbLebLiLsbLhb
LsbLgLsbLgbLgbsbRsbRsbLibLgLsRsbLgbLgbsbLgbLsLsmbLgbLsRsbLsbsbLsRsbLsL
sLsLsmmmbLsbLsbLgbLsLsLsmmbLsLsmbLsbLsLsLsLsLsLsLsLsmmmmmmmbLgbLgLsbLh
bLsbLsbRsbsbsbRiLsbLsbLibLgLsLsmbLsbLsLsLgmbLibLsRsRsmbRgbLibLgbLibLhb
RgRsmbRgbRgbLgbLsLsmbsbLsLsLsLsLsLsLsLsLsLsLsLsLsLsmmmmmmmmmmmmmbLsLsL
smmbLsbLsbLgbLsLsmbLsbRsLsbLsLsLgLsmbLgbLibLgbRiRsmbsbLgbLgbsbRibRjbRs
bLhLsbLsbLjLsmbLjbsbLsLsmbLsRsLsLsLsmmbLsLsmbLgbRsLsbLsbLgLsbLgbLsLsmb
LgbLibLsbLgLsbsbRsbRgRsmbsbLsbLiLsbLibLibRgRsmbLibLsbLibLhbRiRsRsmmbRg
bLcbRgbLsLsmbLiLsbLsbLgbLgbLgLsLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 163851; End: 164352;
Recording: 9-1; Individual: 19; Drug: Control Apo 50 然
bRsRsmbsbLjbLhbLsbLiLsbRgbRjbLsbLsLsLsmmbLgbLsLsLsmmbLgRgbsbsbRcbRsbLg
bLcLsmbLgLsbsbLhbRsbLoRsbLgbRibRibRibRibRgbRibRibRcbRiRsmbRsbRibLiLsRg
bRsRsmbsbsbsbLjLsmbLsLsLsLsLgmmmbLgbLsbRoRsRsmmbRsbLibsbLsbLobLsLgbLsR
sLsbRsRsRsmmbLcbLgLsbLibRsbLcbRiRsmbRcbRibRsbRgbRsbRsRsRsmmbRsRsmbRibR
eRsmbRcbsbRsbLjLsLsmmbLgRsbLgbLgbRcRsRsmmbsbsbLhbLoLsmbLeLsbLgbLgLsLsL
smmbLgbLgbRsbLiLsbLiLsbLhbsbRibLiLsbLgLsbLgbLsbLgbLsbRjbLeLsbLiLsbLsbL
obRhbRgbRgbRcbRsbRobRgbRhRsmbLcbRgbRhRibRgbRgbRibLsbRgbRgbsbLibLsLgbLi
LsLsmbLgbLgLsbLgbLcLgRsbRhRsRimbRgRsRsRgRsRsRgRsmmmmmbsbLgLsLsmbLsLsLs
LsLsmmmmbLsLsLsLsLsLsmmmmmbLsbLgbLsLsLsLsLsmmmmbLsbLsLsRsLsmbLgLsLsmbL
gbRsbLgLsLsLsLsRsRsLsRsRsRsmmmmmmbRgbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 163851; End: 164352;
Recording: 9-1; Individual: 20; Drug: Control Apo 50 然
bRgbLibLgbLjbLsbRgbLsLsmbRsbLiLsbLibLsbLsbLsbsbsbsbLiRsbRjbLgbRjbLibLs
bLibRjbLgbLsbRebRgbRgbLsbLsLsmbsbLjbRibLhbLiRsbRjbLsbLgRsbRibRsbLsbLjb
LibLibLgRsRsmbRcbRibLcbLibRjbRibRsbLibRebRgbRsbsbLjbRjbRgbLjbLsbLgbRcb
LsbLibLiLsbLjLibRsRsLsmbLsLsmbRgbLibLgbLgbLgRsLsbLgbLgbLsbLgbLgbRsbLgb
LgbLibLgbLiLsbLgbLgbLsRsbLiLsLsmbLeLsbLgbLhLsLsmbLiLsbLibRibRjbRsRgbLc
bLiLsbLibLsbLibLiLsbRsbLibLibLibLgLsbLsbLibLsbLibLsbLobLgbLsbLgbRebLsb
RhbRgLsbRibRsbRibLgbLibLgbLgbLgbLibLgbLsbLsbLibLgbLiLsbLgbsbLgbLsLsmbL
gbLgbLibLcbRiLsbRgRsLsmbLjbLhbLgLsbLgLsbLgbLcbRsbRgbLibLeRsbRgbRsbLjbL
ibsbLgbLgbLiLsbLibLgbLgbLgbLgbLgbLgbLiRgbLeLsLibLgbLgbLgbRsbLjLgbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 163851; End: 164352;
Recording: 9-1; Individual: 21; Drug: Control Apo 50 然
bRgLsbRhLsbRibRsbRsbRebLsbRiRsRsRsRemmmbLgbRobRebRhbLgbsbLsLsmbsbLsLsm
bLsbLsbLsbLsbLgLgLsLsmbsbLsLeLsbLsLgLsLsLsLsLsLsRsLsmmmmmbLebLgLsbsbsb
sbsbsbLebLibLhbLiLsbRsbLgbLeLsbsbLsLsRsLsmbLibRsbLhbLebLebLsLsLsLgLsmm
bLebLeLhbLibRjbLcbLiLsbLeLsLgbLebLibLcbLhbRjbRebRgRsRsmmbRebsbLsbRebLs
RebRgbRebRhbLibRiRgRiRsRimbRebRibRgLsbRsbReRgbRiRgbRebLjbRcbLcLsLsRsRs
LsLsLsmmmmmbRobLebLcbLcbLebRibRebsbLjbRsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 163851; End: 164352;
Recording: 9-1; Individual: 22; Drug: Control Apo 50 然
bsbRsbsbsbRsbsbRsRsRgmbRsbRsRsRsRsRsmmmmbRsRgRsRsmmbRgRsRsmmbLsRgRsmbR
sRsmbRsRsRsRsRsRsRsmmmmmmbRsRsRsRsmmmbRsRsRsmmbRsRsRsRsRsRsRsRsRsRsmmm
mmmmmmbRgbRsRsRsmmbRgbRsRsRsRsRsmmmmbRsRgRsmbRgRsRsRsLsmmmbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 163851; End: 164352;
Recording: 9-1; Individual: 23; Drug: Control Apo 50 然
bLsbRsbRsRsRsRsmmmbRsbRsRsRsRsRsmmmmbRsRsRsRsmmmbRgRsmbRibRhbLgbsbRsbR
sRsmbRsRsRsmmbRgbRcbLebLgbLoLsmbLgbLsbRsbRsRsRsmmbRsRsRsRgRsmmmbRgRsLs
mbRsRgbsbLsbRsRsmbRgRsmbRibRjbLsbRsbRgbRsbRgbRgRsmbRhbRsRsRgRsRgmmbRcb
RsbRobsbRcbRcbRcbRiRsmbRebRgbLgbLhLsbLibRhbRsbLsbRsbLsbLsbRsLsbRsbRsbL
sbRsRsmbRgbRgRsRiRsmmbRgRebRgRsRsmmbLjbRcLsbRebRiLsbLgbLgbRibLsRsbRgLs
bRsbRobRebRgRsRsRsRsmmmmbRiLsbRgRsRsmmbLsRibRsLsbRgbRsRgRsmbRsRsRsRsRs
mmmmbRsRsRsRsRgmmmbRibRgbRsRibRgRsmbRsbRsRsmbRgRsRgRsmmbRgbRsLsbRsbRsb
sbRgbRgRsRsmmbRgbLsRsRgRsRsmmbRgbRsRsRsRsRsmmmmbRsbRsbRsbRsRsmbRgbRsbR
gbRsbRsbRsbRgbRcbRib

>ZF Recording 2016-06-02; tW: 300s; Start: 163851; End: 164352;
Recording: 9-1; Individual: 24; Drug: Control Apo 50 然
bLibLjbsbLjbRhbRibRibLjbsbLsbLibRsRsmbLsbLibLgbLgbLhbLibLibLibRibsbRjb
LebLjbLibLgbLgbLgbLgbLibLibRsRsmbLgbRjRsRsmmbLsbLgRsbLgbRjRibRgbRiRibL
sReRsmbLjbLibLibLebLebLgbLiLeLsbRsbRgbLsbLgbLgbRsbRsbLjbLjRsbLjLsmbLjb
LjbRobLjbRjRsmbLjbLjbRcRgbLsRsbRgRhbRjbLcbRsbLjbLiRgbLiRsbLibLiLgbLgLs
bLibLibLibRsbRhRsmbRjbRhbsbLjbLhbLgLibLhLgbLsbLjbLibLcRsbLibLgbRsbRgbL
hbLjbLiLsbLjbRgRsmbRcbRjRibRsRjRsmbRgbLibRsbLgbRsbLhbLgRsbLibLibLsbLjb
LhLgLibLibLgbRsbLiLsbLgbRsbRjRibLgbLjbLjbLgLsbRebLjbLjbLjbLibLgRsRsmbL
jbLgbsbLgbsbRibLjbRjbRjbLibLjbRjRjbLgRsbLibLjRsbRgbRsbLjbRsLsbLjRsbLsR
sbLjbLibLjbLjRsbLjbRgRjbLgbLjRsbLibLibLiRsbLibLgRsbLibLibLgbLcLgRsbLib
LiRsbLjLgbRjbRjbReRsmbRibRgbLhbRgbRjbRjbLjbLjbLgbLibLib

>ZF Recording 2016-06-02; tW: 300s; Start: 163851; End: 164352;
Recording: 9-1; Individual: 25; Drug: PCAP814 10 然 Apo 50 然
bRsRsRsmmbRsLsbRsbRsRsmbRgbRgbRsbRsbRsRsRsRsRsmmmmbLsbsbLsbLsLsLsmmbsb
LsbLsRsLsbLsbLsLsLsmmbLgLsLsLsLsmmmbLsLsRsmbLsLsLsmmbLsbRsbLsRsbLsLsmb
LsbLsLsmbLsbLsbLsbLsbLsbLsLsmbLsLsLsmmbLsLsLsLsRsLsmmmbLsRsLsLsLsmmbLs
bLgbLebLjbLgRsbRjbRsbRsRsRsmmbLsRsLsRsRsmbLsbRoRsmbLibRsbLsLsmbsbRsbLs
LsLsLsLsmmmmbLsbLsbLsbLsbLsbsbRsbLsbLsLsmbLsbRsbRsbLsbLsbLsbLsLsLsmmbL
sbRsbRsLsbRsLsbLeb

>ZF Recording 2016-06-02; tW: 300s; Start: 163851; End: 164352;
Recording: 9-1; Individual: 26; Drug: PCAP814 10 然 Apo 50 然
bLsbLgLsbLsLsmbsbLsbLsLsmbLsRsbsbLsbLsLsmbLsbLsLsmbLsbRsbLiLsbsbLsLsmb
LgLsbLsbLgLsLsmbLsbLsLsmbsbsbRsRsmbsbLsbLsbLsbLgbsbRsRsRsmmbRgRsmbRiRs
mbLgLgLsLgbLsbLgLsLsLsLsmmmbLsbRsbLsbLibRsbRsbLsbRibReRsmbLcbLgbLsLsLs
LgmmbRjbRsbLgLgRgbRebLsbRsbLebLjbLsLsmbRobLsbLsLsmbRsbRsLsbLsbLsRsbRsR
smbLcRsLsLsmbLgbLsLgLsbLgbRsRsLgmbRsbLjbsbRsLsbLcbLsbLsLsmbRgbLgLsbLsb
RsbLsbLsLsLsmmbsbRsbLgbLsbLsLsLsmmbLsLsmbsbLsbLsRsLsbsbLgbLsbLsbLgLsbs
bLsLsLsmmbLsbsbsbsbLsLsLsmmbLsbLsbRsLsbLgbRhbRgbLsRsbLgLcbRsbLsLsmbRsR
sRsmmbRhLsRsRsmbRgRsmbRebRsRsmbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 163851; End: 164352;
Recording: 9-1; Individual: 27; Drug: PCAP814 10 然 Apo 50 然
bLjbLsbLsLsLsmmbLgbLsLsmbLjbLibLiLsbLsLsLsLsmmmbRsbLsbRsbLsbsbLsbsbLsL
smbLsbRsLsLsmbLsLsmbRsbLeLsbLsLebLobLsbLsRsbRsRsmbsbRcbRsbLsbRsbRsbRgb
RsbLsLobRsbLsbRsbsbsbLsbRsbRsbLebRibLobRjbRsLibsbsbRsbRsRsRsLsLsmmmbLs
bLsLsLsmmbLsLsmbLsbLsLsLsmmbLsLsmbRsLsbLsbLsLsmbLsLsLsLsRsmmmbRsbLsbLs
LgLsbLsbLjbLsbLgbRsbRgbRsbRibRgbRsRsRsmmbRgbRsbRsRsmbRsRsmbRibLsRsbRsb
sbsbRsbRsbRsRsLsmbRsbRsRsRsmmbRsRsmbRsbRsbLebRsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 163851; End: 164352;
Recording: 9-1; Individual: 28; Drug: PCAP814 10 然 Apo 50 然
bLcbRsbRsbRsRsmbLjbLcLsmbLsbLsbLsbRsRsRsmmbRsbLsRsRsmbRsRsmbRsbRsbRsbL
sRsRsRsmmbRsRsRsLgmmbRsRsRsmmbLsRsRgRsmbRsbRgbsbsbRsbLsRsbRgRsRsmmbRsR
smbRsRsmbsbLsRsbRsbsbRsbLsbRsRsmbRsRsRsmmbRsbLsbRsbRsRsmbsbsbsbRsRsRsR
sRsmmmmbRsbRgbLibLsbLsbRgbRsRsRsLsmmbLsRsRsRsmmbRgbRsbLsRsRsmbRsRsmbsb
sbRsbRsbRsRsLsmbsbsbRsLsRsRsRsmmbRsbLgLsbRgRsmbRsbRsbRsbLsbLsbRgRsLsmb
sbsbRibRibLsLsmbRiLsbRgbLgbRsbRsRsmbRsbsbRsbRsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 163851; End: 164352;
Recording: 9-1; Individual: 29; Drug: PCAP814 10 然 Apo 50 然
bLoLjRsbLoRsRsmbLcbLgbLgbRgRsmbRsRsRsmmbLgbLgbRobRobLsRcRsmbRobRebRjbR
iRsmbRjbRibRobRcRcbLibLobRcRsRsmmbRcbLobRhbRibLibLiLsbLoRsbLibRhbRsReb
LsRsbRobRoRsRsmmbRcLsbRibRebLgLsbLibLoRsbLcbLoRsbLcbLsbLgbLsbLsbLgbLsL
smbLsbsbLgbsbsbLsRsRsmbLgbLgbLibRsbLobLcbLcbRgRsmbRebRoRsmbRebRoLjbLob
LoLsmbLcbLoRsLoLsmbLcbRcRsmbLcbLcbLsRebRcbRoRsmbRoRsmbRobRoLsbRsbRoRsm
bRobRcbLgbRobRoLsbLobLobLobLobLobLcbsbLsLsmbLsbLibLjbLobLsbRsbRsbRsRsm
bRsbRsbRsbsbRsbLsbsbRsbsbsbRsRsLsRsmbRsbsbRsbRsRsmbsbLsbLjbRsRibLibLeR
sbLgRsbLcbRcRsmbRoRsLsmbRcbRgbLsbLsRsRsmbLgLsbLgbsbLsLsmbRsbLcbRsbRsbs
bRsbsbRjbRcRsmbRjbRiRsmbRobLebLgbRsbLsbLsbRsbsbLibRcbRobLsRsRsmbRoRsRs
mmbRebRoRsmbRoRsLombLibLiRsbRsbRgbLsRsbRsbRsbsbsbLcbLsbLsbLibLsbLsbLcb
RobRebRcbsbLsRoRsmbRcbsbRobRobRibRobLcbLibLhbLobRsLobLobRcbRebRobRsRob
LsbLsRsbRiRgbRhbRibLcbLobLcLsmbLibLjLsmbRhRsmbLsbLjLgRsbLgbLoLsmbLcb

>ZF Recording 2016-06-02; tW: 300s; Start: 163851; End: 164352;
Recording: 9-1; Individual: 30; Drug: PCAP814 10 然 Apo 50 然
bLsbLsLsLgLsLsmmbRsbLsbLsbLgRsbLsbLsLsLsLgLsLsLgLgmmmbRsbRsbLsbLsbRcbL
sRsbLgLgLsbLsLsLsmmbLsLsRsmbLsbsbsbLsLsLsLsLsLsLsRsmmmmmmbsbLsLsRsmbLs
bLsbLsLsLsmmbLsbsbLsLsmbsbRsLsLsLgLsmbLsbsbLebLgbLsLsmbLsRsRgbRobRcbRs
bRsLgbLsLsmbsbLsbLsLsLsmmbLsbLsLsmbLgLsbLsbRsbsbLsLsmbRsLsLsLsmmbLsLsL
smmbLgbLsLsLsmmbLgLsLsLsRgLsmmbLsLgLsbLjbRgbLsLgbLgLsbRsbRsLsLgbLsLsLs
mmbRsRsLsmbsbLsLcbReLsbLsLsmbLsbsbLsLsmbsbLsbLsbLsbLsbLsbLgRsbRsbRsbLs
LsmbLsbLgLsLsLsLsmmmbLsbLsLsLsLsmmmbsbLsbLsbLsbRsLsbRsbsbRsLsLsmbLsbRs
LsLsmbRsLsbRsRsmbLsLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 163851; End: 164352;
Recording: 9-1; Individual: 31; Drug: PCAP814 3 然 Apo 50 然
bRibRcbRgbRsRsmbRgbLsLsmbRiRsmbLsbLibLjbRjbRiRsmbsbRibLgbRgRgRsmbRgbRg
bRgRsmbRgRsRgRsmmbRiRgRiRsmbLebRebLobRgbRgbLgbRibRibLsbRsbRibRgbRsRgbR
gRsLsmbRsbLjLjbLebRcbRgbRibRsbRgbLsRibRsRsmbLsbLsbRsbRcbRgbRsbRibRhbRg
bLsbRibLsbRhbRgbRibRgbLibRibRgbLebRcbRibRjbRsbLibLcbLhLsbLsLsmbRjbLibR
obRgbRgbLcbLibRcbRgRsmbRgbRsbLsbRgbLsLsmbRebRcbLhbLhbsbLibRgbLsbLobRjb
RibRgbRgbRgbRsbRgbRgbRgbRgbLgbRgRsRsLsmmbRgbRibLsbLsbRibRgRsmbRsLsbRib
RgbLsRsRsmbRgbLgbRjbLcbLhbLsbLiRsRsmbLcbLgbRibLibRgbRiRsmbLsbRibLgbRgb
RgbRgbRgbRibRibLibRcbLsbLebLibsbLcbsbRsRsRsmmbRibRibRibRgbRsbRsbRibRgb
LgbLibLcbLibRgbLibLibRsbLsbLibLsLsmbRibRgbLjbLsbLibRsbLgRsbLibLgLibRcb
RgRsmbRhbRgbRgbLsbRsbRibRsRsmbRgbRgbRgbRsLsbRgbRsbRgbRjRgbLgbRsbLsbRhb
RgRsmbRsbRgbRsRsmbRgbRiLsbLsbRibRgbRibRgbRgRsmbRibRibRsbRgbRibRibRsbRs
bRhbRgRgbRgRsmbRibLsbRgbRibRgbsbRibRgLsRsbRibRgRgRsRgmbRgLsbRsRsmbRibR
iLsRsRgbRgRsmbRcbRsbLgbRibLobLcbRsbLobLsbLcRsbRibRsbLsbLgbLibRjbLibRhb
RibRibLibLsbRsbLcbLcbRibRsbRiRsmbRibLsbRcbRsbLcLsmbLcbLobLgLsbRiRsmbRi
LsbRsbRsbsbRgbRgbRgbRgbRsbRsLcbRobRebRibRsLsbRgbLibRgRsmbRsRsmbRgbRgbR
gbLjbLhbLgbRjbLgbRhbRhbRsbLhbRhbRgRsmbRibRibRibRibLgbRcbRiRsmbRsbRsbRc
bRsbLgLsRsbRibRsbRibRgRobLsRhbRibRibRgbRsbRhbRsbRibRgRsmbLsbRibRcbRsbL
sbRsRobLibRhbRhbRibLgbRcbRsbLgbRobRgbRibLsbLgbRjbRcRsmbRsbRgbLsbLhbRib
RebRiRsmbRgbRibRgbRibLobLhbLobLgbRibRgbRgbRiLsbLcbLobRsbRjbLobLobLibRs
bRgbRibLjbLobRgbRgbRgRsmbRsRjbLgbRsbRib

>ZF Recording 2016-06-02; tW: 300s; Start: 163851; End: 164352;
Recording: 9-1; Individual: 32; Drug: PCAP814 3 然 Apo 50 然
bLgbLsbLgRsbLgRsRebLgLsbRibLcbRjbRhRsmbRsbLjbLcbRsbLibRcbRibLhbLiLsbRj
bRjbRhbRibLgbRcbLsbLsbsbLibRiRsmbRibLsbLibLgLsbRjbRibsbLgbLjLibLsLgbRg
bLibLhbLibLhbLsbsbLgRsbRsbRibRgRsmbLgLsbRsbRibLjbsbLsLsmbsbLsLgbLsbLgL
sLsmbsbLjRsbLsLsLsmmbLsbLsLsLsmmbLgbLgbRsbRibRsRsmbRebLsbLjbLeLsbRsbRs
bLgbLhbLsRsbLcbLibRibRibRcbRibLibLgbLgbLgbLgbLsRsbLgbLgbRgbLsbLiLsLsmb
LibLsbLgLsLsmbLgLsbLgbRsbLibLsbLgbRjbLibLgbRcbLebRjbRhbsbLjbsbLiLsbLgb
LgbLsbLcbRgbRjbRibLiLsbLgLgbLsbLgLsbLsbLgbLsLsmbLsLsLsLsmmmbLgbRsRgbLs
bLsLsmbLsLsmbLgLsLsLsmmbLgbLiRsbRsbLsbLgbLgbRgRsmbRsbLsbLgLsbLsbLgLsbL
gLsbLsbLsLsmbRsbLgLsbRsbLsbLsbLsbLiLsbLsLsmbLgbRsbLgbLsbLgbLibLhbRibRg
bLgbRjRsmbRjbRcbLebLgLsbRsbLibLsbLsLsmbLsLsLsmmbRhb

>ZF Recording 2016-06-02; tW: 300s; Start: 163851; End: 164352;
Recording: 9-1; Individual: 33; Drug: PCAP814 3 然 Apo 50 然
bRsbRsbLsbLsbsbsbsbRsbsbsbLsRsbRcbsbLobRsbLsbsbLsbLsRsbLsbLsRsbRsLsbLs
bRsbsbRsbsbLsbsbRsbLsLsmbLsbRsbsbRsbRsRsmbLsbLsbLsLsmbLsbLsLsmbsbRsLsb
LsRsbsbsbsbsbsbsbLsbLsbsbsbsbsbLsbLsLsmbRsbLsLsmbRsLsbsbsbsbsbsbsbsbsb
sbsbLsbsbRsbsbRiRobRcbRcRobRgRsmbRebLhRsbLibRiRsmbRsbRibRcbRiRsRsRsRhR
sRimmmmbLgbLjbRgRsmbLibRhRsmbRsLsbRgbRgLsbRibRgRsmbRsRsmbRiRsmbRibRgRg
bRibRcLhbRibRsbRsRsmbLoLsmbRebRhbRgbRiRsmbRgRobRgbLibLgbLgRsbLsbRjbsbs
bRsbRsbsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 163851; End: 164352;
Recording: 9-1; Individual: 34; Drug: PCAP814 3 然 Apo 50 然
bLsbRsRsmbRsbRsRoRobRibRgbRsRobLgbLsLgbRibsbLsbsbLsbRsRsmbsbsbsbsbsbsb
RsLsbLsbLsbsbsbsbsbsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 163851; End: 164352;
Recording: 9-1; Individual: 35; Drug: PCAP814 3 然 Apo 50 然
bLgbLobRgbRibLcbLcLgLsbLcLsmbLgbLhLgLsRsbRsbLcbRsbLjbLobRsRsmbLhbRsbRg
bRcbRibRsbRgbRgRsmbRibLsbLsbLcbRjbLiLsbLgbLsRsbLgbRgbLjbLobRsbLsbRhRsm
bRsLsbRsLsbLgbRgbRibRgbLgbRibRsLsbLsbRobLjbRibRhbRsbRsbLsbRoLsbLibLhbL
obsbLsbLjLsmbLgbRibRibRhbRgbRibRsbRibRsbRhbLibLgbLibRibRibLhbLsbRibRsb
RobRibRsbLsLsmbRgbLobsbsbsbLsbLhLgbRgbRcbLgbRobLsbRobRsbsbLoLsmbLiLsRs
bRsbsbLibLgbRsbLsbLsbLibLsbLibLsbRsbRsbLcbRgbsbRgbRibRibLgbRibRibRsRgb
LgbLobLibLsbRgbLgbLsbLsbLsRsbLsbLsbLgbRjbRhbRibLsbsbsbsbLhbsbLibLsbLhb
LibLibLoLsmbRsbLsbRibRsRsmbLgbLsLsLsmmbRibRsRsmbRgbRsbLsbRibLsLsmbLcbL
sbRsbLiLsbLsbLcbRibRibRibRsbLsbLgLcbRjbLibLhLsbRsbRjbLibLgbLgbLsbRgLsL
smbLcRsbRsLsbLiLsLsmbLgLsbLsbLhbRgbRgbRsbLsLsLsmmbLgbLsLsLsmmbLhbsbsbR
sbLiLsbRsbLibLgbLibLsbRsbLibRgbsbsbLsbLsbLgbLibLgbLsbRsbLsbLsRsbRob

>ZF Recording 2016-06-02; tW: 300s; Start: 163851; End: 164352;
Recording: 9-1; Individual: 36; Drug: PCAP814 3 然 Apo 50 然
bRsRsmbRsbsbRgLsRsbRsRgbLsbRgbRcRsmbLcLsmbRgbRhRsmbRgbRgRsRsmmbRsbRsRs
mbRsRsmbRsRsRsmmbRsbRibRgbRjbRsRsmbRsbRgbRibRcbRcRsmbRcbRcRsmbReRsmbRs
bRebRebRcRsmbRcbRcbReRsmbRiRsmbRiRsmbRgbLgLsbRcbRgbLjbLhRsbLibLibRgbLh
RsbLgbRgbRjbRsbRgRsRsmmbRsbRsRsRgRsmmbRgbRsRsRsRgRsRsRsRsRsRsRsRsRsmmm
mmmmmmmmbRsRsmbsbRsRsmbRsRsmbsbRsRsRsmmbRsbRgbRsRsmbRsbRsbLsRsRsmbRsRs
RsmmbRsRsRsmmbRgRsmbRsRsRsmmbRsbRgbRsRsmbRsbRsRsRsmmbsbRsbRgbRsbsbRsbR
sbRgbRsbLsLsRsmbRsRsmbRsbRsRsRsRsLsmmmbRgRsRsRsmmmbRgbRgRsmbRgRsRsmmbR
sRsmbRsbRgbRgRsRsmmbRgbsbRgRsmbLibLsLsmbRsRsmbsbsbsbLcbLcLsmbLibLgbRgb
sbLsbRiLsbRsRsmbRsRgbRgRsReRsmmbRsRsRsmmbRgRsmbRsRsmbRsbRsRsRsmmbRsbRs
RsmbRsbRgbRsbRsRsmbRsbRgRsmbRgRsRsmmbRsRsmbRsRsRsmmbRgRsmbRsRsRsmmbRgb
RgbRsRsmbsbRsRsmbRsLsRgbLjRsbLcbLcbLibRiRsmbRcRsmbRcRsmbsbReRsmbRibRoL
sbRebRsbRcRgbRsRsRsRsmmmbRgbRsRgRsRsRsRsRgRsmmmmmbRsRsRsmmbRgRsRgRsRsm
mmbRgbLsbsbsbsbsbsbsbsbsbLsbRgbRgRgRsRsRsRsRsmmmmmbRgRsmbRiRsmbRgbRiRs
mbRibRgbReRsmbRcRsmbReRsmbRcbReRsmbReRsmbRhbRebReRsmbRebRebRiRsmbRcbRh
bRsLsbRebLsbLsbLgLsbLsLsmbLsRsRsmbLsbLsbsbLsbLsLsmbLsLsLsmmbLsLsLsLsLs
LsLsLsLsmmmmmmmmbRsLsbLsLsLsmmbLsbLjbRjRcRsmbRobLebLiRsbLcbLibLibRjbRi
bRobRcbRcRsmbRibRhbRhRsmbRiRsmbReRsmbRjRsmbRcRsmbLsLsmbLgbReRsmbRhbRib
LsbLhbLibLjRsbLibsbLiRsbLibRsRsmbRhbRgbLgbRjbRhbRibRhbRsbLiLsbLibLgRsb
LobRgRsmbLgbLcRsbLibRgbLhbRgbLgbLgbRsLsRsbRjbRcbRsbRgbRgbRgRsRsmmbRsRs
RgRsRsRsRsRsRsRsRsRgmmmmmmmmmbRsRsRsRsRsRsRsmmmmmmbRsRsmbRsbRsRsRgRsRg
RgRimmbRsRsRiRiRsRgRsmmmbRsbsbsbsbRsbRsbRsbRsLsbRjbLjbLsLcLsmbLibRhRsm
bLcbLsRsbRsRsRsRsmmmbLgbRsRsmbLgbLibsbLsbRsbLsbLgLsbsbLsRsRsmbLsbLsbLs
bRsLsLsLsRsmmbLgbRebRoRsRsmmbLhbLgbLsRsbLsbLibLgLsLsLsLgmmbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 163851; End: 164352;
Recording: 9-1; Individual: 37; Drug: PCAP814 1 然 Apo 50 然
bRsLsbLobLcLsRsmbLibLibLgLgbLsRsbRsLeLebRcbRibRebsbRobLcbRcbRcRsmbRcbL
cbLgRsbLobLibLibLcbLoLsmbLibLibLibLcbLoLsmbLcbLobLobLcbRgRsmbRjbRsRcbL
obRhbRhbRobLobsbLebRobRibRhbRobLcbLhbLcbRhRsRsmmbRsRibRsbRcbRcbRiLsbRe
bLcLsmbRcRsmbRebRjRgbLcbLoLsmbLiLsbLcbLgbLcbLsLsmbLcLsmbLsbLobRgbRiRsm
bLobRjbLsLoLsmbRgbLsLcbLibLhbRsbLcbLcbLcLsmbRsbLcLsmbLsbLobRgbLiLsbLgb
LiLsbLhbLsLsmbRsLsbLhbLsbLcLsmbLibLibLhbLiLsbLobRsLsbLhLsLsmbLsbLcRsbL
sRsbRcbLjbsbRcRsmbLsbsbLibRsbRjbRobLcLsmbRhbsbLoLsmbLcLsmbLhLsbRgbRcRs
RsmmbRobRcbRcbRobRcbsbLcbLibLhRsbLgLsbLgbLiLsbRsbLoRsbRgbRibRebLiLsbsb
LibRcbRcbRobRiRsmbRebsb

>ZF Recording 2016-06-02; tW: 300s; Start: 163851; End: 164352;
Recording: 9-1; Individual: 38; Drug: PCAP814 1 然 Apo 50 然
bLsLsLsRsmmbLsLsLsLsmmmbLgbLsLsmbLsbLsLsLsmmbLsbLgbLsbLsLsmbLgbLgbLibL
sLsmbRsLsLibLgbsbLibLsbLgbLgbLsRsbRsLsbLgbLsbRgbLgRoRsmbRobRhRsmbRgRsR
smmbRsbRsbRsbRsbRsbRgbRsRsRsRsRsRsmmmmmbRsRsRsRsRgRsRgRsRsmmmmmmbRsbRi
RiRsmbRsRsmbRgbsbRsRsRsmmbLsbRsbsbRgbLsRsRsRsLsmmbRsbRgbRiRsmbRibRsbLs
bsbRsbLgbLsRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 163851; End: 164352;
Recording: 9-1; Individual: 39; Drug: PCAP814 1 然 Apo 50 然
bRgRsmbRsbRibLsLsRsRsmmbRsbLsbRsRsmbRsRsRsRsmmmbRsbRgbRsRsRsRsRsmmmmbR
gRgRsRgRsmmbRsRsmbLsbRsRsRsRsRsRgRsmmmmmbRsRsRsRsRsLsmmmmbRsRsmbRsRsmb
RsRsRsmmbRsbRsRsmbRsRsRgRsRsRgRsRsRsmmmmmmbRgRsRsRsRsRsmmmmmbLsbLcbsbR
sbRiRsmbRsRsRsRsRsRsRgRsRsRsRsmmmmmmmmmbRsRsRsRsmmmbsbLibLhbRsRsmbRcbR
gRsmbRsRsRsmmbRsRsRsRsRsRsmmmmmbsbLsbRobsbLeLsbLgbsbLgbsbLsLsLsLsLsmmm
mbLgbLsbLsLsLsLsLsLsmmmmmbLsLsLsmmbLgbLgbLgbLsbLeRsbRibRgbRgbRiRsmbRgb
RsbRgbRsbRsRsRsmmbRgbRsbLsbRgbRsRsmbLsRsRsmbRsRsmbRsRsRsmmbRgbRgbRsRsR
sRsRsmmmmbRgRsRgmbLjbsbRcRgRsRsmmbRsbRsbRsbRsRsmbRgLsbRsRsRsRsRgRsmmmm
bRgbRibLsLgbRsbsbRsRsRsRsRsRsRsRsRsmmmmmmmmbRgRsRsmmbLsRsbRsbRsRsRsRsR
sRsRsRsRsRsRsRsRsmmmmmmmmmmmmbRsRsmbRsbRsbRgbRsRsRsRsmmmbRsRsmbRgRsmbR
sbRsRsRsRsmmmbRgbLsLsmbLibLsbLcbRibRiRsRsRsmmmbRgbRsRsRsRsmmmbRsbRgRsR
sRsRsRsRsmmmmmmbRsRsRsRsmmmbRsRsRsmmbRibRsbRsbLsLsmbLsbLhbLsLsLsLsLsRs
mmmmbRcbRsRsRsmmbRsRsmbRsRsRsRsRsmmmmbRsRsmbRsRsRsmmbRsRsRsRsRsRsRsmmm
mmmbRgbRsRsRsRsRsmmmmbRsbRsRsmbRsRsRgRsmmbRsRsRsmmbRgRsmbRsRsRsRsRsmmm
mbRsRsmbRsRgRsRsRsmmmbRsRsRsmmbRgRsRsRsRsRsRsRsmmmmmmmbRsRsmbRsRsRsRsR
sRsRsRsRsRsRsRsmmmmmmmmmmmbRsbRsLsRsbLsRsbRsbRsbRsRsRsmmb

>ZF Recording 2016-06-02; tW: 300s; Start: 163851; End: 164352;
Recording: 9-1; Individual: 40; Drug: PCAP814 1 然 Apo 50 然
bRsRsmbRgRgRsRsmmbLsRsbRgbRsRgbRsRsmbRsRsmbRsbRsRsRsmmbRgbRsRsRsRsRsRg
mmmmbRsRsRsRsmmmbLgbRiRsmbRsRibRsRgRsRsmmbRsRsRsmmbLsbRsRsRsmmbsbRsRsm
bRsbsbRsbLsbRsbsbRhRsmbRgRsRsmmbRsRsmbRsRsRsRgmmbRgRsRsRsmmmbRsRsRsRgR
gRsmmmbLsRsRsRsRsmmmbRgRsRgRsRgmmbRsRsRgmbRsRsRsRsRsmmmmbRsRsRsmmbsbRs
RsmbRsRsmbRsRsRsmmbLsRsRsmbRsRsRgRsmmbLsRgRsRsRsRsRsRsRgRsRsmmmmmmmmbR
sRsmbRsRsRiRsmmbLsRsRsRsRsRimmmbRsbRsRsRsRsRsmmmmbLsLsmbRsRgbRsRsLsRsR
sRgmmbRsRsRgRsRsmmmbRsRsmbsbRsLsRsbRsRsRsRsmmmbRsbRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 163851; End: 164352;
Recording: 9-1; Individual: 41; Drug: PCAP814 1 然 Apo 50 然
bLsLsmbRsLcLsmbLgLsbLgbLgLsLsmbReLsLsmbLsbRgRgbLebLgbLhLsLsLsmmbLebLgR
sLsbRobReRebLiLsLsmbRhRsRsRsRsmmmmbLebLsLsLsmmbLsLsLsLimmbLiLiLsLsmbLi
LsbLiRsbLsbLeLsbLiLgbLhbLiLsbLsbLobLgLsbReRgbLgbRiRsRsRsRsRsmmmmmbRgbR
sRsmbLeLsLgLibLsLsLimbRiRsmbRebRibRgbRcbRiRsRsRsRsRgmmmmbRsbLcLgLibLhL
sbLsRsbRibRsbLcbLeLgbLgLsRsRsmbLgbLebLiLsbLhLsbLhLsbLeLsLsmbLeLsbLiLsb
LeLsbLhbLsRsRsmbRgRsmbRhLsbLsbRsRiRsRsRsmmmbRsRsmbRsRsmbRsRsmbRgbRgbLs
bLjbsbReRsRsRsLsLgmmmbLebRsbLsLsmbLgLsLsmbLsLsmbLsLsLsmmbLebLeLsbLhLsb
LiLsbLeLsRsbRgRgbRgRsmbReRgbLsbLeLsbLsLsLgLsLsmmbLebLeLsLsRsRsRsmmmbRg
RgRsRgRsmmbRsbLebLsLsLsLsLsmmmmbLsbRsbRoLsLsLsLsmmmbLobReRebLcbRcbLcLs
LsmmbLebLiLsLsmbLeLibLgRsRsRsmmbLgbLebLsbLibLibRsRgRsmbReRgRsRimbLsbRi
RsmbLsbLebLsLsLsLsmmmbLiLsbLhLsbLiLsbLgLsLsRsmbReRsRimbRgbRhbRgRsmbLsb
LsbLsbLiLgLsbLiLsLsmbLebLgbRgRsmbRsRsmbLsbLsRsbLgLsbRcbRiRgbRiRsmbRgRs
RsmmbRibRgRsRimbLsbRgbRsbLjbLeLsLsLsLsLsLsmmmmmbLhLsbLsLsmbRiRsRsmmbLi
LsbLeLgLsbLhLsLsmbLiLsLsmbLibLeLsLsLgLembLhLsLsmbRhRsmbRgbLjLebLiLsbLs
bLiLgLsbLibLgLsbLgLsLsLsmmbLgLsLsmbLgLsbLgbLsLsLsLsLsmmmmbLiLsLsLsmmbL
ebLgLsbLiLsLeb

>ZF Recording 2016-06-02; tW: 300s; Start: 163851; End: 164352;
Recording: 9-1; Individual: 42; Drug: PCAP814 1 然 Apo 50 然
bLibLgbLgbLibLgRsbLgbLsbLgbLgbLgLsbLebLibLgbLiLsbLiRsbLiLsbLebLebLeLsb
LeLiLiLsLsRsmbLgLsbRjbRsRsLjmbRibRiRsmbRsRebLiRsbLebLgbLhLeLsbLhbRoLsb
LeLsbLhbLeLsbLeLsbLgbLiLgbLiLsbLeLsRsbLiLsbLhbLcLsmbLcbLeLsbLibLgbLibL
iLsbLgbLsLsmbLgLsbLsbLgLsbLgbLsLsLsRsmmbLsLgbLsLsmbLsbLsbLsbLsbLsbLsbL
gbLsbLsbLsbLgbLgbLsLsmbLsbLsbLsLsmbLgbLsbLsbLsbLsLsmbRsLgbLsbLsLsmbLsb
LsbLsbLsLsmbLsbLgRsbLsbLsbLgbLsbLsLsmbLgbLgbLgbLgbLsbLgbLsLsmbLgbLsbLs
bLsbLsbLsbLsbLsLsmbLsbLsbLsbLsbsbLgbLibRiRsmbRiRsmbRiLsbRibRcbLsbLjLsL
smmbLgbLsbLsLsmbLgbLsLsmbLgbLsbLsbLsLsmbLsLgbLsbLgbLsbRsbLibLsbLgbLgRs
bLgLsbLgbLsLsLsmmbLsLsLsLsmmmbLibLgbLgbLsLsmbLgbLgbLgLsbLibLgLgbLibLgb
LgRsbLgbLgbLiLsbRjbRcbRiLsbLeLgbLoRgbLcLsLsmmbLibLeLsLsmbLeLsbLibLiLeL
sbLhbLebLiLsLsmbLibLgLeLibLebLibLgLsbLgLsbLiLsbLgLsLsmbLsLibRibRcbRibR
oLsRibRhbReRgLsbRhbRibRhbRiRibRcbRhbRgbRibRibRgbRiLsbLgbRgbRsbRgRsmbRg
RsmbRgRsLsmbRgbRsbRgbRiRgbRiRsmbRsbRibRsRsmbRgbRsbLsbLsbLsLsmbLibRibLc
bLgbLgRsbLgbLsbLsbLsRsLsbLgbLsbLsRsbsbLsbLsbLgRsbLsLsmbLsbLsbLsLsmbRsR
smbLsbLgLsbLsbLsLsmbLsLsmbLgbLsbLgbLgbLgbLsbLsbLsbLsLsmbLsbsbsbLsbLsbL
gbLgRsbRsLsbRjbRhbLjbLibRgbLibLgbLgbLsbLgbLsLsmbLsbLgbLsbLgbLgbLsLsmbL
sbLsLsmbLsbLsLsmbLsbLibsbRcbRhbsbRibRobLcLsLgmbLibRhbRibRsLsbRhbRhLsRs
RgbLsbLcbLoLibLiLsbLibLgbLiLsbLibLebLiLiLsbLcbRobLeLsbLebLibLebLebLcbL
gbLcbLeLeLsbLibLgbRebRhbReRsmbRibRibRoLsbRiRsmbRiRsmbRgLsbRibRgbRgbRib
RhbRgbRsbRgbRsbLsbRsRsmbRgbRsRsmbRsbLsbsbRgbLsbLibLsbRcb

>ZF Recording 2016-06-02; tW: 300s; Start: 163851; End: 164352;
Recording: 9-1; Individual: 43; Drug: Control Apo 50 然
bRhbRhbRhbRsbLsbLsbLcbRsLsbLgbLgbLsbLgLsbLibLsLsmbLsLsmbRibRibLobLsRsL
sRsbLgLsbLsLibLibLsbLsbRcbRhbRsbLhbLjbLoLsmbLibRgbLcLsLsmmbLgLsbLgbLgL
sbLobRibRgRsmbRhbRgbRgbRobRoLibLhLsLcbLgbLsbRcbRobRsbLgbLhbRcbLoRsbsbL
gbLsLsLsmmbLsbLibRcRsmbRibRiRsmbRcRsmbRcbLhbLjbLgbLsLsmbLsLsmbLibRgRsL
smbRsbRjbRcbRgLsRsbLsLsmbLsLsmbRgbRgRsmbRgbLgbLsLebLsbRjbRsLibRebRibRs
bRibRoRsmbRibLsbLgbLgbLhbLsbLgbLibLgbLgbLsbLhbRcbsbsbLibLsbRsbRsRsmbRi
bLgbLibLhbLgbRobRgbRebLibLebLsRsbsbsbRebRsbRsbRgbRibRebRiRsmbRibRibRgb
LsbLsbLgbLibLobRhbLsbRibRsbRgbRoLsbRibLgbLiLsbLcbsbRsRsmbLcbLgLsbLgbLs
LsmbRsLsbLsbLobRibRsbLsLsmbLjbLsLibRgbRebLobLobLiLsbRsbLcbLibLiLsbLibL
sbRjbLhbRhLibLsbLibLhbRsRsmbRgbRsbLobLgbLgLsbLgLsbRsLsbLobRcRsmbRjRsmb
RobLgLsbLsbLoLsLsmmbLobLibLibLibRjRsmbRcbLjbLhLsbLsLgbLebRsbRsbRcRgbRs
RebLsLsLsmmbRgbRgLsRsRsmbsbRiRsLsmbReLsbLiLsbLsLsmbRsLsbLsLsLsLsmmmbLi
LsLhLsbLiLsbLsbRcbRgbRhLsbRibRgbRsbsbRhbRgLsbLsbLsbLjbLibLsbLobLoLsmbL
gLsLsLsmmbRsLsRsbRsbLhbLgbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 163851; End: 164352;
Recording: 9-1; Individual: 44; Drug: Control Apo 50 然
bLgbLiLibRcbRiRsmbRebRsbLsbRsbRsRsmbRgbRgbRsbRsbRgbRsRsRgmbRgbRibRgbRi
bRgbRgbRgbRgRsmbRsbRsRsRsmmbRsbRsbRsRsmbRgLsRsRibRgbRgbRsRsmbRgbRsbRgb
RgbRsbRsbRsRsmbRgbRibLibRhbRgbRgbRgbRgbRsbRsbLsbRsbRibRsbRibRgbRgRgbRi
bRsbRsbRsbRsbRsbRsLsbRsLsbRcbRsbsbsbReRsmbRsbRsbRsRsmbsbsbsbRsRsmbRcb

>ZF Recording 2016-06-02; tW: 300s; Start: 163851; End: 164352;
Recording: 9-1; Individual: 45; Drug: Control Apo 50 然
bLhbLcbLebLiLsLibLsbLgbRgbLsLsmbLsLsLsLsmmmbLgLsLsmbLiLsbLgbLgbLiLibRs
bLibLsLsLsmmbLsLsLsmmbLsLsLsLsmmmbRsbRcbLsbRgRgbRsRsRgRsmmbRsRebRibRgR
smbsbRibLibLibLcRsbLgLsbRgbRgbRgRsmbRgbLgRsbRsbRsLsbRsbsbLiLsLsLgLsLsm
mbLsbLsLsmbLgLsbLsLsLsLsLgmmmbRsLsbLiLsLsLsLsmmmbRibLcLsmbLsRsbRgbLeLs
LgbLhbLgbRsLsLsmbsbLiLsbLgLsLsmbLiLsbRebLsLibLhbLibLgbLgLsLsmbsbsbLsbs
bsbRgbLeLsLsmbLeLsbLibLiLsbLgbRgLsbLiLsbLsLsmbLsLsLsmmbLibLibRgbLiLsLs
mbLibLgLsbLgLsbLgLsbLsLsLsLsmmmbRsbLjbLsbLsLsRsmbLeRsbRsRsLsmbLiLsbLsL
smbRgbLhbRsLsbLiLsbLsLsLsmmbLsLsmbLgLsbLsLgbLiLsbLsLsmbLsbLsbLibLgLsLs
mbLsLgbRsbRsLsbLiLsLsLsmmbLsbRgbRebRibRcbRgbLhLsLsmbLgLsbLgLgbLsRsbRsb
LsLsLsmmbLsLsLsmmbLiLsLsLsLsLgLsmmmbLgLsRsbLgLsbLhLsbLgLsLsmbLiLsLsmbL
sLsLsmmbRhbLjbLobRgbLiLsbLsLsmbLgbLiLsbRsbRsbRcRsmbLgbReRsRsmmbRgRsRsL
smmbRibLgbLcb

>ZF Recording 2016-06-02; tW: 300s; Start: 163851; End: 164352;
Recording: 9-1; Individual: 46; Drug: Control Apo 50 然
bsbRsbLsbRsbsbsbsbRgRgRsmbsbsbRgRgbRsRsmbRsRsRsRsRsmmmmbRsRsmbRgRsRsRs
RsRsRsRsmmmmmmmbLsbRcReRsRsmmbRobLebRcbLebRsbRsbRiRgRsRsmmbsbsbsbRsRsR
smmbRsRsRsRsRsRsRsRsRsRsRgLsRsmmmmmmmmmbRgbRsbRebRgRsRsRsRgRsRsRsRsRsm
mmmmmmmb

>ZF Recording 2016-06-02; tW: 300s; Start: 163851; End: 164352;
Recording: 9-1; Individual: 47; Drug: Control Apo 50 然
bLcbLebRobLhbLibLibRobRebLobRobRcbLebLibRobRibRebRobLebLobRobRebRibRsb
LsbLcbLcbLobRebLobLgbLgbLgbRobLebLebLobLebRebRebLobRobLebRcbLobLibLibR
cbRgbLobRobRobRcbLcbRebLobRobRobRgbLobRebRcbRebRcbRhbRobLebLcbLobLjbLo
bRsbRobRhbRobLebRcbLibLebLgbRobRobLobRobLcbLobLobRebRcbRobLibLibRcbLob
LcbRhbRobLibRobLobRebRobRebLsbRobLgbRebLobLebRcbLebLebRcbRobLgbLcbLebR
sbRobRobRgbLebLobLgbLebLebRobLobRgbLcbRobLobLibRcbLhbRobLobRgbRibLebRo
bLcbRobRcbRobLebRobLebRobRcbLobLebRobRjbRobLjbLgbLobRobRobLobLibRobRib
RgbRobLobRobLobLebRibLcbRebLhbLebRsbLcbLebRebRgbLobLsbRobLobLcbLibLjbR
ebLjbLjbRobLobLobRobLebRebLibRobLebLjbRcbRebRobRebRobRebRjbRebRcbLobLo
bRobRjbLsbRebRobLobRebLebLebLjbLebRobLobLsbLjbRebRjbRobRobRcbRobRebLeb
LobRebRobRebRobLcbLobRobLobRsbLobLebRjbRobRsbRebLebRcbRebRobLibLjbRebL
sbLebLebRcbRobRebRebRcbLebRebRcbRebRobRobLibLobRebLobLebLebLebLibRsbLc
bLcbRebRhbRcbLobRobLebRcbLgbRcbLebRobRsbRebRobRsbLobLebLobRobLobRobLeb
LobRobRobLibLebLcbRibRebRjbLobRjbLobLebRibLsbRgbRobLhbRebRgbLebLebLobR
obRobRobRobRebLebRebLcbLobLebLobLobRobLsbLcbLebLobRebLobRsbLcbRobRebRe
bRobRcbRebRhbRcbLgbRobRobRgbRcbRgbLobRobRobRebLcbRcbRjbLobLobLcbLebLcb
LebLobRgbRcbRobRobRcbRcbLcbLebLobRobLhbRibLobLhbRobRebRgbRcbRebLebLebL
cbLsbRcbRcbLjbLebRobLebLebLebLcbLcbRcbLobRobLebLgbRibRcbLebLobLibLcbRg
bRobLcbLcbRibLobRobRobRebRebLobLebLebLsbLobLobLobRibRobRobLcbLobLebLcb
RcbRebRebRebLebRobLgbLcbRebLobRobLobRobLobLjbLcbRebLebLcbRobRobRsbLobR
obRebLobRjbRebRebLebLebRebLobRobLcbLcbRobLobRebRcbLgbLibLobRjbLcbRebRo
bRobLebLjbLibRobLibRebRibLgbLebRcbLobRibLsbRobLcbLhbRobRobLibRobRebRsb
LobRebLobRsbRobRobLebRcbLobRcbLjbLcbLobLobLobLcbLcbLebRgbLcbRibRcbLebR
jbRcbLobLobLjbLcbLhbRobRsbRjbLebRebLcbRgbRcbLobRebRcbRobRebLebLebRjbRo
bRjbLcbLgbRobLobRobLobLobRobLobLebRebLjbLsbRcbRobLcbRebLebLjbLobRcbReb
RobRobRobRebLebRobRebRobRobRjbRobLobRobRobLobLcbRcbLcbRebRobRebLjbRobR
obRcbRebLcbRobLobRcbRobRebLebRcbLebRsbRcbLjbLobLobRobLobLobLebRjbRobRo
bRjbRjbRsbLebLjbLjbRjbRebRcbLebRobRsbRobRcbLebRobRebRobLebLebRebRobRob
RobLobRcbRobLobLobLebLcbLobRsbRjbLebRsbLsbLcbLcbLjbLebLsbLsbRobLebLcbL
ebLebRsbRjbLobRjbLcbLobLebLcbRsbLjbLobRcbRebRobRsbRjbLobRjbLjbRebRjbLo
bLebRebRsbLsbLjbLobLebLsbRobLcbRebRcbLebLjbLsbLebRsbRsbLobLsbLsbLcbRob
LsbLcbRebLebLjbRsbLjbRobLjbLebLobRobLsbRobRcbRsbLobRjbLobLobRsbLsbLebR
ebLsbLebLebRebRjbRsbLsRsbRsRsmbRjbRjbRsbLobRsbRobRebRsbLsRsbLsbLobLebR
ebRsRsmbLsbLebLjbLcbLobRsbLsbLebRebRobLsbLsbRsbLsbLebRsbLjbLobLsbLsbRs
bRsRsmbLsbRsbLjbLjbRobLsbLsbRebLebLjbLsbLobRobRcbLsbRsbRobRjbLobLsbLsb
RsbRobRobRjbLsbLjbLobRsbRsbRjbRjbRobRjbLsbRobLebLsbRsbRsbLsbLjbLsRjbLs
bRsbRsbLsbRsbRebLsbRobRsLsbRsbRsbLjbRjLsbRsbRsbLsbLsbLobLsRsbLsbRsbRsb
RcbRsbRsbRjbLsbRsbLjbsbLsbLjbRobLebRebRgbRobRsbRobLsbRsbLobLsbRsbLsbRs
bLcbRcbRsbLsbLsbRjbLjbLsbRobRsbRobRsbRjbLsbRebLsbLebRebLsbLsRjbRjbRsbL
sbLsbLgbRebRjbRebRjbRcbRebLebLcbRobLebRobRjbRsbLobRjbRcbRobRebRjbRobRe
bLobRobLsbRcbRsbLobLhbRobLobRcbRobRsbLobRjbLobRjbRjbLebRsbRobLebLsbReb
RobLgbRebRgbLebRebRebRcbLobRebLcbLobLobRsbRobLobLobRobRobRobRobLobRcbL
obRcbLsbRgbRobRobRobLobLcbLcbRsbRebLobLgbRjbLjbRebLsbRsbLobLobLcbRcbLo
bLgbRsbLobRebLobRobRebRebRjbRjbLebRcbRobRobLjbRsbRebRebLobLsbLebLobRsb
RobLjbLebLobLsbRebRsbRsbRebRjbRsbLobLsbRsbRsbLjbLebRebRebRsbRsbRebRobL
ebRobRjbLebRsbLcb

>ZF Recording 2016-06-02; tW: 300s; Start: 163851; End: 164352;
Recording: 9-1; Individual: 48; Drug: Control Apo 50 然
bRjRsmbRhbLcbLhbLcbLibLiLsLsmbLcbLiLsbRebRcbRibLibRsbRjRsmbRgbLgbRobRs
bRsbLiLsbLsRsbLgbsbLgbLgbLiLsLsmbLibLsbsbLjLsLsmmbLjLsLsmmbLhbsbLsLsmb
RsbRhbLhbsbsbsbsbRjbLeLsbLgbLiLsbLgLsbLgLsbLsbRsRsmbRiRsmbLgbsbLgLsbsb
LgLsbLsbRjRsmbLcLsmbRsLsbRsbRsbRsRsmbLsbLsLsLsLsLsLsLgLeLgRsmmmmmbRcbs
bLjbRsbRjbRsRsRsRsmmmbLsRsRibRiRebRebRibLsLsmbLebLeLsbLsLsmbLgbLgbLeRs
bRhbRgbRsLsbRibLsbRcbLgbLibLibLsLsmbLgbLgbLsLsmbRibLibRsLsbLsLsLsLsmmm
bLibRsRsmbLgbLjLsmbLhbLsLsmbLgbRhbLsRsRsRsRsmmmbLsRiRsRsRiRgReRsmmmbRi
bLebRsRsRgmbRgRsRsRsRsRsmmmmmbRsRsmbRgbLsRsbRobLibLibLgbLgbLibLgbLiLsb
LhbLsbLebLibRsRsmbRiRsRsmmbLgbLiLsbLsRsbLhRsbLjLsLsLsmmmbLibRgbRjbRsbL
sbRsLsbLsLsmbRsLsbLsbRsbRgbRsRsRsRsRsRsRsRsRsRgRsmmmmmmmmmbRsRsRsRsRgR
sRgmmmmbRsRsRsmmbRgbRsbRgbLsLgLsLsmbLsRsbRhb

>ZF Recording 2016-06-02; tW: 300s; Start: 164354; End: 164855;
Recording: 10-1; Individual: 1; Drug: PCAP814 10 然 Apo 50 然
bLsbRsbRsbsbLsLsmbRsbsbRsbLsRsbLsbRsLsbRsLsbRsbLsbLsbRsbRsbRsbLsbsbLsL
smbLsRsbRsbsbLsbRsbsbLsRsbRsLsbRsbLsbsbRsbsbRsbLsbLsbLsbsbLsRsbRsbRsLs
bRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 164354; End: 164855;
Recording: 10-1; Individual: 2; Drug: PCAP814 10 然 Apo 50 然
bLsLsmbRsbRsbLsLsmbLgbLsLsmbLgbRsLsbRsLsbLsbLsLsmbsbLsLsmbLsbRsbLobLeR
sLsbLebRgbLsbLsbLsLsmbLsbLsLsmbLsbRsbLsbRcbLgbLgbRsRsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 164354; End: 164855;
Recording: 10-1; Individual: 3; Drug: PCAP814 10 然 Apo 50 然
bRsbLgbLgLsbLsbLgbRebRgbLgLibLgLsbsbsbRgbRebLibRebLsbRgbRgRsRsRiRsmmmb
LgbRcRsmbRsbRsLsbsbsbRsRsmbLsbRebsbLsLsLsmmbLibsbLsbLsLsRsmbLsLsmbLsLs
mbLsLibLsbLgbLsRsbRsbLsLsLsLgLgLsLsmmmbLsLsLgLsmbRgbLsbLsLsLsmmbLsLsRs
RsRsmmmbRsbsbLibLsbLgLgRjbRjRsmbRsRsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 164354; End: 164855;
Recording: 10-1; Individual: 4; Drug: PCAP814 10 然 Apo 50 然
bRsbsbsbRsLcbLjbLsbLsbsbsbsbLsbLsbLgLsbsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 164354; End: 164855;
Recording: 10-1; Individual: 5; Drug: PCAP814 10 然 Apo 50 然
bsbLsbLsLsmbLsbLsbRsbLgLsbLsbsbLsLcbLsbsbsbsbLsbRsbsbRsbRsRsLsmbRsRsmb
LjRsRsRsRsRsLsmmmmbRsbRgbLsbRgRsmbLjRsRsRsRsmmmbLsRibRsRsRsmmbRgRsRsLs
mmbLsbRsRsRsLsmmbRsRsRsRsRsRsRsRsmmmmmmmbRgRsRsRsmmmbRsRgRsRsRsRgRgmmm
bLgbReRsmbRjRsRsRsmmmbLsRsbLsRsLhbRibsbRgRsRsRsRsmmmmbsbLsRsbRsbRsbRsR
gRgbLjbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 164354; End: 164855;
Recording: 10-1; Individual: 6; Drug: PCAP814 10 然 Apo 50 然
bsbRsRsmbLsbRsbRsbRsLsbRsbRsLsLsmbLib

>ZF Recording 2016-06-02; tW: 300s; Start: 164354; End: 164855;
Recording: 10-1; Individual: 7; Drug: PCAP814 3 然 Apo 50 然
bsbLsbsbsbRibRgbLsLsRsmbRibLsRsbRgbLsbLsRsbsbRsRsmbRgbRgbLsRsLsbRibRgb
LsRibRsbRibRgbRsRsmbRcbRibLhbLsbLeRsbsbRsbRsbLcbRjbRobLsbLgbRhbRsRiLsb
LsRsbRiRsmbLsLsmbRsRgbRgLsbRgbRgLgbLobLibRsbLsbLsbsbsbsbLsbLsbLsbLsbLs
bLobLhLsbRsLcbRibRsbsbsbsbLgbLsbLoRsbLcLsmbLsRsbLsLsmbLibLcLcLoRsbLeLs
RsbLiLsbRsbLsbLibRsbsbLgbLgbLoRsbLcbRsbRhbRsRgbRsRsmbRibRgLsbRsbRsbRiL
sRsbRibRsbRsbRgbRiRsRgRsmmbRsbLhbLsbLibLobLibsbLsbsbRsbsbRjbLibLsRsbLi
bLgbLgbLoRsRsRsmmbLobsbRhbRiLsRsbLsRsRsLsmbRiLsbLgbRibRgbRcRhLsLsLsmmb
LibLgbLiRsRsLiRsmbLgbLeLgLcLsRsLimbLcbLiLsbRgRsmbLeLsbLeLsLebRcbRgbRcR
smbRibRsLsbLobLsLsmbLsbRsRsmbLgbLibLibRsbLiLsbLsbLibLibLgRsbLgLsbLgLsb
LgLsbLsbLiLsLhbRsRsmbLiLsbLibLgbLgbLgbLgLibLgRjbLibLiLsLgbLgLsbLgbRsbL
hLgbRiRsRsmmbRibRibRsbRibRgbRhbLsbLsbRibLsRsbRiRibRiLsLsmbLjbRsbLhbRcb
RiRsmbRsLsbRibRsbRgLsbRsbRiLsbRgLsbRgbRgbRsbRiLsbRgRsmbRsbRgRsmbRgLsbR
gbRgbRgbRgbRgbRgLsLsmbLjbLibLcRsLibLcbsbLgbLgbLgbLsbLhbLibLsbRsRsmbLib
LgbLgbLibLiLoLsLhmbLib

>ZF Recording 2016-06-02; tW: 300s; Start: 164354; End: 164855;
Recording: 10-1; Individual: 8; Drug: PCAP814 3 然 Apo 50 然
bLsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 164354; End: 164855;
Recording: 10-1; Individual: 9; Drug: PCAP814 3 然 Apo 50 然
bLhbLcLsmbLcLibLibLcLsmbLiLsbLhbLibLibLgbRebRibLibLoRsbLgLsbLsLsmbRcbR
cbRgLsbRibRgLsRiRiRiRsRsmmbRsRibRgRsmbRgbRgRgbRibRsbRgRsRsRsmmmbRibRgb
RgbRgRsmbRgRibRgbRgbsbRgbRgbRibRibRgRsmbRgbRiRsmbRgRsmbRgRsmbRsbRsRsmb
RgbLebLibLsbRobsbLibLeLsRsbRjbLhbRcbRibRgRsmbRsbRibRsbsbsbRgbRiRsLsRsm
bsbRgbLsLsmbsbRgbRgRsmbRsbRibRebRsbLgLsbRiRsmbRgbLjRsbLcbLcLsmbRobRsbR
gbRgbRgbRibRiLsRoRsmbRebRoLsRsLsbLibLsLibLoRsbLibLhbLiLsLobLhbLoRsbRiR
smbReRiRiRhReRsReRsmmbRhRsRhmbRgbLcLsLcmbLiLsbRjbRjbRiRgRsmbRgRebRgbRs
RsRsmmbRgRsmbRgbRgbRibLcbLibLiLsbLcLsmbLsbLebLcLsmbLcLsLcmbLsLgbLoRsbL
sbRgbLjbLgLsbLgbLhbLibsbLgbLiLsLsmbLiLsbRgbLibLibLgLsbLibLiRsbLebLibLc
bLcbLhbRibRoRsmbRgLsRebRibRcbRgbRcRsmbRibRibRiRsmbLgbLgbLibsbLgLsbLsbL
gbLgbLgLsbLsbLgbLgbLibRcbRoLsbRcbRcbRgLsbLgLsbLibLgbLibLgbLgbLgbLgLsbL
gbLibsbRoRsmbLsRibRibRcbRobRgbRoLsbsbRebRcbRsbRobLibRobRibRobRibLsbRcR
sRsmmbRibRcLsbLsbRebRsbRiLsbLsRoLsRsLsbRcbLobLgbLobsbLcLsmbLhbLiLsbLib
LibLsbLobRcbLgbLiLsLsmbLiRsLsbRsbRcbLebLgbLgbLgbLibRcbRibRsRobRcbRibRi
bRgbRhRsmbRcRsmbLcbLibLgLcbLibLgbLhLsbLcRsbRgbLgbRiRsmbRgLsbLobLhbLgLs
bLiLsbLiLsLsmbRcRhRsmbsbRsRsmbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 164354; End: 164855;
Recording: 10-1; Individual: 10; Drug: PCAP814 3 然 Apo 50 然
bLebLgbLsbLsbLsLsLsmmbLsbLsbLsbLsbLsbsbLsLsmbsbLsbLsbLsbsbLsbLsbLsLsmb
LsLsmbRsbLsbLsbLsbLsLsmbLsbRsLsbLsbLsLsLsmmbLsbLsLsmbLsLsmbLsLsmbLsLsL
smmbLsbRsbLsbRsLsbLsLsmbLibLgbLgLsbLsbLsbLsLsmbLsbLsbLsbLsLsmbLsLsmbLs
bLsbLsLsmbRsbLsbLsbLsbLgLsbLsbLsbLsbLsbLsbLsbLsbLsbLsLsmbLsLsmbLsbLsbL
sLsmbLsbLsbLsbLhbRgbLsbRsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 164354; End: 164855;
Recording: 10-1; Individual: 11; Drug: PCAP814 3 然 Apo 50 然
bLsLsmbLcbsbRsbRgbsbsbsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 164354; End: 164855;
Recording: 10-1; Individual: 12; Drug: PCAP814 3 然 Apo 50 然
bRhbLobLiLsLsLsLsLsmmmmbLcLsmbRcbRsbRcLsbRibLiLhLsLsLgLsLsLsmmmbLobLiL
sbRebRhbRhbRgLsbRhbLcLsLsmmbRsbRcRsmbRgRsmbLsLsLgmbLsbRcRsLsmbLibRibLi
LsbRcbRcbRcbRebLcLsmbRsbRobRgbRgbLobLgLsLsLsmmbLeLsLsmbRsLsbLiLsbLiLsb
LsbLiLsbLsbRgLsbLiLsbLsLsmbLibReRsmbLcLsmbLibRgbRhbLibLhbLsbRcbLibRjbR
cbLcbRebLgbRibLobLcLsmbRebRibLcbLhbLoLsmbRjRgbRobLibLsbLcbLsbRgbLiLsbL
cLsLsmmbLcLsmbRsLsLsmbRsLsLsmbLibLgLsbLoLsmbRobRebRgbRsbRcLsRsbLsLsmbL
ibRjRsmbRgbLibLsLsLiLsLsmmbRgbRoLsLsmbRebRjbLcLsmbLcLsmbRgLsbRibRibReb
LsLsmbLcLsmbLiLsbRcbLjbLibLjLebLsLsmbLebLcLsmbRiRsmbRibRibLsbLcbLgLsbL
sLiLebLcbRgLsbRibRgLsbRsbsbRibLhLjbLcLsLsmmbRebRcLsbRgbRcbRibLcLsmbLsb
LcLsmbLgbLcbRgRsmbRsbLhLsbRsbRibRhbRcbRcbLhbLsLsmbRsRsRgmbRobRsLsbRibL
cbLiLsLsmbLcbRebRsbRcbLcLsmbLiLsbLcLsLsLimmbRgLsbRsbRibRibLgbRcbLcbLhL
sbLcbRiRsmbRibLiLsbRebRiRsmbRgbLjbLibLcbRibLcLsmbRsbRsLcb

>ZF Recording 2016-06-02; tW: 300s; Start: 164354; End: 164855;
Recording: 10-1; Individual: 13; Drug: PCAP814 1 然 Apo 50 然
bRsRsmbRsRsmbRsbRsRsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 164354; End: 164855;
Recording: 10-1; Individual: 14; Drug: PCAP814 1 然 Apo 50 然
bLsbLobLibLsbLiRsbRsbRibRibRcbLhbLcbRcbLcbRcbRibRsRsmbLsbLsbsbRcbRebRg
RsmbRcbRobLhbLibLjbLcbLcbLgbLgbLebRcbRobLhbLgbLibLgbLgbRobRgbsbsbRhbRc
RsmbLhbLibRsRibLcbLoLsmbLcbLhbRgRsRsmmbRsRsRgRsRsRsRsmmmmmb

>ZF Recording 2016-06-02; tW: 300s; Start: 164354; End: 164855;
Recording: 10-1; Individual: 15; Drug: PCAP814 1 然 Apo 50 然
bLgLsbLcLsmbLiLsLsmbLsRsbLsLsmbLgbRcbRibRgRgRsmbRiRsmbsbsbRebRibLibLgL
sbLsbLsLsRsmbRobRsLsbRiRgRsmbLcbsbRibRgLsbLibRgbRgLsbLsbRsRsmbLsRsbRsL
sbLsLsmbLsbLsLsmbsbRobRsRsmbRsRsLsRsmbRgRsRsRsmmmbRsRsRsmmbRsLsRsbRoLs
LsmbRobsbsbsbsbLgbRsbLebLoLsmbRhbRsbsbLgbLsLsmbsbLsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 164354; End: 164855;
Recording: 10-1; Individual: 16; Drug: PCAP814 1 然 Apo 50 然
bLebLoLsmbLibLhLiRsLsbLsbLobLcbLeLsLsLhLsRsLsmbRsbLhbLsbLcbLeLsLsmbLeb
sbLsbLiLsbLgbLcLgLsbLsLobLiLsbLgbsbsbRcbRibRgbRgbLsbsbRgbRcbRcbRoRsmbR
iRsmbRgRsmbRsbRsbRgLsbRibLsRsbRgbRgLsLsmbLsbRsRsLsmbRgbRsbRsRsmbRsRsmb
RsbRsbRgbRobRcRcRsRiRsmmbRgLsRsLsRsbRsbRiLsbRgbRobRiRsmbLibLibLobLcLsm
bLsbLiRsRgRsmbLsbLsbLiLsbRsLsbLsbLiLsbLsbLsbLsbLgLsbLcLgbLcbLhLibRsRsm
bsbRebLsRsRsmbRsRgRsmbsbRgbRsRsRsLsRsmmbRsbRsLsbRsbLsbLobLcbLcbLsbLsLg
LsbLcbLsLsLsmmbLgLsbLiLsLhLibLsLsmbLsbLsLsmbLsLsLsmmbLiLgbLcbLibLoLsmb
LgRsbLsbLsbRsbRsbRsbRcbRiRsmbRcbRebRiRsmbRibRiRsRsmmbRgbRobLgLsbLsbRiR
gRsmbRgRgbLsRgRsmbRgbRsRjbRgRhLsbRebRgLsbRiRsRiLsRsmbRobRobRjbRcbRebRs
RsmbRgRsmbRgRsRgRgRiRgmbLhbLibLibLobLobLsbLcbRsRsmbRsRsmbLebLsbLiRsbLj
bLcbRhbLsbRsbLoRsbLcbLhbLhLhLsbLiLsbLebLibRiRsmbRibRgbRgRsRgRembLcbReb
RcbRobRebLobLibLibLobRsbLhbLcbLcbLgbLobLibLcbLibLsbLiLsbLibRgbRcRsmbRg
RsmbRgRsmbRgRsmbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 164354; End: 164855;
Recording: 10-1; Individual: 17; Drug: PCAP814 1 然 Apo 50 然
b

>ZF Recording 2016-06-02; tW: 300s; Start: 164354; End: 164855;
Recording: 10-1; Individual: 18; Drug: PCAP814 1 然 Apo 50 然
bLgbLsLsmbLjRsLsbLgbLibLgLsbLsbLibRgbLsbLibLgLsbRsLsRsRsmbLsbLsbLgLsbL
ibRgRsRsmmbLsbLgRsbLgLsbLhbRgbRsbRibRsbLhbLgbLgRsRsmbLsbLsbLsLsLsmmbRs
bLgbLsLsmbLgLsbLsbLsbLsLsLsLgmmbLsbLsLsRsmbLsbLgbLgbLgbLhbLibRsbLsbLib
LebLhbRsbLsbLgbRgbRsRsRsRsmmmbRjbRsbLjbLsLsmbRsLsbLsLsLsLsLsLsmmmmmbLs
LsLsRsLsmmbLgRsbLgbLsbRsbLgbLsRsLsLsmbLgbLibLibLsLsmbLgbLgbsbLibLgbLib
LgLsLsmbLibRgbLgbLgRsbLsLsLsLsLsLimmmmbLgRsLsbLsbRsRsmbLsbLsLsLsLsLsLs
LsLsLsRsLsLsmmmmmmmmmbLsLsRsmbRsbsbLsbLsLgbsbRsbRjRsmbLsbLiRsbLibLhLsL
sLsLsmmmbLibsbRibLibRsbRgbsbLiLsbRgbRibLsLsmbLgbLhbLiLsLsmbLsLsLsmmbLs
bsbLgbsbLgLsbLgbLhLsbRsbLsbLgLsbRjbLibLsbLsbLsLsmbLsLsLgmbLsbLsLsLsmmb
LgbRsbLgbRjbLcLsmbRgbLgbLsbRsbLibLibRgbLibLgbLibLgbLgbLebRsbRgbRibRibR
sbRsRsmbRsRsRsmmbRsLsbRiRsmbRibLgbLgbLhbLibLgbLibLgbRsbRibLgbLsbsbRibR
gbRsbLjbLibRsLsbLgbsbRoRsmbLebLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 164354; End: 164855;
Recording: 10-1; Individual: 19; Drug: Control Apo 50 然
bRgRsRgmbRsbLsbLoLsmbLsLsLsmmbLeLsLsLsmmbLoRsbRcbLgbLobLgbLibLibLgRsbL
obRsbRebRgRsmbRgbReRsmbRebLobLibLebRebRsRiRgRsmbRgRsRsmmbRsbRgRebLgbLs
bsbLsbsbRgRsRsRsRsRsmmmmmbsbsbRsRsmbsbRgbRsbsbsbsbsbLsRsbRgRsmbRsbLsbR
sbRebLobRsRsmbRoRsmbRcRsmbRgbRiRebRebRcbRsbRgRsmbRebLebLhbLsbLsbLsLsmb
LgbLsbsbsbsbsbLsLhbRsRsRsmmb

>ZF Recording 2016-06-02; tW: 300s; Start: 164354; End: 164855;
Recording: 10-1; Individual: 20; Drug: Control Apo 50 然
bLsLsmbLcbRsbLcLsmbsbLiRsRsmbRjbLgbLibLgbRsRsmbRsbLgbLgbLgbLibLgbRsbLs
bLhbRsbLjbRebLibRibLjbLcbLgbLcbRsbLsbLibRgbLgbLgbLgbLgbLsbLgbLhbRhbLsb
LsbLibLgbLgLsbLoLsmbLsLjbRhbLibLsbLibRsLgbLgbLgbLsbLgbLgbLibLgbLgbRibL
ibLsbLgbLsbsbLgbLgbLgbLsbLsRsbLgbLgbLgbLgbLsbLibLgbLgbLibLibLgbLibLgbL
iLsbLiRsbLsbLgbLgbLsRsRsmbLjRsbLgbLsbLgbLeLsbLobRgbRibRhbRhbRsbRsbLibL
hbsbRsbLgbLgbLibLsLsmbLsbLgLsbLsbRsbRcbRsbLjbLibLgLsbRsbRsbLhbLcbLgbLg
bRsbRsbLhbLibLiLsbLgbLgbLcbLibRgbLsbLjbLgbLgbLsLsmbLgbLibLibLibLibLibL
gLsbLgbLgbLsbLgbLgbLsbLoLsmbRsLsbLiLsbLgbLibLsbLgbLgbLibLibLhbLibLgbLi
bRsbRsLcbRsbLebRsLsbLibLgLsbLsbLibLibLgbLgbLhbLibLgbLgbLibLhbLgbLgbLhb
LibRgbRcbRibRgbRibRgbRgbRsbLsbRibRiLsbRsbRgbLjbRibRhbRibLgbRsbLsbLcbLo
bRsbLgbLibRsbLgbLgbLibLsbLsbRcbRiRsmbRjbRsbRgbRibLibRsbRjbLsbRibRibLgb
RsbLgbRcbRibRgRsmbLsbRgbLobRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 164354; End: 164855;
Recording: 10-1; Individual: 21; Drug: Control Apo 50 然
bLsLsmbRsbLsLsmbRsbRsbRsbLsLsRsmbLsLsmbLjRsbRsLsbRsbRsLsRsLsRsLsbLsRsb
RsRsLsmbRsbLsbLsbLsbLsbRsRsmbsbLsbRsbLjbRsLsbRsbRsbRsLsLsmbLsbRsLsbLsb
RsbRsLsbRsbLsbLsLsmbRsbLsbRsRsmbRsLsbRsLsLsmbLsRsbRsbLsbLsRsLsbRsbLsbR
sRsmbRsbLsLsmbLsLsmbLsbRsRsmbRsbLsbRsbRsbRsLsbLsLsLsmmbLsbRsbLjRsbsbRc
bRsRsmbRiRgRgRsRsmmbRibRgbLhLsbLibRgbLhLsLsmbLgLsbLgbRsLebLgLsLsLsLimm
bLebLgbLebLiLsLsLsLemmbLibRibRcbRgRsmbReRibRibRsbRebRhbRgRebRebRiRsmbR
eRsmbRgRsmbRebRebLiLsbRebReLsbReRsmbRiRsRsmmbRiRgbRibReb

>ZF Recording 2016-06-02; tW: 300s; Start: 164354; End: 164855;
Recording: 10-1; Individual: 22; Drug: Control Apo 50 然
bRsbRgRsmbRsRsRsmmbRsLsbRsRgbRgbRgRsmbRgbRsRsmbsbRiLsbRibRgRsmbRsbRgbR
ibRgbRsRgRgbRgbsbLsRsRgbRiRsmbRsLsbRgbLsLsmbLsbLibLibLsbLgbRsLsLsLgLsL
gLsLsmmbLsbLgLsbRjbLgLsLsmbLsLsmbLibLgRsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 164354; End: 164855;
Recording: 10-1; Individual: 23; Drug: Control Apo 50 然
bRhbRjRsmbRsRsLsmbRobRobRgbRibRgbLsRsbRhbRebRsRgbRsbRibRsLsbRsbRsRsmbR
gbRgbRsRsmbRsbLsRsbRsbRgbRjbRibRsbRsbLobRgbLobRcbRibRgRsmbRsbLobRsbRsb
RsbRibRgRsRsmmbRsRsRsRgRgRimmbRsbRiLsbRgbRgbRibLsbRiRsRsmmbRsRsRsRsRsm
mmmbRsRsmbRsLsbRiRsmbRgRsRsRsmmmbRsRsmbsbRsRsmbRibRsRsmbRibLsbRiLsbRsR
sRgRgRsmmbRsbRgbRsbRsLsbRsbRgRsRsmmbRsRsRsmmbRcbRiRsmbRgbRsRgRsRsmmbRe
bRiRsmbRebRibLsReRgRgRsmbRgbRsRsRsRsmmmbLsbLsbRsRsmbRsRsRsmmbRsRsRsmmb
RsRsmbRsRsRgRsmmb

>ZF Recording 2016-06-02; tW: 300s; Start: 164354; End: 164855;
Recording: 10-1; Individual: 24; Drug: Control Apo 50 然
bRsbLgRsbLjbLjLgbLjbRjbRgRsmbLibLgbRsbRjRjbRsbLsbLibRjbRjbLibLibLhbLib
LibLibLibLibLgbLibLibLibLibLibLgbLibLcbLibLgbsbLgbLsbRgRsmbRebRjRiRibL
jbLsbLsbRsbRsLgbLjbLjbLjbLgbLjbLjbLibLibLibLgRsLgbLibLjLsmbLibLsLsLgmb
LgRsbsbLgbLgbRjbRibLibRjbRsbRsbRsbRgbLjbLjbLjbLjbLjbLgRsbLibLibLibLjbL
gbLibLsbLsLsmbLsbLhbRjbLjLibLsLsmbLhbLibLibLgbLsLebLgbLgLebLebLgbLiRsb
LgRsbLjbLjbLgbLibRgbLjbLjbLiLsbLibLgbLsbRjbRhbRcbRiRsmbsbLibRsRjbRjRjb
RsLjbLjbLjbLgbLjbLgbLgbLsbLjbLgbLgbLgbRjRjbLibLibLjbsbsbRjbLibLgbLibLh
bLhbRjbLgbRsbRgbRgbLcbLibLjbLgbLsbRibLgRsbRjbLjRsbLjb

>ZF Recording 2016-06-02; tW: 300s; Start: 164354; End: 164855;
Recording: 10-1; Individual: 25; Drug: PCAP814 10 然 Apo 50 然
bRsRsRsmmbRsRsLsmbLiLsbRsbLsLsmbsbRsbLgbRsbRsbRsLsbRsLsbLsbRsRsLsmbLsb
RsLgbLsLsmbsbRobRsLsbLgRsbsbsbLsbRsbRgRsmbRsbRsbLsbRsbLsLsmbLsbLsbsbsb
LsbLsLsmbLsLsmbLsbLsbLsRsbLsLsmbLsLsmbLsLsmbLsbLsbLsbRsbLsbsbsbLsLsmbL
sbsbLsbLsbLsRsbLsbLsbLsbsbLsbsbLsbLsbLsLsmbLsLsmbRsLsbLsbLsRsbsbRgbRsb
RsbLsRsbLjbsbRsbRsRsmbRsRsmbRsRsmbRgbRsRsmbRsLsbRsRsRsmmbRhb

>ZF Recording 2016-06-02; tW: 300s; Start: 164354; End: 164855;
Recording: 10-1; Individual: 26; Drug: PCAP814 10 然 Apo 50 然
bsbLsLgLsLsmbLsbsbLcbLgRsbRsRsmbLsLsRsmbLsLsmbLcbRsbLgbRsbLibLgbLsbRjb
LhbLsRsLsbRgbRsRsRsmmbLibLsLsmbsbLsbRobsbLsbLsLsmbLsLsLsmmbLsRsbLsRsbL
sbLsLsmbsbLsbLsbLgLsRsbLsLsmbLgbLsLsLsmmbLsLsmbLsLsLsmmbLgLsbLsLsmbsbL
sLsmbRsbLsLsLgRsLsmbLsLsmbsbLsbLsbRsbLsLsLsLsmmmbLsLsmbLsLsmbLsbLsbLsL
smbLsbLsbsbRsLsLsmbLgbLsbLsLsmbLsbLsbLgbRsbRcbLsLsLsRsmmbRsbLsbLgLsbsb
sbRgbLgbLsbsbRsbLgbLsbsbLsbsbLsbsbsbLsLsmbsbsbLgbLobLsbsbLsLgbLsbLsbLs
LsmbRsLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 164354; End: 164855;
Recording: 10-1; Individual: 27; Drug: PCAP814 10 然 Apo 50 然
bLsbLsbRsbLsbLgbRsLsbsbLsbRsRsmbRgbRsbLsbRsRsmbLsbRsbsbRsbRsLsbRsbRsLs
RsLsLsmbRsRsRsmmbRgRsmbRsbRsbRgbRgbRsRsLsRsmbRsbsbLsbLsbLsbRsbRsbRsbLs
bLsbRsbRsRsmbsbRsRsRsRsmmmbRsbRsbLjbRsLsLsLsmmbLsRgLsLsRsmbRsbsbRsRsmb
LsLsRsmbLsbLjbLsRsbRgbRsbLsbRsbRsbRsbLsbRsbLsbRsRsmbRsLsRsbRsbRsbsbsbL
sb

>ZF Recording 2016-06-02; tW: 300s; Start: 164354; End: 164855;
Recording: 10-1; Individual: 28; Drug: PCAP814 10 然 Apo 50 然
bsbRsRgRsmbLsbRgbRgbLsbRsRsmbRsLsbRgbRsbLsLsmbLsRsbRsbRsbRsLsRsbLsRsLs
bRsbRsRsRsmmbRsbRgbRsbLgbRsRsmbRsbLsRsbRsbRsRsRsRsRsRsmmmmmbRsbRsbRsbR
sbRsRsRsmmbRgbRsRsRsmmbsbRsRsRsmmbRsRgLsbRsbLsRsRsmbRsLsbRsRsRsRsRsmmm
mbRsRsRsmmbRsbRsRsRsmmbRsLsbLsbLibLsbRsbRcbRsRsmbRsRsRsmmbsbRgLsbRsbRs
bRsbRsbsbsbRsbsbsbRsbRsbLsLsmbRsbRgLsbRsbRsRsmbRsRsmbRsRsRsmmbsbsbRsbL
sbRsbRsbRsRsLsmbRgRsmbRsRsRsmmbLjLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 164354; End: 164855;
Recording: 10-1; Individual: 29; Drug: PCAP814 10 然 Apo 50 然
bLsLsmbLgbLibRibRjRsmbLsbLgbsbLsbsbLibLsLsmbLgbRobLjbLebLebLsRsbRsbRsb
LsbLgbLsbLebRoRsmbLobRsbsbRsRsmbRgbsbRsbRgRsmbRgRsmbRcRsmbRoRsmbRcRsmb
RjbRsRsRsRimmbRsRsmbLsbRsbLsRsbRiRsmbRgRsmbRcbRcbRoRsmbLcbLjLsLsmmbLob
LjbLhbLobRsbLsLsmbLsbRobLsbLsbsbLgbRoRsmbRibsbRobRoRsmbLcLsmbLibRsbRsb
LgbLcbLcLsmbRgbRebRcbRobLibLsRoRsmbsbRsbLobLebRsRsmbLjbRibRcbLobLgbLgb
LhbReRsRsmmbRsbLsRsbRgbReRsmbRgRsRsmmbRcbLobLcbsbsbRsbLiLsbLcbLsLsmbLi
bLobLsbRsRsRsLsmmbRsbRsRsmbRobsbsbLsbRcbLsbLsbLsbRsbRgbRsbsbRibLgbLsbR
sbLsLsmbRsbRsbRobLsbRgbRcbLgbLjLcRsbRiRsmbLeLobLcbRobLcbRoRsmbLebLcbRe
bLobRsbLsbRsRsmbLcbRsbLcbRhbRsLjbLobRsbRsLsbLsRsbLsbRgRsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 164354; End: 164855;
Recording: 10-1; Individual: 30; Drug: PCAP814 10 然 Apo 50 然
bsbLsbLsbRsbsbLsbRsLsbLsbLsbRsbLsLsmbLsbRsbsbLsLsLsmmbsbRcbLsbRsRsLsLs
LsmmmbRsbLsbRsbLsRsbLsbLsbLgLsRsbsbRsRsLsmbLgbsbLsbLsbLsRsLsLsmbRsRsLs
RsmbRsbRsbRsbLgbLgRsLsbRsbLgbLsLsmbLsbLsbLsbRsLsbsbLsLsRsmbLsLsLsmmbsb
sbLsbLgLsbLsLsRsmbLgbsbRsLgLsLsmbLsLsmbLsLsmbsbsbLsbsbsbRsbsbLsbLibsbs
bLsLsmbsbsbsbLsbLsbLsbRgbsbLsLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 164354; End: 164855;
Recording: 10-1; Individual: 31; Drug: PCAP814 3 然 Apo 50 然
bLhbLoLsmbLsbLcLsmbLcbRjbLcbRsbLibRhbLibRgbLobLibRjbLcRsbRsbRjbRibRgbR
gbLcbLcbLhbRsbRjbRhbRgbRgLsbRibRgbRgLsbRgRsRgmbRibRgRsmbRgLsbLsbRibRib
RgRsmbRgbRsRsmbRgRsmbRgRsRgRsmmbRibRgbRgbRgRsmbRiRsmbRsbRiRsmbLsRsbLiR
sbLcbLiLsbRjbLsbLibLibLgLsbRcRsmbLjbRjbLgLsbRjbLsbRhbRgRsmbRibRsbLgbRg
bRebLsbLsbRgbRgbRgbRgRibRgbRiLsbRsbRgbRgRsmbRgbRgbRsbRibLgbLcbLibRsbRe
bRjbRcbRsbRgbLsbRibRjbRibsbRibLibRibRgbRibLgbLebLcbRhbRgbRiLsbRjbRiRsm
bRibRgbRjbLsbLsbRsbRibLjbRcRsmbLobLibLsbRhRsmbRgbRgLsbRobLgbRobRcbRgbR
gLsbRgbRebRgbRsbRgbLcbRgbLibLibLibLcbsbLiLsbRsRsRsmmbRgRsmbRcbLhbRgbRo
RsmbRgbRgbRibRsbRsbRgbLebRcbRsbLobLoRsLsbLhLsbRsbRgbRiRsmbRsbRiRsmbRgb
RibLsbsbLcbLhbLhbRgbRobRsRgbRsbRgbRsRsRsmmbLjbLjbRcbRgbRsRsmbRgbRgbRib
RhbRgbRgbLcLsmbRsRjbRhbRsbRgbRsbRgbRgbRhbRsRsmbRgbRjRsRsmmbRsRgbRiRsmb
RibRgRsmbRgbRhbRibRgbRiRsmbRgbRsRgbRibRhbLibRsRsRsmmbRobRibLibRgbRsRsm
bRibRcbRcbRhbRsbRsbRsbRibLcLsmbRibsbLcbLibsbLobLibsbLsLsLsLgmmbLsbLgbR
gbLhbRsRsmbRhbLcbLcbRsLsbLcbLibLibLsRsbLsbLsbRibRgbRibRibsbLgbLobLiLsb
sbsbLgbLgbLcbLsbLhbRsbRiRsRsmmbRibRibRibRgbLsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 164354; End: 164855;
Recording: 10-1; Individual: 32; Drug: PCAP814 3 然 Apo 50 然
bsbsbLsLsmbLsbLiLsbLsbLibRgbLsLsLsmmbLsbRiRsmbLsbRibRsRsRsmmbLjbRsbRsb
LjbsbLsLsmbLibsbLibRcRsmbRsbRgRsmbRsbRibRiRsmbRiRsmbRcbLgbRgRsmbRebRib
RsRsmbRiRsmbRsRsLsmbRibLsbLsLsmbRsbRsbRgbRsbRsRgbLhbLibRibRsbRgRsRsmmb
LsbRgbRibLibLibLcbLgbReRsmbRiRsRsmmbRgbRgRsmbLsRsbRsbLjbLibRgbRjbRibLj
bRibLgLsbRibLsbRgbRgbLeRsbRebRibRsbRibRsRsmbRsbRgRsmbLjbRhbRgbRgbLjbRg
RsmbRgRsmbLsRsbLsbRsbRgbLcbRjbRsRgRsRsLsmmbLgRsbRgbLjbRibRsRsmbRsbRgbL
sbRgbsbRgRsmbRgbLsbLjbRibRsRsLsmbLsbRhRsmbLiLsbRsRsLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 164354; End: 164855;
Recording: 10-1; Individual: 33; Drug: PCAP814 3 然 Apo 50 然
bLsbRsbLsRsRsRsmmbRgRsmbLsLsmbRibRobRjbLsRsbRhbLcRsbLhbRsbRsbsbsbsbsbs
bsbLibLsbRebRsbRsRsmbRoLsbRebRibRibRgRsmbLobLibLhbLobRcRsmbRiRsRjmbLsb
LoRsbRibRgbRiLsbRoRsmbRsRsmbLibRhbRsRsmbRcbLobRgbRgbLsRsbLsLsmbRgbsbRs
bsbsbsbsbsbsbRgbLebLgbRhbLobLhRjbLhbRiRebRgbRgLsbRgbRoRcbRgbLcLsmbLgRs
bLibLcRsbRgbLobLgbRsLibLoRsbRgbLsLhLsbLsbLsbLcbRibLgbRibsbRibRebRobRcR
smbRibRibLsbRsbsbRiRsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 164354; End: 164855;
Recording: 10-1; Individual: 34; Drug: PCAP814 3 然 Apo 50 然
bLgbRoRiRsmbRgbRoLgLsbLgbLibRgbLibLsbLibLsbLibLgbLgbLgbLgbLgbLgLsbRcRs
RsmmbRsbLobsbsbRsbRsbLgbLsbLgLsbLgbLsbLsbLsbLgbLibRsbLoRsbLobLiLibRsLs
bLgbLsLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 164354; End: 164855;
Recording: 10-1; Individual: 35; Drug: PCAP814 3 然 Apo 50 然
bLebLiLsbsbRsLsbLgbLibRsRsmbRjbRobRgbRsbRsRsLsmbLhbsbLsbLibLibsbLsbLsb
LibsbRibLcbLgbLibLgbRsbLsbLgbLsLsmbRsbLiLsbLibLoRsbsbRsLsLsmbLgLsbsbsb
LgbRsbRsbLcbLibLsbLibRgbLgbLcbRibRgbRgbsbLibsbLibLgbLgbLsbLsLsmbLsbLgb
RgLsbLgLsbLsbLsbLgLsbLibLsbRgbLsbLsbLibLgbLgbLsRsbRibLjbLiLsbLsbRsbsbL
hbLsbRgbLgbLcbRiRsmbRhbLiLsbLsbLsbLsbLgLsLsmbLsLsLsmmbLsLsLsmmbLgbRgRs
mbLibLgbRsbRsbLgbLsbLsRsbLgbLsbLsbLgbLgbLgbLsbLgLsbLsbLsbsbLsbLgbLsbLs
LgbLgbLgbLgbLsbRgbLibLgbLibLsbLgbLibLgbLgbRsbLsbLsbLsbLsbLsbLgbLsbLsbL
sLsmbRsbLsbLsbLsLsLsLsLsmmmmbLgLsbLsbLsbLgbLsbLgLsLsmbLsLsmbLsLsLsmmbL
sbLgbLgLsRsLsbRsLsbLsbLgbRsbLsbLgbRsbRsbsbLgRsbLsbLsbLsbLsbLgbLiLsbLgb
RibLcbsbLcRsbLsbRobRcbLgbLcbLsbsbLsbsbsbsbLgLsLiRsbLgLsbRgbLgLsbLsLebL
ibLgRsbLsbLgLgLsbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 164354; End: 164855;
Recording: 10-1; Individual: 36; Drug: PCAP814 3 然 Apo 50 然
bReRsRsRsmmmbRsRsmbRgbRsLhbLhbLsbLhbLgbRsLsbRsbLgbLgLsLsmbLsRsLsbLgbRc
RsmbLjLsRsmbLhbLiRsbLibLcbLcbLgLsbLgLsbLibLhbLibLgbLcbLibRgRsmbLibLgbL
gRsbRhbRjRsRsmmbRebRcbRsbRgbLsbRsbRgRsRsRsRgRsRsRsRsRgRsRsmmmmmmmmmbsb
RsRsmbRsRsRsmmbRsRsmbRsbRgRgRgRsRsmmbRsbLjbsbRibRjLsbRcRsRsmmbRsRsmbLs
LsmbRcbRsRsmbReRsRsmmbRcRsmbRebReRsmbRcRsmbRiRsmbRcbRsRsmbRebRiRsmbLhb
LibLgbLcbLiLsbRgbRgRsmbLhbRsRsmbLibLsbRsLsbLsbLsbLsbLsLsLsLsLsmmmmbLsb
LsbRsRsmbRsbLjbRcRsmbRsbRgRsRsmmbRgRsRgmbRsbRsRsmbsbRsbLsRsRsmbLsRsbLs
RsRsmbRsRsRsmmbRsRsmbRjLsbReRsRcRsmmbReRsmbRibRibLgbRiRebRibLcbLsbLibL
sbLgbLcbLibLibRiRsmbLgbRgbRcbRebLgLsbRsbRsbLgbRsRsmbLsRsbRibRiRsRgRimb
LsRsbsbRsbRgbLgbRsbLebLsRsRsmbRgRsmbLsbRsRsmbLsRsbRsRsmbLsRsbRgbRsRsmb
RgbRsRsmbRsRsmbRsRsLsRsRsRsRsRgmmmmbRsRsmbRsbRsRsRsRsmmmbLsRsbRsRsmbRs
bRsbRsbRiRgbLebRibLjbLgbRsbRgbRgRsmbRsRsmbLhbRcbRoRsmbReRsmbReRsmbRiRs
mbRcRsmbRcRsmbRiRsmbReRsmbRjbLjbLibLsbRhbRsbLgbLgLsbRsRsmbRibRgbRsRsmb
RgbRgbRsRgbRsRsRsRsRgRsRsmmmmmbRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 164354; End: 164855;
Recording: 10-1; Individual: 37; Drug: PCAP814 1 然 Apo 50 然
bLibRobLjLsmbLoLsLsmmbLgbLgbLgbLcRsbLjRsbLhRsbRcRsmbReRsRsmmbRcbLcbRib
RebRcbLiLsbLoLsLsLgmmbLiLsLsLsLsmmmbLcbRobRebLgbsbLcLsmbRcbRiRsmbRcbRh
bLibLcbRsRsmbRgbLoLsmbRjbLibLibRjRjbRsRhbRhbLcbRjbLhbRcRsmbRiRsmbsbLhb
LcLsLsmmbRsRsLsRsmbsbLhbRhbLoLsmbLiLsbRobRiRsmbRobRcbRebRibLsbRiRsmbRh
LsRsbRibRibLcbLobLoLsRsmbRcRsRsmmbRibRsbRgRsRsRsmmmbRsbRobRcbsbRiRsmbs
bRsbsbRsRsRsmmbsbsbRsRsRsRsRsRsRsRsmmmmmmmbRsRgRsmbLobsbLsLsLsLsLsLsLi
mmmmmbLibLsbLiLsbLibRcbRibLgbReLsbRcRsmbRcbRcbLsbRobLgLsLsmbLhbLibLeb

>ZF Recording 2016-06-02; tW: 300s; Start: 164354; End: 164855;
Recording: 10-1; Individual: 38; Drug: PCAP814 1 然 Apo 50 然
bLsLsmbLgbLsLsLsmmbsbLgbLsLsRsmbLsbLsbLsbLgbLgbLgbLsLsLsmmbLsbLsLsmbLs
bLsbLsLgLsbsbLsbLgbLsbLsbLiLgbLibLcbRobLsRsRsmbRsbRsbRsbRgbRebLsbLsbLs
bLsRsbLsbLsbLsLsmbLsLsLsRsLsLsmmmbRsLsLsmbLsbLsLsLsmmbLsLsmbLsbLsbLsbL
sbLsbLsbsbsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 164354; End: 164855;
Recording: 10-1; Individual: 39; Drug: PCAP814 1 然 Apo 50 然
bRsRsRsRsmmmbLsRsbRibLsLsLsmmbLibRgbRhRsmbRsRsRsRsRsmmmmbRgbRsRsRsRsRs
RgRsmmmmmbLsRsbsbRsbsbRsRsRsRsRsmmmmbRgbRsRsRsRsmmmbRsRsRsmmbRsRsRsLsR
sRgRsRsRsRsRsmmmmmmmbRsRsRsmmbRsRsRsRsmmmbRgRsmbRgbRgRsRsRsRsRsRsRsRsR
smmmmmmmmmbRsbRsRsRsRsmmmbRsRsmbRsRsmbRsRsRsmmbRsRsRsRsRsmmmmbRsRsRsmm
bRiRsmbLgRsbLcLsLsmmbLgLsbLsLsLsRsmmbRhRsRsmmbRsRsRsRsRsmmmmbLsLsLsmmb
RgRsRsmmbRsRsRsRsRsRsRsRsRsmmmmmmmmbLhLsbRsRsRsRsRsRgRsmmmmmbRiRgbRsRs
RsmmbRgbRsRsRsmmbRsRsmbRsRsRsRsRsRsRsRsmmmmmmmbsbRsRsRsmmbLsbRgRsmbRiR
smbLsLsLsLsmmmbLebLsLsmbLhbRsRsRgRsmmbLiLsLsLsmmbRsRsmbLsLsLsmmbLsLsLs
LsmmmbLsLsLsmmbLsLsLsLsmmmbLcLsLsmmbLcbLhbLobLgbLsLsRsLsmbLgLsLsLsLgLs
mmbLsbLsLsmbLgLsbLsLsLsmmbLgLsLsLsLsLsLsmmmmmbLgLsbLsLsLsLsLsLsLgLsLsm
mmmmmbsbLgbRsLsbLsLsLsmmbLgLsbRsLsbLsbLsLsLsLsLsLsLsmmmmmmbLsLsLsLsRsL
sLsLsLsLsLsmmmmmmmmbRsbLgLsLsLsLsmmmbLsbLibsbsbLsbRgbRcRsmbRibsbRgRsmb
RgRsRsmmbRsRsRsRsRsmmmmbRsRsmbRiRsmbRsLsbLcbLhLsbLgbLsLsmbLgbRsLsLsLsL
smmmbLgLsLsLsLsmmmbLgbsbLgLsbLsLsmbLgbLiLsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 164354; End: 164855;
Recording: 10-1; Individual: 40; Drug: PCAP814 1 然 Apo 50 然
bLsbRsRsRsRsRsRsRsRsRgmmmmmmmbRsRsRsRgRiRsRsRgRsmmmmmbRsRsRgRsmmbRsRsR
sRsRsmmmmbRsRsRsRsRgLsmmmbRsRsRsmmbRsLsRsRsmbRhRsmbRgLsLsmbLsLsLgmbRsL
hLsbLsLgLgLsbLsLgbLsLsmbLsLsLimbRsRsRsmmbLsLsmbLsLsLgmbRsLsbsbLsLsLsLi
mmbLgLgbLsLgLgbLsLsLimbLeLhLsbRibRjbRgbLsLsLsLsLsLsLsLsLsmmmmmmmmbLsLs
LsLsmmmbLsbLebLibRcbLgLsbRsLgLsLgbLsLsLgLsLgLsmbLiLsbRsLsLsLsmmbLibLib
LebReRebLsbLsbReRsLsmbLsbRsLsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 164354; End: 164855;
Recording: 10-1; Individual: 41; Drug: PCAP814 1 然 Apo 50 然
bLgLsbRgRsRsRsRsmmmmbLebLsLsmbLgbLgLsLsLsmmbRsRsRsmmbRsLsbLsbLcbLibLeL
sbLgLsbLsbRsbRhLsbRgRgbRhbRsbRgRsmbRsbLgbLcbsbsbLsbLiLgLsbLiLsLsmbLiLs
bLhLgLsbLiLsRsRsmbLobLiLsbLsLsLsmmbLgLsbRjbRebLsbLcLsmbLgbLgbLgLsbLsLs
LgLsmbLsbRsLsRsbLsRsbLibRsbRibLeLsLsmbLgLsLsLsmmbLgLsbLibLsLsLsLsLgmmm
bsbLgLsbRsbLobLiLsLsLsmmbLsLgLsLsLsLsLiLgmmmbLsLsLsLsLsmmmmbLgLsLsLsmm
bLgbLibLsLsmbLgLsLsmbRibLcLsmbLibLibLsLgbLsLsmbLoLsLsLsmmmbLebLebLsLgb
LsLsmbLgLsbLgLsLsmbLsRsLsbLsbRsbLsbLebLiLsbRsRsmbLgLsLsLsmmbLgLsbLgbRs
bLsbRsbLiLsLsmbLgbLsLsLsmmbLibLgLsLsmbLsLsLgmbLibRiRsRsRsmmmbRsbRibRsb
ReRgbRgbRgbLgbRsRgRsmbRsRsRsRsRgRsmmmmbRgbLgLsbLebLiLibLiLsLsmbRiRsLsm
bLcLsmbLibLgLsLsLsmmbLibLsLsmbLsbLsbLsLgLgbLgRsbLiLsLgbLgbLsLsmbLibLgL
sLsmbRgbLeLsLsLsLgLsmmbLhLsbLgbLsLsLsmmbLgLsLsmbLsLsmbRebLsbLebLsLsmbL
sLsLsLsmmmbLsLsmbLibLiLsLgLsbRgRsRsRsmmmbLibLhLsbRsRsRsmmbLsRsbLiLsLsL
imbLsLiLsLsLsmmbLgLeLgbLgLsLsmbLeLsbLiLibLgLsbRcRsRgmbRgRsRimbRsRsmbRg
RsmbRibLebLiLsLsmbLsLsLsmmbLsLsmbLsLsLsmmbLsbLsbLsLsLsLsmmmbLgbRsLsbLs
LsmbLiLsbLgLsbLsLsLsLsmmmbLsLgbLsLsmbLsLsLsLsLsmmmmbLiLsLsmbLsbRsLsLgb
LeLsLsmbLsLsmbLgLsbLiLsLsLsmmbLcLsLsmmb

>ZF Recording 2016-06-02; tW: 300s; Start: 164354; End: 164855;
Recording: 10-1; Individual: 42; Drug: PCAP814 1 然 Apo 50 然
bLgbLjbLibLsbRobRgRsmbRsLsbRsbRgbRsbRsLsbsbRsbRsbRsbRsRsmbRgRsmbRsbRgR
smbRgbRsLsRsbRsbRgbsbLebRhRsmbRsbRgbRhRsRgRsmmbRiRsRsmmbReRsReRsmmbRgR
smbRiLsbLgbRsLsbRibRgbRgbRgbRgRsmbRibRsbRsbRgbRgbRgRsRembRgbRgbsbRgbRs
bRibRiRiLsbRsbRsLsbRibRiRsmbRibRhbRgLsRsbLsbLibLiLsbLgLgbRgbsbsbRjRsmb
sbRsRsmbLsbRsRsmbRjbRsbRsbsbRsbRsbRsbLsLsmbRsbRsbRsbRsRsmbRgbRsRsRsmmb
RsRsmbRgbRsbRgbLsbRsbRsbRsbRsbRsbRsbRsbRsRsmbRsRgbRgbRiRsmbRiRsRsmmbLs
RsLsbRibRgRsmbLibRsbRiRsmbRgRsmbRhbRgbRiRsmbRiRgRebRibRgbRebRebRebRibR
iLibLiLsLebLeLeLsbLhLsLsmbLibLibLiLsbLhLgbLhbLibLebLgbLibLgbRsbLgbLgbR
sbRsLsbsbLsbsbsbsbsbsbLsbRsbLsbLgbLsbLsbLgbLsbLsbLsbLgRsbLgbLsLsmbLsbs
bLsLsmbLgbLgbLsbLgbLsbLgbLsbsbsbLibLibRcbRsRsmbRsbRsbsbRgbRsbRsbLsbRgb
RiRsRsmmbRcbLsbRsbRgbRsbRsRsmbRsRsRsmmbRsbRsbRgbRibRsbsbLsbRsbRgRsRsmm
bRgbRsLsbRsbLsbRibLsRsbRgbLjbLjbLobLsRsbLgbLgbLibLsbLgbLsLsmbLsbsbLgbs
bRjbRiLsbRhRsmbRgbLsLsmbRsRsmbsbRsRsLsmbRsRgbRsRsmbRsRsRsRsLsmmmbRsRsm
bRsbRsbRgRsmbRsbRsbRgbRsRsmbsbRibRibLgbRgRiRsmbRgbRiRsRgmbsbRsbRgRsmbs
bRsbRsRibLsLsmbRhbsbRhbRibLsRsbRcbRcRsmbRgRgbRibRebRgbRiRsmbRhbRibRiLs
bRiRsmbRsbRhRsmbRgbRgbRgbRgbRiLsbRsRsmbRibRiRebRibRsbRsbLobLhbLiRsbLib
LiLsbLibLiLgbLsbLibLibLsLsmbLibLgbLgLgbLebLgbLiLsbLgbLibLsRsbLsLsLsmmb
LsbLebLibLgLsbLgbLsLsmbLgLsbLsLsLsmmbLeb

>ZF Recording 2016-06-02; tW: 300s; Start: 164354; End: 164855;
Recording: 10-1; Individual: 43; Drug: Control Apo 50 然
bLsbRebRgbRobRibRobRsbLibRibRcbLsbRibRsLsbLcbLgbLjbLobLjbRhRsmbRgbRsbR
ibRgbRgbRhRsRsmmbRgLsbRgbLsbRsbRgRsmbRebLsRsbLgbLobRsRsRgRsmmbRsRsRsmm
bLsbRsbLjbLhRsbRsbRsbLcLsmbLgbLsbLcbRgbRjbLcbLibRcbRhLsbRsbRjbRcRsmbRs
LsbLgbLibLebLgLsbRibLsbLsbLsbLibLhbLgbLoRsbRcLsbRiRsmbRhbRibRsLsbRiRsm
bLebLebLiLsbLobLgbLgbLibLibLgLsbLgbLibRsLebRcbRibRhRsmbRsRsLsmbLgbLibL
sLsLsmmbLgbRgLsbsbRsbLcbRobRibRgbRibRibLjbRcbsbLcbLsbLsLsmbRsbLibRsbLh
bLsLsmbsbRsLsbRsRsLsmbLsLsLsLsmmmbLjbLebLibLgLsbLoLsmbRsbRjbRsRsmbRiRi
bLibLibLsLsLsmmbLsbLsbLobRsbRsbRibRibRsLsbRsRsLsmbRgbRsbRjRsmbRgbRsRsm
bRsLsbRsbRsbRgbLobLgbLjLgbLsbLgLsLsmbLibRgbLcLsmbRsLsRsbRsbLgbLsLsLsmm
bLsLsmbLsbLgbRhbLsbRhbRibLibLebRjbsbRgbRgLsLsmbRhbLsbRsRsmbRcbLcLsmbLi
bLgbLgbLibLsbRsLsRsbsbLsbRobRsRsRsRsRsmmmmbRsRsRsRsRgRimmmbRsbLeLsbLgb
LiLsbLibLgbRgbReRsmbRibRsbRoLsbRgLsbLgbLsLsmbLsLsLsRgmmbLobLgLsbRsRsmb
RibRgRsmbRhLsbRgbRsbRsRsmbsbRsbRsLsRsbRsbRsbRjRsmbRhbLhbLebLebLgbRjbRh
bLsLsmbRgbLjbRcbRiRsmbLsLsmbLsLsmbRgbRsbRgbRoLsbRcbRibRibRibRsLsRsbRob
RcRsmbRgbRcbRgbRsbRgLsbLsLjLsmbRjbRsbLjbLiLsbLsLsmbLibLibLibLibRgbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 164354; End: 164855;
Recording: 10-1; Individual: 44; Drug: Control Apo 50 然
bRsbLsbLsbLgbRsbLsLsLsLsmmmbLsbLgbLgbLgbLgbLsbLsbLsbLgbLsbLgbLsbLsbLsb
LsbLgbLgbLsbsbsbsbLgbLsbRsbLsbLsbLsbLsbLgbLsbLsbLsbLsbRsLsbLsbLsbRsbLs
bRsbLsbLgbLsbLsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 164354; End: 164855;
Recording: 10-1; Individual: 45; Drug: Control Apo 50 然
bLiLsLsLsLsLgmmmbLhLsLgLgLsbLcbLsbLgbLibsbLsbLgbLsbLgbLsLsLsLsmmmbRebL
sbRebRiRsmbLsbLsbLeRsbLgbRsbLibLibLiLgbLgLgLsbLsbLeLsLsmbLsLgbLibRsRsL
sRsLsmbRobRcbRibLgLsLsLsLsLsmmmmbLsbLiLsbLgbLiLsbLgLsLsmbLgbLgRsbLiLsb
LgLsbLiLsLsLsLsmmmbRgRsmbLgLsbLiLgLgLsLsLsmmbRibRebRgRsmbRebRibRgbLsbL
gLgLsLsLsmmbLsLsLsLsLsmmmmbLgLsRsbLibRgRsRsRgmmbRgRsRsmmbRgRsRsmmbRgRs
mbRebRibLsLsLsmmbRsbsbLsbLsbRsLsbLjbLgLsLsLsLsLsmmmmbLgbLgbRebRcbLsbLg
bLsbLgbLsbLsLsLsLsmmmbLcRgRsmbLgbLgLsbLcLsLsmmbLiLsLsmbLhbLsLsmbRibLob
RgbLhbLibLsbLhbLgLsRsbLgLsbLgLsLsmbLgbLsbLiLsbRsRsLsmbLsLsmbLiLsLgbLsL
sLsmmbLgbLsbLsbLsbLgbLgLsbLgbLsLsLsLsLsmmmmbRsbLiLsLgLgbRgbLgLsLsLsmmb
LiLsbLibLgbLgbLgbLiLsRsbRcRsmbRhbsbLgRsRsLsmbRgbRsRsmbRsbRiRsRsmmbLgbL
gbLiLsbLgLsbLgLsLsmbLgbLiLsLsmbLiLsbRsLsbLsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 164354; End: 164855;
Recording: 10-1; Individual: 46; Drug: Control Apo 50 然
bRgRsRgRsRsRsRsRsRsmmmmmmmbRsbRsbsbRsbLsLsmbRsRsRsRsRsmmmmbReRsmbRgRsm
bRgRsmbRsbRgRsmbRibRgbRebRsbsbsbsbsbRsRsRsmmbRibRgRsRsRsmmmbLgbReRsRsm
mbReRsRsmmbRgbLcbLobLeLsbRsbReRgRsmbRsbRebRebLgbRsRsRsmmbRibRiRsRsRsRs
mmmmbRibRsbReRsmbRsRsRgmbRgRsRgRsRsmmmb

>ZF Recording 2016-06-02; tW: 300s; Start: 164354; End: 164855;
Recording: 10-1; Individual: 47; Drug: Control Apo 50 然
bLobLcbRobLobRobLobRcbRebLobLhbRgbRsbLcbLobRcbRobLebRobLebLobRobLobRcb
LobRcbLjbLgbRcbRobRebLebRjbRobLobRobRobLobRibLibLibLobLobRobRibRobRobR
sbRgbRobLebRebRgbRebRsbRebLobLebRobLobRcbLebRjbRobLobLobLcbRobRobRobRc
bRcbRibLibLjbLgbLobLgbRebRgbRebRobLobLjbLebLobRcbLobRobLcbRobRebLebLgb
LsbLobLcbRjbRobRibLebRcbRebLebRcbLebLobRcbLgbRjbRobRcbLebRobRcbRebRobL
cbLcbLobRibRobLobRcbRgbRgbLobRebRcbLobRcbRjbLebLobRebLgbRsbRcbLhbLgbLo
bRsbLebLibRobLobRobRebRebRcbRobRebLibLebLobRobRcbLebLebLjbLebLobLobRob
LebLobLcbLcbLebRcbLgbLibRibRgbRebLhbRcbLobRcbLobRobLcbRobRobLibLcbRebR
cbRobRibLgbLebRibRcbLebRobRsbLobLsbRobRcbLebLobRobLebLsbLcbLcbRobRobRi
bLebRgbRcbRebLobRcbLcbRobRebRobRibRebRobRgbRsbRjbLebRsbLibRebRjbRcbLhb
RobLibLebRebRobLobLcbRobRgbLobLobRobRjbLsbRgbLobLibRobRebRebLcbLebLebL
sbLcbRgbLobLebRobLcbRgbRibLcbLebLgbLebLobLsbRebRebLobLebRobLebRebRibRe
bRobLebLobLcbLsbRjbLobRebLcbLobRobLgbLobLobRobLjbRobRibRcbRebRebRcbRob
LobRcbLjbRebLebRibLobRjbRcbLobRobRgbRgbLobLcbLebRobRcbRjbRjbRibRjbLgbL
obLcbRcbRobLebRcbRcbLebRjbLebRobRobLebRsbLcbRobRsbLjbLobLebRibRhbLcbLc
bLebLcbLobRgbRebLcbLobLebLcbLobRhbLibLebRsbLcbRcbRobRcbRebRobRsbRgbRcb
RobRibLobLobRobLobLjbRcbLobRgbLsbLobRsbLebLibLobLsbLobRsbLjbRcbRobLebL
ebLobRcbRobLebLebRcbRobRgbLobLobLgbLsbRobRobRebLebLebLibLcbLcbRcbLcbLc
bRobRjbLcbLsbRjbLjbRobLobLobLobLebRcbRcbRhbLhbLebLobLebLebLobLobLobLeb
RebRcbRobRobLobLcbRsbLobRsbLebLibLobLebLobLobLebRcbRobLobLebRjbLebLibL
ebLcbRobRobLgbRobRobLobLebLobRobLcbRebLebRebLobRibLcbLcbRebRgbLobLebLc
bRobLebLobLebLsbLebLobLebLcbLobLobLibLsbLobRebRcbRebLobLebLcbLobRibRob
LobRsbRcbLebRebRobRobLebRebLibLobRobRebLibRebRobRobRebLebLobRgbLobLobR
obLcbLjbLobRcbLobLobLcbRebLebRgbLobLobRsbLobLjbLobLobRobRibLebRjbLebLc
bLcbRebRhbRebLebLebRobRobRobLobRibLcbLibRebRebRsbLobLgbLcbRobRjbRjbLsb
LebLobLobRcbRebRibRobRhbLobLebLebRebRsbRcbLobRobRobRebLcbRcbLebLebRibL
obRsbRibRjbLebRobRcbRsbLsbRcbRjbLebLobLobLcbLobRibLebLibLobLobLebRobRg
bRobLobLobLobRobRobLebLcbLibLcbRobLebLibRebLobLobLsbLhbRebRobRsbRjbRcb
RebLjbLobLobRobLebRebRcbLobRjbRobLsbLobLobRsbLcbLobRcbLebRobLjbLobLgbL
sbLcbRobLobRobLcbRjbRobRobLobRebRobLebRibRobRobRgbRebLobLobLcbLebLobLo
bRobLibLebRebRhbLcbLobRobRobLobRebLibRjbRsbLjbLebRobRcbLobLebRcbRobRsb
RcbLjbRebLcbRobRsbRobRobLobLobLobLobLobLcbLsbRgbLsbRebRcbRsbRobLcbLebL
sbLobLebLobRebLobRobLgbRcbLobLebLobLcbLobRobRebRjbRobRjbLsbLsbLcbLobLc
bRsLsbLcbLcbLibRcRjbLobLebLobLcbRsbRobLjbLebRobRgbLebLcbRobRgbRebRobLo
bLgbLobLjbRcbRebRjbLobRobRsbLcbRobLibRobLobLobRobLebRjbRcbLobRobLobRsR
ebLobLebLcbLebRjbLebLobLibLcbLsbRcbLsbRgbRcRsmbRsLebRobRebRcbRobLebLob
RobLebRcbLsbLebLibRsbLobLobLobRibLhbLsbLjbRsbLobLobLobLobRjbRobLsbLsbL
obLebLobRsbLcbRsbRsbLebRsbRjRebLobRebLsbRsbLsRjbRebLcbLsbRsbReRobRsbRo
bRsbRsbRebLhRsbRsbLobRsbLsbLsLcbRobRsLsbRsLebLobRsbLobRjLsRjRsRoRsLsmm
bRsbRobRsbRsbRsRsmbRsRsLsmbLsbLjbLobLcbRobLobLsbRobLsbRobLebLoRsbRebLg
bLsRsbRsbRobRsbLsbRsLsbLobRsRsmbLsbLsRsbRobLjbLsbRsbLsbRsRsmbRobLjbLeb
RsbLsbLsbRobRobLoLsmbRsbLsbRsbLsbLobRjbRsbRobLoLsmbRebLsRsbLebRobLsbLe
bLjbLsbLsbRebRebLobRebLsRsbRsLsbLsbRobRsRsLsRsLsLsmmbRgbRoLsbLsbLsbLsR
sbRsbLcRsLsbRsLsRsbLobRebRobLjbLsbLsbLsbRobLobRobLobRsRsRsmmbLsbRcbRoL
sLsLsmmbLsLsmbLobRobLcLsmbRsLobRobLeRsbLoLsmbLebRobLsLsLsmmbLeRsbLobLc
bLobLsbLebRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 164354; End: 164855;
Recording: 10-1; Individual: 48; Drug: Control Apo 50 然
bRiRebLsbsbLsbRsRsRsmmbRsRsRsRsRgRiRsRsmmmmmbRgRsRsRimmbRibLsbRibRoLsb
RcbRibRgbRgRsRsRsRsRhRsRsmmmmmmbRibRgRsmbRsRiRsmbRgRgbRgbRsRsmbRgLsbLg
bRsRgReRsmbRgbLgbRiLsbLgLsbRsRsRsRsRiRemmmbReReRsmbLsbRsRgRgRsRsRhRhRg
mmbRiRsmbLsLsmbLibRcbRsRgRsmbRsRsRimbRgbLobLebLgLsbLiLsbLebLsRsbRgbRgb
ReRgbReRsmbRebRsRsLsRsmbRjRgbRsbsbsbsbsbsbsbRsbsbsbLsbsbRsbsbReRgbReRs
mbRhRsmbRibLibsbRsRsRemb

>ZF Recording 2016-06-02; tW: 300s; Start: 164857; End: 165358;
Recording: 11-1; Individual: 1; Drug: PCAP814 10 然 Apo 50 然
bRsLsbRebRobRsbLsbLsbRjbLobLjbRobRobLjbRsbLsbRsbLcbLsbLebRsbRsbLsbRsbL
sbRsbRsbLsbLjbLsbLsbRsLsbRsbRsbRsbRcbRsbRsbRsbLjbRsbLsbRobLsbLsbLoLsmb
LsbRobRsbLebRobRsbRsbLsbRsLsRsbRsbRsbLobRsLsbsbsbLsbLsbLsbRsbLsbRsRsmb
sbRib

>ZF Recording 2016-06-02; tW: 300s; Start: 164857; End: 165358;
Recording: 11-1; Individual: 2; Drug: PCAP814 10 然 Apo 50 然
bRsbsbsbsbRsbLsbRebsbLsLsRsmbRhRsmbLcbLsbLgbLsbLsbsbsbRibLgRsbLsbReRsm
bsbLebLgbLobRsbRsbLsbLcbRcRsRsmmbLgRsbLsbLgbLgLsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 164857; End: 165358;
Recording: 11-1; Individual: 3; Drug: PCAP814 10 然 Apo 50 然
bRsbRsRsmbLgbsbRsbRhLsbRsbRsRsRsmmbRgRsmbReRgRsmbLgLsLsmbRsRsRgRsmmbRi
RsmbRgbRibRsRsmbsbRsRsRsRsmmmbsbRibLgbRcbRibLhLsRsbsbsbRsbLsbLsRgbRebs
bRebRsRsmbLsRgbRgRsmbLjbRsRsmbsbRsRsmbRgRsmbLsbReLsbLjbLsbLoRgRsRsRsmm
mbLsbLgbRiLsbLsRsbRsbRsbRebRjbLsbRsbRsRsRsRsRsRsmmmmmbRsRsRsLsmmbRsRsR
smmbRgRsRsmmbLgbRsRsmbRsRsmbRgRsLsmbRsRsmbRgbRcbRcb

>ZF Recording 2016-06-02; tW: 300s; Start: 164857; End: 165358;
Recording: 11-1; Individual: 4; Drug: PCAP814 10 然 Apo 50 然
bRsbRsbLgbRsbsbRsLsbsbLgbRsbRsbLsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 164857; End: 165358;
Recording: 11-1; Individual: 5; Drug: PCAP814 10 然 Apo 50 然
bLsbLsbLsLsLsLsmmmbLebLsRsRsmbRsbRsRsmbLsLsmbLsbsbRsbLsRsbRjLsRsbsbsbR
sbsbRibRsbsbLjbRsbRgRsRsmmbRsRgbRsLsbRgRsRgLjmbRsbRiLsbRsbLgbLsbsbLjbL
sRsRsLsLsmmbRjbLsbRjbsbsbsbsbsbsbLsbRsbRsLsbsbLsLsmbRsbLsLsmbRsbLsRgbL
sbLsLgLsbRsLsbLsLsmbLsbLsRsLsbRsRsmbRsRsRsRsRsRsRsmmmmmmbRsRsmbRsRsRsR
smmmbLsRsLsbRgLsLsmbsbsbRsRsmbsbLsRsbRsRsmbRgbLsbLgbRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 164857; End: 165358;
Recording: 11-1; Individual: 6; Drug: PCAP814 10 然 Apo 50 然
bRsbLjbRgbLebLgbLjbRebRsbRsbLobRsbRjbRebRsbRsbLobRjbRebLobLsbLebReb

>ZF Recording 2016-06-02; tW: 300s; Start: 164857; End: 165358;
Recording: 11-1; Individual: 7; Drug: PCAP814 3 然 Apo 50 然
bRgRsRsmmbsbRgbRsbRgRsmbRgRsmbRgbRsbRgLsRsLsbRgLgLsRsbRibRgbRebRibRgbR
gbRgbRsLsRsbRiLsbRgbRgRsmbsbRgbRgbRibRgRgbRgLsbLhbLgLgRsbLiRsbLhLsbLib
LibsbLeLsLiLsRsLibLeLgLiLgbLibLgLgLsbLiLgLebLgRsbLoRsbLibRsLgbLgbLgbLj
bRhbRgbRiRsmbRgRsmbRgLgbLjbRhbLcbRcbRcbRiLsbRgbLsRgRsmbRsbRibRcbRsbRgR
smbRibRgbRsbRgRsmbRcbRcLsbLgbLhbLgLsbLobLhbLcLsmbLgLsbLibLsbLiLoLcLsmb
LcLsLgLsmbLiLsRsbLiLcLoReRhRhRebRgRiRsmbRhRsmbRiRibRiRsmbRgbRiLsLsLsmm
bRcbRiRsmbRsbRsbRsbRgRsmbRibRibLibLcRsbLsbRgbLibLoRsbLcbLiRsbRsbLebLcR
sbLhLsRsbLgbLgbRsRsmbLiLobLibLgbRsbLgbRsRsmbRgbRiRhRibRibRhRsmbLsbRsbR
ebRcbRcbRcbLgbRcbRiRsmbRgbRgbReLsbRgbRgRsmbRiLsRsbLcbLobRsLobLibLgbLhb
LoLiRhRgRsRiRembRhbRobRcbLebLgbLiLiLhLsLhbLsbRgbLsbLgbLibRebLibLiLsRsR
smbRibRiRsmbRgbRibRgbRgRsmbRgbRsbRiLsbRsRsmbRibRgbRgLsbRgRsmbRsbRgRsmb
RhbLibLcbLebLcbLcbLhRsbLibLsbLsbRjRsmbRibRebsbRgRsmbLsbRsLsbLsLjbRcRsm
bRcbRhbRsbLeLsbRsLobLcbLhLsbLgbLsbsbLhbLcRsbLoRsbLibLibLibLcLibLcLiLgb
LgLsbLgbLgLsbLibLcLsmbRibRcRsmbRiRsRsmmbRgLsbRibRobRgbRhbRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 164857; End: 165358;
Recording: 11-1; Individual: 8; Drug: PCAP814 3 然 Apo 50 然
bLsRsbLiRebLhbLsbRibLiRsRsmbRgbsbRsLsbRsbRsLsbLsbLsbRsLsbRsbRsbLsbRsbs
bRibRsbRgbRsRsmbRsLsbsbRgbRsRsmbRebRsbLhLsbRgbRsbRiRsRgmbRgLsbLsRgbRgL
sbRhbRgbRjRgbRgbRgRsmbRgbsbRsbRiLsbLjbRcLsbLhbRcbLsbRsRsmbRsLsbRsRsmbs
bRsRsRsmmbRsbRiRsRsmmbRsRsmbRgbRsRsRsmmbRgRsmbsbLsbRgbRgbRgRsmbRgRsmbR
gbRiRsRsmmbRgRsmbRgbRsbLcbLebLsLsmbRibRobLsbRgbRiLsbLsLsmbsbsbRiLsbRoL
sRsRsmbLgbRgbRsRhLsbRibLsbRibRebLsLsmbRjbLcbLgRsbLgbLiRsLgLsbLsbLobRib
LcbRgbLoLsmbLiLsbLoRsbLoRsbRgbLibLgbLibLcLsmbLiLsbLoRibRibRiRsmbRgbRiR
smbRiRsmbRibRgbRiRsLsmbRiRsmbRhbRiRsRcmbReb

>ZF Recording 2016-06-02; tW: 300s; Start: 164857; End: 165358;
Recording: 11-1; Individual: 9; Drug: PCAP814 3 然 Apo 50 然
bsbsbRsLsLsmbsbsbLsbRgbLiLsbLgLsbRjbRsLsLsmbLgbsbsbLsbsbRsLsbsbsbRsLsb
LgbLiLibLoLsmbLobLobLsLsLsmmbRcRsmbRobRcRsLsmbLiLsbRcbRibRsbRcRsmbLgbR
cbRsRsRimbRgRsmbRsRgbRgbRiRhbRgbRgbRiRsmbRgbLsRibRgRsRgmbRibRebRibRgbR
ibLobLcbLcbsbLobLcbLgbLoRsbLibLibLibLibLsbLgLsbLgLsbLgbLgLsbLibLsbLgLs
bLiLsbLiLsbRobRiRsmbRsLsbRgbRgbRgRsmbLsbRgRsRsRsmmmbRgRgbRibRiRsmbReRs
mbLobsbLsRsbsbLcbRhbLjbRobRhLsbRiRsmbRibRsbRcbLiLsbRsbRhbLjLjbLiLsRsbs
bRcbRsbRcbsbLsLsmbsbsbRcbLsLsmbLcbsbLhbLibRsbRjbRcRsmbLgRsbRcbLjbRcRsm
bRibRgbRiRsmbRgbRgLsbRsbRibRobLibLibRjbLsRobRebsbLsbRsbRsbLsbRibLsbsbR
sbsbLsbRsRiRsmbRsRsmbRibRsRsRsRsRsmmmmbLsbRgbRgRsmbRgLsbRgRsmbRsRsmbRs
bRgRsmbLsRsRsmbRsRsmbRsRsmbRgbRcRsLsLsmmbRoRsmbsbRsbRsbRibRsRsLsRsmbRc
bRoRsRsmmbReRsmbRcRsmbLobRebRcbRgbRiRsmbRhbRcbRobRcbRibRgRsRcLsmbRebRe
bRibRiLsLjbLeLsbLibLibLhLsbLhLsbLsLibLibsbsbRoRsmbLjbLcLsLsmmbLsbLgbLi
LsbLgbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 164857; End: 165358;
Recording: 11-1; Individual: 10; Drug: PCAP814 3 然 Apo 50 然
bRsRsmbRsbRgbLsbRsbsbLsbLsbLgbLgbLgLsbLsbLsbLsLsLsmmbLsLsmbLgLsLsmbLsb
LgLsLsLsLsmmmbLsLgbLsbsbLsbLsLsmbLsbLsbLsLsmbLsbLgLsbRsbLgbLsbLsRsbLsL
smbLsLsLsmmbLsLsmbLsbLgLsbRsLsbLgbRsbLsLsLsmmbLsLsRsmbLsbLsLsRsmbLsRsL
sbLsLsmbLsbLsLsmbLsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 164857; End: 165358;
Recording: 11-1; Individual: 11; Drug: PCAP814 3 然 Apo 50 然
bRsbsbRsbRsbsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 164857; End: 165358;
Recording: 11-1; Individual: 12; Drug: PCAP814 3 然 Apo 50 然
bRibLcLsLsmmbRiLsbRsRsmbRjLsbLiLsbLcbRcbRcbLebLebLgLsLsLsmmbLgbLsLsmbL
ibLgLiLsbLsbLsbLgbRsbRcbLoLsmbRibLoLsmbRsLeLsRsbRibRsbRiRibRgbLgbLgLsb
LiLsLsmbLcbLibRcbRcLsbsbRsbRgbRibsbLcLsLsLsmmmbLsbLibLsLsLsmmbLsLsLsLs
mmmbLcbRcRsmbsbRebRibLsLsmbRgLsbRgRsmbRibRgLsbLiLsLsLsLsLsLsLsLgmmmmmm
bLeLsbLcLsmbRiLsLsRsmbLcbLsLsLsLsmmmbRsRsLsLsLsmmmbLcLsmbRiLsbRobLgbRg
bRibRiLsbRsbLcbLcLsmbLcbLsbLsbLiLsbLsRsbRsbLgbLcbRibLcLsLsmmbLiLsbLibL
cbRsLsLsmbRhbRibRibRgRsmbRgLsbRsbRcbsbLgLsLsmbRibRibLeLsbLgbLebsbLoLsm
bRsbLcLsmbLsbLcbRebLiLsbLobLsbRhLsbsbRiRsmbRcbRibsbRsbLsbLsbLsLsmbLeLs
bLibLiLsLsmbLsbReRsmbRhbRhbRibRiLsbLiLsLsLsLimmbLhLsLgLsbLebRibRgbLibL
cLsmbRgLsbRgbRgbRibRsRsmbRgbRgbLgLsbLcbRsbRsRsmbLsbLsLsmbLsLsLsmmbLiLs
LsmbRibRgbLebLsLsLsmmbLibRsbRibsbLeLsLsmbLsLsLsLsLsLgmmmmbLjLsLsRsLsmm
bLebReRsmbRiRsmbRgbRibRiLsLsmbLcbRhLsbRibRsRibLibRiRsmbLjbLhbLsLsLsLeL
smmbLcbRsRsmbsbLeLsLsLsLsmmmbLcLsmbLsbLhbRibRibRibLjbRcRsmbReRsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 164857; End: 165358;
Recording: 11-1; Individual: 13; Drug: PCAP814 1 然 Apo 50 然
bRsbRsRsmbRsRsRsmmbsbRsbRobLsbRebRiRsmbRgbRobRgbLsLsmbLibLsbLobLhbRibL
gRsbRsbLgbLibRobsbLsRsRsmbLhbRcLsLsmbLjbLgRsRsmbsbLjbLsRsbRobLsbsbsbRs
bLsbLsLsmbRsbLsbsbRsbsbRsLsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 164857; End: 165358;
Recording: 11-1; Individual: 14; Drug: PCAP814 1 然 Apo 50 然
bRsbRsLsRsRsmbRgRsRsRsRsmmmmbRcbRsbRhbRsbRcbRcbRsRcbLjbRsRgbRsbsbsbsbs
bLsbLsbLsbLsbRiRsmbLsRsbRgbLjbRcRsmbRhbLibRhbLibLobLhbLcbRcRsmbLiLsbLg
bLobLhbLgbRgbRcbLsRsbRcbRcRsmbLobRcbsbsbRgRsRsmmbsbRgbRhbRcbLoLsmbLcbL
cbLcbLsbLsbRebRsbRcbLibLobLgbsbRsbRiRsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 164857; End: 165358;
Recording: 11-1; Individual: 15; Drug: PCAP814 1 然 Apo 50 然
bLsbLsLsLsmmbLsbsbLsbLsbsbRsbLsbRsRsmbLsbLcRsbLeLsbLgbLgbRoLsbLsbRsRsm
bLsbLsbsbsbLsLsmbLoRsLsbLebLsLsmbLgbRsRsmbsbLsbsbLsbLobRsbLiLsbsbLibLo
LsmbLhbLibLsLsLsLsmmmbLsLsmbRsbRgbLsRsbLsbsbRhLsbRobLsbRsRsmbRsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 164857; End: 165358;
Recording: 11-1; Individual: 16; Drug: PCAP814 1 然 Apo 50 然
bRsbLcbRcbLsbLoLsRsmbLgbLcbLibLcbLcbLibRsbLibLcRsLibLcbLibLsbRcbRiRgRe
RsmbsbRgbLgbLibLoRsbRobRcRsmbRsbRgbLcbLhbLjbsbLhbLobLobRobRiRsmbRibRob
RibRcbRiRsmbRsRsLsmbRsbRsbLcbLcbRcbRcRsmbRgbRgbRcbRcbRcbsbRgRsmbRgRsmb
RgLsbRgbRgbRgbRsbReRsmbRibReRsmbRgbLsbRsbRgbLsRsRsRsmmbRsbsbRgbLcbLebL
ibLobLiLsbLiLsbLibLcbLhRsbRsLsbRgbRsbRjRsmbLoLhbLiRsRsLsmbLgbLibLsLsLs
LsmmmbsbLsLsLsmmbLcbLcbLebLcbLcbLsbLsbLibLibLiLsbLoRsLsbLgRsbRhRsRgmbR
gbRgbRgbLoRsbLcLiLsbsbLibLobLcLoLsmbLgbRsbLhRsbLiLsLsmbLhLhbsbLcbLhbLs
bRibRgbRgRsRgRsRsRsRgmmmmbRsbRsLsbLjLsLjLgmbLibLcRsbLebLhbLibLgLibRsbL
iLsLsmbLibLsbRgbLcLsmbLiLsLsmbLgLsRsbLgLsRsbRsbLsbsbRjbRhbLjbLcbLcLsmb
LhbLibRsbLcbLgRsbLgLsbLsRsbLsLsmbLsbLcbLcbLhbLiLsbLiRsbLgLsLsmbLgbLsbL
gbLsLsmbLcbLibLcLsmbLiLsbLhbLobLhLsbLoLsLsmmbLcbLsbLgbLgbLsLsRsmbLsLsm
bLsbLgbLiLsbLibLcbLcLsmbLcbLcLsmbLibLcbLcLhbLibLcbLgRgbLhLoRsbLoLsmbsb
LgLsbLobLgbLcbLhbLsbRoLsbRobRibRcbRsbRiLsbRgbLsbRgRsmbRgRsLsmbRgRsmbRs
bRsRsRsmmbRgRsRsmmbRgbRsRsmbLebLcbRobRebRiRsmbRibRgbRobRiLsbRobRsRsmbR
obLsbRhLsbRobRjRiRibRsbRobRsbRjbRobRsbRhbLcbLeLsbLcbRgbRsbRsRobRobRsbR
cbRhbLsbRjRoRsmbLsLsLsmmbLoLsmbLgbLibLcbLhRsbRgRgbLobLibLobLcbLcbLibLc
LsmbRgRsRsmmbRgbLcLsmbLhLsbLhbLhbLibLcbRebRcbRgbRcbRjRsmbRibRcRsmbRgbR
cbRhbRibLsbLgbRsLhbLibRcRsmbLjbRsbLcbRiRgRiRebRibsbRebRgRsmbLobLebsbLo
bRsbRobRgbRcbRsLsbLsbRebLcbLibLcLsmbLibLcbLcRsbLgbRcbRsRsmbRebRcbRibRe
bRjbRcLsbLsbRebRobLcbLjbLsbLobLcbLsbLsLcbLcbLgLsbLhbLjbRgbRcRsmbRibLhb
RebRcbRgbRjbLcbLcbLjbRsLsbLibLjbRobRibRiLsbRsRsmbRibLebLcbLiLsbLiRsbLi
bLjLsmbRsRsmbLobLibLibLsLob

>ZF Recording 2016-06-02; tW: 300s; Start: 164857; End: 165358;
Recording: 11-1; Individual: 17; Drug: PCAP814 1 然 Apo 50 然
bLsbsbsbsbsbsbsbsbRsbLsbRsbLebLebLsLgbLcLsmbLiLsLiLsLsLiRsmbLgbLsbLobL
jbLebLgbsbLiLsbRcbRcbRsLjbLibLibLobLiLsbLjbLhLsRsbLsbLgRsbLgbLsbLiLsLg
LsbLcbLhRsbLsbRgbRibRsbRibLsbLsLsmbRobRobRgbRgbLjbLiLsbLgLeLhLhbLgbLjb
LgbLgLsRsRsmbLgbLgbLsbLsbLgbLiLsbRibLibLibLsLsmbRcbRsLjbLgbRjbRibRgbRj
bRhLsbLibLsbLgbRobRgbRgLsbRsRsmbRgbRgbLcLsmbLgRsbLgbLsbRjbLobRobRiRsmb
RsbRgbRibsbRsRsmbRsbLsRsRgbLsbLjbLsRebRibRobLsbRgbRsRsmbRiLsLsmbRsbRsb
LeRsbLsRsbRsLsLsmbLgbLgbLiRsbRobLiLsbLgLsLsmbLsbLsbsbLsbLgLsbLiLsbLobL
jbLibLsbLsbLsRsbLsbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 164857; End: 165358;
Recording: 11-1; Individual: 18; Drug: PCAP814 1 然 Apo 50 然
bLsLsLsLsLsLgmmmmbLsLsmbLsLsLsLsLsmmmmbLgbLgLsbLgbLibRibLcbLgbRsRsmbRi
bRgbLjbLsbLgLsLsmbLgLsbLsRsbLsbRgbRsbLiLsbLsLsmbLsLsmbLgbLgRsbLgbRgbLc
LsmbRibLsLsmbLibRgRsmbRsbRhbLgbLgbLsbRsLsLsmbLgbRsbsbLiLsLsmbRsLsbLgbL
sbRsbsbLsLsLgLiLimbLiLsbLgLsbRibLsbRibLgbRsbsbsbLsLsmbsbRjbLjbLgbLsLsL
sLsLsLsLsLsLsmmmmmmmmbsbLsLsmbLgLsbLiLsbLhbLcLsmbLsbLgLsbLgbLibLsbLsbL
ibLgLsbLibLgbRibLgbLsbsbLsbLsbLibRsbRsbRgbLibLsbRsbLsLsmbLsLsLsLsmmmbL
sLsmbLsLsLsLsmmmbLsbsbLsbsbLsLsLsmmbLsLsmbLsLgbLgbLibRgbLgbLgLsbLibLgb
LgbLibRsbLgbLhLsLsmbRibLhLsbRsbRibRcbLcbLebLcbRibsbRhbLgbRibLgbLsLsmbs
bRsbLsLsmbsbLgbRsLsbRsbLgLsbLgbLsLsLsmmbLgbLgbLgLsbLcbRiRsmbRiLsbLiLsb
LibRgbsbLsLsLsmmbLsLsmbLibsb

>ZF Recording 2016-06-02; tW: 300s; Start: 164857; End: 165358;
Recording: 11-1; Individual: 19; Drug: Control Apo 50 然
bLsLgbLsLsmbLgLsLsLsRsmmbLsbLgbLgLsbLsbLsLsmbLsLsmbLsbLgbRsbLsbLhbRsLs
LsLsmmbLsbLsLgLsbLgbRsbLgRsbLgbRjbsbsbRsRsRsRsRsmmmmbRiRsmbRsLsReRsmbL
gbRgRsmbsbRsRsmbRsbsbRsbRsRsReRgLsmbsbRsbRsRsmbLsRsRsLsRsRsRsRgmmmbRsb
LsbsbRsLebLobRjbLobLoLgbLsLsmbRsbLobRsbsbRcbRgRsmbRsbRhbRibLcbLsbRiRsm
bRgRsmbRsRsRimbRsbRsbRsbRsRsmbRsRsmbRgRsRsRsmmmbRsRsRgmbRgRsRsmmbRsRsR
gRgmbRsRsRsRgRsRsRgRsmmmmmbRsRsmbRibRsRsmbsbRsRgbRsRsmbRgbLsLsmbRsRsRs
RsRsRsRsRsRsRsRsmmmmmmmmmmbRsbRsbRsRsmbRsbRsRibRsRsRsLsmmbRsbsbsbRsbRs
LsbRsRsRiRgmbLsbsbLsLsmbRsbRsbRiLsbRsbLsbRebRgRsLsLsmmbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 164857; End: 165358;
Recording: 11-1; Individual: 20; Drug: Control Apo 50 然
bLibLhbLgbLgbRibRibRhbLgLsbRsbRgbRibRgLsbLgLsbRibRsbRgbRsbRibRgbRsLsbs
bRsRiLsbRgbRsbRsbRgLsbLsbLgbRjbRiRsmbRgbRibRcLsbRibLsbLgbRgbRhbRiLsbRg
bLjbRiLsbRgbRcbRibLhLsbLsbRibRiRsmbRebRibLsbLibLgbLibLgbLibRibLgbLsbsb
LsbLibRibLibLgbLgLsbLibLibLsbLsLsmbLgbLsbLgbLgLsbLsbLobRgbRsbLhbLibLgb
LibLgbLiLsbLcLsmbLcbRibLsbLiLsbLsbLibLibRibLibLgLsbLgbLibLsbRhbRibLgbL
cbLhbLibLibLgbRsbLcbLibLibReLsbRibsbRgbRiLsLsmbRibLhbRgbLjbLibRibLibRs
bRcbLsRebRibRibLgbRhbRgbRhbRibLcbLibRsbLgbLibRsbLiRsbLgbLgbLgbRcbRgbRi
bRcbRgbLcbLibLibRsbRebRsbRibRcbRgbLibLcbLgLsbLibLgbLibLsbLgLsbRsbLibLi
bLibLgbLibLibLibRibLibLsbRcbLibLibRsbRsbLjbLhbLsLsmbLgLsbLsbLibLsbLibL
ibLibRcbLcbsbLibLiRsbRgbRsbRibLibLibLgbLgbLhbRsbLibLsbLsbLhbLibLgbRsbL
ibLsbLgbLibLibLgbLsbLhbLsbLgbLgbLgbLgbRgbRcbRcbLhbRcbRjbLibLjbRsbLibLi
LcbRgbRcbLebLibLibLjbLsLsmbLgbLsbLgbLcbRhbLgbRibRibLjbRhbRsLsbRgbRsbLi
bLcbLgbLgLsbLhLsbLibLgbLgbLsbLgbLibRsbRsbLhbLsbsbLsbRjbLcbLhbLcbLgbLcb
RjbLcbLgbLgbLcbRgbRsbRsbRjbLsLsmbRibRcbRjbLcbLibRcbRjbLsLsmbLgbLcbRjbL
ibLibRcbLcbLjbLsbLgbLgbLcbLgbLibLsbLibLjbLsbLobRibLibLsbLgbLibLgbRjReb
RsbRibRiLsbRgbLgbLgbLhbRgbRsbLibLsbLgbLsbLgbLgbLsbLgbLibLibLebLgbLgbLg
bLgLsbLebLgbRcb

>ZF Recording 2016-06-02; tW: 300s; Start: 164857; End: 165358;
Recording: 11-1; Individual: 21; Drug: Control Apo 50 然
bRsRgbReRsmbRebRgRsmbRgbRcbLhLgbLibLsLcbLgbRgbLcbLsLiLhbLibLcbLiRsbLeL
ibLiLsbLsLsLsmmbLcbLsbLsbLgbLgLsLgLsLgbRebLsLsLsmmbLjbLibLgLsbLsLsmbLi
bLgLsLsLsLsmmmbRhbLebLibLsLibLsLsmbLiLsbLsbLibRobLobRsbLcbRobRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 164857; End: 165358;
Recording: 11-1; Individual: 22; Drug: Control Apo 50 然
bLiRsbLgLsbLgbRsbLiLsbLsbLgbRsbLgLsLsmbRsRsmbLsbRsbLgLgLsbRsbLsbLsbLsb
LebReRsmbsbsbLsbRgbRsbRobRsRsmbRobLebRcRsmbLcbReRcbRoRebRsRobRobRobRob
LebRebLsbLjbLobRsbRjbRhbLcbLsbRgRsmbRibRsbRebLcbLhLsLsmbLcLsLsmmbLhb

>ZF Recording 2016-06-02; tW: 300s; Start: 164857; End: 165358;
Recording: 11-1; Individual: 23; Drug: Control Apo 50 然
bRsRsLsmbRcbRsRgRsmbLsbRibRgbLsbRsbLsbRsRgbRgbRgbLsbRgbRsbLsbLebRsbRsR
smbLsbRsbRsbRgbRsbRsRgbRgbRsbRsLsbRgbRgRsRgmbRgbRsbRsRsmbRgRsmbRsbRsRg
bsbRsRsmbRgbRsbRsbLsLsmbRibRsRsRsmmbLsRsbRsRsRgmbRsRsLsmbRgRsRsmmbRsbR
gbLsbRsbRsRsmbRsbRsbRgbLsRsbRsbRsRsRsRsRsLsmmmmbsbsbRsLsbRsbRgbRsbRsbR
sRsmbLsbRiLsbRsRebRsbLsLsLsmmbLsbLjbLsbLsbLeb

>ZF Recording 2016-06-02; tW: 300s; Start: 164857; End: 165358;
Recording: 11-1; Individual: 24; Drug: Control Apo 50 然
bLjbRjRjbLibLgbRgbRjbLgbLsbRsbLjbLjbLgbLsbRgbRsbRsLjbRibRgbsbsbRsLsbLj
RgbRjbRgbRibRcRsmbReRsmbLibRsRsmbLibLiRsbLibLibLiLsbLgRsbLjRsbLjRsbRsb
RibRibRgbLsbRjbRibRgbRibLjbRibLobLibLibLgbLgbLibLiRebRsbReRsmbRgbRjRgb
LibLiLgbRsLgbLgbLjbRsbLjbLgbRgbRsbRjbRsLjbLgbRjbLjbRjbsbLjbRjbRobLibRe
RsmbRebLibLibLjbsbLhbLiRsbLjbsbLhRsbLhRsbLgRsbLsbLibLhbRjbRjbLjbRsbLiL
sbRsbRjRsmbLiRsbLgbLibLgRsbLibLibLibLsRjRsmbLjRsbLhbRsbLgbLibLibLibLiR
sbLgbRsbRjbRjRsmbRsRsRsmmbLsbRjbRsbLsbRsbRibRgbRjbLibLgbLjRsbRibLgbRgb
RhbRhbRgbLgbRsbsbLjbRjbRsbLsbLgbLhbLhbLgbLgbLgbLgbLiRsbLgbLjbRibRsbRsb
RsbRsbRgbRiRjbLsbLjbRsbLgbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 164857; End: 165358;
Recording: 11-1; Individual: 25; Drug: PCAP814 10 然 Apo 50 然
bRsbRsbRgbLsRsbRsRsRsmmbsbLsLsRsRsmmbsbRsbsbRsRsRsRsmmmbLsbsbRsRsmbLsR
sRsmbRsbRsbsbsbRsbRoRsmbLsbRsbLsRsbRsbRsbRsbRsbRsRsmbsbRsbRsbsbsbsbsbR
oLsbLsbRsbLebRsRsmbsbRsbRsRsLsmbsbLsbRsLsbsbsbLsbRsLsbsbRsbRsRsmbLsbRs
bsbLsbLsbRsbRsRsRsmmbLsRsbRsRsmbRsbRsLsbsbLsbLsbRsLsbLsbLsbRsbRsbRsbLs
bRsbRsbRsbRsbsbRsbRsbRsbRsbsbsbLsbRsbRsbRgRsmbRsbRsLsbRsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 164857; End: 165358;
Recording: 11-1; Individual: 26; Drug: PCAP814 10 然 Apo 50 然
bLsbsbLsbsbLsRsbsbsbLsbLsLsmbLsLsmbLibLsLsRsmbRsLsLsmbsbsbLgbRsbLsbLsb
RsRsmbLsLsmbsbsbsbLiRsbLsbRsbLjLsLsmmbLsbLgbLgRsLsbLgbLsLsRsRsRgmmbRjb
RsRsmbLgbLsRsbLsLsRsmbLsbLgbLsbLsbLsLsmbsbRoRsRsRgmmbsbRsRibLsbRsLsbRg
bRjbLgbLobsbsbLsRsbRsLsLsmbRsbRsbsbsbLsbLsLsmbLsLsRsmbLgRsLsbLsbsbsbLg
bLiLsbLsLsmbLcbRsRsmbRsbLcbLgbLibLebRgbRobLgbRgRsLcmbLibRsLiLsbRsLsRsb
LsLsLsmmbLsLsmbLsbLsLsLsmmbLsLsmbsbRsbRcbLcbRsLgLsbLsbRsbsbRsbRsRsmbLs
bRsLsbLjb

>ZF Recording 2016-06-02; tW: 300s; Start: 164857; End: 165358;
Recording: 11-1; Individual: 27; Drug: PCAP814 10 然 Apo 50 然
bLsbLsLsmbRsbRsRsmbRsbRsbRsbRgbRsbRsLsRsRsmbRsbRsbRsbsbLsLsmbRsbRsRsmb
RsRsmbLsRsbRgbLsbsbRsbRsbRsRsmbRsbLsRsbLsbsbLsbRsbRsbRsRsRsmmbLsbLsbRs
bRsbRgLsbRsbRsLsLsmbRsRsmbRsbRsbLsbRsRsmbLsbRsbLsbLgbRsbRsbRsRsmbRsLsb
RsbRsbLsLsmbLsbRsbRsbLsbLsbRsbsbRsbRsbRsbLsRsbRsbsbRsbsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 164857; End: 165358;
Recording: 11-1; Individual: 28; Drug: PCAP814 10 然 Apo 50 然
bRgbRsbLgbRsRsmbRsbRsbRsbRsbRsbsbRsRsmbRsRsRsmmbRobRsRsmbLgbRebRcbRgbR
obLsRsbRsRsRsmmbRsbRsRsRsmmbRsRsmbRsRsmbsbRsbRsRsRsRsmmmbRsbRsRsRsmmbR
sbRjbsbRsRsmbRsbRgbRsLsbRsbLsbLibRjbRsbLsbRsbRsbRsLsbLsbRsbRgbRsRsmbRs
LsbRsRsmbRsLsbRsbsbRsRsmbRgbLebRsRsmbRsbRsRsmbRsbRsLsLsmbRibLsbLgRgRsm
bRgLgbsbRgbRsbLsbRsbLsbRsbRjbLsbLsLsmbRsbRsRoRsmbRsRsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 164857; End: 165358;
Recording: 11-1; Individual: 29; Drug: PCAP814 10 然 Apo 50 然
bLsbLebLgbLebsbRsRsRsmmbRsRsmbRsbRgbRsbRgbRsbLeRgbRsLsRsbLibLsbLcbRsRs
mbRsbRcbLiLsbRsbLgbRcbRobRsRsmbRibsbRhbLebRsbsbLsRiRsmbLobRsbRcbLsbRsb
RebRgbRgbRsRsmbReRsmbRcRsmbRoRcbRsbRsRsmbRjbLsRsbLjbRebRiRsRsmmbRebRsb
RsRsmbRsbRsbRsbRhRsmbRsRsmbRgbLgbRsbLgbLebLebLgLsbRjbLsRsbRcbLeRcbsbRo
LsRsbLsbLgLsRsbLjLjbRgRsmbRebRsRsmbsbRsbsbLsbRsbRjbRsbsbLsLsmbLgbRcLsb
LcbLgRsbsbRsbRgRsmbRsbLcbLsLsmbLsLsmbReRsRiRsmmbRibRjbLsbLsbRgRsmbRgLs
bLsbLcLsLsmmbLsLeRsbLcbLiLsbRsbRsbRsRsRgRsmmbRebLgbLjbRsLgbLsLibLiLsbR
sRsRsRemmbRsRgRgRsmbRibRgRsRsmmbsbRsbRsbRsbRsbRebReRsmbRsLgbLgbLjbRibL
cbRebLsbsbLsbRebRsbRsbLgbRsbRcRsmbsbRsRhLsbLsRgRsmbRibRsbRgLsbRsbRibRs
RsmbRibRobRjbRsbRgRsmbRgRsReLgmbLsbRebRiLgRsbLoLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 164857; End: 165358;
Recording: 11-1; Individual: 30; Drug: PCAP814 10 然 Apo 50 然
bLsbLsLsmbsbsbsbLibLsbLsbLsbLsLsLsmmbsbRsbLsbsbRjbRsbLsbRsbRsbLsLsmbLs
bRsbsbRsbLsRsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbLsbsbsbLsRsbsbRs
bRsbsbRsbRsbsbRsbLsbRsbRsbRgbLsbRsbLsRsbRobLsLsmbsbsbLsbsbsbLsbLsLsmbL
sLsmbRsRsmbRsLsbsbRgbRhRsmbLsRsbRsbsbRsLsbRsbRsbsbRsbLsbRsbRhLsLsmbRsb
LsbRsbRsbLobRgbLsLsmbLiLsRsRsmbsbRsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 164857; End: 165358;
Recording: 11-1; Individual: 31; Drug: PCAP814 3 然 Apo 50 然
bLsbRsRsmbRibRibRhRsmbRgbsbRiRsmbRibRibRgbRsbLobLibLibRsbLibLsbRjLsbRg
bRibRibRcbRsbLsbLibLgbRjbRcLsbRibRibRsbRgbRibLsbRibLsbLibRiRsmbRiRsmbR
sbRsbRibRgbRgbRgRibRhbRibRgbRgbRcbRsbLgbRcRsmbsbRiRsmbRgRsmbRibRhbRibL
obLcbLgbLcbLgRsbRsbRcbRgRsmbRhbRibRsbRgbLsbLibLjbRsbLcbLobRgRsmbLjbLcb
LgbLcbRhbRsbRibLsbLcbLcbLoLsmbLibLgbLibLcbRgRsmbRgbRgbRgbRibLsbLgbLcbR
sbLjbLsbRjbRgbLeLcbRiRsmbLjbRcbLsRsbRgbLgbsbsbLcbLhbRsbLsbLebRcbRgbLcb
LhbRibLsbRsbRibLsbRsbRsbRgbRibLsRsbRsbRgbRgbLsbRiRsmbRgbRsbRgLsbRgbRgb
RiRsmbLsbRgbRgbRebRibRsbRiRsmbLgbRibRsbRgbRgbRsbRibRsbRgbRgbRgbRjbLhbR
gbLobsbRoRsmbLsbLgbRhbRibRsbRgbRebLgbLhbRgbRhbLobLibRsbLcbRibLcbLibLsb
RsbLcbRibLjbLcbRgRjbRsRobRsbLgbLebLjbRibLcbLobRsRsmbRjbLobRhbLcbLgbLjb
RsRsmbRjbLibLsLsmbRjbRsbRjbRjRsmbRsbsbRgbRebRgbRibRgbRibRibRcbLsbsbLhb
LcbRsRsmbLcLsmbLsbRgRsmbLcbRhbLebLibLiLsbRgbLsbRiRsRsmmbLobRgbLhbLiLsb
RgbRobRibRgRsmbRsbLsLsmbRgbRgbRsbRibRsbLjbLibLgbRcbRibLsbRsbRiRsmbRiRs
mbRibRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 164857; End: 165358;
Recording: 11-1; Individual: 32; Drug: PCAP814 3 然 Apo 50 然
bLgbLsbLibRsbRgbLhLsbLgbLsbLgLsLsmbLgLsLsmbLsbLsbRiLsbLsbLsbLiRsbRibLs
LsmbLibLjbRcRsmbLibLebRibLibRgbLjbLsbRsRsmbRhbLgbLsbLgbLsbLiRsbRcbRibL
gbRsbLgbLgbLgLsbRsbLsbRcbRsRibRibLibRsbRgRsmbRsLsbLibRjbLebLgLsbRsbLiL
sbLgLsbLibRsLsLibRcbRiRsmbLjbLibsbLgbLgbRsbLgbLsbLiLsbLgbLgbRsbRsbLgbR
sbRsbLgbLsbLsLsLsLsLsmmmmbLgRsbRgbRhRsRsmmbLjbLjbLgbLgLsLsRsRsmmbLibLs
bRjbLiRsbRhRsmbLsbLgbsbLibLibLiLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 164857; End: 165358;
Recording: 11-1; Individual: 33; Drug: PCAP814 3 然 Apo 50 然
bRsRsLsRsRgmbRsLsbRgbRgbRoRsmbLhbLcbRsbLgbRibsbRobRgbLsbLebRhRsmbRgbRs
bLsRhbRsbRgbRjbLobLibLgbLibLeRsbLibLibLiRsbRibRibRgRhbRcbRiRsRsRsmmmbR
gbLgbLhRsbLgbRsbRsbRhbRsRgbsbsbRgbLobRibRebLcLsmbLgbLobRgbLibLobRsbRsb
RgbRsbLsbsbsbsbRsRsmbRsbsbRsRibLsbLhbRsbsbsbsbsbsbsbsbRiRsRsmmbLsLsmbs
bLsLsRsmbLsLsmbRgbRsbRgbRcRsRsmmbRibRsbRgbRoRsLsmbRobLoRsRsLsmbRsRibLs
bLcbRsbRjbsbRgbLebsbsbLsbLsbLsbRebLgbLobRgbRjbLobRebLsbLebRebRobRebRiR
sRgmbRcbLhbRcLeRsbRoRsRsLemmb

>ZF Recording 2016-06-02; tW: 300s; Start: 164857; End: 165358;
Recording: 11-1; Individual: 34; Drug: PCAP814 3 然 Apo 50 然
bLgbLsbLsbLsbLsbLsbLibLobRsbRgbRsbRobRoLsbLobsbRibsbRsbLgbsbLibLgbRobL
oLsLcmbRgbRebRgRsmbRjRsmbRiRsmbRgbRgbRgRsmbRsbRibRibLsbRoRgbRobLgLsLsm
bLsbLgbLsbRsbRsbLgbLgbRsbLgbRgbRsbRibLsbsbRsRgbsbRebRebLgbLibLcbRcbRiR
ebLsbLsbLsbLgRsLgbLgbLgbLgRsbLsbLsbLgLsbLgbLgLsLgbLgbLgbRsbLgbLgbLgbLi
bLgbLgbLsbLhRsbLcbLebRobRibRibRsbRibRgbRgRsmbLsbsbLsbRsbRsbRgbLsbsbReb
LgRsbLobLcLsmbLobRcbRibRgbRsbLsRsbRgbRsbLebLhbLoLsmbRsbsbsbsbLobLgLsbR
ibRgbRgbRsLsbRgbRsRsLsmbRsbRhbRoRiRsmbRcRsRgmbRibRibLsbLebLiLsbLgLsbLs
bLgbLsbLgLsbLgbLgbLgbLgLsbLgbLgbLgbLgbLgbLgbLsbLsLsmbLgbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 164857; End: 165358;
Recording: 11-1; Individual: 35; Drug: PCAP814 3 然 Apo 50 然
bLgbLsLsmbLcbRgRsmbRibRcRsmbRibRibRsLsbRgbRsbLcbLibLgbRsbRjbRcRsmbsbRs
RsmbRsbRsLsbRsbLsbLsbRsRgbRgbRgbRsbRiLsbRibRsbRgbRsbRsRsmbRsbRsbRsbRjR
sRsmmbRsbRgbRsbsbLsLsLsmmbRsbLsRsbsbLsbLsLibLgbLsRsbLibLsbLibLcLsmbLgb
LibRgbLhbLiLsbLgbLgLsbLsbLcbLgbsbLsLsmbLsbsbsbLcLsmbRsRsmbLiLsbRsbLibL
ebLsbLsRsRsLsLsmmbLgbLsLsmbLgbLgRsRsmbLgbLsLsmbLsbLgLsbLsLsLsmmbLsbLsb
LsLsmbRsbLgLsLsLsmmbLsbRsbLgbRsRsLsmbRjbRiRsmbLiLsbsbLsLsLsRgmmbRibLeb
LiLsbLgRsbLsbsbLsbLibLibRgbLibRsRsmbLsRsLsbLsLsRsmbsbLsLsmbLibsbLiRsRs
RsmmbLsLsLsmmbLgLsbLgLsbRgRsRsRsmmmbLgbLgLsbLgLsRgRsmbLcbLibsbsbLsbLsL
smbLsbLcbsbRsbLsbRgRsmbRgRsmbLobLsbLgbLgbLsLsmbLsbLgbLsbRsbLsLsmbRsLsL
sLsmmbLsLsmbLsLsmbLsbLsbLsLsmbLgLsbsbRsbLsbLsbLsbLsbLsLsRsmbLgbRsRsmbL
gbRsRsmbLibRgbLibLhLsbsbsbsbLsbsbRsLsbsbLgbLsLsmbLsLsLsmmbLgbLcbsbRgRi
RsmbLhLsLsmbLgbLibLgbRsbLsbLsLsLsLsmmmbLsbRgbLsbLgbLsbLcbLebsb

>ZF Recording 2016-06-02; tW: 300s; Start: 164857; End: 165358;
Recording: 11-1; Individual: 36; Drug: PCAP814 3 然 Apo 50 然
bLsLsmbRsbLsbLsbRsbRsbRsbRsRjbRgbRgRsmbLjbLjbLibLcbLibLibLsRsbLibLibRg
bLjRsbRjbRcbRebRiRsmbRiRsmbLcbRsbLgLsbRsbRsbLsbsbsbsbsbsbsbsbsbsbLsbLs
bRsbsbsbsbRgbRcRsmbRcbRhRsmbRcbRhbRcbRcRsmbRgbLjbLcbLcLsmbLibsbLibLsbL
gbRsbRjbRsbRjRsmbRgbLgbRgRsmbRgbRsbRibRgbLsbLgbLsRsbLgbRgbRsbRibLsbRsb
RsbRgRsmbRgbRsbRiRsmbRsbLsRsbLgbRsRsmbRsbRsRsmbLsbRgbRiRsmbRgbRsbRsbLg
RsbRiRsmbRsRsmbRsbRsbRsbRsRsmbRsbRsbRgbRgbRiRgbRgbRsbRsbRgRsRsRsmmmbRs
bRgRsLsmbLgRsbLjbLibRobRcRsRsmmbRhbLibRcbRgbRsRsmbLsbLsbRsbRsbRsbReRsm
bsbsbRsbsbsbLsbRgbRsbRsbRsRsRsmmbRsRsmbLsRsbRsbRhbRsRgRsRsmmbLsbRsRsmb
RgbRibRgbRgRsmbRsLsbRgbRsbRsbRgbRsbsbRgRsmbRibRiRsRsRsmmmbRsbRsbLsbRsb
RsbRibRsRsmbsbLsRsRsmbRibsbLjLsmbRsbRsRsRsmmbRsRsRsmmbRsbLsbRjRsRsmmbR
gRsmbRsRsmbLsbLsRsbLsRsRsmbRsbRsbRsbRiRsRsRgmmbRgRsRsRsmmmbRsRsmbLsRsR
smbLsbRgRsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 164857; End: 165358;
Recording: 11-1; Individual: 37; Drug: PCAP814 1 然 Apo 50 然
bLgLsLsmbLsLebsbLgRsLsbLgbsbLibLgbLcbRoLsbLoLsmbRsbsbsbRcRsRsmmbRobRob
RcbRobsbLcbRiRsmbLcbRsbRcRsmbsbRcRsRsRsmmmbRibLcLsmbRsRjbLcLsmbRsRsLsL
sRsmmbRcRsmbRgRsRsRsRsRsRsRsRsRsRsmmmmmmmmmmbLcbLobRsRsmbRgRcRsmbsbRsb
sbRcbsbRobRcb

>ZF Recording 2016-06-02; tW: 300s; Start: 164857; End: 165358;
Recording: 11-1; Individual: 38; Drug: PCAP814 1 然 Apo 50 然
bLsLsmbLsbLgbLsbLsbLjbRsbRsbLsbRsLsbRsbLsbsbRsbRsLsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 164857; End: 165358;
Recording: 11-1; Individual: 39; Drug: PCAP814 1 然 Apo 50 然
bLiLsLsmbLsLsmbLgLsLsLgLsLsLsRsLsLsLsRsmmmmmbRsbLgbLgbLgbLebsbRobRgRsm
bRibLjbRiRhRsmbRsRsmbsbsbRebRibLcbLibLgLsbLibLsLsmbLgbLibLibLibRgbLsLs
mbLsLsLsLsLsmmmmbLsLsmbLsbLsLsLsLsLsLsLsLsLsLsLsmmmmmmmmmmbLsLsLsmmbLs
LsLsLsLsRsmmmmbLsLsLsLsLsLsLsLsLsLgLsmmmmmmmmbLiLgbRsbRcRsmbRgRsmbRsRs
LsRsmbRsRsmbRiRsRsmmbRsbRgbLsRsbRibLgRsRsRsmmbRsRgRsRsRsRsmmmmbRsbRsRs
mbRsRsRsmmbRibsbRsLsbRsbRsRsmbRsRsRsmmbRsbRsRsmbRsbLsRsbLsbLibLiLsbLcb
RgRgbRgbLsLsmbsbLobLcbRgbRobRibRgRsmbRsbRsRsRsmmbRsbRsRsRsmmbRgbRsbRsR
sLsmbRgRsmbRsbRebLsbLebRsLsbLsbLsLibLsLsRsmbLsbLsRsbLsLsLsLsLsLimmmmbL
ibLsLsLsmmbRsLsbLsLsmbLsbLgbLsbLsbLsbLgbLsLsLsLsLsLgLsLsLsmmmmmmbRsbLs
bRcbRebRsLsRsRsLsmbRiRsmbLgbRsbLsbRibRgbRibLibLcbLcbRibLhbsbLiRsbRsbRg
bRsRsRsRgRsmmmbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 164857; End: 165358;
Recording: 11-1; Individual: 40; Drug: PCAP814 1 然 Apo 50 然
bLsbRsLgLsLsmbLsLgbsbsbsbRsbLsLsLgmbLsbLiLsLsmbLsLsLimbLsbLibsbLiRsbLs
LsLsLsmmmbLsLsLgmbLsLgLsbLsbLsLsLimbLibLsRgRgbRiRsmbRiRsmbRgbRsRsmbRsR
smbRgRsmbRsRsmbRcbRoRsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 164857; End: 165358;
Recording: 11-1; Individual: 41; Drug: PCAP814 1 然 Apo 50 然
bLiLsLsmbLiLsLsLsLsmmmbLiLgbLebLibLgLsbRsLsLsLsLsmmmbRsbLsLsLsLsmmmbLs
LsmbLsLsLsLsLsmmmmbLgLsLsRsmbLgbLsbLsLsmbRgLsbLsLsLsLsLsLsmmmmmbLsLsRs
mbRsLgLsLsLsLsLsmmmmbRsbRsLsLsmbLgLsbsbLsLsLsRsLsmmbsbLsLsLsLsLsLsmmmm
mbLsbLsRsLsbLiLsbLgLsbLsbLsLsmbRsLsbLeLebLeLsbsbLeLsbLgbRiLgLsLsLsmmbL
gLsLsLsmmbLsbLeLsLsmbLebLhbLgbLsbLcLsmbLeLsbLiLebLsLsLsLsLsLsLsmmmmmmb
LsLsLsLsmmmbLeLsLsLsLsmmmbLebLibLgLsLsLsmmbLsLsmbRsbLsLsLsmmbLsbLsbLsL
smbRsRsmbLsLsmbLsLsmbLsbLsLsmbLsLsLsLsmmmbsbLeLgLsLsLgLsLsmmbLibLiLsbL
gbLeLsbLiLgLsLsmbLgbLsbLsbLgLsLsmbLsLsmbRsbLgLsRsbLsLsmbLsLsLgmbLsLsLs
mmbLsLsmbLhLsLsmbLgLsLsmbLgLsbLsLsmbRsbsbsbLsLsmbLhbLiLsLsmbLsLsLgLsmb
LgbLeLsbLsLsmbRhLsbRcbRhbRsRsmbLgLsbLsLsmbLgbLgbLsbLsbLgbLsbLsLgbLgRsb
LsbLibsbLiLsLsmbLiLsbLibLsLsLsmmbRebRsbRsbRsbRsbRgRsmbRsRsRsmmbRsRsRsm
mbRsbRsbRsbLsbLsbLgLsbLiLsLsLsmmbLsLsmbLsbLsbRsLsLsmbLsbLsbLgLsbLsLsLs
mmbLsbLgbLiLgbLsLsmbRibLhLsbLsLsLsmmbLsLsLsmmbLsLsLsLsLsmmmmbLsLsmbLsL
smbLsbLsbLebLeLgbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 164857; End: 165358;
Recording: 11-1; Individual: 42; Drug: PCAP814 1 然 Apo 50 然
bRsRsmbRjbLcbLsLsLsRsmmbLgbLgbLgbLsLsmbLsLgbLibLobsbLgbLcbLibLsbLgbLgb
RsRibRcbLiLsbRebRibLibRjbRjbRgbLjbsbLjbRibRibRgbLsbRgbRibLgLsbsbRhRsmb
RjRsRsmmbRsRsmbRibLsbLjLsmbLgbLsbLsbLsbLgRsRsmbLgRsbLibLsbRcbRcbRibRsR
smbRgRsmbRgbRsRsmbRgbsbLjbLibLsbLgbLsLsmbLibLsbLgbLgbLgLsbRgRsmbLibLsb
LgbRsbLgbLsLsmbLgbLibLgbLgLsbLibLsRsbLgbLsLgbLgbLsLsmbLgbLgLsbLsLgLsbL
gbLsRsbLgbLsRsbLiLsbLgbLgRsbLgbLsbRsbsbLgLsLgbLsbLsbLsbLsbLcbLsbLiLsbR
jbRjbRobLcbLibLsRsbLgbLibLgbRsbLibLsbLsbLibLgbLgbLgbLgRsbLgbLsbLsbLgbR
sRsmbsbRsbLsbsbLsLsLsmmbRsbLsbsbRsbsbRsbLsLgLsbLsbLsbLgbLgLsbLsLsmbLsb
LgbLsbLsLsmbLsRsbLgbLsLsmbLsbLsRsbRiRsmbLjLsmbLgbLsbLsLsmbRsLsbLsbLsLs
LsmmbLsbLgbLsLsmbLsLsmbsbLsLsmbRsLsLsmbLsbLgbLgbLgLsbLsLgLsbLgbLgbLgbL
sbLiLsbLsLsmbsbLsbLsbsbLsRsbsbsbLsLsLsmmbLibLcbLoLsmbLibLibLsRsbLgbLeb
LgbLibLibLgbRebLsbRobRobLoLsLgmbLebLhLsbLiLsbLjbRsbRsLsbLgbLibLebLsbLg
LiLsbLebLgbRsbRebRsbRoLsbLsLsmbLgLsbLgLsLgbLgLsLsmbLibLgbLsRsRsmbLgLsb
LgbLsbsbRjbRcbRgbRgbRsRsRsRsmmmbRsRsmbRgbRgRsmbLibRhbLjLsmbRiRsmbsbReR
smbLsRsbLsRsLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 164857; End: 165358;
Recording: 11-1; Individual: 43; Drug: Control Apo 50 然
bsbsbLsLsmbLsbLibLsLsmbLibRgbsbRjbLsbRsbLebLebLibLhbLjLsmbLobRibRibRib
LgbLebLgbLsbLibRibLiLsbLebRsbLibLiLsbLgbLiLeLsbsbsbsbLsLsmbLibLsbLebLs
bLiLebLeRsbLobLoLsmbLcLsmbLsLsLimbsbLibRjbLsbRibRibLsbRibRsRsmbRiRsmbR
sRsLsRgmbRgRibRiRsLsmbRgbRsRsmbRcbLobLibLsbLsbRsbLsbsbLsLsLgmbLsbLsLgb
LgbsbsbLsRsbLsbRsLsbLsbLibLsbsbsbsbsbLsLsLsLsmmmbRsReRsmbLcbLibLsRsLgL
sbLsLgRsbLibsbRsbRsbsbRsLsLsmbLiLsbLobRebLebLcbRibRcbsbRsbRsbRsbRgRgbs
bRsRsRsmmb

>ZF Recording 2016-06-02; tW: 300s; Start: 164857; End: 165358;
Recording: 11-1; Individual: 44; Drug: Control Apo 50 然
bLsbLsLsmbLsbLsbLsbLsbRsbLsbLsbRsRsmbLsbLsbsbLsbLsbLsbLgbRjbLsbRsbRsbL
sbRsbRsbLsbLsbRsbRsbRgbRsbLgbLsbRib

>ZF Recording 2016-06-02; tW: 300s; Start: 164857; End: 165358;
Recording: 11-1; Individual: 45; Drug: Control Apo 50 然
bLsLsmbLgLsLsmbLgLsbLgbLgLsbLsLsmbRsbRjbLiLsLsLgmbLibLibLsLsmbLsLsmbLg
bLsbLcLsmbLsbRsRsmbsbLsLsmbLgLsbLsbLgLsLsmbLsLsmbLgLsLsmbRsbLibLiLgbLh
bLsbLsbRsbRcbLebLibLibLgLsbLgLsbLsbLibLgLibLsbLeLsRsLsbLgLsLgbLiLgLsRs
bRobRcbLsbRcbLibRcbLhbsbLgbRsbLsbLsLsmbLsbLgLsbLsLgLsbRgbRcbRsRsRsmmbR
gbRsbLgbRibRcbRsbRsbRsbLsLsmbLsbLobLebsbLsbRibRgbLsbsbRsbRgbRgbRsbLsLs
mbRsbLibLsLsmbLibLgbLibLsbRgbRiRsmbRibRibLgbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 164857; End: 165358;
Recording: 11-1; Individual: 46; Drug: Control Apo 50 然
bRgRiRsRsmmbRiRsmbRibRsRsRgRsLsRsmmbRsRsRsRsmmmbRgRsRimbRebRebRibRgbRe
RsmbRebReLsbRebRibRiRsmbReRebRsbRebRiRsRsReReRsmmmbRebRsbRebLobRcbRcbs
bsbLiRsbRiRsmbRhbRgRibReRsmbRebRhbRebRgbReRsmbRgRsmbRhRsRsRsmmmbRhbRib
RibRgbRsReLsbRebRebReRsmbRobLebRgbRebRibRsRibRsRsRsRgmmbRsReRsmbRibsbR
iRsReRemb

>ZF Recording 2016-06-02; tW: 300s; Start: 164857; End: 165358;
Recording: 11-1; Individual: 47; Drug: Control Apo 50 然
bRsLsbLsbRcRsLoLsmmbLoRsbRcbRcbsbRgRsmbReRsmbRhbRibLsRibRsbLsRsbLgLsLs
mbLsbLsLibLcbRsbLsRsRsmbRsRhRsRsLsmmbRgRsmbReRsRsLsmmbLsbLsRsbReRsmbRg
RsmbRebLcbLcbRoRsmbLjbReRsmbRebLebLcLsmbRebLibRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 164857; End: 165358;
Recording: 11-1; Individual: 48; Drug: Control Apo 50 然
bRsReRsmbRsRsRsRgRsRsmmmmbReRiRgRsRsReRsmmmbRebRebRgRebRebsbsbRsRsmbRg
bsbRebRebRsLsbRsRsmbsbsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 165359; End: 165900;
Recording: 12-1; Individual: 1; Drug: PCAP814 10 然 Apo 50 然
bLsbLsbsbLsbLsbLsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 165359; End: 165900;
Recording: 12-1; Individual: 2; Drug: PCAP814 10 然 Apo 50 然
bLsbLsbRsbRsLsbLgRsbLgbLsLsmbLsbLsbLsLsmbLsbLsLsmbLsbRebsbLibRjbLsbLsb
RsLsbRebLobRsbLsbLsbLiLsbLsbsbsbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 165359; End: 165900;
Recording: 12-1; Individual: 3; Drug: PCAP814 10 然 Apo 50 然
bLebsbRsLsRsbLebRsLsLsmbLgLsLsmbLsbRsbLgbRsbLsLsmbLsRsLgLgbLgbLsbLgbLs
bLsLsmbLjbLsLsmbRsbsbsbsbsbsbLibLgRsRsmbRsbLsLsLimbLoLsmbLebRsRsRsmmbR
gbLsRsbRsRsmbRgRsmbRsbLsbRsbRsRsRsmmbRcbsbsbsbsbRsbRgbRgbRsbRgRsmbRjbR
cbsbRgbRsLsLgLsbLgLsLsmbLsbLsLsmbLgbLsbsbLgLsLsLsmmbRebRgLsbRsRsmbRgbR
gLsRsbRgbRobLsbLgbLsLsLsmmbLsLsmbRsbLsLsmbLiLsbLgbLsbRsLsLsmbLsbLsLsRs
mbLebRsRsRsRsmmmbRsbLsRsbRsbLebRgbRgbRsRsmbRsRsRsmmbLsbRgbLsRsRsmbRgRs
mbRjLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 165359; End: 165900;
Recording: 12-1; Individual: 4; Drug: PCAP814 10 然 Apo 50 然
bLsLsmbRsLsLsmbLsbsbsbsbLsbsbLgbLiRsbRsbRsbRsbLsbsbLsbRsbRsbLsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 165359; End: 165900;
Recording: 12-1; Individual: 5; Drug: PCAP814 10 然 Apo 50 然
bRsRsmbRgRsRsmmbReRsLsmbRsbRsRsRsRsLsmmmbsbLsLsLsmmbsbsbLsRsbRsbLsLsLs
mmbLsbLsRsbRsbLsbRsRsmbLsLsmbLsLsmbRgbLgbLsLsmbLsLsmbRsRsRembRsRsRsRsR
gLsmmmbRsbLsRsRsRsmmbRsRgLsRsbLsRsRsRsRsRsRsRsRsRsmmmmmmmmbRsbRgbsbLsR
sRsmbRsRsRsRsRsmmmmbRgRsLsRsmbLsLsmbRgRgLsRsbRsRsLsmbRsbRsRsRsLsRsLsmm
bRsRsRsRsRsmmmmbsbRsbsbRsbLsRsRsRsmmbRgbsbRsRgLsbLsbLsRsbsbRsbRsLsRsRs
mbRsbRsRsRsRsLsmmmbRsbRsRsRsmmbRgLsbLobsbsbsbsbRsRsRsmmbsbRsbLsbRsbLsb
RgRsmbsbLsLsRsRsmmbLsbRsbLsRsbRsbRsRsRsLsmmbsbsbRgRsmbRgLgbRibRsRsLsmb
RgRsRsRsmmmbRgRsmbRsRsRsmmbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 165359; End: 165900;
Recording: 12-1; Individual: 6; Drug: PCAP814 10 然 Apo 50 然
bLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 165359; End: 165900;
Recording: 12-1; Individual: 7; Drug: PCAP814 3 然 Apo 50 然
bsbRgRsmbRgbRibRcLsbRhbLibLibLibLgbsbLoRsbsbRsbLgbLcbLiLibRsLsLsmbRibR
gRsmbRgRsmbRgReRsmbRgbLsbRcRsRimbLhbRcbRiLsbRgbRiRgbRiRsmbRiLibLjbLibL
gbRsbLibRjbRsLsRsbLsRsbLgbLibRibLsbsbsbsbsbRsbLsLcbLcLsmbLcLsRsmbLcbLc
LgLsLsmbLibLgbLsLibLoRsLsRsbLsbRibRibLsLobRibLiLsbLsbLcbLobLsRsbRiRsmb
RgRgRibRiRsmbRiLsRsRsLsmbRibLsRsbRgbRsLsbRgbRgbRgRsmbRgbRgbRgbRoRsmbLs
bsbRibRsLcbLcbLhRsbRsbRhbsbRiRsmbRgbRgbRsRcLsbsbRcbsbRcRsmbRhbRiRgbRsb
RsbsbRibRsRsmbRgbLjbLibLobLhbLgbLobLgLsbRgbLcbRsRjbsbsbLgbRcRsmbRibRib
RcbRcbRgbRiRsmbLsbRiRsmbsbRsbRgRsmbRsRsRsmmbRgbRobLibRobRhbRhbRsbRibRg
LsbLgbLoLsmbLobLcbLhRsbLiLcLsmbLiLgbLiLsRsbLoLgbLcLsmbRjbRsRsRsmmbRgRi
bRgbLsLsmbLgLsRsbRsRsmbReRsmbRibLibLsLobsbLsbLiLsbLibLobRobRcbRsLsbRib
RiLibLhbRobRiRiLsRcbRibRhRsRcmbLgLiRsRibLeLebLebLeLsbLeLsLhbLiRsbLibLi
bLsbRhbRcbRibRiLsbLibLoRsbLhbLibLibLcbLebLiRebRiRsmbRgbRgbRjbRgbRibLib
LoLsRsmbRgbLjbLsbRsbRiRsmbLjbLoRsbLibRcbRiRsmbRcbRcbRcbLcbLhbLgbLcbLcb
LibRjbsbRjLsLsmbsbLobLiLsbLiLsbRgbLiLsLsmbRjbLobLcRsbLhbLeLsbRsbsbsbLs
RsRjbLibRcbRiRsmbLsbRobLcbLcLsmbLcbRgbRiRsmbRibsbRiRsRhLsmbRoLsbRibRhb
RgRsRgReRembRgLgbLeLcLcbLjbRcbLibLgbLiLsbLoLsmbLcRsbLibLhRsbLiLebLsRsb
RoLsbRibRgRsmbRgbRgRsmbRsRsRsmmbRsbRgbLjbLsLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 165359; End: 165900;
Recording: 12-1; Individual: 8; Drug: PCAP814 3 然 Apo 50 然
bRgbRgbRgRsmbRsRsmbRgbRsbRgRsLsmbRgRsmbLsbRgbRgbRgRsRiRsmmbRgRsmbRgbRs
RsmbRgRsmbRgbRgRsmbRgRsRsmmbRgbLjbLcLsmbLcLsLombLcbLobLibsbLsbsbsbsbsb
sbRcbRoLsLsmbLoLsmbLhLsbLcbRgRsLoRsmbLsbLoLsLsRsmmbRgbLibLoRsbRgbRiRsm
bRgbRiRsmbRhRiRibRibRiRsmbRhbRibRiRsRgmbRgRsRimbRebRsbRibRgbRgRsRgmbRe
RsRsRiRsmmmbReRibRgbRiRsRhmbRebRebRibRgRsmbRsbRgbLsbRgRsmbRsLjbLobRoRs
mbRcbLoLsmbRgbLsbLibLsbLhbLibLgbRcbRgbRcLsbRcRiRsmbRsRebRgbRgbRebRcbRg
bRgbRhbRibRgRsmbRsbRgbRiRsmbRiRsRgmbRibLibLcLsmbLoLsLsmmbLhRsbLcbLoLsm
bLcRsbLhbLgbLcbLgbLcbsbLibLsbLobLebLcbLcReLsbRhbLibLhLcbLiLsbLhLsbLibR
ibRsbsbsbsbLsbsbRgRsmbLsbRsbRiLsLsmbLsRsbLcbLcbRebLobRsbLgbLiRsRsLsRsm
bLcbLcbLeLsbLhRsRsmbLcLsRsLcRsmbLibLobLoLhLcLsRsmbLiRsbsbLiLsbLsLsmbLg
bLsbLgbLsLsRsmbLsbLsbLibRsbLsLsRsmbLsbLgLsbRsbLsbsbLibRcbRibRobLcbLcLs
mbRgbLibLsbLsRsbLgLsLsmbLgbRob

>ZF Recording 2016-06-02; tW: 300s; Start: 165359; End: 165900;
Recording: 12-1; Individual: 9; Drug: PCAP814 3 然 Apo 50 然
bLgLsbsbRsbLsLsmbLsLsmbLibLiLsLsmbRcRsmbRcbRibRcbRebRcRsmbLcLoLsmbLibs
bLibLcLsmbLsbLgbLsbLibsbLgLsbLgLsLsmbLsbLsLsmbLsRsbLgLsLsmbLgbsbLobLcL
cLsmbLhLsLsLsmmbLcLsmbsbLobRibRibRebRhLsbRibLeRsbLsbRebLsbLsbRsbRgbReb
RibRebRebRobRebsbRgbRgbRibRgRsLsmbRiRsmbLgbLcbRcbRibLgbLcbLobLsRsbLsbL
sbLhbLsLsmbLebLgbLcbRcbRcRsmbRhLsLsmbLeLsbLibRcRsmbRgbRibRoLsbRibRobRh
LsbLgbLcbLobLobLibLeLsbLgbRsbRebLsbRoRsmbLeLsbRgLsbRsbRsbRsbsbsbLsbLsb
LsLsLsmmbLsbLebRsLsbLgbLiLsLsmbLcbRoRsmbRcRsmbRibRebRsRsLsmbLcbLcbLcLs
mbLsLsmbLibLsRsbLsbLgLsbLgLsbLibRsbLsLsmbLgLsbLgbLsbLsbLsbLsLsmbLgbLsb
LsLsLsmmbLsLsmbLiLsbsbLsLsLsmmbLsLsmbLsLsmbRsbLgLsbLsbLebRsbLibLsbLsbL
gLsbLsbLiLsbsbLsbLsbLgbLgbLsbLsLsLsmmbLibLsbLsbLsLsmbLiLsbLsbsbLsbsbLs
LsLsmmbRsLsbLsLsmbLsbLsLsLsmmbLsLsLsmmbLibLsLsmbLsbLsbLsbLsLsRsLsLsRsm
mbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 165359; End: 165900;
Recording: 12-1; Individual: 10; Drug: PCAP814 3 然 Apo 50 然
bLsLsmbLsbLsbLsbRsbLsbLsbsbRsbLsRsbLsRsbLsbLsbLsLsRsmbLsbLsbLsbLsbLsLs
mbsbLsbRsLsbLsLsmbRsbLsbsbLsbsbLsbLsRsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 165359; End: 165900;
Recording: 12-1; Individual: 11; Drug: PCAP814 3 然 Apo 50 然
bRcbsbLsRsbsbLsbsbRsbLsLsmbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 165359; End: 165900;
Recording: 12-1; Individual: 12; Drug: PCAP814 3 然 Apo 50 然
bLsLsLsLgLsLsmmmbLgLibLgLibLhLsbRgRsmbRgbRibRgbRiLsbLcbLeLsbLibLiLsLsm
bRgRsLsmbLiLsbRgbLsLiLsbLgbLsbLsLsLsmmbLeRebLcLsLsLgLimmbLsLsLsLsLsLsL
sLsmmmmmmmbLsLsLsLsmmmbLgLsbReRsmbRcbLeLsLgLsLsLiLsmbLgbLiLsbLeRsRsRsL
smmbRsRcRsmbsbRsLsbLgLsbReRsmbRsRsRsmmbRsbRsLcLsmbLsLsLembLsLsLsLgmmbL
hLsbLebRgbRsbLhLsLiLgbLsbLiLsLsLsLgLsmmbsbLcbRgRsmbLcLgLsbRiRsRsRsmmmb
RcLsbLjbLebLiLsbRgbLhLsbLiLsbLiLsbLsbLsbLsbRibRibRhLsLeLsLsLsmmbLeLsbR
hbRcLsbLhLsbsbReRsmbLsbRsbLeLibLsLsmbLgbLgLsLsLembLibLsbRgRsmbRjbRebRc
bLiLeLsLsmbLgLsLsmbLsRsbLebRjbLibLgLsLsLsLsLsmmmmbLgLsbLsLsLsLsLsmmmmb
LibRjbsbRhbLjLjbRhbLsbLebLeLsbLcbLsLsmbRhRsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 165359; End: 165900;
Recording: 12-1; Individual: 13; Drug: PCAP814 1 然 Apo 50 然
bRsbRjbLsbRsbRsbLsLsmbLsbRebRsbRsbLsRsbRsRsmbLsRsbLsRsbRsLsbLsLsmbRsRs
mbRsLsbsbRsbRsbRsbRsbLsbRsbRsbLsbRsbLsRsbLsLsmbLsbLsRsLsbLsLsLsmmbsbRs
bLsbRsbLjbRobLob

>ZF Recording 2016-06-02; tW: 300s; Start: 165359; End: 165900;
Recording: 12-1; Individual: 14; Drug: PCAP814 1 然 Apo 50 然
bRsbRsRgbRsLsRsLsRsbLjbLcbLgbLibLsbLibLcbRsbLgbLhbLhbRcbLjbLobRibRjRcb
LsLgbLjbLebLebRgbRsRsmbRsRsmbRsRsmbRsbRgbRsbRhbRiRsmbRgbLibLsbLgbsbRsb
sbsbRgbRibRcLsbRsbRcbsbLibLcbLibRgbRgRsmbRgbRgbLgbLsbRcbLsbRibReRsmbRg
bRgbRibRgbRgbRcbRcbRsbRcRsmbRibRcbsbRgRsmbLiRsbRgRsmbRhbRsbRgRsmbRibRi
bLibLgbRcbLsRsbRsRobRcbRsbLobLsbLibLgbRgRsmbRsbRsRsRsRsRsmmmmbRsbRsRsm
bLcbLcbLsbLibLcLsLsmmbLsbRcbRoRsmbLiLsbLibRhbLibRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 165359; End: 165900;
Recording: 12-1; Individual: 15; Drug: PCAP814 1 然 Apo 50 然
bRsRsmbRsbRcbsbRsbLebRsRsmbLcbLgRsbRsbRsbLsbLsbLsbLebLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 165359; End: 165900;
Recording: 12-1; Individual: 16; Drug: PCAP814 1 然 Apo 50 然
bsbLiLsbLhbLhRsbLhLcbLibLcbRsbRjbLcbLhbLiLsbLhbLhbLcbLcbLebRibRibLiLsb
RgbLcbLcLsmbRsLsbLsLsmbLsLibRiRsmbLebLgbLibLeLsbLsbLcbLhbLiLsbRibRcbRc
bRgbRobRibLcbLcLsmbRsbsbLoLsmbLibRsbLobLcbRjRsmbRcRsmbRgbRobRgbRhLsbRi
bRoLsbRibLcLsmbLcbLibLoLsmbLsbLobLsbLibRjbLoLsLsmmbRiLsbRcRsmbRhbRgLsL
smbLhbLibLeLsbLobLibLcbRsbLcbRhbLcLsmbLsbRobsbRebRgRsmbRhbRobRsLsbRibR
obRgbRgRsmbRcLsbRjRgbRgbRhbLsbLiLsbLcbRgbLibLcbRgbLibLcRsLsbLcbLcbRgbR
sbRhbRgbLiLsbLhRsbLcbLgbRjbRsRcbRiLsbRcbRsLsbRoRsRsRsmmmbRgbRcbRibRcbR
gbRibLsRsbRhbRgRcbRgbRibLsbRcLsbRibRgLsbLibRobRibRgbRcbLgbRobRgbRhbRgb
RibRjRibRgbRcLsbLobLhbLgbLcbLgbLobLhbLibLobLsLsmbLobLobRsbRibLeLsbLgbL
cLsmbRibRibLhLsbLgbLgbLhLsbLibLhbLibLhbLgbRsbRgbLgbLibLhbLsLibLibLobLo
LsmbLcbLibLibRsLsbLjLhbRgbLsbLebLibRsbLibRsbLcbRcbRcLsbRibRobRgbRjbLjb
LcbLhbRjLsRcLsbRibRcbRgbRsbLcRsbLgbLsbLibLcbLiLsbLibRhbRobRgbRcbRobRiR
smbLhbLibLeLsbLgLsbLeLsbLcbLhbLsLhbRsbLcbLibLgbLobRsRibRjRgRsmbLibLiLs
bLibLgbRcRobRgRsRsmmbRoLsbLgbLibLcbRjRsmbRoRsmbLobRhRsmbReRsmbRgbRoRsm
bRgbRibLibLcbsbLsbLcbLibLibLibRoRsmbRibRcbRsLsLsmbRsRgRsmbRiLsbRgbLjbL
obLsbRobRiRsmbRcbRsbLobLcLsmbLibLibLcbLgbLhbLsbLibLibLhLgLsbLcLsmbLcLs
mbLcbLibLgbLcbLiLsbRsbLeLsbLcbLibLhbRsbRgbLcbLgbLobRsRsmbLcLibLsbLcLsm
bLobLsbRhbRiRsmbRibRcbRcbLsbRibLsLcb

>ZF Recording 2016-06-02; tW: 300s; Start: 165359; End: 165900;
Recording: 12-1; Individual: 17; Drug: PCAP814 1 然 Apo 50 然
bRobLsRsbRoRsmbLcbLibLgbLsbLibLsbLsLsmbLoLsmbLcbLhbLibLibLgbLgbLgbLibL
ebLgLsbRsRhbLhbLgbLgLsbLgbLsLsmbLgbLgbLsbLibRcbRibLsLcLsmbRebLcbLibLgL
sbRibLsbLgbLgbLebLibLibLibRibRibRibLjbLibRobLcbRsRsmbRcbRoLsLsmbLsLsmb
RsbRgbRiLsbRsLsbLjbLobLgLsbLjbLsbRobLsbRsbRsbRobRjbRjRsRsmmbRcRsLsmbLs
bRjbRoLsbRhbRsRsmbLsbRgbLsbRcbRiRsmbRhLsbLgbLoLsmbRsLsbRgbRsRgbRsLsbLc
bRobRgbRiLsbLsbRoLsLsmbLcLsmbLibLgbRsbRobLobRcbRobRibLsbLgbLiRsbLiLsbR
sRsLgLsLeLeLiLsmbLhRsbLoLsmbRsLibLibLcbRsbLsbLebLeLgbLgbLiRsLsbLibLcbR
ibRiLsbRibRibLjbLcbRsbRsbRiLsbRgbLjbRobsbRsbRsbsbLibsbRobLibLobRsbRgbL
hLsbRobRgbLsbRsbRiRsmbRsLsbRsbsbsbRiLsbLcLsmbLiRsbLhbLgbLsRsbLgbRsbsbs
bRsbLibLibLsbLcLsmbLibLibLibLibLsLsLsmmbLgbLsLsmbLgbLgRsbLsbsbRsbRhbLs
bRsbLcbLibLibsbLobLobLgLsLsmbLgRsbLgLsbLsbLsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 165359; End: 165900;
Recording: 12-1; Individual: 18; Drug: PCAP814 1 然 Apo 50 然
bLgbLiLsLsLsmmbRgbRibRibRibLcbLsbLibLibRgRsRsmmbRgbLcLsmbLsbLsbRsbLgLg
LsLgbLsLsLsLsLsLsLsmmmmmmbLgbLgLsbLgLsLsmbLibLgbLsbRibRsLsbRsbRsRsRsmm
bRibLhLsbLsLsmbLgLsLsmbLgbLsLsmbLsLsLsLsLsLgLsmmmmbRsRsLsmbLsLsmbsbLgb
LgLsbLgbLhLsbRiLsbsbRgbLeLsbLibsbLsLsmbLibLcLsmbLhbLgLsbRibRsbRsRsmbRs
bRsRsmbLsbLsRjRsmbRgRsmbRsLsbRsbLeLsbLsbLhLsbRsLsbRgbLsbLjLsRsmbLibLsL
smbLsLsmbLgLgLsbLibLgLsbLgbRsbLcbsbRibLiLsbRgbLsLsmbRsLsRsbRiLsbLsbLib
LiLsbLibLcbLsbRiLsbLjbLibLibLsLsLsmmbLgLsbRgbLsLsLsLsmmmbLsLsLsLsLsRsm
mmmbLsbLsLsLsmmbLgbLsbLsLsLsLsmmmbLgbLhbRibRsbLhbLeLsLsLsmmbsbRgbRibLg
bLsLsLsmmbRsbLsLsLsLsmmmbLsbLsLsmbsbLsbRsLgbLsLsLsmmbsbLibLgLsbLhLsbRi
LsbLsLeLsbRgbRibsbLsbLsbLiLsLsLsmmbRibLsbLsbLsbLsbRsbsbLsLsmbLgLsbRsLs
bRsLsbLsLsmbLsLsLsLgLsLimmbLibLibRibRgbLgbRsLsbLsLgLsbRsLsLgLsRsbRgbsb
LgbLsLsLsmmbLgbLgbLsLsRsmbLsLgbRsLsbLhbRiLsbRgLsbsbLebsbLgLsbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 165359; End: 165900;
Recording: 12-1; Individual: 19; Drug: Control Apo 50 然
bLsLsmbRsbRsLsRiRsRgRsmmbLibsbsbLsRsbRgRsRgRsRgRsRsRsRgmmmmmbRsRsmbRsb
sbRsbRsRibLsRsRsmbRsRsmbRsbRgRsRsmmbRsRsRsmmbRgRsRsRsmmmbLobLsbLibLsLs
mbLsbLsbsbLgbLgLsbsbsbLgbLsLsLsLsRsLsLgmmmbLsbLsbLsbsbsbsbsbLsRsbsbsbL
sbsbsbRsbsbLsLsLsLsmmmbLsLsLiLgmbRsbRsbRsbRsbRsbsbRsbLgbLsbsbLsbLsbsbL
sbsbsbLsbsbRsbLsLsLsmmbLgLgLsLsmbLgLsbLiLsbRsbRsbLsRsbLsbLgbLsbsbsbRsR
smbRsbLsbsbRiRiReRsmbsbLcbLsbRsbLoRsbRsbRebRhbLsbLcLsmbLgLsLsmbLibLgLg
LsLsmbLsLsLsLsmmmbLibRjbRibRebRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 165359; End: 165900;
Recording: 12-1; Individual: 20; Drug: Control Apo 50 然
bRibRebLibRgLsbLsbLgbLibRgLsbRibLgbLibLgbLgbLgbRgbLgbLgbRcbLcbLgbRhbRg
bLibLibRibLgbLibRgbLgbLgbLgbLgbLsbLibRgLsbRjbRsbLhLsbRgbLibRsLibLsbLgb
LgbLcbRgbLsbLgbRsbRgLsbLcbRsbRjbLibLiRsbLgbLgbLsbLgbLgbLebRsLsbLsbRsLs
bRcbRibRjbRsbRibLcbRsbRgbsbsbRhbRhbLcbRgbLsbLibLibRsbRjbLibLiLsbLibLsb
LsLjbRsbRjbLgbLjbRcbLcbRhbLgbLsLsmbLgbLgbLgbLsRsbLgbLgbLgbLsLsmbLgbLgb
LgbLgbRsbLgbLgbLjbLibLgbLgbLsbLgRsbLsbLsbLibRgLsbLgbLgbLgbLsbLgLsbLgbL
sLsmbLsbRsbRjbRibLsbRsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 165359; End: 165900;
Recording: 12-1; Individual: 21; Drug: Control Apo 50 然
bRebLiLsbLibLebLsLsLsLsmmmbLgRsbLcbRsbLsLeLgbLiLsbLsLgbRobLcbRgbRgbRsb
RobRoLsbLgRsbLgRsbLibLgLsRsbLgbRobRsbRiRsmbRgRhbLsbRobLsbLsbLsbLhbLsbL
ibLebRsbsbLibLsbLgbLiLsbLsbLsLsLsmmbLebsb

>ZF Recording 2016-06-02; tW: 300s; Start: 165359; End: 165900;
Recording: 12-1; Individual: 22; Drug: Control Apo 50 然
bLgbsbRebLcLsLsmmbRsbsbLsbsbRsRsmbLgbLsbLsbLsbsbLsRsbRsbsbLsbRsbLsbsbs
bsbRsbLsRsLsbRsbLsbRsbRsRsmbsbRsbRsbRsbLsbRsLsbLsbRsbLsLsmbRsLsbLsbsbL
sbLsbRsRsLjmbRsbsbRsLjbsbsbRsbLsbLsbsbRsLsbLsRsbsbRjbLsbsbRsLsbsbLsbRs
RsmbLsRsbRsLsbsbsbLsbLsRsbsbsbRsbRsbRsbRjLsbLsbRjbLsLsmbRsbsbLsbsbsbLs
LsmbRsRsmbRsbLsbsbLsbsbRsLsbsbsbLsbLsbLsbLsbsbRsLsbLsRsbLsbLsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 165359; End: 165900;
Recording: 12-1; Individual: 23; Drug: Control Apo 50 然
bLsbRsbRsbLgLsbRsbRjbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 165359; End: 165900;
Recording: 12-1; Individual: 24; Drug: Control Apo 50 然
bLgbLsbLjbRgbLsbRiRsmbRebLibLjRsbLjbRibLjbLgbLiLsbLgbLibRibLgbsbLsbLgL
sbLsbLjbRsbRsbRibsbsbLsbRsbLjbLjbLobLjRsbLibLgbLjbLhbLgRsbRsRsmbRgbRsb
LsbRjbRgbRgbsbsbRsbLjbLsbRgbLsbLjRsRgRsmbRjbRjLsbLgbRjbRsbLsbLjbLsbRsb
RsbLcbLibLgLsbLgbLibLibLjbLsbRgbLgbLobLibLsRsbLjbLsbsbRjbReRgbLibLjbLi
bLibRsRjbLgbLjbRjbLgbRsbLjLsRsmbRsbRebLibLibLgbLibLibLibLhLsbLgbLjbLgb
sbLgbLjbLibRjRsmbRibLjbLjRsRsmbLgbRgbReRsmbRgRsmbRgbRibRibRibRiRsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 165359; End: 165900;
Recording: 12-1; Individual: 25; Drug: PCAP814 10 然 Apo 50 然
bRsbRsbRsRsLsRsmbRsbLsbRsbRsLsRsbLsbsbRsRsmbLsbRsbRsbLsbRsbReLjbLsRsRi
bRsbLjbRsbRsbRsbRsLsbRsbLsRsbRibRsbRsbRsbLjbLsbLgbRgbLibLsLsmbLgRsbLgL
sbLsbsbsbRsbRsbLsbsbLsbLsbRsbsbLsbLsbLsbRsbRsbLsLsmbLsbLsbLsbLsLsmbLsL
smbRsbLjLsmbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 165359; End: 165900;
Recording: 12-1; Individual: 26; Drug: PCAP814 10 然 Apo 50 然
bRgbRsbsbRsLsRsbRcRsmbLsbsbRsbLjbRsbLgLsbLsLsmbLsbsbLsLsLsmmbLsbLgbLsb
LsbLsbLsLsLsmmbsbLsRsbLsbLsRsbLsRsLsbLsLsmbLgbLsbLsLsmbLsbLsbLsLsRsmbs
bsbLsbLgbLsLsLsLsmmmbLsLeLgbLsbRsbsbRsLsbLsLgbRgRsRsmmbLsRsbRcRsmbsbsb
RsLsRsbsbRsRsmbRobRhbRsRsmbLgRsbRsbRsbsbLsLgLsbsbLsLsmbLsLsLsLsmmmbLsL
smbLsLsLsLsLsmmmmbLsbsbLsbLsLsmbLsLsLsmmbLsLsLsmmbsbsbLgbLsbLsbLgbLhbR
ebLsbRsbLsLsmbsbRsbLsbRhRsRsmmbsbLsRsbRgbLgbLsbLsRsbLsbRgbRsbRgRsmbRsR
sRsmmbLeb

>ZF Recording 2016-06-02; tW: 300s; Start: 165359; End: 165900;
Recording: 12-1; Individual: 27; Drug: PCAP814 10 然 Apo 50 然
bLsbsbRsRsmbLsbRgbLsbLsRsbRsLsLsmbLsbLsbLsbRgbRsbLsRsRsRsmmbRsbRsLsRsb
RsbLsbRsbRsLsbRsRsmbsbsbsbRsbLsLsLsmmbLsbRsRsRsLsmmbLjbRsbRgbRjbsbsbRs
LsbLsbRsRsmbRsbsbRsRsmbsbLgbRsbLsbLsbsbRsbsbsbsbsbLsRsbLsbLjbsbsbsbsbs
bsbsbsbRsbLsbRsRsmbRsLsbLsbRsRsmbRsbRgbRsbLebLsbRsLsbRsbLsbLsbLsbLsRsb
RsbLsbRsbRsRsmbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 165359; End: 165900;
Recording: 12-1; Individual: 28; Drug: PCAP814 10 然 Apo 50 然
bLgRsRsmbLsbLsbRsbRsRsRsRsmmmbRjLsbsbLsbRsbLsRsbLsbRjbLobRsbRsbLsbRobR
gbLsbRsbRsbRsRsmbRsbsbRsbsbRsbRsbRsRsLsmbsbRsRsmbRsbRsRsmbRjRsmbLsRsbR
sbRsbRsbRgLsRsRsmbRsbRsRsRsmmbLsbsbRsbsbRgbRsbLsRsbsbRjbLebLsbRiRgbLsb
RsbLsbRsbRsbsbRsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 165359; End: 165900;
Recording: 12-1; Individual: 29; Drug: PCAP814 10 然 Apo 50 然
bsbRibRgRiRsLgmbRgbRsbRsbRsRsmbRsbRgbLsbRgbRsLhbRsbLsLsRsmbLebRsbRgRgR
sLsmbLhbRsRsmbRsbRsRsmbRiRsmbRgbRsbRsbLsbLebLebRiLsbRebLibRsbsbRsRsRgm
bRsbRsRsRsRsLimmmbRiRsmbLsbRsRgbRobLsRsbLsLsmbLgLsbRgLeLsRibLsbLebLsLs
mbLsbRebLgbLiLsbRcbRgbsbRibLgbRsRgbRgbsbRsRebRebRsRgRsmbRsRsmbReRsLsmb
RsbRsbRsRsRgmbRebsbLgLsbLgbLebLsbLibRsbLgLoRsbRsbRsbRsRsmbRsRsmbLsbLsb
RibRsRsmbRiLcbLsbLsbLiLsLsmbRobRsbRebLsLsmbLsLsmbLgLiLiLgbLeRsRsmbLgbs
bsbLsbLsLsmbsbsbLsRsbLsRsbLebLgbRgbRiRsRsmmbRgRsmbRsbRsRsmbRgbRsbLgbRi
bRebLsbsbRsRsRsmmbRsRsmbRiRgbLebRebRsRsRsmmbRsLsRsbRsRsRgRsmmbLsRobRcL
sLsRsmbRsbRsbRsbRsRsmbRgbLsRebLgRsbRsRsRsRgRsmmmbLiLsRsbLeRsbRsRebLsbL
sLsmbRsbsbRgbLsbLsLsmbsbLgRsbLebLebsbRjbLiLsRsLsbRgLsbLgLjbLsbLsLgLsbL
cRsbsbRgbLgbLsLebLebLsRsLsLgRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 165359; End: 165900;
Recording: 12-1; Individual: 30; Drug: PCAP814 10 然 Apo 50 然
bRsbLsbLsbRsbsbRsbLebLebLgRsbsbsbRjbLsRebLcbLjLsmbsbLsbRsbLsbsbLsLsmbL
sbRsbsbLsbLsbRsLsLsmbsbsbLobRgbRsbRgLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 165359; End: 165900;
Recording: 12-1; Individual: 31; Drug: PCAP814 3 然 Apo 50 然
bRsbRgbRhRsmbLibLsbRsbLhbRsRsmbRibRobLsbRibsbLsbRgbRgbRgbRibRsbRibRgbR
ibRsbRgbRgbRibRsbRsbRibRibRsbRsbLjLhbLcbLgbRsbLgbLcbRgbRibRiRsmbLcbLib
RjbLhRsbLibsbLiRsbLibRibRibRobRgbLsbRgRsmbRibLcbLhbLsbLoRsbRiLsbRibRgb
RsRobRsbLibRsbsbRobRiRsmbRibLgbRibRsbLsLsmbRgbRsbRsRsmbRsRsRsRsmmmbRsb
RgbLsLsmbRsRiLsbRcbRgbLhbRhbRcbRsbLcbLsbLiLsbRsLsbRibRgbLsbRibLiRsbReb
RgbLhbLibRsRsmbRcbLcLsmbLgbLiLsbRgbLhRsbLibLjbsbsbLibRsbRibRgbRibRibRg
bRcbRgbLsbRsRsmbReRsmbLgbRiRsmbRhbRgbRibRibLsbLhbRibRibRsRsmbLgbRibLgb
RibRibRibsbLsbRsbRsbRibsbRgRsmbRhbLibRebRgbRhbRgbRibRibLibRjbRgRsmbRib
RsRsmbLibLsbRobLsRsbRgbRgRsmbRhbLgbRibRobLibRibRgbRibRgbRgbsbRsRsmbRib
RgbRibRsLsbLhbRgbRgbRgbRgbLobLcbRjRsmbLcLsmbLcbLsbsbLsbLsbLiLsbRgbLebL
ibRgbRsbLsbLsbsbLeLsbRsbLcbRgbRibLibRsRgbRibRhbRcLsbLsLibRibRsbRgbRsRg
bLsbLgbLibLcbLiLsbLibRgbRcbRhbRgbRsbLsbRibLsbRobRobRsbRcRsmbRiRsmbLgbL
sLcLsmbLcbLiLsbRjbRcbRibRgbRgbRgRsmbLjbRcbRgbRsRsmbRgRsmbRibRgbRjbRibL
ebLobLhLsRsLsbRsbLobRjRgbRgbRibLcbLsbLebLibRsbRibRsbRibRibRgbRibRibRsb
RobRcbLgbRhbRibLsbLsbRibRgbRibRsRsmbRgbLsbLsbsbRibRibRgRsmbRgbRsbRgbRi
RsmbRsbLobLsLsLsLsmmmbLoLsmbLsbLcbRsbRsbRibRobRsRsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 165359; End: 165900;
Recording: 12-1; Individual: 32; Drug: PCAP814 3 然 Apo 50 然
bRgbLibLsLsRsmbLgLsLsmbLgLsbLibLsbLgbRsbLgbRjbLibLgRsRsmbRcbLhbRjbLsbL
ibRjRsmbsbLibLgRsbLgLsbsbRsLsbLgbLgbLgRsbRsRsRsmmbLgLsbLsLsmbLsbLsLsmb
RsbLibRgbRiRsmbLsbLsLibLgLsLsLgmbRcbLsbLgLsbLsLsmbRcbLsbLjbLgbRjbLhbRj
bRsbRibLgRsbLsbRjRsRsRsmmmbLjbsbLhbLcLsmbRgRsRsmmbLsbRsbLsLsmbRjbLhbRh
RsmbLsbLjbLjbRjbRgbLhbRjbRsbsbLcbRjbRibRibLjbLgLsLsmbRsRgbRibRibLsbRib
sbLjbRgbLhbRebLgbLsLsmbRsbLgLsbLsbRiRsmbLebLhbRsbRgbLgbLgLsbLgLsLsmbLs
bLibRebRhbLgbsbLib

>ZF Recording 2016-06-02; tW: 300s; Start: 165359; End: 165900;
Recording: 12-1; Individual: 33; Drug: PCAP814 3 然 Apo 50 然
bLsbLsbRsbsbRibsbsbRsbRsbRebRsbRgbRibRebRsbsbLjbRsbRsbsbLsbRsRsRsLsLsR
sLsmmmbLsbRsbsbRibLibRebLgLsbLobRobRsbsbRsbsbRsbLjbLsbsbsbsbsbRsbLsRsb
LsRsbsbsbRebRebLibRsRgbRhbLsLsRsmbRsbLgbRsRsmbsbsbsbRsLsLsmbsbRsbRsbRs
bsbsbRsRsmbRsbsbLsbLsbLsbLsbsbLsbsbsbsbLsRsLsbLsbLsbLsbRsbLsbsbsbsbLsb
RsLsbRsbRsbLsbLsLsmbLsbLsRsbRsbReRgbRsbRsLsLgbLsbRsbRibRsbRsLsbRsbRsbs
bLsbLsbRsbRgRsmbRsbsbsbsbsbsbsbsbsbsbsbLsbRsbRsbRsLsRsbRsLsbLsbLsbLjbL
sbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 165359; End: 165900;
Recording: 12-1; Individual: 34; Drug: PCAP814 3 然 Apo 50 然
bLgRsbLgLsbLoLsLsmmbRebRhRsmbLhbLibRhbRibRhbRoLsLsmbLgLsbLcbLgbRsbLsbL
sbLgLsbLsbLgbLsbLsbLsLsmbLgbLsbLhLsbRibLobLobRsbRjbRibRobRsbRhbRgbRiLs
bLsbsbRsbRsbLcbRsbsbRsbsbsbRsbRibRsbLoLsmbRcbLobLcbLobRibRcRsmbRsbLibL
iLsbLibLsLsmbRobRebLsbRjbRibRgRsmbRobLebLibLgbLsLsmbLgbLiLsbLgbLgLsbRi
RsmbRibRjbLsRsbRibRgbRsbLgbLgbLgbLgbLgLsLsmbLgbLoLsmbLhbRcbLsbRgbRhbLs
bRhRsmbRgbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 165359; End: 165900;
Recording: 12-1; Individual: 35; Drug: PCAP814 3 然 Apo 50 然
bsbsbLibLibLsbLsLsLsRsmmbLoLsmbsbRsRibLgbLobRibsbsbLgbLsLsmbLiLsLsmbRs
bLobRsbRgbLsLsLsmmbRiRsmbRibLsbRsbRsbRsRsmbRsRsmbRsRsRsmmbRsbRsbLsbsbR
gbRsbRgbsbRsbRsbRsRsmbRsbLjLsmbRcbRgbRgRsmbRjRsmbLsbLibRsLsbLsbRsRsLsm
bLgbLsbLibLsLsmbLsLsmbsbLibLgbRjbRcbRsLsbRobsbLsLsmbLsbLsbLibLgbsbsbLs
LsLsmmbLsLgbLsLsmbLgLsbLibRsbRiRsmbRgbRibLibLgbsbLsLsmbLgbsbRsbsbsbLhb
LobLsbLsbRsbLcbRibRcbLsbLibLsLsmbLsLsmbLsRsbLsbLsLsmbsbLibLgbRhbLsLhLs
bsbRsbLsLsmbLsbLgbRsbLiLsbLsRsbRibLjbLiLsbLsLsLsmmbLsbLgbLhbLsbRsRsLsm
bRibLgRsbLsbLibLgbLgLsbRsbLsLsmbLsLsmbRsbLgbLsbLsLsLsmmbLsRsbRsbLcbRgR
smbLgbLsLsmbsbLsbsbLsLsmbLsLsmbLsRsbRsbLiLsbLgbLsbLsLsLsmmbLsLsmbRsbLi
LsbRsRgbLsbLcbRsbLgbLsRsbLsbLgLsbLsLsmbLsLsmbRsRsmbLgLsbLsbRsbLjRgLsbR
sbLoLsmbLibRgbRsbLsbLsbLsbLibLcLsmbLgbLgbLiLsLibLgbLobLcLsmbRibRgRsmbR
sbRobRibLhLsbLgLsbLsRsRsmbLgLsRsbRsbRsbLsbLgRsbRgRsmbRsbLsLsmbRsLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 165359; End: 165900;
Recording: 12-1; Individual: 36; Drug: PCAP814 3 然 Apo 50 然
bRibRsRsmbRgRgbLsbLibRsRiRsmbLsLsmbRsbRsRsmbRgRsRsRsRsRgRsRsRsmmmmmmmb
RsbRsbRsRsRsmmbRsbRsRsRsmmbRsbRsbRsRsmbRebLibLiLsbLiRsbLhbLibRgRsmbRcR
smbReRsmbLgbRsRsmbRsRsmbRiRsRsmmbRgRgRsmbRgbRgRsRsmmbRgRsmbRsbRsbRsbsb
RsbRsRsmbLsbRsbRibRsbRsRsmbRsRsmbRgRsmbRsbRsbRsbRgRgbRsRsmbRsRsmbRsRsR
smmbRgRsRsmmbRsRsRsmmbRgbRhRsmbLibRhbRsRsmbRsRsmbRsbRsbRsbRgRsRgRsmmbR
gbRsRsmbsbRsRsmbLsbRsRsmbRjRsmbRsRsmbRsbRsRsmbRsbRgbReRsmbLibLgbRsbLsb
LibLsbLsRsRsLsmbLsLsLsmmbLsLsLsLsmmmbRsRsmbRjRsmbsbLsRsbsbsbRsbsbsbsbs
bRcRsRsmmbLebRsbLsbRsLsbRsbRebRsRsRsmmbLsRsbsbRgbRsbLsRsbLsRsbLhbRsbLi
RsbRjbRhRsmbRsRsmbRgbRsbLsbRibRgbRsbRsRsRsmmbLsbRgbRgbLsLsmbLsbLsLsmbR
gbRsLsRsbRibsbRsRsRsmmbLsRsbLjbLcbRgbRsbRsRsmbRgbRsRsRsmmbRsbRsRsmbRsR
smbRsbRgRsmbRsRsmbRsRsmbRsbRsbsbRsRsmbLsRsbRsRsmbLhLsRsbRgRsRsmmbRebLg
LsRsRgRsmbRgbRsbRsRsmbLsbRsbRsRsmbRsRsmbLsbRsbsbsbRebLhbLjLsmbLibLsbLg
bLsbLsbLsLsmbLsbLsbRsbLsbLsbRsbRibRsRsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 165359; End: 165900;
Recording: 12-1; Individual: 37; Drug: PCAP814 1 然 Apo 50 然
bsbLsLsmbRcRsmbRcbLhbLcbLsbLiLsbLsbRjRsRsmmbRcbRsbRjRiLsRsbLgLsLsLsLsL
sRsRsmmmmmbRsRsRsRsRsRsLsRsRsRsRsRsRsRsmmmmmmmmmmmbLobRcbLoLsmbRsRsmbR
sbLjbsbRhRsRsRsRsRsmmmmmbLobsbRobLsbLoLsmbRgbsbLjbRsLsLsLsmmbsbsbsbRcR
smbLobLobRsRsmbRoLsbLcbLcbLcbLibLibRsbLsRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 165359; End: 165900;
Recording: 12-1; Individual: 38; Drug: PCAP814 1 然 Apo 50 然
bLsbRsbRgbLsbRsbRsbLsbLsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 165359; End: 165900;
Recording: 12-1; Individual: 39; Drug: PCAP814 1 然 Apo 50 然
bRsRsRimbRsLsbLsbRgRgRsmbRsbRgbRobLjLsLsLsmmmbLgbsbLgbRsbLebLsbLsLsmbL
sbLsbLsLsmbLsbRsbLcbRsbRibRhRsmbRgReRsmbRhbRgbLsbLebLsRsbLsbRsbRsbLhbL
gbRsLsbLcLsmbRsbRsRsmbLeLsbLcbRibRiRsmbRiRsmbRgbRsRsmbRgbRsbRgbLsbRcbL
ebLgbLgbLibRjbLibLgbLibLsbLsLsmbRcbRsbRgbRcbRsRsmbRsRsmbRgbReRibLgbRsb
RgRsmbRibRgRsmbRgbRgbRgbRgbRibRsbLsRsbRsbLobRsbLsbLgbLibLcbRcbRsbRebRs
bLobLibRhRsLsmbRsbRsRgbRebRibsbLsLgbLgbLsLsmbLibLsbLsbLsbLgbLsLgbLsbLg
RsbLibLgbLsbLibRsbLibLsbsbLsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 165359; End: 165900;
Recording: 12-1; Individual: 40; Drug: PCAP814 1 然 Apo 50 然
bRibRsbLobLebLsbRsbLsbLsbRsbRsbLsbRjbRjbRsbRjbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 165359; End: 165900;
Recording: 12-1; Individual: 41; Drug: PCAP814 1 然 Apo 50 然
bLsLsmbLsLsLsmmbLsLsLsmmbLsLeLsbLsbRgbLsLsmbLgLsLsmbRsLsbLgbLsLsLsmmbL
sRsbLsRsbLsbLsLsmbRsbLsRsbLgLsbLgRsbLsbLgLsbLsbsbsbLsLsmbLsLsLsmmbLsLs
LsmmbLsbLsbLsbLsbLsRsbLsLgLsLsmbLsLsLsmmbLgbLsbLsbLsbLsLsmbLsbLgbLgLgb
RcbLsRsbRsRsmbRsbRhbLebLgbLgRsbLgLsbLsbLsbLsbLibLsLsmbLsbLsbLsbLgbLebL
ibLsbLgLsbLsbLsbLgLsbLsbLsbLebLibLibLhbLsbLsbRsbLsLsmbLsbLebLibLibLgbL
obLsbLsbLsbLsbLsbLsLsmbLsRsbRsRjRsmbRsbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 165359; End: 165900;
Recording: 12-1; Individual: 42; Drug: PCAP814 1 然 Apo 50 然
bLibRhRsmbRgRsmbLsbRsbLsbRsRsmbLsRsRsmbRsRsmbRgbLsbRsRsRsmmbRsRgbLsRgR
smbsbRgRsmbsbRsbRhRsmbRgbRsbLsRsbRgbLsLsmbRsLsRsbLgbLgbLsbRsLgRsbLgbLs
bLgbLgbLsLsLgmbLgLsbLsLsLgmbLsLsRsLimbLhLsbLgLsbLgbLsbsbLsbLsLsmbLsbsb
LgRsbLgRsbRgbRsLsbLsLsLsLsmmmbLgLsbLsbLsbLsLsLsLsLsmmmmbLsLgRsLsLsmbLg
bLsLsmbLgLsbLiRsLsRsbLsbLsbsbsbRsbLibLiLsLsLsLgmmbLgbLsLsLsmmbLsLsmbLi
LsbRsbRsRsmbRhbRcbLgbRcRsRsmmbRsRgbRgRsmbRsRsmbRibLhbLcbLsbLsbLsLsLsLs
LsmmmmbLsbLsLsRsLsmbLsLsLsLsmmmbLgLsbLsLsmbLsLsmbLsbLgbLibRiRsmbRcRsmb
RsRsmbLsbLgRsLsbRebLsRsRgbRsbRsRgbRsRsRsmmbRsRsRgmbRgRsRsmmbRsbLibLcbL
gbLgbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 165359; End: 165900;
Recording: 12-1; Individual: 43; Drug: Control Apo 50 然
bRsRhbRebRsRhbRebRsbRgRsmbLsbsbRsRsLsRsRsRgLsmmbRsRsRsRsmmmbRsRsmbRgbR
sRsRsmmbRsLsRsRsLsRsmbRibRgbRgbLsLsmbRsRgRgRsmbRsbRsRsmbRsbRsRsmbsbsbR
sRsLsmbRsLsRsLsbRsRsRsRsRsRsmmmmmbRgRsmbLsbRsRgbRgRsRgRimbRsbRebRhLsbR
obRibRiRsmbsbsbsbRgLsbRibLgbRgRebRibRiRsmbRibLiRsbRsbLsbLsLsLsLsLimmmb
LsbLgbLsbLsbLsbLsbLsbLsbLsbLobRsRsmbsbsbsbRsLsbLsRsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 165359; End: 165900;
Recording: 12-1; Individual: 44; Drug: Control Apo 50 然
bLibsbLsbLsbLgbLgbLsbRsbLgbLsbRjbLjbLgbLsbLsbLsbRibsbRgbsbLsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 165359; End: 165900;
Recording: 12-1; Individual: 45; Drug: Control Apo 50 然
bRiRebLebRsbLsLsmbRibLcbLgbLgRsbLgbLcbLgbRgbLgbLgbRibRgbRsRsmbRcbLebRs
bLjbLebLsbRobRcbLsbLgbLobLsbRibLsbRgRsRsmmbRibRibRgbLsbRgbRgbLsbRebRsb
LsLsmbLgbRsbRibRgRgbLsbRibRsbRsbLsRgbsbRibRsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 165359; End: 165900;
Recording: 12-1; Individual: 46; Drug: Control Apo 50 然
bRebRebRgRsmbRebRgLsbRibRebRebRsRsmbRebRsRsRsRiRsmmmbRhbRebRibRsRibRgb
RsRgRsmbRiRsmbRibRibRibLsbsbsbsbRgRiRebRebRiRgRsmbRibRibReRhbRgRebRebR
ebReRsmbRsLsbRiRgbReRsmbRsbsbsbsbRsRiRsRsmmbRhbRsReRsmbRgRgbRgRsmbRgRs
RimbsbsbRiRhRsRsmmb

>ZF Recording 2016-06-02; tW: 300s; Start: 165359; End: 165900;
Recording: 12-1; Individual: 47; Drug: Control Apo 50 然
bsbsbsbLsRsLsRsbsbLgbRsLiLsbsbLsLsRsRsmmb

>ZF Recording 2016-06-02; tW: 300s; Start: 165359; End: 165900;
Recording: 12-1; Individual: 48; Drug: Control Apo 50 然
bRgLsbRgbRsRsRsRsRgRsRsRsmmmmmmbLsbRsRsRsRsRsRsRsRsRsRsmmmmmmmmmbRsbRs
RsRiRsRgmmbRsbRsbReRgLsbsbRsRsRsRimmbReRsRgRsRsmmmbRgReRiRsmbRgRsRgRgR
embRsLsbLsbRsbLoRsbLjbRjbRjbLebLibLsbsbRsLsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 165902; End: 170403;
Recording: 13-1; Individual: 1; Drug: PCAP814 10 然 Apo 50 然
bRebRgbLsbLsbLsbRsbLsbsbRsbLsbLsLsmbLsbRsbsbRsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 165902; End: 170403;
Recording: 13-1; Individual: 2; Drug: PCAP814 10 然 Apo 50 然
bLgRsbRsbLibLsbLgLsbRjbsbLiLsbLsbLsbLgLsbLsbRsbLsbLsbLsbLsbLsbLsLsmbLs
bRsLsbLsbLsbRobReRsRsmmbRsbLgbLsbLsLsmbRebLgbRibRgRsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 165902; End: 170403;
Recording: 13-1; Individual: 3; Drug: PCAP814 10 然 Apo 50 然
bRgbLgLsLsmbLibLsLsmbRsbLsRsLsLsLsmmbLgbLsLsmbLsbRsbRgRcbsbLgLsbLsLsmb
LeRsbRiLsbLsbRgbLibLiRgbLsbLsbLiLsbsbRgLsbRibRibLsLsmbRsRsRsmmbRibsbRs
RsRsmmbRgbRgRsRsRsmmmbRsRsmbRgbRgRsRsmmbRgbRhRsmbRsRsmbRsbRcbLiRsbRsRs
mbRsbRsRgbRgbRgbRsbRibRsRsmbLsbRibRsLsbRsbLsLsmbRsRsRsmmbLgbRsbLsbRebL
ebLobRsbsbRgbRgLsLsmbLibLebRebRgbRsRsRsRsmmmbRjbLgbRsbLcbLsRsbLgLsLsmb
LsbRgbRgRsmbRgbLgbRsLsRsbLsRsRsmbRsbRsRsmbRebRsbRsRsmbRsbRsbRsRsRsmmbR
sbLsbRibLsbRsbRsRsmbLsRsRsRsmmbRsbRsbRgbsbRsbLcRsRsmbLgbRsbRsbsbLsbsbs
bLsLsmbRsbsbRsbRsRsmbsbLsbRsRgRsmbRsbRsRsRsRsmmmbLsbRgbRsRsmbRiRsRsRsm
mmbLsRebLgLsLsRsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 165902; End: 170403;
Recording: 13-1; Individual: 4; Drug: PCAP814 10 然 Apo 50 然
bRsbRsbRsLsbRsbsbLsLsmbRsbRsRsmbsbLsbLsLsmbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 165902; End: 170403;
Recording: 13-1; Individual: 5; Drug: PCAP814 10 然 Apo 50 然
bRgRsRsmmbRsbsbsbRgRsRsRsRsmmmmbRsbRsRsmbRsRsmbLsRsRsmbRsbRsRsmbRsbRsR
sRsRsRsmmmmbsbRsRsmbRgRsmbRsRsLsRsmbRsRsLsRsmbLsRsLsRsbLsRsbRsbRsbRsbs
bRsRsmbLgRsbsbRsbRsbRsbRsRsRsmmbsbRsLsbRsbRsbRsRsRsmmbLsbRsRsmbRsLsbLs
bRgLsbRgbRsbsbLsbRgbLsRsbLsRsRsmbsbsbsbRsRsRsmmbLsLsLsmmbRsbRsRsRsRsmm
mbRgRsmbLgRsRsmbRsbRgbLsRsRsRsRsmmmbRgLsRsRsmbRsbRsbsbsbsbsbRsRsLsRsLs
mbRsRsRsmmbsbRgbsbRsbRsRsmbLsRsRsRsmmbRsbLsbRsRsmbsbRgbRgLsbRsbRsLsbLs
RsbsbsbsbsbRsRsRsmmbsbRsRsmbRgbLebRgbsbLsLgbLsbLsbLsLibsbRsbsbsbRsLgLs
bLgLsbRgbRsLjbRsbLsbsbRgbRsbRsLsRsbRsbRsbLeb

>ZF Recording 2016-06-02; tW: 300s; Start: 165902; End: 170403;
Recording: 13-1; Individual: 6; Drug: PCAP814 10 然 Apo 50 然
b

>ZF Recording 2016-06-02; tW: 300s; Start: 165902; End: 170403;
Recording: 13-1; Individual: 7; Drug: PCAP814 3 然 Apo 50 然
bRsRsmbRibRcbsbLoLsmbLcLsmbLcRsLsbRcbRsbRiLsLsmbRsbRsRsmbRgRsRsmmbLsRs
RsmbRgbLeRsbRcbsbLcbRcbRibRsbRsbsbsbLsbLjbRhRsRsmmbRcRsmbRibLsbLcbRobR
iRsmbRgbRibRcbLsbLibLcbLhRsbLibLobLoRsbLcbRgbLhLsbRjbRsLsbRoRiRsmbRhRs
mbRoRsRcmbRhLsbRgbRiRsRhRiRsmmbRiRsmbRgbLcLsmbLcLiRsbLebLiLsLhLsLcbLcL
smbLcLsmbLeLsbLeLebLiLcbsbRsbsbLsLgbRcbLcbLobLcbLebLiLsbLebLjbRcbRgbRg
bLcbLcbLcbLibRebRcbRcbRhbLibLgLsbLibLgLsbLgbLebLcbLibLibLgbRibRibsbsbR
iRsmbRgRsmbLjbRsLsbRsRcbRsRebsbRsLhbRgbLhbLiLsbLcbsbLcbLhbLhbRsRgRsmbL
obLcLsmbRibLsLobLebLibLcLsLsmmbLoRsbLgbRhbRcRsmbRibRhbRibLsRsbLjbsbLeb
RcRsmbRibRcRsRsmmbRhbRiRsmbRiRsmbsbRoLsbRcbRibLsbLjbLcbLcbLibLiLsLsLoL
oLsmmbLgbLibLhLoRsbLcbLhRsRibLsbRsRibRibRebRcbRibRiLsbRoRsLsLsmmbLebLg
bLibRibLibRhLsbRhRsmbReRsmbRsRsmbLiRsbLibLcbRoRsRsmmbRcbRjbLibRebRgbRi
bRibLjbLsLcbRsbLsbLsbLcbLiRsbRcbRebLjbLibLcbRcbsbRhRsmbRibLhRsbRgRsmbR
jbLibLhbRhbsbsbsbLgbLgbLjLgbRcbRhRsmbRsbRsbLebRcRsmbRjbRcbRcbLsRsbLgbR
hbRsLsbRibRsbRibRjbLsbLhbLobLcbLiLsLsmbLhbLgbRibReb

>ZF Recording 2016-06-02; tW: 300s; Start: 165902; End: 170403;
Recording: 13-1; Individual: 8; Drug: PCAP814 3 然 Apo 50 然
bRoRsmbRibRiRsmbRibRhbRhbRiRebRibRibRibLsbRibRsbRsbLsbRsbRsbRsbRsbRsRg
bRsbsbsbLsLsmbRibRsbRsbLsbLsbLsbRgRsRsmmbLgbRsbRsRgbLjbLobLcbLiLsbLcRs
bLibLhRsbLsbsbLsLsmbRcRsmbLsbLgbLsbLibLsbLiRsbRcbRsbRobsbLjLsLsmmbLhbL
sbRsbLgbLsLsmbLsbLsLsRsmbLsLsmbLsbLgLsbLsLsmbLsbLsbRsLsbLgbLsbLiRsbLsb
LsRsbLhbRcbRsRsmbLiLsbLgLsbRsbsbLsbsbLsbsbLsLsmbsbLsbLsLsRsmbLgLsLsmbL
sLsmbLsLsmbLsbLsLsLsLsLsmmmmbLsbLobLjbLhRsbLcbLgbLgbLgbLibLsbLsbLgbLsL
sLsmmbLsLsLsmmbLsLsmbLsLsmbRsLsbLgLsbRsbLsbLsRsbLsLsmbLgbLgLsbRsLsRsbL
cbRgbRebRgRsmbRgRsmbRsRsmbRsRsmbRsbRsRsmbLsRhbRsRsRsmmbRsbRsRibRsbRebR
ibLgRsbsbLsRsbLsLsmbRebLsLsmbsbsbsbLhbRsRsRsmmbLsbRsLsbsbLgLsbLsbLsbLs
LsmbLsLsmbLsbLgLsbLsbLsLsLsLsLsmmmmbRsbLsRsbLiLsbRsbsbLgLsbsbsbLsbLsLs
mbLibLobLcbLibLibLsbLsbLsbLsbLgbsbLibLsbLsLsmbLsLsmbLgLsRsbLibLsbLgbLs
RsLsbLsbsbLibLsbLgLsbLsLsmbLsLsRsmbLsbLgbLsbLsLsmbLsbLsbLsLsLsmmbLgbLg
bLsbsbLsbLsbLsLgLsbLsLsmbsbLsbLsLsmbLgLsLsRsmbLsbLcbLobLcLsLsmmbLgLsLs
mbLsbLsbLsLsLsLsLsmmmmbLsRsLsLsmbLobLcbLibLgbLoRsbLcbLcbLcbLcLsRgmbRob
RoRibRcLsRsbRibsbsbsbLsbsbLsbsbLsbRsbRsbRsbRsbRsbsbsbRsbsbsbRsRsmbLsbL
sbLsbsbRibLsRsbsbRsbLsbRsbLsbRsbLjLgbsbRsbRsbRsRhbRgRsmbLgbsbsbsbLjbRc
RsmbRsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 165902; End: 170403;
Recording: 13-1; Individual: 9; Drug: PCAP814 3 然 Apo 50 然
bLsbLsbLgbLgbLsLsmbLsLsLsmmbLsLsmbLsbLsRsLsbLsbLsLsmbLsbLsbLsbRsLsbLgb
LsbRsLsbLgbLsbLsbLsLsmbLsLgbsbLsLsLsmmbLsbLsLsLsmmbRsbLgbsbLsbLgbRsRsm
bLsbLsLsmbLgLibsbLsbsbLgLsbLsbsbLgbLsLsmbLsLsLsmmbLsLsLsmmbRgbsbLsbRsb
RsbRgbRebRebReRgbRgbsbRsRsmbRgbRgbRgRsLsmbRsbLsbRsbRibRgbRsRgbLsRsbRsR
smbsbRsRsmbsbRsbRsRsmbRgbRgbRgRsmbRsRsRsmmbRiRsmbRsRoRsmbRobRcbsbsbRsb
RibRgRsmbRsbRgbRgbRsbRgRsmbRsRgRsmbRsbRgRsmbsbsbRgbRsRsRsRsmmmbsbRsLsR
sbRsbRsRsmbRiRgbRsRsmbRsRsmbRgbLsbRsbRibRgbRgLsRsbRsbRgRsmbRsRsmbRsbRs
bRgbRsbRsbRsRsRsRiRsmmmbRsbsbRsbRsbRgbRsbRgbRgRsmbRobRoRsmbRsbRsRsmbRs
RsRsmmbRsbRgbRsbRgRsmbRgbRsRsmbRgbRgbRibRgbRgRsmbsbRgRsmbRgbRsRsmbRsRs
mbRsRsmbsbRgRsmbRsRsmbRsRsmbRgbRsRsRsmmbRsRsmbsbLsbRgbRgRsmbRgRsmbRsbR
sRsmbRgRsLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 165902; End: 170403;
Recording: 13-1; Individual: 10; Drug: PCAP814 3 然 Apo 50 然
bLsbLsbLsbsbsbRsbLsbLsbRsbsbRsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 165902; End: 170403;
Recording: 13-1; Individual: 11; Drug: PCAP814 3 然 Apo 50 然
bsbsbRgbRsbRsbRgbRjbRibRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 165902; End: 170403;
Recording: 13-1; Individual: 12; Drug: PCAP814 3 然 Apo 50 然
bLcLsmbLsbRsRsmbLiLiLsLsmbLhLsLsmbRibRcRsmbLcbLgLsLsmbLsLsmbLsLsLsLsLs
mmmmbLebLcLsmbsbLsbLiLsbLibLgLsbLgLsbLeLsbLgLsbRibRgLsbLhbLhLsbLcLsmbL
cLsmbLsLsmbRibRibRgbRsRsmbRcLsbRiLsLsmbLgLsbRsLsbLsLsLsmmbLjLsmbLsLsmb
LiLsbLsbLhbsbRsRsRsmmbLsLsmbRsbRsbsbLsbRsbLiLsLsLsRsmmbRjbsbLsLsLeLsRs
mbLeLsbRibLcLsLsmmbRsbLgLsLsLimbLsLhLgbLibLcLsLsmmbRsRsRsRimmbRgbRcbRs
bsbLsLsLsLsmmmbLibRcRsmbRcLsbLeLsLsmbLeLsbLibRiRsmbRsLsbRsRsmbLsbsbsbR
gRsmbRibRibLcLsmbLgLsLsmbLiLsbRgbLiLsbLeLgbLibsbLgbLgLibLsLsmbLsLgLsLs
mbRibLgbLeLsLsLsmmbLhbRgLsbLhbLcLsmbRgRsmbRgbRgbLsLsLsmmbRsLsbRibRsbLe
bLsLgLebsbLhLsbRsLsLsLsmmbRgRsmbRjRgbRiLsLsmbLcLsmbLsbLsLsmbLiLsRsbRsL
sLsmbLsbRsRhbRgbReLsRsLeLsbLiLsbLgbLgLsbRjbRjbLhLsLeLgLsLsmbLiLsbLcbLg
bLeLsLsmbRebReLsLsmbLgLsLsmbsbsbsbsbsbRcLsbRsLsbLsLsmbRgRsRsRsRsRsmmmm
mbLsRsbLsLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 165902; End: 170403;
Recording: 13-1; Individual: 13; Drug: PCAP814 1 然 Apo 50 然
bRjbLsbRobsb

>ZF Recording 2016-06-02; tW: 300s; Start: 165902; End: 170403;
Recording: 13-1; Individual: 14; Drug: PCAP814 1 然 Apo 50 然
bRsbLsbRgRgbRsRsmbRsbsbLibLhbRobRibLsbRobRobRgRsLsmbRobRobLobLibLibLiR
sRgbRhbRcbRcbLsbRobRobRcbsbLsLsLsmmbRsbsbLsbLgRsLsbLsLsmbRebLjbsbLcbLc
bLibLibLobRobsbRibRgRsmbRjRsmbRsLsbLgbRiRibRsRsmbRgbRsbRgbsbsbRgRgbRsR
sRsRsRsRsmmmmmbLsbRiRsRsRsRgmmmbLsbLsbLibLsbsbLibLsbLsbLiLsbRoRsmbsbLo
bRcbRsRsmbLgbRsbRgRsmbsbRgbLgbLsLsLsLsLhmmmbsbRsLsbLcbRhRsmbRcbLsbRebR
obsbRcbLibLibLcbRsRsRsmmbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 165902; End: 170403;
Recording: 13-1; Individual: 15; Drug: PCAP814 1 然 Apo 50 然
bsbsbsbLsbRobLgbRsbRsbRoRsmbRsRsmbRsbRgbsbRsbLsRsbRibLibsbRsbLcbRsLsLs
mbLgLsbLgLsbLsLsLsmmbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 165902; End: 170403;
Recording: 13-1; Individual: 16; Drug: PCAP814 1 然 Apo 50 然
bRsbRcbRgbRibRgRsmbRgLsbLsbLsbLiLsbLebLiLsbRsbLhbsbLcLsLsmmbLcLsmbLgbL
iLgbLcbLcbLsLsmbLcbLsLsmbLcbLcbLebLobLobLobLsbLeLsbLhbLsbLcRsbLcLsmbLi
LsbRgbLsbLebRcRsmbRibRobRgRsmbRjbRebRgbRsRsmbRcbRsLsbLoLsRsmbLcbLgLsbR
hRsRsmmbRiRsmbRibRhbRiRsmbRibRgbRibLcLsmbLebLhbRsRsRsRgmmbRibRibRhRsmb
LcbsbLobLiLsbLibLcbLsbLibLgbsbLgbLoLsmbLcbLcbLebLebLobLibLoLsmbLcbLobR
gbsbLcLsmbLebLcbLcbLcLsmbLcbLgLsbLcLsLsmmbLhbRgbLgbLhLsbRhbRsRsmbLcbLi
bRsRsmbLsbLobLgbLhLsLsmbLjLsmbLibLcLsmbLebLsbLibLibLgbLebRcbRcRsmbRobR
ibLjLsmbLoLsmbRgbLcbLcbLibLhbLhLsbLobRsbLobLibLhLsbLobLobLibLibLgbLcbL
ibLjbLcbLibLjbRebLcbLibLcbLcbRsbLjLgbRsbLebLiLsbLsRsLsbLsbLeLsbsbRebRh
bRiRsmbRcRsmbRebRgbRhbRibLcbsbRsbLcLsmbLcbLjLsLsmmbLcLsmbLcLsmbRsbLibR
ebRgRsmbLsLsmbLsbLhLsLsmbLhbLiLsLsLsmmbsbRsbLgbLsbLcbLsbLhbLebLibLcbRs
RsmbRgbsbLcLsmbLobLgbLeLgbLibLsbLebRsbsbsbsbLiLsLsmbLibLsLsmbRcbLcbLcb
LibLhLsbLibRibLiLsbLebLibLcbLcLsmbLcb

>ZF Recording 2016-06-02; tW: 300s; Start: 165902; End: 170403;
Recording: 13-1; Individual: 17; Drug: PCAP814 1 然 Apo 50 然
bRjbLcbRsRobRsbLhbRcbRebLcbLgRsLsbRgRsmbRsbLiRsbLgbLibRgbLsbLsbsbLcbLi
bLcLsmbLsLsmbLsbLiLsbLgbRsRsRsmmbsbRsbLgbLsLsmbLsLsmbLsLsmbRsbLgLsbRsL
sRsbLgbLgLsbLsbLibLgbLgbLsLsmbLsbLgLsbLsbLgbLsbLgLsbLsbLgLsbLiRsbLiLsb
LgbLcbRsbRibLobLibLiLsbLcLsmbLcbsbLgbLhbLgbLcLsmbLhbLsbLcbLgbLgbRhbReb
LgbRobRsRsmbRibRoLsbRobLsbRebLcLsmbLhbRjLjbLebLibsbsbRjbRcbLibRcbLjbLc
LsmbLjbLibLhbRebsbsbRibsbRcbsbsbsbRcbLcLsLsmmbLgLsbLsbRcRsmbRsRsmbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 165902; End: 170403;
Recording: 13-1; Individual: 18; Drug: PCAP814 1 然 Apo 50 然
bLsbLsbsbLsLgLsLgbLsLsLsRsLsmmbLgLsbLhbRsLsbRcbLhLsbRiLsbLhbRsbLiLsLsL
sLsmmmbRibLibLsbLibRsRsmbRgbsbRsRsmbLeLsbLoLsmbLhbRibRjbLcLsmbLcbRgLsb
LgbRibRiRsmbLjLsmbLibLgbLcbLsbRgbRiLsbLgLgLsbLsbLgbRsbRsLsbsbLsLsLsLsR
sLgLsmmmbLgLsLsmbLgbLgbLiLsbRgbLgLsbsbLsLsRsmbRgbLibLgbRsLsbLsLsmbLsbL
sLsLsLsmmmbsbsbLsbLgbsbLgLgLsbLgLsbLgbLiLsbRibRibLsbLjbRiLsRsbLgbRgbLs
LsmbRebLgLsbLsbLsLsmbLsLsLgLsmbLgbLgbLsLsmbRsbLibLgLsbLcLsmbRibRsbRsbL
ibRsRsRsmmbsbLsbLiLsLsmbLsbLsLsLsmmbsbsbsbsbsbLsLsmbLsbLgbLhLsbRgbLcbL
sbLhbLeLgbsbLcLsmbLcbLcbLebRcbsbsbRibsbRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 165902; End: 170403;
Recording: 13-1; Individual: 19; Drug: Control Apo 50 然
bsbRsLsRsRsRsRsRiRiRsRsmmmmmbRiRsmbRgRsRsmmbRsbLsRsbRsRsmbRsRsRsRsRsmm
mmbRgbReRsRsmmbsbRsbRgRsRimbRgbRsbRsRsRsRsmmmbRsbRsRsmbRgbRsRsmbsbRsRs
mbsbsbRebRsLsbsbRsbRsRsRsRsRgmmmbRsRsmbRsRsmbLsLsmbRgbsbsbsbsbLiLsbsbs
bsbLsbsbLsLsmbLsLsmbsbLsbLsLgLhRsbLiLibLsLsmbLsbsbsbsbsbLsbRsbsbReRiRs
RsRsmmmbLgbRobRibLoRsLsLsLgLeLimbLsLsLsmmbRsbsbsbsbRsbLsbsbsbLgbRsbRsb
LibLgbRsRsLsmbLiLsbsbLsbsbLsLsLsmmbLsbLsbRsRsmbsbsbRsbLsbLsLsmbLgLgLgb
LeLsLhbLcbsbLcLsmbLgbLobLcbLcLsmbLgbRsbRsbLcLhbRibRsRibsbRsLsbRgbRsRgb
Rsb

>ZF Recording 2016-06-02; tW: 300s; Start: 165902; End: 170403;
Recording: 13-1; Individual: 20; Drug: Control Apo 50 然
bRjbLjbRcbLsLsmbLgbLgbLsbLgbRebRibLibLibRsRsmbLsbLgbLgbLsLsmbLgbLibRgb
RibRebRgbLjbRcbsbLsRsbLibRibLgbLibRsLsbLsbLibRibLsbLgLsbLiLsbRjbRhbLib
LiLsbLiLsbLgbLsRsbLibLgbLsbRcbRhbRgbRsbRjbLsbLebRiLsbLcbLgLsbLgLsbLiLs
bLgbRsbRsbLgbLsLsLsmmbLgbLsbLgbRsbLgbLgbLsbLsLsmbLgbLgbLgLsbLsbLsbLgbL
gbLgbLgbLsbLcbRgbsbLgbLgbLgbLgbLsbLsLsmbRsbLibLgbLhbLibRsbRibsbLibRgbR
hbLgbLgbLgbLsbLsbLgbLsbLsbLgbRcbRhbRcbRsbRsLibLibLgbLgbLgbLsbLibLsbLjb
LhbLsbRsbLgbLgbLgbRsbLgbLibRsbLibRjbLhbRhbRgbLsbLsbLsbLgbRsLsbLsbLsbsb
LgbLgLsbLobLgbRcbLsRsbLsbRobRibRibsbLiLsbLgbRgLsbRsbLsbLsLibLsLsmbsbLg
bLsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 165902; End: 170403;
Recording: 13-1; Individual: 21; Drug: Control Apo 50 然
bLcbLgbLjbLibRebRiLsbLsRsbRsbRgbRgbRobRjRsmbRsbRiRsmbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 165902; End: 170403;
Recording: 13-1; Individual: 22; Drug: Control Apo 50 然
bRebLobRebLgbLobLjbRcbRebLobRobRebLobRobLobRhbLsbRobLcbLebLhbLgbRobRob
RebLebLcbLgbLsbLsbRhbLobLcbLebLobRobLobRobRebLhbLibRebLcbRibRibRobLcbL
obRobLsbRobLobLhbLcbLcbLcbLebLebLobLibLobRebRebRibRobRebRebRobLgbRobRo
bRobLobLsbLobLebRobLebRobRobLobRibRobRcbLobLibRebRebLobLebRgbRobLcbLob
RobRobLebRobLgbLobLobRobRebLibRobLobRcbRgbLebRobRebLobLobRhbLobRebRobR
obRcbRobLobRebLcbRobRobLcbLobLobRobRobLobRobRobRobLcbLobLebLebRobLibRs
bRebRobRobRobLobLobRgbLibLobRobRebRebRgbRebRcbLibRcbRjbLcbLobRgbRgbLob
RebLobRibRobLebLibRcbRobRobRobRobRobRcbLobLobLibRobRobLcbLcbLobRcbRebR
obRobLcbRebLcbLobLebRobRsbLgbLobLcbRebRsbLobRobRcbLobLobRgbRibRibRobRi
bRcbRobRebLobLobRobLcbRobRobRobRhbRcbLebRobLobLsbLgbLobRobRebLobRobLob
RhbLobRcbRobLobLobRcbLobLobRcbLobRcbLobRibRobLebRobLobLobLobLobRobLobR
obRsbLobLobRebLibRobLebRcbLebRhbLcbRibLobRobLibRcbRobLcbLcbRobLobLobRe
bLgbLobRcbRibRgbRobLibRobRjbLsbRobLobRebRibLsbLobLebLobLcbRobRibLobLeb
LobRobLebLobRibLibRhbRibRobLebRibRebRobRobRcbLebRcbRobLibLobLcbLebRobR
cbLebRibRcbLobRebLobLobRobRebLobLgbLebLobLobRcbLsbLebLibRobRebLobRobRg
bLobRobRobLhbLibRgbLobLcbRsbRobLcbLobRobLcbRobLebLcbLgbLibLcbLobLobLcb
LobRobLgbRsbRobRcbLobLobRebLobLebRobRgbRebLibRobLibLcbRgbLobLebLobRobL
obRgbRobLibRobLcbRebLsbLobLibLebLobLobLobRcbLgbRebRibRgbLebLobLhbRobLo
bRobRgbRobRebRcbRibRcbLebLobRcbRobRobLcbRobRobRobRobLebRobRcbRobLobLgb
LgbRobRebLibRebLobLhbLibLcbRsbRebRcbRibRebLobLobRebRebLibRebLcbLhbLcbL
obRebLgbLgbRobRobLebRobRcbLgbRobRebRebLebLebRgbLobRhbLobRobRibRsbRobRs
bLcbLobLebRcbLebRobLcbLcbRobRcbLcbRebRobRcbRobLobLobRebLgbLebRebLcbReb
RibRebLsbLebLebRsbRobRobLgbRsbLcbLcbLcbLibRobLobRobRibRcbRsbLsbRibLcbL
obRobRebRobRibRibRibLgbLibLebLhbLebRhbLobLobLobLebRgbRjbRibRobLcbRcbLs
bRebLcbLobLibRcbLobLobRobLibLhbLobRobLobLhbLgbLsbRobLebRobLsbLobLhbLob
LobLobLobLobRhbRebLebRgbLebLjbRibRcbRibLebLcbRobRibLhbLcbRobLobRhbRobR
gbLobRobLibRobRibLibRcbLebLcbLhbRobLobLibLobLobRebLobRobLobLebLcbRobLc
bRibLobRobRobLebLobLobLobRobLebLobRibRobRobLobRobRcbLobRgbRgbLobRebLob
RebRobRibRobRobRibRobRcbLobRebLebLobLobRobLobLobLgbLhbRebLobLebRcbRebR
ebLobRcbLibRobLobLobLibLibLebLsbRobLsbLcbRebRgbRgbRcbRobLcbRebLobRsbRo
bLgbLobLcbRobRibLobRobRebLobLsbRsbLcbLobRobRobLebRcbRobLebRibRebLobLeb
RebLgbRgbLibLhbLobLebRcbRebLobRobLobLibRcbRgbLobLobLobLcbLebRobRebRobL
hbRebLebRobLebLobRsbLobRobRebRobRobRobLobLobRcbLobLsbLcbLobLobRcbLobRg
bLcbRobRcbLobLebRebLobRsbRibRobRobLgbLcbLcbLcbLsbLobLobLobRebRobRobLcb
RobLebRgbRgbLcbLebLcbRcbRsbLcbLebLobRgbLobRebLobRobLobLgbLibLobLcbLsbR
ebLobLobRcbRebRibLobLebLibLsbLibRebRcbRobRgbLibLobLobRibRebLebRobRobRi
bLobLobLobRobLobRebRjbRobLgbLobRebRcbRcbRebLobLobLcbLobRibRsbRcbLobRcb
RibLobRcbRjbLobRcbLobLobRobLebLobRebRcbRobRsbLcbLjbRsbRgbRgbLibLebLobR
gbLobLebLebRcbLsbLobRobLcbLobRobLobRobLobLobLobLebLcbRebLcbRsbRsbRjbLj
bLsbRebRobLebRobLsbLebRobLobLobLobRsbRobLebRobRcbLebRgbRsbRcbLobRebLob
LobLcbRebLcbRjbLcbRobRobLobRebLobLcbLjbRjbLsbRsbRcbLebRebRjbLcbRsbRjbL
ebLobRsbLjbLobRhbLobRobLebRcbLobLjbRobLgbRebLebRebRjbLobLobLobLsbLobRo
bLebLcbLsbLobRsbLsbRsbLebRebLsbRjbLjbRobRcbRobLobRjbRebRebLjbLobRebRsb
LobRobLgbLcbRobRobRjbLjbLebLebLobRcbLobLjbLsbRsbRjbRsbRsbLebLsbRobLebL
sb

>ZF Recording 2016-06-02; tW: 300s; Start: 165902; End: 170403;
Recording: 13-1; Individual: 23; Drug: Control Apo 50 然
bLhbLsbLobLebLobRebLsbLsbLebLebRobRcbRcbRcbRjbLjbRebRibRsbRjbLobLebRcb
LobRgbRhbLsbLebLebLobLobRobRobLobRobRgbLcbRgbLebRjbRobRibLcbRobRibRebR
cbRebRobLobRgbLebLobRebLsbRcbRobRgbRebRobRobLobRobLebLobLsbLgbRcbLobRo
bLobRebRobRobRgbLebRcbLcbLcbRobRobLgbLcbRobLcbRobRgbLobLibLebRobLobLcb
LebRibRebRebRobRobLobLcbLebLebLebRobRobRobRcbLobRobRcbRobLobRcbLibLsbR
obLgbLebRobRobLobRobRobRcbLebLebLobRobRobLebLobLsbRcbRcbRobLobLsbRobRo
bLobLibRebLgbRjbLsbLobLobRgbRjbLjbLobLobRobLobLobLcbLibLobRjbRobLebLsb
RobLgbLobRobRjbRibLebLcbRjbRebLobRobLobRobRgbLsbLobRsbLobRcbRsbRobLobL
obLsbLjbRobRebLgbRobLebRobLjbLebRcbLcbRebRobRibRobLjbRjbLcbLebLobLobRe
bLebLobRobRobLjbRsbLobRobLcbLebRebRjbLobLjbRgbRebRsbRsbRjbLebLobRobRob
LobRobRebRobRobLibLobLobRjbRobLsbLsbRebLcbLcbRebLobRsbRobRcbLjbLobLgbL
obRebLjbRobLsbRgbRebRobLobLebRebRobLebRebRebLobRjbLcbLjbLobLjbLebRgbLo
bLebRebRebLobLobLcbLjbLobRobLebLobLjbRebRobRjbLsbRebLcbRibRobRjbRgbRjb
RobRobLjbRebRobRobLobLsbLobRjbRobRobRobLebLjbLobLcbRcbRcbRcbRcbRobLobR
ebLobLobLsbLobLjbRobRcbRjbRobLgbRobLebLsbRobLebRebRgbRobRjbRjbRibLsbRe
bLebRjbRebRobLobLebLebRcbRebLjbRobLcbRobRjbLobLebRobRebLsbLjbLobLobRgb
RgbLsbRsbRobRobRjbRjbRebRobLcbRebLcbLcbLjbRobLjbRobLjbRobRebLcbRsbLebL
jbRhbRobRobRobLobRobRsbLcbLobLebLobRobRobRebRebRobLebRobLobLobLebRobLj
bRcbRobRcbLebRcbRibLebLobLebRebLobRjbRobLobLgbRjbLsbRobLebRobLobLobRjb
LobLobRobRsbLgbLobRobRobRcbRobRobLgbLobLobRobLobRobLjbLobLobRobRobRcbL
obRobRobLobRjbRcbLgbRsbRobLobLobLcbRebRobRgbLsbRobLgbLibLobRobLobLobRo
bLibLobRcbRobRobRobLobLgbLobLebLcbRcbLobLobRobRebRebLibRobRobRcbRgbLob
LibRobRcbRobRobLobLjbLebRebRibRcbRobRobLobRebRcbRjbLobLobRebLhbRjbLobR
obRebLobLobRobRebLgbRcbLsbLobRobRebRebRobLcbLobLobRobLsbLobLobRobRcbLo
bLobLobLobLobLobRsbLcbRcbRgbRobRobLobLsbLobLcbRcbRibRgbLgbLgbRobRobLob
LcbRibRobLebRebLobRebRobLobLjbLibRobLebRgbLobLibRcbRibLobRgbLobRgbLobL
sbLgbRsbRobRobRgbRobRsbLebLobLobRobLobLobRcbLcbLobLobLobLobRibRobLibRs
bLobRebRebLebRhbRebLobRobRcbLebRcbRgbLibLobLjbRcbRibRobRsbLhbLobLobLob
LcbRhbRsbRobLobLsbRobLibRgbRsbLebRhbRobLobRebLcbLebLcbLebLobLobRobLobL
obRobRobLobRebLibLgbLobRobRobRobLebRobLsbRobLobRibLgbRobRobRibLsbLobLo
bRobLcbLcbLobRibLsbLebRsbRobRebRebRobLgbRgbRsbRgbRebLobRobRobLobRcbRsb
LobLobRobLobRobLjbLobLsbLobLcbRobLobRsbRcbLcbLobLobLobLjbLobLsbRjbLgbR
ebLibRsbLgbRobLgbRsbLobLjbRobLebLobRobLcbRebLsbLsbRobRobRobRgbRobLcbLe
bRobLebLsbRebLhbLobLobRobRebRobRibRsbRgbLsbRibLobRobRcbRsbRibRobLobLeb
RobLobLebLibLobRobLibRebRgbLebLobLobRebLobLsbLebLobRgbRjbRjbLebLsbLobL
obRcbRobRobRobLcbRebRobLobLobLobLebRsbLobRhbRjbLsbRebRjbLob

>ZF Recording 2016-06-02; tW: 300s; Start: 165902; End: 170403;
Recording: 13-1; Individual: 24; Drug: Control Apo 50 然
bLgbsbRgRsRsmmbsbLibLsbLibLibLibLhbLsbLgbRjbRsbRsbLibLsbLsbLsbLsbLjbRs
bRgRsmbRjRsmbLjbRsRsmbRsRsmbLibRjRsmbsbLibRsbRsbLgbLsbRsbRsbLcbLibLgbL
hbLgLibLjbRsbLjbLjbLjbLgRsbLgbLgbLjbLgbLibLjLsmbLhbLgbLgbLiLsbLibLjbLg
bLjLibRsbsbLjbLjbLgbLgbsbLjLgbLjbRsbLibLjbLibLsbLjbLjLibLhbLcbLjbLjbLj
bLibLcbLibLjbLgbLibsbRgRsmbsbLjbLjbRsbRsbRebLgbRgRsmbLsbLgbLhbLsbLsbLe
bLcbLibLsbLjbRjbRhbRjbRgbLjbLgbLibLsbRibLgbsbLibLsbLsbLgRsbLsLibLjbLgb
LcbLhbLsbLjRsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 165902; End: 170403;
Recording: 13-1; Individual: 25; Drug: PCAP814 10 然 Apo 50 然
bRsbRsbLsbsbRsbLsRsbLsLsmbsbRsbLsbLjbRgbLsbsbsbLsbLgLsLsmbLsbLsbRgbLgL
sRsbLsRsbLjbRsbLsbRsbLsRsbLsLsLsmmbLsLsRsmbsbsbsbLsbLsbLsbLsbLsbLsbLsb
LsLsmbLsLsmbsbsbRsbLsLsmbLjLsmbLsLsmbLgRsbLsRsLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 165902; End: 170403;
Recording: 13-1; Individual: 26; Drug: PCAP814 10 然 Apo 50 然
bLsbLsLsmbLsbRsbLsbRibLibLsLsmbLobsbRsbLsRsbLsbsbLsbRibRsLibRobReLsbRs
bLsRsbsbsbLsbRsbLsLsLsmmbRsbLsLsRsmbLsbRsbLgbLsbRsbLsbLibLsbRsLsbLjbLs
bRsbLsbRsLsbLsbsbsbRsRsRsmmbRibLobLsbLobRsbLsbsbRsbRsbRsbRsbsbRsLsbRsR
smbsbLsbRsbRsbRsbRsbRsbRebsbsbLsbsbsbsbRsRsLsmbLcLsRsRsRsmmmbsbRgRsmbR
sRsmbsbRgbRsbLsbLsbRsbRsbRsbRsRsmbRsRsmbRsbRsRsRsmmbRsbRjbRsbRsbRgRsRs
mmbLgbRsbRsbLgbLebsbRsRsRsRgmmbRsbRsbLiRibRcbLsRsbRsbsbLsRsRsmbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 165902; End: 170403;
Recording: 13-1; Individual: 27; Drug: PCAP814 10 然 Apo 50 然
bRsRsmbLsRsbRgbRsbRsbsbLsbLsbRgbRsbLsbLsLsLsmmbLsbLsRsbRsbLsbRsbsbsbRs
bRsbRebRsLsbLsRsbRsbLsbRsbLsbRsbRsLsbRsbLsbRsRsmbRsbLsbRsbRsbLsRsbRsbL
sbRsbLsbRsbRsbLsbLsbLsbLsbLsbsbsbsbRsLsbRsbRjRsmbLsbLsbLsbRsbLsbRsRsRs
mmbRsbRsbLsRsbLsRsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 165902; End: 170403;
Recording: 13-1; Individual: 28; Drug: PCAP814 10 然 Apo 50 然
bRgbLgbRsbRsbRobLgbLsbRgRsmbLsbRgbRsbLsbRsbLsbsbRsbRsbRsbsbsbRsRsmbLsR
sLsbRsbsbRsbRsbRsbRsLsbLsbLsbLsbRsbRsLsbRsbRsbRsLsbRsbRsbsbRsLsRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 165902; End: 170403;
Recording: 13-1; Individual: 29; Drug: PCAP814 10 然 Apo 50 然
bLgbLiRsbLsLsLsmmbLsLebRsbRibRsLsbLsRsLsbRsRsmbRsbsbRibRgbRsLsbLsbReRs
RsmmbRsRsmbRsbLsRsbLjbLsLsmbRsbRgRsRsRsRsmmmmbsbRsbLsbRobLsLgbRiLgLsbL
obLgRsbLsRsRsmbsbRebLebRjbLsLobLsbRgbLsbRsLsbRsbRsbsbRsRsRsmmbLsRgbsbL
gbLgbRsbLcbLsbRgbLgbRcRsmbRhbLebRebRgbLgbLsbLebLsLgbRobRsRsmbLcbRebLsR
sbRgbLsbLsbRsLsbLgbLcbRiRsmbsbLsRsbRsbRsRsRsmmbsbRsRsRsmmbRsRsRsRsmmmb
RgLcbLgbLgbRebLsLsLgLsmbLsbLsbLsbLsbLibRsbRcRsmbRsbRsRebRgbRcLsbLgbLib
LsbLgbLgbLsLsmbLsRsbLsLhbLgbLsbLgbLibRsRsRsmmbRgbRgbLsbLeRsbLjbRhLgbLg
bRiLsbRgbRiRsmbLebLobsbLebLsbLsLgbLsbLgbLgLsbLsLsmbRsbLibRibLoLsmbRsbs
bRsbsbRsbRgbLsbRsbLebLobRgbLgLsbLsLsmbLsbsbLibsbLsbRsLsRsbLebLsLsmbRgb
ReLsbLsLsRsLsLsRsmmbRebRsbsbLib

>ZF Recording 2016-06-02; tW: 300s; Start: 165902; End: 170403;
Recording: 13-1; Individual: 30; Drug: PCAP814 10 然 Apo 50 然
bLeLsbLsLsmbsbsbsbLsbsbsbLsbRsLsbsbRgbRsbLobLgLsbsbsbsbLgLsbRsbRsbLsbR
sbLgbRebLebRsbLsRsbLsLsmbsbsbLsbsbLsRsbRsLsbsbsbRsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 165902; End: 170403;
Recording: 13-1; Individual: 31; Drug: PCAP814 3 然 Apo 50 然
bLcbLcbLhbRcbRgRsmbRjbLibRgbRibRsbRgbRgbRsbRsRsmbRhbRgbRibRsbLgbRiRsmb
RsRibRibLibRcbLsbRibRcbRsbLsbRcbRhbLsbLiLsbLcbLgbLibRsbLsbRhRsRsmmbRib
RibLgbRibLobLgbLebRsbRgbRibRgRsmbRsRsmbLjbRibLcRsbLibLgbLgbRjbLcLsmbLi
LsbRsbLcbRsbRibRsbLcbLcbLgRsLsbRibRhbRgbRgbRgbLjbLcbLibLsbLsbLcbRsbRjb
RhbRgRibLsbRsbRibRebsbRsbLebLiLsbLsbRsbLobRgbRibRgbRiRsmbLobLibRsLsbLs
LsmbLiLsbRsRsmbRjbRcbRibRgbRsRsmbRsbRgRsmbRgbRibRsbRsbRsRcRsmbRgbRgbLs
bRibLsRsbRgbRsRsmbRgLsbRibRgbRibRgbRsLsbRibRgbRsbRsRgbRsbRgbRiRsmbLhbL
obLgLsbLsbLsbLsbRsbRjbRobRiRsmbRgbRcbRibRsRsmbRgbRgbLgbLebLiLsbRgbLibL
sbLibRgbLobRsbRsbLsLsLsmmbLebLsbLgbLgLsbLsLsmbRjbLebRjbRcbRgRsmbRsRsmb
RgbRsRgbRcbRhbRibRibsbRsbRsRcRsmbRiRsmbRcRsmbRsbLsLsLsmmbRgbRcRsmbRgbR
sbRhRsmbRibLibLeLsbLoRsbLsLsmbLcLsmbLsbLibRsLiLsbRjRsmbLcbRjRsmbRhRsmb
RgbRibLcbLhbLsbLibLibRsbRibLibsbLcbLsbRsRsmbRsbRibLcbLsLcbRgbRgbRibLjb
RsbLsLgbsbLcbLibLsbLcbRsbRgbLcbLibLgbRsbsbLgbRgbLgbLgbLsbLiLsbLsRsbRsL
sbRsbRcbRobRsbLgbRsbLsbLgbLiLsbRsbRsbLhbLsbLsbRsRsmbRhbLebLibLibLibRgb
LsbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 165902; End: 170403;
Recording: 13-1; Individual: 32; Drug: PCAP814 3 然 Apo 50 然
bsbLjLsmbRiLsbsbRsbLgbRsbsbLibRsbRjbRhbLjbRsbRibsbRjbRiRsmbLebRsbRsbLj
bRcbLsbRgbLebRhbLjbRsbRibLsbLjLsLsmmbRcbLebLibRsbLgbsbLibRgRsmbRiLsbLj
bLgbLibRsbRgbLcLsmbRjbRjLsbRiLsRsbLhbLjLsmbLsRsbLibLcbLiLsbsbRsbRibRiR
smbRgRsmbRsbRgbRebLsRibLsbLcbRsbLgLsRsbRgLsbLjLgbRsRsmbLhbLsbLhRsbRgbL
cbLcbRgLsbRiRsmbLsbRgRgbLsbRcbRibRibLiLsRsbRsbRgbRsbRsbRiRsmbLsbLeLsbL
iLsbLeRsRsRsmmbReRgbRcbRsbRcbLsbRiRsmbRibLcbRibLcbRsLgbLhLsRsLsbLsbLiL
sLsmbLsRsbLgbsbLsbLiLsbLsbRobRibLiRsRsmbRhRebRsbLgLsbLjLsmbLsbLibRgbLs
bLibRiRsRsmmbRsbRsRsRsmmbRsRsmbRgRsmbLsbRsbRsRsmbRgRsRsmmb

>ZF Recording 2016-06-02; tW: 300s; Start: 165902; End: 170403;
Recording: 13-1; Individual: 33; Drug: PCAP814 3 然 Apo 50 然
bRsbRsbLsbLsLsmbLsbsbRsbLsLsRsmbsbLsbLsbLsbRsLsbLsbsbsbLsbRsbLsbLsbLsb
LsbRsbsbRsbLsbsbsbsbsbsbsbLsbsbsbsbLsLsmbLsbRsLjbLsbsbRsbRsbLsbRsbRsLs
LsRsmbRsLsbRsLsbLsLsmbLsbLsbLsbsbsbRsbsbsbLsbRsLsbLsLsmbsbsbLsbRsLsbRs
bRsbsbRsbRsbsbLsbLsbsbRsbsbsbsbsbsbRsRsmbRgbRgbRsbRsbRibRsbLsLsLsLsmmm
bRsbRsbLsLsmbRiRsmbRsbRsRsmbRsbRsbRsbsbRsbRsbRsbsbsbRsbLsbRsLsbRsbLsRs
bLsRsLsbsbLsbLsbRsbLsbsbsbsbsbsbsbRsLsRsbRsbLsRsLsbsbRsLsRsLsLsmbLsRsL
sLsLsmmbsbsbRsbsbsbLsRsbRsLsbRsbsbLsLsmbRsLsbRiRsmbRsbRsbRsbRsbRsbLsbL
sbLsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 165902; End: 170403;
Recording: 13-1; Individual: 34; Drug: PCAP814 3 然 Apo 50 然
bRgbLsbRsbRibRcbLhbRgbRsbLcbLhbLgbRebLgbRhbRhbRjbLebLgLsbLsbLsbLsbLsbL
sbLsLsmbLsbLgRsRsmbRebRobLsbRsRobRobLgbsbRcbRobRibRiRgRibLeLsbLiLeLsLs
LiLeLsLhLembLeLibRcRiRsRembRebsbRgLsbRgbRsbLsbRsLsbRgRsmbLsbLsbRgbRsbR
ibLoLsmbLsLibReRiReRsmbRoLsbLeLsbLhbLeLgLsbLcRsbLsLobLhLsbRhRibRhbRiLs
bRiRoLibLiLsbLhbLcbRebRobLcbRsbLsbRsRsmbRsbsbsbLsbRsbRsRsmbLebLsbRobLh
LobRjRiRsmbLjbLsLibLsbRjbLebRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 165902; End: 170403;
Recording: 13-1; Individual: 35; Drug: PCAP814 3 然 Apo 50 然
bLsbLsbsbLsRsbLsbLsbLsbRhbLhbsbLsbLsbsbLgbRsLsbLsbLsLsLsmmbLsRsbLgbRgb
LgbLgRsbsbRsRsmbRsbLsbLgbRsLsbLsbLsLsLsmmbLsbLgRsbLjLgbLsbLgbLsbLsbLjL
smbLgRsbRgbLsbLsLsmbLibsbLsbRsbLgLsbLsLsmbLsbLsLsLsLsmmmbLsLsLsmmbLsbL
sbLsbRsbRsbLgbLibLgbLiLsbLsbRsbLsLsmbLiRsbLgbLgRsbLgbLibLsbRgRsmbLgLsb
LgbLsbLgbLsLsmbLjRsRsRsmmbLsLsmbLgbRsLsbLgRsbLgLsLsRsRsLsLsmmmbLibLgbL
gbLibRsbLsbLhLsLsmbLgbLsbLsbLsbLsLsLsmmbLsbLiLsbLsLiRsbRjbLibLgbLgbLiR
sbLibLiRsbLobLsbLoRsbRgbLhLsbLsbLsbRoRsmbRsRsmbsbsbLibLsbLgLsbLibLcbLg
bsbRsbsbLhbsbRsbLsbLsbLibLsbRsLsbLsbLsbRsbLgLsLsLsmmbLgLsbLsbLgRsLsbLs
LsLsLsmmmbLgRsbRgbRsbLsbLsLsmbLgbLgbLsLsLsRsmmbLsLsLsLsLsmmmmbLsLsmbLe
bRibLibLgbLgRsbLibRsbsbLsLsmbLibLsLsmbLsbsbLgbLsLsmbLsbLcLsmbLhbRsbRhb
RsRsmbLobLiLsbLibLibRgRsmbsbsbLibLibLibRsbLcLsLsmmbLiLsbLsbLsLsLsmmbLs
LsmbLsbLsbLgbLgbLhbLgbsbsbsbLebLiLsbRgbLcbLiLsbRsbLsbLcbsbLcLsmbRsRsmb
sbLsbRsbsbLibLobRsbRsRsmbRhbLsLsmbsbLsbLsRsbLsbRsbLiLsbLsLsmbLsbLsbRsb
LgLsLsmbRsbLibLibLsbLsLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 165902; End: 170403;
Recording: 13-1; Individual: 36; Drug: PCAP814 3 然 Apo 50 然
bsbsbsbLsLeRsbsbLibLjLsmbRsRsmbLibLsbLibRsbRiRsRsmmbLgbRgbReRsmbRsRsmb
LibLsbReRsmbRsbLsbLsbRgbRsbRsRgbRsRsRsRsRgmmmbRsRsmbsbLsbsbsbRsRsmbRsR
smbLsbLcbRsbRebRcRsmbLsLsmbLsbRsbReRsRsmmbRsRgbRgbLsbRsLsbLsbRsbRjRsRs
mmbLsRsRsmbLsbsbLcbRsbLibRsbRjRsmbRsbRsbRibLsbRsRsmbRebLsbLjLsmbLiLsbL
iRsLsbRhRsmbLibRebRsbRsRsRsRsmmmbRsbsbsbRgbRsRsRsmmbLsLsRsmbRsbRsbRsRs
RsRsmmmbRsbRsbRsbRsLsbRsbRsRsmbLsRsbRsRsmbRsbRsbRsLsbsbsbRjbLjbLsbsbRs
RsmbsbRsbRsLsbRsRsmbLsLsmbLjbLsbRhbLcbLgbLsbLibLgbRgbRjbRsbLsbLsbRsRsm
bRsLsbRsbLjbRjRsmbsbLjbLsLjbLsbsbLeRsbsbLgbLsbsbsbsbsbLsbRsbsbsbRjbLsR
sbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 165902; End: 170403;
Recording: 13-1; Individual: 37; Drug: PCAP814 1 然 Apo 50 然
bRsbRsRsmbRsbLjbsbsbsbRsbLoLsmbLhbLobLjLsmbsbLsLsLsLsLsLsLsLsLsLsLgRgm
mmmmmmmmbLhRsbRoRsmbsbLcLsLsmmbLobLcbRsbsbsbsbsbsbsbLiRsbRcbRsRsRsmmbs
bRsRsRsRsmmmbRgbLsbsbLsLsLsLsLsLsLsLsLsLsRsRsLsmmmmmmmmmmbRsRsRsmmbRsR
sRsmmbRsRsRsRsRsRsRsRsRsRsmmmmmmmmmbRsbsbsbRsbsbsbRsRsRsRsRsRsRsRsRsRs
RsRsRsRsRsmmmmmmmmmmmmmmbsbRhbLsLibLibLcbLobLobLobLsLsLsLsLsmmmmb

>ZF Recording 2016-06-02; tW: 300s; Start: 165902; End: 170403;
Recording: 13-1; Individual: 38; Drug: PCAP814 1 然 Apo 50 然
bRsbRib

>ZF Recording 2016-06-02; tW: 300s; Start: 165902; End: 170403;
Recording: 13-1; Individual: 39; Drug: PCAP814 1 然 Apo 50 然
bLgLsbLgbLgLgLsbLsLgbLsLsmbLsbLibLsLsRsmbLibLgbRsRsLsmbLibLsbLgLsbLgbL
ibLsbLsLsmbLsbLgbLgbLibLsbLsLsmbLsbLgbLsbLsbLgbLsRsbLgbLsLsmbLsbLsbLib
LsRsbLgbLebLsbRsbLgbRsbLsbLgbLsbLgbLsbLsbLsbLsbLsbLsbLgbRsbLsbLsbLhbLg
bRcbRcbRgbRgbRgbLsLsmbLsbLsLsmbLibLibLibLsbLgbLebRsbLgbRsbLibLsbLgbLsL
smbLsbLibLgbLsbLsbLsbLsbLgbLgbLgbLsbRsbLgbRibRgbLgLsbsbsbRsbLsbRsbRsbR
sbRjb

>ZF Recording 2016-06-02; tW: 300s; Start: 165902; End: 170403;
Recording: 13-1; Individual: 40; Drug: PCAP814 1 然 Apo 50 然
bRibRgbRobLsbRsbRebRsbRsbLsbLjbsbRsbRobLsbRsbLsbRsbLjbLsbRsLob

>ZF Recording 2016-06-02; tW: 300s; Start: 165902; End: 170403;
Recording: 13-1; Individual: 41; Drug: PCAP814 1 然 Apo 50 然
bLsbLsbLsbLsbRsbRsbRebRobRhbLgbLsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 165902; End: 170403;
Recording: 13-1; Individual: 42; Drug: PCAP814 1 然 Apo 50 然
bLgbLsbLsLsLsmmbLsLsmbLsbLsLsLsLsLsLsLsLsLsLsLsLsLsLsmmmmmmmmmmmmmbLib
LsbRgbLibLsbLsLsLsLsmmmbLiLsLsLsmmbLgbLsLsLsmmbLsLsLsLsmmmbsbLsLsLsLsL
sRsmmmmbLgLgbLgbRsbLsLsmbLsbLsbLgbRsRsmbsbsbLsLsLsmmbLsLsmbLsLsmbLsLsm
bLsLsLsmmbLsLsmbLsbRsLsLsLsmmbLsLsLsmmbLsLsLsLsmmmbLsLsLsLsLsLsLsLsmmm
mmmmbLgbLgLsLsLsmmbLsbLsLsRsmbsbLsLsRsmbLsRsbLsLsmbLsbLsLsLsmmbLsLsLsm
mbLsbLsLsLsLsLgLgmmmbLsLsLsLsmmmbLsLsmbLsLsLsLsmmmbLsLibLgbLsbLgLsLsLs
LsLgLsmmmbLgbLsLsmbLsbLsbLsbLsbLsbLgbLibLiLsLsLsmmbLgRsLsbsbLiLsLgbLsL
sLsLsLsLsLsLsLsLsLsLsLsLsmmmmmmmmmmmmmbsbLsLsRsmbLsLsLsLsmmmbLsLsRsLsm
bLsLsRsmbLsbLsLsmbLsLsmbLgLsbLsLebsbRcbRibRebLgbLhLsbLgLsbReRsRsmmbLsb
LgbLsbRgbLsbLsbReRsmbLsbLsLgLgbLgbLgbLsLsmbsbsbRsbLgLsbLsRsLsbLgbLgbLg
bLgLsLsLsmmbLgRsbLsLgbLsLgbLsbsbsbLsLsmbsbLgLsLsmbsbLgLsLsmbLsLsLsLsLs
LgmmmmbLgLsLsLsLsLgmmmbRsbLgLsbLsbLsLsmbLsbLgbLgRsbLsLsmbLiLsbLsbsbLeb
LgbLsLsRsLgmbLsLgLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 165902; End: 170403;
Recording: 13-1; Individual: 43; Drug: Control Apo 50 然
bRgbsbLsbsbsbLsbRsbsbRsbLsbLsbLsbRsbLgbLgbsbRobLjbRobRgRsmbRsLsbRsbRgb
RsbRsbRjbRsbsbRsbRsbRgbRsbRsLsbLsbLsRsbLsbLsbRsbRsbLsLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 165902; End: 170403;
Recording: 13-1; Individual: 44; Drug: Control Apo 50 然
bRsbRsbLibLebLibRcbRgLsbLgRsRcRsmbRsLcRsbRgbRibLsbLobRcRsmbLsLsmbLiRsb
LibRobsbLgbRebRiRsmbRcbRobRebRcRsRsmmbLiLsbLoLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 165902; End: 170403;
Recording: 13-1; Individual: 45; Drug: Control Apo 50 然
bRsbRobLsbLjbLsbRsbLsbRsbRsbRsbLsbLsbLsbRsbLsbRsbLgbLsbRsbRsbRgbLobLcb
RhbLsbRsbLsbRsbRsbRsbRsbLgbRsbRgbRgbLsbRhbLsbLsbLsbLsbRsbRsbRebRgbLsbR
gb

>ZF Recording 2016-06-02; tW: 300s; Start: 165902; End: 170403;
Recording: 13-1; Individual: 46; Drug: Control Apo 50 然
bReRgbRsReRsmbRiReRsmbRsbRiRgReLsbRhRsmbReRsmbRiRsRsmmbsbRsbRsLsbRsbRg
RgbReRsRgRembRsRgRgbLsbRsRsmbRhbRsRebRgRsmbRibRsReRgbRiRgbRgRsmbsbRebR
gLsRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 165902; End: 170403;
Recording: 13-1; Individual: 47; Drug: Control Apo 50 然
bRsbRsRobRsbLsbLsbRobRsbLsbLobLcbLobLebRsbRobLsbRobLebRgbLobRsbLsbLjbR
obLibLcbRobRsbRobRsLobRsbRobLobLsRsLsbReRsmbLsbLsLsmbRobLsRsLobLsReLsb
LsbLsRebRsRsmbRcbRsbLsbLsLsRsmbLebRobRsbLcbLoLsmbLjbRobLobRobRgbLsbRob
LsbRobRsLsRsLcbRsbRebRsbRsbRsbLsbLsbLsbRobLsbRsLoLebLeRsbRsbLsbLsLoLeb
RcbRebRjbRcbRsbLsbLsbLobRebRobLobRcbLjbRebLobRcbLobLsbLsLobLsRsbRsbLcb
RoRsmbRsbRiLsbRobRsbLsRebLobRobRcbLobLobRebRgbRobRgbLsbLebRibRobLsbRob
LsbRebRebRsbLsbRsbLsLsLsmmbLjbLobRsbLsbRebLobRebRsbLobRhLsbRsbLsbRsbRo
bRsbRsbRobLjbRebLjbLjbLsbRsbRsbRjbRcbLcbLobRhbRsbRobLcbLsbLebLobLobLob
RebLsLebRebLibRobLjbRsbRebRsbRsLebLebRgRhbLsbLsbLsbLsbLjLsmbRcRjbLobLe
bLobLebRobRebLobRibLobRgbRjbLobLobLsbRobRebLibRobLibLcbLobRebRibRcbLjb
LjbLobRsbRsbLobLsbRsbLsbLsbRsbLobLobLsbRsbRgbLobRsbLsbRobLsbLsbLeRsbRs
bLsbRsbLobLsbLsbLsLsRsmbRobLsbLebRobRcbLsbRobLebRjbLobRcbLebRcbRobRebR
obRcbLibRebRcbRhbLobRobRobLebRobRsbRebLgbRebRcbRobLjbRsbLcbRebRobRobRo
bLjRjbRsbRsbLsbLsbRcbRobLobRebLjbRobLobRebRsbRjbLsbLebRebLobLsbRsbRsbR
sbRebLobRsbLgbLsbRcbLobLcbRsbLobLcbRsbRibRjbLebRsbRobRebLsbLjbLsbLsbLs
bLobRcbLobLgbLobLobLcbRjbLobRobRcbRcbRsbRsbLebLobLebLobRibRebRcbRcbLeb
LebRsbLsbLcbRobRobLebLobLebLebRcbLjbRobRebLobLebRebLibRobRebRsbLcbRcbL
hbLobRsbRsbLebLsbRobRobRebLjbRsbLsbLgbRsbLsbRobLebLibLsbLsbLebRsbRebRs
bRjbLsbRsbRobRsbLsbRhbLsbRebRobLcbLebRcbLobLobLebRobRcbLsbLobLobLebLeb
RobRebRebLebRobLsbLebRcbLjbRobLgbRobLgbLsbRibRjbLobLobRcbLebRebRcbLsLs
mbLsbRsbLsbRjbRsRsmbLsbLobLsbRjbLsLebRobLsbRsbLjLsmbRobRebRgbRsbRsbLjb
LsbRsbRsbRebLebRcbLobRobLibLgbLibLebRobLhbRcbRebRsbRcbLsbLobRcbLobLobR
ebLsbReRsRsmmbLsbRsbLsbRsbLsbRsbRjbRebLsbRcbLobRcbLebLobLjbLcbRebLsbLh
bRebRobRsbLobRobLsbRjbLebRsbRobRcbRobRobLobRsbLsbRsbLebLsbLsbRjbLsbRsb
RebRsbLjbRsbRebLsbRsbLjbRobRjbRobLobRobLsbLsbLebLobRebLobRcbRobLsbRsbR
cbLgRebLsbLsRsbLcbRsbLsbLebRcbLsbLebLjbRsbRsbRsbLobRsbLsbRebRebLebLobR
cbLobLsbLsbLobRsbRobRebRsbRsbRebLobRobRobRjbRebRsbRsbRebLcLobLobRebLob
LsbLebRjbRobRobLobRobRsbLsbLcbRebRobLcRsbRebLsbRsbLsRsbRobRobRsbLebReb
RoRsmbRebLobRcbRebRobRebLebRobLebLsbLsbRebLjbLebRebLobRobRsbRobLsbRebL
gbLobLobRsbRcbRcbLebRebRjbRcbRebLebLobRsbRebRebLcbRsbRsbRobRobLebRcbRe
bRsbRgbRsbLobLobLsbRjbLebRjb

>ZF Recording 2016-06-02; tW: 300s; Start: 165902; End: 170403;
Recording: 13-1; Individual: 48; Drug: Control Apo 50 然
bsbRsRsRsRimmbLjbLgbsbLsbsbRsbRsRsmbsbsbRsRsLsRsmbsbRsRsLsmbLsLsRgmbRe
bsbRjbRgReRsRsRsLemmmbsbRsbsbsbRsbRsbsbRsbsbRsbRsbsbsbRsbRsbsbLsbsbRsb
RsbRsbLsbRgbRsbReLgbsbLsbLsbRsbLsbsbRsb

